
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-13801-14100*
  '("8-oxo-G" "A-1D" "A-B-E" "A-CDK2" "A-PRC2" "A-allele" "A-related" "A1"
    "A129T" "A134V" "A181-A197" "A2008" "A2274223C3765524T7922612" "A247P"
    "A247P-5" "A265D" "A265V" "A267S" "A2780and" "A2780cis" "A2780cis-shGDF15"
    "A2780cis-shGDF15-1" "A2780cisR" "A437G" "A437G+A581G" "A581G" "A7" "A789N"
    "A86fs" "A9" "A937V" "AA+IAA" "AAAA" "AAAG" "AAO-HNS" "AB209195.1" "AB3"
    "ABBC2" "ABO" "ABSCIEX" "ACAM-2000" "ACAM-luc" "ACTACA" "ACTL10" "AD169"
    "AD169-UL21a-RXL2" "ADAM10-Ct" "ADAM23" "ADR2" "ADVIA" "AEC" "AEPB2" "AER"
    "AF647-conjugated" "AF750-conjugated" "AFF1" "AGC" "AGEGA" "AGKAA" "AH93%"
    "AIC" "AICNL" "AID-core" "AID-αRIM" "AID-αRIM1" "AID-γ-subunit" "AIF1L"
    "AIPC" "AIRNI-AGEAA" "AIRTI" "AKT-S473" "AKT-mediated" "AKT1-miR-149"
    "ALIX-lipid" "ALK5i" "ALND" "ALUs" "AM" "AMBRA" "AMBRA1-PP2A-mediated"
    "AMBRA1-defective" "AMBRA1-knocked-down" "AMP-αRIM-2" "AMPK-family"
    "AMPKΔCBM" "ANCOVA" "ANCSI" "ANKRD27" "ANRNI-AGEAA" "ANRNI-AGKAA"
    "ANRNI-FAKAA" "AOCS" "AP-1-depen-dent" "APM" "AR-LBD"
    "AR-estradiol-stimulated" "AR-ligand" "AR-null" "AR-regulated"
    "AR-transcriptional" "ARE-Luc" "AREG-EGFR-PTEN-null" "ARG1" "ARG2-MTOR2"
    "ARG2-RICTOR-AKT-MTORC1-RPS6KB1" "ARMS-PCR" "ASAP3" "ASCO" "ASD-like"
    "ASDs" "ASO-miR-1228" "ASO-miR-1228-transfected" "ASO-miR-1228-treated"
    "ASPM" "AT1R" "ATCC" "ATM-RAD3-related" "ATMi" "ATOH7" "ATP-binding"
    "ATR-dependent" "ATRX-DNA" "ATRX-RNA" "ATRX-RNA-DNA" "ATRX-RNA-PRC2"
    "ATRX-Repeat" "ATSP-7041" "AU-1" "AU-565" "AU1-tagged" "AU5" "AU5-hShoc2"
    "AUBP" "AVSA" "AYCC" "AZ191" "AZD" "AZD-7762" "AZM" "Ab" "Abcam" "Abdallah"
    "Abrahamsen" "Ac-K-103" "AcK" "AcR" "Actinomycin" "Active-Motif" "Ad-BRCA1"
    "Ad-GFP" "Ad-STK33-C" "Ad-STK33-N" "AdSurp-Hsp70+CIK" "Addgene" "Aerts"
    "Affymetrix" "Africa" "African" "African-American" "African-Americans"
    "African–American" "Afro-Caribbean" "Ag" "Agrocybe" "Akagi" "Akt1" "Akt1-3"
    "Alb-Cre-ER" "Alb-ERT2-Cre" "Alexa" "Alexa-488" "Alexa568" "Alexa568-3"
    "Allanore" "Allen" "Alpha-Screen" "AlphaScreen" "Alzheimer" "Alzheimer's"
    "Alzheimer’s" "Ambra1-defective" "Ambrogini" "Ambry" "Amemiya" "America"
    "American" "Americans" "Amersham" "Amish" "AmpliSeq" "Anglong"
    "Annexin-propidium" "Anolis" "Anselmi" "Aoyagi" "Arabia" "Arden"
    "Arg155–Asp20" "Argyrin" "Armitage" "Arnt-like" "Ashkenazi" "Ashwell"
    "Ashwell-Morell" "Asian" "Asians" "Assam" "Asuragen" "At-risk" "AtKINUa"
    "Atlanta" "Aubaidy" "Austria" "Autism" "Avitabile" "Aviv" "Axin2-rtTA"
    "Axis-Shield" "Az" "AzaC" "A–S1H" "A–S2C" "A–S3C" "A’" "B-Catenin" "B-ZIP"
    "B-crystallin" "B-lymphoid" "B-positive" "B-related" "B-statistics"
    "B-subunit" "B-subunits" "B-type" "B-ultrasound" "B1" "B1-directed" "B16"
    "BACS2" "BAG6" "BAIP3" "BALB" "BARTs" "BAT" "BAT-box" "BAY-11-7082"
    "BBR3464" "BBSs" "BC033528" "BC200" "BCA" "BCAC" "BCAS2-C" "BCAS2-FL"
    "BCAS2-N" "BCCP" "BCL" "BCOR" "BCR-intrinsic" "BCSCs" "BD" "BE1" "BEC-7402"
    "BECN" "BFA" "BH3-domain" "BH3-mimetic" "BH3-mimetics" "BH3-only" "BHK"
    "BIM1" "BIOMED2" "BIR2" "BJ-hTERT" "BKCa-siRNA" "BKV" "BL1" "BLASTN"
    "BLBCs" "BLVRB" "BMI" "BML" "BMMK" "BMN" "BMN-673" "BMS" "BMS-936558"
    "BMS911543" "BN82002" "BN82685" "BOD1" "BRAFwt" "BRC5" "BRCA1-null"
    "BRCA1-proficient" "BRCA1-proficient-MDA-MB-231" "BRCA1-silent"
    "BRCA1→miR-146a→EGFR" "BRCT1-2" "BRCT5-6" "BRD" "BRD-8899" "BRE-luc"
    "BRO1-related" "BROCA" "BSC40" "BT-570" "BUN" "BV" "BYL" "BYL-719"
    "BaL-Luc" "Bager" "Bahamas" "Baiocchi" "Bak-dependent" "Bak-mediated"
    "BamHI" "Banasik" "Bao" "Bar-Sela" "Barbados" "Barrett" "Barrett's"
    "Barros" "Barry" "Bartek" "Baserga" "Batf" "Baumbusch" "Bax"
    "Bax-immunoprecipitates" "Bayesian-inspired" "Bazz" "Bcat" "Bcat-KO"
    "Beckman" "Beclin-1protein" "Beclin-1reduced" "Becton" "Beek" "Begg"
    "Begg's" "Behcet" "Benekli" "Benjamin" "Benjamin-Hochberg" "Benjamini"
    "Benjamini-Hochberg" "Beral" "Berkenpas" "Bernat" "Bertani" "Bethesda"
    "Bgn" "BiL" "Biggs" "Billerica" "Bio" "Bio-Layer" "Bio-Rad" "BioChain"
    "BioDigitalValley" "BioGPS" "BioGRID" "BioMax" "Biolabs" "Bioline"
    "Biologicals" "Biomed2" "Biosafety" "Biosystems" "Biotech" "Biotechnologie"
    "Biotek" "Bis" "Blbp" "Blu557" "Blu577" "Blumenstein" "Boehringer"
    "Bojesen" "Bolton" "Bona" "Bone-Marrow-Derived" "Bonferroni" "Bonome"
    "Bosque" "Boston" "Bowen" "Bowen-Conradi" "Boyden" "Boyle" "Braak"
    "Brachmann" "Brachuyry" "Brachyruy" "Bradner" "Brazil" "Briggs" "Brinker"
    "Brk" "Brodovich" "Brodsky" "Broer" "Broet" "Brower" "Brownlow" "Brunet"
    "Brunn" "Bruton" "Bruton’s" "Btk" "Buchholz" "Burdon" "Burkitt" "Burkitt's"
    "Burnett" "Burnett-Hartman" "Bursać" "Busch" "C-C" "C-CDH1-Substrate"
    "C-YFP-PLK1" "C-a" "C-alpha" "C-c" "C-coactivator"
    "C-coactivator-substrate" "C-d" "C-domain" "C-interacting" "C-interaction"
    "C-lobe" "C-lobes" "C-loop" "C-term" "C-terminally" "C-trap" "C-type" "C-ζ"
    "C113A" "C11orf21" "C173A" "C1si-ready" "C2" "C20orf144" "C226-229A" "C28"
    "C3" "C3H10T1" "C4" "C482R" "C5" "C52A" "C59R+S108N" "C6" "C6-CSAHA"
    "C6-cSAHA" "C7-cSAHA" "C85–C105" "C8orf13" "C8orf13-BLK" "CAAX" "CACGTG"
    "CAEBV" "CAEBV-T" "CAGA-luc" "CAGGCC" "CALGB" "CBD-KD" "CBFA2T2" "CBM-KD"
    "CBP-selective" "CBS-4" "CBS3" "CC-115" "CC-223" "CCDC22" "CCNE"
    "CCR5-gp120" "CCRl" "CCh" "CD147-pcDNA3.1" "CD243" "CD28-activated"
    "CD3-associated" "CD31-immunopositive" "CD44s" "CD44 + " "CD52"
    "CD8-d2EGFP" "CD8a-GFP" "CD8a-d2EGFP-IRES-Nef" "CDC265C" "CDCA2"
    "CDK9-pS175" "CDKN2B-AS1" "CDKNA1" "CDKNA2" "CDSs" "CD–UbPrg" "CELF1"
    "CENP" "CEP55-Tsg101" "CEPH" "CEU" "CFX" "CG-dinucleotides" "CGG" "CGIs"
    "CH040" "CH077" "CH077mCherry" "CHART-seq" "CHI3L2" "CHIP"
    "CHIP-proteasome-mediated" "CHIP-shRNAs" "CHK2*1100delC-expressing"
    "CHK2-virus" "CHMP4-noninteractive" "CI0.1" "CI0.1 " "CI0.5" "CI1" "CI10"
    "CI10 " "CI2" "CI20" "CI40" "CI5" "CI5 " "CI95%" "CICs" "CK1γ" "CK1δ"
    "CK1ε" "CK2-P-XRCC1" "CKI-ε" "CKI-ε-FoxO3" "CKI-ε-mediated" "CKK-8" "CLTC1"
    "CMO2.5" "CMV-Cav-1" "CMVt" "CNVRs" "CNVs" "COBRA" "COG" "COLT" "COMD5"
    "COMMD" "CONTRA" "CORUM" "COS-1" "CP10" "CP17" "CP2139" "CP29" "CP32"
    "CP673451" "CPAF-inhibitor" "CPAT" "CPBP" "CPEB1" "CQQ6" "CR18" "CR25"
    "CRCC4" "CREG1" "CRISPR" "CRL-1739" "CRL-2280" "CRL-5971" "CRL4A" "CRMP2A"
    "CRMP2B" "CRMP2B-A267" "CRPCs" "CRR2" "CS-ROSETTA" "CS-Rosetta" "CSC-like"
    "CSDE1" "CSMD1" "CSNK1" "CSNK1α1" "CSRD" "CT-mapping" "CTAX" "CTAX-P"
    "CTAs" "CUL4A-EGFR-induced" "CV=1.13%" "CV=17.1%" "CV=58.4%" "CV=82" "CW"
    "CX-4945" "CXCLR" "CXCR4-mediated" "CXXC" "CYFRA21-1" "CYL1" "CYP24A"
    "CaMKKβ" "CaP" "CaP-specific" "Caffarelli" "Calabrese" "Calbiochem"
    "Calvin" "CamKIIa" "Camargo" "Cambridge" "Cameroon" "Camilleri-Broet"
    "Campbell" "Canada" "Capillary-chip" "Caramés" "Carl" "Carlsbad"
    "Carpinteria" "Carson" "Cartilage-specific" "Caspase3-postive" "Castrillon"
    "CatI" "Catarino" "Catto" "Caucasians" "Caveolae" "Ccn3" "Cdc16p" "Cdc23p"
    "Cdc27p" "Cdc42-dependent" "Cdc42GDP" "Cdc42GTP" "Cdk4" "Celastraceae"
    "CellQuest" "CellTiter-Glo" "CellTiter-blue" "CentriMo" "Ch10q26.11"
    "ChIP-PCR" "ChIP-PET" "ChIP-qPCR" "ChIP-reChIP" "ChIPSeeqer" "Chakravarty"
    "Chan" "Chemical-Shift-ROSETTA" "Chemicon" "Cheng" "Chi-square" "Chicago"
    "Ching-Shih" "Chip-on-chip" "Chirang" "Chk1-pS296" "Chk1-pS345" "Chk2"
    "Chlamydiaceae" "Chlamydiales" "Cho-Rok" "Chorio" "Chorio-Allantoic" "Chou"
    "Chou-Talalay" "Chr" "ChrX" "Christensen" "Chromatin-immunoprecipitation"
    "Ciclin" "Cin8p" "Cindrova-Davies" "Cip" "Cip1" "Cirhin" "Cirstea"
    "Cis-Dichlorodiamineplatinum" "Cis-Pt" "Cit-neg" "Cit-pos" "Cl" "Clara"
    "CldU" "Clerici" "Cln3" "ClueGO" "ClusPro" "Cochran" "Cochran–Armitage"
    "Cohen" "Collins" "Collun" "Colony-forming" "CompPASS" "ConSite" "Conery"
    "Conradi" "Console" "Continuum" "Coomassie" "CopGFP-Polβ" "Cordenonsi"
    "Correa" "Corynebacterium" "Cowden" "Cox" "Cox-regression" "CpG-DNA"
    "CpG-DNA-stimulated" "Cq" "Craen" "Cre-recombination" "CreDRG" "Cree"
    "Crohn" "Crohn's" "Cruz" "Ct" "Ctrl" "Cu-Zn-superoxide" "Cuffdiff"
    "Cufflinks" "Cuffmerge" "Cul1" "Cullis" "Cy" "CycY" "Cys-X-X-Cys" "Cyst"
    "Czech" "Cα" "Cαs" "Cβ" "Cε" "D-box" "D-peptide" "D-score" "D0-7" "D1-Rac1"
    "D137A" "D187A" "D1D2" "D1D2-Ub-scattering" "D1D2–UbPrg" "D2" "D2-I"
    "D2S1481" "D2S1494E" "D4" "D5" "D67K" "D67K-Ube2w" "D7S522" "D850V" "DALI"
    "DAMP" "DAVID" "DBC" "DBCs" "DBLCL" "DBSs" "DDIWK" "DDP-chemoresistance"
    "DDX1were" "DDX56" "DE" "DEBC" "DEFB122" "DGCR6" "DHL-4" "DHL-6" "DIANA"
    "DIANA-mT" "DIANA-microT" "DIAPH" "DIAPH-mediated" "DIAPH1-dependent"
    "DICHROWEB" "DKAVEYGLIQPNQDGE" "DKC" "DL-221" "DL221" "DLA" "DLD1" "DM2-C"
    "DMBAD" "DMFS" "DNA-SCARS" "DNA-adducts" "DNA-damage-dependent"
    "DNA-damage-inducing" "DNA-damage-treated" "DNA-protein" "DNRs" "DNase-HS"
    "DNase-hypersensitive" "DNase-seq" "DNase1" "DO1" "DPP3" "DPPH" "DPSD"
    "DPYSL2-R" "DPYSL2A" "DPYSL2A-F" "DPYSL2B" "DPYSL2B-F" "DPYSL2C" "DSBs"
    "DSGILS" "DSGXXS" "DSGXXSS" "DSGXXT" "DT29" "DUSP12" "DUSP5-PD" "DUSP–Ubl"
    "Daecke" "Dako" "Dammam" "Dana" "Danes" "Danio" "Danish" "Danvers"
    "Darmstadt" "Datta" "Davies" "Davis" "Deben" "Delhi" "Delta" "Deng"
    "Denmark" "Density-dependent" "Derynck" "Dfit" "Dharmacon" "Diaspora"
    "Dibrugarh" "Dichlorodiamineplatinum" "Dickinson" "Dictyostelium" "Diego"
    "Diels" "Dld1" "Dojindo" "Dominant-negative" "Donati" "Dose–response"
    "Double-mutant" "Double-or" "Down-modulation" "Dox" "Doxo" "Doxo+TNF"
    "Dp53" "Dp53-null" "Dp53ΔC" "Dp53’s" "DpSGFCLDpS" "DpSGILSpS" "DpSGVETpS"
    "DpSGXXSpS" "DpSGXXpS" "Drabkin" "Drabkin's" "Drugbank" "Dual-Glo"
    "Dubowitz" "Dulbecco" "Dulbecco’s" "Dunnett" "Dunnett’s" "Duolink" "Duox2"
    "DuoxA2" "Dupuytren" "Durando" "Dynabeads" "Dynal" "Dzięgielewska-Gęsiak"
    "Düren" "D–S2F" "E-Boxes" "E-Cdk2" "E-box" "E-cadherin"
    "E-cadherin-deficent" "E-catherin" "E-subunit" "E-suppression" "E-type"
    "E-value" "E12" "E14-14.5" "E14.5-E17.5" "E1A" "E204X" "E286fs" "E2A"
    "E2F-only" "E2F-responsive" "E2F3a" "E2L3" "E2~Ub" "E2–E3" "E3-competent"
    "E3-ligase" "E310Q" "E47" "E471G" "E474A" "E5.5" "E6AP-300" "E7" "E7-16"
    "E7L67R" "E8.5" "E9.5" "EBC" "EBD-PD" "EBD–PD" "EBERs" "EBNAs" "EBVaGC"
    "EBVnGC" "ECAC" "ECM-receptor" "ECOG" "ECRs" "ED50-value" "EFGP" "EFL1"
    "EGF-family" "EGF-independence" "EGF-induced" "EGF-like" "EGFR-AS1"
    "EGFR-ligand" "EGFR-positive" "EGFR-triggered" "EGFRwt" "EHEC" "EHT1080"
    "EI4EBP1" "EIF1AX" "EIF2α" "EK-6136" "ELISAPLUS" "EML4-AL" "EMT-like"
    "ENST00000269305" "EP300-mediated" "EPEC" "EQA" "ER+" "ER-Golgi"
    "ER-somatic" "ER-to-Golgi" "ERB-B" "ERBB3-YAP" "ERBB4-YAP"
    "ERBB4-dependence" "ERBB4–YAP" "ERE-firefly" "EREs" "ERFR" "ERK-pathway"
    "ERR" "ERΔTax-inducible" "ERΔtax" "ERα-NEAT1" "ESCRT-0" "ESCRT-I" "ESCRTs"
    "ESCRTs-0" "ESE" "ESS" "ETV7" "EX14" "EZ1" "EZN" "EZN-2968" "Early-Passage"
    "East-Asian" "Ebert" "Ec" "Edelman" "Edge-betweenness" "Egger" "EglN"
    "Ehrlich" "Eighty-eight" "Eighty-four" "Eighty-nine" "Eiken" "El" "El-Far"
    "Eluates" "Elwell" "Eman" "Empore" "EndoH" "EndoMT" "Engel" "Engels"
    "England" "English" "Enhancer" "Enroth" "Env-receptor" "Enzon"
    "Enzyme–Ligand" "EoE" "Epcam" "EpiTect" "Epithelial-Mesenchymal"
    "Epithelial-mesenchymal" "Epithelial–mesenchymal" "ErbB1-4" "ErbB2-ErbB3"
    "ErbB2-dependent" "ErbB2-negative" "ErbB2-overexpressing" "ErbB3-ErbB4"
    "Erk" "Erlangen" "EspF" "EspJ" "EspJ-R" "EspJ28-217" "EspJR79A" "Estado"
    "Europe" "European" "European-descendent" "Evans" "EvilFit" "Expedeon"
    "ExxxLL" "Eμ-Myc" "F-Pα1" "F-Pβ6" "F-T1" "F-Z1" "F-actin" "F1" "F113fs"
    "F19A" "F1WD40" "F1–F6" "F2" "F2-2" "F2-3" "F2-isoprostanes" "F2H" "F3H"
    "F3b" "F4" "F4-1" "F4-11" "F4-6" "F5" "F6" "FA-O" "FA-like" "FACS-mRG"
    "FACSCalibur" "FAD" "FADD-like" "FAK-dependent" "FAKAA" "FANCL_C307A"
    "FASH" "FASL" "FASTSNP" "FDG-PET" "FENG" "FEZF2" "FFDM" "FFPE" "FFQ"
    "FGEGA" "FGF" "FGFR1c" "FGFR2CD" "FGFR2IIIc" "FGKAA" "FIGO" "FIP1L" "FISH"
    "FKBPs" "FL2" "FLAG" "FLAG-8A-NDRG1" "FLAG-Mdm2" "FLAG-NLS-hp53"
    "FLAG-NRF2" "FLAG-NRF2-induced" "FLAG-hp53" "FLT3ITD" "FLT3ITD+ve" "FLT3WT"
    "FLuci" "FNA-HER2" "FNA-HER2-negative" "FNA-HER2-negativity"
    "FNA-HER2-positive" "FNA-HER2s" "FOCUS-Luc" "FOCUS-shCtl" "FOCUS-shFzd2"
    "FOPglow" "FORGE" "FOXM" "FOXM1-EE" "FOXN4" "FOXP-3" "FPKM" "FRA7G" "FRQ"
    "FRS2αP" "FTI-277" "FUBP1" "FUCCI" "FV" "FV10-ASW" "FV1000" "FXS-like"
    "FXXLF" "Famos" "Farber" "Fastenberg" "Fc-CD95L-induced" "FcRγ-chain" "Fcγ"
    "FcγR" "FcγRs" "FdUMP" "Fe" "Fearon" "Febbo" "Ferroni" "Fifty-five"
    "Fifty-nine" "Fifty-seven" "Filder" "Findeisen" "Fine-Gray" "Fine-mapping"
    "Finnish" "First-generation" "Fischer" "Five-day" "Flachsbart" "Flag"
    "Flag-CHIP" "Flag-Polβ" "Flag-tagged-TRAF6" "FlagSUMO1" "Fleiss-Cohen"
    "Fletcher" "Flox" "Flt" "Fluka" "Fluorodeoxyglucose-positron" "Fluoromount"
    "Fluoruracil" "Fluoview" "Fn" "Foley" "Follow-up" "Forkhead-Box"
    "Forty-eight" "Forty-five" "Forty-four" "Forty-seven" "Forty-six"
    "Forty-three" "Forty-two" "FoxO" "Foxq1" "Frac" "Francisco" "Frankfurt"
    "Fraumeni" "Frederiksen" "French" "Fu-rong" "Fumitremorgin" "Furness"
    "Fzd2-driven" "Fzl" "Fzl2-Fyn" "G-allele" "G-band" "G-coated" "G-induced"
    "G-quadruplexes" "G-to-A" "G0" "G1" "G1-G2-G3-G4-G5" "G1-S" "G1-arrest"
    "G1-to-S" "G12C" "G12V" "G1–S" "G2" "G2-M" "G2274223C3765524T7922612"
    "G2274223T3765524C7922612" "G5-G4-G1-G2-G3" "G84-K104" "G84–K104" "G84–K93"
    "G85–C105" "G94–K104" "GAAAG" "GAC" "GADD45α" "GAGGG" "GATOR" "GAW"
    "GB1-fusion" "GBD" "GBM046x" "GBR" "GC-MS" "GCASS" "GCB" "GCB=11" "GCN4"
    "GCS" "GCS-100" "GDF15and" "GF109293X" "GF109320X" "GFP-APC3Δloop"
    "GFP-GSC-shSema3C" "GFP-LC3B" "GFP-NSTCs" "GFP-PC12" "GFP-Polη"
    "GFP-Sp1-4A" "GFP-Sp1-4D" "GFP-fused-APC3Δloop" "GFP-positive" "GFP-tag"
    "GG" "GI" "GICs" "GLOBOCAN" "GMBs" "GMR" "GNSO" "GO-terms" "GPB1" "GPB2"
    "GPCR-Hippo" "GRE" "GRGDS" "GSC923" "GSE11783" "GSE14764" "GSE15622"
    "GSE18520" "GSE19829" "GSE21034" "GSE21035" "GSE26712" "GSE28735" "GSE3149"
    "GSE31684" "GSE32036" "GSE32688" "GSE40419" "GSE50929" "GSE58840"
    "GSE58877" "GSE58878" "GSE60335" "GSE9891" "GSK925293" "GSM935377" "GSR1"
    "GST-CD148DA" "GST-FynSH2" "GST-SAP97-624" "GST-SAP97-SH3" "GST-SAP97wt"
    "GST-STARD9-MD" "GST-STK33-C" "GST-STK33-N" "GST-Tat" "GST-WW" "GST-alone"
    "GST-fusion" "GST-pulldown" "GST-tag" "GSTPs" "GTEx"
    "GTPase-activating-like" "GU149302" "GU149303" "GW14.5-GW18.2" "GW17.5"
    "GWASs" "Gabon" "Gadd45α" "Gag" "Gag-derived" "Gain-of-function" "Garcia"
    "Gaussia" "Gaussian" "Gautier" "GePS" "Gea" "Gel-electrophoretic" "GenMute"
    "GenScript" "Genbank" "Gencode" "GeneJammer" "GeneMANIA" "Genedata"
    "Gene–environment" "Genomatix" "Genome-wide" "Germ-line" "German" "Germany"
    "Giannakou" "Gibbs" "Giemsa" "Giguere" "Girard" "Gleason" "Glinsky"
    "Gln22Stop" "Glostrup" "Glu154–Gln97" "GmbH" "Gokmen" "Gokmen-Polar"
    "Golaghat" "Golic" "Golubovskaya" "Gomez" "Gomez-Herreros" "González"
    "Goth" "Gothenburg" "Gourh" "Gram-negative" "GraphPad" "Grasso" "Grb2"
    "Grb2-mediated" "Grn1" "Groucho" "Group" "Gtr1-GTP" "Gtr2-GDP" "Guangzhou"
    "Gudmundsson" "Gy" "GÖ6983" "Gęsiak" "G→T" "H&E" "H-2-deoxyglucose"
    "H-89-treated" "H-RasV12" "H-bond" "H-bonded" "H-score" "H1" "H135A"
    "H184B5F" "H1963" "H1993" "H2B-Ac" "H3" "H3AcK9" "H3K27" "H3K27-Ac" "H3K56"
    "H3K9" "H3K9-14" "H3K9-Ac" "H3S10" "H3S10P" "H3S10ph" "H3T11" "H3T6"
    "H3T6ph" "H4" "H4K12-Ac" "H4K16" "H4K16ac" "H4K20" "H7" "HA-D4"
    "HA-DDX1and" "HA-Myr-AKT2" "HA-Nck1" "HA-Ubs" "HA-eIF4E-expressing"
    "HA-eIF4E-positive" "HA-immunoprecipitation" "HA-p38DN" "HA-specificity"
    "HA-tag" "HA-β-TrCPΔF" "HADC4" "HAEC" "HAECs" "HARRT" "HATi" "HBEC" "HBECs"
    "HBMG2" "HCC-LM3" "HCC1937B" "HCMV-APCmut-infected" "HCMV-RXL2mut-infected"
    "HCMV-UL21a-RXL" "HCMV-UL21a-RXL2mut" "HCMV-UL21a-RXL2mut-infected"
    "HCMV-WT-infected" "HCMV-ΔUL21a-infected" "HCT11" "HCT116-p53–null" "HDA1"
    "HDAC2-repressive" "HDAC4-null" "HDAC8–ligand" "HEBCS" "HER2-breast"
    "HER2-concordant" "HER2-discordant" "HER2-disease" "HER2-human"
    "HER2-positivity" "HER2-postive" "HER2-status" "HER2CA-NRF2"
    "HER2CA-induced" "HER2CA-mediated" "HERC" "HERC2-F1" "HERC2-F2" "HERC2-F4"
    "HERC2-F5" "HERC2-F6" "HERC2-HCIP" "HERC2-interaction" "HEY" "HGBM" "HGVS"
    "HH550" "HH610" "HI-I-05" "HI-II-14" "HIF-α" "HIF-β" "HJ162" "HJ162-NTSVS"
    "HK" "HK-2-pBrachyury" "HKCL2" "HKL2000" "HL-R" "HLA-DP-DR" "HLI98" "HLMFs"
    "HLMTs" "HLY-1" "HMBG" "HMBG-1-mediated" "HMG2b" "HMGB1-transcripts" "HMLE"
    "HMLEs" "HN" "HNF1-α" "HNK" "HNSCCs" "HNTEP" "HP1-β" "HPRD" "HPRT" "HPS90"
    "HPV-E6b" "HPV6b-E7" "HR-DSBR" "HR-DSBR-competent" "HR=1.60" "HRP-reactive"
    "HRasV12" "HRs" "HSCP" "HSCPs" "HSP90-mediated" "HSP90-regulated"
    "HSP90also" "HSQC" "HSQC-TROSY" "HT-12v3" "HT1080" "HT116" "HT7900" "HTLV"
    "HTLV-1-Tax-expressing" "HTLV-1-associated" "HTLV-1-infected" "HTLV-I"
    "HTori-3" "HUBL" "Hadjiolov" "Haebig" "Haeusler" "Hagenbuchner" "Haiman"
    "Hairy" "Hairy-related" "Half-life" "Halliwell" "Hamaratoglu" "Hamburg"
    "Hammad" "Hans" "HapMap" "HaploReg" "HaploView" "Haque" "Hardy-Weinberg"
    "Hardy–Weinberg" "Hartman" "Hartsfield" "Harvard" "Harvey" "Hashimoto"
    "Hasselbalch" "Hattab" "Haura" "Hawkes" "HbA1c" "Hda1p" "Hdm2L468A" "Hecl"
    "Hee" "Heidelberg" "Hematopathology" "Hemminki" "Henderson"
    "Henderson–Hasselbalch" "Henze" "Hepa1c1c7" "Hepatocyte-specific"
    "Hercules" "Hernandez" "Hernandez-Gea" "Herr" "Herreros" "Hertel" "HgCl"
    "Higaki" "High-Affinity" "High-Dose" "High-dose" "High-grade"
    "High-mobility" "High-risk" "Highly-overexpressed" "Hilgendorf" "Hilska"
    "Hinman" "Hippo" "Hippo-Yap" "Hippocrateaceae" "His-CD20" "His-c-Myc"
    "His-c-Myc-C" "His-c-Myc-N" "His-tag" "His-ubiquitin" "His6GST" "Hispanic"
    "Hispanics" "HistoQuest" "Histone-2B–GFP-expressing" "Hitchcock"
    "Hiwatashi" "Hjelmborg" "Hoadley" "Hochberg" "Hochest" "Hodgkin"
    "Hodgkin's" "Hodgkin’s" "Hoechst" "Hoechst33342" "Hoechst33432" "Hoggart"
    "Hoivik" "Holdsworth-Carson" "Holliday" "HomoMINT" "HomoloGene" "Hotair"
    "Hotspot" "Houston" "Houzet" "Howe" "Howie" "Howley" "Hoxc" "Hoxd" "HuEx"
    "Huang" "Hukka" "Huntington" "Huntington's" "Hurthle" "Hutterite" "Huynh"
    "HxY" "Hydroa" "HyperLasso" "I-II" "I-III" "I-IIIA" "I-IV" "I-block" "I-lV"
    "I-ε" "I1-1" "I1-2" "I108-G129" "I1170N" "IAA" "IC25" "IC50" "IC50s" "ICA"
    "ICA-17043" "ICH" "ICN" "ICON7" "ICON8" "IE" "IE2-86" "IE2-costaining"
    "IEC" "IEC-CA" "IECs" "IEO" "IGF-1-stimulated" "II-III" "II-IV" "III-1"
    "III-13" "III-2" "III-4" "III-IV" "IIIA" "IIIB-IV" "IIIα" "III–IV" "IIa"
    "II–IV" "IK3CA" "IKCMDYGFIKPVS" "IKKβ" "IM+GC" "IMMT" "IMR" "INKa" "INPP"
    "INPP5F-V5" "INSS" "INT" "INT-IEO" "IP-MS" "IPed" "IQ" "IQGAP1-mediated"
    "IQR" "IR-tail" "IR-tails" "IRB" "IRC" "IRC-083864" "IRES-GFP" "IRF27"
    "ISGs" "ISIS183750" "ISRE-LUC" "ISSSTE" "ITAM" "ITC" "ITD" "ITT-Grb2"
    "ITT-like" "IVIG" "IVIS" "IVT" "IVa" "IX71" "IX81" "Iadevaia" "Ig-like"
    "IgA" "IgY" "Igα" "Ile146–Val46" "Illumina" "ImageJ" "ImageStream"
    "Immuno-RNA" "Immuno-precipitation" "ImmunoChip" "Immunohistochemical"
    "Inc" "Infinium" "Inp" "Inp-seq" "Input" "Input-seq" "Instituto"
    "Inter-individual" "InterPro" "Intra-tumour" "Invitrogen" "InvivoGen"
    "Iowa" "Ira1" "Iran" "Isl1" "Iα" "Iε" "Iκb" "I–III" "I–IV" "I–S1N"
    "I–mediated" "J-R" "JA3" "JAK-STAT1" "JAK2-phosphorylation-deficient"
    "JAK2V617F" "JAK2V617F-mutation" "JCRB0254" "JFCR24" "JFCR39" "JHU" "JIANG"
    "JJ78" "JM-a" "JNJ" "JNK-dependent" "JNK-mediated" "JNK2-dependent" "JQ1"
    "Jackson" "Jacobsen" "Jagged" "James" "Japanese" "Jarai" "Jarboui" "Jeang"
    "Jeghers" "Jelinek" "Jena" "Jeong" "Jetset" "Jevtana" "Jewish" "Jin"
    "Jing-an" "Jolla" "Jordan" "Jorhat" "Jose" "Jpx" "Jung" "Junger"
    "Jurkat-ERTax" "Jurkat-Tat-CCR5" "Jurkats" "K-ATPase" "K-activated"
    "K-dependent" "K-fibre" "K-fibres" "K-insensitive" "K-sensitive" "K-to-R"
    "K-α1" "K0" "K107-E128" "K107–E128" "K137-W145" "K206" "K206A" "K244"
    "K244A" "K41R" "K476A" "K61R" "K63A" "K8" "K81R" "K9" "K911fs" "KB-V1"
    "KB14-1" "KBF14-2" "KD-CBM" "KEGG" "KEPI" "KF" "KFB-1" "KFB14-1" "KFB14-2"
    "KGlu" "KIF1A-MD" "KIF1Bβ" "KIM12" "KITD814V" "KITD816V" "KITWT" "KIhI31"
    "KLF3B" "KO240" "KRASmt" "KTM" "KU" "Kaaks" "Kallmann" "Kalra" "Kamrup"
    "Kandoth" "Kang" "Kaplan" "Kaplan-Meier" "Kaplan-Meyer" "Kaplan–Meier"
    "Kaposi" "Kaposi’s" "Karbi" "Karlra" "Karnofsky" "Karube" "Kashmir"
    "Kashmiri" "Kato" "Katz" "Kelch" "Kelch-like" "Kellis" "Kendellen" "Kew"
    "Ki-67" "Ki-67-negative" "Ki-67-positive" "Kim" "Kip" "Kip1p" "Kirsten"
    "Kirsten-K" "Kit-8" "Klacid" "Klebe" "Klenow" "Knippschild" "Knock-down"
    "Knudsen" "Kodak" "Kohrt" "Koller" "Kolmogorov" "Kolmogorov-Smirnov"
    "Konishi" "Koom" "Kops" "Korea" "Korean" "Koren" "Kote" "Kote-Jarai"
    "Kramer" "Krebs" "Kruskal-Wallis" "Krüppel-like" "Kulkarni" "Kumamoto"
    "Kumper" "Kung" "Kungsholmen" "Kuningas" "Kyoto" "K–Q" "L-Myc" "L-NIL" "L1"
    "L10" "L2" "L3" "L301R" "L4" "L5" "L579A" "L7" "L8" "L9" "LAP-STARD9-MD"
    "LC-MS-MS" "LC3-I" "LC3B-II" "LC3BI" "LC3BII" "LC50" "LCBI" "LCBII" "LCC6"
    "LC–MS-MS" "LDCT" "LEF-positive" "LEI" "LEOPARD" "LH7" "LIANG" "LIC" "LISA"
    "LL" "LLL-3" "LMP2A+" "LO" "LOD" "LPBA" "LR" "LRC" "LRRK2-IN1" "LRRK2-PD"
    "LSD1-associated" "LSD1-regulated" "LSM710" "LSU" "LT73" "LTE" "LTED"
    "LTEDs" "LTG" "LTQ-Velos" "LTR-Cav-1" "LTR-IR-GFP-RRE-IR-Cav-1"
    "LTR-IRES-GFP-RRE-IRES-Cav-1" "LTR-IRES-GFP-RRE-IRES-Cav-1~3"
    "LTR-RRE-IR-GFP" "LVI" "LacZ" "Laemmli" "Lakhimpur" "Lancaster" "Landon"
    "Lane2" "Lane3" "Lange" "Lappas" "Large-Zonula" "Large-scale" "Large-sized"
    "Larocca" "Late-onset" "Late-term" "Lats1" "Lauren" "Lauren’s"
    "Leave-one-out" "Lef" "Lefkowitz" "Left-sided" "Lewes" "Lewy" "Leydig" "Li"
    "Li-Fraumeni" "Liangchun" "LigPlot" "Ligand-receptor" "Lingxia"
    "Lipofectamine" "Lit-BM" "Lit-BM-13" "Lit-NB-13" "Liu" "Livant" "LncRNA"
    "Log-rank" "Lonardo" "Long-Evans" "Long-range" "Long-standing" "Loriot"
    "Loss-of-function" "Lu" "Luc+Dox" "Luc2-Tomato" "Lucas" "Luckenwalde"
    "Luminex" "Lumry" "Luria" "Luria–Bertani" "Lv-shBCAS2#1-treated" "LxCxE"
    "Ly-10" "Ly-19" "Ly-4" "Ly-7" "Ly294002=0.53" "Ly294002=0.81"
    "Ly294002=1.09" "Lymphoprep" "Lys-Glu-Asn" "Lysis" "López" "M&M" "M-BMSC"
    "M-BMSCs" "M-MRCA" "M-MSP" "M-MuLV" "M-Nef" "M-Nefs" "M-Vpu" "M-Vpus"
    "M-group" "M-phases" "M-stage" "M-tropic" "M10" "M1M2" "M6" "MAD-MB231"
    "MADT" "MAPK-pathway" "MAPKAP" "MAPKAP2" "MAR345" "MBEN" "MBF"
    "MCF-10A+AREG" "MCF-10A+EGF" "MCF10" "MCF10A-pINDUCER20" "MCF7-#1"
    "MCF7-#2" "MCF7-SCR" "MCF7-shBRCA1#1" "MCF7HER2" "MCF7HER2-MCF7pcDNA"
    "MCF7pcDNA" "MCF7pcDNA3" "MCFDCIS" "MCM2-7" "MCMs" "MDA-MB-231cells"
    "MDA-MB-434" "MDABM468" "MDAMD468" "MDEC" "MDR" "MDSC" "MDV" "MDV-3100"
    "ME1,2" "MECA-32" "MEK-CA" "MEK-CA-induced" "MEK-CA." "MEME" "MES-OV" "MEV"
    "MFEs" "MFI" "MFIs" "MH-12" "MHC-I" "MHCs" "MIRUMIR" "MK-1755" "MKLP"
    "ML171" "MLT10" "MM" "MNK-eIF4E1" "MNK1-AA" "MNK1-TD" "MNK1-phosphonull"
    "MNK1a" "MNS16A" "MOAs" "MP-100" "MPS" "MRCAs" "MRN" "MS" "MS-CompPASS"
    "MSCV" "MSCV-vector" "MSK-IMPACT" "MSKCC" "MTC-TT" "MTEFD1"
    "MTORC2-AKT-MTORC1-RPS6KB1" "MTS" "MTUZ-1" "MUT-MMP-2-3" "MUTZ-1"
    "MUTZ-1and" "MaSPCs" "Macherey" "Macherey-Nagel" "Mad2-low" "Madan"
    "Maddocks" "Mailand" "Maimon" "Malinen" "Mankin" "Mannheim" "Marchini"
    "Markov" "Martinez" "Martinez-Noël" "Mason-Pfizer" "Mass-Extend"
    "MassARRAY" "Massachusetts" "Massague" "Masson" "Masson’s"
    "Mastermind-like" "Masuda" "Mateos" "Material" "Mathas" "Maxi" "Mayo" "Mbp"
    "McBride" "McCole" "McFadden" "McGrath" "McGue" "McKay" "McNamee" "Mdm2"
    "Mdm2-BiLC" "Mdm2-split" "MdmX-overexpressing" "MeDIP" "Mediatech"
    "Megabases" "Meier" "Mendez" "Meniere" "Meniere's" "Menten" "Merck"
    "Mesenchymal-type" "Met-Gly-Ub" "MetaCore" "Methods" "Metzger" "Mexican"
    "Mexico" "Meyer" "Mg-ATP" "Mga" "MiR-149" "MiR-34s" "MiRNA-149" "Mian"
    "Michael" "Michaelis" "Michaelis-Menten" "Michaelis–Menten" "MicroMaxTM"
    "Microsatellite" "Millipore" "Milner" "Mir-660" "Mirus" "Mith-A"
    "MitoTracker" "Miura" "Miyamoto" "Miyazono" "Mmp" "Mmps" "Mnk1" "Mnk2"
    "Mocarski" "Mohammad" "Molleken" "Mondo" "Monosome" "Morell" "Morgan"
    "Morzadec" "Mottonen" "Mspone" "Mspone-binder" "Mst1" "MuTE-positive"
    "Multi" "Multi-Mode" "Munich" "MutantDp53" "Mxd" "Mxd-14" "Myc-DDK-tagged"
    "Myc-gene" "Myc-levels" "MycBoxII" "Myr-AKT-induced" "Myxoid" "N-BMSCs"
    "N-Glycosidase" "N-HA" "N-HPV16" "N-MRCA" "N-MRCAs" "N-Nefs" "N-Nitroso"
    "N-SH3" "N-TAZ2" "N-Ube2w-KK" "N-YFP-REST" "N-acetyl" "N-domain" "N-factor"
    "N-glycosylation" "N-labeled" "N-labelled" "N-linked" "N-lobe"
    "N-myristoylation" "N-nitroso" "N-terminal-Ubiquitome" "N0" "N136-W145"
    "N1IC" "N1IC-high" "N1IC-low" "N3D" "N51I+C59R+S108N" "N548A" "N=10"
    "NADPH" "NBT" "NCBI" "NCBI's" "NCD-fed" "NCI" "NCI-H508" "NCI-H660"
    "NCI-H716" "NCI60" "NCR" "NCRs" "NCSLC" "NCT00949988" "NDA" "NEAT1_1"
    "NEAT1_2" "NEAT1’s" "NECD3" "NEHJ" "NF-E2-like" "NF-kappa-B"
    "NF-kappa-beta-activation" "NF-κB-dependent" "NF-κB-mediated"
    "NF-κB-promoter-driven" "NF-κB-regulated" "NF-κB1" "NFAT2CIP" "NFE2L2-ARE"
    "NFEL2" "NFKB" "NFĸB" "NFκB" "NH" "NH-amide" "NHDF" "NI" "NICD-CBF1-HES"
    "NICD3" "NIEHS" "NL" "NL4-3" "NL4-4-3" "NLENG" "NLENG1-IRES" "NLSs"
    "NM_007294" "NOD-SCID" "NOHA" "NOX-3" "NOXs" "NPo" "NRG1-ERBB4-YAP"
    "NRG1–ERBB4-mediated" "NR_024490" "NS-like" "NSH3" "NTHi" "NTS161–163"
    "NTSVS" "NU-7441" "NUP9" "NVALT" "NVALT-4" "NWGR" "Na" "Naba" "Nagel"
    "Naji" "Naji’s" "Naka" "Nanodrop" "Narla" "Nass" "Neill" "Neils" "Nek"
    "NetPhos-2" "Netherlands" "Neu-Ulm" "Neumüller" "Neurogenin" "Neurospora"
    "Next-generation" "NextGen" "Nf2-Yap" "Ngn" "Nigeria" "Nikon" "Ninety-four"
    "Ninety-two" "Nod-Like" "Nodal" "Node-betweenness" "Noh" "Noonan"
    "Noonan-like" "Nopp140-RNAi" "Norway" "Notch1-3" "Notch1-4"
    "Notch1-depndent" "Nov" "Novex" "Noël" "Nrf2" "Nrf2-ARE" "Nrf2-null"
    "Nrf2–EpRE" "Nthy" "Nthy-ori" "Nu" "Nucleospin" "Nullbasic"
    "Nullbasic-FLAG" "Nullbasic-FLAG-V5-6" "Nullbasic-FLAG-mCherry"
    "Nullbasic-binding" "Nullbasic-induced" "Nullbasic-interacting"
    "Nullbasic-mCherry" "Nullbasic-mediated" "Nutilin-3" "Nyalendo" "Nybo"
    "O-ADCC" "O-CDC" "O-MRCA" "O-MRCA-NTSVS" "O-Nef" "O-Nef-mediated" "O-Nefs"
    "O157" "OAG" "OCFRE" "OCT3" "OHdG" "OMIM" "ONOO" "OR" "OR=0.52" "OR=0.54"
    "OR=0.57" "OR=0.69" "OR=1.23" "OR=1.25" "OR=1.49" "OR=1.93" "OR=2.46"
    "OR=3.33" "OR=3.65" "ORFeome" "ORs" "OSVZ" "Occludens" "Ocludin"
    "Off-target" "Ohio" "Ohshima" "Ojibway" "Ojibway-Cree" "Olsen" "Olson"
    "Olympus" "OmniExpress" "OncodriveFM" "Oncomine" "OriGene" "OriP" "Orissa"
    "Osborne" "Oslo" "Overexpression" "P#1816" "P0" "P1" "P112Q" "P13K"
    "P190Lfs" "P1H4" "P1–P1" "P1–P10" "P2" "P27fs" "P4-P6" "P44A" "P53AIP" "P6"
    "P7" "P7170" "P72R" "P=0.0001" "P=0.0011" "P=0.0035" "P=0.005" "P=0.0051"
    "P=0.0062" "P=0.0063" "P=0.007" "P=0.0070" "P=0.0073" "P=0.0166" "P=0.026"
    "P=0.03" "P=0.032" "P=0.038" "P=0.04" "P=0.045" "P=0.12" "P=0.175"
    "PAK1T423E" "PANDA" "PAPL" "PARPi" "PARTEK" "PAS" "PCR-RFLP" "PCTK"
    "PCTK1-knock-down" "PD-00332991" "PD98509" "PDA" "PDBcode" "PDGF" "PDGF-DD"
    "PDGF-R-β" "PDGFR-based" "PDGFRA-targeted" "PDGFα" "PEA-15-overexpressing"
    "PEQLAB" "PEST" "PET-CT" "PF-0047736" "PF-03084014" "PF-05212384"
    "PF-477736" "PGGFRβ" "PH-like" "PHENIX" "PHLLP" "PI-5-P" "PI3CA"
    "PI3Ki-naïve" "PI3Kis" "PI3Kp110β" "PI5P4Kβ" "PIKCA" "PIP3-mediated"
    "PIP4K2" "PKC-ε" "PKC-ζ" "PKC-ξ" "PKC1" "PKCβ1" "PKCεM486A" "PKCεsi1"
    "PKR-like" "PLAPON" "PLCβ" "PLCβ-and" "PLCγ-isozymes" "PLINK" "PLK1-C-YFP"
    "PLK1siRNAs" "PLKsiRNA" "PLoS" "PMA" "PMI-PenArg" "PMI-s-s-TAT" "PMI-γ"
    "PML-IV" "PNA-PCR" "PNU074654" "POLYPHEN-2" "PPAR-γ2" "PPI"
    "PPIase-activity-deficient" "PPIs" "PPPSPxS" "PPxY" "PQ385AV" "PQC"
    "PQPKKKP" "PR-lncRNA-1" "PR-lncRNA-10" "PR-lncRNA-17" "PR-lncRNA-18"
    "PR-lncRNA-2" "PR-lncRNAs" "PR-negative" "PRC2-RNA" "PRC4" "PRDKC" "PREPTM"
    "PRIDE" "PRKAA-T172" "PRP-PEST" "PSA+Gleason" "PSA+Gleason+Tumor" "PSC-833"
    "PSMA-luc" "PTBF" "PTCK1" "PTEN-competent" "PTEN-null" "PTF" "PTPη"
    "PTR187" "PUA-30" "PXD001461" "PY-20" "PaTu" "PaTu-8988t" "Packings" "Paik"
    "Pakistani" "Palles" "Palmirotta" "Pan-acetyl" "Paneth" "Papillomaviridae"
    "Parkinson" "Parkinson's" "Parkinsonian-like" "Pathania" "Pavlović"
    "Pawlikowska" "Pbk" "Pcorr" "Pdgfd" "PeBoW" "Pearson" "Pederson" "Pei-Jung"
    "Pellatt" "PenArg" "Peng" "PennCNV" "PeproTech" "Pereboom" "PerkinElmer"
    "PerlPrimer" "Peru" "Pervin" "Petersen" "Peutz" "Peutz-Jeghers" "PfATPase6"
    "Pfam" "Pfdhfr" "Pfirrmann" "Pfizer" "Pharoah" "Phaser" "Phe-core" "Phelps"
    "Philadelphia" "Philips" "Phophatase-1" "Phyre" "Pin1-WW" "Pino"
    "Pittsburgh" "Planelles" "Pleckstrin" "Plkl" "Ploemen" "Plp" "Plp-CreERT2"
    "Polekhina" "Polo-box" "Poly-glycine" "PolyJet" "PolyPhen" "Polycomb-group"
    "Polyomaviridae" "Polysomes" "Polβ-KD" "Polβ-proficient" "Polη-proficient"
    "Portman" "Pp" "Pp38MAPK" "Pr3SNP" "Pr3SNP_HR" "PrDos" "Pradesh" "Prdxs"
    "PredictSNP" "Prescott" "Principal-component" "Pro-MMP-9" "Pro-PREPTM"
    "Pro-caspase-8" "Profiler" "ProlineProlineProlineSerine" "Promega"
    "ProteinExpress" "ProteinPilot" "ProteinQuest" "ProteomeXchange"
    "ProtoScript" "Pt-DNA" "Pt1" "PtdIns-3,4" "PtdIns-3,4-P" "PtdIns-4,5-P"
    "Pt–Cl" "Pull-down" "PxPxxxR" "P = 0.008" "P = 0.03" "P = 0.04" "Q1"
    "Q1-Q4" "Q150X" "Q2" "Q3" "Q4" "Q=15.6" "QFI-PCR" "QGY" "QGY-4" "QGY-C"
    "QIAamp" "QKO" "QQD" "QT" "QT-PCR" "QW" "QW-1624F2-2" "Qi" "Qi-ming"
    "Qiagen" "Qo" "Qu" "Qubit" "Quddus" "QuickChange" "Quintanilla"
    "Quintanilla-Martinez" "R-ADCC" "R-CDC" "R-proteins" "R-squared" "R0" "R1"
    "R1192P" "R14A" "R175H" "R2" "R248X" "R285S" "R2N1d-GFP-miR-125a-5p"
    "R2N1d-YFP" "R2d" "R3" "R3128X" "R335X" "R457X" "R5" "R79A" "R7–S118" "R9"
    "RAC-α" "RAD51B8" "RAEB" "RB-intact" "RB1-E2F" "RBP-jk" "RBs" "RCA-I"
    "RDRs" "RE-1" "REG-γ" "REJO" "REMBRANDT" "REST-interaction" "REST4" "REx"
    "RFLP" "RFP-GSC" "RFPL" "RGB-286638" "RGD" "RHG" "RIDD" "RIG-I-Like" "RII"
    "RIKEN" "RING-between-RING-type" "RING–RING" "RIPA" "RLuci" "RMCE" "RMRP"
    "RMSD" "RMSDs" "RNA" "RNA-RNA" "RNA-like" "RNA-seV2" "RNAaseA" "RNAhybrid"
    "RNAi-S2-013" "RO-5963" "ROC-COR-kinase" "RP-HPLC" "RP11-467J12.4"
    "RPA32-coated" "RPCI" "RPCI’s" "RPPAs" "RPS6-S235" "RRE-dependent" "RRLAF"
    "RRLFQ" "RRS" "RTK" "RUNX" "RXL1" "RXRXXS" "RXRγ" "RXXS" "RXXT" "RZZ"
    "Rab1A-AA" "Rab1A-C2S" "Rab1A-GDP" "Rab1A-GTP" "Rac1" "Rac1-GTP"
    "Rac1-independnet" "Rac1Q61L" "Rac1activity" "RacGEFs" "RacGTPases"
    "RacN17" "Rad3" "Rad3-related" "RagC-dependent" "Rajender" "Ramachandran"
    "Ramdas" "Ramjaun" "Raoux" "Raptor-Rheb15" "Ras-8" "Ras-family"
    "RasGAP-expressing" "Rat-16" "Rb-E2F" "Rb-null" "Rbx1" "Re-expression"
    "Re-introduction" "ReBiL’s" "Reactome" "Red-induced" "Red-tetR" "RefSeq"
    "Refmac" "RegulomeDB" "Regulon" "Reissantia" "Remy" "Renard" "Renault"
    "Renilla" "Resistin-shRNA" "Rev" "Rheb-GTP" "Rho-family" "RhoA" "RhoA-GDP"
    "RhoA-GTP" "RhoG" "RhoGDI1" "RhoGDP" "RhoGTP" "RhoN19" "Rhodamine-123"
    "Rieger" "Riener" "Rigaku" "Rip-Cre" "Roche" "Rockville" "Rodriguez" "Roh"
    "Rohon" "Rohon-Beard" "Romero" "Rora" "Rosenbluh" "Roswell" "Rothmund"
    "Rothmund-Thomson" "Rozowsky" "Rph1p" "Rubbi" "Runyan" "Ryu" "S-9" "S-LAM"
    "S-Met" "S-adenosyl-methionine" "S-glutathionylation" "S-oxidation"
    "S-trans" "S-transferase" "S-transferases" "S-transition" "S0–S6" "S1"
    "S1-S2" "S10A" "S10B" "S11" "S11A" "S11B" "S11C" "S11D" "S12A" "S12B"
    "S12C" "S13A" "S146" "S146A" "S15-20" "S1778" "S19-MLC2" "S1C" "S1–S4"
    "S1–S6" "S2-013" "S21" "S235" "S236" "S241fs" "S244" "S261splice" "S2A"
    "S2B" "S2C" "S2D" "S2E" "S2F" "S2G" "S2H" "S2I" "S2J" "S2N" "S3" "S304"
    "S304pS305" "S305" "S312" "S316" "S316pS317" "S317" "S33" "S342" "S352"
    "S3C" "S3iii" "S436A+A437G" "S436A+A437G+K540E" "S436F+A437G" "S462" "S4A"
    "S4B" "S4C" "S4D" "S4E" "S4F" "S4F–S4H" "S52AS88A" "S5A" "S5A-H" "S5A–C"
    "S5D" "S6" "S632" "S633" "S641" "S6A" "S6C" "S6RP" "S7" "S75A" "S7A" "S7B"
    "S7–S12" "S8" "S807" "S811" "S8A" "S8B" "S8C" "S8D" "S8E" "S8F" "S9" "S910"
    "S910A" "S935" "S935A" "S955" "S973" "S976" "S99A" "S9A" "S9C" "S9–S11"
    "SA-β-gal-positive" "SAC-defective" "SAHp53-8" "SAKAA" "SATIII" "SATa"
    "SB431452" "SBE13" "SBF" "SBS1" "SBS2" "SC-3" "SCCOT" "SCF-195" "SCF-286"
    "SCFβ-TrCP" "SCIEX" "SCRATCH1" "SCRATCH2" "SDS-page" "SDS–10%PAGE"
    "SDS–polyacrylamide" "SELDI-TOF" "SEQUEST" "SFCA" "SFCA-PF" "SFV" "SGEAS"
    "SGKAA" "SGKGA" "SGKs" "SH-EPTET21" "SH-SY5Y-ObRb" "SH2-SH3" "SH2-domain"
    "SH2B1β" "SHMT1+SHMT2" "SHMT2α" "SIFT" "SINE" "SIOPEN" "SIRT"
    "SIRT1-Strong" "SIRT1-Tat" "SIRT1-Weak" "SIRT1-high" "SIRT1-low"
    "SIRT1-null" "SIRT1-pecific" "SIRT1-postive" "SIRT1and" "SIVcpz" "SIVtan"
    "SJ-172550" "SKI" "SKI-DLBCL" "SKKU" "SKOV" "SKP1-cullin-F-box" "SL0044"
    "SLNB" "SM22cre" "SMAC-mimetic" "SMP14" "SNAC-K" "SNAILP" "SNAl1"
    "SNF-related" "SNF2-like" "SNO-FLAG-SIRT1" "SNPset" "SNPwas" "SNV" "SNVs"
    "SOC3" "SOX-FLAG-SIRT1" "SPARTA" "SPD" "SPEC" "SPUD" "SQ-MAP" "SQCCs"
    "SQSTM" "SR-IκBα" "SREBP" "SREBP1-c" "SRY-box" "SS632" "SSVV" "SSc"
    "STAIP1" "STARD" "STARD9-MD" "STARD9-MD's" "STAT-related" "STAT3-Y705F-GFP"
    "STAT3-YF" "STATA" "STIL" "STK33-C" "STK33-N" "STK33KO" "STK33Tg" "SU11275"
    "SUM-102" "SUM-1315" "SUM-225" "SUM-229" "SUVmax" "SW-480" "SW55-Ti"
    "SWItch" "SWOG" "SXXS" "SYBR" "SYDY" "SZ" "Sabatini" "Sabo" "SafeStain"
    "Sakoda" "Samavati" "Samuels" "Sanchez" "Sanger" "Saporita" "Sartorius"
    "Saudi" "Scatchard" "Sce" "Schicht" "Schips" "Schizosaccharomyces"
    "Schrader" "Schwachman" "Schwachman-Bodian-Diamond" "Schwachman-Diamond"
    "Sciencell" "Scotland" "Scripps" "Seckel" "Seder" "Seguridad"
    "Self-renewal" "Selleck" "Sema3C–PlexinA2" "Semi-quantification"
    "Semi-quantitative" "SensiMix" "Seoane" "Ser-166" "Ser1000" "Ser159–Asp100"
    "Ser1981" "Ser198Argfs" "Ser199" "Ser204" "Ser209" "Ser21" "Ser217"
    "Ser221" "Ser33" "Ser363" "Ser387" "Ser45" "Ser63-c-Jun" "Ser807" "Ser9"
    "Ser9-phospho-GSK-3β" "SeraMir" "Sertoli" "Servicios" "Setiawan"
    "Seventy-eight" "Sh3" "ShRNA1" "ShSIRT1-1" "ShSIRT1-2" "Shakoori" "Shao"
    "Shapiro" "Shapiro-Wilk" "Sharma" "Shen" "Shete" "Shih" "Shimokado"
    "Short-Hairpin" "Short-term" "SiBIS" "SiCON" "SiGenome" "Sigma–Aldrich"
    "SignaGen" "Simbolo" "Simkania" "SimplyBlue" "SinceTsc1c" "Singh"
    "Single-SNP" "Single-channel" "Single-locus" "Single-point"
    "Single-residue" "Single-site" "Sinha-Datta" "Sinica" "Sip1" "Sir2p"
    "Sirtuin" "Sirtuin-3" "Sixty-eight" "Sixty-five" "Sixty-three" "Sjögren"
    "Sjögren's" "Skibbens" "Skp1" "Skp1-Clu1-F-box" "Slack-Davis" "Sloan"
    "SlowFade" "Smad" "Smad-Bim" "Smad-mediated" "Smad1" "Smad2" "Smads"
    "Smetana" "Smirnov" "Snail" "Snail1acts" "Sociales" "Soerensen" "Softmax"
    "Sondalle" "Sonvilla" "Sos" "Soucek" "Sp1-4A-expressing"
    "Sp1-4D-expressing" "SpSP" "SpSV" "Spanish" "Spearman" "Spearman’s"
    "SpectraMax" "Spitz" "Springer" "Spurdle" "Src" "Src-K295M" "Src-family"
    "SrcSH1" "SrcSH1-K295M" "SrcY527F" "Stacey" "Staf" "Stat3-C" "StataCorp"
    "Steady-State" "Steady-state" "Stedim" "Stephania" "Stillman" "Stockholm"
    "Stopped-flow" "Stratagene" "Strep" "Strep-tag" "Streptactin"
    "Streptavidin-IP" "Structure-function" "Sub-confluent" "Sui" "Sukawa"
    "Sunnyvale" "Supermix" "Supernat" "Sussman" "Suwon" "Suzuki" "Swanson"
    "Sweden" "Swedish" "Switzerland" "Syk-family" "Sánchez" "S " "T-AML" "T-C"
    "T-P-X-K" "T-Pα2" "T-Pβ1" "T-arm-like" "T-category" "T-helper"
    "T-leukaemia" "T-lymphoma-forming" "T-lymphotropic" "T-regulatory"
    "T-stage" "T-to-G" "T1" "T1079-Lats" "T14" "T145A" "T18" "T1B" "T1D"
    "T1–15" "T2" "T202" "T24" "T2DM" "T3" "T32" "T346" "T356" "T366" "T37" "T4"
    "T41" "T41-β-catenin" "T41β-catenin" "T7-pFB" "T8" "TAB-seq" "TAK-TAB"
    "TAK1-TAB1-TRAF6-UBC13" "TAMRA-R" "TAPI-1" "TAR" "TAS" "TAT-PMI" "TATA"
    "TAZ-siRNA-transfected" "TAp63α" "TAp63αFWL" "TAp63β" "TAp63γ" "TAp73"
    "TAp73-depedent" "TAp73α" "TAp73β" "TAp73γ" "TB-7248" "TB40"
    "TB40-specific" "TBF" "TBL" "TBS" "TCACACCT" "TCCCA" "TCGA-25-1328" "TCRαβ"
    "TCRγδ" "TCoB" "TEAD-regulated" "TEAD1-4" "TEFb" "TEV" "TFBSs" "TFIIIA"
    "TGF-RI" "TGF-RII" "TGF-β-receptor" "TGFBs" "TGFb" "TGFp" "TGFβRII" "TGG"
    "TGN46-positve" "TIC" "TKA" "TKDs" "TLE" "TLR-agonist" "TMCB" "TNBCs"
    "TNET" "TNF-induced" "TNFR1-dependent" "TNFR1-mediated" "TNF⍺-induced"
    "TNKLPD" "TO" "TOMTOM" "TOPglow" "TOT" "TPA" "TPB" "TPO-level" "TPO185"
    "TPR10" "TPR12" "TPR13-14" "TPR14" "TPR8" "TPR9" "TRAIL-R"
    "TRAIL-susceptible" "TRAM-34" "TRAM-7" "TRAM-85" "TRANASFAC" "TRANSFAC"
    "TRB" "TRC1" "TRC1-transduced" "TRIMa" "TRNASFAC" "TROSY" "TRPC6-like"
    "TRPC6M131T" "TRβ2" "TS1-33" "TS1–14" "TS1–15" "TS1–20" "TS1–23" "TS1–33"
    "TSC-deficiency-related" "TSC2-null" "TSC2-re-epression"
    "TSC2-re-expressing" "TTAGGG" "TTT" "TUG-1" "TUJ-1" "TUSC"
    "TUSC4-defieicent" "TUSC4-knockdown-only" "TWIST-YB-1" "TXT" "TXTP50"
    "Tail" "Taipei" "Taiwan" "Taiwanese" "Talalay" "Tamra-R9" "Tamura" "Tanaka"
    "Tangier" "Tantalus" "Taqman" "Taqman-CNV" "TargetScan" "TargetScanV5.2"
    "Tarma" "Tarma-R9" "Tartrate" "Tarzana" "Tat" "Tat-dependent"
    "Tat-mediated" "Tat-stimulated" "Taufkirchen" "Tax-expressing"
    "Tax-inducible" "Tax-mediated" "Taxvig" "Taz" "Tc1" "TccP" "Tcf" "Tcof"
    "Temecula" "Ten-eleven" "Tenovin" "Tenovin-1" "Tenovin-6" "Tert" "Tet-SEC4"
    "Tet-off" "Tet-on" "TetO-YAP" "TetO-Yap" "TetON" "Tetrahymena" "Tg"
    "Th-MYCN" "Th17" "Th2" "Th2-cell" "Thailand" "Tham" "Thanatos" "TheTsc1c"
    "Thermo" "Thirty-five" "Thirty-four" "Thirty-one" "Thirty-seven" "Thomas"
    "Thomson" "Thorleifsson" "Thr183" "Thr202" "Thr204" "Thr359" "Thr41" "Thr5"
    "Thr877-to-Ala" "ThreonineProline" "Thumati" "Tiam1shRNA" "Tier2" "Tikoo"
    "Tindall" "Tinsukia" "TirC" "TissueFAXS" "Titen" "TlMP2" "Tm" "ToF" "Tokyo"
    "Tol" "Toll-Like" "Toll-Like-Receptor" "Toll-like" "Tomlinson" "Top-10"
    "Topoisomerasi" "Torregroza" "Tosyl" "Tosyl-L-arginine" "Toyoda"
    "Trabajadores" "TransAm" "TransIT-293" "TransMir" "Trastuzumab" "Traugh"
    "Tremblay" "TriCheck" "TriFast" "Tricostatin" "TriplatinNC" "TripleTof"
    "Tris-HCl" "Tris-borate–EDTA" "Tris–HCl" "Tris–glycine" "Triton-insoluble"
    "Trojan" "Tropix" "Tsai" "Tsc1c" "Tsix" "Tsutani" "Tuazon" "Tuj1" "Tukey"
    "Tukey-Kramer" "Tumarkin" "Tumorscape" "Turnbull" "Twenty-four"
    "Twenty-one" "Twenty-seven" "Twenty-six" "Twenty-three" "Twenty-two"
    "Twist1" "Tx600" "TxT50" "TxTP50" "Tyr-P" "Tyr1007" "Tyr185" "Tyr202"
    "Tyr204" "Tyrer" "TΔS" "TβRI" "U-A" "U-MPS" "U-test" "U1" "U133"
    "U133plus2" "U14680" "U2-OS175" "U20S" "U251" "U251EGFR" "U251EGFRind"
    "U251V" "U2OS175" "U43746" "U73122" "U87EGFR" "U87V" "U95" "UBP" "UCI"
    "UCI-107" "UCL" "UCSC" "UCSC-hg18" "UIC2" "UICC" "UL21a-PR"
    "UL21a-RXL-mutant" "UL21a-RXL-mutant-infected" "UL21a-RXL2-deficient"
    "UL21a-RXL2-mutant" "UL21a-RXL2-revertant" "UL21a-RXL2mut-infected"
    "UN45A-depleted" "UNC45" "UNC45B" "UPNs" "UPRosome" "USA" "UTR&promoter"
    "UTR-luciferase-reporter" "UTRs" "UTUC" "UTUCs" "UUO" "UV-C" "UV-RIP"
    "UV-crosslink" "UV-irradiated" "UV-irradiation" "UW228-Myc-ER" "UbPrg"
    "UbcH5c~Ub" "Ube2t-FANCL_C307A" "Ube2w-131" "Ube2w-131-KK" "Ube2w-KK"
    "Ube2w~Ub" "Ubiquitome" "Ubp8" "Ubs" "Ueda" "Ulm" "Ultra-15" "UniPROBE"
    "UniProt" "Upa" "Uppsala" "Urine-based" "Utah" "V-shaped" "V1" "V2" "V303R"
    "V306R" "V30K" "V5" "V5-tagged" "V600E" "VAD" "VAFs" "VATL" "VDREs"
    "VEGF165" "VLDL" "VS168" "VSs" "VT" "VZ" "Valderrama" "Valderrama-Carvajal"
    "Valta" "Vanderbilt" "VarScan" "VariMax" "Varma" "Varp" "Vav-family" "Vav1"
    "Vehicle-treated" "Velos" "Venn" "Verdoliva" "Vienna" "Vignais" "Vip"
    "Vivaspin" "Vleugels" "Vogt" "Vps2" "W181splice" "W4" "WBC" "WDEC" "WGCNA"
    "WI" "WILMA" "WIP" "WITO" "WRE" "WRE-luc" "WSR1" "WST-1" "WT-374V"
    "WT-BMPR2" "WT-EGFR" "WT-ERK3" "WT-LKB1" "WT-MMP-2-3" "WT-MYC" "WT-STAT3"
    "WT-Ub" "WT145" "WTFAK" "WTKIT" "WTPAK1" "WTp53" "Wa5" "Waddell" "Wald"
    "Wallis" "Waltham" "Warburg" "Warr" "Warthin" "Web-based" "Weinberg"
    "Welch" "Well-developed" "Wellcome" "Werner" "West-European" "Western"
    "Whitesides" "Whitney" "Whole-Body" "Whole-body" "Wierer" "Wilcoxon"
    "Wildey" "Wilk" "Willcox" "WinMDI" "Winooski" "Wnt-5A" "Wnt1-CreDRG"
    "Wnt1-Creembryos" "Wnt5-Fzd2-expressing" "Wnt5a–Fzd2-mediated" "Wnt5b"
    "Wnt5–Fzd2-dependent" "Wnt5–Fzd2-mediated" "Wnt5–Fzd2-signaling" "Wong"
    "Wu" "Wysocka" "X+P" "X-RA" "X-boxbinding" "X-genes" "X-protein" "X-ray"
    "X-rays" "X-shaped" "X4" "XIII" "XP30RO-EGFP-Polη" "XRCC1-m1" "XRCC1-m2"
    "XRCC1-m3" "XRCC1-m4" "XRCC1-m5" "XRCC1and" "XRCC1complex" "XTT" "Xa" "Xba"
    "Xi" "Xie" "Xkid" "Xu" "Y-axis" "Y-box" "Y126splice" "Y15" "Y204" "Y251A"
    "Y2H" "Y319F-I212D" "Y589" "YAP1isan" "YASARA" "YDY" "YFP-SAP97-S642D"
    "YFP-SAP97-T629A" "YFP-SAP97-T629D" "YMW208" "YPT6" "YPT7" "YU2-luc" "YXN"
    "YXNM" "YXXM" "Yamamoto" "Yamamura" "Yanagida" "Yang" "Yap" "Yat" "Yat-sen"
    "YawG" "Yes-associated" "Yong" "Yong-sheng" "York" "Yph1–24" "Yph1–45" "Yu"
    "Yuen" "Yugoslavia" "Yung" "Ywhaz" "Z-Dock" "Z-Score " "Z-VAD" "Z-score"
    "Z-scores" "ZFYV9" "ZL" "ZNF143-free" "ZNF143-mediated" "ZSTK474-naïve"
    "ZYFVE9" "Zeiss" "Zeng" "Zengi" "Zhang" "Zhao" "Zheng" "Zhou" "Zighelboim"
    "ZnF" "ZnF–UBP" "Zorbax" "Zytolight" "ZΨ" "a-catenin" "a2macroglobulin"
    "aA" "aCGH" "aDNA" "aOR" "aa113–317" "aa1613–1781" "aa173-317" "aa173–264"
    "aa173–276" "aa173–317" "aa192–262" "aa1–210" "aa1–260" "aa20-25"
    "aa211–439" "aa238–305" "aa261–514" "above-threshold" "abraxane"
    "absorbance" "acH3K9K14" "acH4K16" "acceptor-stem-like" "acetonitrile–0.2%"
    "acetyl-lysine" "acetylation-defective" "acetylation-mimetic"
    "acetylcholine" "acetyllysine" "achaete" "achaete-scute" "acid-binding"
    "acid-loaded" "acid-mediated" "actetate" "actin-cytoskeleton"
    "actin-remodeling" "activation-loop" "activation-state" "activators"
    "active-like" "active-site" "acute-phase" "acyl" "acyl-carnitines"
    "acyl-enzyme" "acyl-intermediate" "add-back" "adduct" "adducts" "adeno"
    "adenoma-carcinoma" "adenoma–carcinoma" "adhesiveness" "adjuvan" "adnexa"
    "adolescents" "advanced-stage" "aegerita" "aeruginosa" "affimetix"
    "affimetrix" "affinity-classes" "after-load" "afterload" "agar"
    "age-appropriate" "age-associated" "age-dependent" "age-distribution"
    "age-related" "aged-match" "agents-alone" "aggregation-inducing" "agonists"
    "air-liquid" "alarmin" "alcohol-fed" "alcohol-vehicle" "algorithm"
    "algorithms" "all-in-one" "all-or-nothing" "allTsc1c" "alleles"
    "allergy–related" "allograft" "alpha-helical" "alpha-helices"
    "alpha-thalassemia" "althought" "alveoli" "ambra1a" "ambra1b" "amino-acid"
    "amino-terminal" "amino-terminus" "aminoacids" "aminoethyl" "ammonium"
    "amniocytes" "amoeboid" "amplex" "amplicon" "amplicons" "amplimers"
    "amylases" "anaplasia" "anchorage-independent" "andApc" "andArf" "andAsgr2"
    "andMnk" "andSMMC7721" "andSt3gal4" "andTrkC" "andTsc1c" "andin" "andp53"
    "aneuploid" "aneuploidy" "aneurysms" "angio" "anions" "anisotropy"
    "annulus" "anorexia" "anosmia" "antagonise" "antagonist-agonist"
    "anterograde" "anticancer-trials" "anticodon" "antigen"
    "antigen-affinities" "antigen-loss" "antigens" "antimorph" "antimouse"
    "antiparallel" "antiplasmin" "antirabbit" "antisense-like" "antitetherin"
    "antitumour" "anxiety-like" "apical-basal" "aplasia" "apo-structures"
    "apoptose" "apoptosis-proficient" "appropriateness" "arboxy" "areata"
    "arisen" "arrest-independent" "arrest-induced" "arsenic-mediated"
    "arteriosus" "arthroplasty" "artificially-designed" "arylidene" "as-yet"
    "as-yet-unaffected" "aspartate-tryptophan-glycine-arginine" "assette"
    "assoc" "at-risk" "athanogene" "attacinB" "atypia" "autism-like"
    "autism-spectrum" "auto-induction" "auto-inflammatory" "autoanalyzer"
    "autolysosome-like" "automatism" "autoradiography" "autoregulate"
    "autosampler" "average-lived" "avium" "axial" "axis32" "axon" "azalide"
    "azauracil" "azoxymethane" "bB" "back-calculated" "back-to-back"
    "backed-up" "bafilomycin" "basal-enhanced" "basal-like" "basal-type"
    "base-excision" "base-pairings" "basutinib" "bead-bound"
    "beads-on-a-string" "begun" "benn" "benzodiazepinedione" "beta-blockers"
    "beta-lactam" "beta-negative" "beta-sheets" "beta-strand" "beta-strands"
    "beta-tg" "betweenandwas" "betweenness" "betweentitania" "bi" "bi-allelic"
    "bi-cistronic" "bi-directionally" "bi-orientation" "bicultamide" "bicuspid"
    "bidentate" "bidomain" "biliverdin" "binding-domain" "binding-domains"
    "bio-informatics" "bio-layer" "bio-markers" "bio-structural" "bioassay"
    "biochemicals" "biochemists" "biolayer" "biologically-defined"
    "biomarker-chemotherapy" "biomass" "biomolecules" "biopsy-proven"
    "biospecimen" "biospecimens" "bioterrorism" "biotherapy" "biotin-CBM"
    "biotin-tags" "bis-acrylamide" "bis-arylidene" "bisphosphate"
    "bisphsphoate" "blocker" "blockers" "blood-brain" "bone-marrow-derived"
    "bone-tropic" "bony-related" "bortezomib-induced" "bortezomib-treated"
    "bothTsc1c" "bothp53" "box-1" "box-containing" "bp" "bradykinesia"
    "branched-chain" "break-apart" "breakpoint" "breast-cancer-specific"
    "breast-ovarian" "brefeldin-A" "bright-field" "brightfield"
    "broad-spectrum" "broader" "bromoethyl" "bronchioli" "browser" "buchananii"
    "build-up" "built-in" "burnt" "burnt-out" "butnot" "by-products"
    "c-JunSer63" "c-Met-shRNA3" "c110rf30" "cDKO" "cFN" "cIAP" "cMAF" "cNCR"
    "cNCR_HR" "cNCRs" "cSM22cre" "cSMAcre-ER" "caMEK" "calcein-loadable"
    "calciferol" "caliper" "calipers" "calledhp21" "callosum" "calorimetry"
    "camtothecan" "cancer-favourable" "cancer-relevant" "candidate-gene"
    "caner" "cannulas" "cap-binding" "cap-dependent" "cap-pull"
    "capillary-like" "capsid" "carbonyl" "carboplatin-sensitivity"
    "carboxycytosine" "carboxyfluorescein" "carboxyl" "carboxyl-terminal"
    "carboxymethoxyphenyl" "cardia" "cardiac-specific" "cardiomyopathies"
    "cargo-loaded" "carinii" "carnitine" "carnitines" "carotid" "carriers"
    "cartilage-specific" "case-control" "case-controlled" "case-only"
    "case–control" "caspase-3-like" "castPCR" "castaneus" "catabolizes"
    "catalytically-defective" "catch-up" "catenation-challenged"
    "catenation-dependent" "catenation-sensitive" "catenation-triggered"
    "catenin-based" "catherin" "cause-and-effect" "ccRCC" "ccRCCs" "ccl2"
    "cdk2-binding-domain" "celiac" "cell-autonomous" "cell-cycle-related"
    "cell-density" "cell-intrinsic" "cell-of-origin" "cell-permeable"
    "cell-to-cell" "cell-type-specific" "celllines" "cells" "cellular-context"
    "center-square" "central-south" "centromere" "cerebellum" "cerevisiae"
    "cfDNA" "cfosEGFP" "channel-dependent" "channel-forming" "chaperon-like"
    "charcoal-stripped" "charcoal-treated" "cheaper" "checkpoint-associated"
    "checkpoint-component" "checkpoint-dependent" "checkpoint-mediated" "chemo"
    "chemo-immunotherapy" "chemo-sensitivity" "chemoattractant"
    "chemoradiationand" "chemoradiotherapy" "chemoresistant" "chemoresponse"
    "chemotype" "chi-square" "childhood-onset" "chloromethyl" "choline"
    "chordates" "chosen" "chr11q13.5" "chr12q13.3" "chr14q12" "chr19"
    "chr19q13.11" "chr2p23.1" "chromatid" "chromatids" "chromatin-remodeling"
    "chromo-some" "chromosome-associated" "chromosome-specific"
    "circadian-regulated" "circuitry" "cis-diammineplatinum" "cisTarget"
    "cisplatin-sentitive" "cisplatin–GSH" "cistromes" "class-1" "class-3"
    "classifier" "clean-up" "clear-cell" "clear-cut" "clearer"
    "clinic-pathologic" "clinic-pathological" "clinically-available"
    "clinically-relevant" "clinicaltrials" "clinicians" "clinico"
    "clinico-pathological" "clinicopathological-feature"
    "clinicopathological-features" "clinicopathologically-matched"
    "clone-to-clone" "closed-hand" "cm–100" "coactivate" "coactivates"
    "coactivator-1α" "coactivator-dependent" "cobblestone-like" "codon"
    "codon72" "codons" "coeliac" "coiled-coil" "cold-shock" "cold-treated"
    "cold-treatment" "coli" "collagen-like" "collagens" "collapsin"
    "colonocytes" "colonoscopy" "colony-formation" "colony-forming"
    "colorectomy" "colorectum" "colour-coded" "combination-induced"
    "combination-shTEX14+shSCYL1" "comlex" "commonest" "comorbid" "compacta"
    "complete-case" "complex-like" "complexs" "composites" "comprison"
    "comutations" "concatemer" "concatemers" "concave-up" "condensate"
    "conditionalTsc1" "conductance" "condyle" "conformance" "confounders"
    "consensus-binding" "contact-dependent" "continuum" "contributs" "contries"
    "control-shRNAs" "control-siRNA-transfected" "control-siRNA-treated"
    "controlApc" "copy-number" "copy-number-variations" "coregulators"
    "correlationship" "corticosteroids" "cosediments" "cost-effective"
    "cost-effectively" "cost-effectiveness" "covalently-dimerized" "covariate"
    "covariates" "coworkers" "crassa" "cribrosa" "cross-activates"
    "cross-hybridization" "cross-over" "cross-phosphorylate" "cross-react"
    "cross-reacts" "cross-regulate" "cross-resistance" "cross-section"
    "cross-sectional" "cross-sectioned" "cross-species" "crossover"
    "crosspeaks" "cryosections" "cryptochrome" "cryptorchid" "cryptozoospermia"
    "crypt–villus" "crystal-packing" "ctDNA" "cuboidal-like" "cullin-4A"
    "cullin-RING" "cullin-RING-like" "current-smoker" "curvatures" "cut-off"
    "cut-offs" "cut-out" "cyan" "cycinE2" "cyclin-B1-Cdk1" "cyclin-R42A-GFP"
    "cycloA" "cyclodextrin" "cyclohexanone" "cycloheximide-chase"
    "cyclophillin" "cyclosqualenoids" "cyclotide" "cytokine-like" "cytology"
    "cytomembrane" "cytoskeletal-triggered" "cytosplasm" "d-quantitation"
    "d2EGFP" "dEGFR" "dHJ" "dI-dC" "dKDM5" "dL" "dMnt" "dRAB1" "dRP" "dS"
    "dS6K" "dVpu" "damage-apoptosis" "damage-associated" "damage-based"
    "damage-dependent" "damage-independent" "damage-induced" "damage-inducible"
    "damage-inducing" "damage-repair" "damage-tolerance" "damage–induced"
    "damage–inducible" "dao-5" "dark-stained" "dasatinib-treated"
    "data-dependent" "dataset" "datasets" "dbSNP" "ddPCR" "de-condensation"
    "de-differentiate" "de-escalation" "de-expression" "de-identified"
    "de-phoshorylated" "de-regulated" "de-regulation" "de-repress"
    "de-repressed" "de-repression" "de-stabilization" "deaths" "decapo"
    "decidua" "decile" "deciles" "deconvolve" "dedifferentiate" "deep-brain"
    "deeper" "degradation-competent" "degree-controlled" "degron" "del0"
    "del339FS" "delE11" "delavayi" "deleter" "delta199" "denaturants"
    "density-dependent" "deoxynucleotidyl" "deoxyuridine" "depolarises"
    "depolymerise" "depolymerizers" "derivate" "descriptors" "destabilises"
    "detoxifiers" "developmental-specific" "di-hydro-testosterone"
    "di-nucleotide" "diGly-antibody" "diaminopentane" "diammineplatinum"
    "diazadicyclo" "dibutyrate" "dicarboxaldehyde" "dichloride"
    "dichlorodihydrofluorescein" "dichotonomies" "dichroism" "dideoxy"
    "diencephalon" "diet-induced" "diffuse-type" "diffusion-controlled"
    "difluoride" "digoxygenin" "dihydrochloride" "dihydropteridinone"
    "dihydropyrene" "dihydroxy" "dihydroxyphenylglycine" "dihydroxyvitamin"
    "diluents" "dimercaptans" "dimerises" "dimerization-defective" "dimorphism"
    "dinucleotides" "dioxopiperazine" "dioxygenases" "dipeptidyl" "diphenylene"
    "diphosphate" "diploid" "diptherium" "dis" "disbalance" "discoideum"
    "discoidin" "disconcordance" "discrepant" "disialoganglioside"
    "disinhibits" "disquilibrium" "disrupter" "disruptors"
    "distant-metastasis-free" "dithiocarbamate" "doi" "domain-A"
    "domain-domain" "domain-only" "domain-peptide" "dominant-negative"
    "dominant-positive" "donor-recipient" "dormancy" "dosage-dependent"
    "dosage-sensitive" "dose-and" "dose-dependency" "dose-dependently"
    "dose-finding" "dose-intensive" "dose-response" "dose–response" "dot-plot"
    "double-filter" "double-functional" "double-hairpin" "double-knockout"
    "double-mutant" "double-mutation" "double-null" "double-strand" "doublings"
    "down-modulated" "down-modulation" "down-stream" "downregulators"
    "downstrem" "doxycycline-tunable" "doxycyline" "drawn" "drop-outs"
    "droplet" "droplets" "drug-naïve" "drug-response" "drug-sensitivity"
    "dsDNA-ATRX-RNA" "du" "dual-immunoprecipitation" "dual-role" "ducts"
    "ductus" "duplexes" "dural" "dwarfism" "dyphenylpricryl"
    "dyphenylpricryl-hydrazine" "dyskinesia" "dyslipidemia" "dysphagia"
    "dysplasia" "eIF3–HERC2" "eIF4E-OFF" "eIF4E-cap" "eIF4E-dependent"
    "eIF4E1-S209" "eIF4E1-S209A" "eIF4E1-S209D" "eIF4E1-cap-mediated"
    "eIF4E1-driven" "eIF4E1-eIF4E3" "eIF4E1-mediated" "eIF4E2-directed"
    "eIF4E2-modulated" "eIF4E3-D199" "eIF4E3-driven" "eIF4F-3" "eNOSmRNA"
    "eQTL" "early-late" "early-mid" "early-onset" "early-passage" "early-phase"
    "early-response" "early-stage" "easy-to-perform" "ections" "ectodomain"
    "ectodomains" "eczema-like" "ed" "edema" "edge-betweenness" "egulators"
    "eigengene" "eigenvectors" "eight-cell" "ele" "elec" "electrochemotherapy"
    "electron-dense" "electron-transfer" "electrophysiology" "element-binding"
    "eluate" "embryoid" "embryonic-related" "emphasises"
    "empirically-controlled" "empty-vector-transfected" "encephalomyelitis"
    "end-on" "end-stage" "end-to-end" "endocrinopathies" "endoderm"
    "endomethrium" "endometria" "endometrioid" "endometrium" "endophthalmitis"
    "endoscopies" "endoscopy" "endothelial-mesenchymal" "endotoxemia"
    "endpoint" "endpoints" "endproducts" "ene" "ent" "enterocityc" "enthalpies"
    "enthalpy" "enthalpy–entropy" "entropies" "entropy" "enzyme-DNA"
    "enzyme-ligand" "enzyme–ligand" "enzyme–substrate" "eosin" "eosinophilia"
    "eosinophils" "epiphenomenon" "epipodophyllotoxin" "epithelia"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-pancreatic"
    "epithelial-to-mesenchymal" "epithelial–mesenchymal" "epithelium"
    "epithelium-like" "eq" "erature" "erial" "erminus" "error-attachments"
    "erythrocytes" "erythrocythemia" "estrogen-response-element" "et"
    "ethoxyphenyl" "etoposid" "etopside" "et " "euglycemia" "ever-smoker"
    "everyTsc1c" "evolutionarily-conserved" "ex" "ex-smokers" "exRNA"
    "exocrine" "exoenzyme" "exome" "exomes" "exon-level" "exons" "exons-1–2"
    "experimentally-driven" "expressers" "expression=0.21±0.08"
    "expression=0.38±0.2" "expression=0.54±0.35" "extra-genomic"
    "extra-nuclear" "extra-placental" "extra-ribosomal" "extra-thoracic"
    "extracellular-signal" "extracted-ion" "ex " "factor-1" "factor-2"
    "fail-alignment" "fail-attachments" "failsafe" "falciparum" "fallen"
    "fallot" "false-positives" "false-positivity" "family-wise" "far-reaching"
    "fast-exchange" "fast-growing" "fatiga" "fatpads" "feed-back" "feedforward"
    "female-specific" "fertility-proven" "fibroblast-like" "fibroblastoid"
    "fibrosus" "fifty-six" "filipodia" "fill-in" "fine-needle" "fine-tune"
    "fine-tuned" "fine-tuner" "fine-tuning" "finger-like" "firewall"
    "first-generation" "first-line" "first-order" "first-tier" "five-year"
    "fixed-cell" "flash-frozen" "flavonoid" "flip-flop" "flow-cytometric"
    "flufenamate" "fluid-phase" "fluorescent-labeled" "fluoresces"
    "fluorine-18" "fluorochinolones" "fluorodeoxyglucose"
    "fluorodeoxyglucose-positron" "fluorometer" "fluorophore"
    "fluorouracil-epirubicin-cyclophosphamide" "fms-like" "fold-increase"
    "folic" "follicles" "follow-up" "followed-up" "forebrain" "forin"
    "fork-induced" "fork-inducing" "formazan" "formulaThis" "formylcytosine"
    "forwas" "foscarnet" "foskolin" "four-molecule" "four-point-one"
    "four-stranded" "four-subunit" "frac" "frailer" "frame-shift" "frameshift"
    "freeze–thaw" "fresh-cut" "fromApc" "fromAsgr2" "fromEif4e" "fromSt3gal4"
    "fromTsc1c" "front-line" "front-rear" "frozen" "fulminant"
    "fulvestrant-treated" "furan-4,5-dione" "fusion-tag" "gB" "gDNA"
    "gain-of-function" "gain-of-functions" "galectin" "gallbladder"
    "gastrectomy" "gastro" "gastro-esophageal" "gastro-oesophageal"
    "gatekeeper" "gelatinizes" "gemcitibine" "gender-specific" "gene-2"
    "gene-body" "gene-by-gene" "gene-dense" "gene-environment" "gene-gene"
    "gene-knock" "gene-level" "gene-metabolite" "gene-regulatory"
    "gene-rich-regions" "gene-therapy" "gene-to-gene" "genetic-based"
    "genetic–clinicopathologic" "gene–environment" "gene–mortality" "genic"
    "geninstein" "genome-scale" "genome-wide" "genotoxic-induced"
    "genotype-phenotype" "genotypically-targeted" "geranylgeranylacetone"
    "germ-line" "germline" "gestalt" "gingivalis" "glia" "glomeruli"
    "glomerulonephritis" "glucopyranoside" "glucorcorticoid"
    "glucose-deprivation-induced" "glucose-insulin" "glutamine-ADP" "glutamyl"
    "glutathione-sepharose" "glutatione" "glycan" "glycemia" "glycogen-mimic"
    "glycosoaminoglycans" "goes" "gone" "gossypol" "gpb1" "gpb2"
    "gram-negative" "greater" "greater-than-monomer" "greatest" "groupTsc1c"
    "growth-permissive" "growth-regulatory" "growth-stimulatory"
    "growth-suppressive" "gt" "guanylate" "guanylyl" "guilt-by-association"
    "guilt-by-profiling" "gut-associated" "h-treatment" "hA" "hARG1" "hA–hI"
    "hChk1" "hCry1" "hCycT1" "hESCs" "hIRE1" "hIgG1" "hMeDIP" "hORFeome" "hPrp"
    "hPrp19" "hSer20" "hShoc2" "hTS–RNA" "hTS–TS1–33" "hTert" "hU6" "hUNG-DNA"
    "hUTP14a" "hUTP14c" "hUTP4" "haRAS" "half-consensus" "half-dimer"
    "half-life" "half-lives" "half-of-the-sites" "half-site" "hallmarker"
    "hand-over" "handTsc1c" "handside" "haplo" "haplo-insufficiencies"
    "haplo-insufficiency" "haplo-insufficient" "head-and-neck" "head-to-tail"
    "heart-shape" "heart-specific" "heavier" "heavy-smoking" "helices" "helix"
    "helix-1" "helix-3" "helix-4" "helix-5" "helix-loop-helix" "helix-to-coil"
    "helix-α3" "helix–loop–helix" "hemagglutinin-tag" "hematoxylin-eosin"
    "hemolysates" "hepatocyte-specific" "hepatocyte-speciﬁc" "hepatoid"
    "heptad" "heptamer" "heregulin-ErbB" "heregulin-ErbB4" "heritages"
    "herpesvirus-5" "hetNOE" "hetero" "hetero-dimer" "hetero-dimers"
    "hetero-oligomeric" "heterotrimer" "heterozygote" "hetorodimers" "hexamer"
    "hg18" "hg19" "hidden" "high-FGF8-expressing" "high-MOI" "high-affinity"
    "high-confidence" "high-degree" "high-density" "high-dose"
    "high-expression" "high-fidelity" "high-grade" "high-invasion" "high-level"
    "high-mobility" "high-multiplicity" "high-priority" "high-quality"
    "high-resolution" "high-risk" "high-score" "higher-energy" "higher-grade"
    "higher–molecular" "highest-quartile" "highly-induced" "hindbrain"
    "hippo-campal" "hippocampi" "histochemistry" "histologically-confirmed"
    "histologies" "histology" "histone-3" "histone-deactylase" "histopathology"
    "histoscore" "histotype" "histotypes" "hitherto-unreported" "hoc"
    "holo-APC" "holoenzymes" "homo-oligomerize" "homogenates" "homolog"
    "homolog-1" "homologies" "homologs" "homomer" "homozygote" "homozygotes"
    "hormone-receptor" "hormone-receptor-positive" "hormone-related" "hormones"
    "host-protective" "host-response" "host-targeted" "host–pathogen"
    "hot-spot" "hotspots" "hp53's" "hr" "hr " "hsa-miR-122-5p"
    "hsa-miR-1228-5p" "hsa-miR-125a-5p" "hsa-miR-134" "hsa-miR-141-3p"
    "hsa-miR-146b-3p" "hsa-miR-151-3p" "hsa-miR-155" "hsa-miR-181b"
    "hsa-miR-181c" "hsa-miR-192-5p" "hsa-miR-193a-5p" "hsa-miR-194"
    "hsa-miR-199a-5p" "hsa-miR-205" "hsa-miR-206" "hsa-miR-218"
    "hsa-miR-26a-5p" "hsa-miR-30a" "hsa-miR-433-3p" "hsa-miR-486-5p"
    "hsa-miR-503" "hsa-miR-518a-3p" "hsa-miR-520c-3p" "hsa-miR-7a" "hsa-miR-7b"
    "hsa-mir-1273a" "human-Polβ" "human-XRCC1" "hundred
seventy-one"
    "hydralazine-treatedTsc1c" "hydrazide" "hydrogen-bonds" "hydroxamate-SAHA"
    "hydroxy" "hydroxybutyloxime" "hydroxylase-deficient"
    "hydroxylase-independent" "hydroxymethylcytosine" "hydroxynonyl"
    "hyper-IgE" "hyper-proliferation" "hyper-replication" "hyperaminoacidemia"
    "hyperinsulinemia" "hyperinsulinemia-euglycemia"
    "hyperinsulinemic-euglycemic" "hyperoxia" "hyperproliferate"
    "hyperresponsiveness" "hypo-methylation" "hypodiploid" "hypoglycaemia"
    "hypoglycemia" "hypomorph" "hypomorphs" "hypopharynx" "hyposmia"
    "hypovolemia" "iCLIPS" "iCOGS" "iSHMT" "iSHMT1" "iSHMT1+2" "iSHMT1+iSHMT2"
    "iSHMT2" "iSHMTs" "iSelect" "iTaq" "ice-cold" "identifier" "igh-confidence"
    "ii" "iii" "ike" "ill-defined" "imatinib-naïve" "imidazole"
    "immediate-early" "immune-competent" "immune-deficient" "immune-effector"
    "immune-mediated" "immune-modulatory" "immune-precipitation" "immuno-blot"
    "immuno-complex" "immuno-histochemistry" "immunoassay" "immunocomplex"
    "immunocomplexes" "immunocytochemistry" "immunodeficiency-associated"
    "immunoglobulin" "immunoglobulin-like" "immunohistochemistry"
    "immunophilins" "immunoprecipitaiton" "immunoreactions" "immunostrategies"
    "immunotherapies" "immunotherapy" "in-depth" "in-frame" "in-house"
    "in-line" "in-situ" "in-turn" "in-vitro" "in-vivo" "inAsgr2" "inEif4e"
    "inFmr1" "inMnk" "inSNP" "inSirt1" "inSt3gal4" "inTsc1c" "inactive-like"
    "inary" "increasesthe" "indel" "indels" "independently-derived"
    "independnet" "indirectly-related-at-best" "individuate" "indole-2-one"
    "induced-sensitization" "inefficacy" "inertness" "infection-induced"
    "infections" "infectiousness" "inflammation-associated"
    "inflammation-induced" "inflammation-like" "inflammation-responsive"
    "informatics-based" "information-gain" "ingle" "inh-II" "inhibitionn"
    "inhibitor-1" "inhibitor-17-AAG" "inhp21" "injectant" "injectino" "inocula"
    "inositol-1,4" "inositol-5-phosphatase" "inotuzumab" "inpuc" "input-output"
    "inside-out" "insulin-induced" "insulin-mediated" "insulin-stimulated"
    "intactness" "integrant" "integrants" "integrin-ligand" "inter-SH2"
    "inter-cellular" "inter-centromere" "inter-chromosomal"
    "inter-connectivity" "inter-domain" "inter-individual" "inter-kinetochore"
    "inter-mouse" "inter-person" "inter-regulatory" "inter-strand"
    "inter-subunit" "inter-tumor" "inter-tumoral" "interaction-defective"
    "interactions" "interactome" "interactomes" "interacton" "interchip"
    "interferometry" "interferon-alpha2" "intermediate-risk"
    "intermediate-slow" "intermembrane" "interolog" "interphosphate"
    "interquartile" "interstrand" "intestinal-specific" "intestinal-type"
    "intestine-specific" "intima-media" "intitania" "intoAsgr2" "intra"
    "intra-S" "intra-amniotic" "intra-articular" "intra-cardiac"
    "intra-individual" "intra-membrane" "intra-platelet" "intra-strand"
    "intra-tumoral" "intracardiac" "intrachip" "intramembrane" "intraperson"
    "intrastrand" "intron" "intronless" "introns" "invaginations" "invariant"
    "iodoacetamide" "ionic" "ip53" "iquitin" "ird5" "irradiation-induced"
    "ischemia-reperfusion" "isobutylmethylxanthine" "isoenzyme" "isoenzymes"
    "isopropyl" "isotype" "isotypes" "isozyme" "issue-context" "iv" "ivs"
    "ivs8" "iκB-α" "jk" "jumeaux" "k-fiber" "k-fibers" "kME"
    "kappa-light-chain-enhancer" "kappabeta" "karyotype" "karyotypes" "kbp"
    "kcal" "kd" "kelch-like" "kg" "kilobases" "kilocalories" "kinas"
    "kinase-substrate" "kinesin-10" "kinesin-3" "kinesin-like"
    "kinesin–microtubule" "kinetochore-MT" "kinetochore-to-pole" "kinetochores"
    "kinome" "kinome-wide" "knock-down" "knock-in" "knocked-down" "knockin"
    "knocking-down" "knownTP53" "labor-intensive" "laborations" "lac"
    "lactones" "laevis" "lamina" "lane1" "large-budded" "large-cell"
    "large-diameter" "large-scale" "large-size" "laser-induced"
    "laser-irradiated" "late-onset" "late-passage" "late-stage" "later-stage"
    "lateral-sliding" "lavage" "least-mean-square" "left-sided" "left–right"
    "lentiviral-expressed" "lentiviral-mediated" "let-7a" "let-7a-2"
    "let-7a-3p" "leucyl" "leveles" "levels" "library-derived"
    "library-transduced" "life-long" "lifespan" "ligand-receptor" "light-dark"
    "like-ECH-associated" "limb-girdle" "limma" "lincRNA-RoR" "lincRNA-p21"
    "lineage-specification" "lipid-raft" "lipid-rafts" "lipoatrophy"
    "lipopolysaccharide" "literature-based" "literature-derived" "littermate"
    "littermates" "live-cell" "livedoid" "lncRNA" "lncRNA-10" "lobules"
    "lobuloaveoli" "loc285194" "localizations" "loci-specific" "loco-regional"
    "locomoter" "locus-specific" "log-additive" "log2" "log2-fold" "log–log"
    "long-duration" "long-lasting" "long-lived" "long-patch" "long-range"
    "long-standing" "long-survival" "longer-lasting" "longevity-associated"
    "lookup" "loss-of-function" "loss-of-function-mutant" "low-FGF8-expressing"
    "low-affinity" "low-attachment" "low-dose" "low-energy" "low-fidelity"
    "low-grade" "low-invasion" "low-level" "low-malignant"
    "low-molecular-weight" "low-oxygen" "low-passage" "low-penetrance"
    "low-resolution" "low-risk" "low-score" "lower-apoptotic" "lower-grade"
    "lowest-quartile" "loxP" "lumens" "lupus-like" "lymph-node"
    "lymphadenectomy" "lymphadenopathy" "lymphnode" "lymphoblastoid"
    "lymphoblasts" "lymphoid-like" "lymphoma-2" "lymphopenia" "lymphopoetin"
    "lysine-less" "lysine-reactive" "lysine-to-arginine" "lysogeny" "m7GTP"
    "mAChR" "mAChRs" "mAbs-CDC" "mCherry" "mCherry-LC3IIl" "mGluR-LTD" "mGluRs"
    "mIg" "mIgD" "mIgE" "mIgG-BCR-expressing" "mIgG-BCR-induced"
    "mIgG-BCR-mediated" "mIgG-BCR-specific" "mIgG-BCRs" "mIgG-ITT"
    "mIgG-molecules" "mIgG1" "mIgG1-expressing" "mIgG2a-BCRs"
    "mIgG2a-Grb2N-SH3" "mIgG2a-YF-Grb2-SH3" "mIgM-BCR-like" "mIgM-BCRs" "mIgY"
    "mK" "mM" "mMECs" "mRFP-REST" "mRNA" "mT" "mTOR-p70S6K-IRS" "mV"
    "machine-learning" "macro-orchidism" "macroorchidism" "macrophage-tropic"
    "male-female" "mammary-specific" "mammoplasty" "mammosphere" "mammospheres"
    "mangabeys" "marcescens" "marker-positive" "marscescens" "martrigel"
    "masse" "masses" "mastectomy" "master-switch" "match-normal"
    "maternal-fetal" "matrilysins" "matrisome" "matrix-regulatory"
    "maximum-likelihood" "mcBox" "mcl2p115" "mcl2p315" "mcl2p53m" "mcl2pwt"
    "mdivi-1" "mean±SEM" "mean ± SEM" "medulla" "melanin" "melanogaster"
    "mellitus" "membrane-proximal" "memory-type" "menin-null"
    "mercaptosuccinate" "mesenchymal-like" "mesenchymal-specific"
    "mesenchymal-type" "meshwork" "mesoderm" "mesylate" "meta-analytical"
    "metagene" "metagenes" "metal-binding" "metallo" "metallo-enzyme"
    "metallohydrolases" "metallopeptidases" "metalloprotease-2"
    "metallothionin" "metaphase-to-anaphase" "metastasectomies"
    "metastasectomy" "methoionine" "methoxybenzaldehyde" "methyl-donor"
    "methyl-β-cyclodextrin" "methyladenine" "methylcytosine" "methylene"
    "methylene-THF" "methylphosphate" "methylthioadenosine" "mevalonate"
    "miR-101" "miR-105" "miR-122" "miR-122-AKT3" "miR-1226" "miR-1228"
    "miR-1228's" "miR-1228-mediated" "miR-1228-mut" "miR-1228-p1546"
    "miR-1228-p866" "miR-1228-promoted" "miR-124" "miR-124-AKT3"
    "miR-125a-5p-induced" "miR-125b-1" "miR-1273" "miR-1273a" "miR-130a"
    "miR-135b" "miR-139" "miR-143" "miR-146" "miR-146a" "miR-146b" "miR-148a"
    "miR-148b" "miR-149" "miR-149-AKT1" "miR-149-AKT1-mTOR" "miR-155" "miR-17"
    "miR-17,20a" "miR-17-5p" "miR-17-92" "miR-17~92" "miR-18" "miR-181b"
    "miR-184" "miR-184-AKT2" "miR-18a" "miR-18a-5p" "miR-19" "miR-192"
    "miR-195" "miR-19a" "miR-19a-3p" "miR-19b" "miR-19b-1" "miR-19b-1-3p"
    "miR-19b-3p" "miR-20" "miR-200bc" "miR-206" "miR-206-based"
    "miR-206-induced" "miR-206-transfected" "miR-20a" "miR-20a-5p" "miR-215"
    "miR-22" "miR-23b" "miR-24-1" "miR-25" "miR-27a" "miR-27b" "miR-29s"
    "miR-302d" "miR-302d-AKT1" "miR-30a-5p" "miR-32" "miR-33b" "miR-34"
    "miR-34aexpression" "miR-34b" "miR-34c" "miR-363" "miR-367" "miR-374a"
    "miR-378" "miR-423" "miR-4707-5p" "miR-484" "miR-486" "miR-504" "miR-506"
    "miR-519d" "miR-550" "miR-574-3p" "miR-613" "miR-708" "miR-708-AKT2"
    "miR-92" "miR-92-1" "miR-92b" "miR-96" "miR-NAs" "miR125a-5p" "miR17-92"
    "miRDB" "miRNA-149" "miRNA-17–92" "miRNA-34b" "miRNA-449" "miRNA-like"
    "miRNA-mimic-negative" "miRNAome" "miRWalk" "miRanda" "mice" "micro-CT"
    "micro-PET" "micro-computed" "micro-deletion" "micro-metastatic"
    "micro-positron" "micro-pre-tRNA-like" "micro-scale" "micro-vesicles"
    "micro-vessels" "microRNA-143" "microRNA-145" "microRNA-23b" "microT"
    "microalbuminuria" "microanatomy" "microarchitectures" "microarray-chip"
    "microarrayarray" "microdomain" "microdomains" "microenvironment-dependent"
    "microenvironment-induced" "microfuge" "micrographs" "micrometastases"
    "micropenis" "microplate" "microplates" "microsomia" "microsurgery"
    "microtuble" "microtubule-depolymerization" "microvasculature"
    "microvasculatures" "microvessel" "mid-dorsal" "mid-gestation" "mid-late"
    "midbrain" "midterm" "millisecond" "minichromosome" "minisatellite"
    "miniscule" "minor-groove" "minus-end-directed" "minute-2" "mir" "mir-143"
    "mir-660" "mir-660-induced" "mis-fold" "mis-sense" "misalignments"
    "miscroscopy" "mismatches" "missense" "mith" "mith-A" "mithramycin-A"
    "mitochondrial-independent" "mitochondrial-mediated" "mitoses" "mitotoxin"
    "mitotoxins" "mixed-meal" "mmuno" "mock-infected" "mock-transfected"
    "mock-treated" "moderate-to-strong" "moduli" "modulo" "modulus" "mono-Ub"
    "mono-institutional" "mono-orientated" "mono-orientation"
    "mono-ubiquitinylated" "monocyte-derived" "monocyte-lineage"
    "monocytogenes" "monodentate" "monolayer" "mononucleosomes" "monopartite"
    "monophosphate" "monopole" "monosomes" "monotherapies" "monotherapy"
    "mono–adenosine" "morbidities" "morphant" "morpholinyl" "morphometry"
    "mortem" "most-highly" "most-robustly" "motif-containing" "motifs" "motile"
    "mtROS" "mucosa" "multi-cancer" "multi-domain" "multi-drug"
    "multi-factorial" "multi-feature" "multi-functional" "multi-gene"
    "multi-genic" "multi-institution" "multi-institutional" "multi-layers"
    "multi-ligand" "multi-modal" "multi-nucleate" "multi-organ" "multi-panel"
    "multi-platform" "multi-protein" "multi-sequence" "multi-step"
    "multi-subunit" "multi-therapy" "multi-variable" "multicenter"
    "multicentre" "multidomain" "multienzyme" "multigene" "multihit"
    "multilevel" "multilineage" "multilocus" "multinucleate"
    "multiple-membraned" "multiple-to-multiple" "multiplex-PCR" "multiplicate"
    "multiprotein" "multisite" "multistage" "multisubunit" "multivariate"
    "muridarum" "muscle-invasive" "muscle-mediated" "muscle-specific"
    "musculus" "mutGATA3" "mutations" "myc-tag" "myocardium" "myocytes"
    "myofibroblast-differentiation" "myofibroblasts" "myoid" "myrAKT"
    "myristate" "n=11" "n=13" "n=14" "n=15" "n=2" "n=20" "n=24" "n=28" "n=3"
    "n=4" "n=5" "n=50" "n=53" "n=624" "n=659" "n=78" "n=8" "nAChR" "nAChRs"
    "nMDP" "nM–10" "nano" "nano-scale" "nanoSIMS" "nanobeads" "nanoliquid"
    "nanoscale" "naphthofurandione" "nasopharynx" "naturally-occurring"
    "ncomms6201" "ncomms6383" "ncomms6399" "ncomms6413" "ncomms6456"
    "ncomms6496" "ncomms6582" "ncomms6685" "ncomms6809" "ncomms6812"
    "ncomms6887" "near-background" "near-complete" "near-identical" "near-zero"
    "nearest" "nearly-intact" "necrosome" "needle-aspiration"
    "negative-feedback" "negative-regulator" "neo-adjuvant" "neo-synthesis"
    "neoadjuvant" "neocortex" "neointima" "neoplasias"
    "neoplastically-transformed" "nephropathy" "network-based" "neu-induced"
    "neu-positive" "neurite" "neuro-cardio-facial-cutaneous" "neuroendocrine"
    "neurosphere" "neurospheres" "never-smokers" "never-smoking" "newer"
    "newly-diagnosed" "next-generation" "nigrastriatum" "nitroblue"
    "nitroblue-tetrazolium" "nitroindazole" "nitroso" "nitrosureas" "no-labor"
    "no-ligand" "node-betweenness" "node-negative" "nodes" "nodules"
    "noncancer" "noncognate" "nonfat" "nonhistone" "nonimmune" "nonmacrophage"
    "nonmacrophage-tropic" "nonmalignant" "nonmuscle" "nonmutant" "nonobese"
    "nonrare" "nonredundant" "nonsense-mediated" "nonsignificant" "nonsmall"
    "nontarget" "nontrastuzumab" "nontumour" "nor-NOHA" "nosteroid" "nt"
    "nteractome" "nucleases" "nucleatum" "nucleo" "nucleoproteins"
    "nucleotides" "nul-p53" "numberDof" "n = 11" "n = 3" "n = 4" "n = 13"
    "n = 3" "n = 4" "n = 8" "oRG" "oblongata" "obstructive-azoospermia"
    "occurrences" "oesteoblasts" "oestrogen" "oestrogens" "ofApc" "ofArf"
    "ofSt3gal4" "ofTrkB" "ofTrkC" "ofTsc1c" "ofYap" "off-rate" "off-rates"
    "off-target" "off-targets" "offs" "ofhp21" "ofin" "ognate" "oldTsc1c"
    "oldest-old" "oldest-olds" "oligo" "oligomerizaiton" "oligos"
    "oligosaccharide-binding" "omain" "omics" "omolog" "omomyc" "on-going"
    "on-rates" "on-target" "onco-Vav-expressing" "oncogene-tumor"
    "oncogenotype" "oncologists" "oncology" "oncomiRs" "oncotargets"
    "one-and-a-half" "one-carbon" "one-dimensional" "one-ended" "one-sided"
    "one-step" "one-tenth" "one-third" "one-way" "one-year" "ontogeny"
    "oocytes" "oophorectomy" "open-field" "open-label" "operator-dependent"
    "ophthalmoscopy" "opsono" "opsono-phagocytosis" "orAsgr2" "orEif4e"
    "orSt3gal4" "orTrkB" "orchidism" "orchiopexy" "order-of-magnitude"
    "organelle" "organelles" "ori" "ornithine" "oropharynx" "orthavanadium"
    "ortho" "ortholog" "orthologue" "orthologues" "osteoblasts" "osteoid"
    "osteophytes" "osteoprogenitors" "otif" "otitis" "ourTsc1c" "out-bred"
    "out-compete" "outs" "over-activated" "over-activation" "over-activity"
    "over-and" "over-drive" "over-expand" "over-expands" "over-load"
    "over-proliferation" "over-representation" "overdominant" "overex"
    "overgrew" "overridden" "overthrown" "overview" "oxidases" "oxoglurate"
    "oxygenase-1" "ozogamicin" "p110C" "p21-dependent" "p21-null" "p21T145D"
    "p27-Ser10" "p27-mediated" "p27kip" "p300-mediated" "p32FoxO3"
    "p38-MNK-eIF4E1" "p38-MNK2b" "p38MAPK" "p53-Ser20" "p53-Venus"
    "p53-checkpoint" "p53-defective" "p53-dependence" "p53-family" "p53-like"
    "p53-lncRNAs" "p53-miR221" "p53-minus" "p53-nul" "p53-null" "p53-null-HCT8"
    "p53-status" "p53-transcriptionally" "p53-wildtype" "p53DD" "p53I254R"
    "p53MH" "p53R248W" "p53R273H" "p53R280K" "p53RE" "p53REs" "p53Y220C"
    "p53null" "p53oligo" "p53siRNA" "p55α" "p5xATF6GL3" "p63RhoGEF-activation"
    "p73-metabolic" "p73α" "p85α–p110δ" "p95HER2" "p=0.0001" "p=0.0003"
    "p=0.001" "p=0.0013" "p=0.002" "p=0.0024" "p=0.003" "p=0.004" "p=0.005"
    "p=0.006" "p=0.008" "p=0.009" "p=0.01" "p=0.012" "p=0.013" "p=0.014"
    "p=0.015" "p=0.017" "p=0.018" "p=0.019" "p=0.02" "p=0.022" "p=0.023"
    "p=0.024" "p=0.026" "p=0.027" "p=0.028" "p=0.031" "p=0.037" "p=0.038"
    "p=0.041" "p=0.0451" "p=0.046" "p=0.048" "p=0.05" "p=0.07" "p=0.073"
    "p=0.0811" "p=0.084" "p=0.09" "p=0.093" "p=0.14" "p=0.151" "p=0.16"
    "p=0.17" "p=0.176" "p=0.20" "p=0.24" "p=0.273" "p=0.28" "p=0.287" "p=0.33"
    "p=0.34" "p=0.366" "p=0.3782" "p=0.40" "p=0.41" "p=0.582" "p=0.66" "p=0.68"
    "p=0.683" "p=0.71" "p=0.74" "p=0.78" "p=0.95" "p=0.99" "p=1.5e-5"
    "p=2.7×10" "pAla102Thr" "pBABE" "pBABE-empty" "pBABE-miR-206" "pBABE-puro"
    "pBKCa" "pBrachyury" "pBudCE" "pCIenv" "pCIgag" "pCIpol" "pCMO2.5" "pCav-1"
    "pDONR" "pDONR223" "pEF1α-mCherry-53BP1" "pEGFPD" "pEGFR" "pENTR-D-TOPO"
    "pEZX" "pErB2" "pErbB1-4" "pErbB2" "pErbB3" "pErbB4" "pFDR" "pFN+III-13"
    "pFlag" "pFlag-CMV2" "pGCH" "pGEX" "pGEX-6P1" "pGEX-6P1-DUSP5"
    "pGL3-Basic-luc" "pGL3-basic" "pGL3-miR-146a-luc" "pGSK-3α" "pGW"
    "pGW-cfosEGFP" "pGag" "pGag-CTE" "pGag-RRE" "pH" "pH3ser10" "pHACE"
    "pHAGE-P" "pHSP90" "pH " "pINDUCER" "pINDUCER10-encoded" "pINDUCER20"
    "pINDUCER20-encoded" "pIκBα" "pM" "pMDM2" "pMIG" "pMIG-myrAKT" "pMLC"
    "pMT-p53-Venus" "pMek" "pNF" "pNF-κB" "pNL4-3" "pNPP" "pPAK1" "pPROM"
    "pRB-AB" "pRPA32" "pRb-AB" "pRbAB" "pRb–E2F-controlled" "pRb–E2F-dependent"
    "pS" "pS175" "pS2056" "pS235" "pS240" "pS473" "pS529" "pS536" "pS552"
    "pS65" "pS675-β-catenin" "pS727" "pS908" "pS935" "pS955" "pSD31" "pSD400"
    "pSGK3" "pSMAD1,5,8" "pSTAT" "pSTAT1-dependent" "pSTAT3" "pSmad2" "pSmad3"
    "pStat5" "pSuper" "pT202" "pT235" "pT240" "pT308" "pT320" "pT37" "pT389"
    "pT68" "pTERT" "pTERT-Luc" "pTNM" "pTatz" "pTyr-PAK1" "pTyr-PAK1-dependent"
    "pTyr-PAK1-independent" "pTyr285" "pTyr285-PAK1" "pUL21a-APCmut"
    "pUL21a-RXL" "pUL21a-RXL-dependent" "pUL21a-RXL2" "pUL44" "pWWP-Luc"
    "pWZL-Neo-Myr-Flag-Dest" "pWZL-Neo-Myr-Flag-ILK" "pY174" "pY416-Src"
    "pY654-β-catenin" "pY705" "pYAP" "pack-years" "pair-wise" "paired-end"
    "pairings" "pairwise" "pan-Sirtuin" "pan-cancer" "pan-fibroblast"
    "pan-phospho-FGFR" "pan-specific" "panbronchiolitis" "papain-like"
    "para-methoxybenzaldehyde" "para-nitrophenol" "paracine" "paracrine"
    "paralog" "paralogues" "paraoxonase-1" "parenchyma" "parent-offspring"
    "parietalis" "parity-induced" "partially-silenced" "partum" "pathobiology"
    "pathogen-induced" "pathophysiology" "pathways" "pcDNA" "pcDNA3-EGFP"
    "pcDNA3-p53" "pcDNA4" "pcp53WT" "pectoris" "pedestal-like" "pellucidum"
    "penetrance" "penetrant" "peptidases" "peptide-nucleic-acid-mediated"
    "peptide-nucleic-acid-mediated-polymerase" "peptides" "peptide–RNA"
    "peptidoglycan" "peptidylprolyl" "peqGOLD" "perhaps" "peri-aortic"
    "peri-implantation" "peri-nuclear" "peri-tumoral" "peri-vascular"
    "perifoine" "peritoneum" "perlican" "permeabilities" "permeant"
    "person-years" "phagophore" "pharmacophore" "phase-contrast" "phenacetin"
    "phenethyl" "phenotype-and" "phenyl" "phenylenediamines"
    "phenylmethylsulfonyl" "phosho" "phosphate-binding" "phosphate-phosphate"
    "phosphatidylcoline" "phosphatidylinositide"
    "phosphatidylinositol-5-phosphate" "phospho-MDM2" "phospho-Ser63"
    "phospho-p38" "phosphoSmad2" "phosphoantibody" "phosphodegron"
    "phosphodegrons" "phosphodiester" "phosphoethanolamine" "phosphofructose"
    "phosphoinositides" "phosphomutants" "phosphopeptide" "phosphoribosyl"
    "phosphoribosyl-pyrophosphate" "phosphorothioate" "phosphoryations"
    "phosphorylation-defective" "phosphorylation-dimerization"
    "phosphorylation-state" "phosphoserines" "phosphosite" "phosphosites"
    "phosphotransfer" "photodamage" "photomicrographs" "picrosirius"
    "pifithrin-α" "pipette-type" "pitchoune" "pixel" "pixels" "placebo-treated"
    "placodes" "plasmacytoid" "plasmon" "plate-like" "plateward" "platin"
    "platinum-response" "platinum-sensitivity" "platinum-taxane"
    "platinum–drug" "pleura" "ploidy" "plus-end" "plus-end-directed"
    "plus-ends" "pmTOR" "pocket-forming" "point-mutant" "polII" "pole-to-pole"
    "poleward" "pole–pole" "polo-box" "poly-A" "poly-ADP-ribose" "poly-HA-Ub"
    "poly-HA-ubiquitin" "poly-L-lysine-coated" "poly-pyrimidine"
    "poly-ubiquitinylation" "polycistron" "polycistrons" "polymerase-1"
    "polymerase-I-mediated" "polymorphismin" "polymorphismwith"
    "polypharmacology" "polyphenol" "polyphenols"
    "polyphosphate-4-phosphatases" "polyphosphoinositides" "polyploid"
    "polysomy" "polyub" "pombe" "poorer" "poorest" "poorly-defined"
    "poorly-differentiated" "pore-forming" "position-weight"
    "positive-correlationship" "positive-feedback" "positive-regulator"
    "positive-relationship" "positron" "positve" "post-DNA" "post-NICD3"
    "post-UV" "post-XCI" "post-chemotherapeutic"
    "post-chemotherapeutic-treated" "post-damage" "post-drug" "post-endocytic"
    "post-imatinib" "post-induction" "post-infection" "post-infusion"
    "post-injection" "post-lysis" "post-menopausal" "post-mitochondrial"
    "post-mitotic" "post-natal" "post-nuclear" "post-partum" "post-radiation"
    "post-recurrence" "post-registration" "post-release" "post-stimulation"
    "post-tanscriptional" "post-therapy" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-translation" "post-translational" "post-translationally"
    "post-transplant" "post-transplantation" "post-treatment" "postcoculture"
    "postmortem" "postuptake" "potassium-induced" "potato-specific" "ppE1A"
    "ppE7" "ppHPV" "ppHPV16-E7" "prebound" "predicators" "preterm"
    "pri-miR-1228" "priori" "pro-Caspase-1" "pro-EGFR" "pro-MMP-2" "pro-MMP-9"
    "pro-angiogenic" "pro-autophagic" "pro-autophagy" "pro-biglycan"
    "pro-carcinogenic" "pro-caspase-3" "pro-caspase-8" "pro-caspase-9"
    "pro-caspases" "pro-death" "pro-drug" "pro-fibrotic" "pro-growth"
    "pro-inflammation" "pro-inflammatory" "pro-invasive" "pro-lymphangiogenic"
    "pro-metastatic" "pro-migratory" "pro-neoplastic" "pro-proliferation"
    "pro-proliferative" "pro-survival" "pro-tumoral" "pro-tumorigenic"
    "pro-tumour" "proCOL1A1" "proTAME" "proband" "probands" "procaspase-3"
    "procaspases-3" "processome" "procoagulant" "product-limit"
    "product-moment" "proenzyme" "proenzymes" "proform" "progeny" "progestin"
    "prognostic-predictive" "prognostic–predictive" "programnmrK" "progrowth"
    "prokaryotes" "prolif" "proliferating-cell" "proliferator-activated"
    "prolif­eration" "proline-hydroxyproline" "proline-rich"
    "proline-to-serine" "prolyl-hydroxylases" "promoter-Luc"
    "promoter-proximal" "promoters" "proof-of-concept" "proof-of-principle"
    "propanoate" "propargyl" "prophase-prometaphase" "proportional-hazards"
    "proprotein" "prorecombinant" "prostaglandins" "prostatectomy"
    "protease-like" "proteases-collectively" "proteasome-blockade"
    "proteasome-inhibitor" "proteasome-mediated" "protein-5" "protein-97"
    "protein-DNA" "protein-RNA" "protein-coding" "protein-fragment"
    "protein-interaction" "protein-like" "protein-metabolite" "protein-nucleic"
    "proteins" "proteins-like" "protein–DNA" "protein–RNA" "protein–ligand"
    "proteolytically-cleaved" "proteome" "proteome-scale" "proteome-wide"
    "proteomic-coupled" "proteomics-based" "proteomics-mass" "proteosome"
    "protions" "proto-oncoprotein" "protomer" "protomers" "protooncogene"
    "proven" "ps-long" "pseudo-downregulation" "pseudo-isogenic"
    "pseudo-positivity" "pseudogenes" "ptprj" "puc" "pull-down" "pulled-down"
    "pulposus" "pulse-chase" "pump-out" "punctae" "puro" "purpura" "pval"
    "pyridylmethyl" "pyriform" "p = 0.002" "p = 0.003" "p = 0.005" "p = 0.006"
    "p = 0.009" "p = 0.012" "p = 0.013" "p = 0.017" "p = 0.02" "p = 0.024"
    "p = 0.03" "p = 0.048" "p = 0.005" "p = 0.007" "p = 0.008" "p = 0.009"
    "p = 0.015" "p = 0.031" "p = 0.05" "p = 0.07" "p = 0.09" "q-value"
    "q21.3–q22" "q3d" "q=0.00168" "q=0.186" "qMSP" "quadruplexes" "quant"
    "quant-log" "quasi" "quasi-twofold" "quinonemethide" "r=0.74" "r=0.88"
    "r=0.89" "r=0.966" "rAd-NC" "rAd-p21" "rHRG" "rRNA" "rVista"
    "radiation-induced" "radioiodine" "radiotherapies" "raft-dependent"
    "random-effects" "rank-order" "rapalog" "rapalogs" "rapalogues" "rarer"
    "rat-Polβ" "rationale-driven" "re-accumulate" "re-added" "re-applied"
    "re-assembly" "re-biopsy" "re-close" "re-closure" "re-couple"
    "re-distribution" "re-emerge" "re-enter" "re-established" "re-establishing"
    "re-evaluate" "re-evaluated" "re-examine" "re-examined" "re-express"
    "re-expressed" "re-expression" "re-grow" "re-growth" "re-introduced"
    "re-organization" "re-oxygenation" "re-plated" "re-plating"
    "re-polymerization" "re-probing" "re-programmed" "re-programming"
    "re-purposing" "re-replication" "re-repression" "re-seeded"
    "re-sensitization" "re-sensitize" "re-sensitized" "re-sequencing"
    "re-solubilization" "re-stimulation" "re-warmed" "reChIP" "reaccumulates"
    "reaction-restriction" "read-out" "readout" "readouts" "realtime" "reby"
    "receptor-ligand" "receptor-like" "receptor-β" "receptor-γ" "recognises"
    "recombinant-PDGF-DD" "recombination-type" "recruitm" "redirect"
    "redirects" "redox-and" "reduc" "reencounter" "reenter" "reevaluate"
    "refractoriness" "regions" "regrown" "regrowth" "regulator-1"
    "regulator-like" "regulators" "related-loci" "relaxant" "remodeler"
    "remodelers" "remodeling" "renilla" "reno" "reno-protective"
    "repair-deficiency" "repair-induced" "repeat-containing"
    "reperfusion-induced" "replication-associated" "reponse"
    "reporter-containing" "representativeness" "repressors" "rerio"
    "resensitizes" "residue-residue" "residues" "responder" "responders"
    "response-time" "resultes" "reticulata" "reticulocytopenia" "retrogene"
    "retrovirus" "reuse" "reverse-phase" "reverse-transcription" "revertant"
    "rhenium-188-HEDP" "rhodamine-123" "rhombomeres" "ribo" "ribo-some"
    "ribose" "ribosomopathies" "ribosomopathy" "right-most" "right-sided"
    "rigidity-dependent" "risen" "risk-alleles" "risk-associated"
    "risk-factors" "risk-predicting" "risk-reducing" "ro1" "robustly-induced"
    "rod-like" "rong" "root-mean-squared" "roscovitin" "rotarod" "roteins"
    "round-cell" "rpm" "rs10050046" "rs10055201" "rs10183914" "rs1027702"
    "rs1042522" "rs1045485" "rs10483727" "rs1062292" "rs1062292T" "rs1063192"
    "rs10891068-rs10891069-rs622822-rs17110877" "rs11037575" "rs110419"
    "rs11083838" "rs11096955" "rs11161237" "rs11236791" "rs11543848"
    "rs11770199" "rs11781865" "rs11979158" "rs12155555" "rs12206094"
    "rs1238371" "rs12461917" "rs12525536" "rs12535536" "rs12538371" "rs1253871"
    "rs13172201" "rs13174814" "rs13174818" "rs13174919" "rs1317814"
    "rs13207865" "rs13277113" "rs13277113A" "rs1438673" "rs145741678"
    "rs147013405" "rs148064770" "rs1546894" "rs1561817" "rs167769" "rs17065417"
    "rs17088251" "rs17213431" "rs17586365" "rs1800566" "rs1800668" "rs1806649"
    "rs1900004" "rs1935949" "rs2010572-rs16838070-rs6715398-rs16838083"
    "rs2071747" "rs2072454" "rs2075110" "rs2274223" "rs2274223A" "rs2279744"
    "rs231948" "rs231956" "rs23948" "rs246992" "rs246995" "rs2619046"
    "rs2735940" "rs2736098" "rs2736100" "rs2736122" "rs2736340" "rs2736340C"
    "rs2736340T" "rs2802292" "rs2853668" "rs2886161" "rs2898261" "rs3213176"
    "rs33961405" "rs34231037" "rs35652124" "rs367948" "rs3731343" "rs3749930"
    "rs3765524" "rs3765524C" "rs3768716" "rs3774937" "rs3774937-C" "rs379266"
    "rs3800231" "rs3811699" "rs3815700" "rs3837184" "rs388047" "rs400181"
    "rs402710" "rs4236601" "rs4256621-rs4876115-rs6558504-rs17064153"
    "rs4336470" "rs4430796" "rs4430796A" "rs445678" "rs4648011" "rs4648011-G"
    "rs4656461" "rs4754425" "rs479744" "rs4880" "rs4946935" "rs4947986"
    "rs4977756" "rs5029306" "rs5030328" "rs532841" "rs55646091" "rs561681"
    "rs57045236" "rs621554" "rs62329728" "rs6435862" "rs6721961" "rs6726395"
    "rs6970202" "rs6970262" "rs6992443" "rs712829" "rs725344" "rs73229635"
    "rs74732520" "rs7557529" "rs763317" "rs7654599" "rs7667298" "rs7705526"
    "rs7725218" "rs7734992" "rs7762395" "rs7922612" "rs7922612C" "rs8008716"
    "rs8041227" "rs845561" "rs845661" "rs9692301" "rs9818758" "rsik" "s-AML"
    "s-transferases" "s00439-014-1515-4" "s10549-014-3227-9"
    "s12858-014-0027-0" "s12866-014-0277-4" "s12881-014-0131-4"
    "s12964-014-0069-3" "s12964-014-0072-8" "s12967-014-0355-2"
    "s12977-014-0118-4" "s12977-014-0121-9" "s13023-014-0165-x"
    "s13046-014-0097-2" "s13046-014-0104-7" "s13046-014-0108-3"
    "s13058-014-0464-0" "s13075-014-0491-3" "s80" "s91-29" "sAPPα" "sEGFR-Fc"
    "sFlt1" "sMTid" "sMTid-02" "sMTide" "sMTide-02" "sVEGFR2" "sVEGR2"
    "saline-formulation" "salpingo" "salpingo-oophorectomy" "salt-bridge"
    "salt-bridges" "salted-tea" "samarium-153" "sc-50" "scaffold-like"
    "scale-up" "scamble" "scatterplots" "schizophreniform" "screenings" "scute"
    "second-generation" "second-line" "second-order" "second-tier"
    "secondary-AML" "secretome" "seed-sequence" "selections" "selenomethionine"
    "self-activating" "self-association" "self-control" "self-identified"
    "self-interaction" "self-regulate" "self-renew" "self-renewal"
    "self-ubiquitination" "semi" "semi-active" "semi-automatic" "semi-dry"
    "semi-log" "semi-open" "semi-quantitative" "semi-redundant" "semi-solid"
    "sen" "senesce" "senescence-like" "senescent-like" "sense-intronic"
    "sense-overlapping" "sensitizer" "sensorchip" "separation-of-function"
    "sequence-dependence" "sequence-dependent" "sequence-driven"
    "sequence-specific" "serine-to-alanine" "serine-to-proline" "serology"
    "serotype" "serum " "servo" "set-up" "sex-differential" "sex-specific"
    "sgH5" "sgH5-Alexa568" "sgHT1-6" "sgHT2" "sgHT4" "sgHT5" "sgL5" "sgLucHep3"
    "sgRNA" "sgRNA-Alexa568" "sgRNAs" "sh2-2" "sh3" "shAR" "shATP6AP1" "shATRX"
    "shATRX’s" "shBCAS2#1" "shBCAS2#2" "shBRCA1" "shBRCA1-#1-MCF7" "shBRCA1-#2"
    "shBRCA1-MCF7" "shCUL4A" "shCont" "shCtl" "shFKBP5" "shGDF" "shGDF15"
    "shGDF15-A2780cis" "shHRBL" "shHSP90B1" "shIKKε" "shLuc" "shNT" "shNeg"
    "shPHD3" "shPRKDC" "shPRKDC-3" "shPRKDC-5" "shRHOA" "shRNA"
    "shRNA-control-GFP" "shRNA1" "shRNA2" "shResistin" "shResistin-Luc"
    "shRhoC" "shRhoC-1" "shRhoC-2" "shSNX22" "shScr" "shSema3C" "shTRC"
    "shTRC1" "shTRC1-A2780cis" "shTRC1-transduced" "shaken" "shallower"
    "sham-surgery" "sham-surgery-subjected" "shcontrol" "sheddases" "sheng"
    "short-chain" "short-hairpin" "short-patch" "short-range" "short-survival"
    "short-term" "short-treatment" "shp53" "shp53-lentiviral" "shβ-arrestin-1"
    "si-FAK" "siANXA2" "siBKCa" "siBRCA1" "siBRCA1_13" "siBRCA1_14" "siCTL"
    "siCYLD" "siCav-1" "siControl" "siCtrl" "siEGFR" "siHECW1–5" "siIRF7"
    "siLMP" "siLMP2A-transfected" "siNeg" "siRNA-Brachyury" "siRNA3" "siRNAs"
    "siTRAF6" "sialomucin" "sialomucins" "sib-pair" "sicker" "side-by-side"
    "side-chain" "side-chains" "side-effect" "side-effects" "side-population"
    "sidechain" "sidechains" "sideroblasts" "sig" "signal-to-noise"
    "signaling-complexes" "signiﬁcant" "silico" "similarly-regulated"
    "similarly-treated" "simpler" "simplest" "single-SNP" "single-base"
    "single-case" "single-cell" "single-center" "single-channel" "single-copy"
    "single-cycle" "single-gene" "single-institution" "single-letter"
    "single-locus" "single-nucleotide" "single-site" "single-strand"
    "single-turnover" "singly-liganded" "singly-spliced" "sister–sister"
    "sites" "situ" "six-lysine" "six-well" "size-exclusion" "skin-derived"
    "sleep–wake" "small-angle" "small-cell" "small-cell-lung" "small-diameter"
    "small-molecule" "small-scale" "small-vessel" "smaller-by-scale" "smokers"
    "snapshot-like" "socio" "socio-economic" "soft-agar" "soft-tissue"
    "solenoids" "solid-phase" "solute" "solvent-accessible" "somites" "spacer"
    "spacers" "spatial-temporal" "spatio" "spatio-temporal"
    "specific-expression" "specifically-perturbed" "specifically-targeted"
    "speciﬁc" "spectrometer" "sphere-formation" "sphere-forming" "sphincter"
    "sphingosine" "splenectomy" "spore-like" "ssDNA" "stainings" "statuson"
    "steady-level" "steady-levels" "steady-state" "stem-cell" "stem-like"
    "stem-loop" "stem-loops" "stem-truncation" "stemness" "step-wise"
    "stepwise" "stiffness-associated" "stochastically-induced" "stopped-flow"
    "stopped–flow" "strain-dependent" "streptavidin–biotin" "stress-activated"
    "stress-dependent" "stress-fibers" "stress-induced" "stress-inducing"
    "stress-mediated" "stress-neurotransmitter-induced" "stress-related"
    "stress-response" "stress-responsive" "stress-specific" "stress-tolerance"
    "stress-triggered" "stressful" "stressors" "stromelysins" "stromielysins"
    "strontium-89" "structural–functional" "structure-activity"
    "structure-based" "structure-function" "structure-specific"
    "structure–activity" "structure–function" "sub-G1" "sub-assembly"
    "sub-cellular" "sub-clones" "sub-compartments" "sub-complex" "sub-diploid"
    "sub-epithelial" "sub-group" "sub-line" "sub-lines" "sub-millisecond"
    "sub-mitotic" "sub-motif" "sub-network" "sub-networks" "sub-optimal"
    "sub-pathway" "sub-pathways" "sub-phases" "sub-phenotypes" "sub-population"
    "sub-type" "sub-types" "sub-unit" "sub-units" "subG0" "subG1" "subclass"
    "subcluster" "subcompartments" "subcomplex" "subcomplexes"
    "subcutaneously-inoculated" "subdiploid" "subdomain" "subfamilies"
    "sublines" "subnetworks" "subsample" "subseries" "subset" "subsets"
    "substitution-inert" "substrate-liganded" "substrates" "subsystems"
    "subthreshold" "subtype" "succinate" "succinimidyl" "sulfomucins"
    "sulfophenyl" "super-enhancer" "super-repressor" "superdomains"
    "superhelix" "supernatant" "supernatants" "suppressing-functions"
    "surgically-induced" "survival-time" "symmetry-related" "synapse"
    "synapses" "synergism" "syringae" "t-MDS" "t-SAHA" "t=0" "t=4.8" "tPTEN"
    "tRNA-like" "tacrolimus" "tail-binding" "target-decoy" "target-gene"
    "targetome" "taxol-carboplatin" "tegmentum" "telencephalon"
    "temperature-sensitive" "template-specific" "ten-eleven" "tensin-like"
    "tension-mediated" "tertiary-care" "testings" "tether-disrupting"
    "tetrakis" "tetralogy" "tetramethoxypropane" "tetraploid" "tetrazolium"
    "thalamus" "thaliana" "theApc" "theDp53" "theEif4e" "theI" "theRhoA"
    "theSt3gal4" "theTsc1c" "thep16" "thepolymorphism" "therapy-sensitive"
    "theseTsc1c" "theta" "thiogalactopyranoside" "thiol-SAHA" "three-chamber"
    "three-dimensional" "three-hybrid" "three-step" "three-year"
    "threonine-rich" "thrombocythemia" "thrombus" "thymidilate" "thymineless"
    "thymocytes" "tight-binding" "time-by-covariate" "time-course"
    "time-dependently" "time-lapse" "time-of-flight" "time-period" "time-point"
    "time-points" "time-release" "time-scale" "time-sequence" "time=0"
    "timeframe" "timepoints" "tinnitus" "tissue+" "tissue-destructive"
    "tissue-resident" "titer" "titers" "titres" "to-date" "to50%" "toSt3gal4"
    "toll-like" "tonic-clonic" "topoIIa" "topolyvinylidene" "toxicants"
    "traceless" "trachomatis" "trait-associated" "tranducers" "tranformants"
    "trans-activator" "trans-farnesylthiosalicylic" "trans-membrane"
    "trans-well" "transcript-specific" "transcription-PCR"
    "transcription-repair" "transcription-translation–based"
    "transcription–PCR" "transcriptome" "transcriptomes" "transcripts"
    "transdominant" "transducer" "transductants" "transfectant" "transfections"
    "transferase-mediated" "transfusedAsgr2" "transgene-OFF" "transition-state"
    "translation-repressive" "translatome" "translatomes" "transmigrate"
    "transposon" "transversions" "transwell" "transwells" "tratsuzumab"
    "treated-MES-SA" "treatedTsc1c" "treatment-naïve" "tri-mehylation"
    "tri-peptide" "trichrome" "triciribine=0.49" "triciribine=0.51"
    "triciribine=0.52" "triethanolamine" "triggered-TF" "triphosphate"
    "triple-membrane-passing" "triple-mutant" "triple-negative"
    "triple-positive" "triploid" "trisphosphate" "trophoblasts" "trypsine" "ts"
    "tti" "tube-like" "tubule" "tubules" "tubulo" "tubulo-papillary"
    "tumor-like" "tumor-microenvironment" "tumor-node-metastasis"
    "tumor-permissive" "tumor-protective" "tumor-supportive"
    "tumor-suppressive" "tumorigenic-associated" "tumorogenesis-associated"
    "tumorsphere" "tumorspheres" "tumor–like" "tumour-associated"
    "tumour-necrosis" "tumour-promoting" "tumour-stroma" "tumour-suppressing"
    "tumour-suppressive" "tumour-suppressor" "tumours" "turned-on"
    "tweezer-like" "twenty-member" "twenty-seven" "twin-Strep" "two-E2"
    "two-component" "two-electron" "two-hybrid" "two-month" "two-pronged"
    "two-sided" "two-state" "two-step" "two-steps" "two-tailed" "two-thirds"
    "two-way" "txr" "type-1" "type-2" "type-III"
    "tyrosine-phosphorylation-regulated" "tyrosyl" "uRF" "ubiquitin-propargyl"
    "ubiquitin~ubiquitin" "ultiple" "ultra-fine" "ultra-low" "ultra-pure"
    "ultralow" "ultralow-attachment" "uman" "un" "uncoupler" "under-expressed"
    "under-expression" "under-production" "undergoes" "undergone" "undertaken"
    "undirect" "uni" "unit-length" "univariate" "unmet" "unsignificant"
    "untreatedTsc1c" "up-reguleted" "up-ward" "upper-bound" "upper-right"
    "upper-third" "urban-dwelling" "urea" "ureter" "urine-based"
    "urokinase-receptor" "urokinase-type" "urothelium" "usingtitania" "utero"
    "uveal" "v-Src-PEC" "v-Src-oncogene" "v-Src-transformation" "vDNA" "vRG"
    "vaccinatum" "vacciniforme–like" "vacuolar-type" "vacuole" "vacuoles"
    "vaiants" "value=1.9e–12" "values" "variola" "vasculopathy" "vector-only"
    "vehicle-treated" "vera" "versusTsc1c" "vervet" "vesicle-like"
    "vesicle-mediated" "vestigial-like" "vi" "vide" "videomicroscopy" "villus"
    "vinca" "viremia" "viriato" "virus-like" "virus-strain-dependent"
    "virus–S-peptide" "vise" "vitr" "vitro" "vivo" "viz" "voltage-activated"
    "vs.Tsc1c" "wNAPPA" "wSMAcre-ER" "water-centric" "water-soluble"
    "water-soluble-tetrazolium" "weak-to-absent" "weakest" "webserver"
    "well-accepted" "well-compartmentalized" "well-conditioned"
    "well-conserved" "well-defined" "well-designed" "well-designs"
    "well-differentiated" "well-diffracting" "well-discussed" "well-documented"
    "well-maintained" "well-ordered" "well-oxygenated" "well-phenotyped"
    "well-powered" "well-ranked" "well-recognized" "well-resolved"
    "well-spread" "well-structured" "well-studied" "well-suppressed"
    "well-to-moderately" "west-central" "wet-lab" "whereasAsgr2" "whereasEif4e"
    "whole-body" "whole-cell" "whole-exome" "whole-genome" "whole-mount"
    "whole-tissue" "wide-field" "wide-ranging" "wide-scale" "wide-scope"
    "wide-type" "withEif4e" "withand" "wk" "wks" "workers" "workflow" "workup"
    "world-wide" "wortmanmin" "wortmannin=0.35" "wortmannin=0.59"
    "wortmannin=1.55" "wt-Vav1" "wt-Vav1-expressing" "wtGATA3" "wtMEK" "x-ray"
    "x-ray–induced" "x10" "xMAP" "xanthine-xanthine" "xanthomas" "xchange"
    "xenoarray" "xl" "xx" "yellow-colored" "yet-to-be" "young-onset" "ypN"
    "ypN0" "ypN1" "ypN2" "ypT1-2N0" "ypT3-4N0" "ypT4" "ypTNM" "ypt" "ypt1-ts"
    "ypt6" "ypt7" "yrosine" "z-VAD" "z-score" "zfPAI-1" "zig" "zinc-dependent"
    "zinc-inducible" "zipper-like" "zymogen" "zymography" "Ämmälä" "×
10"
    "×0.195" "×1" "×10" "×SDS" "× 10" "× 10" "êB" "÷0,633" "÷9" "Δ-KK" "Δ1"
    "Δ1-66" "Δ16" "Δ19" "Δ2" "Δ251–257" "Δ32" "Δ512-1283" "Δ622-670" "Δ705–730"
    "Δ90" "ΔC" "ΔCBM" "ΔCCR5" "ΔCT" "ΔCTD" "ΔCV" "ΔCat" "ΔDUSP" "ΔE746-A750"
    "ΔF" "ΔG" "ΔH" "ΔI" "ΔNTCF4" "ΔNp53" "ΔNp63" "ΔNp73" "ΔNp73α" "ΔS"
    "ΔUL21-infected" "ΔUL21a" "ΔWD40" "ΔXist" "Δdegron" "Δinsert" "Δlinker"
    "Δloop" "Δt" "Δtax" "Δ~Ub" "ΔΨ" "ΨxKE" "α-CD28" "α-CD3"
    "α-FLAG–immunoprecipitated" "α-NAC" "α-Per2" "α-amino" "α-factor"
    "α-granule" "α-helical" "α-helices" "α-helicity" "α-helix" "α-hook"
    "α-isoform" "α-p53" "α-pTyr" "α-smooth-muscle" "α-subunit" "α-β" "α10"
    "α11" "α11–α12" "α12" "α1β1γ1-AMPK" "α1β2γ1" "α2-3,6" "α25-helix" "α3"
    "α3β1" "α4" "α4β1-EDA" "α5" "α5-β1" "α6β1" "α7-nAChRs" "α7-nicotinic" "α9"
    "α9β1" "αB" "αB-helix" "αC" "αC-helix" "αN-terminus" "αRIM-1" "αRIM-2"
    "αRIM-CBS-3" "αRIM2-CBS-3" "αβγ-trimeric" "β-ID" "β-adrenergic"
    "β-arrrestin-1" "β-catenin-independent" "β-catenin-interaction"
    "β-coefficients" "β-galactose" "β-galactoside" "β-grasp" "β-isoform"
    "β-like" "β-oxidation" "β-sheet" "β-sheets" "β-strands" "β-subunit"
    "β-subunits" "β-synthetase" "β-γ" "β1-subunit" "β3" "βA" "βBcat-KO" "βMen1"
    "βMen1-KO" "βPIX" "βTRCP-interaction" "γ-32P" "γ-D-Glu-mDAP" "γ-GCL"
    "γ-H2AXγ" "γ-IR" "γ-glutamate" "γ-lactones" "γ-radiation" "γ-subunit" "γ1"
    "γ1–3" "ε-amino" "ε2" "κB" "κB-alpha" "κB-reporter" "κBα" "κappa" "λ=1.54"
    "μCi" "μL" "μg" "μg " "μl" "μl " "μmol" "υm" "φXXXXφXXφ" "φXφXXXXφ"
    "φXφXXXXφXXφ" "χ2" "‘SPUD’" "‘gatekeeper’" "‘hotspot’" "∆TS1" "≅50%" "≧10"
    "⍺-induced"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-13801-14100*
  '("CMO2.5" "infectiousness" "vpu -defective proviral NL4-3" "SIVtan"
    "Tantalus" "C-loop" "anterograde" "NTSVS" "to50%" "ExxxLL" "CP2139" "YDY"
    "SYDY" "HJ162" "DDIWK" "Gaussia" "MHC-I" "MRCAs" "antitetherin" "MRCA"
    "Africa" "Cameroon" "SIVcpz" "sooty mangabeys" "mangabeys"
    "aberrantly proliferating MaSPCs" "robust DSBs" "quiescent HMEC/hTERT"
    "Rad3-" "/radiation" "Replication stress-induced DSBs"
    "secondary mammospheres" "The adult mammary epithelium" "MaSPCs" "lobules"
    "WAP-driven transgenes" "FVB/N" "anaplasia" "n=2" "acini/ducts"
    "ductal/alveolar" "WAP promoter-driven transgenes"
    "almost incessant pregnancy/lactation" "pregnancy/lactation" "partum"
    "PABC" "successive pregnancy/lactation" "lactogenic mammary epithelium"
    "S/G2/M" "Rad3" "=28" "n=14" "10.1038/ncomms6812" "Sánchez"
    "a global overview" "value=1.9e–12" "doxo" "PR-lncRNA-1" "limma"
    "non-annotated" "CPAT" "TOMTOM" "nearest" "Cuffdiff" "pseudogenes"
    "Gencode" "Cuffmerge" "Cufflinks" "PANDA" "p53REs" "~3%" "BC033528" "BAG6"
    "_002812" "chr1:36804800-36856000+" "proenzymes" "compound C646"
    "propanoate" "differentially expressed lncRNA/mRNA" "lncRNA/mRNA"
    "the respective control U251" "Hochest" "cyclohexanone" "arylidene"
    "Clinicians" "MEV" "HATi" "± 0.8" "P -value " "P -value" "≥ 2" "_8"
    "1 × 10" "PRIDE" "ProteomeXchange" "10.1038/ncomms6887" "diptherium"
    "Corynebacterium" "possibly further tyrosine kinases" "phosphotransfer"
    "ETD" "nanoliquid" "glutatione" "SrcSH1" "TirC" "SrcY527F"
    "constitutively active SrcY527F" "adherent EPEC" "EspJ-R/D" "EspJ-R"
    "TccP/EspF" "O157:H7" "EHEC" "-R" "WIP" "1 H–" "syringae" "Phyre"
    "the enteropathogenic Escherichia coli (EPEC)" "coli (EPEC)" "opsono"
    "EspJ" "protein A36" "pedestal-like" "EPEC" "8 p" "/high" "m / z"
    "S-transferase" "1 H" "E -value" "Fcγ" "Non-receptor tyrosine kinases"
    "siCtrl" "siBRCA1_13" "_14" "_13" "siBRCA1" "8 h" "sensitizer"
    "NADP/NADPH oxidase" "diphenylene" "non-viable" "1 h" "p53 siRNA" "Enzon"
    "EZN" "HTLV" "ERTax" "ERΔTax" "etopside" "ERΔtax-" "ERΔtax"
    "non-HTLV-1-infected" "Δtax" "ERtax" "non-HTLV-1-associated" "Sabo" "6KR"
    "cyclin-dependent kinase inhibitor 1A" "phosphomutants" "293Tv" "SUMO2/3"
    "biomass" "-PLCβ" "flufenamate" "loss-of-function-mutant" "TRPC6-/-"
    "Gα 12/13" "PLCβ" "isozymes-" "edema" "12/13" "q/11" "non-transfected"
    "5-bromo-2" "α 12" "Gα q/11" "6/7" "A/A’" "C- domains" "2g6z" "C-domain"
    "N-domain" "AVSA" "DPSD" "YASARA" "PTR187" "Jeong" "nmol/min"
    "The GST-S147P exhibited V max  = 0" "Δt" "Absorbance" "pNPP"
    "cleaved DUSP5 contained 43% alpha helix" "DICHROWEB" "lysogeny" "pGEX"
    "circular dichroism" "dichroism" "= 0.13 " "= 0.63 " "Z-Score " "Z-Score"
    "miR-19a-3p" "de-repress" "miR-18a-5p" "miR-20a-5p" "dihydroxy" "KRASmt"
    "oncogenotype" "decile" "targetome" "miR-19b" "reponse" "HBEC" "hypomorphs"
    "HBECs" "mature miR-19a" "mature miR-18a" "Dharmacon" "GSE32036" "CAGGCC"
    "H1993" "polycistrons" "polycistron" "p = 0.05" "p = 0.01" "de-repressed"
    "19b-1" "miR-19a" "miR-18a" "miR-17-5p"
    "a chemoresistant histological subtype" "perifoine" "I-II"
    "a serous histology" "any other histological subtype"
    "a distinct histological subtype" "chemoresistant histological subtype"
    "+3" "Brodovich" "Tanaka" "tardive dyskinesia" "dyskinesia" "13/101"
    "100/374" "8/24" "93/452" "204/452" "26wk" "800g" "18/140" "116/515"
    "10/35" "124/621" "21/35" "261/621" "rs1800566" "CAU" "PDA" "arteriosus"
    "ductus" "=659" "toxicants" "NFEL2" "Kelch" "hyperoxia"
    "epidemiological confounders" "HT7900" "Biosystems (ABI)" "Biosystems"
    "VLBW" "p=0.038" "p=0.20" "=0.037" "S-transferases" "10.1038/ncomms6809"
    "Mcms" "5-ethynyl-2" "Pbk" "MCMs" "minichromosome" "severe hypoglycemia"
    "βBcat-KO" "The severe hypoglycemia" "βMen1" "Herr" "Bcat" "Jiang" "16 h"
    "/ +" "poorest" "INSS" "mutated ALK TKDs" "P-loop" "cat /K" "‘gatekeeper’"
    "R1192P" "phosphate-binding P-loop" "the inactive TKD" "the mutated TKDs"
    "purified mutated ALK TKDs" "TKDs" "PredictSNP" "classifier" "Algorithms"
    "megabases" "‘hotspot’" "COG" "TKD" "disialoganglioside" "non-activating"
    "Non-phosphorylated" "relapsed/refractory" "Kohrt"
    "constitutively active myrAKT" "−198 " "Burkitt's" "ozogamicin"
    "inotuzumab" "LGL" "co-incubated" "pMIG" "myrAKT" "-198 " "-313" "BAT-box"
    "BAT" "−313" "+52 " "MFIs" "CD52" "NCBI's" "GSE50929" "Benjamin"
    "1,2 Both non-Hodgkin's" "2 μg/ml" "anti-Human" "= 25" "shRhoC" "shControl"
    "shRhoc-1" "shRhoC-2" "non-zero" "shCont" "shRhoC-1" "T24T cells" "RhoG"
    "RhoGDI1" "p=0.028" "p=0.05" "anti-sense" "μL/min" "x 10" "BECN" "LC3BII"
    "LCBII" "LCBI" "aggressive subsets" "p  = 0.002" "p  = 0.005" "100 uM"
    "factor-2" "femoral condyle" "condyle" "Mankin" "osteophytes"
    "arthroplasty (TKA)" "TKA" "arthroplasty" "10 ng/mL" "class I/II"
    "martrigel" "Dichlorodiamineplatinum" "Tca8113/DDP" "n = 50" "NU/NU"
    "mg/m 2" "docking/scaffold" "Ras/Raf" "Noonan-like" "LEOPARD" "Noonan"
    "neurites" "hShoc2" "AU5" "S2G" "1-3" "tetracycline-inducible TAp73β"
    "aminoacids" "Reactome" "carnitines" "carnitine" "methylphosphate" "Urea"
    "methylthioadenosine" "ornithine" "phosphoethanolamine" "choline"
    "entering Krebs's" "entering Krebs" "Krebs" "Welch" "biochemicals" "8h"
    "S-adenosyl-methionine (SAM)" "Du" "16h" "MEN"
    "non-small cell lung carcinoma (NSCLC)" "NECD3" "–NICD3" "hydrazide"
    "methoxybenzaldehyde" "endocrinopathies" "autoregulate" "AnnexinV/7AAD"
    "AB3" "Mastermind-like (MAML)" "jk" "complex-like" "scute" "achaete"
    "newer" "oncotargets" "cells/colony" "shp53" "Hdm2L468A" "polyub" "MOAs"
    "cIAP" "MOA" "a 3-day" "rs11543848" "rs11979158" "rs12535536" "Intron"
    "rs17586365" "Pittsburgh" "rs1253871" "GRE" "NIEHS" "rs1238371" "Brower"
    "95CI" "aOR" "HPV+P16+" "101/118" "HPV+" "rs845661"
    "only rs17586365 rare minor allele homozygotes" "rs12538371" "rs2075110"
    "SNPS" "Armitage" "Cochran" "rsik" "rs712829" "appropriateness"
    "hypopharynx" "oropharynx" "HPV +" "rs845561" "synonymous SNP rs2072454"
    "rs2072454" "p = 0.022" "rs6970262" "Lange" "mitotically active endometria"
    "endometria" "Quddus" "MDEC" "WDEC" "endometrium (PE)" "EIC"
    "Non-significant" "P = 0.048" "P = 0.01" "n = 14" "= 17" "= 78" "= 26"
    "co-existing" "n = 20" "n = 13" "n =11" "Arunachal Pradesh" "Pradesh"
    "Sharma" "Pfdhr" "Thailand" "Gabon" "Peru" "FGEGA" "AGEGA" "SGEAS" "AIRTI"
    "AICNL" "Kamrup" "Orissa" "Delhi" "Assam" "Jorhat" "Lakhimpur" "Tinsukia"
    "Dibrugarh" "Golaghat" "88/94" "5/94" "89/94" "Anglong" "Karbi" "Pfdhps"
    "S436A+A437G" "SAKAA" "FGKAA" "SGKAA" "SGKGA" "AGKAA" "FAKAA" "ANCSI"
    "ANRNI" "Pfdhfr" "38/63" "A437G" "AGEAA" "Chirang" "AIRNI" "falciparum"
    "et al . in" "Hilska" "Morgan" "ypTanyN+" "UICC" "sphincter" "ypT" "ypN+"
    "ypTNM" "ypN" "preoperative chemoradiotherapy" "chemoradiotherapy"
    "underwent preoperative chemoradiationand" "chemoradiationand" "p =0.046"
    "p =0.005" "p =0.002" "p =0.022" "p =0.027" "p =0.048" "=0.011" "p =0.006"
    "knockdown/perturbation" "LPBA" "ERFR" "approximately 1.5 h" "K-sensitive"
    "K-insensitive" "reciprocal co-immunoprecipitaiton" "immunocomplexes"
    "~13%" "~35%" "ESCRT-I" "0.4-ml" "Beckman" "4-ml"
    "the post-nuclear supernatant (PNS)" "TBS" "GenScript" "orthavanadium"
    "60-mm" "CQ" "35-mm" "SignaGen" "GenMute" "PolyJet" "Dulbecco’s"
    "Biologicals" "Mediatech" "non-shared" "ESCRTs" "~85%" "~8%" "~2%" "~15%"
    "1A3" "namely Drosophila melanogaster" "marscescens" "marcescens"
    "co-depleted" "AttacinB" "attacinB" "ird5" "fatiga" "non-hypoxic"
    "which targets IκB" "and 3α" "anti-bacterial" "treatment/prevention"
    "progrowth" "completely reduc ed" "reduc" "processing/activation"
    "buchananii" "Reissantia" "polymerase-1" "Hippocrateaceae" "Celastraceae"
    "cyclosqualenoids" "camtothecan" "Vinca" "quinonemethide"
    "the more active form MCAK SS632/633DD" "centromeres/kinetochores"
    "misalignments" "SS632/633AA" "Hecl" "SS632/633DD" "regrowth" "EFGP"
    "SS/DD" "SS/AA" "MTs" "depolymerizers" "S632/S633" "centromere/kinetochore"
    "non-phosphorylatable" "1a3" "growth/metastasis" "Drabkin's" "Drabkin"
    "injectino" "0/6" "6/6" "a publicly available algorithm" "H184B5F/M10"
    "R2N1d" "SeraMir" "disrupter" "± 1" "Non-transformed" "p = 0.04" "125a-5p"
    "P = 0.0062" "P = 0.04" "95% CI = 0" "P = 0.004" "resultes" "Haura"
    "amplex" "condensate (EBC)" "EBC" "condensate" "NOXs" "PD98509" "48-hour"
    "p = 0.038" "JAK-STAT1/2" "GMBs" "U87V" "U251V" "p5xATF6GL3" "EIF2α" "GICs"
    "U87EGFR" "U251EGFRind" "U251EGFR" "neurospheres" "EGFRwt" "1h" "2000g"
    "10ng/ml" "Pfirrmann" "Caramés" "LVF" "homolog-1" "fibrosus (AF)"
    "pulposus (NP)" "fibrosus" "annulus" "pulposus" "bafilomycin" "LC3-II/I"
    "1 h" "24 h" "lysosomal/vacuolar" "48 h" "Karube" "Renault" "Kops" "Biggs"
    "Brunet" "Giguere" "Tremblay" "Vogt" "Howe" "Wildey" "Akagi" "McFadden"
    "Philips" "Huynh" "Valderrama" "Shimokado" "Higaki" "Hagenbuchner"
    "p32FoxO3" "Miyazono" "Renard" "Knippschild" "Traugh" "Tuazon" "Naka"
    "Kato" "Waddell" "Conery" "Ramjaun" "Nass" "Seoane" "Yamamura" "Vignais"
    "Torregroza" "Runyan" "Remy" "Engel" "Enroth" "Zhang" "Derynck" "Garcia"
    "Massague" "RII" "5 ng/mL" "PDGF/PDGFR" "histochemistry" "nu/nu"
    "Foxq1-driven chemoresistance" "NCR" "nontarget" "CONTRA" "rVista"
    "HMLE/LacZ" "4T1/NT" "HMLE/Foxq1" "TGFb" "DUSP12" "NRC" "SIOPEN" "NCI60"
    "= 0.042" "2x" "Mith" "expression/activity" "mith" "phospho-I"
    "epiphenomenon" "-R2" "a very strong synergism" "CI10 " "CI5 " "CI0.1 "
    "re-sensitization" "receptor/ligand" "Samuels" "ED" "-mut-protected"
    "I κ B" "anti-tumoral" "5 ng/mL" "=0.51" "κ B" "10 ng/mL" "oncomirs" "Mir"
    "LT73" "LDCT" "IEO" "INT" "ko" "nonsmall" "deaths/year" "kinesin-3"
    "activity/function" "Nek" "A/B" "∼25–30%" "∼18%" "serine-to-alanine"
    "HA-β-TrCPΔF" "ΔF" "DpSGXXSpS" "phosphodegrons" "eluates" "Plkl"
    "DpSGILSpS" "DpSGFCLDpS" "DpSGVETpS" "phosphoserines" "S316:S317"
    "S304:S305" "SpSV" "SpSP" "DpSGXXpS" "–STARD9-MD" "DSGILS" "orthologues"
    "nonphosphorylatable/nondegradable" "STARD" "DSGXXSS" "Xkid" "thaliana"
    "AtKINUa" "DSGXXT" "SCFβ-TrCP" "DSGXXS" "multisubunit" "1 h" "∼8%"
    "papillary carcinoma—a subtype" "tricheck" "2p21" "Mbp" "Hashimoto"
    "Warthin" "Hurthle" "relatively subtle nuclear atypia" "TriCheck" "SPEC"
    "Zytolight" "Febbo" "radioiodine" "tumor–like" "≥2" "fluorochinolones"
    "lymphopenia" "MAC" "avium" "encephalomyelitis" "Hiwatashi"
    "auto-inflammatory" "S6RP" "GÖ6983" "IQR" "glomerulonephritis"
    "panbronchiolitis" "oxidases" "azalide" "mg/L" "AZM" "T202/Y204" "T-helper"
    "n = 4" "caspase 3/7" "p = 0.017" "p = 0.006" "p = 0.008" "p = 0.002"
    "p = 0.001" "co-stimulatory" "Lingxia" "InterPro" "ShSIRT1-2" "ShSIRT1-1"
    "correlationship" "cells/well" "axis32" "sirtuins" "Tert" "≥ 50%"
    "10 ng/ml" "Anti-Rabbit" "ShRNA1" "P = 0.02" "multihit" "PPPSPxS"
    "BRAF V600E -transformed IECs" "mouse intestinal epithelium" "colonocytes"
    "Phelps" "agonists/antagonists" "ΔNTCF4" "TOPFLASH" "wtMEK" "comprison"
    "caMEK" "transformed IECs" "IEC" "IECs" "4,6-diamidino-2-phenylindole"
    "n =53" "72 h" "Min/+" "angio-" "angio" "transmigrate" "capillary-like"
    "TargetScanV5.2" "re-seeded" "auto-" "bidomain" "positve" "Haebig"
    "S910A/S935A" "S910A/935A" "S976" "pS955" "pS908" "S973" "S955" "phosho-"
    "phosho" "pS935" "TMCB" "S910/S935" "casein kinase 1α" "30 mins" "CK1ε"
    "ANTI-FLAG" "CK1δ" "non-transgenic" "anti-invasive" "phospho/total" "DMBAD"
    "p/T" "Bazz" "total/phosphorylated" "9/21" "Ploemen" "biliverdin" "FAD"
    "S-glutathionylation" "GSTPs" "Halliwell" "GSR1" "A2780cisR" "Nrf2/EpRE"
    "DMCA" "multigene" "isoenzymes" "glutamyl" "dimercaptans"
    "phenylenediamines" "EpRE" "Polyphenols" "Michael" "polyphenol"
    "polyphenols" "=9" "nuclear/cytosolic" "Jarboui" "Naji’s" "Naji" "Gautier"
    "Nullbasic and exogenous DDX1were" "Nullbasic:DDX1" "pGCH"
    "Interferometry (BLI)" "Interferometry" "capsid" "Pfizer" "pGag"
    "cellular organization/cytoskeleton" "SCIEX" "ProteinPilot" "DDX56"
    "β-like" "transdominant" "× 1 " "1 h" "8 × 10" "p  = 0.02"
    "nuclear/cytoplasmic" "~ 80%" "p = 0.02" "~ 25%"
    "the predominant histology" "re-biopsy" "U-test" "P  = 0.013" "P  = 0.004"
    "2  + " "/ 2" "P  = 0.006" "Daecke" "shHRBL" "NLENG" "Jeang" "Houzet"
    "dVpu" "CD4++" "CLTC1" "4 independent genome-wide screenings" "Viral titer"
    "Genome-wide RNA interference screenings" "screenings"
    "late endocytic organelles" "non-infected" "rs10183914" "Taiwanese"
    "the PD-associated combined haplotype G AGC AAAA" "rs2886161" "rs7557529"
    "GAAAG" "AAAG" "GAGGG" "Goth" "Gothenburg" "neurosphere" "kelch-like"
    "rs35652124" "AAAA" "rs6726395" "p = 0.024" "1 – 3" "rs6721961" "≥ 5"
    "rs1806649" "= 0.042" "p = 0.048" "Gea" "Hernandez"
    "prolonged starvation favored CTGF re-expression" "proCOL1A1" "wortmanmin"
    "GFP-LC3B" "autophagic vacuoles" "vacuoles" "LC3-II/-I" "S7B" "S5A" "7 d"
    "PRDKC" "BioGPS" "TetOn" "H1963" "NU-7441" "shPRKDC-3" "shPRKDC" "OmoMyc"
    "CSNK1" "≤ 0.05" "* P  " "** P  " "*** P  " "#3" "non-druggable" "CSC-like"
    "P  = 0.001" "P  = 0.028" "/ 2" "lobuloaveoli" "YAP/TEAD" "uveal"
    "ERBB4/YAP/TEAD" "ERBB4/YAP" "Hippo/YAP" "myristate" "pINDUCER20-encoded"
    "27Ala" "MSCV-vector" "MSCV" "pINDUCER" "Cordenonsi" "YAP/Hippo" "MST1/2"
    "LATS1/2" "mouse mammary epithelium" "JM-a" "PPxY" "re-plated" "3 hrs"
    "anti-V5" "mcl2p53m" "mcl2p115" "mcl2p315" "UTR&promoter" "pcp53WT"
    "mcl2pwt" "CCL2/A549" "&promoter" "cells/100" "Δ16" "monocytes/" "Pellatt"
    "LTG" "Haplotypes" "risk/protection" "S/S" "L/S "
    "a polymorphic tandem repeat minisatellite" "minisatellite" "ins/del" "LL"
    "rs2736098" "MNS16A" "= 0.016" "95%CI = 1" "p = 0.002" "/S " "2X"
    "rs2735940" "p = 0.006" "p = 0.017" "95% CI = 0" "= 0.51" "dose/schedule"
    "Gokmen" "Brachmann" "vehicle/fulvestrant" "P7170/fulvestrant" "Smad1/5"
    "wks" "mg/kg/d" "T47D/FR" "MCF-7/LTED" "protooncogene" "PIK3CA /PTEN"
    "PIK3CA / PTEN" "P-p70S6K" "Schicht" "FOXP-3+" "FOXP-3" "affimetix"
    "affimetrix" "CD4+CD25+Foxp3+" "SSC" "immunostrategies" "Batf"
    "CD4+CD25+FOXP-3+" "CD4+CD25+Foxp-3+" "handside" "adeno-" "cryosections"
    "Raji Burkitt's" "Anti-human" "15 min" "ΔCT" "LVI" "micrometastases"
    "tissue+/serum " "tissue+/serum–" "tissue+/serum" "nontrastuzumab" "BCSS"
    "Oncology (ASCO)" "ASCO" "DMFS" "ADVIA" "n  = 53" "26.4 ± " "P  = 0.005"
    "P  = 0.015" "= 104" "= 11" "± 1" "P  = 0.012" "95% CI " "95% CI = 1"
    "P  = 0.001" "= 1" "1.05-1.65" "Loriot" "cfDNA" "ctDNA" "0–1"
    "mono-institutional" "Yu" "≥25%" "positive/positive" "negative/negative"
    "biospecimens" "n = 3" "n = 4" "n = 15" "= 9" "n = 11" "= 23" "≥50%" "≥2 "
    "p = 0.008" "p = 0.009" "PEST" "microvasculatures" "microvasculature"
    "RAS mutant tumors underwent hepatectomy" "metastasectomies"
    "patients underwent metastasectomy" "CALGB"
    "our series commonly underwent metastasectomy" "metastasectomy"
    "peritoneum" "21–1" "p=0.004" "p=0.024" "p=0.07" "chemoresponse" "Bonome"
    "Liu" "Singh" "etoposid" "shTRC1-" "TRC1-" "TRC1" "A2780cis-shGDF15-1"
    "shGDF15-" "shTRC1" "shGDF15" "shTRC" "Genedata" "Proteome" "p21 Waf1/Cip1"
    "vehicle-treated A2780cis" "the ovarian cancer model A2780cis" "shGDF"
    "mol/" "*** P  " "** P  " "* P  " "n=4" "≥150 " "μ mol/L" "Nyalendo"
    "HAECs" "eNOSmRNA" "RhoA/Rac1" "HMBG" "endproducts" "box-1"
    "non-stimulated" "Tosyl" "TEV" "co-associate" "TPR12" "30/TPR14"
    "the subsequent helix" "TPR9" "TPR8" "zig" "subdomain" "DALI"
    "roughly one-and-a-half turn superhelix" "superhelix" "RMSDs" "Helices"
    "selenomethionine" "Streptactin" "a minimal APC3-APC16 subcomplex" "D-box"
    "APC3Δloop" "Strep" "subcomplex" "protomer" "protomers"
    "parallel and form superhelical solenoids" "curvatures" "solenoids"
    "antiparallel" "superdomains" "holo" "Δloop" "quasi" "subcomplexes"
    "non-native" "Z-scores" "co-association" "RING-like" "Complex/Cyclosome"
    "Topoisomerasi" "g/ml" "p53siRNA" "MPS" "nul" "hSer20" "U2-OS/e" "U2-OS175"
    "aa20-25" "1p36" "17p13" "a semisynthetic epipodophyllotoxin derivate"
    "derivate" "epipodophyllotoxin" "osteoid" "FL2" "increasesthe"
    "phosphatidylcoline" "neonatal rat cardiac myocytes" "ELISAPLUS"
    "Quantitative morphometry" "morphometry" "-tg" "tg" "phospholipase D-1"
    "FASL" "DED" "∼5-fold" "16 h" "Burdon" "Ramdas"
    "a strong association forwas" "Barbados" "Caribbean" "forin" "forwas"
    "Thepolymorphism" "polymorphismin" "inSNP" "Thorleifsson" "SNPwas"
    "polymorphismwith" "andin" "thepolymorphism" "95% CI=0" "OR=0.69"
    "95% CI=1" "OR=1.49" "OR=0.54" "OR=0.52" "ofin"
    "the trabecular meshwork (TM)" "OAG" "cribrosa" "IOP" "Tham" "rs4236601"
    "rs1900004" "rs4656461" "ATOH7" "Pakistani" "PEXG" "PACG" "POAG" "±1.5"
    "nonimmune" "hyperresponsiveness" "characteristic facial gestalt" "gestalt"
    "hypoglycemia" "delE11" "FOXO1/3a" "FOXO1/3" "240/244" "235/236"
    "_181523.2" "HSCT" "intravenous immunoglobulin (IVIG)" "IVIG" "purpura"
    "lipoatrophy" "Rieger" "p50α" "p55α" "PASLI" "p85α" "Lucas" "re-sequencing"
    "gene/SNP" "Yamamoto" "Zighelboim" "Supernat" "Hoivik" "Kellis" "HaploReg"
    "Boyle" "RegulomeDB" "Howie" "Marchini" "Wellcome" "Infinium" "MLT10"
    "Sakoda" "Thomas" "Shen" "Prescott" "rs1317814" "rs2853668" "rs2736100"
    "eQTL" "Kandoth" "the larger TCGA RNASeq dataset"
    "publically available datasets" "non-endometrioid" "Pharoah" "rs7725218"
    "rs13174818" "the optimal subset" "Hoggart" "HyperLasso" "rs62329728"
    "rs13174814" "rs7705526" "Tyrer" "OCAC" "BCAC" "ECAC" "iCOGS" "Bojesen"
    "COGS" "James" "Turnbull" "Stacey" "Shete" "Petersen" "McKay" "Jarai"
    "Kote" "Haiman" "Gudmundsson" "rs4430796" "Setiawan" "Spurdle" "Palles"
    "Fearon" "Tomlinson" "Briggs" "Hemminki" "Beral" "Kaaks" "at 5p15"
    "iSelect" "5p15" "P  = 0.041" "P  = 0.032" "P  = 0.03" "= 0.13"
    "P  = 0.009" "1 × 10" "n  = 3" "8 × 10" "= 9" "P  = 0.0001" "χ  2" "≥5"
    "~5 %" "5 × 10" "= 1" "= 7" "× 10" "= 4" "Droplet" "VAFs" "Non-Hodgkin's"
    "UPNs" "ddPCR" "droplet" "CSMD1" "VAF" "refractory Hodgkin's" "exomes"
    "AML/MDS" "N-Nitroso" "Non-Hodgkin" "non-pathogenic" "anti-tumour"
    "Shakoori" "proliferation/viability" "cell proliferation/viability"
    "permeant" "12/29" "S641/645" "GSK3 S21/9" "25/29" "S21/9" "GSK3α/β"
    "recognises" "3/29" "xMAP" "quantitative immunoassay" "14/29" "S146A"
    "mg/cm 2" "electrochemotherapy" "T145A/S146A" "RXXS/T" "reaccumulates"
    "Chk1-pS345" "PF-477736" "γ-H2AXγ" "LCL" "lymphoblastoid"
    "co-immunostaining" "subdiploid" "DBSs" "p21 waf1" "48 hrs" "p21 Waf1"
    "mevalonate" "Argyrin" "#25" "QKO" "re-replication" "Co-deletion" "Zhao"
    "co-existent" "Maddocks" "ME1,2" "bisphsphoate" "phosphofructose" "cDKO"
    "subsequent de-expression" "omomyc" "Soucek" "co-deletion" "inRb1 +" "BCOR"
    "TRβ2" "RXRγ" "Grasso" "miR-17~92" "3KR/3KR" "apoptose" "senesce" "Eμ-Myc"
    "isoenzyme" "PDK" "DKO" "miR-34c" "co-occurrences" "S52AS88A" "CSRD"
    "approximately 3–4 h" "gpb2" "gpb1" "YMW208" "Ira1/2" "reenter" "proTAME"
    "MAPKAP" "eYFP" "16 h" "Penicillin/Streptomycin" "mir" "webserver"
    "MIRUMIR" "miR-148b" "biological replicate"
    "multiple biological replicates" "technical replicates" "let-7a" "miR-374a"
    "miR-1273a" "6TP53−/−" "Ser1981" "let-7a-2" "PLoS" "Aerts" "cisTarget"
    "TransMir" "pval" "non-DDR" "BLASTN" "365a-3p" "numberDof" "18-30nt"
    "miRNAome" "NAs" "h" "Hg18" "= 0.0009" "miR-20a" "9/10" "A247P"
    "aa1613–1781" "Δ1" "doxycyline" "homologies" "MKLP" "ESCRT"
    "a shorter fragment aa173–264" "aa173–264" "this minimal region aa173-317"
    "aa173-317" "BRC5" "HMG2b" "KLCC" "kinesin-like" "non-conservative" "+Dox"
    "non-sequence-specific" "BMS911543" "α2-3,6" "RCA-I" "fromSt3gal4"
    "splenectomy" "BMMK" "intoAsgr2" "andAsgr2" "orAsgr2" "ofSt3gal4"
    "Essential Thrombocythemia (ET)" "andSt3gal4" "InSt3gal4" "fromAsgr2"
    "inSt3gal4" "inAsgr2" "platelet circulatory lifespan"
    "the circulatory lifespan" "MKs" "Essential Thrombocythemia"
    "Thrombocythemia" "The highly conserved endocytic AMR" "AMR" "Morell"
    "Ashwell" "anti-phosphotyrosine" "or 2 μM" "non-inclusion" "JAK1/2"
    "currently 0.7 mg/kg/day" "Morzadec" "phagophore" "Arg2  +/+"
    "-cystine-HCl (BEC)" "NOHA" "bromoethyl-" "bromoethyl" "pBudCE" "ARG1"
    "methyladenine" "236:RPS6" "236: RPS6" "HAEC" "-II" "reuse"
    "AKT-MTORC1-RPS6KB1" "wk" "LC3A/B" "and 3rd" "2  +" "JFCR24" "JFCR39"
    "inefficacy" "PI3Kis" "non-negligible" "BYL-719" "= 2" "P  = 0.004"
    "P  = 0.01" "immunohistochemical stainings" "Immunohistochemical stainings"
    "stainings" "Snail1acts" "DNAP" "HA-p38 DN" "co-Smad" "Smads" "dI-dC"
    "anti-phospho-Ser63" "Twenty-one" "-8-phenyl-4H-1-benzopyran-4-one"
    "co-regulators" "phosphatidylinositide" "p21−/−"
    "the isogenic colon cancer cell lines HCT116 p21+/+" "p21+/+" "SBE13"
    "MDA-MB-231 cells" "and 3 rd" "Hilgendorf" "non-stressed" "S807/S811"
    "72 h" "2–3 " "non-apoptotic" "non-transcriptional" "punctae" "LC3BI"
    "fluoresces" "-dichlorodihydrofluorescein" "dichlorodihydrofluorescein"
    "chloromethyl" "non-genotoxic" "μg/μL" "N-acetyl" "10.1038/ncomms6685"
    "Furness" "the cell-type-specific penetrance" "Varma" "Erythro-9-3-" "EHNA"
    "hydroxynonyl" "Blu577" "Yanagida" "Toyoda" "penetrant" "TopoIIa"
    "PKCεM486A" "very few wild-type kinases" "CLEM" "siControl" "failsafe"
    "overridden" "non-disjunction" "dioxopiperazine" "bis" "topoIIa" "RZZ" "Cε"
    "Brownlow" "P -values" "±1" "RAD3-related" "=0.0008"
    "metaphase-to-anaphase" "H3T6" "H3T6ph" "~39%" "~56%" "~42%" "nonhistone"
    "coactivate" "coactivates" "1×10" "~5-fold" "Trojan" "Gs"
    "the pivotal nick-producing enzyme 8-oxo-guanine-DNA glycosylase"
    "8-oxo-guanine-DNA glycosylase" "8-oxo-Gs" "H3S10ph" "overthrown" "EREs"
    "servo" "Rad3-related" "non-mammalian" "biochemists" "anti-cleaved" "C/D"
    "Golic" "Titen" "aneuploid" "inpuc" "puc" "Brinker"
    "mitosis often cause segmental aneuploidy" "McNamee" "RHG" "Brodsky"
    "Dp53’s" "GMR" "decapo" "DIAP" "Dp53" "Dp53ΔC" "ΔNp53" "ofArf" "andArf"
    "Saporita" "metallothionin" "intitania" "betweentitania" "monosomes"
    "usingtitania" "the small ribosomal subunit processome" "tti" "titania"
    "RGB-286638" "Cirstea" "PeBoW" "bothp53" "p53DD" "Iadevaia" "Donati" "6AU"
    "azauracil" "Herreros" "Gomez" "regulon" "SBF" "Neumüller" "Modulo"
    "pitchoune" "jumeaux" "viriato" "modulo" "Calvin" "Lewy" "Hutterite"
    "Conradi" "Bowen" "hUTP14a" "retrogene" "intronless" "hUTP14c"
    "hUTP4/Cirhin" "Cree" "Ojibway" "Baserga" "Sondalle"
    "the small ribosomal subunit (SSU) processome" "Tikoo" "dwarfism" "Werner"
    "RMRP" "RRF" "exocrine" "Schwachman" "reticulocytopenia" "Thumati" "DKC"
    "Pereboom" "H/ACA" "haplo" "Tcof" "/treacle" "Collins" "Narla"
    "Ribosomopathies" "nucleolar re-organization" "roscovitin" "ribosomopathy"
    "Bursać" "cardiovascular pathophysiology" "Sussman" "Avitabile" "Pederson"
    "non-rRNA" "G1-G2-G3-G4-G5" "YawG" "NFĸB" "INKa" "Milner" "Rubbi" "LSU"
    "SSU" "the second internal transcribed spacer" "non-ribosomal" "processome"
    "Olson" "Hadjiolov" "Cullis" "Jordan" "Smetana" "Busch" "Overview"
    "ribosomopathies" "oncologists" "non-nucleolar" "co-precipitates"
    "Factor-1" "co-localizations" "non-stress" "hallmarker" "RFPL"
    "protein-like" "co-activation" "P = 0.002" "22q12.3" "HLA/APM" "pSTAT"
    "Th1/Tc1" "MDSC" "Th1/Th2" "MFI" "ITSM" "p=0.04" "Luminex" "BMS-936558"
    "hIgG1" "-CD28" "BMS" "p=0.0001" "p=0.02" "TCR/CD28" "co-inhibitory"
    "immunotherapies" "PBL" "Tc1/Th1" "Th17" "re-introduced" "p=0.002"
    "P-values" "TUSC4-" "TUSC" "the mammary fatpads" "fatpads"
    "MDA-MB-231cells" "Sce" "HRD" "3p21.3" "A/G" "Wierer" "PLKsiRNA" "EE"
    "FOXM" "MCF7/LTEDs" "dihydropteridinone" "PLK1siRNAs" "HCC1428/LTED"
    "Z-score" "siCTL" "renilla" "downregulators" "JUNB" "MCF7/LTED" "2 x"
    "72 h" "microvessel" "Raoux" "Hattab" "CD10+/BCL6+/MUM1/IRF4+" "DBLCL"
    "18q21" "polysomy" "Brunn" "all possible deciles" "deciles"
    "the cytomorphologic subtype" "tetraploid" "triploid" "Karyotypes" "8q24"
    "BCL2+" "MYC+" "≥40%" "non-GCB" "BCL6+" "IRF4+" "BCL6-" "BCL"
    "plasmacytoid" "WBRT" "ECOG" "KPS" "Karnofsky" "dural" "COO" "Hans"
    "aggressive subtype" "p = 0.07" "p = 0.09" "n = 4" "as 1+" "as 2+"
    "Lauren’s" "Lauren" "tubulo" "unusual aggressive histotypes" "hepatoid"
    "histotypes" "histotype" "Cohen" "lymphnode" "and 3+" "HLI98" "Tenovin"
    "benzodiazepinedione" "Koom" "a convenient and useful non-invasive"
    "Sirtuin-3" "Warburg" "sirtuin" "Korean" "hepatectomy" "hotspots" "n =4"
    "72h" "84.2±3.2%" "88.8±3.6%" "67.5±2.8%" "QIAGEN" "10-cm"
    "TSC2-re-expressing" "146.8±21.7%" "50±12%" "IFN α/β" "Multicenter" "±10%"
    "±12%" "n =3" "RIDD" "UPRosome" "cIAP1/2" "VAD" "members—is" "un-"
    "an essential organelle" "non-silencing" "—is" "caner" "XRCC1-m5"
    "XRCC1-m4" "XRCC1-m3" "SGC7901/DDP" "BGC823/DDP" "× SDS" "Kit-8" "S/T"
    "myoid" "progestin" "non-proliferative" "S10A" "confocal miscroscopy"
    "miscroscopy" "IMMT" "nonredundant" "hundred
seventy-one"
    "the 27 unique F5 HCIPs" "the unique F3 HCIPs" "COMMD" "Holliday" "HCIP"
    "D-score (NWD)" "FV" "NA" "PLAPON" "IX81" "Fluoview" "+DAPI" "SlowFade"
    "Coverslips" "Sloan" "GePS" "Kodak" "BioMax" "antirabbit" "antimouse"
    "ProteinExpress" "BD" "TNET" "nonfat" "NWD" "CompPASS" "UniProt" "SEQUEST"
    "Velos" "Francisco" "Packings" "autosampler" "Famos" "acetonitrile/5%"
    "Empore" "Eluates" "rpm" "REx" "HCIPs" "microfuge" "Noël" "Mirus"
    "InvivoGen" "ZFYV9" "pDONR" "ORFeome" "Howley" "TetON" "GAW" "CMVt"
    "pDONR223" "pFlag" "Mailand" "Neils" "omain (RLD)" "erminus" "arboxy"
    "omain" "ike" "HERC" "multidomain" "kinases" "INPP" "PARTEK" "Ch10q26.11"
    "athanogene" "REMBRANDT" "Ras/Extracellular signal regulated kinase"
    "2/signal transducer and activator of transcription 3" "-kinas" "kinas"
    "10q26.11" "10q" "U133 plus2" "U133" "30 min" "Co-IP" "phosphoSmad2/3"
    "oesteoblasts" "Zhou" "healthy parenchymal HLMFs"
    "the classic fibroblast-like" "depolarises" "TGFβRII" "ICA-17043" "ICA"
    "NFC" "HLMF" "HLMFs" "= 0.0003" "= 0.0008" "Smad 2/3" "Smad2/3"
    "non-linear" "subsystems" "phosphoribosyl" "Mondo" "Mxd" "feedforward"
    "disinhibits" "offs" "NextGen" "dKDM5/LID" "MycBoxII" "Mga" "continuum"
    "dMnt" "E-box (CACGTG)" "CACGTG" "non-targets" "E-boxes" "E-Boxes"
    "nonobese" "insulin-glucose–" "euglycemia" "hyperaminoacidemia"
    "mTOR-p70S6K" "GSKβ" "p-p70S6K" "ANCOVA" "μmol" "mTOR" "∼20%" "∼60%" "∼40%"
    "∼30%" "n = 11" "HVLL" "Hydroa" "Martinez" "Quintanilla" "spearman" "AHCT"
    "corticosteroids" "TCRγδ" "adequate workup" "TCRαβ" "karyotypes" "situ"
    "lymphadenopathy" "Hematopathology" "Ohshima" "severe CAEBV" "fulminant"
    "overt leukemia/lymphoma" "America" "STLPDC" "ANKL" "CAEBV"
    "non-immunocompromised" "T/NK-cell" "M-group" "P-group" "systemic TNKLPD"
    "T/NK" "TNKLPD" "CD8+" "heterotrimer" "chromatin-bound MRN" "MRN/CtIP"
    "one-ended DSBs" "BKV" "viral genomes" "RNAaseA" "pS2056" "kilobases"
    "∼49%" "non-focal" "pT68" "timeframe" "dHJ" "BSC40" "non-replicating"
    "theta" "concatemer" "monomeric viral genomes" "the SV40 viral genome"
    "Xba" "ATMi" "NEHJ" "repair replication-associated DSBs" "concatemers"
    "Seckel" "KU" "MRN" "KU70/80" "Papillomaviridae" "Polyomaviridae"
    "the viral genome" "*  p" "≤  0.05" "* p" "∼90%" "non-homologous"
    "dichotonomies" "siNeg" "shNeg" "pM" "co-dependence" "co-dependent"
    "doublings" "The high-grade serous histologic subtype" "co-inhibition"
    "OCs" "OC" "1 × 10" "Caspase3/7" "Co-treatment" "non-cellular" "bio"
    "urothelium" "castPCR" "TaqMan" "ureter" "P = 0.046" "P = 0.001" "MHCs"
    "biotherapy" "CD3+" "AdSurp-Hsp70+CIK" "atypia" "CIK" "PDTX" "BALB/C"
    "Anti-tumor" "anti-tumor" "PIKCA" "p=0.176" "ipsilateral pleura parietalis"
    "parietalis" "pleura" "histology (SQCC)" "histology (AD)" "-wildtype"
    "dideoxy" "co-occur" "=0.002" "n=24" "Rosenbluh" "Shao" "Valta" "Sonvilla"
    "12,809 binary PPIs" "interolog" "LR" "biological datasets"
    "85,083 unique PPIs" "BioGRID" "almost all PPIs" "HomoMINT" "HPRD" "T3/4"
    "T1/2" "colorectal epithelium" "RUNX" "Mspone"
    "the mouse mammary carcinoma cell line SC-3" "SC-3" "colonoscopy"
    "5-Bromo-2" "to 14-3-3" "3/4" "acH4K16" "non-enzymatic" "H4K16" "H3K56"
    "inhibition/expression" "Tricostatin" "Hodgkin's" "Hodgkin" "Hda1p"
    "anti-AML" "comparative transcriptome" "GenBank" "the orally available JNJ"
    "JNJ" "xenoarray" "the non-silencing control lentiviral supernatants"
    "BioDigitalValley" "ProteinQuest" "around 300 nt" "realtime"
    "infections/selections" "amplification/" "snapshot-like"
    "The BH3-mimetic drug gossypol" "gossypol" "DBC" "DBCs" "platin"
    "RAS-transformed HMLEs" "haRAS" "HMLEs" "U/ml" "p = 0.013" "ER +"
    "p = 0.004" "moderate-to-strong" "the proband’s" "interstrand" "Δ512-1283"
    "LC50" "KFB14-2" "FA-like" "DEB" "KFB14-1" "The proband's" "Finnish"
    "_007294: c" "*35" "_597del" "_007294:c" "Canada" "FORGE" "OMIM" "Dubowitz"
    "A prophylactic mastectomy" "Mastectomy" "1990g" "microsomia" "D2-I"
    "MCF10" "transcription/activity" "other fibrillar collagens" "perlican"
    "XI" "discoidin" "secretory alveoli" "lumens" "Ser199/Ser204" "disassemble"
    "multiprotein" "SH2B1β" "independnet" "constitutively active JAK2 V617F"
    "Y3F" "SNAILP" "nonmuscle" "TCoB" "mitoses" "p110C" "sphingosine" "GBD"
    "PRL dramatically changes adhesiveness" "adhesiveness" "mammary epithelia"
    "chemoattractant" "tranducers" "Tyrosyl" "tyrosyl" "p38 MAPK" "pSTAT5"
    "JAK2 V617F" "PAK1 T423E" "Molleken" "Elwell" "pixel" "nMDP" "micrographs"
    "bacterial attachment/internalization" "Swanson" "aeruginosa" "Fischer"
    "muridarum" "mean ± SEM" "LSM 710" "γ1" "Co-localization" "intraperson"
    "representativeness" "biospecimen" "RPCI’s" "Western New York" "York" "FFQ"
    "p=0.001" "Taxvig" "DBBR" "RPCI" "Roswell" "immunochip" "Sjögren's"
    "Sjögren" "Gourh" "rs2736340" "rs1062292" "Allanore" "HaploView" "P-value"
    "rs1062292T" "rs13277113" "C8orf13-BLK" "PUMCH" "French" "vaiants"
    "rs2736340T" "rs13277113A" "MassARRAY" "= 0.03" "χ2" "χ 2" "P = 0.04"
    "95%CI " "Olsen" "oldest-olds" "Abrahamsen" "Eiken" "Banasik" "Kuningas"
    "Jacobsen" "a retrospective lookup" "lookup" "rs3800231" "rs12206094"
    "rs479744" "nonsignificant" "Nybo" "rs2802292" "Ambrogini" "Paik"
    "Haeusler" "Arden" "Pino" "Schips" "Miyamoto" "Warr" "Hinman" "Castrillon"
    "follicles" "Peng" "Giannakou" "Junger" "Melanogaster" "Tindall" "Broer"
    "Bao" "Bona" "Zeng" "Soerensen" "Pawlikowska" "Flachsbart" "Anselmi"
    "Willcox" "Hjelmborg" "Christensen" "McGue" "Frederiksen" "oldest-old"
    "ADL" "Danes" "P  = 0.006" "SP/SASP" "amniocytes" "PGPS" "Pp38 MAPK"
    "pg/ml" "Pp38MAPK" "Romero" "decidua" "bacterial antigens" "alarmin"
    "p38MAPK" "pPROM" "preterm" "non–infectious" "p = 0.007" "= 0.0009"
    "p = 0.009" "p = 0.015" "p = 0.031" "= 0.0003" "Thr183/Tyr185" "n = 13"
    "= 11" "n = 8" "non-infectious" "monocytogenes" "CH040" "ex " "inocula"
    "WITO" "REJO" "RLU" "postcoculture" "YU2" "IMCs" "postuptake" "M-tropic"
    "∼2%–3" "pixels" "non-CD3-associated" "brightfield" "∼75%" "vDNA" "hr "
    "transwells" "IMC" "uninfected/healthy" "uninfected/"
    "uninfected/dead/dying" "infected/healthy" "dead/dying"
    "apoptosis/necrosis" "ImageStream" "cell surface viral antigen" "-GFP  +"
    "Jurkats" "T/F" "virological synapses" "VSs" "cell-to-cell"
    "transmitted/founder" "et " "nonmacrophage" "= 10" "∼2%" "∼25%" "GFP +"
    "S3C" "S2F" "∼10-fold" "GFP  +" "oxygenase-1" "phospho-ERK1/2" "dipeptidyl"
    "3A4" "HER2CA" "~1.5-fold" "~2-fold" "Co-expression" "Kelch-like" "ASD/FXS"
    "mGluRs/" "overex" "FXS/ASD" "Ras/ERK/Mnk" "inMnk" "Mnk1/ Mnk2" "Ras/Erk"
    "CamKIIa" "Mmps" "prorecombinant" "cannulas" "Ras/MAPK/Mnk" "orchidism"
    "ASD-like" "dihydroxyphenylglycine" "subthreshold" "andMnk" "rotarod"
    "C57Bl/6" "MAPK/ Mnk" "cosediments" "inEif4e" "ribo" "ki/ki" "inFmr1"
    "repetitive/" "Macroorchidism" "-Tg" "FXS-like" "thalamus" "proprotein"
    "knockin" "Ras/" "CPEB1" "roteins" "/Mnk" "mGluRs" "macroorchidism" "LTD"
    "CGG" "ASDs" "Mmp" "1/S" "μg/μl" "~50%" "~25%" "re-repression"
    "global 5hmC" "TAB" "hMeDIP" "MeDIP" "carboxycytosine" "formylcytosine"
    "dioxygenases" "5mC" "5hmC" "hydroxymethylcytosine" "Non-Malignant" "shNT"
    "Allen" "shSema3C" "tumorsphere" "non-stem" "tumorspheres" "histoscore"
    "PlexinA2/D1" "the neural circuitry" "TGFp" "autocrine/paracrine" "NSTCs"
    "NSTC" "caspase3/7" "co-culture" "co-cultured" "3B" "co-immunofluorescence"
    "two/three" "PenArg" "sMTid" "in vivo biological readouts" "disruptors"
    "3b" "SAHp53-8" "ATSP-7041" "ATSP" "sMTide" "SJ-172550" "cyclotide"
    "weak and transient PPIs"
    "random integrated cells generated higher total BiLC" "integrant"
    "FANCL_C307A" "Ube2t-FANCL_C307A" "integrants" "_C307A" "BiL"
    "xchange (RMCE)" "BiLC" "RMCE" "xchange" "assette" "unmet" "LISA" "ReBiL’s"
    "ReBiL" "signal-to-noise" "HIV-1 proviral genomes" "SFCA" "E-subunit"
    "heptad" "TAR" "C-type" "viremia" "HARRT" "H4K12-Ac" "PRC4"
    "the proviral genome" "Ac" "pS529" "pS175 +" "pS175+" "phosphoantibody"
    "Dynal" "CD8a-d2EGFP-IRES-Nef" "Planelles" "Bosque" "weakest" "2D10" "Ec"
    "the bacterial supernatants" "histone-3" "HLMTs" "class-3" "du" "Kaposi’s"
    "Kaposi" "class-1/2" "Fn" "nucleatum" "gingivalis" "TEFb" "HAART" "H3K9"
    "NL 4-3" "N/C" "ubiquitination/degradation" "stability/degradation"
    "stabilisation/degradation" "nucleus/cytosol" "shBCAS2#1" "HNTEP" "hPrp"
    "ERR" "15 min" "rapalog" "all three DNA damage-induced phosphoryations"
    "phosphoryations" "4 hrs" "4hrs" "PIKK" "mTORC1/2" "HCT116 p53 +/+"
    "ubiquitination/deubiquitination" "Txr" "shFKBP5" "shAR"
    "stability/activity" "phosphorylation/activity" "ribose" "subseries"
    "FKBPs" "tacrolimus" "peptidylprolyl" "immunophilins" "PHLLP" "solute"
    "mitotoxins" "txr" "mitotoxin" "-2 H -tetrazolium" "non-treated" "Malinen"
    "the remote VDREs" "de-condensation" "co-occupation" "Pervin" "leveles"
    "12C" "VDREs" "Stillman" "Mendez" "JHU" "shBRCA1-#1" "cyclophillin" "WT145"
    "KO240" "SiGenome" "XTT" "form secondary mammospheres"
    "EB1089-treated mammospheres" "Mammospheres"
    "secondary and tertiary mammospheres" "non-adherent" "Mammosphere"
    "catabolizes" "cytosplasm" "0.1–1" "QW-1624F2-2" "non-calcemic" "OH"
    "calciferol" "Dihydroxyvitamin" "VDRE" "p21waf1" "QW" "dihydroxyvitamin"
    "1 hr" "w/v" "15 mins" "non-permissive" "#1-" "subG1" "shBRCA1" "~20%"
    "5382insC" "co-repressors" "co-occupies" "Thomson" "Rothmund" "BML" "CDCA2"
    "Smirnov" "Kolmogorov" "PennCNV" "26/34"
    "identified nine repeatedly deleted CNVRs" "CNVRs" "OncodriveFM" "VarScan"
    "SNVs" "endometrioid" "person-years" "adnexa" "18q" "17q12"
    "PIK3CA /INPP4B/SGK3" "IGF-1-stimulated" "BYL" "soft agar" "pT320"
    "Tumorscape" "SGKs" "AGC" "PtdIns-3,4" "PtdIns-3,4-P" "phosphoinositides"
    "PIK3CA /" "PIK3CA/" "RXRXXS/T" "Barros" "RacGTPases" "PAK1T423E" "LIC"
    "PAK1+/+" "PAK1−/−" "2-3" "co-infected" "*p" "Tiam1 shRNA" "RacGEFs"
    "WTFAK" "FAK+/+" "KITD816V+" "FLT3ITD+ve" "FLT3ITD+" "WTKIT" "FAK−/−"
    "FAK+" "FLT3WT" "Golubovskaya" "lane 1" "KITWT" "KITD814V" "pStat5"
    "FLT3ITD" "KITD816V" "ITD" "10ng/mL" "pPAK1" "RacN17" "~5%" "~ 30%"
    "PPAR-γ2" "cells/cm 2" "S807/811" "OIM" "succinimidyl" "carboxyfluorescein"
    "multilineage" "2× SDS" "1 hr" "15 min" "5 × 10" "S4F" "inSirt1"
    "interacton" "BRCT5-6" "BRCT1-2" "3KQ" "3KR" "Sirtuin" "Co-IPed"
    "Sirt1  +/+" "Anti-FLAG" "Yung" "Blumenstein" "Cindrova-Davies" "Lappas"
    "coworkers" "Carson" "Ämmälä" "Davies" "T37/46" "Transducer"
    "re-oxygenation" "stressful" "15 min" "De-identified" "Livant" "re-couple"
    "AREG-EGFR-PTEN-null" "growth/survival" "expression/phosphorylation"
    "motile" "COLT" "pFDR" "quant" "Hochberg" "cell lines/conditions" "pT389"
    "pT202/Y204" "gefitinib-treated MCF-10A+EGF" "pS536" "pT308" "pT235/pT240"
    "pS65/pT37" "time=0" "MCF-10A+EGF" "MCF-10A+AREG" "RPPAs" "pS473" "omics"
    "Seq" "an aggressive and drug-resistant subset" "Masuda" "SUM-229"
    "SUM-1315" "motility/invasion" "HG19" "aggressive TNBCs" "=50"
    "combination-shTEX14+shSCYL1" "levels/function" "amplicon" "Δ705–730"
    "Δdegron" "egulators" "RDRs" "REST4" "this aggressive subtype"
    "phosphodegron" "RE-1" "HER2+" "EX14" "CYL1" "EX"
    "the aggressive triple-negative breast cancer subtype (TNBC)"
    "subtype (TNBC)" "non-catalytic" "=8" "hetero-"
    "the characteristic concave-up Scatchard" "intra-" "ligand-bound ECRs"
    "A265D" "around 3 kcal/mole" "kcal/mole" "A265V" "Springer" "back-to-back"
    "clearer" "Spitz" "ΔC" "ΔS" "ΔH" "ΔG" "Gibbs" "Y251A/R285S" "sensorchip"
    "isothermal titration calorimetry (ITC)" "calorimetry (ITC)" "≤10-fold"
    "GCN4" "Fc" "dEGFR" "Scatchard" "ECRs" "ECR" "half-of-the-sites" "outs"
    "XY" "subsample" "Aviv" "Hartman" "Burnett" "Catarino" "ε2" "90+" "MADT"
    "Danish" "1.8–3" "75+" "78+" "Stockholm" "TTAGGG" "C/C" "T/T" "Swedish"
    "Kungsholmen" "= 0.84" "anorexia" "basutinib" "CXCLR" "=10" "~6-fold"
    "4-to-5-fold" "Glinsky" "CCRl" "multiplicate" "metallo" "Tartrate"
    "intracardiac" "QT" "m/min" "retroviruses" "Kim" "Filder" "PEC" "H & E"
    "Kramer" "Tukey" "I-block" "Tropix" "difluoride" "topolyvinylidene"
    "PREPTM" "iNtRON" "×SDS" "proliferation/survival" "Biotech" "Stedim"
    "Sartorius" "Vivaspin" "ScienCell" "Sciencell" "zymogen"
    "cell proliferation/differentiation" "SB431452" "Immunocytochemistry"
    "MMP-2/9" "WST" "–10 ng/mL" "uncontrolled expression/activation"
    "modulating axonal growth/regeneration" "BBB" "Non-cell" "multisite"
    "HPV-E6b" "LXCXE" "an approximately 40 residue spacer" "spacer"
    "pRb-AB:ppE7" "ppE1A" "ppHPV" "~1000-fold" "Bernat" "E7L67R" "retrovirus"
    "anti-acetyl-lysine" "BJ" "-α 3" "N-TAZ2:E7" "1:0.25" "pRbAB" "1:0.5"
    "B-subunit" ":TAZ2" "programnmrK" "Pulldown" "serotype" "LxCxE" "TAZ2"
    "HPV6b" "α 4" "α 3" "N-labeled" "= 28" "co-activators"
    "immature osteoblasts" "Schrader" "co-culturing" "moduli" "modulus" "× 1"
    "NOD/SCID" "this medically inoperable subset" "comutations" "-WT/unknown"
    "histologies" "ie" "FFDM" "LRC" "WT/unknown" "at least 100 Gy"
    "v-Kiras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "1-year" "Oncology" "Histology" "SBRT" "= 20"
    "non–small" "non–small-cell" "mt" "Maxi" "TFIIIA" "GATOR"
    "the largest subfamilies" "KIM12" "isogenic DLD1" "DLD1" "P-S6K1"
    "immunohistochemistry (IHC)" "Rheb15" "CAAX" "Duolink" "immunocomplex" "dS"
    "YPT7" "YPT6" "ts" "ypt" "subfamilies" "vacuole" "re-stimulation" "leucyl"
    "rapalogs" "non-cancerous" "de-identified" "intermembrane" "homolog" "NHDF"
    "CellTiter" "A2780cis" "Mdivi-1" "mdivi-1" "inhibitor-1" "caspase-3/7"
    "E-suppression" "cobblestone-like" "/TLE" "co-repressor"
    "transcriptional co-repressors" "fibroblastoid" "24h"
    "Epithelial-to-Mesenchymal" "UN" "co-chaperone" "co-purified"
    "IKCMDYGFIKPVS" "DKAVEYGLIQPNQDGE" "calipers" "polyploid" "ploidy" "UNC45B"
    "UNC45" "co-precipitated" "co-purifies" "Nu/Nu" "1/ S" "endoscopies" "Wu"
    "pTNM" "more advanced T-stage" "Ryu" "lymphadenectomy" "gastrectomy"
    "= 0.001" "CD44 + " "stem cell-like" "2q23.1" "20q11" "all benign CNVs"
    "Megabases" "cryptozoospermia" "IRB" "heritages" "Clinically relevant CNVs"
    "pAla102Thr" "#9" "#8" "#6" "2E–F" "2C–D" "Leydig" "PolyPhen-2" "p=0.007"
    "ACTL10" "CBFA2T2" "orchiopexy" "non-obstructive" "Sertoli" "cryptorchid"
    "20q11.22" "CNVs" "CNV" "aCGH" "NOA" "non-small cell lung carcinoma" "Katz"
    "Zheng" "Tensin-Like" "tensin-like" "co-localizes" "μ g/mL" "detoxifiers"
    "potential trait-associated SNPs" "rs3749930" "the individual SNP’s"
    "the previously described promoter SNP" "p=0.031" "p=0.017"
    "donor/recipient" "several intronic SNPs" "p=0.006" "paraoxonase-1"
    "p=0.048" "rs3811699" "rs1800668" "rs9818758" "SNPset" "p=0.01" "LTOG"
    "p=0.012" "=0.028" "nuclear factor (erythroid-derived 2)-like" "p=0.026"
    "=0.01" "undirect" "endomethrium"
    "Ambra1  +/gt apparently healthy bronchioli" "bronchioli"
    "transcription factor-1" "masses" "pulmonary parenchyma" "alveoli"
    "+AMBRA1" "PXP" "PxPxxxR" "F3b" "co-regulation" "de-stabilization" "c" "Pp"
    "morphant" "hyperproliferate" "+/gt" "gt/gt" "AMBRA1-" "AMBRA"
    "de-regulation" "co-transfecting" "Protein Phosphatase 2A"
    "at least partially overlapping cistromes" "cistromes" "ZNF143-" "ZNF"
    "TCCCA" "ACTACA" "Staf" "BOD1"
    "a well-studied transcriptional co-regulator" "this restrictive subset"
    "available ChIP-seq datasets" "wildtype" "E2F3a" "THAP11/extended"
    "co-occupy" "ed" "reChIP" "scatterplots" "Pairwise" "Thanatos"
    "BRCA1 associated protein-1" "Yang" "HxY" "Wysocka" "co-regulator"
    "a metazoan transcriptional co-regulator" "factor-1" "hg19" "co-occupied"
    "Morphometric descriptors" "descriptors" "glucorcorticoid" "RLA"
    "isobutylmethylxanthine" "non-induced" "n = 3" "Non-targeting"
    "Hoechst 33342" "and 3T3" "fibroblast-like" "PAPL" "MTEFD1" "Verdoliva"
    "Findeisen" "melanin" "ASPH" "VATL" "TPA" "longer responders" "TPB" "TRB"
    "T1B" "Meyer" "&M" "BRAFwt" "M-stage" "÷29+" "TMZ/FM" "interchip"
    "intrachip" "mass/charge" "individuate" "ToF" "SELDI"
    "only certain subsets" "nitrosureas" "abraxane" "responder"
    "shorter responders" "m/z" "p = 0.008" "= 20" "the largest dataset"
    "a larger subset" "LO" "Baumbusch" "intactness" "reevaluate" "Kang"
    "=  0.04" "=  0" "95% CI  " "=  1" "p = 0.05" "BRCA1 / 2" "intrastrand"
    "phosphorothioate" "Koller" "Tamura" "co-precipitation"
    "well-designed sgRNAs" "-O-methylated" "-deoxyuridine" "deoxyuridine"
    "sgL5" "Caspase 3/7" "sgH5" "FUCCI" "Alexa568" "vide" "sgHT5" "sgHT2"
    "sgLucHep3" "Lipofectamine" "anticodon" "pairings" "Genbank" "cheaper"
    "heptamer" "living cells various artificially-designed sgRNAs"
    "pre-tRNA-like" "HNSCCs" "sgRNAs" "sgRNA" "ZL" "48 h" "heterozygotes"
    "Brazil" "Iran" "A:T" "G:C" "440delG" "_466dupCCGCCCGGCACCC" "_639del19"
    "*57" "AIC" "codon 72" "Nephropathy" "Barrett's" "Barrett" "adeno" "HNSCC"
    "clinico" "SCCOT" "ubiquitome" "Perhaps" "α NH 2" "sidechains" "Δ~Ub"
    "discoideum" "Dictyostelium" "Δ-KK" "aegerita" "Agrocybe"
    "the dimer-disrupting mutation V30K/D67K" "V30K/D67K" "V30K" "crossover"
    "SPARTA" "helix-3" "Ramachandran" "Chemical-Shift-ROSETTA" "ROSETTA"
    "Rosetta" "HN" "crosspeaks" "-helix" "TROSY" "HSQC" "sidechain" "-helices"
    "hetNOE" "Ubs" "αNH 2" "Ube2w~Ub" "εNH 2" "/BD" "mono-Ub" "iquitin"
    "RING-between-RING-type" "E2~Ub" "Ubiquitome" "αN-terminus" "re-applied"
    "1hr" "Cα" "ConSite" "+121" "+115" "deoxynucleotidyl" "transfectants"
    "transfectant" "Annexin V-APC/7-amino-actinomycin D" "9/9" "85/120" "2/25"
    "0/20" "BGS" "CACTTTG" "vitr" "44 K" "48 h" "24 h" "APC/" "non-tumor"
    "Durando" "anti-FLAG" "Polη" "24 h" "electrophysiology" "theseTsc1c"
    "relaxant" "Trichrome" "Tsc1/2" "inTsc1c" "RVSP" "versusTsc1c" "2–3"
    "T2−/−" "andTsc1c" "wSMAcre" "conditionalTsc1" "Patchy PAS"
    "sarcomeric cardiomyopathies" "cardiomyopathies" "versusTsc1c/cSM22cre"
    "oldTsc1c/cSM22cre" "PH3+" "MYH7+" "Hoechst" "theTsc1c/cSM22cre"
    "number/mg" "theTsc1c" "treatedTsc1c/cSM22cre" "untreatedTsc1c/cSM22cre"
    "ofTsc1c/cSM22cre" "mg/kg/day" "inTsc1c/cSM22cre" "omolog"
    "aortic aneurysms" "fallot" "tetralogy" "aneurysms" "gatekeeper"
    "afterload" "cSMAcre" "T2+" "Tsc1c/cSM22cre" "2 +" "n=3" "p = 0.026"
    "± 1.5" "± 0.8" "anti-phospho" "non-invasive" "Girard" "non-adenocarcinoma"
    "A 5-year's" "sen" "Yat" "cumulative smoking pack-years" "pack-years"
    "PI3CA" "p = 0.005" "= 94" "~90%" "Non-small-cell" "gastric epithelium"
    "the normal colonic mucosa" "polyphosphoinositides" "Kashmiri" "= 6.29"
    "G2274223T3765524C7922612" "G2274223C3765524T7922612"
    "A2274223C3765524T7922612" "Hukka" "rs7922612C" "rs3765524C" "rs2274223A"
    "GWASs" "Pcorr" "Kashmir" "rs2274223" "inositol-1,4" "P = 0.74" "= 8"
    "= 14" "= 0.011" "= 0.003" "Riener" "Broet" "FASH" "ICH" "= 0.002" "= 8"
    "Brachuyry" "Rodriguez" "CW" "tubular epithelium" "Larocca" "axial"
    "Brachyruy" "7d" "UUO" "pBrachyury" "HK" "TCACACCT" "BBSs"
    "an important signal transducer" "-Brachyury" "at least 24 h" "BV"
    "interstitial myofibroblasts" "EndoMT" "obstructive nephropathy"
    "nephropathy" "Brachyury" "48 h" "Non-immune" "5 ng/ml" "cells/100 " "24 h"
    "Epithelial-to-mesenchymal" "α9β1" "allograft" "spatio" "pFN+III-13" "j"
    "III-13" "cFN" "pMLC" "α4β1" "anti-parallel" "Toll-Like" "Plp" "CreDRG"
    "Creembryos" "ofYap" "a 2-hour" "massive forebrain" "Flox/Flox" "Flox/"
    "andTrkC" "ofTrkB" "Glia" "/BrdU" "migratory NC cells around E8.5" "E8.5"
    "orTrkB" "ofTrkC" "rtTA" "Tuj1" "Isl1/2" "E9.5" "Yap/Taz" "Hamaratoglu"
    "Lats1/2" "Mst1/2" "Blbp"
    "large-diameter neurotrophic tyrosine kinase receptor (Trk) B-positive"
    "B-positive" "around E9.5" "Ngn" "Neurogenin" "somites" "Taz" "24-hour"
    "stem/progenitor" "Kendellen" "gemcitibine" "ALK4/5/7" "Lonardo"
    "epithelial mammary carcinoma cells dedifferentiate" "dedifferentiate"
    "paracine" "Seder" "13/17" "13/36" "metallopeptidases" "SNAl1/Snail"
    "ZEB2/Sip1" "ALK5i" "SR-IκBα" "INHBA/Activin A" "α/β" "TGFBs" "endoderm"
    "hESCs" "βA" "βA ( INHBA )" "Venn" "SPD" "and 3D" "N3D" "Supernatants"
    "Naïve" "CICs" "-1β" "non-malignant" "=51" "=26" "U133 Plus 2" "mg/mL"
    "10 ng/mL" "chemo-" "intermediate/ high" "Fletcher" "TB-7248" "GI"
    "Talalay" "Chou" "IC25" "mesylate" "naïve" "re-sensitized" "/ high"
    "arisen" "Ciclin" "Nutilin-3" "co-localize" "Elisa" "TP53−/−" "SMP14" "48h"
    "NICD3" "ICN" "proteosome" "P=0.026" "P=0.007" "P= 0.005" "P=0.038" "1 +"
    "+1" "BIOMED2" "commercial gDNA" "gDNA" "260/280"
    "ultraviolet light absorbance" "non-FFPE" "co-purification" "Haque" "Foley"
    "Simbolo" "Neill" "Deben" "artificial FFPE" "EQA" "‘SPUD’" "N/Q"
    "Nanodrop:Qubit" "n=78" "EZ1" "QIAamp" "Qiagen" "CV" "=78" "p=0.3782" "=13"
    "SPUD" "QFI" "fluorometer" "Asuragen" "UCL" "Waltham" "workup" "Nanodrop"
    "Qubit" "=15" "=82" "7/8" "=58" "sAPP α" "non-conventional"
    "subcompartments" "BFA" "localization/activity" "sAPPα" "homogenates"
    "Braak" "hippocampi" "PxxP" "SAP97wt" "relevant PKC phosphosites"
    "phosphosites" "dibutyrate" "Autoradiography" "Ct"
    "a previously uncharacterized protein kinase C phosphosite" "phosphosite"
    "μ Ci" "GRGDS" "α3β1" "synapse" "CD44s" "Rac1 activity" "pY416-Src" "ZFN"
    "amoeboid" "Co-Immunoprecipitation" "CD8 +" "P13K/Akt" "TRNASFAC"
    "TRANASFAC" "CPBP" "TRANSFAC" "MCF7pcDNA"
    "the combined external breast tumor tissue datasets" "BLVRB"
    "the five external tumor tissue datasets" "MCF7 HER2" "expressers"
    "/protein 1a" "Tol" "Noh" "Hee" "begun" "Benjamini" "non-expression" "ER+"
    "273/459" "335/502" "349/502" "MCF7HER2" "Regulon" "ALDH+" "OCT3/4" "POLII"
    "HER2+/−" "10 ng/ml" "a strong synergism" "The strong in vitro synergism"
    "p27kip" "Burkitt" "re-growth" "T/C" "PF-0047736" "NFKB" "AZD-7762" "AZD"
    "all non-Hodgkin's" "The strong synergism" "synergism" "IC50s" "non-toxic"
    "oophorectomy" "salpingo" "PARPi" "64/133" "Ambry" "Diaspora" "ivs"
    "Cowden" "≥45" "_8614C" "_5160A" "4/7" "45/156" "26/103" "47/180" "BROCA"
    "Bahamas" "Nigeria" "non-genetic" "= 0" "= 0.016" "= 0.001" "95 % CI"
    "dysplasia" "serology" "disconcordance" "This histological subtype" "4/10"
    "#1816" "the intestinal subtype" "7/13"
    "their predominant histological subtype" "sialomucin" "sulfomucins"
    "sialomucins" "Subtype" "Mdm2/x" "IGC" "Correa" "IM+GC" "1/10"
    "Non-malignant" "non-cancer" "10/15" "all-in-one" "Gy" "Gy/min" "PHA"
    "SU11275" "scamble" "DOX" "pSD400" "shRNA3" "siRNA3"
    "predicting non-response" "meshwork" "mercaptosuccinate" "MAPKAP2"
    "C52A/C173A" "active MAPKAP2" "Prdxs" "anti–rabbit" "T41β-catenin"
    "pY654-β-catenin" "pS675" "tranformants" "onco-Vav-" "filipodia" "pY174"
    "semi-solid agar" "monolayer" "overgrew" "A789N" "Δ1-66"
    "non-hematopoietic" "unsignificant" "AcR" "Pleckstrin"
    "proto-oncogene Vav1" "hidden" "nonmutant" "rs621554" "rs532841" "FASTSNP"
    "ESE" "methoionine" "HGVS name" "HGVS" "_000008.11:g" "aA:BB" "homozygotes"
    "aA:bb" "Scotland" "GBR" "CEPH" "Utah" "its intronic SNP rs561681"
    "nonrare" "drawn" "Kaplan" "HEBCS" "Cdc42GDP" "RhoGDP" "RhoGTP" "CDKN2A/B"
    "co-occurs" "overdominant" "homozygote" "the CDK6 intronic SNP rs3731343"
    "rs3731343" "heterozygote" "The DLC1 intronic SNP rs561681" "rs561681"
    "P = 0.0001" "P = 0.003" "= 0.0008" "P = 0.0035" "Chan"
    "proteins/interactions" "algorithms" "pmTOR" "RLuci" "FLuci" "miR-302d"
    "Markov" "MFEs" "miR-302d-AKT1" "miRWalk" "microT" "oncomiRs" "betweenness"
    "RNAhybrid" "P = 0.003" "P = 0.008" "immunocytochemistry" "40-year-old"
    "Coomassie" "40-year-olds" "IIa" "transcription factor-2" "OA" "10 ng/ml"
    "60-year-olds" "Co-transfections" "60-year-old" "XRCC1/pHSP90"
    "XRCC1/HSP90" "XRCC1/" "pHSP90/XRCC1" "Thr5/7" "pHSP90" "XRCC1 and" "88TAg"
    "92TAg" "re-assembly" "TM/K206A/K244A" "TM/K206A" "K206A/K244A" "KTM"
    "Polβ/XRCC1 complex" "BMN-673" "BMN" "CopGFP" "copGFP" "Polβ/XRCC1complex"
    "dRP" "L301R/V303R" "Polβ/XRCC1" "Polβ" "non-redundant" "LC-MS/MS" "β 3"
    "#10" "5/7" "~80%" "re-expression" "prokaryotes" "Deeper" "carinii"
    "co-operativity" "1HVY" "2ONB" "folic" "+2–4" "μl/min" "Zorbax"
    "spectrometer (ABSCIEX)" "nano" "ABSCIEX" "spectrometer" "TripleTof"
    "iodoacetamide" "SafeStain" "SimplyBlue" "non-complementary" "QuickChange"
    "xx" "∆TS1" "bicistronic reporter constructs TS1-wt" "IVT" "4H1I" "4GYH"
    "PHENIX" "o" "Refmac" "Phaser" "HKL2000" "Datasets" "MAR345" "VariMax"
    "MicroMaxTM" "Rigaku" "dihydrochloride" "diaminopentane" "Expedeon"
    "SDS–10%PAGE" "v/v" "-thiogalactopyranoside" "thiogalactopyranoside"
    "isopropyl" "Bertani" "Luria" "Thermo" "Biolabs" "England" "nucleases"
    "FdUMP" "thymineless" "-triphosphate" "-deoxyuridine-5" "-monophosphate"
    "monophosphate" "LC–MS/MS" "co-crystallize" "noncancer" "miR-1228-p1546"
    "LRP1/miR-1228-p866" "miR-1228-p866" "pcDNA3" "nontumour"
    "ASO-miR-1228-transfected" "QGY7703/pcDNA3" "H&E" "G1/G0" "pri-miR-1228"
    "migration/invasion" "endophthalmitis" "&E" "Fastenberg" "Ag"
    "modern vitreoretinal microsurgery" "microsurgery"
    "The retinal pigment epithelium (RPE)" "epithelium (RPE)" "eosin"
    "indirect ophthalmoscopy" "ophthalmoscopy" "Cip/Kip" "= 7" "PaTu-8988t"
    "PaTu" "ets" "~2.5-fold" "U251" "LSM710" "Jena" "Carl" "Zeiss" "Ulm"
    "Fluka" "diazadicyclo" "Fluoromount" "Alexa" "Ywhaz" "HPRT" "PerlPrimer"
    "Universal SYBR Green Supermix" "SensiMix" "Supermix" "Luckenwalde"
    "Bioline" "SYBR" "CFX" "Frankfurt" "ProtoScript" "hexamer" "1–3 µ"
    "TriFast" "Erlangen" "GmbH" "Biotechnologie" "PEQLAB" "peqGOLD" "Düren"
    "Nagel" "Macherey" "Nucleospin" "Novex" "Dynabeads" "-glucopyranoside"
    "glucopyranoside" "Munich"
    "Secondary antibodies goat anti-mouse and goat anti-rabbit" "Denmark"
    "Glostrup" "Danvers" "penicillin/streptomycin" "Dulbecco" "Heidelberg"
    "German" "Hamburg" "PeproTech" "Darmstadt" "Merck" "Taufkirchen" "McCole"
    "CCH" "Metzger" "late endosomes/lysosomes" "EGF-like" "DAMP" "CCh" "mAChRs"
    "mAChR" "Acetylcholine" "non-essential" "non-significant" "Non-neuronal"
    "10.1038/ncomms6582" "PHD3-/-" "neoplasias" "co-substrates" "oxoglurate"
    "Fe" "refractoriness" "kappa-light-chain-enhancer" "hypoglycaemia" "HGBM"
    "PHD3 −/−" "GBM046x" "AzaC" "EglN" "conformance" "nonmalignant" "Henze"
    "epigenetic/genetic" "*** P" "** P" "* P" "SIRT1and" "adjuvan" "Xie" "Mian"
    "PF-03084014" "immunotherapy" "SIRT1 and" "SIRT1/N1IC" "bicuspid" "N1IC"
    "n = 3" "= 0.037" "= 5" "= 0.042" "p = 0.003" "= 0.001" "p = 0.027"
    "co-localization" "non-histone" "vaccinatum (EV)" "vaccinatum" "responders"
    "bioterrorism" "variola" "Samavati" "possible co-association"
    "an antiviral firewall" "firewall" "bacterial peptidoglycan"
    "bacterial lipopolysaccharide (LPS)" "infectious ACAM-2000" "RIP1K"
    "a significantly higher titer" "titer" "necrosome" "titers" "ACAM-2000"
    "ACAM" "5 ng/ml" "althought" "Collun" "Hawkes" "overexpression/activation"
    "LLL-3" "Benekli" "WST-1" "= 24" "= 51" "= 35" "Hoadley"
    "BRCA1→miR-146a→EGFR" "a transcriptional coregulator/corepressor"
    "mature miR-146a" "TNBCs" "indirectly-related-at-best" "mammospheres"
    "siEGFR" "MFE" "pEZX" "Semi" "miR-146b" "gain/loss" "HCC1937B"
    "re-expressed" "HMLE" "mutation/deficiency" "BLBCs" "Co-transfection"
    "epithelial-to-mesenchymal" "miR-146a" "p53R175H/TAp63α" "TAp73" "TAp63β"
    "p53/TAp73α" "p73α" "ΔI" "p53R248W" "p53R273H" "HCT116−/−" "ΔNp73α"
    "p53Y220C" "TAp63γ" "ΔNp73" "TAp73γ" "TAp73α" "TAp73β" "TAp63α" "p53R175H"
    "10 ng/ml" "alpha-thalassemia" "masse" "Kd" "Hoxd" "Hoxc"
    "biological replicates" "metagene" "2lox" "ΔXist" "loxP" "2LOX" "uRF"
    "pulldowns" "X-genes" "two biological replicates" "ChrX" "Chr" "castaneus"
    "musculus" "Xa" "X/c" "five biological replicates" "eluate" "10–1" "Hotair"
    "dsDNAs" "≫200" "dsDNA" "noncognate" "Tetrahymena" "K d ’s" "nt" "ATRX+"
    "Immuno" "shATRX’s" "X+P" "dox" "embryoid" "shScr" "Scr" "shATRX"
    "mononucleosomes" "remodelers" "IP-MS" "AEPB2" "Jpx" "Tsix" "Xi" "XCI"
    "~100%" "#4" "re-purposing" "dormancy" "pMek" "chemo" "Fzl" "caliper"
    "PXXP" "∼3-fold" "polypharmacology" "Kinome" "Dld1" "7/pS" "BT-570" "shCtl"
    "FOPglow" "TOPglow" "Ocludin" "Epcam" "Wnt5b" "mesenchymal-like"
    "adenomatous polyposis coli" "mesoderm" "Wnt5a/b" "pStat3"
    "high-quality binary PPIs" "Wilcoxon" "proto" "subnetworks" "VT" "SM"
    "transposon" "binary PPIs" "composites" "Interactome" "hORFeome" "Pfam"
    "binary datasets" "Co-Frac" "binary PPI" "significantly more PPIs" "CORUM"
    "co-complex" "three-dimensional co-crystal" "wNAPPA" "~14,000" "Y2H"
    "HI-I-05" "nteractome" "uman" "high-quality binary literature PPIs" "RRS"
    "MAPPIT" "ultiple" "ingle" "inary" "erature" "the human binary interactome"
    "all possible PPIs" "PPI" "PPIs" "IVa" "UIC2" "amplimers" "nmol/L"
    "MCF-7/TxTP50" "non-MDR" "MCF-7/TxT50" "co-selected" "Jevtana" "vinca"
    "MCF-7/CTAX" "PSC-833" "CTAX" "two sex-specific risk haplotypes" "ABO"
    "DLA" "DNRs" "mortem" "the associated SNP" "SZ-" "NCRs" "Y-axis" "DPYSL2 A"
    "DPYSL2 B" "rs445678" "rs400181" "rs367948" "Harvard" "amplicons"
    "five SZ-associated SNPs" "dorsal diencephalon" "oblongata" "rhombomeres"
    "telencephalon" "_I1-1" "_PxPr" "I1-1" "cfosEGFP" "pGW" "tegmentum"
    "the hindbrain, anterior and posterior lateral line ( anterior lateral line and posterior lateral line , white arrowheads in xref , A−C) placodes"
    "Rohon" "placodes" "hindbrain" "midbrain" "diencephalon" "dpysl2b"
    "dpysl2a" "orthologs" "rs73229635" "rs11781865" "rs379266" "Pr3SNP_HR"
    "Pr3SNP" "rs3837184" "_HR" "_LR" "non-neuronal"
    "encompassed SZ associated SNPs" "cNCR" "rs17088251" "McGrath" "PolyPhen"
    "A267S" "dbSNP" "CEU" "Sanger" "DNR" "postmortem" "cNCRs" "axons" "CRMP2B"
    "CRMP2A" "DPYSL2A" "DPYSL2B" "RefSeq" "axon" "collapsin" "PNS" "CNS"
    "rs5029306" "rs12155555" "Jewish" "Ashkenazi" "rs1561817"
    "a parametric heterogeneity LOD" "LOD" "8p12" "8p" "6p22" "13q33" "10q22"
    "in 1q42" "20s" "SZ" "paralogs" "8p21.2" "P = 0.008" "P = 0.013" "= 11"
    "~3.5-fold" "P = 0.026" "= 0.0003" "P = 0.007" "= 0.007" "hg18" "~30%"
    "Baiocchi" "pErbB1-4" "weak-to-absent" "colorectal mucosa" "PY-20" "Xu"
    "exogenous rHRG" "rHRG" "hetero" "pErbB4" "pErbB3" "pErbB2" "pEGFR"
    "colorectomy" "ErbB" "30 min" "non-ABCA1" "non-lipid-raft" "complexs"
    "LC3-I" "DEBC" "BHK" "droplets" "CE" "Tangier" "TSC1/2" "Anti-mouse"
    "non-functional" "an external dataset" "a larger dataset" "Vanderbilt"
    "Massachusetts" "Farber" "Dana" "1.11-2.08" "p=0.009" "p=0.34" "p=0.66"
    "p=0.008" "=624" "=53" "MSKCC" "2–2 µ" "g/mL" "Roh" "U73122" "otif (ITAM)"
    "otif" "yrosine" "mmuno" "ML171" "RGD" "Davis" "uncoupler" "Hitchcock"
    "a unique N-terminal four-point-one" "four-point-one" "FERM" "VI"
    "pulldown" "non-covalently" "mean ± SEM" "anti-human" "non-receptor" "IMR"
    "KEGG" "Kyoto" "CentriMo" "MEME" "methylated CpG dinucleotides" "ALUs"
    "SINE" "genic" "gene/transcript" "PET7+" "CGIs" "Rozowsky" "GA 2x" "Inp"
    "cell lines/sequencing" "cell lines/treatment" "Actinomycin" "hrs" "UCSC"
    "Browser" "∼70%" "∼5%" "10.1038/ncomms6383"
    "several clinically relevant endpoints" "PCSM" "CRPCs" "hydroxy" "ICI"
    "H3AcK9" "_024490" "NEAT1_1" "_1" "tumour/benign" "ERE" "NEAT1_2" "_2"
    "NEAT1’s" "HuEx" "prostatectomy" "11q" "ChIPSeeqer" "Oncomine"
    "photomicrographs" "NEPC" "neuroendocrine" "=14" "subnuclear organelles"
    "a cancer-favourable transcriptome" "oestrogens" "Oestrogen" "oestrogen-"
    "transducers" "programme/cascade" "Chakravarty" "NEAT1" "≥8" "8 × 10"
    "~70%" "30 min" "non-prostate" "P =0.03" "RAEB" "sideroblasts" "Mathas"
    "anti-proliferative" "MTUZ-1" "MUTZ-1 and" "proform" "Datta" "caspase-3/8"
    "dithiocarbamate (PDTC)" "dithiocarbamate" "hTERT" "MUTZ-1" "celllines"
    "non-denaturing" "contributs" "shCUL4A" "NCSLC" "pSuper" "agar"
    "the normal bronchial epithelia" "benn" "light/dark" "5 × 10" "30 min"
    "=25" "=20" "=17" "~40%" "S2B" "intestinal RhoA" "multistage" "Paneth"
    "enterocityc" "DIAPH" "fromApc" "HCT8/S11" "30min" "amylases" "andApc"
    "controlApc" "shRHOA" "SI" "exoenzyme" "LS174T/W4" "theApc"
    "azoxymethane (AOM)" "azoxymethane" "theRhoA" "ofApc" "min/+"
    "the intestinal epithelium" "colorectal cancer progression/metastasis"
    "progression/metastasis" "mg/Kg" "Non-canonical" "Co-immunoprecipitation"
    "10.1038/ncomms6456" "Engels" "IgY" "virus-like" "YXXM" "YXN" "YXNM"
    "the amino-acid sequence SSVV" "XIII" "pos" "neg"
    "the chimeric mIgG2a-YF-Grb2-SH3" "Sos" "mIgG2a" "transductants" "deleter"
    "ninefold higher IgG1 titres" "IgG1+" "gB" "mIgG1" "fl/fl" "Igα/β"
    "the phospho‐ITT" "fluorophore" "mIgM-BCR-like" "γ2am" "Anolis" "4xA" "YA"
    "mIgY" "isotype" "microanatomy" "mIgE" "SSVV" "mIgD" "the PTK Bruton’s"
    "phospholipase C-γ2" "mIg" "mIgM" "reencounter" "titres" "isotypes"
    "Bruton’s" "Bruton" "BCRs" "C57BL/6" "C-terminally" "αB" "Calabrese" "αC"
    "αC-helix" "CBS-3/AMP" "AMP/CBS-3" "α3" "AMPKΔCBM" "interferometry"
    "biolayer" "carboxyl" "C-interacting" "ΔCBM" "Ni" "nanobeads" "AlphaScreen"
    "the regulatory αC-helix" "McBride" "Polekhina" "αRIM-2" "αRIM-1" "αRIM"
    "CBS-3" "CBM" "AMP/ADP" "cyclodextrin" "IC 50" "non-physiological"
    "anti-stress" "re-solubilization" "PQC" "-KO" "KO" "senescence-like" "dis"
    "pS727" "pY705" "CHX" "SiBIS-" "SiCON" "SiBIS" "Bis" "non-phosphorylated"
    "pHACE" "2-2" "2–2" "5-3" "regrown" "secretome" "activation/elimination"
    "presence/absence" "5 × 10" "or 2 μM" "or 2  μ M" "C/EBP"
    "nucleotides/metabolites" "Cq" "multienzyme" "ip53" "iSHMTs" "SCR"
    "iSHMT1+2" "7-AAD–AnnexinV-APC" "iSHMT1+iSHMT2" "SHMT2 α" "SHMT2α" "TOT"
    "iSHMT2" "iSHMT1" "scr" "iSHMT" "GSE40419" "thymidilate" "≤0.05" "μ l"
    "x10" "μ L" "P =0.0035" "~10%" "El" "Eman" "Dammam" "Hammad" "Mohammad"
    "Ion Torrent exome" "SNV" "Amemiya" "Americans" "Europe" "Arabia" "nitroso"
    "transversions" "Netherlands" "Switzerland" "Yugoslavia" "racial/ethnic"
    "senescent-like" "Palmirotta" "non-synonymous" "Exons" "InDel" "POLYPHEN-2"
    "SIFT" "Q150X" "colorectum" "kd" "Kirsten" "Harvey-" "Harvey" "Saudi"
    "Five-year" "priori" "relocalizes" "hChk1" "S8F" "S8D" "EV" "GADD45α"
    "+γ-IR" "-luc" "hCry1" "yet-to-be" "Supplemental Figure S3iii" "S3iii"
    "PQPKKKP" "NLSs" "monopartite" "vi" "356-574/683-872" "prebound"
    "Mdm2/hp53" "S1C" "+MG132" "hp53/hPer2" "-hp53" "goes" "minute-2"
    "multilevel" "Vip" "Rora" "Δ19" "antimorph" "Iε/δ" "locomoter"
    "cryptochrome" "hPer2/hp53" "hp53's" "hp53" "≤ 0.05" "S9C" "S9A" "S4B"
    "non–small cell lung carcinoma" "p53 +/+" "/+" "anti-cancer"
    "the pharmacodynamic marker sVEGFR2" "important interactive covariates"
    "rs34231037/C482R" "schizophreniform" "rs10050046" "chordates"
    "immunoglobulin-like" "Rs34231037" "disquilibrium" "Chicago" "European"
    "Genomes" "The causative SNP" "rs725344" "4q11-q12" "Lancaster"
    "the most significant SNP" "PWV" "Intra-" "rs34231037"
    "736 healthy Old Order Amish" "Amish" "sVEGFR2" "oncology" "1/3" "= 3"
    "5 ng/mL" "Ig-like" "= 0.51" "= 0.12" "= 0.01" "=2" "TICs" "TIC"
    "wt/mutGATA3" "wtGATA3" "mutGATA3" "mammosphere" "browser" "hTert-" "hTert"
    "kbp" "TNBC" "BLBC" "basal-like" "socio" "non-Hispanics" "coregulators"
    "bicultamide" "CRPC" "AIPC" "polII" "non-CaP" "Gleason" "GSE21034"
    "non-Hispanic"
    "the publicly available clinical prostatic tumor microarray dataset"
    "nosteroid" "FXXLF" "α12" "α11" "LBD" "RMSD" "RSMD" "WILMA"
    "Gene Ontological (GO)/pathways" "actetate (CPA)" "actetate"
    "the ligand promiscuous protein interactome" "interactomes"
    "defining real and novel biological endpoints" "endpoints" "MDV" "African"
    "Thr877-to-Ala" "co-activator" "non-metastatic" "Liangchun" "Sui" "theI"
    "midterm" "Deng" "The Begg’s" "Egger" "0.61–1.34" "Asians" "co-dominant"
    "HWE" "0.638–1.518" "G-allele" "A-allele" "IARC" "GLOBOCAN" "rarer"
    "Caucasians" "AG/GG" "AA/AG" "= 0.84" "95% CIs" "p = 0.03" "p = 0.005"
    "-trisphosphate" "trisphosphate" "frameshift" "antitumour" "bi"
    "/deletions" "= 1/" "assoc" "duplexes" "lac" "hUNG-DNA" "millisecond"
    "Entropy" "cat /" "oligo" "aDNA" "shallower" "interphosphate" "elec"
    "ammonium" "Z Ψ" "ZΨ" "KF" "KGlu" "1/" "anisotropy" "oligos" "the cratic
entropy"
    "+ 1" "TRIMa" "anti-HIV" "êB" "viral genome" "Anti-HIV" "SFV/HLR"
    "SFV/LTR-IR-GFP-RRE-IR-Cav-1" "pCIenv" "pCIpol" "pCIgag" "NL" "pEGFPD"
    "SFV" "LTR-IR-GFP-RRE-IR-Cav-1" "LTR-RRE-IR-GFP" "NL4-3" "reby" "pTatz"
    "pNL4-3" "WNNMTWMQW" "LTR-IRES-GFP-RRE-IRES-Cav-1" "RRE" "IRES" "LTR"
    "-2 H-tetrazolium" "co-transfected" "the clinical transcriptomic dataset"
    "PF-05212384" "clinicaltrials" "metagenes" "NFAT2CIP" "IC50" "Jetset"
    "CCNE" "FUBP1" "CSDE1" "SKOV-3-" "SKOV"
    "ovarian cancer transcriptomic datasets" "progress/recur" "five-year"
    "non-small-cell" "= 2" "= 4" "p = 0.003" "= 5" "= 3" "FFPE" "GeneMANIA"
    "***P" "a larger subcluster" "subcluster" "ccRCCs" "UCs" "**P" "ccRCC"
    "ClueGO" "DGE" "UTUCs" "microsatellite" "Catto" "the predominant subtype"
    "phenacetin" "*P" "UC" "UTUC" "=7" "~88%" "doi:10.1186"
    "bronchoalveolar lavage (BAL) fluid eosinophilia" "-β1" "eosinophilia"
    "stressors" "type 2A" "the esophageal mucosa" "mucosa" "GTEx" "Varp"
    "chr19" "ISGs" "Crohn's" "FPKM" "rs55646091" "chr12q13.3" "chr19q13.11"
    "ANKRD27" "chr11q13.5" "chr2p23.1" "5×10" "OmniExpress" "Illumina"
    "lymphopoetin" "endoscopy" "the esophageal epithelium" "EoE" "log 2" "−5 -"
    "log2" "11q13" "diverse polynuclear platinum chemotype" "chemotype" "AGD"
    "IGROV-1/Pt1" "sublines" "procaspase-3" "p53+/+" "HCT116 p53+/+" "∼6%"
    "ognate" "TATA" "ortho" "promoter/gene" "Tarma" "nanoscale" "BBR3464" "Cl"
    "Pt" "inertness" "nanoSIMS" "glycosoaminoglycans" "biomolecules"
    "TriplatinNC" "-I" "re-enter" "G 0 /G 1" "×
10"
    "-to-" "their complementary sites/regions" "Whitesides" "Klebe"
    "co-workers" "lactones" "Portman" "metallohydrolases" "Bradner"
    "acetyllysine" "Rajender" "Lumry" "entropies" "°= 0"
    "G °remains nearly invariant" "°remains" "invariant" "kcal" "Hasselbalch"
    "Henderson" "miniscule" "eq" "whose ionization enthalpies"
    "triethanolamine" "anions" "A 2 kcal/mol higher favorable binding enthalpy"
    "°value" "MH-12/4" "dihydropyrene" "MH-12" "bidentate" "monodentate"
    "kcal/mol" "injectant" "kilocalories" "viz" "isozyme" "enthalpies"
    "entropy" "enthalpy" "pharmacophore" "isozymes" "= 2" "= 4" "= 7"
    "tumor-suppressive miR-23b" "miR-27a" "pathways/targets" "miR-24-1"
    "Ehrlich" "-UTRs" "Spearman’s" "tumour-suppressive miR-23b/27b"
    "miR-1/133a" "~60%" "developed contries" "contries"
    "tumor-suppressive miR-23b/27b" "the tumor-suppressive miR-23b/27b"
    "trypsine" "miR-23b/27b" "27b" "miR-23b" "pSTAT3" "HNK" "PCI-37B cells"
    "phosphorylated/active" "vivo" "JJ012/Luc" "shResistin" "MUT-MMP-2-3"
    "WT-MMP-2-3" "mismatches" "Targetscan" "miRDB" "miRanda" "mT" "DIANA"
    "zymography" "Transwell" "MiR-519d" "gallbladder" "miR-519d" "d"
    "Anti-rabbit" "non-coding" "G-quadruplexes" "quadruplexes" "*1100delC"
    "1100delC" "FRQ" "day/night" "ortholog" "crassa" "Neurospora" "Rph1p"
    "mtROS" "OriP" "a mutated genome" "lifespan" "diploid" "remodeler"
    "intergenic spacers" "spacers" "genomes" "redirects" "RXXT" "RXXS"
    "Polo-like kinase-1" "protein phosphatase 2A" "Polo-like kinase-3" "laevis"
    "pombe" "Schizosaccharomyces" "cerevisiae" "redirect" "phosphodiester"
    "10.1038/ncomms6399" "HUBL" "~10-fold" "α5" "helices" "α4" "Paralogues"
    "CD–UbPrg" "Dfit" "EvilFit" "plasmon" "PrDos" "ΔDUSP" "FP" "Menten" "UbPrg"
    "propargyl" "CD" "SAXS" "α9" "helix" "BL1" "non-crystallographic" "QQD"
    "D1D2" "paralogues" "Ubp8" "UBP" "ZnF" "Clerici" "Ubl" "μl " "2+" "=5"
    "non-overlapping" "Tg" "eukaryotic initiation factor 2α" "factor 2α" "Tm"
    "anti-obesity" "ObRb" "1: 1,000" "10/13" "ADAM23" "CDKNA2" "7/10"
    "the triple-negative subtype" "aneuploidy" "Profiler" "EpiTect" "WBC"
    "p = 0.012" "p = 0.03" "p = 0.005" "= 0.037" "= 0.002" "= 0.01" "p = 0.013"
    "= 0.011" "+2" "= 0" "10.1038/ncomms6413" "Landon" "microarrayarray"
    "heavier" "Sabatini" "translatomes" "eIF4F-3" "delta199" "eIF4E1-S209A"
    "eIF4E1-S209D" "readouts" "non-target" "translation/protein synthesis"
    "T-leukaemia" "tPTEN/MNK" "Ueda" "tPTEN" "TD" "methylene" "ethoxyphenyl"
    "aminoethyl" "p-eIF4E1" "Immunohistochemistry" "HLY-1" "phosphonull"
    "a highly aggressive and heterogeneous non-Hodgkin’s"
    "a highly aggressive and heterogeneous non-Hodgkin" "Osborne" "rapalogues"
    "b" "MNK2a" "Maimon" "non-Hodgkin’s" "a unique translatome" "translatome"
    "eIF" "ablates" "GCB" "#2" "co-treated" "=11" "non-Hodgkin" "TWIST/YB-1"
    "Camargo" "NK/T" "Kalra" "Karlra" "non-correlation" "19/213" "Sukawa"
    "p=0.003" "=24" "coverslips" "protions" "siLMP2A-transfected"
    "332.0%±15.5%" "1284.8%±38.2%" "276.7%±14.6%" "siLMP" "pBabe" "83.8%±5.7%"
    "87.6%±14.0%" "36.1%±8.1%" "LMP2A+/HER2" "38/281" "1/63" "gastro"
    "epidermal growth factor receptor-2" "І" "BARTs" "BamHI" "EBNAs" "EBERs"
    "Huang" "Beek" "generally diffuse-type histology" "cardia" "Guangzhou"
    "EBER" "LMP2A+" "nucleus/cytoplasm" "TWIST" "EBVnGC" "EBVaGC" "E-box"
    "=0.027" "=3" "3+" "simplest" "Occludens" "pyriform" "PCTK" "Chorio"
    "hypodiploid" "un" "LigPlot" "phenyl" "hydroxybutyloxime" "indole-2-one"
    "the NH-amide" "NH-amide" "carbonyl" "NH" "H-bond" "PDBcode" "VMD"
    "Drugbank" "healthy cerebellum (CB)" "neurite"
    "The most aggressive MB subtype" "MBEN" "histopathology" "medulla"
    "cerebellum" "CSNK1α1" "kinome" "a 2D" "I α" "-2H-tetrazolium"
    "NCI/ADR-RES" "chemoresistant" "Upa" "B-related" "17/24" "19/24" "18/24"
    "21/24" "Wnt-5A" "IVIS" "Thr41/Ser45" "foskolin" "5-aza-2" "+494-+664"
    "COBRA" "MCF7/ADR2" "resensitizes" "S/G2" "acquired chemoresistance" "⍺-"
    "transcriptomes" "Doxo + TNF" "endpoint" "paracrine" "non-cell"
    "TNF⍺-induced" "⍺-induced" "or/and" "BCSCs" "transwell" "DAVID" "ETV7"
    "de-regulated" "Fluoruracil" "Doxo+TNF" "Doxo" "Transcriptome"
    "co-regulated" "Toll-like" "non-transformed" "cytoplasmic/nuclear"
    "English" "Jin" "Suzuki" "more reliable and exact predicators"
    "predicators" "Begg's" "Begg" "95% CI" "95%CI" "ORs" "Iα" "Coli"
    "E-catherin" "catherin" "cytomembrane" "= 0.65" "P = 0.03" "= 0.010" "≥4"
    "= 0" "CTAs" "cMAF" "non-neuronal cells" "or 2μM" "ultralow"
    "Fumitremorgin" "stemness" "the shortest fragment 195bp" "195bp"
    "Genomatix" "non-targeting" "shcontrol" "shβ-arrestin-1" "ele" "SKKU"
    "Affymetrix" "α7-nAChRs" "sig" "prolif" "nAChR" "nAChRs" "acetylcholine"
    "Stem-like" "× 10" "co-transfection" "stem-like" "non-smokers"
    "10.1038/ncomms6496" "Pathania" "subsets" "Konishi" "Buchholz" "oestrogen"
    "mMECs" "co-contributor" "Bartek" "co-cultured cells"
    "a non replication fork-associated DSB" "role/s" "inefficient SFR" "CldU"
    "hypomorph" "incomplete resolution/repair" "UV laser-induced DSBs"
    "185delAG" "phospho-RPA32-coated ssDNA" "UV-" "pRPA32"
    "the mammary epithelium" "undergoes" "ssDNA" "SFR" "si" "ShLuc" "DSBs"
    "undertaken" "UV" "mcBox" "SATa" "SATIII" "MCFDCIS" "mammoplasty"
    "individual prophylactic mastectomy" "mastectomy" "mammary epithelium"
    "deeper" "a heterozygous BRCA1  mut/+ genotype" "DSB" "wt" "DSBR" "mut/+"
    "1:5,000" "1:1,000" "GFP+" "De-repression" "AUBP" "multinucleate" "QGY"
    "A/CDK2" "E/CDK2" "Houston" "Selleck" "±0.31" "±0.16"
    "3-(4,5-dimethyl-thiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium"
    "-5-" "sulfophenyl" "carboxymethoxyphenyl" "MTS" "UTRs" "-to-S" "rong"
    "LIANG" "FENG" "LEI" "JIANG" "sheng" "Yong" "neointima" "ONOO" "μmol/L"
    "xanthomas" "Jeghers" "Peutz" "G 1 /S" "mean±SEM" "MetaCore" "breakpoint"
    "Pin1-/−" "Pin1-/-" "-iv" "-ii" "-i" "ITC" "-iii" "H3S10"
    "isothermal titration calorimetry" "calorimetry" "μl" "laborations" "Kew"
    "Qu" "dimerises" "speciﬁc" "BRD-8899" "BRD" "S6A" "μg/g"
    "online supplementary figure S5A–C" "S5A–C" "Ad-STK33-C" "Ad-STK33-N"
    "pTERT" "signiﬁcant" "STK33KO" "STK33Tg" "shRNA2" "HKCL2" "p=0.005"
    "Multivariate" "11p15" "bioassay" "S4A" "S2C" "S2A" "co-IP" "8-week-old"
    "emphasises" "Intra" "HGSC" "BRCA1/2" "covariate" "multicentre" "revertant"
    "non-ovarian" "HRs" "the high-grade serous subtype" "=10.5" "= 0"
    "time-by-covariate" "=0" "formulaThis" "multi" "AOCS" "Mayo" "Bolton"
    "non-carriers" "HGSOC" "Germline" "EOC" "/2" "=4" "= 1" "10-year" "-UTR"
    "TargetScan" "HFD" "-fed" "melanogaster" "orthologue" "littermates" "1  +"
    "R-squared" "Dunnett’s" "Dunnett" "Scripps" "WinMDI" "CellQuest" "Jose"
    "Dickinson" "Becton" "FACSCalibur" "IX71" "OriGene" "pWZL-Neo-Myr-Flag-ILK"
    "pWZL-Neo-Myr-Flag-Dest" "Addgene" "puro" "pBABE" "pcDNA" "Uppsala"
    "Amersham" "Renilla" "Jolla" "Stratagene" "GeneJammer"
    "a quantitative autoradiography" "autoradiography" "V/cm" "μCi" "WI"
    "Promega" "Klenow" "μL" "-GAC" "GAC" "TTT" "TGG" "BCA" "shaken"
    "phenylmethylsulfonyl" "Korea" "Suwon" "Diego" "Calbiochem" "Taipei"
    "Sinica" "shLuc" "Bethesda" "1.41o" "ImageJ" "PerkinElmer" "Billerica"
    "Millipore" "Germany" "Mannheim" "Boehringer" "pH " "340PC" "microplates"
    "Lewes" "Roche" "Softmax" "Sunnyvale" "SpectraMax" "microplate" "Kumamoto"
    "Dojindo" "Tarzana" "HistoQuest" "Vienna" "TissueFAXS" "Nikon" "Tokyo"
    "Olympus" "Carpinteria" "Dako" "diluents" "GA" "Atlanta"
    "Immunohistochemical/immunocytochemical" "Rockville" "DMEM" "Lu" "Jung"
    "RIKEN" "ATCC" "Taiwan" "Kung" "Cheng" "Jackson" "BioChain" "anti-rabbit"
    "anti-mouse" "Invitrogen" "Temecula" "Chemicon" "Cambridge" "Abcam" "Cruz"
    "pNF" "Ser21/Ser9" "Ser217/Ser221" "Thr202/Tyr204" "IκBα at" "GSK-3α/β"
    "Thr359/Ser363" "FTI-277" "Aldrich" "morpholinyl" "phenethyl" "Ohio" "Shih"
    "β3" "PH-like" "non-ANK" "interactome" "HSP90/CHIP" "β1" "A262V" "BALB/c"
    "non-canonical" "AEC" "Aoyagi" "IKKß" "-3β" "KEPI" "triphosphate"
    "-bisphosphate" "bisphosphate" "non-canonically" "S6 kinase/inhibitor" "IQ"
    "× 10" "μg/mL" "lavage" "supernatant" "exRNA" "parenchyma" "eosinophils"
    "A/P" "Spanish" "exome" "rs11096955" "lymphoblasts" "multicenter"
    "comorbid" "Behcet" "WTCCC" "IgA" "Crohn" "celiac" "Immunochip" "HapMap"
    "4q24" "non-immune" "Taqman" "GG" "eigenvectors" "PCA" "Tumarkin" "×10"
    "coeliac" "E2L3" "NF-κB1" "antigens" "IED" "tinnitus" "rs4648011"
    "rs3774937" "unilateral SNHL" "bilateral SNHL" "uni" "ImmunoChip"
    "Meniere's" "SNHL" "Meniere" "= 0.002" "Kaplan–Meier" "= 0.003"
    "monotherapies" "anti-inflammatory" "timepoints" "HU" "karyotype"
    "interferon-alpha2" "kappabeta" "HSCP" "HSCPs" "Tsai" "JAK2V617F-"
    "DEFB122" "anti-oxidative" "burnt" "JAK2V617F" "vera (PV)"
    "essential thrombocythemia (ET)" "vera" "thrombocythemia" "Philadelphia"
    "= 0.008" "= 0.01" "= 4" "CD34+" "Na" "siBKCa-" "Abdallah" "ionic" "+60"
    "pCav-1" "pBKCa" "NPo" "siCav-1" "mV" "siBKCa" "WB" "endometrium"
    "multifunctional membrane microdomains" "microdomains" "non-clathrin"
    "invaginations" "microdomain" "BKCa" "conductance" "vise" "butnot" "Kumper"
    "re-establishing" "BE1" "LH7" "methylcytosine" "dinucleotides" "LTE"
    "statuson" "Ebert" "Subsequent immunohistochemistry" "qMSP"
    "race/ethnicity" "the only two covariates" "only 5 candidate SNPs" "A/C"
    "PLINK" "rs11083838" "CC" "potential covariates" "g/cm 2" "kg/m 2"
    "strengthening/remodeling" "CAMKII" "osteoprogenitors"
    "their tibial microarchitectures" "microarchitectures" "TL" "TBL" "PTF"
    "PTBF" "TBF" "osteoblasts" "rs12461917" "the Pearson's" "Wald" "Spearman"
    "Pearson" "±6.2" "= 0.001" "SILAC" "CENP-H-" "phenocopies" "utilise"
    "mono-orientation" "depolymerise" "Skibbens" "ring-like" "∼50%" "≥150"
    "transgenes" "non-detectable" "anti-poleward" "GSK925293" "monopole"
    "K-fibres" "plateward" "mono-orientated" "non-biorientated" "CENP-Q-"
    "CENP" "mRFP" "destabilises" "CCAN" "K-fibre" "microtuble" "oocytes"
    "poleward" "= 2" "= 3" "approximately 180 bp" "CRISPR/Cas9"
    "the autoregulatory positive-feedback circuitry" "co-occupancy" "nucleate"
    "H3K27" "nucleates" "indel" "-enhancer" "UniPROBE" "UTR"
    "heterozygous indels 2–18 bp" "hotspot" "indels" "GTTAGGAAACGG" "bp"
    "fetal thymocytes" "thymocytes" "-seq" "seq" "STIL" "1p33" "enhancers"
    "ischemic AKI" "tubule" "hypovolemia" "the proximal tubules"
    "detached tubular epithelium" "PAS" "BUN" "Boston" "/direct" "AKI"
    "geranylgeranylacetone" "acute renal ischemia/reperfusion"
    "a rational algorithm" "aplasia" "AER" "forebrain" "ontogeny" "Hartsfield"
    "hypoplastic anterior corpus callosum" "absent septum pellucidum"
    "callosum" "pellucidum" "whose genotype" "the proband's" "hyposmia" "EndoH"
    "/Ca 2+" "/IP 3" "OCFRE" "FGFR2CD WT bound FRS2αP" "FGFR2CD" "ent"
    "recruitm" "FGFR1c" "vitro" "proband" "lip/palate" "hand/foot"
    "normosmic CHH" "co-occurrence" "micropenis" "Probands" "anosmia"
    "Kallmann" "probands" "SHFM" "CHH" "oligomerizaiton" "ClusPro" "silico"
    "GCS-100/MCP" "GCS-100" "GCS" "xl" "dichloride (CDDP)" "dichloride"
    "diammineplatinum" "ori" "Nthy"
    "unique aspartate-tryptophan-glycine-arginine (NWGR)" "NWGR" "galectins"
    "galectin" "lymphoma-2" "Anti-apoptotic" "load/size" "IHC/FISH"
    "tratsuzumab" "CYFRA 21-1" "significantly higher FNA-HER2s" "1+" "Az"
    "proven" "One representative subtype" "21-1" "antigen (CEA)"
    "unnecessary SLNB" "neoadjuvant" "ALND" "SLNB" "cytology" "FNA-HER2s"
    "immunoassay" "FNA" "= 1" "P  = 0.04" "distal tubules" "tubules" "Campbell"
    "G α  q/11" "−Dox" "Dox" "paralog" "p-YAP/YAP" "glomeruli" "reno"
    "Lefkowitz" "blockers" "subclass" "AT1R" "co-transcription factor" "μ g/ml"
    "SMAD4−/−" "WRE" "SIL/+" "luc" "normal intestinal epithelium" "visualise"
    "Microsatellite" "antagonise" "villus" "commonest" "coli" "=0.008"
    "P =0.04" "μ g" "μ g " "Sanchez" "Mocarski" "Hertel" "HCMV-UL21a-RXL2mut"
    "MCMV" "the low-passage endotheliotropic strain TB40" "Caffarelli"
    "circuitry" "G0/G1" "replicate" "G1/S" "nucleoproteins"
    "instead contained precociously separated sister chromatids" "non-mitotic"
    "Giemsa" "centromeres" "plate-like" "Numerous acentric chromatid"
    "centromere" "nucleo" "TB40" "AD169" "IE" "foscarnet" "pUL44" "ΔUL21a"
    "HCMV-UL21a-RXL2mut-infected" "traceless" "RXL1" "APCmut" "co-precipitate"
    "RXL2" "RRLAF" "RRLFQ" "RXL" "proteome" "Cyclin E1" "APC/C" "de-repression"
    "chromatids" "UL21a" "RXL/Cy" "chromatid" "complex/cyclosome" "pUL21a"
    "lamina" "#1" "Non-infected" "DL 221" "HT1080" "Myxoid"
    "Ion Torrent AmpliSeq" "Hotspot" "AmpliSeq" "~77%" "Boyden" "Luc"
    "co-treatment" "Brk/PTK6" "phosphopeptide" "BAY" "NIH 3T3/v-Src"
    "non-receptor tyrosine kinase"
    "the most common lung cancer histological subtype" "LCC" "~17%" "μg"
    "NVALT" "Edelman" "angiogenic prostaglandins" "prostaglandins" "Tsutani"
    "histological subtype" "=0.80" "stepwise" "a significantly higher SUVmax"
    "=0.001" "Fluorodeoxyglucose" "positron" "fluorodeoxyglucose" "SUVmax"
    "=0.003" "P =0.007" "10.1038/ncomms6201" "doi" "González"
    "the columnar epithelium" "re-sensitize" "photodamage"
    "the invasive Chlamydiaceae" "Chlamydiaceae" "Chlamydiales" "Simkania" "=1"
    "MOI" "–RBs" "RBs" "infectious progeny" "progeny" "μg " "CPAF"
    "anti-phospho-MDM2" "a transcriptional co-activator" "videomicroscopy"
    "Venus" "RIPA" "Laemmli" "lysis" "trachomatis" "ex" "Sweden" "Czech"
    "Austria" "dimorphism" "11q22.3" "collagens" "1.37–3.04" "=3.65" "= 2.04"
    "1G-6A" "1G-5A" "2G-5A" "2G-6A" "1.34–2.77" "=1.93" "1.14–3.23" "genotypes"
    "Weinberg" "C/T" "1G/2G" "stromielysins" "matrilysins" "gelatinizes"
    "stromelysins" "fallen" "risen" "dysphagia" "haplotypes" "5A/6A" "OSVZ"
    "Ki67+" "PDGFRβ:D850V" "∼10%" "co-staining" "GW17.5" "greatest" "SOX2+"
    "CP673451" "developing neocortex" "LGE" "DS/DE" "Pdgfd" "GW14.5" "cyan"
    "ASPM" "withand" "at least one dataset" "betweenandwas" "2.2e-16"
    "workflow" "HomoloGene" "identifier" "VZ/SVZ" "ISH" "kME" "WGCNA"
    "eigengene" "oRG" "vRG" "SVZ" "VZ" "ections ( GCASS )" "GCASS" "ections"
    "erial" "ene" "deconvolve" "PDGFD/PDGFRß" "developing mouse neocortex"
    "constitutively active PDGFRß" "dorsal human neocortex" "PDGFRß"
    "radial glia" "glia" "neocortex" "= 15" "rs5030328" "rs4754425" "synapses"
    "guanylate" "rs6992443" "testings" "Haplotype" "rs11161237" "=0.0003"
    "rs11770199" "GWAS" "Late-onset Alzheimer’s" "AD"
    "The most significant SNP" "haplotype" "SNPs" "late-onset Alzheimer’s"
    "re-close" "Qo" "Qi" "comlex" "inhibitionn" "downstrem" "MitoTracker"
    "re-closure" "succinate" "GS" "IAA" "myocytes" "ischemia/reperfusion"
    "glycogen synthase kinase-3β" "mK" "ΔΨ" "Huntington's" "Alzheimer's"
    "Parkinson's" "Parkinson" "Huntington" "Phophatase-1" "littermate" "siCYLD"
    "nasopharynx" "otitis" "NTHi" "TUNEL" "reticulata" "compacta"
    "bradykinesia" "nigrastriatum" "NI" "nitroindazole" "1-methyl-4-phenyl-1"
    "Endotoxemia" "Hepa1c1c7" "guanylyl" "GNSO" "pyridylmethyl" "-tetrakis"
    "tetrakis" "permeabilities" "HgCl" "biotin" "SOX" "SXXS" "SIRT"
    "endotoxemia" "p53-" "p" "coactivator-1α" "Alzheimer’s" "Alzheimer"
    "diphosphate" "di-nucleotide" "CXXC" "immuno" "degron"
    "lipopolysaccharide (LPS)" "peptidoglycan" "anti-apoptotic" "organelles"
    "AP1-" "AP" "ISRE-" "ISRE" "penetrance" "IκB" "enhancer" "κB"
    "co-localized" "simpler" "frozen" "gone" "Barry" "Yuen" "Whitney"
    "receptor type-2A" "1.25–2.13" "1–3" "DFS" "BCCP" "NCI" "subtypes"
    "monotherapy" "IYCC" "AYCC" "= 0.002" "P = 0.015" "P = 0.03"
    "semi-automatic detection/screening" "iv" "iii" "automatism" "organelle"
    "x" "non-compensated" "a geometric alignment algorithm" "semi" "and 2D"
    "algorithm" "germline" "Missense" "ectodomains" "non-specific" "blocker"
    "geninstein" "SKI" "TAPI-1" "1.5–2.5-fold" "hetorodimers"
    "heterologous epithelia" "epithelia" "C-term" "ΔCTD" "HA" "hr" "ELISA"
    "sFLT1" "supernatants" "iCLIPS" "intramembrane" "sheddases" "intra"
    "ectodomain" "utero" "placental trophoblasts" "trophoblasts" "homomer"
    "immunoglobulin" "sFlt1" "Flt" "ablate" "GST-CD148DA" "perhaps" "ptprj"
    "RhoA" "A431D/E-cadherin" "764AAA" "CDSs" "genotype" "multilocus" "glycan"
    "N-linked" "zfPAI-1" "rerio" "Danio" "Bager" "Craen" "Vleugels" "Berkenpas"
    "neutral pH" "urea" "denaturants" "imidazole" "pH" "pathophysiology"
    "a premature stop codon"
    "undetectable plasminogen activator inhibitor type-1 (PAI-1) antigen"
    "type-1" "Ferroni" "Knudsen" "microalbuminuria" "CIMT" "carotid" "Madan"
    "hyperinsulinemia" "dyslipidemia" "Michaelis" "acyl" "Mottonen"
    "vasculopathy" "livedoid"
    "age-dependent spontaneous coronary arterial thrombosis and alopecia areata"
    "areata" "1/2" "pectoris" "the arterial intima" "intima" "myocardium"
    "procoagulant" "thrombus" "type-2" "+12"
    "an insertion (5G)/deletion (4G) polymorphism" "/deletion"
    "polymorphism (RFLP)" "+11" "RFLP" "intron" "polymorphisms" "VLDL"
    "lipopolysaccharide" "introns" "vervet" "NCBI" "alpha-helices" "hA"
    "peptidases" "antigen" "TAFI" "antiplasmin" "Lysis" "proenzyme" "overview"
    "U/mL" "discrepant" "Myofibroblasts" "α-SMA+" "pathobiology" "Bgn"
    "broader" "homologs" "Dupuytren" "IPF" "subset" "TFBSs" "Ccn3/Nov" "Naba"
    "2 additional biological replicates" "immunohistochemistry" "replicates"
    "transcriptome" "matrisome" "picrosirius" "pSmad3" "pSmad2"
    "myofibroblasts" "Masson’s" "trichrome" "Masson" "hypodermis" "FACS"
    "non-degradable" "transducer" "subtype"
    "publicly available microarray datasets" "datasets" "Tcf/Lef" "SSc"
    "Fraumeni" "Li" "et" "Wong" "Rb" "dataset" "p=0.015" "=1.60" "=0.0024"
    "pairwise" "=0.015" "p=0.03" "UCI" "hyper" "exons" "codons" "missense"
    "almost every codon" "codon" "clinicians" "FIGO" "PFS" "chemoresistance"
    "LOF" "Iowa" "TCGA" "Kaplan-Meier" "SQCCs" "histology" "Clara" "epithelium"
    "P=0.04" "covariates" "multivariate" "Univariate" "P=0.03" "poorer" "=0.03"
    "Meier" "=0.007" "=0.12" "immunoreactions" "undergone" "5-year" "=0.04"
    "IHC" "3q26" "Genome" "IIIA" "Asian" "univariate" "Japanese" "SQCC"
    "genome" "I/II" "flavonoid" "mg/kg" "kg" "μg/ml" "greater"
    "furan-4,5-dione" "3-benzoyl-naphtho" "BN82002" "IRC" "naphthofurandione"
    "/S" "Evans" "holoenzymes" "ii" "6,7-di-O-acetylsinococuline" "Diels"
    "delavayi" "Stephania" "Inc" "GraphPad" "interquartile" "Wallis"
    "Bonferroni" "hoc" "Wilk" "Shapiro" "StataCorp" "STATA"
    "a sensitive colorimetric readout" "readout" "TransAm" "Hercules" "Bio"
    "dicarboxaldehyde (NDA)" "fluorescent adducts" "NDA" "dicarboxaldehyde"
    "adducts" "formazan" "NBT" "tetrazolium" "nitroblue" "TNB"
    "tetramethoxypropane" "absorbance" "adduct" "dyphenylpricryl" "Koren"
    "Winooski" "Biotek" "Multi" "USA" "Carlsbad" "Norway" "Oslo" "hemolysates"
    "Erythrocytes" "autoanalyzer" "Miura" "°C" "erythrocythemia" "pre"
    "Estado (ISSSTE)" "ISSSTE" "Estado" "Trabajadores" "Sociales" "Servicios"
    "Seguridad" "Instituto" "Mateos" "López" "Biosafety" "polymorphism (SNP)"
    "SNP" "polymorphism" "eventually developed T2DM" "Pavlović" "Kulkarni"
    "American" "8-hydroxy-2-deoxy-guanosine" "OHdG" "Zengi" "Jelinek" "Aubaidy"
    "Gęsiak" "DPPH" "glycemia" "possible potential confounders" "confounders"
    "BMI" "PRE" "chosen" "HbA1c" "mmol/L" "mg/dL" "Mexico" "Mexican"
    "mellitus (DM)" "mellitus" "disbalance" "erythrocytes" "TAS"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-13801-14100*
  '(("human tetherin and target" . SPARSER::COLLECTION)
    ("depen" . SPARSER::DRUG)
    ("specifically target human tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P4-CCR5" . SPARSER::COLLECTION)
    ("Vpu or Nef proteins" . SPARSER::COLLECTION)
    ("EGFP, or AU-1" . SPARSER::COLLECTION)
    ("total and internalized tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tetherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NTS" . SPARSER::PROTEIN)
    ("the parental Nef proteins" . SPARSER::PROTEIN)
    ("HUM-rep" . SPARSER::COLLECTION) ("rep" . SPARSER::PROTEIN)
    ("Vpu and various Nef proteins" . SPARSER::COLLECTION)
    ("contemporary HIV-1 O nef alleles" . SPARSER::ALLELE)
    ("a minimal promoter" . SPARSER::PROMOTER)
    ("All ancestral Nef proteins" . SPARSER::PROTEIN)
    ("CD4 and MHC-I" . SPARSER::COLLECTION)
    ("Vpu and EGFP" . SPARSER::COLLECTION)
    ("primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("another viral protein" . SPARSER::PROTEIN)
    ("other viral antagonists" . SPARSER::MOLECULE)
    ("Tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFNα2" . SPARSER::PROTEIN)
    ("interferon-α" . SPARSER::DRUG)
    ("the essential nucleotide" . SPARSER::NUCLEOTIDE)
    ("Myc or Ras" . SPARSER::COLLECTION)
    ("RPA1 and γH2AX" . SPARSER::COLLECTION)
    ("Chk1 and H2AX" . SPARSER::COLLECTION) ("ATR/ATM" . SPARSER::COLLECTION)
    ("p53 (pS15) and Chk1 (pS345)" . SPARSER::COLLECTION)
    ("the downstream effectors histone H2AX (pS139), p53 (pS15) and Chk1 (pS345)"
     . SPARSER::COLLECTION)
    ("ATM- and Rad3-" . SPARSER::COLLECTION)
    ("the meiotic recombination 11 (Mre11)/radiation sensitive 50 (Rad50)/Nijmegen breakage syndrome protein 1 (NBS1) or MRN complex"
     . SPARSER::COLLECTION)
    ("the meiotic recombination 11 (Mre11)/radiation sensitive 50 (Rad50)/Nijmegen breakage syndrome protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both luminal and basal-like tumors ( xref )" . SPARSER::COLLECTION)
    ("basal K14" . SPARSER::PROTEIN) ("WAP-driven eIF4E" . SPARSER::PROTEIN)
    ("Exogenous eIF4E" . SPARSER::PROTEIN)
    ("involution-resistant neoplastic foci" . SPARSER::PROTEIN)
    ("eIF4E-ON" . SPARSER::COLLECTION)
    ("eIF4GI and 4E-BP1" . SPARSER::COLLECTION)
    ("strong oncogenes" . SPARSER::ONCOGENE)
    ("transgene-ON" . SPARSER::COLLECTION) ("PI-MECs" . SPARSER::COLLECTION)
    ("eIF4GI and eIF4F" . SPARSER::COLLECTION)
    ("exogenous HA-eIF4E" . SPARSER::COLLECTION)
    ("the mammary-specific whey acidic protein (WAP) promoter"
     . SPARSER::PROMOTER)
    ("exogenous eIF4E" . SPARSER::PROTEIN) ("HA-eIF4E" . SPARSER::COLLECTION)
    ("eIF4E, eIF4GI and 4E-BP1" . SPARSER::COLLECTION)
    ("eIF4GI" . SPARSER::PROTEIN)
    ("the cap-dependent translation initiation complex eIF4F"
     . SPARSER::PROTEIN)
    ("4E-BP1 and 4E-BP2" . SPARSER::COLLECTION)
    ("lactating" . SPARSER::MOLECULE)
    ("c-Myc or H-RasV12" . SPARSER::COLLECTION) ("RPA1" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::GROWTH-FACTOR) ("pS15" . SPARSER::PROTEIN)
    ("whey acidic protein" . SPARSER::PROTEIN)
    ("mRNA cap-binding protein" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("strong apoptosis inducer" . SPARSER::MOLECULE)
    ("SERPINB5 , CDKN1A , BCL2L1 and BBC3" . SPARSER::COLLECTION)
    ("SERPINB5 , FAS , CDKN1A and BCL2L1" . SPARSER::COLLECTION)
    ("SERPINB5 , FAS , CDKN1A , BCL2L1 , BBC3 , BAX and MDM2"
     . SPARSER::COLLECTION)
    ("p53 and PR-lncRNA-1 or PR-lncRNA-10" . SPARSER::COLLECTION)
    ("the transcription factor JUNB or the apoptosis regulators BIRC6, TP53I3 and FAS"
     . SPARSER::COLLECTION)
    ("BIRC6, TP53I3 and FAS" . SPARSER::COLLECTION)
    ("the DNA polymerase subunit POLA1 or the growth factor TGFB2 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("BCL2L and BIRC3" . SPARSER::COLLECTION)
    ("p53 and these two lncRNAs" . SPARSER::COLLECTION)
    ("a non-annotated monoexonic intergenic lncRNA" . SPARSER::RNA)
    ("intergenic lncRNAs" . SPARSER::RNA)
    ("at least one transcript differentially" . SPARSER::PROTEIN)
    ("the proximal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("80 lncRNAs and 155 unassigned genomic regions ( xref )"
     . SPARSER::COLLECTION)
    ("CDKN1A , BAX and BBC3" . SPARSER::COLLECTION)
    ("CDKN1A , BBC3 , PCNA and BAX" . SPARSER::COLLECTION)
    ("an active transcription chromatin" . SPARSER::BIO-COMPLEX)
    ("post-tanscriptional regulators" . SPARSER::REGULATOR)
    ("TUG" . SPARSER::PROTEIN) ("RoR" . SPARSER::PROTEIN-FAMILY)
    ("LncRNAs" . SPARSER::RNA) ("NaVO 3" . SPARSER::MOLECULE)
    ("e–12" . SPARSER::PROTEIN) ("SERPINB5" . SPARSER::DRUG)
    ("BIRC6" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("POLA1" . SPARSER::PROTEIN) ("BCL2L" . SPARSER::PROTEIN)
    ("E−12" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("pri-microRNAs" . SPARSER::RNA) ("v19" . SPARSER::PROTEIN)
    ("HATs, and p53" . SPARSER::COLLECTION)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("CDK1 , CCNG1 , CCNE2 , CCNB2 , Reprimo, GTSE1 , PTEN , SFN , TP53I3 and DDB2"
     . SPARSER::COLLECTION)
    ("CDK1 , CCNG1 , CCNE2 , CCNB2 and p53" . SPARSER::COLLECTION)
    ("RalGDS/AF-6" . SPARSER::COLLECTION) ("RalGDS" . SPARSER::PROTEIN)
    ("p53/TP53" . SPARSER::COLLECTION) ("p300/EP300" . SPARSER::COLLECTION)
    ("BAG" . SPARSER::PROTEIN-FAMILY)
    ("less toxic candidate drugs" . SPARSER::DRUG)
    ("reprimo" . SPARSER::PROTEIN)
    ("CDK1, CCNE2, Reprimo, PTEN, SFN and RRM2" . SPARSER::COLLECTION)
    ("P53 and p21" . SPARSER::COLLECTION)
    ("TP53I3 ( PIG3 ) and P53AIP" . SPARSER::COLLECTION)
    ("CDK1 , CCNG1 , CCNE2 , CCNB2 , Reprimo ( RPRM ), GTSE1 ( B99 ), PTEN , SFN ( stratifin ), RRM2 , TP53I3 ( PIG3 ) and P53AIP"
     . SPARSER::COLLECTION)
    ("AIP" . SPARSER::PROTEIN) ("stratifin" . SPARSER::PROTEIN)
    ("RPRM" . SPARSER::PROTEIN) ("Reprimo" . SPARSER::PROTEIN)
    ("S100A7 , MMP3 , BCL2 , HMOX1 , APCS , IGF1 , SP3 , FOS , CXCL1 , TIMP3 , DUSP6 , MAPK10 , CLEC7A and TLR8"
     . SPARSER::COLLECTION)
    ("APCS" . SPARSER::PROTEIN)
    ("F12 , KLKB1 , GTSE1 , CETN2 , PLK4 , KLF11 , KLF3B and HBM"
     . SPARSER::COLLECTION)
    ("23773 mRNAs and 1949 differently expressed mRNAs" . SPARSER::COLLECTION)
    ("PARP, caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("t(8;21)-positive acute myelocytic leukemia (AML)" . SPARSER::PROTEIN)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("p300 and p300/CBP-associated factor" . SPARSER::COLLECTION)
    ("nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Very few specific HAT inhibitors" . SPARSER::INHIBITOR)
    ("Enzymes" . SPARSER::ENZYME) ("three principal types" . TYPE)
    ("caspase-3, caspase-9 and PARP" . SPARSER::COLLECTION)
    ("LncRNA" . SPARSER::RNA)
    ("caspase-9 and poly ADP-ribose polymerase (PARP)" . SPARSER::COLLECTION)
    ("caspase-3, caspase-9 and poly ADP-ribose polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("p300/CREB-binding protein" . SPARSER::COLLECTION)
    ("Tumor protein p53-inducible protein 3" . SPARSER::PROTEIN)
    ("Family Member 1" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("BCL2-associated athanogene 6" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("STK40" . SPARSER::PROTEIN)
    ("Serine/threonine kinase 40" . SPARSER::PROTEIN)
    ("NU9056" . SPARSER::DRUG) ("B99" . SPARSER::PROTEIN)
    ("CCNG1" . SPARSER::PROTEIN) ("TLR8" . SPARSER::PROTEIN)
    ("CLEC7A" . SPARSER::PROTEIN) ("MAPK10" . SPARSER::PROTEIN)
    ("SP3" . SPARSER::PROTEIN) ("S100A7" . SPARSER::PROTEIN)
    ("KLF3" . SPARSER::PROTEIN) ("KLF11" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("CETN2" . SPARSER::PROTEIN)
    ("GTSE1" . SPARSER::PROTEIN) ("KLKB1" . SPARSER::PROTEIN)
    ("A2M" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN) ("C646" . SPARSER::MOLECULE)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("bacterial effectors" . SPARSER::EFFECTOR)
    ("actin and Rho" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("ExoT" . SPARSER::PROTEIN)
    ("Several other bacterial toxins" . SPARSER::MOLECULE)
    ("given Src" . SPARSER::PROTEIN)
    ("Abl and possibly further tyrosine kinases" . SPARSER::COLLECTION)
    ("CagA" . SPARSER::PROTEIN) ("Src and Abl/Arg" . SPARSER::COLLECTION)
    ("a bacterial effector protein" . SPARSER::PROTEIN)
    ("the same tryptic peptide" . SPARSER::PEPTIDE)
    ("the tryptic peptide" . SPARSER::PEPTIDE)
    ("–b 12 )" . SPARSER::COLLECTION) ("HCD" . SPARSER::PROTEIN)
    ("trypsin, thermolysin or elastase" . SPARSER::COLLECTION)
    ("elastase" . SPARSER::PROTEIN)
    ("Src or constitutively active SrcY527F" . SPARSER::COLLECTION)
    ("-Src" . SPARSER::COLLECTION)
    ("Nck, WIP and N-WASP" . SPARSER::COLLECTION)
    ("extensive structural homology" . SPARSER::PROTEIN)
    ("AvrPphF-ORF2" . SPARSER::COLLECTION)
    ("ARTs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ART" . SPARSER::PROTEIN)
    ("Cdc42, Rac1, Nck and N-WASP" . SPARSER::COLLECTION)
    ("the autoinhibitory state" . SPARSER::BIO-STATE)
    ("Csk" . SPARSER::PROTEIN)
    ("an enteropathogenic Escherichia coli (EPEC) protein" . SPARSER::PROTEIN)
    ("Tir and FcγRIIa" . SPARSER::COLLECTION)
    ("the phagocytic Fc-gamma receptor FcγRIIa" . SPARSER::PROTEIN)
    ("Nck–WIP–N-WASP" . SPARSER::COLLECTION)
    ("the bacterial effector Tir" . SPARSER::PROTEIN)
    ("Tir" . SPARSER::PROTEIN) ("TOP3" . SPARSER::PROTEIN)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1 K" . SPARSER::PROTEIN)
    ("core protein" . SPARSER::PROTEIN)
    ("ADP- ribosyltransferase" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abl/Arg" . SPARSER::PROTEIN)
    ("Protein kinase domains" . SPARSER::PROTEIN-FAMILY)
    ("b 12 )" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("diphtheria toxin" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("ORF2" . SPARSER::PROTEIN) ("FcγRIIa" . SPARSER::PROTEIN)
    ("Fc-gamma receptor" . SPARSER::PROTEIN-FAMILY)
    ("N-WASP" . SPARSER::PROTEIN)
    ("53BP1 , RB1 , E2F1 , HECW1 , and ERN1" . SPARSER::COLLECTION)
    ("proteins and Cdk4" . SPARSER::COLLECTION)
    ("cyclin C/Cdk3" . SPARSER::COLLECTION) ("phenocopies" . SPARSER::PROTEIN)
    ("potentially toxic ubiquitinated proteins" . SPARSER::PROTEIN)
    ("TNFRSF9 or DR4" . SPARSER::COLLECTION)
    ("TNFAIP3 , TNFRSF9 , and TNFAIP8L1" . SPARSER::COLLECTION)
    ("HECW1 and vice versa" . SPARSER::COLLECTION)
    ("an HECT, C2, and WW domain containing E3 ubiquitin protein ligase also known as NEDL1"
     . SPARSER::COLLECTION)
    ("BRCA1 or ERN1" . SPARSER::COLLECTION)
    ("DUSP5, TRIML2, and BIRC3" . SPARSER::COLLECTION)
    ("ERN1, HECW1, DUSP5, TRIML2, and BIRC3" . SPARSER::COLLECTION)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("RB1-E2F1" . SPARSER::COLLECTION) ("p53 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 or siCtrl" . SPARSER::COLLECTION)
    ("γ H2AX, BRCA1, or 53BP1" . SPARSER::COLLECTION)
    ("BRCA1, or 53BP1" . SPARSER::COLLECTION)
    ("RNF8 and BARD1" . SPARSER::COLLECTION)
    ("bortezomib or carfilzomib" . SPARSER::COLLECTION)
    ("Food and Drug Administration (FDA)-approved and experimental drugs"
     . SPARSER::COLLECTION)
    ("BRCA1 and HR" . SPARSER::COLLECTION) ("PARPs" . SPARSER::MOLECULE)
    ("the most severe types" . TYPE) ("CLSPN" . SPARSER::PROTEIN)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F1 or 53BP1" . SPARSER::COLLECTION) ("Bortezomib" . SPARSER::DRUG)
    ("bortezomib and carfilzomib" . SPARSER::COLLECTION)
    ("carfilzomib" . SPARSER::DRUG) ("Cdk3" . SPARSER::PROTEIN)
    ("cyclin C" . SPARSER::PROTEIN) ("TRAILR1" . SPARSER::PROTEIN)
    ("TNFAIP8L1" . SPARSER::PROTEIN) ("TNFRSF9" . SPARSER::PROTEIN)
    ("NEDL1" . SPARSER::PROTEIN) ("DAPK2" . SPARSER::PROTEIN)
    ("TRIML2" . SPARSER::PROTEIN) ("HECW1" . SPARSER::PROTEIN)
    ("p-H3" . SPARSER::PROTEIN) ("pRB1" . SPARSER::PROTEIN)
    ("RBBP8" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("ERN1" . SPARSER::PROTEIN) ("rotenone–TRAIL" . SPARSER::COLLECTION)
    ("p53 and Bcl-X" . SPARSER::COLLECTION)
    ("BAK and Bax" . SPARSER::COLLECTION)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("TRAIL or rotenone" . SPARSER::COLLECTION)
    ("annexin V/PI" . SPARSER::COLLECTION) ("ethidium" . SPARSER::MOLECULE)
    ("iodonium (DPI)" . SPARSER::MOLECULE) ("NADP" . SPARSER::MOLECULE)
    ("iodonium" . SPARSER::MOLECULE) ("/p53" . SPARSER::COLLECTION)
    ("NF- κ B, p53 and AP-1" . SPARSER::COLLECTION)
    ("NF- κ B or AP-1" . SPARSER::COLLECTION)
    ("ERK1/2, JNK and p38" . SPARSER::COLLECTION) ("fmk" . SPARSER::PROTEIN)
    ("Rotenone or TRAIL" . SPARSER::COLLECTION)
    ("-ATPase activity" . SPARSER::COLLECTION) ("ouabain" . SPARSER::DRUG)
    ("oxidoreductase" . SPARSER::PROTEIN) ("NADH" . SPARSER::MOLECULE)
    ("AKT and NF- κ B" . SPARSER::COLLECTION)
    ("c-FLIP and IAPs" . SPARSER::COLLECTION)
    ("Bax and BAK" . SPARSER::COLLECTION)
    ("apoptosome and caspase-9 activation" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("DcR1 and DcR2, and osteoprotegerin" . SPARSER::COLLECTION)
    ("DcR2, and osteoprotegerin" . SPARSER::COLLECTION)
    ("DR4 or DR5" . SPARSER::COLLECTION)
    ("TRAIL and rotenone" . SPARSER::COLLECTION)
    ("rotenone-treated cells form" . SPARSER::FORM)
    ("Rotenone" . SPARSER::PROTEIN) ("rotenone" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN) ("per 2" . SPARSER::PROTEIN)
    ("per 3" . SPARSER::PROTEIN) ("c-FLIPs" . SPARSER::PROTEIN)
    ("PD98058" . SPARSER::DRUG) ("SHetA2" . SPARSER::DRUG)
    ("BCl-X" . SPARSER::PROTEIN) ("N -acetylcysteine" . SPARSER::DRUG)
    ("BCL-X" . SPARSER::PROTEIN)
    ("cellular FLICE-like inhibitory protein" . SPARSER::PROTEIN)
    ("specifically target HIF-1 α" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE) ("S -2" . SPARSER::PROTEIN)
    ("Bim/Bid" . SPARSER::COLLECTION) ("Jurkat-ERTax" . SPARSER::PROTEIN-PAIR)
    ("HTLV-1-Tax-expressing T-cell" . SPARSER::PROTEIN)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("all five prosurvival proteins" . SPARSER::PROTEIN)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("antibody and TRAIL" . SPARSER::COLLECTION)
    ("tunicamycin and etopside" . SPARSER::COLLECTION)
    ("anti- and proapoptotic proteins" . SPARSER::COLLECTION)
    ("the non-HTLV-1-infected leukemic T-cell line Jurkat" . SPARSER::PROTEIN)
    ("Zidovudine (AZT)" . SPARSER::DRUG)
    ("vincristine, cyclophosphamide, doxorubicin and prednisone"
     . SPARSER::COLLECTION)
    ("etoposide, carboplatin and prednisone" . SPARSER::COLLECTION)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("Zidovudine" . SPARSER::DRUG)
    ("TRAIL and anticancer drugs ( xref )" . SPARSER::COLLECTION)
    ("anti-CD95, TRAIL and anticancer drugs ( xref )" . SPARSER::COLLECTION)
    ("TRAIL and the anticancer drugs etoposide and doxorubicin"
     . SPARSER::COLLECTION)
    ("Chetomin" . SPARSER::DRUG) ("chetomin" . SPARSER::DRUG)
    ("reduced anti-CD95-" . SPARSER::ANTIBODY)
    ("anti-CD95-" . SPARSER::ANTIBODY) ("Bim or Bid" . SPARSER::COLLECTION)
    ("anti-CD95, TRAIL and etoposide" . SPARSER::COLLECTION)
    ("CD95-" . SPARSER::PROTEIN) ("CD95L-" . SPARSER::PROTEIN)
    ("Bid or Bim" . SPARSER::COLLECTION)
    ("an estrogen receptor-tax fusion protein (ERtax) or an estrogen receptor-truncated tax (lacking the first 12 amino acids) fusion protein (ERΔtax)"
     . SPARSER::COLLECTION)
    ("Bid, Bim and PUMA" . SPARSER::COLLECTION)
    ("Bim, Bid and PUMA" . SPARSER::COLLECTION)
    ("both anti- and proapoptotic proteins" . SPARSER::COLLECTION)
    ("the non-HTLV-1-associated leukemic T-cell line Jurkat"
     . SPARSER::PROTEIN)
    ("MT-2 and MT-4" . SPARSER::COLLECTION)
    ("etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("the apoptotic effector proteins Bak (Bcl-2 antagonist/killer) and Bax (Bcl-2-associated X protein)"
     . SPARSER::COLLECTION)
    ("Noxa and PUMA" . SPARSER::COLLECTION)
    ("the essential proteins" . SPARSER::PROTEIN)
    ("prosurvival Bcl-2 proteins" . SPARSER::PROTEIN)
    ("HTLV-1-infected leukemic T-cell" . SPARSER::PROTEIN)
    ("Bim and Bid" . SPARSER::COLLECTION) ("Bid and Bim" . SPARSER::COLLECTION)
    ("proapoptotic BH3-only proteins Bim (Bcl-2-interacting mediator of cell death) and Bid (BH3-interacting domain death agonist)"
     . SPARSER::COLLECTION)
    ("ATL" . SPARSER::PROTEIN) ("IL-2 " . SPARSER::PROTEIN)
    ("IFN- α" . SPARSER::PROTEIN) ("interferon- α" . SPARSER::DRUG)
    ("HIF-1 β" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("MT-4" . SPARSER::PROTEIN) ("MT-2" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("BH2" . SPARSER::MOLECULE)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("multi-SUMO" . SPARSER::COLLECTION) ("SUMO1-Flag" . SPARSER::COLLECTION)
    ("c-MYC and N-MYC" . SPARSER::COLLECTION)
    ("p300, CREB, and p53" . SPARSER::COLLECTION)
    ("SUMO and c-MYC" . SPARSER::COLLECTION) ("MYC (EV)" . SPARSER::PROTEIN)
    ("DMSO or MG132" . SPARSER::COLLECTION) ("NCL" . SPARSER::PROTEIN)
    ("firefly luciferase as well as renilla luciferase" . SPARSER::COLLECTION)
    ("MYC and actin" . SPARSER::COLLECTION)
    ("N-MYC and c-MYC" . SPARSER::COLLECTION) ("SH-EP" . SPARSER::PROTEIN)
    ("100 nM 4-OHT and 500 ng/mL tunicamycin" . SPARSER::COLLECTION)
    ("100 nM 4-OHT and 5-ethynyl-2" . SPARSER::COLLECTION)
    ("ubiquitin and both SUMO1 and SUMO2/3" . SPARSER::COLLECTION)
    ("SUMO1 and SUMO2/3" . SPARSER::COLLECTION)
    ("MYC and FlagSUMO1" . SPARSER::COLLECTION)
    ("approximately 12 kDa" . SPARSER::PROTEIN)
    ("approximately 64 kDa" . SPARSER::PROTEIN)
    ("SUMO1 or SUMO2/3" . SPARSER::COLLECTION)
    ("SUMO1, SUMO2 or SUMO3" . SPARSER::COLLECTION)
    ("E1, E2 and E3" . SPARSER::COLLECTION) ("SCF-FBXW7" . SPARSER::COLLECTION)
    ("GSK3-FBXW7" . SPARSER::COLLECTION)
    ("a DNA binding transcription factor and a master regulator"
     . SPARSER::COLLECTION)
    ("PIAS1" . SPARSER::PROTEIN) ("UBE2I" . SPARSER::PROTEIN)
    ("Ubc9" . SPARSER::PROTEIN) ("TFAP2A" . SPARSER::PROTEIN)
    ("AP-2 alpha" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("subunit 1" . SPARSER::PROTEIN)
    ("Transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("-TRPC6" . SPARSER::COLLECTION)
    ("TRPC6 (reviewed in [ xref ]) and PLCγ1" . SPARSER::COLLECTION)
    ("G protein- ( xref ) or tyrosine kinase-coupled ( xref ) receptors"
     . SPARSER::COLLECTION)
    ("G protein-" . SPARSER::PROTEIN) ("DMS" . SPARSER::DRUG)
    ("a specific PLC ε siRNA or Rho-inhibiting toxin ( xref )"
     . SPARSER::COLLECTION)
    ("TRPC6 and PLC" . SPARSER::COLLECTION) ("RhoGEF" . SPARSER::PROTEIN)
    ("TRPC6-PLC" . SPARSER::COLLECTION)
    ("PLCγ-isozymes" . SPARSER::PROTEIN-PAIR)
    ("significantly less angiotensin II-induced proteinuria"
     . SPARSER::PROTEIN)
    ("synaptopodin" . SPARSER::PROTEIN)
    ("pulmonary smooth muscle cells TRPC6" . SPARSER::PROTEIN)
    ("diacylglycerols (DAG)" . SPARSER::DAG) ("diacylglycerols" . SPARSER::DAG)
    ("phospholipases" . SPARSER::PROTEIN) ("TRPC" . SPARSER::PROTEIN)
    ("the classical or canonical TRP family" . SPARSER::PROTEIN-FAMILY)
    ("TRP" . SPARSER::AMINO-ACID) ("ROCE" . SPARSER::PROTEIN)
    ("diacylglycerol (DAG)" . SPARSER::DAG)
    ("DAG-sensitive classical transient receptor" . SPARSER::RECEPTOR)
    ("PLC ε  1" . SPARSER::PROTEIN) ("Gα q" . SPARSER::PROTEIN)
    ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("Chloride channel" . SPARSER::PROTEIN) ("protein C" . SPARSER::DRUG)
    ("CD144" . SPARSER::PROTEIN) ("PLCβ1" . SPARSER::PROTEIN)
    ("PLCγ 2" . SPARSER::PROTEIN) ("PLCγ 1" . SPARSER::PROTEIN)
    ("PLCβ 3" . SPARSER::PROTEIN) ("PLCβ 2" . SPARSER::PROTEIN)
    ("PLCβ 1" . SPARSER::PROTEIN) ("P112" . SPARSER::PROTEIN)
    ("TRPC1" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("Rho-GEF" . SPARSER::PROTEIN) ("TRPC6" . SPARSER::PROTEIN)
    ("TRPC3" . SPARSER::PROTEIN)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("DUSP5/ERK" . SPARSER::COLLECTION)
    ("soluble S147P protein" . SPARSER::PROTEIN)
    ("DUSP5 and pERK" . SPARSER::COLLECTION) ("a soluble form" . SPARSER::FORM)
    ("ERK-DUSP5" . SPARSER::COLLECTION)
    ("pre-reaction complex and slower rate" . SPARSER::COLLECTION)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("pThr-Glu-pTyr" . SPARSER::COLLECTION)
    ("DUSP5 and pERK2" . SPARSER::COLLECTION)
    ("a possible pathway around pERK2" . SPARSER::PROTEIN)
    ("ps" . SPARSER::PROTEIN) ("threonine (TPO)" . SPARSER::AMINO-ACID)
    ("pERK2" . SPARSER::PROTEIN) ("max  " . SPARSER::PROTEIN)
    ("nitrophenol" . SPARSER::MOLECULE)
    ("kDa, and DUSP5" . SPARSER::COLLECTION)
    ("both wild type DUSP5 and S147P proteins" . SPARSER::COLLECTION)
    ("Rh " . SPARSER::MOLECULE) ("Rh" . SPARSER::MOLECULE)
    ("cleaved DUSP5 and S147P recombinant proteins" . SPARSER::COLLECTION)
    ("dynamic light" . SPARSER::PROTEIN)
    ("pure untagged DUSP5 and S147P proteins" . SPARSER::COLLECTION)
    ("pure untagged DUSP5" . SPARSER::PROTEIN)
    ("The soluble protein" . SPARSER::PROTEIN)
    ("soluble GST-DUSP5 protein" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("GST-DUSP5" . SPARSER::COLLECTION)
    ("the soluble and insoluble components" . SPARSER::COMPONENT)
    ("Rosetta" . SPARSER::PROTEIN)
    ("generating soluble protein" . SPARSER::PROTEIN)
    ("glutathione-S-transferase (GST)" . SPARSER::PROTEIN)
    ("DUSP5 and mutant" . SPARSER::COLLECTION)
    ("Vascular malformations" . SPARSER::PROTEIN)
    ("vascular malformations" . SPARSER::PROTEIN)
    ("anionic sulfate" . SPARSER::MOLECULE) ("EBD" . SPARSER::PROTEIN)
    ("dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("full-length glutathione-S-transferase-tagged DUSP5 and serine 147 proline mutant (S147P) proteins"
     . SPARSER::COLLECTION)
    ("MKP3" . SPARSER::PROTEIN) ("Cdc25B" . SPARSER::PROTEIN)
    ("DUSP-5" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("P-1" . SPARSER::PROTEIN) ("MAP Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTH and NR2C2" . SPARSER::COLLECTION) ("PTH" . SPARSER::PROTEIN)
    ("The miR-92a and miR-1226" . SPARSER::COLLECTION)
    ("the individual mature miRNAs" . SPARSER::PROTEIN)
    ("the primary transcript around miR-92a" . SPARSER::MOLECULE)
    ("inhibitors and the miR-17~92 primary transcript" . SPARSER::COLLECTION)
    ("TLR3 and the NFκB complex" . SPARSER::COLLECTION)
    ("TNF, IFNG, IL1B, OSM, IFNL1 and IFNA2" . SPARSER::COLLECTION)
    ("OSM" . SPARSER::PROTEIN) ("IFNG" . SPARSER::PROTEIN)
    ("Regulators" . SPARSER::REGULATOR)
    ("miR-92a and p53" . SPARSER::COLLECTION)
    ("three seed-sequence families and one miRNA" . SPARSER::COLLECTION)
    ("p53-wildtype" . SPARSER::PROTEIN-PAIR)
    ("the other mature miRNAs" . SPARSER::PROTEIN)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("the mature miRNAs" . SPARSER::PROTEIN)
    ("the LNA-based miR-92a and miR-1226" . SPARSER::COLLECTION)
    ("sequence-dependent genomic targets" . SPARSER::TARGET-PROTEIN)
    ("the miR-92a and miR-1226" . SPARSER::COLLECTION)
    ("LNA or RNA" . SPARSER::COLLECTION) ("mature miR-92a" . SPARSER::MOLECULE)
    ("TP53 and p53" . SPARSER::COLLECTION)
    ("miR-19b-1 and miR-92a" . SPARSER::COLLECTION)
    ("miR-19b-1" . SPARSER::PROTEIN-PAIR)
    ("the inhibitors of miR-92a and miR-1226" . SPARSER::COLLECTION)
    ("919 single-stranded competitive inhibitors" . SPARSER::INHIBITOR)
    ("a mature miRNA" . SPARSER::PROTEIN)
    ("Oligonucleotides" . SPARSER::MOLECULE)
    ("both tumor promoters (oncomiRs) or tumor suppressors"
     . SPARSER::COLLECTION)
    ("Complex (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("EML4/ALK" . SPARSER::COLLECTION) ("EML4 and ALK" . SPARSER::COLLECTION)
    ("post-transcriptional gene regulators" . SPARSER::REGULATOR)
    ("NR1I2" . SPARSER::PROTEIN) ("pregnane X receptor" . SPARSER::PROTEIN)
    ("NR2C2" . SPARSER::PROTEIN) ("C13orf25" . SPARSER::PROTEIN)
    ("IFNA2" . SPARSER::PROTEIN) ("IFNL1" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("CYP24A1" . SPARSER::PROTEIN)
    ("an orally bioavailable AKT inhibitor" . SPARSER::INHIBITOR)
    ("capecitabine" . SPARSER::DRUG)
    ("mTORC1 (a downstream effector of AKT) and mTORC2 (an upstream stimulator of AKT)"
     . SPARSER::COLLECTION)
    ("cisplatin ( xref , xref ) and paclitaxel ( xref )" . SPARSER::COLLECTION)
    ("bevacizumab or perifosine" . SPARSER::COLLECTION)
    ("RMG1-CR and RMG2-CR" . SPARSER::COLLECTION)
    ("AKT-mTOR" . SPARSER::COLLECTION) ("AKT and S6K1" . SPARSER::COLLECTION)
    ("46 ovarian SACs" . SPARSER::PROTEIN)
    ("cisplatin or bevacizumab" . SPARSER::COLLECTION)
    ("alkylphospholipid" . SPARSER::DRUG) ("Perifosine" . SPARSER::PROTEIN)
    ("ovarian SACs" . SPARSER::PROTEIN) ("SACs" . SPARSER::PROTEIN)
    ("serine–threonine" . SPARSER::COLLECTION)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("aggressive forms" . SPARSER::FORM) ("AKT-mTORC1" . SPARSER::COLLECTION)
    ("bevacizumab or cisplatin" . SPARSER::COLLECTION)
    ("perifosine" . SPARSER::PROTEIN) ("EG2" . SPARSER::PROTEIN)
    ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("a hypomorphic NQO1 variant" . SPARSER::VARIANT)
    ("this hypomorphic variant" . SPARSER::VARIANT)
    ("personal communication Dr" . SPARSER::MOLECULE)
    ("GSTP1 , HMOX1 , SOD2 and GCLC" . SPARSER::COLLECTION)
    ("emphysema" . SPARSER::PROTEIN)
    ("this variant and BPD outcomes" . SPARSER::COLLECTION)
    ("the homozygous variant genotype" . SPARSER::PROTEIN)
    ("the heterozygous variant genotype" . SPARSER::PROTEIN)
    ("this variant and BPD using" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN) ("Va" . SPARSER::MOLECULE)
    ("A larger cohort" . SPARSER::MOLECULE)
    ("the homozygous variant NQO1 genotype" . SPARSER::PROTEIN)
    ("flavoprotein" . SPARSER::MOLECULE)
    ("SOD2 , HMOX1 , GSTP1 and GCLC" . SPARSER::COLLECTION)
    ("a missense hypomorphic NQO1" . SPARSER::PROTEIN)
    ("the NFE2L2 SNP and severe BPD met" . SPARSER::COLLECTION)
    ("severe BPD met" . SPARSER::AMINO-ACID)
    ("NQO1 and NFE2L2" . SPARSER::COLLECTION)
    ("NFE2L2 and NQO1" . SPARSER::COLLECTION)
    ("a homozygous state and severe BPD" . SPARSER::COLLECTION)
    ("the homozygous state" . SPARSER::BIO-STATE)
    ("SOD2 , HMOX1, GSTP1, and GCLC" . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase catalytic subunit (GCLC)" . SPARSER::PROTEIN)
    ("detoxification enzymes like glutathione S-transferases isoforms (GST) and cytochrome P450 oxidases( xref , xref )"
     . SPARSER::COLLECTION)
    ("isoforms (GST)" . SPARSER::ISOFORM)
    ("a basic leucine zipper transcription factor" . SPARSER::PROTEIN)
    ("uric acid and F2-" . SPARSER::COLLECTION)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("surfactant" . SPARSER::PROTEIN)
    ("the NQO1 and the NFE2L2 SNPs" . SPARSER::COLLECTION)
    ("a homozygous state" . SPARSER::BIO-STATE)
    ("the hypomorphic NQO1 SNP" . SPARSER::PROTEIN)
    ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("SOD2, NFE2L2 , GCLC , GSTP1 , HMOX1 and NQO1" . SPARSER::COLLECTION)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("HO1" . SPARSER::PROTEIN) ("NF-E2-related factor-2" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("HMOX1" . SPARSER::PROTEIN)
    ("anti-oxidant response elements" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Nuclear factor erythroid-2 related factor-2" . SPARSER::PROTEIN)
    ("a β-catenin inhibitor and an mTOR inhibitor" . SPARSER::COLLECTION)
    ("TCF and β-catenin" . SPARSER::COLLECTION)
    ("Mcm2 , Ccnd1 and Myc" . SPARSER::COLLECTION)
    ("proteins and Pbk" . SPARSER::COLLECTION)
    ("highly frequent MEN1" . SPARSER::PROTEIN) ("Sunitinib" . SPARSER::DRUG)
    ("Everolimus" . SPARSER::MOLECULE)
    ("PKF115-584 (0.5 mg kg −1 ) or vehicle in vivo every 3 days"
     . SPARSER::COLLECTION)
    ("the pivotal proliferative genes" . SPARSER::GENE)
    ("ethynyl" . SPARSER::MOLECULE) ("Men1-" . SPARSER::PROTEIN)
    ("Antagonist" . SPARSER::MOLECULE)
    ("key proproliferative genes" . SPARSER::GENE)
    ("Ccnd1 , Myc and Mcm2" . SPARSER::COLLECTION) ("Ccnd1" . SPARSER::PROTEIN)
    ("PCNA , MCM2 , PBK , CCNA2 , CCNB2 and CCND2" . SPARSER::COLLECTION)
    ("Mcm2 and Pbk" . SPARSER::COLLECTION) ("Mcm2" . SPARSER::PROTEIN)
    ("Mcm" . SPARSER::PROTEIN) ("proteins and PBK" . SPARSER::COLLECTION)
    ("Western blot and quantitative real-time reverse transcription–PCR (RT–PCR)"
     . SPARSER::COLLECTION)
    ("Ctnnb1" . SPARSER::PROTEIN) ("menin and β-catenin" . SPARSER::COLLECTION)
    ("normal β-cell" . SPARSER::PROTEIN) ("LEF/TCF" . SPARSER::COLLECTION)
    ("STZ" . SPARSER::DRUG) ("Streptozotocin" . SPARSER::DRUG)
    ("MLL, HDACs and Sirt1" . SPARSER::COLLECTION) ("Menin" . SPARSER::PROTEIN)
    ("proproliferative genes" . SPARSER::GENE) ("MEN1-" . SPARSER::PROTEIN)
    ("menin" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("C-myc" . SPARSER::PROTEIN) ("anti-Phospho" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("β-Cell" . SPARSER::PROTEIN)
    ("type XI" . SPARSER::PROTEIN) ("FAT1" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN) ("Cyclin B2" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("PDZ binding kinase" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("Mki67" . SPARSER::PROTEIN)
    ("PKF115-584" . SPARSER::DRUG) ("β-cell" . SPARSER::PROTEIN)
    ("von Hippel–Lindau" . SPARSER::PROTEIN) ("Men1" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN)
    ("crizotinib or other ALK inhibitors" . SPARSER::COLLECTION)
    ("a predictive therapeutic biomarker" . SPARSER::MOLECULE)
    ("I1171 variants (ceritinib) or F1174 variants (PF-06463922)"
     . SPARSER::COLLECTION)
    ("global conformation" . SPARSER::BIO-CONFORMATION)
    ("each mutated ALK TKD variant" . SPARSER::VARIANT)
    ("FEP" . SPARSER::PROTEIN)
    ("all mutated ALK TKD variants" . SPARSER::VARIANT)
    ("the macrocyclic inhibitor PF-06463922" . SPARSER::DRUG)
    ("ceritinib" . SPARSER::DRUG) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("mutated ALK variants" . SPARSER::VARIANT)
    ("robust biomarkers" . SPARSER::MOLECULE)
    ("both amplified MYCN and F1174-mutated ALK" . SPARSER::COLLECTION)
    ("Matched constitutional DNA" . SPARSER::DNA)
    ("glutamine or leucine" . SPARSER::COLLECTION) ("Ros1" . SPARSER::PROTEIN)
    ("Ros" . SPARSER::PROTEIN) ("intact ALK" . SPARSER::PROTEIN)
    ("a cell-surface neural receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mutated variants" . SPARSER::VARIANT) ("PF-06463922" . SPARSER::DRUG)
    ("GD2" . SPARSER::MOLECULE)
    ("idelalisib (PI3Kδ inhibitor) and rituximab" . SPARSER::COLLECTION)
    ("idelalisib" . SPARSER::DRUG)
    ("ibrutinib (BTK inhibitor) and rituximab" . SPARSER::COLLECTION)
    ("ibrutinib" . SPARSER::DRUG)
    ("specifically knock-down LYN, FYN or LCK" . SPARSER::COLLECTION)
    ("LYN, FYN or LCK" . SPARSER::COLLECTION) ("CSK" . SPARSER::PROTEIN)
    ("immunotoxins" . SPARSER::DRUG)
    ("anti-CD38, anti-CD52 or anti-CD19" . SPARSER::COLLECTION)
    ("Ofatumumab" . SPARSER::DRUG)
    ("chimeric rituximab and fully human ofatumumab" . SPARSER::COLLECTION)
    ("murine L27 antibody, chimeric rituximab and fully human ofatumumab"
     . SPARSER::COLLECTION)
    ("fully human ofatumumab" . SPARSER::DRUG)
    ("chimeric rituximab" . SPARSER::DRUG)
    ("LYN, LCK and FYN" . SPARSER::COLLECTION)
    ("bafetinib (a dual BCR-ABL/LYN inhibitor) and dasatinib (BCR/ABL and SFKs inhibitor)"
     . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("pMIG-GFP" . SPARSER::COLLECTION)
    ("C124S-mutated form" . SPARSER::FORM)
    ("Oct-1/Oct-2" . SPARSER::COLLECTION)
    ("del2, del1 and del0" . SPARSER::COLLECTION)
    ("pGL4-CD20" . SPARSER::COLLECTION) ("Ly-1" . SPARSER::PROTEIN)
    ("signed-rank" . SPARSER::PROTEIN)
    ("rituximab- and ofatumumab-mediated CDC" . SPARSER::COLLECTION)
    ("Dasatinib and PP2" . SPARSER::COLLECTION)
    ("inhibitors and antibodies" . SPARSER::COLLECTION)
    ("CD20, CD21 and CD22" . SPARSER::COLLECTION)
    ("CD38, CD52 and CD19" . SPARSER::COLLECTION)
    ("CD20 and CD22" . SPARSER::COLLECTION)
    ("CD21 and CD22" . SPARSER::COLLECTION)
    ("complement regulatory proteins (CD46 and CD55) and other B-cell molecules (HLA-DR, ICAM-1, CD52, CD38)"
     . SPARSER::COLLECTION)
    ("CD46 and CD55" . SPARSER::COLLECTION)
    ("rituximab and ofatumumab" . SPARSER::COLLECTION)
    ("rituximab-" . SPARSER::DRUG) ("FYN, LCK and LYN" . SPARSER::COLLECTION)
    ("LCK" . SPARSER::PROTEIN)
    ("Neither imatinib, an inhibitor of BCR-ABL, c-KIT and platelet-derived growth factor receptor (PDGFR), nor tandutinib"
     . SPARSER::COLLECTION)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("BCR-ABL, c-KIT and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("PDGFR and c-KIT" . SPARSER::COLLECTION) ("tandutinib" . SPARSER::DRUG)
    ("ofatumumab and rituximab" . SPARSER::COLLECTION)
    ("ofatumumab" . SPARSER::DRUG)
    ("Dasatinib and more selective compounds" . SPARSER::COLLECTION)
    ("bafetinib and PP2" . SPARSER::COLLECTION)
    ("dasatinib or PP2" . SPARSER::COLLECTION)
    ("100 nM dasatinib (a clinically-available multi-target tyrosine kinase inhibitor) or 10 μM PP2 (a more selective inhibitor of BCR-associated SFKs)"
     . SPARSER::COLLECTION)
    ("FcR" . SPARSER::PROTEIN-FAMILY)
    ("SYK, BTK or PI3K" . SPARSER::COLLECTION)
    ("cyclophosphamide-" . SPARSER::DRUG) ("therapeutic mAbs" . SPARSER::DRUG)
    ("an excellent molecular target" . SPARSER::TARGET-PROTEIN)
    ("fludarabine" . SPARSER::DRUG)
    ("bafetinib (BCR-ABL/LYN inhibitor) and dasatinib (BCR-ABL/SFKs inhibitor)"
     . SPARSER::COLLECTION)
    ("BCR-ABL/LYN" . SPARSER::COLLECTION) ("bafetinib" . SPARSER::DRUG)
    ("attractive molecular targets" . SPARSER::TARGET-PROTEIN)
    ("BTK and AKT" . SPARSER::COLLECTION)
    ("the adaptor molecule B-cell linker protein (BLNK) and its downstream signaling components"
     . SPARSER::COLLECTION)
    ("tyrosine kinase (BTK) and phospholipase Cγ2 (PLCγ2)"
     . SPARSER::COLLECTION)
    ("linker protein (BLNK)" . SPARSER::PROTEIN)
    ("Igα/Igβ" . SPARSER::COLLECTION)
    ("BLK, FYN and LYN" . SPARSER::COLLECTION) ("LYN" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN)
    ("anti-CD20 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("RPL29" . SPARSER::PROTEIN)
    ("anti-IgM" . SPARSER::PROTEIN) ("Oct-2" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN) ("del1" . SPARSER::PROTEIN)
    ("del2" . SPARSER::PROTEIN) ("del3" . SPARSER::PROTEIN)
    ("hCD20" . SPARSER::DRUG) ("CD21" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("ICAM-1" . SPARSER::PROTEIN)
    ("CD55" . SPARSER::PROTEIN) ("CD46" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("PI3Kδ" . SPARSER::PROTEIN)
    ("phospholipase Cγ2" . SPARSER::PROTEIN)
    ("linker protein" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN) ("MS4A1" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("urinary proteins" . SPARSER::PROTEIN)
    ("particular KRT8" . SPARSER::PROTEIN)
    ("RhoC, ROCKI and ROCKII" . SPARSER::COLLECTION)
    ("ROCKII" . SPARSER::PROTEIN) ("ROCKI" . SPARSER::PROTEIN)
    ("Src and caveolin" . SPARSER::COLLECTION)
    ("KRT8 and MREG" . SPARSER::COLLECTION)
    ("Both KRT8 ( xref ) and MREG ( xref )" . SPARSER::COLLECTION)
    ("keratin 8, and MREG" . SPARSER::COLLECTION)
    ("melanoregulin" . SPARSER::PROTEIN) ("MREG" . SPARSER::PROTEIN)
    ("RhoC and RhoGDI2" . SPARSER::COLLECTION)
    ("RhoGDI2 and RhoC" . SPARSER::COLLECTION)
    ("shRNA or shRhoC-1" . SPARSER::COLLECTION) ("Lul2" . SPARSER::PROTEIN)
    ("RhoC shRNA #2 (herein identified as shRhoC-2) almost completely eliminated RhoC"
     . SPARSER::PROTEIN)
    ("shRhoC-2" . SPARSER::COLLECTION) ("shRhoC-1" . SPARSER::COLLECTION)
    ("GST-Rhotekin" . SPARSER::COLLECTION) ("Rhotekin" . SPARSER::PROTEIN)
    ("RhoC and Rac1" . SPARSER::COLLECTION)
    ("GFP-RhoGDI2" . SPARSER::COLLECTION)
    ("RhoC/RhoGDI2" . SPARSER::COLLECTION)
    ("Rac1, Cdc42 and RhoG" . SPARSER::COLLECTION)
    ("Rac2 and RhoB" . SPARSER::COLLECTION)
    ("RhoGDI2, and Cdc42" . SPARSER::COLLECTION)
    ("Rac1, Rac2, Cdc42, RhoA, RhoB, RhoC and RhoG" . SPARSER::COLLECTION)
    ("Rac1 or RhoA" . SPARSER::COLLECTION)
    ("Rac1 and RhoC" . SPARSER::COLLECTION) ("versican" . SPARSER::PROTEIN)
    ("Guanine" . SPARSER::PROTEIN) ("RhoC" . SPARSER::PROTEIN)
    ("inhibitor (GDI)" . SPARSER::INHIBITOR) ("ARHGDIB" . SPARSER::DRUG)
    ("Keratin 8" . SPARSER::PROTEIN) ("PKN3" . SPARSER::PROTEIN)
    ("keratin 8" . SPARSER::PROTEIN) ("Rac2" . SPARSER::PROTEIN)
    ("KRT8" . SPARSER::PROTEIN) ("D4-GDI" . SPARSER::PROTEIN)
    ("GDI2" . SPARSER::PROTEIN) ("LuL2" . SPARSER::PROTEIN)
    ("RhoGDI2" . SPARSER::PROTEIN) ("- 1" . SPARSER::PROTEIN)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("lapatinib and chloroquine" . SPARSER::COLLECTION)
    ("chloroquine and lapatinib" . SPARSER::COLLECTION)
    ("shRNA or shRNA" . SPARSER::COLLECTION) ("c-IF" . SPARSER::COLLECTION)
    ("GFP-puncta" . SPARSER::COLLECTION) ("BII" . SPARSER::PROTEIN)
    ("bot" . SPARSER::PROTEIN) ("MGF" . SPARSER::PROTEIN)
    ("Hunk" . SPARSER::PROTEIN) ("HER2/neu" . SPARSER::COLLECTION)
    ("Hormonally Upregulated Neu-associated kinase" . SPARSER::KINASE)
    ("neu" . SPARSER::PROTEIN) ("HUNK" . SPARSER::PROTEIN)
    ("receive targeted inhibitors" . SPARSER::INHIBITOR)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("Rsk1" . SPARSER::PROTEIN)
    ("COL2A1 , COL9A1 , COMP , and ACAN" . SPARSER::COLLECTION)
    ("COMP" . SPARSER::PROTEIN) ("HDAC4 and HDAC7" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, and HDAC3" . SPARSER::COLLECTION)
    ("cartilage anabolic genes" . SPARSER::GENE)
    ("ACAN and COL2A1" . SPARSER::COLLECTION) ("ACAN" . SPARSER::PROTEIN)
    ("HDACis" . SPARSER::MOLECULE) ("CAIA" . SPARSER::PROTEIN)
    ("IL-1 and matrix-degrading enzymes [ xref ]" . SPARSER::COLLECTION)
    ("Phlpp1" . SPARSER::PROTEIN)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("an especially strong HDAC4" . SPARSER::PROTEIN)
    ("MMP1, MMP3, MMP13 and ADAMTS4" . SPARSER::COLLECTION)
    ("catabolic enzymes" . SPARSER::ENZYME)
    ("IL-1 and TNF-α" . SPARSER::COLLECTION)
    ("the possible role HDAC" . SPARSER::PROTEIN)
    ("both aggrecan (Figure  xref A) and COL2A1 (Figure  xref B)"
     . SPARSER::COLLECTION)
    ("enzymes, MMP3, MMP13 and ADAMTS4" . SPARSER::COLLECTION)
    ("MMP1, MMP3, MMP13, and ADAMTS4" . SPARSER::COLLECTION)
    ("IL-1 or TNF-α" . SPARSER::COLLECTION)
    ("global inhibitors" . SPARSER::INHIBITOR) ("butyrate" . SPARSER::PROTEIN)
    ("The classical HDACs family" . SPARSER::PROTEIN-FAMILY)
    ("the zinc-dependent classical HDACs family" . SPARSER::PROTEIN-FAMILY)
    ("some anabolic genes" . SPARSER::GENE)
    ("ADAMTS4 (aggrecanase 1) and ADAMTS5 (aggrecanase 2)"
     . SPARSER::COLLECTION)
    ("MMP1 (Matrix metalloproteinase 1), MMP3 (Matrix metalloproteinase 3) , MMP13 (Matrix metalloproteinase 13), ADAMTS4 (aggrecanase 1) and ADAMTS5 (aggrecanase 2)"
     . SPARSER::COLLECTION)
    ("IL-1β or TNF-α" . SPARSER::COLLECTION) ("NAB1" . SPARSER::PROTEIN)
    ("COL9A1" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("HDAC 4" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("IL-1" . SPARSER::PROTEIN)
    ("safranin O" . SPARSER::DRUG) ("—3" . SPARSER::PROTEIN)
    ("RPD3" . SPARSER::PROTEIN) ("ADAMTS5" . SPARSER::PROTEIN)
    ("ADAMTS4" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("PTEN, PDCD4, TMP1 and TIMP-3" . SPARSER::COLLECTION)
    ("chemoresistance" . SPARSER::PROTEIN)
    ("Recently several miRNAs" . SPARSER::PROTEIN)
    ("DDP-chemoresistance" . SPARSER::PROTEIN-PAIR)
    ("Bcl-2/Bcl-XL" . SPARSER::COLLECTION)
    ("PTEN ( xref ) and Caspase-3 ( xref )" . SPARSER::COLLECTION)
    ("PDCD4, TIMP3, PTEN ( xref ) and Caspase-3 ( xref )"
     . SPARSER::COLLECTION)
    ("mTOR, Ki67, Bcl-2, and MMP-2" . SPARSER::COLLECTION)
    ("WP1066 and DDP" . SPARSER::COLLECTION)
    ("DDP or WP1066" . SPARSER::COLLECTION)
    ("DDP and WP1066" . SPARSER::COLLECTION)
    ("miR-21 and STAT3" . SPARSER::COLLECTION)
    ("DDP and 24" . SPARSER::COLLECTION) ("STAT/miR-21" . SPARSER::COLLECTION)
    ("STAT3/miRNA" . SPARSER::COLLECTION)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION)
    ("proteins, and mitochondria" . SPARSER::COLLECTION)
    ("multiple chemotherapeutic drugs" . SPARSER::DRUG)
    ("PTEN, TIMP3 and PDCD4" . SPARSER::COLLECTION)
    ("STAT3/miR-21" . SPARSER::COLLECTION)
    ("cisplatin (DDP)" . SPARSER::MOLECULE)
    ("cisplatin sensitive or resistant group" . SPARSER::MOLECULE)
    ("STAT3 and miR-21" . SPARSER::COLLECTION) ("TIMP-3" . SPARSER::PROTEIN)
    ("TMP1" . SPARSER::PROTEIN) ("MiR-21" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("Ras-Raf-ERK" . SPARSER::COLLECTION)
    ("shRNA-Shoc2-GFP" . SPARSER::COLLECTION) ("myoblasts" . SPARSER::PROTEIN)
    ("Raf and Ras" . SPARSER::COLLECTION)
    ("Erbin and Shoc2" . SPARSER::COLLECTION) ("Erbin" . SPARSER::PROTEIN)
    ("fibroblast growth factor-receptor (FGFR) and tropomyosin-related kinase (Trk) families"
     . SPARSER::COLLECTION)
    ("tropomyosin" . SPARSER::PROTEIN)
    ("siRNA and shRNA" . SPARSER::COLLECTION)
    ("an essential protein" . SPARSER::PROTEIN)
    ("/N-Ras" . SPARSER::COLLECTION) ("M-Ras/Shoc2/PP1c" . SPARSER::COLLECTION)
    ("M-Ras and C-Raf" . SPARSER::COLLECTION)
    ("the dual specificity kinases MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotrophins" . SPARSER::PROTEIN) ("AKT or GSK3" . SPARSER::COLLECTION)
    ("shRNA-Shoc2" . SPARSER::COLLECTION) ("EGF or NGF" . SPARSER::COLLECTION)
    ("Grb2, Ras, Raf, MEK, and ERK" . SPARSER::COLLECTION)
    ("RTK-ERK" . SPARSER::COLLECTION) ("HA-ERK1" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("protein phosphatase 1 (PP1c) and M-Ras (a Ras family member)"
     . SPARSER::COLLECTION)
    ("SCRIB" . SPARSER::DRUG) ("Ras-Raf" . SPARSER::COLLECTION)
    ("Shoc2/Sur8" . SPARSER::COLLECTION) ("MEK-ERK" . SPARSER::COLLECTION)
    ("PI3K, p120GAP, NF1, MEKK1, Rin1, AF-6, PKC-ξ, and Nore1"
     . SPARSER::COLLECTION)
    ("AF-6" . SPARSER::PROTEIN) ("EGF and NGF" . SPARSER::COLLECTION)
    ("Raf, MEK and ERK" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("Ras and Raf" . SPARSER::COLLECTION) ("Spry2" . SPARSER::PROTEIN)
    ("Desmoglein-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor-receptor" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN)
    ("IQ motif containing GTPase activating protein 1" . SPARSER::PROTEIN)
    ("MP1" . SPARSER::PROTEIN) ("MEK partner 1" . SPARSER::PROTEIN)
    ("KSR1" . SPARSER::PROTEIN)
    ("kinase suppressor of Ras1" . SPARSER::PROTEIN)
    ("Shoc 2" . SPARSER::PROTEIN) ("ERK-2" . SPARSER::PROTEIN)
    ("ERK-1" . SPARSER::PROTEIN) ("C-RAF" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("M-Ras" . SPARSER::PROTEIN)
    ("PP1c" . SPARSER::PROTEIN) ("Sur8" . SPARSER::PROTEIN)
    ("Nore1" . SPARSER::PROTEIN) ("Rin1" . SPARSER::PROTEIN)
    ("MEKK1" . SPARSER::PROTEIN) ("p120GAP" . SPARSER::PROTEIN)
    ("Ral-GDS" . SPARSER::PROTEIN) ("Shoc2" . SPARSER::PROTEIN)
    ("DNA-repair" . SPARSER::DNA) ("PUMA and p21" . SPARSER::COLLECTION)
    ("aspartate, alanine, valine, leucine and isoleucine"
     . SPARSER::COLLECTION)
    ("Only 2 measured metabolites" . SPARSER::MOLECULE)
    ("glutamine and glutamate" . SPARSER::COLLECTION)
    ("metabolite and p73" . SPARSER::COLLECTION)
    ("methyltetrahydrofolate" . SPARSER::MOLECULE)
    ("Cystathionine" . SPARSER::MOLECULE)
    ("its demethylated byproducts S-adenosylhomocysteine (SAH) and cystathionine (Figure xref )"
     . SPARSER::COLLECTION)
    ("its demethylated byproducts S-adenosylhomocysteine (SAH)"
     . SPARSER::MOLECULE)
    ("S-adenosylhomocysteine (SAH)" . SPARSER::MOLECULE)
    ("hydroxyproline and proline-hydroxyproline" . SPARSER::COLLECTION)
    ("hydroxyproline" . SPARSER::MOLECULE) ("Arginine" . SPARSER::AMINO-ACID)
    ("Polyamines" . SPARSER::MOLECULE)
    ("putrescine and spermidine" . SPARSER::COLLECTION)
    ("spermidine and spermine" . SPARSER::COLLECTION)
    ("spermidine" . SPARSER::MOLECULE) ("putrescine" . SPARSER::MOLECULE)
    ("amino acids and amino acid" . SPARSER::COLLECTION)
    ("a pivotal cofactor" . SPARSER::MOLECULE) ("CoA" . SPARSER::MOLECULE)
    ("coenzyme" . SPARSER::MOLECULE)
    ("the only TCA cycle metabolites" . SPARSER::MOLECULE)
    ("acetyl-CoA and citrate" . SPARSER::COLLECTION)
    ("citrate" . SPARSER::PROTEIN)
    ("glucose and pyruvate" . SPARSER::COLLECTION)
    ("p53/p73" . SPARSER::COLLECTION)
    ("arginine-proline" . SPARSER::COLLECTION)
    ("polyamines" . SPARSER::MOLECULE) ("pentose" . SPARSER::MOLECULE)
    ("serine-glycine" . SPARSER::COLLECTION)
    ("intracellular ATP and increases ROS content [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("PUMA [ xref – xref ] and BAX [ xref , xref ]" . SPARSER::COLLECTION)
    ("transcriptional competent TAp73 isoforms" . SPARSER::ISOFORM)
    ("S-adenosylmethionine (SAM)" . SPARSER::DRUG) ("GLS-2" . SPARSER::PROTEIN)
    ("S-adenosylhomocysteine" . SPARSER::MOLECULE)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("S-adenosylmethionine" . SPARSER::DRUG)
    ("sporadic MTC" . SPARSER::PROTEIN) ("metastatic MTC" . SPARSER::PROTEIN)
    ("the more aggressive subtypes" . SPARSER::PROTEIN)
    ("ASCL1, CgA, calcitonin, and SYP" . SPARSER::COLLECTION)
    ("oncogene or tumor" . SPARSER::COLLECTION)
    ("Notch3 or nonspecific siRNA" . SPARSER::COLLECTION)
    ("nonspecific siRNA" . SPARSER::PROTEIN)
    ("purified human recombinant HDAC’s" . SPARSER::PROTEIN)
    ("HDAC-Glo" . SPARSER::COLLECTION)
    ("a functional Notch3" . SPARSER::PROTEIN)
    ("Notch3 and NICD3" . SPARSER::COLLECTION)
    ("Notch1 or Notch2" . SPARSER::COLLECTION)
    ("a known bifunctional reagent" . SPARSER::MOLECULE)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("doxycycline and vehicle" . SPARSER::COLLECTION)
    ("PARP and p27" . SPARSER::COLLECTION)
    ("Mcl-1, p21, and cyclin D1" . SPARSER::COLLECTION)
    ("CgA, calcitonin, and SYP" . SPARSER::COLLECTION)
    ("HES1, HES5, HEY1, and HEY2" . SPARSER::COLLECTION)
    ("HES2 and HES6" . SPARSER::COLLECTION)
    ("TT-TRE and TT-TRE" . SPARSER::COLLECTION)
    ("ASCL1 and CgA" . SPARSER::COLLECTION)
    ("sporadic and inherited MTC" . SPARSER::PROTEIN)
    ("MZ-CRC-1" . SPARSER::COLLECTION)
    ("ASCL1, CgA, SYP, and calcitonin" . SPARSER::COLLECTION)
    ("NET" . SPARSER::PROTEIN) ("HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("DNA binding transcription factor CSL (also called CBF-1, RBP-jk, Lag-1), the co-activator Mastermind-like (MAML), and other proteins ( xref ) which subsequently induce expression of Hairy/Enhancer"
     . SPARSER::COLLECTION)
    ("Hairy-related (HEY) transcriptional repressors" . SPARSER::REPRESSOR)
    ("HEY" . SPARSER::PROTEIN-FAMILY) ("Enhancer" . SPARSER::PROTEIN)
    ("MAML" . SPARSER::PROTEIN) ("Mastermind" . SPARSER::PROTEIN-FAMILY)
    ("CSL" . SPARSER::PROTEIN)
    ("metalloprotease and γ-secretase" . SPARSER::COLLECTION)
    ("DLL1, DLL3, DLL4, JAG1, and JAG2" . SPARSER::COLLECTION)
    ("Delta" . SPARSER::PROTEIN) ("synaptophysin (SYP)" . SPARSER::PROTEIN)
    ("SYP" . SPARSER::PROTEIN) ("synaptophysin" . SPARSER::PROTEIN)
    ("CgA" . SPARSER::PROTEIN) ("chromogranin" . SPARSER::PROTEIN)
    ("incurable MTC" . SPARSER::PROTEIN) ("calcitonin" . SPARSER::PROTEIN)
    ("MTC" . SPARSER::PROTEIN) ("Notch 3" . SPARSER::PROTEIN)
    ("Notch2" . SPARSER::PROTEIN) ("–2µ" . SPARSER::PROTEIN)
    ("HEY2" . SPARSER::PROTEIN) ("HEY1" . SPARSER::PROTEIN)
    ("HES5" . SPARSER::PROTEIN) ("HES2" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("ICD 2" . SPARSER::PROTEIN)
    ("HDAC 10" . SPARSER::PROTEIN) ("NCOR1" . SPARSER::PROTEIN)
    ("HDAC 3" . SPARSER::PROTEIN) ("HDAC 6" . SPARSER::PROTEIN)
    ("HDAC 2" . SPARSER::PROTEIN) ("HDAC 8" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("CBF1" . SPARSER::PROTEIN)
    ("Lag-1" . SPARSER::PROTEIN) ("CBF-1" . SPARSER::PROTEIN)
    ("JAG2" . SPARSER::PROTEIN) ("JAG1" . SPARSER::PROTEIN)
    ("DLL4" . SPARSER::PROTEIN) ("DLL3" . SPARSER::PROTEIN)
    ("ASCL1" . SPARSER::PROTEIN)
    ("Notch3 intracellular domain" . SPARSER::PROTEIN)
    ("proteins and MdmX" . SPARSER::COLLECTION)
    ("the p21 core promoter and the dhfr (dihydrofolate reductase) promoter ( xref )"
     . SPARSER::COLLECTION)
    ("Mcl-1, XIAP, and cIAP2" . SPARSER::COLLECTION)
    ("survivin, Mcl-1, XIAP, and cIAP2" . SPARSER::COLLECTION)
    ("p53 and p53-null" . SPARSER::COLLECTION)
    ("survivin, XIAP, cIAP2, and Mcl-1" . SPARSER::COLLECTION)
    ("a poor p21 Western blot" . SPARSER::PROTEIN)
    ("other Mdm2/MdmX complex–associated proteins" . SPARSER::PROTEIN)
    ("Mdm2 or MdmX" . SPARSER::COLLECTION) ("Mdm2/MdmX" . SPARSER::COLLECTION)
    ("irinotecan (pro-drug of SN-38) and topotecan" . SPARSER::COLLECTION)
    ("shC and shp53" . SPARSER::COLLECTION) ("shC" . SPARSER::PROTEIN)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 and Hdm2" . SPARSER::COLLECTION) ("FLAG-HdmX" . SPARSER::COLLECTION)
    ("p53/mdm2/mdmx" . SPARSER::COLLECTION) ("mdmx" . SPARSER::PROTEIN)
    ("ATM, p53, and p21" . SPARSER::COLLECTION)
    ("p53 and MdmX" . SPARSER::COLLECTION) ("Hdm2–HdmX" . SPARSER::COLLECTION)
    ("Hdm2–p53" . SPARSER::COLLECTION)
    ("p21 , Hdm2 , and PUMA" . SPARSER::COLLECTION) ("HdmX" . SPARSER::PROTEIN)
    ("mub-p53" . SPARSER::COLLECTION) ("p21 and PUMA" . SPARSER::COLLECTION)
    ("MdmX and Mdm2" . SPARSER::COLLECTION) ("p53/Mdm2" . SPARSER::COLLECTION)
    ("Puma and Noxa" . SPARSER::COLLECTION)
    ("colon cancer, KRAS, APC , and p53" . SPARSER::COLLECTION)
    ("topotecan and irinotecan" . SPARSER::COLLECTION)
    ("SN-38 and topotecan" . SPARSER::COLLECTION)
    ("camptothecin, topotecan, and SN-38" . SPARSER::COLLECTION)
    ("topotecan or SN-38" . SPARSER::COLLECTION)
    ("Bim, Puma, and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Mcl-1, Bcl-2, and Bcl-XL" . SPARSER::COLLECTION)
    ("survivin, cIAP, and XIAP" . SPARSER::COLLECTION)
    ("Mdm2–p53" . SPARSER::COLLECTION) ("Mdm2–MdmX" . SPARSER::COLLECTION)
    ("E3-competent Mdm2" . SPARSER::PROTEIN)
    ("irinotecan and topotecan" . SPARSER::COLLECTION)
    ("UbCH5c" . SPARSER::PROTEIN) ("B12)" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("TOP1" . SPARSER::PROTEIN)
    ("SN-38" . SPARSER::DRUG) ("FL118" . SPARSER::DRUG)
    ("highly associated single genetic variants" . SPARSER::VARIANT)
    ("a known glioma risk-associated genetic variant" . SPARSER::VARIANT)
    ("homozygous minor (T) allele" . SPARSER::ALLELE)
    ("EGFR or EGFR-AS1" . SPARSER::COLLECTION)
    ("RegulomeDB positional weight matrices" . SPARSER::PROTEIN-FAMILY)
    ("CDPCR-3" . SPARSER::COLLECTION) ("TFB" . SPARSER::PROTEIN)
    ("the last shared exon" . SPARSER::PROTEIN)
    ("tobacco and HPV" . SPARSER::COLLECTION)
    ("SNPs, rs2072454 and rs2075110" . SPARSER::COLLECTION)
    ("MLR" . SPARSER::PROTEIN) ("a synonymous SNP" . SPARSER::PROTEIN)
    ("exact genotype" . SPARSER::PROTEIN)
    ("risk-associated polymorphisms" . SPARSER::PROTEIN)
    ("cigarettes and alcohol" . SPARSER::COLLECTION)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("Tobacco and alcohol" . SPARSER::COLLECTION)
    ("Polymorphisms" . SPARSER::PROTEIN) ("H4K20me1" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("H3K27Ac" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("informative biomarkers" . SPARSER::MOLECULE)
    ("SH, AH, and EC" . SPARSER::COLLECTION) ("Cao" . SPARSER::MOLECULE)
    ("AH, CH and EC" . SPARSER::COLLECTION) ("AH and CH" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION) ("EC and AH" . SPARSER::COLLECTION)
    ("EC and SH" . SPARSER::COLLECTION) ("SH and AH" . SPARSER::COLLECTION)
    ("PDEC" . SPARSER::PROTEIN) ("AH" . SPARSER::MOLECULE)
    ("Cyclin D1 and Ki-67" . SPARSER::COLLECTION)
    ("optimal use antimalarial drugs" . SPARSER::DRUG)
    ("Artemisinin" . SPARSER::DRUG) ("artesunate" . SPARSER::DRUG)
    ("triple Pfdhr + Pfdhps" . SPARSER::PROTEIN) ("Pfdhps" . SPARSER::PROTEIN)
    ("triple mutant Pfdhps AGEAA (26%) haplotypes" . SPARSER::PROTEIN)
    ("the triple resistance-associated haplotype" . SPARSER::PROTEIN)
    ("the resistance-associated dhfr haplotypes" . SPARSER::PROTEIN)
    ("Goa" . SPARSER::PROTEIN) ("ANRNI" . SPARSER::PROTEIN)
    ("particularly dhfr and dhps genes" . SPARSER::GENE)
    ("dhfr and dhps" . SPARSER::COLLECTION)
    ("either one gene or both genes (single to quadruple)"
     . SPARSER::COLLECTION)
    ("the next common dhfr-dhps haplotypes" . SPARSER::PROTEIN)
    ("ANRNI-AGEAA" . SPARSER::PROTEIN-PAIR)
    ("Triple mutant haplotypes" . SPARSER::PROTEIN)
    ("dhfr-dhps" . SPARSER::COLLECTION) ("AIRNI-AGEAA" . SPARSER::PROTEIN-PAIR)
    ("AGEAA" . SPARSER::PROTEIN) ("the triple mutant AIRNI" . SPARSER::PROTEIN)
    ("a triple mutant" . SPARSER::MUTANT) ("Haplotype" . SPARSER::PROTEIN)
    ("AIRNI" . SPARSER::PROTEIN) ("haplotypes" . SPARSER::PROTEIN)
    ("sulfadoxine and pyrimethamine" . SPARSER::COLLECTION)
    ("sulfadoxine" . SPARSER::DRUG) ("Sulfonamides" . SPARSER::DRUG)
    ("sulphadoxine" . SPARSER::DRUG)
    ("triple mutant haplotype AGEAA" . SPARSER::PROTEIN)
    ("haplotype AGEAA" . SPARSER::PROTEIN) ("Sulphadoxine" . SPARSER::DRUG)
    ("haplotype" . SPARSER::PROTEIN)
    ("Triple mutant haplotypes AIRNI" . SPARSER::PROTEIN)
    ("haplotypes AIRNI" . SPARSER::PROTEIN) ("pyrimethamine" . SPARSER::DRUG)
    ("dhps" . SPARSER::PROTEIN) ("dhfr" . SPARSER::PROTEIN)
    ("antifolate resistance-associated genetic polymorphisms"
     . SPARSER::PROTEIN)
    ("antifolate" . SPARSER::MOLECULE) ("A-G" . SPARSER::PROTEIN)
    ("C-G" . SPARSER::PROTEIN) ("C-T" . SPARSER::PROTEIN)
    ("T-G" . SPARSER::PROTEIN) ("G-A" . SPARSER::PROTEIN)
    ("a relatively large consecutive cohort" . SPARSER::MOLECULE)
    ("the 7th UICC TNM" . SPARSER::MOLECULE)
    ("ypT1, ypT2, ypT3, and ypT4" . SPARSER::COLLECTION)
    ("the most frequently mutated tumor-associated gene" . SPARSER::GENE)
    ("the anal verge" . SPARSER::PROTEIN) ("verge" . SPARSER::PROTEIN)
    ("low p53 (<50% nuclear staining) and high p53 (≥50%)"
     . SPARSER::COLLECTION)
    ("ypT3" . SPARSER::PROTEIN) ("ypT2" . SPARSER::PROTEIN)
    ("ypT1" . SPARSER::PROTEIN) ("TRG3" . SPARSER::PROTEIN)
    ("TRG1" . SPARSER::PROTEIN)
    ("ESCRT-II, ESCRT-III and Vps4" . SPARSER::COLLECTION)
    ("Vps23/TSG101" . SPARSER::COLLECTION)
    ("Vps37/HCRP1" . SPARSER::COLLECTION)
    ("the alternative mechanism traffic activated EGFR" . SPARSER::PROTEIN)
    ("continuous EGF" . SPARSER::PROTEIN) ("ALIX-siRNA" . SPARSER::COLLECTION)
    ("CQ" . SPARSER::PROTEIN) ("poison" . SPARSER::MOLECULE)
    ("the peripheral membrane protein EEA1" . SPARSER::PROTEIN)
    ("EGFR and PAR1" . SPARSER::COLLECTION)
    ("membrane-associated ALIX" . SPARSER::PROTEIN)
    ("ALIX and HD-PTP" . SPARSER::COLLECTION)
    ("a CHMP4 interaction-defective mutant I212D GFP-ALIX"
     . SPARSER::COLLECTION)
    ("soluble protein" . SPARSER::PROTEIN)
    ("ALIX and CHMP4b" . SPARSER::COLLECTION)
    ("soluble proteins" . SPARSER::PROTEIN) ("GST-ALIX" . SPARSER::COLLECTION)
    ("HA-ALIX" . SPARSER::COLLECTION) ("FLAG-ALIX" . SPARSER::COLLECTION)
    ("an anti-GFP antibody or a mouse IgG (negative control antibody)"
     . SPARSER::COLLECTION)
    ("EGFR and CHMP4b" . SPARSER::COLLECTION)
    ("N-ethylmaleimide (NEM)" . SPARSER::MOLECULE)
    ("GFP-ALIX" . SPARSER::COLLECTION)
    ("5 mM MgCl 2 and 250 mM sucrose" . SPARSER::COLLECTION)
    ("HPO" . SPARSER::PROTEIN) ("digitonin" . SPARSER::MOLECULE)
    ("Proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fractions 9 and 10 contained soluble proteins" . SPARSER::PROTEIN)
    ("Immobilized GST and GST tagged proteins" . SPARSER::PROTEIN)
    ("DTT and proteinase" . SPARSER::COLLECTION)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("GST and GST" . SPARSER::COLLECTION)
    ("N-Ethylmaleimide (NEM)" . SPARSER::MOLECULE)
    ("1 mM dichlorodiphenyltrichloroethane (DTT) and proteinase inhibitor cocktail (Sigma)"
     . SPARSER::COLLECTION)
    ("dichlorodiphenyltrichloroethane (DTT)" . SPARSER::MOLECULE)
    ("Triton X-100 (TX)" . SPARSER::MOLECULE)
    ("dichlorodiphenyltrichloroethane" . SPARSER::MOLECULE)
    ("chloroquine (CQ)" . SPARSER::PROTEIN)
    ("DNA In Vitro Transfection Reagent or GenMute" . SPARSER::COLLECTION)
    ("activated EGFR and possibly other receptor tyrosine kinases"
     . SPARSER::COLLECTION)
    ("possibly other receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HD-PTP and ALIX" . SPARSER::COLLECTION)
    ("multivesicular liposomes" . SPARSER::PROTEIN)
    ("liposomes" . SPARSER::PROTEIN)
    ("the unconventional phospholipid lysobisphosphatidic acid (LBPA)"
     . SPARSER::MOLECULE)
    ("lysobisphosphatidic acid (LBPA)" . SPARSER::MOLECULE)
    ("LBPA" . SPARSER::MOLECULE)
    ("the ESCRT-0 component STAM2 [ xref ] and the ESCRT-I component UBAP1 [ xref ]"
     . SPARSER::COLLECTION)
    ("traffic activated EGFR" . SPARSER::PROTEIN)
    ("EGF or EGFR" . SPARSER::COLLECTION)
    ("a well-recognized ESCRT-III associated protein" . SPARSER::PROTEIN)
    ("the highly oligomerized ESCRT-III complex" . SPARSER::BIO-COMPLEX)
    ("Vps24, and Vps2" . SPARSER::COLLECTION)
    ("Snf7/Vps32" . SPARSER::COLLECTION) ("ILVs" . SPARSER::PROTEIN)
    ("ALIX" . SPARSER::PROTEIN) ("TSG101" . SPARSER::PROTEIN)
    ("Vps23" . SPARSER::PROTEIN) ("HCRP1" . SPARSER::PROTEIN)
    ("Vps37" . SPARSER::PROTEIN-FAMILY) ("F-I" . SPARSER::PROTEIN)
    ("CHMP4b" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("lysobisphosphatidic acid" . SPARSER::MOLECULE)
    ("UBAP1" . SPARSER::PROTEIN) ("STAM2" . SPARSER::PROTEIN)
    ("HD-PTP" . SPARSER::PROTEIN) ("annexin 1" . SPARSER::PROTEIN)
    ("PAR1" . SPARSER::PROTEIN) ("Hp95" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("ALG-2" . SPARSER::PROTEIN)
    ("ESCRT-II" . SPARSER::PROTEIN-FAMILY) ("Vps32" . SPARSER::PROTEIN)
    ("Snf7" . SPARSER::PROTEIN-FAMILY) ("Vps20" . SPARSER::PROTEIN)
    ("Vps4" . SPARSER::PROTEIN) ("CHMP4" . SPARSER::PROTEIN)
    ("ESCRT-III" . SPARSER::PROTEIN-FAMILY)
    ("p21 and RelA" . SPARSER::COLLECTION)
    ("CDK6 and p21" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("IMD" . SPARSER::PROTEIN-FAMILY) ("TAK1 and IKK" . SPARSER::COLLECTION)
    ("IκBα, A20 or Cyld" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN)
    ("Drosocin and Diptericin" . SPARSER::COLLECTION)
    ("Diptericin" . SPARSER::PROTEIN) ("Drosocin" . SPARSER::PROTEIN)
    ("HIF and Cyld" . SPARSER::COLLECTION) ("IKK/Ird5" . SPARSER::COLLECTION)
    ("HIF-1α and CDK6" . SPARSER::COLLECTION)
    ("RelA and/or its canonical binding partner Cyclin D1"
     . SPARSER::COLLECTION)
    ("p100, IAP1 and phospho-RelA" . SPARSER::COLLECTION)
    ("p100 and IAP1" . SPARSER::COLLECTION)
    ("HIF-1α knockdown no longer de-repressed NF-κB" . SPARSER::PROTEIN)
    ("RelA and IKKβ" . SPARSER::COLLECTION)
    ("HIF-1α and TAK1" . SPARSER::COLLECTION)
    ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("CDK6 and TBK1" . SPARSER::COLLECTION)
    ("IKK and TAK1" . SPARSER::COLLECTION)
    ("p100 and IL-8" . SPARSER::COLLECTION)
    ("A20, Cyld, DDX3, IAP1 and XIAP" . SPARSER::COLLECTION)
    ("targets and luciferase" . SPARSER::COLLECTION)
    ("IL-8, IκB-α and p100" . SPARSER::COLLECTION)
    ("Immune cells release several pro-inflammatory cytokines"
     . SPARSER::PROTEIN)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION) ("dif" . SPARSER::PROTEIN)
    ("the antibacterial genes drosocin and diptericin" . SPARSER::COLLECTION)
    ("the pro-angiogenic cytokine IL-8 ( xref ) and the inflammatory regulator TNF-α ( xref )"
     . SPARSER::COLLECTION)
    ("the pro-angiogenic cytokine IL-8" . SPARSER::PROTEIN)
    ("HIF-1α and NF-κB" . SPARSER::COLLECTION)
    ("ldh and caix" . SPARSER::COLLECTION)
    ("ird5  1 homozygous mutant" . SPARSER::MUTANT)
    ("NF-κB (IKK)" . SPARSER::PROTEIN)
    ("inflammation-induced HIF" . SPARSER::PROTEIN-FAMILY)
    ("ldh , caix and fatiga" . SPARSER::COLLECTION) ("caix" . SPARSER::PROTEIN)
    ("ldh" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("no commercially available antibodies" . SPARSER::ANTIBODY)
    ("lacz-diptericin" . SPARSER::COLLECTION)
    ("drosocin and diptericin" . SPARSER::COLLECTION)
    ("diptericin" . SPARSER::PROTEIN) ("drosocin" . SPARSER::PROTEIN)
    ("drosomycin" . SPARSER::PROTEIN) ("NF-κB and HIF" . SPARSER::COLLECTION)
    ("Low oxygen (hypoxia) and inflammation" . SPARSER::COLLECTION)
    ("p100 and interleukin" . SPARSER::COLLECTION)
    ("TAK and IKK, and CDK6" . SPARSER::COLLECTION)
    ("IKK, and CDK6" . SPARSER::COLLECTION)
    ("the NF-κB dimer and its translocation into the nucleus ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("RelA (p65), RelB, c-Rel, NF-κB1 (p105/p50) and NF-κB2 (p100/p52)"
     . SPARSER::COLLECTION)
    ("p105/p50" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("the major inflammation-responsive transcription factor"
     . SPARSER::PROTEIN)
    ("ligase (VHL)" . SPARSER::LIGASE)
    ("PHD1, PHD2 and PHD3" . SPARSER::COLLECTION)
    ("HIF-1α–HIF-1β" . SPARSER::COLLECTION) ("gene ( EPO )" . SPARSER::GENE)
    ("-RCGTG-3" . SPARSER::COLLECTION) ("EPO" . SPARSER::PROTEIN)
    ("erythropoietin" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("TAK-IKK" . SPARSER::COLLECTION) ("TAK" . SPARSER::PROTEIN)
    ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("pyruvate dehydrogenase kinase 1" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG) ("Ird5" . SPARSER::PROTEIN)
    ("il-8" . SPARSER::PROTEIN) ("anti-microbial" . SPARSER::DRUG)
    ("E. coli )" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("prosurvival signaling proteins (Akt, mTOR and NF-κB) and NF-κB-regulated antiapoptotic proteins (Bcl-2, Bcl-xL, c-IAP1 and survivin)"
     . SPARSER::COLLECTION)
    ("prosurvival signaling proteins" . SPARSER::PROTEIN)
    ("Akt, mTOR and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and progrowth" . SPARSER::COLLECTION)
    ("Akt/PBK" . SPARSER::COLLECTION) ("PBK" . SPARSER::PROTEIN)
    ("Bad, procaspase-9, and Forkhead" . SPARSER::COLLECTION)
    ("DR4 and DR5" . SPARSER::COLLECTION)
    ("procaspase-8 and effector" . SPARSER::COLLECTION)
    ("Bcl-2 and inhibitors" . SPARSER::COLLECTION) ("MADH" . SPARSER::PROTEIN)
    ("Akt/NF-κB/mTOR" . SPARSER::COLLECTION) ("celastrol" . SPARSER::MOLECULE)
    ("c-Jun N-terminal kinase (JNK) and poly (ADP-ribose) polymerase-1 (PARP-1)"
     . SPARSER::COLLECTION)
    ("Triterpenoids" . SPARSER::MOLECULE)
    ("etoposide and retinoids" . SPARSER::COLLECTION)
    ("retinoids" . SPARSER::DRUG) ("traditional medicine" . SPARSER::DRUG)
    ("AKT/NF-κB/mTOR" . SPARSER::COLLECTION)
    ("NF-κB-regulated antiapoptotic Bcl-2" . SPARSER::PROTEIN)
    ("c-IAP1" . SPARSER::COLLECTION)
    ("prosurvival phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("poly (ADP-ribose) polymerase (PARP-1) and procaspases-3"
     . SPARSER::COLLECTION)
    ("pristimerin (PM)" . SPARSER::DRUG) ("PM" . SPARSER::PROTEIN)
    ("pristimerin" . SPARSER::DRUG) ("triterpenoid" . SPARSER::MOLECULE)
    ("Pristimerin" . SPARSER::DRUG) ("caspases -3" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("nucleate" . SPARSER::PROTEIN)
    ("centromeric MCAK" . SPARSER::PROTEIN)
    ("densely polymerized tubulin" . SPARSER::PROTEIN)
    ("SS632/633AA" . SPARSER::PROTEIN) ("MCAK SS632/633AA" . SPARSER::PROTEIN)
    ("INCENP and Hec1" . SPARSER::COLLECTION) ("INCENP" . SPARSER::PROTEIN)
    ("SS/AA or MCAK" . SPARSER::COLLECTION)
    ("neither MCAK SS/AA nor MCAK SS/DD" . SPARSER::COLLECTION)
    ("exogenous MCAK" . SPARSER::PROTEIN)
    ("pericentrin and DAPI" . SPARSER::COLLECTION)
    ("this pro- and prometaphase arrest (Fig. xref )" . SPARSER::COLLECTION)
    ("wild type MCAK and its mutants (Fig. xref )" . SPARSER::COLLECTION)
    ("EGFP-tagged wild type MCAK or its variants" . SPARSER::COLLECTION)
    ("wild type MCAK or its mutants" . SPARSER::COLLECTION)
    ("either wild type MCAK or its mutants" . SPARSER::COLLECTION)
    ("α-tubulin, pericentrin and DNA" . SPARSER::COLLECTION)
    ("this phosphomimetic mutant" . SPARSER::MUTANT)
    ("catalytically more active" . SPARSER::ACTIVE)
    ("SS/AA" . SPARSER::PROTEIN) ("SS/DD" . SPARSER::PROTEIN)
    ("MCAK SS/AA" . SPARSER::PROTEIN)
    ("the phosphomimetic mutant MCAK SS/DD" . SPARSER::PROTEIN)
    ("MCAK SS/DD" . SPARSER::PROTEIN)
    ("alanine or aspartic acid" . SPARSER::COLLECTION)
    ("Plk1 and GST" . SPARSER::COLLECTION) ("Kif2a" . SPARSER::PROTEIN)
    ("Pin1, cyclin B1 and sororin" . SPARSER::COLLECTION)
    ("sororin" . SPARSER::PROTEIN) ("Plks" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1 (Cdk1) and Polo-like kinase"
     . SPARSER::COLLECTION)
    ("MTs" . SPARSER::PROTEIN) ("key mitotic kinases" . SPARSER::KINASE)
    ("mitotic centromere-associated kinesin (MCAK)" . SPARSER::PROTEIN)
    ("Kif2c" . SPARSER::PROTEIN) ("MG 132" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("Kif2b" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin" . SPARSER::PROTEIN)
    ("a convenient and reliable biomarker" . SPARSER::MOLECULE)
    ("a circulatory prognostic biomarker" . SPARSER::MOLECULE)
    ("aldh1a3" . SPARSER::PROTEIN) ("pre-mirna" . SPARSER::COLLECTION)
    ("mirna" . SPARSER::PROTEIN) ("snp" . SPARSER::PROTEIN)
    ("mmp11 and vegfa" . SPARSER::COLLECTION) ("mmp11" . SPARSER::PROTEIN)
    ("vegfa" . SPARSER::PROTEIN) ("YFP or GFP" . SPARSER::COLLECTION)
    ("both R2N1d ( xref ) and MDA-MB-231 cells ( xref )" . SPARSER::COLLECTION)
    ("R2N1d" . SPARSER::PROTEIN)
    ("R2N1d-YFP and R2N1d-GFP-miR-125a-5p" . SPARSER::COLLECTION)
    ("R2N1d-YFP" . SPARSER::COLLECTION)
    ("HDAC5 and HDAC7" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC5" . SPARSER::COLLECTION)
    ("HDAC7 and HDAC9" . SPARSER::COLLECTION)
    ("HDAC5 , HDAC7 , and HDAC9" . SPARSER::COLLECTION)
    ("miR-125a-5p and HDAC4" . SPARSER::COLLECTION)
    ("miR-125a-5p directly targets HDAC4" . SPARSER::PROTEIN)
    ("HDAC1 or HDAC2" . SPARSER::COLLECTION)
    ("miR-125a-5p and the 3" . SPARSER::COLLECTION)
    ("HER2/ErbB2" . SPARSER::COLLECTION)
    ("histone- and non-histone" . SPARSER::COLLECTION)
    ("histone-" . SPARSER::PROTEIN) ("hsa-miR-21" . SPARSER::COLLECTION)
    ("miRNAs and their mRNA" . SPARSER::COLLECTION)
    ("a useful prognostic biomarker and offer" . SPARSER::COLLECTION)
    ("a useful prognostic biomarker" . SPARSER::MOLECULE)
    ("DP2" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("MT-3" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("myeloid leukemia–1" . SPARSER::PROTEIN) ("aldh1" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pri-miRna" . SPARSER::RNA)
    ("MiR-125a-5p" . SPARSER::MOLECULE) ("PGL3" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("miR-125a-5p" . SPARSER::MOLECULE)
    ("IL-6 or NOX4" . SPARSER::COLLECTION)
    ("microenvironmetal IL-6" . SPARSER::PROTEIN)
    ("Autocrine IL-6" . SPARSER::PROTEIN)
    ("NF-κB, STAT3 and AP-1" . SPARSER::COLLECTION)
    ("gp80 and gp130" . SPARSER::COLLECTION)
    ("IL-6 and NOX4" . SPARSER::COLLECTION)
    ("NOX4 or Akt" . SPARSER::COLLECTION) ("MEK/Erk" . SPARSER::COLLECTION)
    ("LY294002 (30 μM) or wartmannin (10 μM)" . SPARSER::COLLECTION)
    ("wartmannin" . SPARSER::MOLECULE) ("NAC or DPI" . SPARSER::COLLECTION)
    ("NAC (25 μM) and DPI (10 μM, an inhibitor of NADPH oxidase)"
     . SPARSER::COLLECTION)
    ("DPI" . SPARSER::PROTEIN) ("ROS/PI3K/Akt" . SPARSER::COLLECTION)
    ("DCF and amplex" . SPARSER::COLLECTION)
    ("JAK1 and STAT3" . SPARSER::COLLECTION)
    ("JAK1/STAT3" . SPARSER::COLLECTION) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("siltuximab and P6" . SPARSER::COLLECTION) ("siltuximab" . SPARSER::DRUG)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("IL-6, and IL-6" . SPARSER::COLLECTION)
    ("their own IL-6" . SPARSER::PROTEIN)
    ("IL-6R and IL-6" . SPARSER::COLLECTION)
    ("siRNA or mAbs" . SPARSER::COLLECTION)
    ("microenvironmental cytokines" . SPARSER::PROTEIN)
    ("NOX3, NOX4, NOX5, Duox1, and Duox2" . SPARSER::COLLECTION)
    ("Duox" . SPARSER::PROTEIN) ("IFN-γ and LPS" . SPARSER::COLLECTION)
    ("NF-κB, STAT3 and HIF1α" . SPARSER::COLLECTION)
    ("various inflammatory cytokines" . SPARSER::PROTEIN)
    ("NOX4/Akt" . SPARSER::COLLECTION) ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("NOX4/ROS/Akt" . SPARSER::COLLECTION)
    ("NOX4 and IL-6" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN) ("DCFH-DA" . SPARSER::DRUG)
    ("Duox2" . SPARSER::PROTEIN) ("NOX5" . SPARSER::PROTEIN)
    ("gp91 phox" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide phosphate oxidase" . SPARSER::PROTEIN)
    ("NOX4" . SPARSER::PROTEIN) ("NADPH oxidase 4" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN)
    ("Shc, Gab1, and Grb2" . SPARSER::COLLECTION) ("LIgand" . SPARSER::LIGAND)
    ("EGFR-TBK-1-IRF3" . SPARSER::COLLECTION)
    ("EGFR, TBK1 and IRF3" . SPARSER::COLLECTION)
    ("IFIT1 and IRF3" . SPARSER::COLLECTION)
    ("IRF3 and IRF3" . SPARSER::COLLECTION)
    ("TGF-alpha and IFI27 and IFIT1" . SPARSER::COLLECTION)
    ("TGFa and IFI27" . SPARSER::COLLECTION)
    ("TGFa and IFIT1:p" . SPARSER::COLLECTION)
    ("IFIT1:p" . SPARSER::BIO-COMPLEX) ("TGFa" . SPARSER::PROTEIN)
    ("TGF-alpha, and IFIT1 and IFI27" . SPARSER::COLLECTION)
    ("Tofacitinib" . SPARSER::DRUG) ("Ruxolitinib" . SPARSER::DRUG)
    ("EGF or erlotinib" . SPARSER::COLLECTION)
    ("IFNβ and IFNα" . SPARSER::COLLECTION)
    ("IFIT1 and IRF27" . SPARSER::COLLECTION)
    ("IFNα and interferon" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("secondary signaling proteins" . SPARSER::PROTEIN)
    ("GST-IRF3" . SPARSER::COLLECTION) ("the cellular IRF3" . SPARSER::PROTEIN)
    ("IRF3 and both IRF3 and TBK1" . SPARSER::COLLECTION)
    ("IRF3-TBK1" . SPARSER::COLLECTION) ("EGFR-IRF3" . SPARSER::COLLECTION)
    ("IRF3 or TBK1" . SPARSER::COLLECTION) ("MDAMD" . SPARSER::DRUG)
    ("EGF or Erlotinib" . SPARSER::COLLECTION)
    ("IRF3 and/or TBK1" . SPARSER::COLLECTION)
    ("The Tank-binding kinase (TBK1) and IKKε" . SPARSER::COLLECTION)
    ("AEBSF" . SPARSER::DRUG) ("benzenesulfonyl" . SPARSER::MOLECULE)
    ("BiP/GRP78" . SPARSER::COLLECTION) ("BiP" . SPARSER::PROTEIN)
    ("EGFR and IRF3" . SPARSER::COLLECTION)
    ("IRF3, TBK1 and EGFR" . SPARSER::COLLECTION)
    ("IFI27 and IFIT1" . SPARSER::COLLECTION) ("LUC" . SPARSER::PROTEIN)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("RNA and TLR" . SPARSER::COLLECTION)
    ("IFIT1, IFI27 and TRAIL" . SPARSER::COLLECTION)
    ("EGFRvIII" . SPARSER::PROTEIN) ("IFIT1 and IFI27" . SPARSER::COLLECTION)
    ("exogenous EGF and 55 genes" . SPARSER::COLLECTION)
    ("EGR1 and EGR2" . SPARSER::COLLECTION)
    ("EGFR, IRF3 and TBK1" . SPARSER::COLLECTION)
    ("IRF3 and its kinase TBK1" . SPARSER::COLLECTION)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("TBK1, IRF3, and EGFR" . SPARSER::COLLECTION)
    ("Shc-EGFR" . SPARSER::COLLECTION) ("IRF3 and TBK1" . SPARSER::COLLECTION)
    ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("canonical ERK and Akt" . SPARSER::COLLECTION)
    ("IFI27, IFIT1, and TRAIL" . SPARSER::COLLECTION)
    ("Annexin –V" . SPARSER::PROTEIN) ("PCDNA3" . SPARSER::PROTEIN)
    ("a 20µ" . SPARSER::PROTEIN) ("PCR 2µ" . SPARSER::PROTEIN)
    ("GSK 2606414" . SPARSER::DRUG) ("Vitamin A" . SPARSER::MOLECULE)
    ("PcDNA 3" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("TBK-1" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("GL3" . SPARSER::PROTEIN) ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK2606414" . SPARSER::DRUG) ("EIF2" . SPARSER::PROTEIN)
    ("IFIT1" . SPARSER::PROTEIN) ("IFI27" . SPARSER::PROTEIN)
    ("p62 and Beclin-1" . SPARSER::COLLECTION)
    ("Yue-Hua" . SPARSER::COLLECTION)
    ("a vacuolar ATPase inhibitor" . SPARSER::INHIBITOR)
    ("relatively normal NP" . SPARSER::PROTEIN)
    ("the central NP" . SPARSER::PROTEIN)
    ("LC3 and Beclin-1reduced" . SPARSER::COLLECTION)
    ("resveratrol and bafilomycin" . SPARSER::COLLECTION)
    ("resveratrol (8 μM), nicotinamide (12 mM) or SIRT1-siRNA"
     . SPARSER::COLLECTION)
    ("nicotinamide or SIRT1-siRNA" . SPARSER::COLLECTION)
    ("nicotinamide or siRNA" . SPARSER::COLLECTION)
    ("Resveratrol (8 μM) or nicotinamide (12 mM)" . SPARSER::COLLECTION)
    ("activator or inhibitor" . SPARSER::COLLECTION)
    ("Beclin-1 and LC3" . SPARSER::COLLECTION)
    ("long-lived proteins" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("cartilage-specific extracellular matrix (ECM) components"
     . SPARSER::COMPONENT)
    ("LBP" . SPARSER::PROTEIN) ("SIRT1-siRNA" . SPARSER::COLLECTION)
    ("Resveratrol" . SPARSER::PROTEIN)
    ("LC3 and Beclin-1" . SPARSER::COLLECTION) ("DDD" . SPARSER::MOLECULE)
    ("IVD" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("class O" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("the possible kinase" . SPARSER::KINASE)
    ("phosphatases or kinases" . SPARSER::COLLECTION)
    ("FoxO3 and Smad" . SPARSER::COLLECTION) ("CKI-ε (WT)" . SPARSER::PROTEIN)
    ("TGF-β and Wortmannin" . SPARSER::COLLECTION)
    ("Wortmannin or not" . SPARSER::COLLECTION)
    ("TGF-β, or IGF-1" . SPARSER::COLLECTION)
    ("FoxO3-siRNA" . SPARSER::COLLECTION) ("Smad-FoxO3" . SPARSER::COLLECTION)
    ("bim" . SPARSER::PROTEIN) ("FoxO3 and Smad2/3" . SPARSER::COLLECTION)
    ("Bax and Bcl-xL" . SPARSER::COLLECTION)
    ("Annexin V-PI" . SPARSER::COLLECTION) ("Smad-Bim" . SPARSER::PROTEIN-PAIR)
    ("p53 or β-catenin" . SPARSER::COLLECTION) ("Fish" . SPARSER::PROTEIN)
    ("PKB/Akt" . SPARSER::COLLECTION)
    ("potent transcription activators and tumor suppressors"
     . SPARSER::COLLECTION)
    ("FoxO1, FoxO3 and FoxO4" . SPARSER::COLLECTION)
    ("Bim and Bmf" . SPARSER::COLLECTION) ("Bmf" . SPARSER::PROTEIN)
    ("AP-1, TFE3 and FoxO" . SPARSER::COLLECTION)
    ("SnoN, Tid1 and Akt" . SPARSER::COLLECTION) ("Hua" . SPARSER::PROTEIN)
    ("SnoN" . SPARSER::PROTEIN)
    ("type I (TGF-RI) and type II (TGF-RII) serine/threonine kinase"
     . SPARSER::COLLECTION)
    ("a heteromeric receptor complex" . SPARSER::BIO-COMPLEX)
    ("CKI-FoxO/Smad-Bim" . SPARSER::COLLECTION)
    ("FoxO/Smad" . SPARSER::COLLECTION) ("CKI" . SPARSER::PROTEIN)
    ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("reverse Transcriptase" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("smad2" . SPARSER::PROTEIN) ("Runx-1" . SPARSER::PROTEIN)
    ("smad4" . SPARSER::PROTEIN) ("FoxO4" . SPARSER::PROTEIN)
    ("Tid1" . SPARSER::PROTEIN) ("Evi-1" . SPARSER::PROTEIN)
    ("TFE3" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("less toxic PDGFR inhibitors" . SPARSER::INHIBITOR)
    ("a dominant-negative PDGFR" . SPARSER::PROTEIN)
    ("traits and chemoresistant" . SPARSER::COLLECTION)
    ("immuno" . SPARSER::PROTEIN)
    ("imatinib and paclitaxel" . SPARSER::COLLECTION)
    ("imatinib and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin or paclitaxel" . SPARSER::COLLECTION)
    ("doxorubicin and paclitaxel" . SPARSER::COLLECTION)
    ("ABL" . SPARSER::PROTEIN) ("which targets PDGFRs" . SPARSER::PROTEIN)
    ("PDGFRβ and PDGFRα" . SPARSER::COLLECTION)
    ("PDGFRs , or PDGFRβ" . SPARSER::COLLECTION)
    ("HMLER/Foxq1" . SPARSER::COLLECTION)
    ("anew construct expressing two shRNAs" . SPARSER::RNA)
    ("PDGFRα or PDGFRβ" . SPARSER::COLLECTION)
    ("inHMLE/Foxq1" . SPARSER::COLLECTION)
    ("Foxq1 , Twist1 , and PDGFRs" . SPARSER::COLLECTION)
    ("Foxq1 and Twist1" . SPARSER::COLLECTION) ("seV" . SPARSER::PROTEIN)
    ("Twist1 and Zeb2" . SPARSER::COLLECTION)
    ("Transcription factor (TF)" . SPARSER::PROTEIN)
    ("PDGFRα and β promoters" . SPARSER::COLLECTION)
    ("different cellular biologic" . SPARSER::DRUG)
    ("EMT, and drug" . SPARSER::COLLECTION)
    ("Foxq1, Twist1, and PDGFRs" . SPARSER::COLLECTION)
    ("doxorubicin (IC 50 : 24.05 vs. 62.58 nmol/L, respectively) and paclitaxel (IC 50 : 36.30 vs. 96.04 nmol/L, respectively; xref )"
     . SPARSER::COLLECTION)
    ("Sh" . SPARSER::PROTEIN-FAMILY) ("-shRNA3" . SPARSER::COLLECTION)
    ("doxorubicin (MTT IC 50 values: 137.4 vs. 36.78 nmol/L for Foxq1 and LacZ, respectively) and paclitaxel (MTT IC 50 values: 3.62 vs. 0.61 nmol/L for Foxq1 and LacZ, respectively; xref and xref )"
     . SPARSER::COLLECTION)
    ("Foxq1 and LacZ" . SPARSER::COLLECTION) ("LacZ" . SPARSER::PROTEIN)
    ("CD44 and CD24" . SPARSER::COLLECTION)
    ("Snail , Twist1 , and Zeb2" . SPARSER::COLLECTION)
    ("traits, and chemoresistance" . SPARSER::COLLECTION)
    ("Foxq1/Twist1/PDGFRs" . SPARSER::COLLECTION)
    ("Zeb1, and Zeb2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("Foxc2" . SPARSER::PROTEIN) ("PDGFRs" . SPARSER::PROTEIN)
    ("Foxq1/Twist1" . SPARSER::COLLECTION)
    ("Twist1, Zeb2, and PDGFRα" . SPARSER::COLLECTION)
    ("transcription factor and EMT-inducing gene" . SPARSER::COLLECTION)
    ("traits and chemoresistance" . SPARSER::COLLECTION)
    ("c-ABL" . SPARSER::PROTEIN) ("F-P" . SPARSER::PROTEIN)
    ("shRNA3" . SPARSER::PROTEIN) ("Foxq1" . SPARSER::PROTEIN)
    ("particular SNPs" . SPARSER::PROTEIN)
    ("TP53 and TP53" . SPARSER::COLLECTION)
    ("Pediatric Oncology Europe Neuroblastoma Group" . SPARSER::MOLECULE)
    ("SNPs and NB" . SPARSER::COLLECTION)
    ("EFS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNPs, and Sanger" . SPARSER::COLLECTION)
    ("publicly available anti-cancer drug" . SPARSER::DRUG)
    ("genotypes and drug" . SPARSER::COLLECTION)
    ("a complex and heterogeneous pediatric cancer" . SPARSER::COLLECTION)
    ("SNP309" . SPARSER::PROTEIN) ("HSD17B12" . SPARSER::PROTEIN)
    ("IL31RA" . SPARSER::PROTEIN) ("LMO1" . SPARSER::PROTEIN)
    ("HACE1" . SPARSER::PROTEIN) ("CASP 8" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("TRAIL- and XIAP-targeting molecules" . SPARSER::COLLECTION)
    ("only poor competitive inhibitors" . SPARSER::INHIBITOR)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("BV6 and TRAIL" . SPARSER::COLLECTION)
    ("BIR1 and BIR2" . SPARSER::COLLECTION) ("BIR1-2" . SPARSER::COLLECTION)
    ("BIR" . SPARSER::PROTEIN) ("genetically neither Bax-" . SPARSER::PROTEIN)
    ("Bax-" . SPARSER::PROTEIN)
    ("the pro-apoptotic BH3-only proteins Bik and Bim" . SPARSER::COLLECTION)
    ("Bik and Bim" . SPARSER::COLLECTION) ("Bik" . SPARSER::PROTEIN)
    ("PI3K, Akt and CDK" . SPARSER::COLLECTION)
    ("TRAIL and Fc" . SPARSER::COLLECTION)
    ("mithramycin or BV6" . SPARSER::COLLECTION)
    ("BV6 and mith-A" . SPARSER::COLLECTION)
    ("Bcl-X (Bcl-X L ) and Survivin" . SPARSER::COLLECTION)
    ("caspase-9 and Bid" . SPARSER::COLLECTION)
    ("Apoptosome" . SPARSER::BIO-COMPLEX)
    ("bortezomib and TRAIL" . SPARSER::COLLECTION)
    ("Puma and Bcl2-interacting mediator of cell death" . SPARSER::COLLECTION)
    ("TRAIL- or Fc-CD95L-induced" . SPARSER::COLLECTION)
    ("TRAIL-" . SPARSER::PROTEIN) ("TRAIL or Fc" . SPARSER::COLLECTION)
    ("bortezomib or MG132" . SPARSER::COLLECTION)
    ("TRAIL and an Akt, PI3K or CDK inhibitor" . SPARSER::COLLECTION)
    ("Akt, PI3K or CDK" . SPARSER::COLLECTION)
    ("triciribine and deguelin" . SPARSER::COLLECTION)
    ("deguelin" . SPARSER::DRUG) ("triciribine" . SPARSER::MOLECULE)
    ("Akt, PI3K and CDK" . SPARSER::COLLECTION)
    ("the primarily pro-inflammatory ligand TNF" . SPARSER::PROTEIN)
    ("-wt" . SPARSER::COLLECTION) ("Caspase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases, JNK, p38 and ERK"
     . SPARSER::COLLECTION)
    ("Fc-CD95L" . SPARSER::COLLECTION)
    ("TRAIL and CD95L" . SPARSER::COLLECTION)
    ("cytochrome c and second mitochondria-derived activator of caspase"
     . SPARSER::COLLECTION)
    ("SMAC" . SPARSER::PROTEIN) ("the mature enzyme" . SPARSER::ENZYME)
    ("the mature heterotetrameric p12-p17 molecule" . SPARSER::MOLECULE)
    ("p12-p17" . SPARSER::COLLECTION)
    ("the second mitochondria-derived activator of caspase mimetic BV6"
     . SPARSER::MOLECULE)
    ("mithramycin" . SPARSER::DRUG)
    ("X-linked inhibitor of apoptosis protein (XIAP)" . SPARSER::PROTEIN)
    ("bortezomib and MG132" . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG)
    ("PI3K, Akt or cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("-mut" . SPARSER::COLLECTION)
    ("agonistic TRAIL death receptor antibodies" . SPARSER::ANTIBODY)
    ("BIR1" . SPARSER::PROTEIN) ("leukemia 1" . SPARSER::PROTEIN)
    ("Bcl2-interacting mediator of cell death" . SPARSER::PROTEIN)
    ("CDK 9" . SPARSER::PROTEIN) ("zVAD-fmk" . SPARSER::DRUG)
    ("CD95L" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN)
    ("apoptotic protease-activating factor 1" . SPARSER::PROTEIN)
    ("BH3-interacting domain death agonist" . SPARSER::PROTEIN)
    ("p19" . SPARSER::PROTEIN) ("a chain" . SPARSER::PROTEIN)
    ("TRAIL-R2" . SPARSER::PROTEIN) ("TRAIL-R1" . SPARSER::PROTEIN)
    ("TRAIL receptor 1" . SPARSER::PROTEIN) ("p110 α" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("second mitochondria-derived activator of caspase" . SPARSER::PROTEIN)
    ("miRNA and its target gene" . SPARSER::COLLECTION)
    ("proteases and other regulators" . SPARSER::COLLECTION)
    ("nutlins" . SPARSER::DRUG)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("p14 arf and p53" . SPARSER::COLLECTION) ("/PI" . SPARSER::COLLECTION)
    ("neg" . SPARSER::PROTEIN) ("pos" . SPARSER::PROTEIN)
    ("MDM2/p53" . SPARSER::COLLECTION) ("p21 WAF1/CIP1" . SPARSER::COLLECTION)
    ("a key regulator of the expression and function of p53"
     . SPARSER::COLLECTION)
    ("p14 arf" . SPARSER::PROTEIN)
    ("ubiquitin–protein ligase" . SPARSER::PROTEIN)
    ("p21 WAF1" . SPARSER::PROTEIN)
    ("Bora, Kizuna, and STARD9" . SPARSER::COLLECTION)
    ("the mitotic kinase" . SPARSER::KINASE)
    ("centrosomal components" . SPARSER::COMPONENT)
    ("β-TrCP-" . SPARSER::PROTEIN)
    ("the STARD9 mitotic kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("another major ubiquitin ligase" . SPARSER::PROTEIN)
    ("numerous mitotic kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitotic kinases" . SPARSER::KINASE)
    ("Plk1 (phosphorylation) and SCFβ-TrCP (ubiquitination)"
     . SPARSER::COLLECTION)
    ("the degradation-competent S316A mutant" . SPARSER::MUTANT)
    ("Cul1 or β-TrCP" . SPARSER::COLLECTION)
    ("anti-ubiquitin and anti-GST" . SPARSER::COLLECTION)
    ("ubiquitin-" . SPARSER::PROTEIN) ("HA-β-TrCP" . SPARSER::COLLECTION)
    ("Plk1-KD" . SPARSER::COLLECTION)
    ("BI2536 or GSK461364" . SPARSER::COLLECTION)
    ("other mitotic kinases" . SPARSER::KINASE)
    ("the S312A single mutant and the double and triple mutants"
     . SPARSER::COLLECTION)
    ("HA-Plk1-KD" . SPARSER::COLLECTION) ("HA-Plk1" . SPARSER::COLLECTION)
    ("-Plk1-KD" . SPARSER::COLLECTION)
    ("p105 and CDC25A" . SPARSER::COLLECTION)
    ("the two phosphoserines—example p105 (DpSGVETpS) and CDC25A (DpSGFCLDpS; xref ; xref )"
     . SPARSER::COLLECTION)
    ("–tobacco" . SPARSER::DRUG) ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IκBα, claspin, and Emi1" . SPARSER::COLLECTION)
    ("L11, and L12" . SPARSER::COLLECTION)
    ("claspin, Bora, and Emi1" . SPARSER::COLLECTION)
    ("protein–β-TrCP" . SPARSER::COLLECTION)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("serine-" . SPARSER::AMINO-ACID)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Emi1 and Bora" . SPARSER::COLLECTION)
    ("Nlp and stathmin" . SPARSER::COLLECTION) ("Nlp" . SPARSER::PROTEIN)
    ("Kizuna" . SPARSER::PROTEIN-FAMILY) ("Bora" . SPARSER::PROTEIN)
    ("antimitotic" . SPARSER::MOLECULE)
    ("egulatory protein–related lipid" . SPARSER::LIPID)
    ("PCM" . SPARSER::PROTEIN)
    ("mitotic kinesin inhibitors" . SPARSER::INHIBITOR)
    ("mitotic kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cis and trans" . SPARSER::COLLECTION)
    ("a largely uncharacterized mitotic kinesin and putative cancer target"
     . SPARSER::COLLECTION)
    ("a largely uncharacterized mitotic kinesin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Plk1 and SCFβ-TrCP" . SPARSER::COLLECTION)
    ("mitotic kinases" . SPARSER::KINASE) ("SCFb-TrCP" . SPARSER::COLLECTION)
    ("TrCP" . SPARSER::PROTEIN) ("Rpl32" . SPARSER::PROTEIN)
    ("S-tag" . SPARSER::PROTEIN) ("CDC27" . SPARSER::PROTEIN)
    ("PDB 1" . SPARSER::PROTEIN) ("30K" . SPARSER::PROTEIN)
    ("EMI1" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("GSK461364" . SPARSER::DRUG) ("L12" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("KIF1A" . SPARSER::PROTEIN)
    ("Cin8" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinesin-5" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("Emi1" . SPARSER::PROTEIN) ("kinesin-13" . SPARSER::PROTEIN)
    ("STARD9" . SPARSER::PROTEIN) ("RET-PTC" . SPARSER::COLLECTION)
    ("follicular variant PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALK-EML4" . SPARSER::COLLECTION)
    ("TFG and GTF2IRD1" . SPARSER::COLLECTION)
    ("underwent FISH and IHC" . SPARSER::COLLECTION)
    ("an attractive potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("thyroglobulin" . SPARSER::PROTEIN)
    ("1 tall cell variant PTC, 1 Hurthle cell variant PTC (again with some solid areas), and 1 Warthin tumor–like variant"
     . SPARSER::COLLECTION)
    ("PTC, 1 Hurthle cell variant PTC (again with some solid areas), and 1 Warthin tumor–like variant"
     . SPARSER::COLLECTION)
    ("6 unencapsulated follicular variant PTCs"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fluorochrome" . SPARSER::MOLECULE) ("ALK/EML4" . SPARSER::COLLECTION)
    ("underwent both FISH and IHC" . SPARSER::COLLECTION)
    ("FISH and IHC" . SPARSER::COLLECTION)
    ("BRAF , RAS , EIF1AX , PPM1D , and CHEK2" . SPARSER::COLLECTION)
    ("RET , BRAF , PPARγ , NTRK1 , NTRK3 , THADA , and FGFR2"
     . SPARSER::COLLECTION)
    ("EML4 , STRN , TFG , and GTF2IRD1" . SPARSER::COLLECTION)
    ("TFG" . SPARSER::PROTEIN) ("STRN" . SPARSER::PROTEIN)
    ("THADA" . SPARSER::PROTEIN) ("PTCs" . SPARSER::PROTEIN)
    ("aggressive variants" . SPARSER::VARIANT) ("GTF2IRD1" . SPARSER::PROTEIN)
    ("NTRK3" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("PPM1D" . SPARSER::PROTEIN) ("EIF1" . SPARSER::PROTEIN)
    ("lactam" . SPARSER::MOLECULE)
    ("atypical mycobacterium avium complex (MAC)" . SPARSER::BIO-COMPLEX)
    ("complex (MAC)" . SPARSER::BIO-COMPLEX)
    ("NFAT and MAP kinase" . SPARSER::COLLECTION)
    ("a strong inducer" . SPARSER::PROTEIN)
    ("mononuclear leukocytes and polymorphonuclear leukocytes"
     . SPARSER::COLLECTION)
    ("polymorphonuclear leukocytes" . SPARSER::PROTEIN)
    ("mononuclear leukocytes" . SPARSER::PROTEIN) ("ionomycin" . SPARSER::DRUG)
    ("A major activating factor" . SPARSER::PROTEIN)
    ("p70S6K-GST" . SPARSER::COLLECTION)
    ("calcineurin-NFAT" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION) ("CsA" . SPARSER::PROTEIN)
    ("IL-17 (p = 0.017) and IFN-gamma (p = 0.003)" . SPARSER::COLLECTION)
    ("IL-2 (p = 0.036), IL-10 (p = 0.003), IL-13 (p = 0.006), IL-17 (p = 0.017) and IFN-gamma (p = 0.003)"
     . SPARSER::COLLECTION)
    ("IFN-gamma" . SPARSER::PROTEIN)
    ("a fluorescent tracer" . SPARSER::MOLECULE) ("Zithromax" . SPARSER::DRUG)
    ("ERK, p38 and mTOR" . SPARSER::COLLECTION)
    ("severe forms" . SPARSER::FORM) ("RAPA" . SPARSER::DRUG)
    ("the exact molecular targets" . SPARSER::TARGET-PROTEIN)
    ("Fas-FasL" . SPARSER::COLLECTION)
    ("various pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-8, IL-17 or tumor necrosis factor" . SPARSER::COLLECTION)
    ("macrolide" . SPARSER::MOLECULE)
    ("CLM and other macrolides" . SPARSER::COLLECTION)
    ("eukaryotic ribosomes" . SPARSER::BIO-COMPLEX)
    ("antimicrobial substances" . SPARSER::SUBSTANCE)
    ("Macrolides" . SPARSER::MOLECULE)
    ("agonistic anti-CD3/anti-CD28 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("CLM" . SPARSER::PROTEIN) ("clarithromycin" . SPARSER::DRUG)
    ("azithromycin" . SPARSER::MOLECULE) ("macrolides" . SPARSER::MOLECULE)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("CD80" . SPARSER::PROTEIN) ("Th-1" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN) ("Cyclosporin A" . SPARSER::MOLECULE)
    ("calcineurin inhibitor" . SPARSER::PROTEIN)
    ("FK506 binding protein 12" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("PCAF/SIRT1" . SPARSER::COLLECTION)
    ("a crucial barrier" . SPARSER::PROTEIN)
    ("various stemness-associated genes" . SPARSER::GENE)
    ("Oct4 and Nanog" . SPARSER::COLLECTION) ("RH" . SPARSER::MOLECULE)
    ("Sox2, Smo and Bmi-1" . SPARSER::COLLECTION)
    ("several associated genes" . SPARSER::GENE)
    ("Oct4, Nanog, Sox2, Bmi-1, Cripto, Tert, Smo and Lin28"
     . SPARSER::COLLECTION)
    ("Smo" . SPARSER::PROTEIN)
    ("p53 and stemness-associated genes" . SPARSER::COLLECTION)
    ("stemness-associated genes" . SPARSER::GENE) ("ShRNAs" . SPARSER::RNA)
    ("Scr-ShRNA" . SPARSER::COLLECTION) ("Scr" . SPARSER::PROTEIN)
    ("ShRNA" . SPARSER::PROTEIN) ("NAM and CD133" . SPARSER::COLLECTION)
    ("TNM-classification" . SPARSER::MOLECULE)
    ("Oct4-SIRT1-p53" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("several stemness-associated genes" . SPARSER::GENE)
    ("Oct4, Nanog, Cripto, Tert and Lin28" . SPARSER::COLLECTION)
    ("Cripto" . SPARSER::PROTEIN) ("HIF-1 alpha" . SPARSER::PROTEIN)
    ("cyclin G2" . SPARSER::PROTEIN) ("prominin-1" . SPARSER::PROTEIN)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FAP" . SPARSER::PROTEIN)
    ("KRas or Raf1" . SPARSER::COLLECTION)
    ("APC or β -catenin" . SPARSER::COLLECTION)
    ("Axin or the degradation complex" . SPARSER::COLLECTION)
    ("Axin1 and GSK3" . SPARSER::COLLECTION)
    ("CK1 and GSK3" . SPARSER::COLLECTION)
    ("LRP5 and LRP6" . SPARSER::COLLECTION) ("Lrp5" . SPARSER::PROTEIN)
    ("KRAS G12V and BRAF V600E -transformed IECs" . SPARSER::COLLECTION)
    ("KRas or BRaf" . SPARSER::COLLECTION)
    ("the KRas G12D or BRaf V637E alleles" . SPARSER::COLLECTION)
    ("serrated" . SPARSER::PROTEIN)
    ("KRAS, BRAF and MEK1" . SPARSER::COLLECTION)
    ("KRAS and RAF1" . SPARSER::COLLECTION)
    ("KRAS, BRAF or MEK" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION) ("BRAF:ER" . SPARSER::BIO-COMPLEX)
    ("wild-type LRP6 or LRP6–5A mutant" . SPARSER::COLLECTION)
    ("PPPS/TP" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("BRAF/MEK/ERK" . SPARSER::COLLECTION)
    ("an extracellular antagonist" . SPARSER::MOLECULE)
    ("acyltransferase" . SPARSER::PROTEIN) ("KRas" . SPARSER::PROTEIN)
    ("ERK1/2 and Lrp6" . SPARSER::COLLECTION)
    ("normal BRaf" . SPARSER::PROTEIN) ("BRAF/ERK" . SPARSER::COLLECTION)
    ("BRaf" . SPARSER::PROTEIN) ("U0126 or PD184352" . SPARSER::COLLECTION)
    ("Lrp6" . SPARSER::PROTEIN) ("KRAS and MEK1" . SPARSER::COLLECTION)
    ("Akt and PKA" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("soft agarose" . SPARSER::MOLECULE)
    ("c-Myc and Fra-1" . SPARSER::COLLECTION)
    ("a dominant-negative TCF4 mutant" . SPARSER::MUTANT)
    ("KRAS/MEK" . SPARSER::COLLECTION) ("Axin2 and Lef1" . SPARSER::COLLECTION)
    ("MEK1 or KRAS" . SPARSER::COLLECTION)
    ("KRAS or MEK1" . SPARSER::COLLECTION)
    ("activated MEK ( xref , panels 4–6) or oncogenic KRAS ( xref , panels 10–12)"
     . SPARSER::COLLECTION)
    ("typical honeycomb cell surface β-catenin" . SPARSER::PROTEIN)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("KRAS or caMEK" . SPARSER::COLLECTION)
    ("MEK1 or MEK2" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("Axin, GSK3β and CK1" . SPARSER::COLLECTION)
    ("sporadic CRCs" . SPARSER::PROTEIN)
    ("SMAD4 and TP53" . SPARSER::COLLECTION)
    ("KRAS/MAPK" . SPARSER::COLLECTION) ("KRAS/BRAF/MEK" . SPARSER::COLLECTION)
    ("KRAS, BRAF or MEK1" . SPARSER::COLLECTION)
    ("c-Myc , Axin2 and Lef1" . SPARSER::COLLECTION)
    ("Lef1" . SPARSER::PROTEIN)
    ("KRAS/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("Fra1" . SPARSER::PROTEIN) ("Myd88" . SPARSER::PROTEIN)
    ("LRP5" . SPARSER::PROTEIN) ("DKK-1" . SPARSER::PROTEIN)
    ("LGK974" . SPARSER::DRUG) ("SB216763" . SPARSER::DRUG)
    ("SCH772984" . SPARSER::DRUG) ("PD184352" . SPARSER::DRUG)
    ("ICG-001" . SPARSER::DRUG) ("Fra-1" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("T-Cell Factor 4" . SPARSER::PROTEIN)
    ("the pro-metastatic gene ANXA2 and the potent pro-lymphangiogenic factor VEGFC ( xref )"
     . SPARSER::COLLECTION)
    ("the potent pro-lymphangiogenic factor VEGFC" . SPARSER::PROTEIN)
    ("the pro-metastatic gene ANXA2" . SPARSER::PROTEIN)
    ("proteolytic ECM" . SPARSER::PROTEIN)
    ("CXCL1 and IL8" . SPARSER::COLLECTION)
    ("CSF2 , CXCL1 , IL8 , CCL2 and VEGFC" . SPARSER::COLLECTION)
    ("ANXA2 or KRAS" . SPARSER::COLLECTION)
    ("KRAS or ANXA2" . SPARSER::COLLECTION)
    ("interleukin-8, CXCL1 and CSF2" . SPARSER::COLLECTION)
    ("CSF2 and VEGFA" . SPARSER::COLLECTION) ("VEGFA" . SPARSER::PROTEIN)
    ("the two siRNAs used significantly reduced NF-κB luciferase activity compared with control cells"
     . SPARSER::PROTEIN)
    ("KRAS and/or ANXA2" . SPARSER::COLLECTION)
    ("ANXA2 and KRAS" . SPARSER::COLLECTION)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("HRAS as well as NRAS" . SPARSER::COLLECTION)
    ("pro-angiogenic and pro-invasive cytokines" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("cytokines and pro-angiogenic" . SPARSER::COLLECTION)
    ("cytokine and pro-angiogenic" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("RELB and NFKB2" . SPARSER::COLLECTION)
    ("CXCL1 and VEGFC" . SPARSER::COLLECTION)
    ("CXCL1, CCL2, CSF2, MMP9 and VEGFC" . SPARSER::COLLECTION)
    ("cytokines, growth factors and proteases" . SPARSER::COLLECTION)
    ("VEGFC" . SPARSER::PROTEIN)
    ("pro-inflammatory and pro-angiogenic molecules" . SPARSER::MOLECULE)
    ("the highly invasive PDAC cell lines PANC-1" . SPARSER::PROTEIN)
    ("a strong negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("coherent modulators" . SPARSER::PROTEIN)
    ("KRAS and ANXA2" . SPARSER::COLLECTION)
    ("pro-angiogenic cytokines and growth factors" . SPARSER::COLLECTION)
    ("KRAS and annexin" . SPARSER::COLLECTION) ("annexin" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("Gr1" . SPARSER::PROTEIN)
    ("nuclear factor erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("LYVE-1" . SPARSER::PROTEIN) ("NF- κB" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("CSF2" . SPARSER::PROTEIN)
    ("BAY-117082" . SPARSER::DRUG) ("miR-21" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("C–C motif" . SPARSER::PROTEIN) ("ANXA2" . SPARSER::PROTEIN)
    ("Rab7L1 and ARHGEF7" . SPARSER::COLLECTION)
    ("CK1α and Rab7L1" . SPARSER::COLLECTION)
    ("the multivalent complex" . SPARSER::BIO-COMPLEX)
    ("GTPase or kinase" . SPARSER::COLLECTION)
    ("GAPs and GEFs" . SPARSER::COLLECTION) ("ArfGAP1" . SPARSER::PROTEIN)
    ("Rab7" . SPARSER::PROTEIN) ("a classical GEF" . SPARSER::GEF)
    ("ARHGEF7 and LRRK2" . SPARSER::COLLECTION)
    ("at least one other protein" . SPARSER::PROTEIN)
    ("kinase and GTP" . SPARSER::COLLECTION)
    ("LRRK2 and GTP" . SPARSER::COLLECTION)
    ("individual and pooled siRNAs" . SPARSER::PROTEIN)
    ("an immediate kinase" . SPARSER::KINASE)
    ("LRRK2 and Rab7L1" . SPARSER::COLLECTION)
    ("LRRK2/TGN46" . SPARSER::COLLECTION)
    ("LRRK2/Rab7L1" . SPARSER::COLLECTION)
    ("LRRK2, Rab7L1 and ARHGEF7" . SPARSER::COLLECTION)
    ("LRRK2 and TGN46-positve" . SPARSER::COLLECTION)
    ("LRRK2 and TGN" . SPARSER::COLLECTION)
    ("LRRK2/ARHGEF7" . SPARSER::COLLECTION)
    ("possibly other GTPases" . SPARSER::GTPASE)
    ("ARHGEF7 and potentially other GTPases (see discussion)"
     . SPARSER::COLLECTION)
    ("potentially other GTPases" . SPARSER::GTPASE)
    ("LRRK2-ARHGEF7" . SPARSER::COLLECTION)
    ("LRRK2 and ARHGEF7" . SPARSER::COLLECTION)
    ("CK1α and LRRK2" . SPARSER::COLLECTION)
    ("CK1α and ARHGEF7" . SPARSER::COLLECTION) ("NTC" . SPARSER::PROTEIN)
    ("XIC" . SPARSER::PROTEIN)
    ("pS910, pS935, pS955 and pS973" . SPARSER::COLLECTION)
    ("epsilon" . SPARSER::PROTEIN) ("WEE1 and LRRK2" . SPARSER::COLLECTION)
    ("CK1α and WEE1" . SPARSER::COLLECTION)
    ("a physiologically relevant kinase" . SPARSER::KINASE)
    ("IC261 and LRRK2-IN1" . SPARSER::COLLECTION)
    ("IC261 and D4476" . SPARSER::COLLECTION)
    ("CK1α ( CSNK1A1 , Z= −3.14, −3.44) and WEE1 ( WEE1 , Z= −3.73, −4.45)"
     . SPARSER::COLLECTION)
    ("−3 or greater" . SPARSER::COLLECTION)
    ("no unambiguous kinase substrate" . SPARSER::SUBSTRATE)
    ("LRR" . SPARSER::PROTEIN) ("COR" . SPARSER::PROTEIN-FAMILY)
    ("D-glucose" . SPARSER::MOLECULE) ("IC 1" . SPARSER::PROTEIN)
    ("BAG5" . SPARSER::PROTEIN) ("RGS2" . SPARSER::PROTEIN)
    ("Rab5b" . SPARSER::PROTEIN) ("gamma 3" . SPARSER::PROTEIN)
    ("gamma 2" . SPARSER::PROTEIN) ("gamma 1" . SPARSER::PROTEIN)
    ("IC261" . SPARSER::DRUG) ("CSNK1A1" . SPARSER::PROTEIN)
    ("Rab7L1" . SPARSER::PROTEIN) ("Leucine-rich repeat" . SPARSER::PROTEIN)
    ("ARHGEF7" . SPARSER::PROTEIN) ("TGN46" . SPARSER::PROTEIN)
    ("CK1α" . SPARSER::PROTEIN)
    ("BCL-2 and its pro-survival partner BCLxL [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("BCLxL" . SPARSER::PROTEIN) ("BIM and BMF" . SPARSER::COLLECTION)
    ("BH3 only protein BMF" . SPARSER::PROTEIN) ("BMF" . SPARSER::PROTEIN)
    ("c-Jun as well as cyclin D1 (inhibited by BAD)" . SPARSER::COLLECTION)
    ("BAD [ xref ] and c-Jun" . SPARSER::COLLECTION)
    ("MTA3, SNAIL, and CXCR4" . SPARSER::COLLECTION)
    ("c-Jun, cyclin D1, β-catenin, and Sp1" . SPARSER::COLLECTION)
    ("both BCL-2 and its antagonist BAD" . SPARSER::COLLECTION)
    ("p-BAD/BAD" . SPARSER::COLLECTION) ("BAD/p-BAD" . SPARSER::COLLECTION)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("c-Jun and JNK" . SPARSER::COLLECTION)
    ("Ras-MEKK-MEK-ERK" . SPARSER::COLLECTION) ("MEKK" . SPARSER::PROTEIN)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("target and its receptor" . SPARSER::COLLECTION)
    ("CXCL12/SDF1" . SPARSER::COLLECTION) ("p-STAT5" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("p-GSK-3β" . SPARSER::COLLECTION)
    ("β-catenin, STAT and AKT" . SPARSER::COLLECTION)
    ("pro-angiogenic VEGF" . SPARSER::PROTEIN)
    ("cyclin D1 and c-jun" . SPARSER::COLLECTION)
    ("Cyclin D1 and c-Jun" . SPARSER::COLLECTION)
    ("p-BAD" . SPARSER::COLLECTION)
    ("Other pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("BCL-2 and BAD" . SPARSER::COLLECTION)
    ("proteins, BIM and BCL-2" . SPARSER::COLLECTION)
    ("Akt/p-Akt" . SPARSER::COLLECTION)
    ("proteins, MMP10, VEGF, SNAIL, CXCR4, E-cadherin and TlMP2"
     . SPARSER::COLLECTION)
    ("C4-2" . SPARSER::PROTEIN) ("AKT-induced" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE) ("TIMP-2" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("MTA3" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("MMP10" . SPARSER::PROTEIN)
    ("both Nrf2 inducers and an inhibitor" . SPARSER::COLLECTION)
    ("inducers and an inhibitor" . SPARSER::COLLECTION)
    ("a potential chemotherapeutic adjuvant" . SPARSER::DRUG)
    ("GSTP1 and GSR1" . SPARSER::COLLECTION)
    ("ferrous iron and biliverdin" . SPARSER::COLLECTION)
    ("bilirubin" . SPARSER::MOLECULE) ("catabolism" . SPARSER::PROTEIN)
    ("Nfr2" . SPARSER::PROTEIN) ("Catechol" . SPARSER::PROTEIN)
    ("Nrf2 and subsequently phase II enzymes" . SPARSER::COLLECTION)
    ("subsequently phase II enzymes" . SPARSER::ENZYME)
    ("electrons" . SPARSER::MOLECULE) ("normoxia" . SPARSER::PROTEIN)
    ("GSTP1 and HO-1" . SPARSER::COLLECTION) ("Catalase" . SPARSER::PROTEIN)
    ("H 2 O 2 and O" . SPARSER::COLLECTION) ("tBHP" . SPARSER::MOLECULE)
    ("semiquinones or quinones" . SPARSER::COLLECTION)
    ("semiquinones" . SPARSER::MOLECULE) ("GST and GSR" . SPARSER::COLLECTION)
    ("GST3/GSTP" . SPARSER::COLLECTION) ("GSTP" . SPARSER::PROTEIN)
    ("Nrf2, GSTP1 and HO-1" . SPARSER::COLLECTION) ("GCLM" . SPARSER::PROTEIN)
    ("trigonelline" . SPARSER::DRUG) ("alkaloid" . SPARSER::MOLECULE)
    ("Trigonelline" . SPARSER::DRUG) ("Nrf2 and Hoechst" . SPARSER::COLLECTION)
    ("nuc" . SPARSER::PROTEIN) ("cyt" . SPARSER::MOLECULE)
    ("cisR" . SPARSER::PROTEIN) ("HCA" . SPARSER::PROTEIN)
    ("aqueous media" . SPARSER::PROTEIN)
    ("their nucleophilic form" . SPARSER::FORM)
    ("exogenous substances" . SPARSER::SUBSTANCE)
    ("phase II cytoprotective genes" . SPARSER::GENE)
    ("thioredoxin and glutathione" . SPARSER::COLLECTION)
    ("GSR , GPx and glutamyl" . SPARSER::COLLECTION) ("GGT" . SPARSER::PROTEIN)
    ("GSTs" . SPARSER::PROTEIN) ("hydroperoxides" . SPARSER::MOLECULE)
    ("isothiocyanates" . SPARSER::MOLECULE) ("bisphenols" . SPARSER::MOLECULE)
    ("EpRE" . SPARSER::PROTEIN) ("Nrf2–EpRE" . SPARSER::PROTEIN-PAIR)
    ("Maf and Jun" . SPARSER::COLLECTION)
    ("curcumin, epigallocatechin gallate and resveratrol"
     . SPARSER::COLLECTION)
    ("resveratrol" . SPARSER::PROTEIN) ("phytochemicals" . SPARSER::DRUG)
    ("catechol/quinone" . SPARSER::COLLECTION) ("catechol" . SPARSER::PROTEIN)
    ("GSTP1 and GSR" . SPARSER::COLLECTION) ("GSR" . SPARSER::PROTEIN)
    ("Nrf2 and phase II enzymes" . SPARSER::COLLECTION)
    ("electrophile" . SPARSER::MOLECULE) ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("riboflavin kinase" . SPARSER::PROTEIN)
    ("hydrogen peroxides" . SPARSER::MOLECULE) ("NRf2" . SPARSER::PROTEIN)
    ("cm −1" . SPARSER::PROTEIN) ("GST3" . SPARSER::PROTEIN)
    ("CCA-3" . SPARSER::PROTEIN) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("epigallocatechin gallate" . SPARSER::DRUG)
    ("adenosine deaminase (ADAR) and poly(A) binding protein (PABPC1)"
     . SPARSER::COLLECTION)
    ("HNRNPM" . SPARSER::PROTEIN) ("HNRNPF" . SPARSER::PROTEIN)
    ("RHA" . SPARSER::PROTEIN) ("MBP-Rev" . SPARSER::COLLECTION)
    ("both viral proteins" . SPARSER::PROTEIN)
    ("excessive DDX1" . SPARSER::PROTEIN)
    ("traffic Rev" . SPARSER::PROTEIN-FAMILY)
    ("incompletely spliced viral mRNA" . SPARSER::PROTEIN)
    ("Matrin 3 and serine/arginine-rich splicing factor 1"
     . SPARSER::COLLECTION)
    ("ASF/SF2" . SPARSER::COLLECTION) ("ASF" . SPARSER::PROTEIN)
    ("DEAH" . SPARSER::PROTEIN-FAMILY)
    ("RRE-containing viral mRNA" . SPARSER::PROTEIN)
    ("unspliced viral mRNA" . SPARSER::PROTEIN)
    ("total viral mRNA" . SPARSER::PROTEIN)
    ("all accessory and regulatory genes" . SPARSER::GENE)
    ("the cytomegalovirus (CMV) immediate-early promoter" . SPARSER::PROMOTER)
    ("an anti-DDX1 or anti-FLAG" . SPARSER::COLLECTION)
    ("anti-DDX1 or anti-FLAG" . SPARSER::COLLECTION)
    ("DDX3, DDX5, DDX18, DDX19, DDX21 and DDX24" . SPARSER::COLLECTION)
    ("DDX1 co-immunoprecipitated both Rev" . SPARSER::PROTEIN-FAMILY)
    ("Endogenous DDX1 and Nullbasic proteins" . SPARSER::COLLECTION)
    ("Nullbasic proteins" . SPARSER::PROTEIN)
    ("anti-DDX1 and anti-FLAG" . SPARSER::COLLECTION)
    ("Rev and Nullbasic-FLAG" . SPARSER::COLLECTION)
    ("purified Myc-DDK-tagged DDX5" . SPARSER::PROTEIN)
    ("BSA and Nullbasic-FLAG-V5-6 " . SPARSER::COLLECTION)
    ("Bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("highly purified Myc-DDK-tagged DDX1" . SPARSER::PROTEIN)
    ("DDK" . SPARSER::BIO-COMPLEX) ("-Rev" . SPARSER::COLLECTION)
    ("DDX3 and DDX17" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("MYC-Rev" . SPARSER::COLLECTION) ("pcDNA3-HA" . SPARSER::COLLECTION)
    ("HA-DDX17" . SPARSER::COLLECTION) ("HA-DDX3" . SPARSER::COLLECTION)
    ("HA-DDX1" . SPARSER::COLLECTION)
    ("The Gag-derived proteolytic product capsid (CA) protein"
     . SPARSER::PROTEIN)
    ("Rev-dependent viral mRNA" . SPARSER::PROTEIN)
    ("DDX1, DDX3 or DDX17" . SPARSER::COLLECTION)
    ("DDX1, DDX3 and DDX17" . SPARSER::COLLECTION)
    ("NB-FLAG-mCherry" . SPARSER::COLLECTION)
    ("FLAG-mCherry" . SPARSER::COLLECTION)
    ("nuclear Nullbasic interactors" . SPARSER::PROTEIN)
    ("Nullbasic interacting proteins" . SPARSER::PROTEIN)
    ("helicases, DDX1, DDX3 and DDX17" . SPARSER::COLLECTION)
    ("viral mRNA" . SPARSER::PROTEIN)
    ("glycine and alanine" . SPARSER::COLLECTION)
    ("DDX5, DDX17, DDX21, DDX24, DDX36, DDX47 and DDX56" . SPARSER::COLLECTION)
    ("incompletely spliced viral mRNAs" . SPARSER::PROTEIN)
    ("DDX17, DDX21, DDX24, DDX36, DDX47 and DDX56" . SPARSER::COLLECTION)
    ("DDX5/p68" . SPARSER::COLLECTION) ("Rev’s" . SPARSER::PROTEIN-FAMILY)
    ("CRM1 and other cellular components" . SPARSER::COLLECTION)
    ("RanGTP" . SPARSER::PROTEIN)
    ("receptors and nucleophosmin (NPM)" . SPARSER::COLLECTION)
    ("receptors and nucleophosmin" . SPARSER::COLLECTION)
    ("NPM" . SPARSER::PROTEIN) ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral structural, enzymatic and accessory proteins" . SPARSER::PROTEIN)
    ("viral RRE-containing mRNA" . SPARSER::PROTEIN)
    ("4 kb viral RNAs" . SPARSER::RNA) ("BLI" . SPARSER::PROTEIN)
    ("Rev and other cellular proteins" . SPARSER::COLLECTION)
    ("the Rev nucleocytoplasmic transport complex" . SPARSER::BIO-COMPLEX)
    ("singly spliced viral mRNA" . SPARSER::PROTEIN) ("GS1" . SPARSER::PROTEIN)
    ("gas 1" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("CH 3" . SPARSER::MOLECULE) ("type B" . SPARSER::PROTEIN)
    ("V5-6" . SPARSER::PROTEIN) ("PABPC1" . SPARSER::PROTEIN)
    ("poly(A) binding protein" . SPARSER::PROTEIN) ("eEF1" . SPARSER::PROTEIN)
    ("matrin 3" . SPARSER::PROTEIN) ("Cos-1" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("serine/arginine-rich splicing factor 1" . SPARSER::PROTEIN)
    ("Matrin 3" . SPARSER::PROTEIN) ("DHX9" . SPARSER::PROTEIN)
    ("Ala - His" . SPARSER::MOLECULE) ("DDX19" . SPARSER::PROTEIN)
    ("DDX18" . SPARSER::PROTEIN) ("V5-6 " . SPARSER::PROTEIN)
    ("DDX47" . SPARSER::PROTEIN) ("DDX36" . SPARSER::PROTEIN)
    ("DDX24" . SPARSER::PROTEIN) ("DDX17" . SPARSER::PROTEIN)
    ("DDX3" . SPARSER::PROTEIN) ("Asp - Glu" . SPARSER::MOLECULE)
    ("transportin 1" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("XPO1" . SPARSER::PROTEIN)
    ("exportin 1" . SPARSER::PROTEIN) ("DDX1" . SPARSER::PROTEIN)
    ("-2 [ xref ] and DKK1 [ xref ]" . SPARSER::COLLECTION)
    ("BRCA1 (rho = 0.696, P  < 0.001) and TS (rho = 0.620, P  < 0.001, Spearman rank correlation test)"
     . SPARSER::COLLECTION)
    ("BRCA1 or TS" . SPARSER::COLLECTION)
    ("docetaxel (rho = 0.900, P  < 0.001) and pemetrexed (rho = 0.836, P  < 0.001)"
     . SPARSER::COLLECTION)
    ("quinazoline" . SPARSER::MOLECULE)
    ("cisplatin and taxanes" . SPARSER::COLLECTION)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("BRCA1 (rho = 0.696, P < 0.001) and TS (rho = 0.620, P < 0.001)"
     . SPARSER::COLLECTION)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("docetaxel and pemetrexed" . SPARSER::COLLECTION)
    ("BRCA1 and TS" . SPARSER::COLLECTION) ("Bmi-1" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("CK19" . SPARSER::PROTEIN)
    ("EPS15, DNM3, ATP6AP1 and IDH3G" . SPARSER::COLLECTION)
    ("proteins and receptors" . SPARSER::COLLECTION)
    ("EPS15 and DNM3" . SPARSER::COLLECTION)
    ("HRB and HRBL" . SPARSER::COLLECTION)
    ("DNM3, IDH3G and EPS15" . SPARSER::COLLECTION)
    ("DNM3, IDH3G, EPS15, and ATP6AP1" . SPARSER::COLLECTION)
    ("HRBL, SNX22 and HSP90B1" . SPARSER::COLLECTION)
    ("DNM3, IDH3G, EPS15 and ATP6AP1" . SPARSER::COLLECTION)
    ("viral or cellular proteins" . SPARSER::PROTEIN)
    ("HSP90B1 and IDH3G" . SPARSER::COLLECTION) ("nexins" . SPARSER::PROTEIN)
    ("EPS15 and HRBL" . SPARSER::COLLECTION) ("transferrin" . SPARSER::PROTEIN)
    ("HRB" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("IDH3G, SNX22 and DNM3" . SPARSER::COLLECTION)
    ("DNM3, SNX22, HRBL, IDH3G, HSP90B1, EPS15 and ATP6AP1"
     . SPARSER::COLLECTION)
    ("SIF" . SPARSER::PROTEIN-FAMILY)
    ("HRBL, HSP90B1 and SNX22" . SPARSER::COLLECTION)
    ("ATP6AP1, IDH3G, DNM3 and EPS15" . SPARSER::COLLECTION)
    ("HRBL, EPS15 and HSP90B1" . SPARSER::COLLECTION)
    ("vpu" . SPARSER::PROTEIN)
    ("EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15; 4 fold) and ATP6AP1 (ATPase, H+ Transporting, Lysosomal Accessory Protein 1; 1.25 fold)"
     . SPARSER::COLLECTION)
    ("DNM3 (dynamin 3; 1.7 fold increase of CD4 residual expression compared to non-targeting shRNA-expressing cells), SNX22 (sorting nexin 22; 1.5 fold), HRBL (HIV-Rev binding protein Like; 1.6 fold), IDH3G (Isocitrate dehydrogenase; 1.9 fold), HSP90B1 (Heat shock protein 90 kDa beta member 1; 1.3 fold), EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15; 4 fold) and ATP6AP1 (ATPase, H+ Transporting, Lysosomal Accessory Protein 1; 1.25 fold)"
     . SPARSER::COLLECTION)
    ("all the HIV genes and a GFP marker gene" . SPARSER::COLLECTION)
    ("TGN" . SPARSER::PROTEIN) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("CLTB (Clathrin, light chain) and CLTC1 (Clathrin, heavy chain like 1)"
     . SPARSER::COLLECTION)
    ("CLTC" . SPARSER::PROTEIN) ("Clathrin" . SPARSER::PROTEIN)
    ("CLTB" . SPARSER::PROTEIN) ("Genome-wide shRNA" . SPARSER::PROTEIN)
    ("a genome-wide shRNA" . SPARSER::PROTEIN)
    ("short interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs)"
     . SPARSER::COLLECTION)
    ("the immature viral envelope complex gp160" . SPARSER::PROTEIN)
    ("antigenic peptide" . SPARSER::PEPTIDE)
    ("four possible new HIV-1 replication co-factors" . SPARSER::MOLECULE)
    ("cellular co-factors" . SPARSER::MOLECULE)
    ("EPS15, DNM3, IDH3G and ATP6AP1" . SPARSER::COLLECTION)
    ("Isocitrate" . SPARSER::DRUG) ("HRBL" . SPARSER::PROTEIN)
    ("three viral proteins" . SPARSER::PROTEIN) ("Vpu" . SPARSER::PROTEIN)
    ("tryptophan 5-monooxygenase" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN) ("Mas5" . SPARSER::PROTEIN)
    ("V-ATPases" . SPARSER::PROTEIN-FAMILY)
    ("V-ATPase" . SPARSER::PROTEIN-FAMILY) ("DNM2" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("Adaptor protein" . SPARSER::PROTEIN)
    ("AP2A2" . SPARSER::PROTEIN)
    ("envelope glycoprotein gp160" . SPARSER::PROTEIN)
    ("β-COP" . SPARSER::PROTEIN) ("gp160" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor Receptor Pathway Substrate 15"
     . SPARSER::PROTEIN)
    ("EPS15" . SPARSER::PROTEIN) ("beta member 1" . SPARSER::PROTEIN)
    ("Heat shock protein 90 " . SPARSER::PROTEIN)
    ("HSP90B1" . SPARSER::PROTEIN) ("IDH3G" . SPARSER::PROTEIN)
    ("Lysosomal Accessory Protein 1" . SPARSER::PROTEIN)
    ("H+ Transporting" . SPARSER::PROTEIN) ("ATP6AP1" . SPARSER::PROTEIN)
    ("sorting nexin 22" . SPARSER::PROTEIN) ("SNX22" . SPARSER::PROTEIN)
    ("dynamin 3" . SPARSER::PROTEIN) ("DNM3" . SPARSER::PROTEIN)
    ("sib" . SPARSER::DRUG)
    ("the PD-associated haplotype GAAAA" . SPARSER::MOLECULE)
    ("SNPs and three functional promoter SNPs" . SPARSER::COLLECTION)
    ("AGGG" . SPARSER::PROTEIN) ("AGA" . SPARSER::PROTEIN)
    ("SNPs and the three functional promoter SNPs (SNPs 2, P1, P2, P3, 3, 4 ,5 and 6 according to gene direction, for rs numbers see Table  xref )"
     . SPARSER::COLLECTION)
    ("AAS" . SPARSER::MOLECULE) ("FH" . SPARSER::PROTEIN)
    ("three functional SNPs" . SPARSER::PROTEIN) ("GAAAA" . SPARSER::MOLECULE)
    ("toxic redox" . SPARSER::PROTEIN) ("DA-quinones" . SPARSER::MOLECULE)
    ("hydroquinones" . SPARSER::MOLECULE)
    ("neuroprotective enzyme heme oxygenase 1" . SPARSER::PROTEIN)
    ("sulforaphane [ xref ] and curcumin" . SPARSER::COLLECTION)
    ("sulforaphane or curcumin" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::PROTEIN)
    ("cytoprotective genes" . SPARSER::GENE)
    ("which targets Nrf2" . SPARSER::PROTEIN)
    ("its repressor protein kelch-like ECH-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ferrous iron" . SPARSER::MOLECULE) ("-quinones" . SPARSER::MOLECULE)
    ("quinones" . SPARSER::MOLECULE) ("an idiopathic form" . SPARSER::FORM)
    ("dopamine (DA)" . SPARSER::DRUG) ("a functional SNP" . SPARSER::PROTEIN)
    ("SNPs and haplotypes" . SPARSER::COLLECTION) ("SNP 3" . SPARSER::PROTEIN)
    ("SNP 1" . SPARSER::PROTEIN) ("SNP 2" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("PINK1" . SPARSER::PROTEIN)
    ("6-Hydroxydopamine" . SPARSER::DRUG) ("erythroid 2" . SPARSER::PROTEIN)
    ("the autophagic program and highlight new potential targets"
     . SPARSER::TARGET-PROTEIN)
    ("the fibrogenic mediator CTGF" . SPARSER::PROTEIN)
    ("rapamycin, Torin 1 or RICTOR" . SPARSER::COLLECTION)
    ("rapamycin or Torin 1" . SPARSER::COLLECTION)
    ("CCN" . SPARSER::PROTEIN-FAMILY)
    ("LY294002, wortmannin or 3-MA" . SPARSER::COLLECTION)
    ("the central autophagic gene ATG7" . SPARSER::PROTEIN)
    ("a maladaptive form" . SPARSER::FORM)
    ("ACTA2 and CTGF" . SPARSER::COLLECTION)
    ("ACTA2 and proCOL1A1" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR) ("new MTORC2" . SPARSER::PROTEIN)
    ("a classical inducer" . SPARSER::PROTEIN)
    ("an autophagic substrate" . SPARSER::SUBSTRATE)
    ("-ATPases" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("PIK3C3/VPS34-PIK3R4-AMBRA1" . SPARSER::COLLECTION)
    ("TGFB" . SPARSER::PROTEIN) ("COL1A1 and COL3A1" . SPARSER::COLLECTION)
    ("CTGF and ACTA2" . SPARSER::COLLECTION)
    ("RPS6KB1/p70S6K" . SPARSER::COLLECTION)
    ("3 different class I phosphoinositide 3-kinase and class III phosphatidylinositol 3-kinase (PtdIns3K) inhibitors"
     . SPARSER::INHIBITOR)
    ("phosphoinositide 3-kinase and class" . SPARSER::COLLECTION)
    ("COL1A1 (collagen, type I, α 1) and COL3A1" . SPARSER::COLLECTION)
    ("ACTA2/αSMA" . SPARSER::COLLECTION) ("SQSTM1/p62" . SPARSER::COLLECTION)
    ("Ad-CA" . SPARSER::PROTEIN) ("S6D" . SPARSER::PROTEIN)
    ("MTORC1 " . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("1A1" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("PIK3R4" . SPARSER::PROTEIN) ("PIK3C3" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("COL3A1" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("heat shock transcription factor (HSF)" . SPARSER::PROTEIN)
    ("TMPRSS2:ERG" . SPARSER::BIO-COMPLEX) ("HSF" . SPARSER::PROTEIN)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRKDC-MYC" . SPARSER::COLLECTION)
    ("which signals checkpoint proteins CHK1 and CHK2" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("mTOR/PRKDC" . SPARSER::COLLECTION)
    ("PRKDC inhibitors such as NU-7441 and KU0060648" . SPARSER::COLLECTION)
    ("a vital component" . SPARSER::COMPONENT)
    ("DR5, GSK3B, and SAE1/2" . SPARSER::COLLECTION) ("BET" . SPARSER::PROTEIN)
    ("Modulators" . SPARSER::PROTEIN)
    ("further support MYC" . SPARSER::PROTEIN)
    ("MYC protein and mRNA" . SPARSER::COLLECTION)
    ("previously reported genes" . SPARSER::GENE)
    ("CDK2 and GSK3B" . SPARSER::COLLECTION)
    ("L-MYC isoform 1 (L-MYC1) or L-MYC isoform 2 (L-MYC2)"
     . SPARSER::COLLECTION)
    ("Parp1" . SPARSER::PROTEIN) ("‘A’ or" . SPARSER::PROTEIN)
    ("a dominant-negative MYC mutant" . SPARSER::MUTANT)
    ("MAX" . SPARSER::PROTEIN) ("c-" . SPARSER::PROTEIN)
    ("RAS and MYC" . SPARSER::COLLECTION)
    ("BCR-ABL, EGFR, HER2, ALK, and mutant" . SPARSER::COLLECTION)
    ("PRKDC and MYC" . SPARSER::COLLECTION)
    ("CellTiter-Glo" . SPARSER::PROTEIN-PAIR)
    ("Genes and proteins" . SPARSER::COLLECTION) ("PRKDC" . SPARSER::PROTEIN)
    ("heat shock transcription factor" . SPARSER::PROTEIN)
    ("OCT-1" . SPARSER::PROTEIN) ("SAE1" . SPARSER::PROTEIN)
    ("ARK5" . SPARSER::PROTEIN) ("Brd4" . SPARSER::PROTEIN)
    ("D-G" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("gag-pol" . SPARSER::PROTEIN)
    ("KU0060648" . SPARSER::DRUG) ("isoform2" . SPARSER::PROTEIN)
    ("isoform1" . SPARSER::PROTEIN) ("L-MYC2" . SPARSER::PROTEIN)
    ("L-MYC1" . SPARSER::PROTEIN) ("L-MYC" . SPARSER::PROTEIN)
    ("N-MYC" . SPARSER::PROTEIN) ("gamma-tubulin" . SPARSER::PROTEIN)
    ("A’" . SPARSER::PROTEIN) ("EMT and TAZ" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9, and MMP-14" . SPARSER::COLLECTION)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("TAZ, MMP-9, MMP-2, N-cadherin, vimentin, β-catenin, and Snail"
     . SPARSER::COLLECTION)
    ("TAZ, MMP-9, MMP-2, E-cadherin, β-catenin, N-cadherin, vimentin, and Snail"
     . SPARSER::COLLECTION)
    ("vimentin and Snail" . SPARSER::COLLECTION)
    ("si-NC" . SPARSER::COLLECTION) ("si-TAZ" . SPARSER::COLLECTION)
    ("si" . SPARSER::PROTEIN) ("OCT4, SOX2, and Nanog" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION) ("SK" . SPARSER::PROTEIN)
    ("N-cadherin, vimentin, Snail, and Slug" . SPARSER::COLLECTION)
    ("OCT4, Nanog, and SOX2" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN)
    ("transcriptional coactivator with PDZ binding motif (TAZ)"
     . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN)
    ("transcriptional coactivator with PDZ binding motif" . SPARSER::PROTEIN)
    ("ERBB4 and YAP/Hippo" . SPARSER::COLLECTION)
    ("NRG1 and other ERBB4 agonists" . SPARSER::COLLECTION)
    ("EGF, WNTs, and LPA" . SPARSER::COLLECTION) ("WNTs" . SPARSER::PROTEIN)
    ("mammary ERBB4" . SPARSER::PROTEIN)
    ("ERBB4 and YAP/TAZ" . SPARSER::COLLECTION) ("verteporfin" . SPARSER::DRUG)
    ("Lapatinib and erlotinib" . SPARSER::COLLECTION)
    ("EGF/EGFR/PDK1" . SPARSER::COLLECTION)
    ("ERBB1/EGFR" . SPARSER::COLLECTION) ("ERBBs" . SPARSER::PROTEIN)
    ("a bona fide YAP activator and one" . SPARSER::COLLECTION)
    ("a few known soluble YAP regulators" . SPARSER::REGULATOR)
    ("EGF, and LPA" . SPARSER::COLLECTION)
    ("a ERBB4/YAP/TEAD ternary complex" . SPARSER::BIO-COMPLEX)
    ("the binary YAP–TEAD complex" . SPARSER::BIO-COMPLEX)
    ("ERBB4–TEAD" . SPARSER::COLLECTION)
    ("ERBB4 and LATS1" . SPARSER::COLLECTION)
    ("exogenous ERBB4" . SPARSER::PROTEIN)
    ("simvastatin or lovastatin" . SPARSER::COLLECTION)
    ("simvastatin" . SPARSER::DRUG)
    ("HMGCR , HMGCS1 , and LDLR" . SPARSER::COLLECTION)
    ("LDLR" . SPARSER::PROTEIN) ("HMGCR" . SPARSER::PROTEIN)
    ("TGF-β and mevalonate" . SPARSER::COLLECTION)
    ("EGFR–PI3K–PDK1" . SPARSER::COLLECTION)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA) ("EGF-" . SPARSER::PROTEIN)
    ("NRG1–ERBB4" . SPARSER::COLLECTION)
    ("ERBB4 and TEAD" . SPARSER::COLLECTION)
    ("V5-tagged ERBB4 CYT-2" . SPARSER::PROTEIN)
    ("TEAD1 and ERBB4" . SPARSER::COLLECTION)
    ("CTGF , CYR61 , and ANKRD1" . SPARSER::COLLECTION)
    ("ERBB3 and ERBB4" . SPARSER::COLLECTION) ("ERBB4-" . SPARSER::PROTEIN)
    ("CYT-2 and pINDUCER10-encoded" . SPARSER::COLLECTION)
    ("dobutamine" . SPARSER::DRUG) ("Dobutamine" . SPARSER::DRUG)
    ("NRG1/ERBB4" . SPARSER::COLLECTION)
    ("CYT-1 or CYT-2" . SPARSER::COLLECTION)
    ("glucagon and epinephrine" . SPARSER::COLLECTION)
    ("glucagon" . SPARSER::PROTEIN) ("Agonists" . SPARSER::AGONIST)
    ("The apical-basal polarity proteins NF2, AMOT, and α-catenin"
     . SPARSER::COLLECTION)
    ("NF2, AMOT, and α-catenin" . SPARSER::COLLECTION)
    ("AMOT" . SPARSER::PROTEIN)
    ("TEAD1-4, p73, SMAD, and RUNX" . SPARSER::COLLECTION)
    ("NRG1 (Neuregulin 1) and ERBB4" . SPARSER::COLLECTION)
    ("full-length ERBB4 and the ICD isoforms" . SPARSER::COLLECTION)
    ("Part" . SPARSER::COMPONENT) ("esters" . SPARSER::MOLECULE)
    ("-converting enzyme" . SPARSER::COLLECTION) ("TACE" . SPARSER::PROTEIN)
    ("TAB2/N-CoR" . SPARSER::COLLECTION) ("EGFR/ERBB" . SPARSER::COLLECTION)
    ("ERBB" . SPARSER::PROTEIN) ("EGF or LPA" . SPARSER::COLLECTION)
    ("lapatinib or erlotinib" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("YAP/TAZ" . SPARSER::PROTEIN)
    ("ERBB1" . SPARSER::PROTEIN) ("HMG-coA" . SPARSER::DRUG)
    ("HMGCS1" . SPARSER::PROTEIN) ("GAL-4" . SPARSER::PROTEIN)
    ("S1P" . SPARSER::PROTEIN) ("sphingosine 1-phosphate" . SPARSER::DRUG)
    ("ANKRD1" . SPARSER::PROTEIN) ("Neuregulin 1" . SPARSER::PROTEIN)
    ("CYT-2" . SPARSER::PROTEIN) ("CYT-1" . SPARSER::PROTEIN)
    ("N-CoR" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("neuregulin 1" . SPARSER::PROTEIN)
    ("luciferase, and GFP" . SPARSER::COLLECTION) ("ccl" . SPARSER::DRUG)
    ("p53-CCL2" . SPARSER::COLLECTION) ("mcl" . SPARSER::PROTEIN)
    ("CCL2 or other chemokines" . SPARSER::COLLECTION)
    ("CCL2/CCR2" . SPARSER::COLLECTION)
    ("Macrophages/monocytes" . SPARSER::COLLECTION)
    ("the gene’s" . SPARSER::GENE)
    ("chemokines and chemokine" . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN) ("C-11" . SPARSER::PROTEIN)
    ("mcL2" . SPARSER::PROTEIN) ("p115" . SPARSER::PROTEIN)
    ("AG as well as GG and AG + GG" . SPARSER::COLLECTION)
    ("telomerase RNA component (TERC)" . SPARSER::RNA)
    ("the MNS16A genotype and the hTERT rs2736098 variant"
     . SPARSER::COLLECTION)
    ("AG " . SPARSER::PROTEIN) ("genotype and hTERT" . SPARSER::COLLECTION)
    ("ins/ins" . SPARSER::COLLECTION) ("SS" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN) ("MNS" . SPARSER::PROTEIN)
    ("Beta-2 microglobulin" . SPARSER::PROTEIN) ("16A" . SPARSER::PROTEIN)
    ("Ib" . SPARSER::DRUG)
    ("PIK3CA -mutant (MCF-7, T47D) and PTEN -deficient (ZR75-1) ER+ breast cancer cells"
     . SPARSER::COLLECTION)
    ("PIK3CA (encodes the p110α catalytic subunit of PI3K) and loss-of-function"
     . SPARSER::COLLECTION)
    ("MLN0128 and rapamycin" . SPARSER::COLLECTION)
    ("BEZ235, GDC-0980, MLN0128, and AZD2014" . SPARSER::COLLECTION)
    ("PI3K/mTOR dual inhibitors" . SPARSER::INHIBITOR)
    ("BEZ235 and GDC-0980" . SPARSER::COLLECTION)
    ("MECA" . SPARSER::PROTEIN-FAMILY)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("P7170 primarily targets mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("buparlisib" . SPARSER::DRUG) ("P-S6 and P-AKT" . SPARSER::COLLECTION)
    ("fulvestrant and P7170" . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG)
    ("PI3K, mTORC1, and mTORC2" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("PARP or caspase-3/7" . SPARSER::COLLECTION)
    ("AKT and mechanistic target of rapamycin" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("/AKT/mTOR" . SPARSER::COLLECTION)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("GDC-0980" . SPARSER::DRUG) ("AZD2014" . SPARSER::DRUG)
    ("MLN0128" . SPARSER::DRUG) ("RAD001" . SPARSER::DRUG)
    ("BEZ235" . SPARSER::DRUG) ("Smad1" . SPARSER::PROTEIN)
    ("ALK1" . SPARSER::PROTEIN)
    ("activin receptor-like kinase" . SPARSER::PROTEIN)
    ("P-S6" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("Anti-estrogen" . SPARSER::DRUG) ("anti-estrogens" . SPARSER::DRUG)
    ("med" . SPARSER::PROTEIN) ("BATF and IL-6R" . SPARSER::COLLECTION)
    ("a possible better target" . SPARSER::TARGET-PROTEIN)
    ("IL-10, STAT5 and IL-17A" . SPARSER::COLLECTION)
    ("STAT5 and FOXP-3+" . SPARSER::COLLECTION)
    ("BATF and RORγT" . SPARSER::COLLECTION)
    ("different histological types" . TYPE)
    ("IL-10 and IL-17A" . SPARSER::COLLECTION)
    ("Il2ra , Ctla4 , Icos , Folr4 , Lag3 , Il10 , Il21 and Foxp3"
     . SPARSER::COLLECTION)
    ("IL-2, IFN-γ, and IL-10" . SPARSER::COLLECTION)
    ("BATF and vice versa" . SPARSER::COLLECTION)
    ("STAT3/BATF" . SPARSER::COLLECTION)
    ("squamous carcinoma STAT3" . SPARSER::PROTEIN)
    ("IL6R , RORC and BATF" . SPARSER::COLLECTION)
    ("IL-17a" . SPARSER::PROTEIN) ("Il10 , Il6 and Il21" . SPARSER::COLLECTION)
    ("Folr4 , Ctla4 , Icos , Il2ra and Lag3" . SPARSER::COLLECTION)
    ("Il2ra" . SPARSER::PROTEIN) ("Il6" . SPARSER::PROTEIN)
    ("IL-6R/BATF/STAT3" . SPARSER::COLLECTION)
    ("BATF and STAT3" . SPARSER::COLLECTION) ("pS-STAT3" . SPARSER::COLLECTION)
    ("pY-STAT3" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("effector and CD4+CD25+FOXP-3+" . SPARSER::COLLECTION)
    ("FOXP-3" . SPARSER::COLLECTION) ("both histological types" . TYPE)
    ("OCT" . SPARSER::PROTEIN) ("mRNA and proteins" . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("ATF/CREB" . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN)
    ("IL-6, STAT3, RORγT and BATF" . SPARSER::COLLECTION)
    ("JAK1-Tyk-2" . SPARSER::COLLECTION)
    ("JAK1 and IL-6" . SPARSER::COLLECTION)
    ("the predominant histological subtypes" . SPARSER::PROTEIN)
    ("Foxp3 , Ctla4 , Icos , Il10 , Il21 , Folr4 and Lag3"
     . SPARSER::COLLECTION)
    ("Lag3" . SPARSER::PROTEIN) ("Il10" . SPARSER::PROTEIN)
    ("Ctla4" . SPARSER::PROTEIN) ("Rorc" . SPARSER::PROTEIN)
    ("Icos" . SPARSER::PROTEIN) ("BATF and a protein" . SPARSER::COLLECTION)
    ("Signal transducer and activator of transcription 3 (STAT3), Basic leucine zipper transcription factor, BATF and a protein"
     . SPARSER::COLLECTION)
    ("Basic leucine zipper transcription factor" . SPARSER::PROTEIN)
    ("RORC" . SPARSER::PROTEIN) ("BATF" . SPARSER::PROTEIN)
    ("IL-6R and CD4+CD25+Foxp-3+" . SPARSER::COLLECTION)
    ("AT-3" . SPARSER::PROTEIN) ("Ror γ t" . SPARSER::PROTEIN)
    ("gp80" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("IL-6RA" . SPARSER::PROTEIN) ("Tyk-2" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN)
    ("Epidermal-growth factor" . SPARSER::PROTEIN) ("Folr4" . SPARSER::PROTEIN)
    ("Il21" . SPARSER::PROTEIN) ("RORγT" . SPARSER::PROTEIN)
    ("RAR-related orphan receptor C" . SPARSER::PROTEIN)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("preoperative HER2 ECD" . SPARSER::PROTEIN)
    ("a more aggressive form" . SPARSER::FORM) ("Ren" . SPARSER::PROTEIN)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("Melting" . SPARSER::DRUG)
    ("PNA" . SPARSER::PROTEIN) ("plasma)" . SPARSER::PROTEIN)
    ("K-RAS" . SPARSER::PROTEIN) ("PTP-PEST and FAK" . SPARSER::COLLECTION)
    ("PTHLH" . SPARSER::PROTEIN) ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatectomy" . SPARSER::PROTEIN)
    ("the dominant genotype" . SPARSER::PROTEIN)
    ("cases undergoing hepatectomy" . SPARSER::PROTEIN)
    ("HAI" . SPARSER::PROTEIN) ("KRAS or NRAS" . SPARSER::COLLECTION)
    ("oncogenes and patients" . SPARSER::COLLECTION)
    ("RAS or PIK3CA" . SPARSER::COLLECTION)
    ("RAS and PIK3CA" . SPARSER::COLLECTION) ("mCRC" . SPARSER::PROTEIN)
    ("PTP-PEST" . SPARSER::PROTEIN) ("parathyroid hormone" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("3–1" . SPARSER::PROTEIN) ("HR 3" . SPARSER::PROTEIN)
    ("v 19" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4A , p27 Kip1 , and GDF15" . SPARSER::COLLECTION)
    ("basal p16 INK4A" . SPARSER::PROTEIN)
    ("p27 Kip1 and p53" . SPARSER::COLLECTION)
    ("PCNA and cell cycle-dependent kinases (CDKs)" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclin D1" . SPARSER::COLLECTION)
    ("CHEK2 and p53" . SPARSER::COLLECTION)
    ("PPAR γ ligands and chemotoxic reagents like etoposid and doxorubicin"
     . SPARSER::COLLECTION)
    ("chemotoxic reagents" . SPARSER::MOLECULE) ("NSAID" . SPARSER::PROTEIN)
    ("cisplatin, docetaxel, and mitoxantrone" . SPARSER::COLLECTION)
    ("P4HA2 and LMNA" . SPARSER::COLLECTION) ("Dai" . SPARSER::PROTEIN)
    ("basal p27 Kip1" . SPARSER::PROTEIN) ("TRC" . SPARSER::PROTEIN)
    ("GDF15, DRAM1, SULF2, P4HA2, and LMNA" . SPARSER::COLLECTION)
    ("LMNA" . SPARSER::PROTEIN)
    ("phospho-p27 Kip1 and phospho-p38 α" . SPARSER::COLLECTION)
    ("Bcl-2, cyclin D1 or p21 Waf1/Cip1" . SPARSER::COLLECTION)
    ("Further western blot" . SPARSER::PROTEIN) ("RelC" . SPARSER::PROTEIN)
    ("CHEK1 and CHEK2" . SPARSER::COLLECTION)
    ("DDR and p53" . SPARSER::COLLECTION)
    ("platinum-regulated genes and pathways for a better understanding"
     . SPARSER::COLLECTION)
    ("a stress-responsive cytokine" . SPARSER::PROTEIN)
    ("doxorubicin, genistein, and carboplatin" . SPARSER::COLLECTION)
    ("genistein" . SPARSER::PROTEIN) ("NSAIDs" . SPARSER::DRUG)
    ("SP1" . SPARSER::PROTEIN) ("P16 INK4A" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("S46" . SPARSER::PROTEIN)
    ("p27 KIP1" . SPARSER::PROTEIN) ("P4HA2" . SPARSER::PROTEIN)
    ("SULF2" . SPARSER::PROTEIN) ("PPAR γ" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN)
    ("Growth differentiation factor 15" . SPARSER::PROTEIN)
    ("ing" . SPARSER::PROTEIN-FAMILY) ("TLR-2" . SPARSER::PROTEIN)
    ("-2 and TLR-4" . SPARSER::COLLECTION)
    ("RAGE, RhoA and NF-κB" . SPARSER::COLLECTION)
    ("CD44, PDGF receptor, and LOX-1" . SPARSER::COLLECTION)
    ("RAGE and HMGB-1" . SPARSER::COLLECTION)
    ("RAGE and NF-κB" . SPARSER::COLLECTION)
    ("MT1-MMP and RAGE" . SPARSER::COLLECTION)
    ("RAGE and MT1-MMP" . SPARSER::COLLECTION)
    ("RAGE-MT1-MMP" . SPARSER::COLLECTION)
    ("HMGB-1/RAGE" . SPARSER::COLLECTION)
    ("monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("Rac/NADPH oxidase" . SPARSER::COLLECTION)
    ("cytokines and tissue factor" . SPARSER::COLLECTION)
    ("inflammatory macrophages" . SPARSER::PROTEIN) ("LPC" . SPARSER::PROTEIN)
    ("Lysophosphatidylcholine" . SPARSER::MOLECULE)
    ("new biologically active substances" . SPARSER::SUBSTANCE)
    ("interleukins" . SPARSER::PROTEIN) ("RAGE/MT1-MMP" . SPARSER::COLLECTION)
    ("RAGE or MT1-MMP" . SPARSER::COLLECTION)
    ("MT1-MMP and HMBG" . SPARSER::COLLECTION) ("TLR-4" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("tissue factor" . SPARSER::PROTEIN) ("LOX-1" . SPARSER::PROTEIN)
    ("lectin-like oxidized LDL receptor-1" . SPARSER::PROTEIN)
    ("Tissue factor" . SPARSER::PROTEIN) ("HMGB-1" . SPARSER::PROTEIN)
    ("efficient APC/C and cell cycle inhibitors" . SPARSER::COLLECTION)
    ("efficient APC/C" . SPARSER::PROTEIN) ("TAME" . SPARSER::MOLECULE)
    ("the other APC3 molecule’s" . SPARSER::MOLECULE)
    ("APC6 and APC7" . SPARSER::COLLECTION) ("that APC16’s" . SPARSER::PROTEIN)
    ("APC3-APC16-APC7" . SPARSER::COLLECTION)
    ("APC7-APC16" . SPARSER::COLLECTION) ("alanines" . SPARSER::AMINO-ACID)
    ("APC3 and its complex" . SPARSER::COLLECTION)
    ("APC10-APC1" . SPARSER::COLLECTION)
    ("This latter mutant" . SPARSER::MUTANT)
    ("alanine and arginine" . SPARSER::COLLECTION)
    ("GST-APC7" . SPARSER::COLLECTION)
    ("APC3-APC7-APC16" . SPARSER::COLLECTION)
    ("APC7 and APC16" . SPARSER::COLLECTION) ("sepharose" . SPARSER::MOLECULE)
    ("Glutathione" . SPARSER::DRUG)
    ("APC3, APC7, and APC16" . SPARSER::COLLECTION)
    ("APC3 and APC7" . SPARSER::COLLECTION)
    ("the opposite APC6 molecule and one molecule" . SPARSER::COLLECTION)
    ("APC3Δloop-APC16" . SPARSER::COLLECTION)
    ("holo-APC" . SPARSER::COLLECTION) ("holo" . SPARSER::PROTEIN)
    ("hydrogen bonds involving APC16’s" . SPARSER::PROTEIN)
    ("APC16:APC3" . SPARSER::BIO-COMPLEX) (":APC3Δloop" . SPARSER::BIO-COMPLEX)
    ("holo-APC/C" . SPARSER::COLLECTION) ("APC6-CDC26" . SPARSER::COLLECTION)
    ("HOP-Hsp70" . SPARSER::COLLECTION) ("HOP" . SPARSER::PROTEIN)
    ("APC8 and APC6" . SPARSER::COLLECTION)
    ("the 6th and 7th TPR" . SPARSER::PROTEIN)
    ("subdomains" . SPARSER::PROTEIN)
    ("a symmetric homodimer" . SPARSER::HOMODIMER)
    ("APC3Δloop" . SPARSER::PROTEIN) ("GFP-APC3Δloop" . SPARSER::PROTEIN-PAIR)
    ("APC3 or APC3Δloop" . SPARSER::COLLECTION)
    ("APC3 and APC16" . SPARSER::COLLECTION)
    ("APC3-APC16" . SPARSER::COLLECTION) ("APC/C" . SPARSER::PROTEIN)
    ("nondegradable Cyclin B1" . SPARSER::PROTEIN)
    ("Cyclin B1 and Securin" . SPARSER::COLLECTION)
    ("a western blot" . SPARSER::PROTEIN)
    ("CDH1 or CDC20" . SPARSER::COLLECTION)
    ("Ub-CyclinB" . SPARSER::COLLECTION) ("CyclinB" . SPARSER::PROTEIN)
    ("polyubiquitinate" . SPARSER::PROTEIN)
    ("monoubiquitin or short ubiquitin" . SPARSER::COLLECTION)
    ("monoubiquitin" . SPARSER::PROTEIN) ("that APC3’s" . SPARSER::PROTEIN)
    ("APC3, APC7 and APC16" . SPARSER::COLLECTION)
    ("APC8 and APC3" . SPARSER::COLLECTION) ("cryo-EM" . SPARSER::COLLECTION)
    ("Substrate" . SPARSER::SUBSTRATE) ("APC1 and APC10" . SPARSER::COLLECTION)
    ("homologous Ile-Arg" . SPARSER::COLLECTION)
    ("APC10 and coactivators" . SPARSER::COLLECTION)
    ("CDC26, APC13, and APC16" . SPARSER::COLLECTION)
    ("roughly 14 TPRs" . SPARSER::PROTEIN) ("TPRs" . SPARSER::PROTEIN)
    ("homologous homodimeric tetratricopeptide repeat (TPR) proteins"
     . SPARSER::PROTEIN)
    ("APC8, APC6, APC3, and APC7" . SPARSER::COLLECTION)
    ("APC1, APC4, APC5, and APC15" . SPARSER::COLLECTION)
    ("APC2-APC11" . SPARSER::COLLECTION)
    ("APC2 and APC11" . SPARSER::COLLECTION)
    ("cullin and RBX" . SPARSER::COLLECTION) ("RBX" . SPARSER::PROTEIN)
    ("APC3, APC16, APC7, and APC10" . SPARSER::COLLECTION)
    ("APC12/CDC26" . SPARSER::COLLECTION) ("aka" . SPARSER::PROTEIN)
    ("typically either CDC20 or the homologous CDH1" . SPARSER::COLLECTION)
    ("the homologous CDH1" . SPARSER::PROTEIN)
    ("typically either CDC20" . SPARSER::PROTEIN) ("KEN" . SPARSER::PROTEIN)
    ("Securin" . SPARSER::PROTEIN)
    ("TPR proteins and the APC/C" . SPARSER::COLLECTION)
    ("the symmetric APC3 dimer" . SPARSER::DIMER)
    ("APC16 and APC7" . SPARSER::COLLECTION)
    ("coactivators, CDC20 and CDH1" . SPARSER::COLLECTION)
    ("Ile-Arg" . SPARSER::COLLECTION) ("Ile" . SPARSER::AMINO-ACID)
    ("APC16, CDC26, and APC13" . SPARSER::COLLECTION)
    ("APC7, APC3, APC6, and APC8" . SPARSER::COLLECTION)
    ("cullin-RING-like" . SPARSER::PROTEIN-PAIR)
    ("a massive E3 ligase" . SPARSER::LIGASE) ("Hsl1" . SPARSER::PROTEIN)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("UBA1" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE) ("potential peptide" . SPARSER::PROTEIN)
    ("UBE2S" . SPARSER::PROTEIN) ("UBCH10" . SPARSER::PROTEIN)
    ("Cdc26" . SPARSER::PROTEIN) ("Cdc27" . SPARSER::PROTEIN)
    ("Cdc16" . SPARSER::PROTEIN) ("S. cerevisiae )" . SPARSER::PROTEIN)
    ("APC12" . SPARSER::PROTEIN) ("APC15" . SPARSER::PROTEIN)
    ("APC11" . SPARSER::PROTEIN) ("APC2" . SPARSER::PROTEIN)
    ("APC1" . SPARSER::PROTEIN) ("APC10" . SPARSER::PROTEIN)
    ("Lys-Glu" . SPARSER::MOLECULE) ("APC8" . SPARSER::PROTEIN)
    ("APC6" . SPARSER::PROTEIN) ("APC3" . SPARSER::PROTEIN)
    ("APC7" . SPARSER::PROTEIN) ("APC13" . SPARSER::PROTEIN)
    ("CDC26" . SPARSER::PROTEIN) ("APC16" . SPARSER::PROTEIN)
    ("CDK4/cyclinD1" . SPARSER::COLLECTION) ("Yan" . SPARSER::PROTEIN)
    ("p53 and miR-34a" . SPARSER::COLLECTION) ("www-p53" . SPARSER::COLLECTION)
    ("p–p53" . SPARSER::COLLECTION) ("nul-p53" . SPARSER::PROTEIN-PAIR)
    ("miR-34a, and CDK4" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION) ("BrDU" . SPARSER::DRUG)
    ("p53 and the promoter" . SPARSER::COLLECTION)
    ("bisulphite" . SPARSER::MOLECULE) ("mut-p53" . SPARSER::COLLECTION)
    ("wt-p53" . SPARSER::COLLECTION) ("anti-p-p53" . SPARSER::COLLECTION)
    ("mature miR-34a" . SPARSER::MOLECULE)
    ("cMET, Bcl-2, E2F3/5 and cyclin-dependent kinase 4/6"
     . SPARSER::COLLECTION)
    ("pri-miR" . SPARSER::COLLECTION)
    ("an evolutionary conserved miRNA family" . SPARSER::PROTEIN-FAMILY)
    ("miR-34a and miR-34b/c" . SPARSER::COLLECTION)
    ("p-p53" . SPARSER::COLLECTION) ("TopoII" . SPARSER::PROTEIN)
    ("cyclophosphamide, etoposide and carboplatin" . SPARSER::COLLECTION)
    ("methotrexate and/or ifosfamide" . SPARSER::COLLECTION)
    ("Doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("ifosfamide" . SPARSER::DRUG)
    ("a variety of pre- and postoperative chemotherapeutic combinations"
     . SPARSER::COLLECTION)
    ("unmethylated miR-34a, reduced expression of CDK4 and cell cycle arrest"
     . SPARSER::COLLECTION)
    ("dominant-negative form" . SPARSER::FORM) ("mir-34a" . SPARSER::MOLECULE)
    ("C-22" . SPARSER::PROTEIN) ("L- glutamine" . SPARSER::MOLECULE)
    ("miR-34 as" . SPARSER::MOLECULE) ("MiR-34a" . SPARSER::MOLECULE)
    ("p13" . SPARSER::PROTEIN) ("KIR6.2 and SUR1" . SPARSER::COLLECTION)
    ("PED/PEA15" . SPARSER::COLLECTION)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classical PKC isoforms" . SPARSER::ISOFORM) ("PLD" . SPARSER::PROTEIN)
    ("PED/PEA-15-PLD-1" . SPARSER::COLLECTION)
    ("PLD-1 and PLD-2" . SPARSER::COLLECTION)
    ("PLD-1 or PLD-2" . SPARSER::COLLECTION)
    ("PI3K, Akt, p70s6k and ERK" . SPARSER::COLLECTION)
    ("p70s6k" . SPARSER::PROTEIN) ("Omi/HtrA2" . SPARSER::COLLECTION)
    ("Omi" . SPARSER::PROTEIN) ("Sur1, Kir6.2 and Foxa2" . SPARSER::COLLECTION)
    ("Foxa2" . SPARSER::PROTEIN) ("Sur" . SPARSER::PROTEIN)
    ("the pro-apoptotic Bim" . SPARSER::PROTEIN) ("Wt" . SPARSER::PROTEIN)
    ("Propranolol" . SPARSER::DRUG) ("Complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("IL-1β-converting enzyme (FLICE)" . SPARSER::COLLECTION)
    ("Fas-associated protein" . SPARSER::PROTEIN)
    ("IL-1β-converting enzyme" . SPARSER::COLLECTION)
    ("FLICE" . SPARSER::PROTEIN) ("JNK and p38" . SPARSER::COLLECTION)
    ("propranolol" . SPARSER::DRUG)
    ("pro-apoptotic genes Bcl-xS and Bad" . SPARSER::COLLECTION)
    ("Bcl-xS and Bad" . SPARSER::COLLECTION)
    ("PED/PEA-15" . SPARSER::COLLECTION) ("PED" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN) ("SUR1" . SPARSER::PROTEIN)
    ("KIR6.2" . SPARSER::PROTEIN) ("PEA15" . SPARSER::PROTEIN)
    ("PLD1" . SPARSER::PROTEIN) ("s6k" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("PLD-2" . SPARSER::PROTEIN)
    ("HtrA2" . SPARSER::PROTEIN) ("Kir6.2" . SPARSER::PROTEIN)
    ("Bcl- xS" . SPARSER::PROTEIN) ("Bcl- xL" . SPARSER::PROTEIN)
    ("Bcl- x" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("phospholipase D" . SPARSER::PROTEIN) ("procaspase-8" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("stress-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type 2" . SPARSER::PROTEIN) ("PLD-1" . SPARSER::PROTEIN)
    ("PEA-15" . SPARSER::PROTEIN) ("Afro-Caribbean" . SPARSER::PROTEIN-PAIR)
    ("Afro" . SPARSER::PROTEIN)
    ("a yet unidentified causative variant" . SPARSER::VARIANT)
    ("regulating endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("nitric oxide, and transforming growth factor" . SPARSER::COLLECTION)
    ("the caveolin 1 ( CAV1 ; OMIM:) and caveolin 2 ( CAV2 ; OMIM:) genes [ xref ]"
     . SPARSER::COLLECTION)
    ("the Atonal homolog 7 ( ATOH7; OMIM:) gene" . SPARSER::GENE)
    ("a secondary type" . TYPE)
    ("TMCO1 , ATOH7, and CAV1" . SPARSER::COLLECTION)
    ("SIX homeobox 1" . SPARSER::PROTEIN) ("CAV2" . SPARSER::PROTEIN)
    ("caveolin 2" . SPARSER::PROTEIN)
    ("transmembrane and coiled-coil domains 1" . SPARSER::PROTEIN)
    ("TMCO1" . SPARSER::PROTEIN) ("FOXO and GSK3α/β" . SPARSER::COLLECTION)
    ("nSH2, inter-SH2, and cSH2" . SPARSER::COLLECTION)
    ("p85α and p50α" . SPARSER::COLLECTION)
    ("FOXO and GSK3" . SPARSER::COLLECTION)
    ("p85α/p110δ" . SPARSER::COLLECTION)
    ("p50α and p55α" . SPARSER::COLLECTION)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION) ("PRR" . SPARSER::PROTEIN)
    ("p50α" . SPARSER::PROTEIN)
    ("p85α and the adaptor-binding domain" . SPARSER::COLLECTION)
    ("p85α and p110δ" . SPARSER::COLLECTION)
    ("a healthy control subject and immunoprecipitated p110δ"
     . SPARSER::PROTEIN)
    ("p85α-myc" . SPARSER::COLLECTION) ("PTEN and SHIP1" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("substantially more basal phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("delE11 p85α and the p110 catalytic subunit" . SPARSER::COLLECTION)
    ("p85α, p55α, and p50α" . SPARSER::COLLECTION) ("delE" . SPARSER::PROTEIN)
    ("the first intronic nucleotide" . SPARSER::NUCLEOTIDE)
    ("CD4/CD8" . SPARSER::COLLECTION) ("Rituximab" . SPARSER::DRUG)
    ("ESR" . SPARSER::PROTEIN) ("IBD" . SPARSER::PROTEIN)
    ("target PI3K or its downstream effectors (i.e., mTOR inhibition with rapamycin)"
     . SPARSER::COLLECTION)
    ("p110 and p85α" . SPARSER::COLLECTION)
    ("monomeric p85α" . SPARSER::PROTEIN)
    ("p85α and p110" . SPARSER::COLLECTION)
    ("free monomeric p85α" . SPARSER::PROTEIN)
    ("the catalytic p110α, p110β, and p110δ proteins and the regulatory p85α, p55α, p50α, p85β, and p55γ proteins"
     . SPARSER::COLLECTION)
    ("p110α, p110β, and p110δ" . SPARSER::COLLECTION)
    ("p85α, p55α, p50α, p85β, and p55γ" . SPARSER::COLLECTION)
    ("p85α" . SPARSER::PROTEIN) ("p85α–p110δ" . SPARSER::PROTEIN-PAIR)
    ("d -glucose" . SPARSER::MOLECULE)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GS1101" . SPARSER::DRUG) ("CD57" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("myc–tagged" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("cSH2" . SPARSER::PROTEIN)
    ("nSH2" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("p55γ" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("p110δ" . SPARSER::PROTEIN)
    ("possible additional low frequency causal variants" . SPARSER::VARIANT)
    ("CLPTM1L and/or TERT" . SPARSER::COLLECTION)
    ("prioritized risk-associated variants" . SPARSER::VARIANT)
    ("only found risk variants" . SPARSER::VARIANT)
    ("endometrial cancer risk-associated SNPs" . SPARSER::PROTEIN)
    ("endometrial tumour histological subtypes" . SPARSER::PROTEIN)
    ("The third endometrial cancer risk SNP" . SPARSER::PROTEIN)
    ("RAD21 and CTCF" . SPARSER::COLLECTION)
    ("the most likely causal SNPs" . SPARSER::PROTEIN)
    ("1b" . SPARSER::PROTEIN)
    ("the endometrial cancer risk SNPs" . SPARSER::PROTEIN)
    ("reported no further associated SNPs" . SPARSER::PROTEIN)
    ("the novel endometrial cancer risk SNPs" . SPARSER::PROTEIN)
    ("local SNPs" . SPARSER::PROTEIN) ("missing genotypes" . SPARSER::PROTEIN)
    ("these novel endometrial cancer SNPs" . SPARSER::PROTEIN)
    ("three new independent endometrial cancer risk variants"
     . SPARSER::VARIANT)
    ("the endometrial cancer risk variants" . SPARSER::VARIANT)
    ("nearly 2,000 5p15.33 SNPs" . SPARSER::PROTEIN)
    ("TERT (Supplementary Table 7) or CLPTM1L (Supplementary Table 8)"
     . SPARSER::COLLECTION)
    ("both TERT (Fig.  xref c) and CLPTM1L (Fig.  xref d)"
     . SPARSER::COLLECTION)
    ("1c" . SPARSER::PROTEIN)
    ("the previously reported cancer-associated variants" . SPARSER::VARIANT)
    ("at least eight different types" . TYPE)
    ("multi-SNP" . SPARSER::COLLECTION)
    ("12, 4 and 10 distinct SNPs" . SPARSER::PROTEIN)
    ("this particular SNP" . SPARSER::PROTEIN)
    ("at least one SNP" . SPARSER::PROTEIN)
    ("one associated SNP" . SPARSER::PROTEIN)
    ("MLH1 , MSH2 , MSH6 , PMS2, POLE or POLD1" . SPARSER::COLLECTION)
    ("POLE" . SPARSER::PROTEIN)
    ("previously reported cancer-associated SNPs" . SPARSER::PROTEIN)
    ("comprehensive fine-mapping" . SPARSER::PROTEIN)
    ("fine-mapping" . SPARSER::PROTEIN)
    ("TERT and CLPTM1L" . SPARSER::COLLECTION) ("RAD21" . SPARSER::PROTEIN)
    ("MERIT40" . SPARSER::PROTEIN) ("RAD51B" . SPARSER::PROTEIN)
    ("peak 2" . SPARSER::PROTEIN) ("A ‘" . SPARSER::PROTEIN)
    ("SLC6A18" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("CYP19A1" . SPARSER::PROTEIN) ("HNF1B" . SPARSER::PROTEIN)
    ("POLD1" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN)
    ("healthy elderly individuals harboring HSPCs" . SPARSER::PROTEIN)
    ("TET2 and NUP98" . SPARSER::COLLECTION) ("VAF" . SPARSER::COMPONENT)
    ("fraction (VAF)" . SPARSER::COMPONENT)
    ("TET2 and NUP9" . SPARSER::COLLECTION)
    ("at least one HSPC" . SPARSER::PROTEIN)
    ("DNMT3A and NPM1" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("rare HSPCs" . SPARSER::PROTEIN) ("Tp53" . SPARSER::PROTEIN)
    ("healthy chemotherapy-naïve" . SPARSER::PROTEIN)
    ("t-MDS" . SPARSER::PROTEIN-PAIR) ("Ly-6" . SPARSER::PROTEIN)
    ("ACK2" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("Ly6C" . SPARSER::PROTEIN)
    ("N-ethyl-N-nitrosourea" . SPARSER::MOLECULE) ("MDS 3" . SPARSER::PROTEIN)
    ("SNAP25" . SPARSER::PROTEIN) ("NUP98" . SPARSER::PROTEIN)
    ("currently available GSK3 inhibitors" . SPARSER::INHIBITOR)
    ("carbonate" . SPARSER::MOLECULE) ("GS and CRMP-2" . SPARSER::COLLECTION)
    ("NFκB and GS" . SPARSER::COLLECTION)
    ("GSK3 substrates CRMP, NFκB and GS" . SPARSER::COLLECTION)
    ("GS and two additional established GSK3 substrates" . SPARSER::COLLECTION)
    ("p65-RelA" . SPARSER::COLLECTION) ("CRMP" . SPARSER::PROTEIN)
    ("recognises both the α and β isoforms" . SPARSER::ISOFORM)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GS and translational initiation factor eIF2B" . SPARSER::COLLECTION)
    ("translational initiation factor eIF2B" . SPARSER::PROTEIN)
    ("The predominant kinase" . SPARSER::KINASE)
    ("PKA, p90Rsk and S6K1" . SPARSER::COLLECTION)
    ("p90Rsk" . SPARSER::PROTEIN-FAMILY) ("Rsk" . SPARSER::PROTEIN)
    ("an unusual kinase" . SPARSER::KINASE)
    ("a 51 kDa polypeptide and the β-isoform" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("a poor biomarker" . SPARSER::MOLECULE)
    ("glycogen synthase, RelA and CRMP-2" . SPARSER::COLLECTION)
    ("GSK3 A" . SPARSER::PROTEIN) ("GSK3 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHIR99021" . SPARSER::MOLECULE) ("CRMP-2" . SPARSER::PROTEIN)
    ("ATM or p53" . SPARSER::COLLECTION) ("BJ" . SPARSER::PROTEIN)
    ("REG" . SPARSER::PROTEIN) ("UCN-01 and PF-477736" . SPARSER::COLLECTION)
    ("ATR-GSK3β" . SPARSER::COLLECTION)
    ("p21 Waf1-T145A/S146A" . SPARSER::PROTEIN-PAIR)
    ("other chemotherapeutic drugs" . SPARSER::DRUG) ("-1 " . SPARSER::PROTEIN)
    ("BLM or etoposide" . SPARSER::COLLECTION)
    ("the exogenous wild type p21 Waf1 protein" . SPARSER::PROTEIN)
    ("BLM and Chk1" . SPARSER::COLLECTION) ("p21 Waf1" . SPARSER::PROTEIN)
    ("GST-p21 Waf1" . SPARSER::PROTEIN-PAIR)
    ("REGγ or pre" . SPARSER::COLLECTION)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("the Chk1 inhibitors UCN-01 and PF-477736 xref" . SPARSER::COLLECTION)
    ("p53 and p21 Waf1" . SPARSER::COLLECTION)
    ("KU55933 and VRX0466617" . SPARSER::COLLECTION)
    ("the 26S proteasome inhibitor MG132 or the translation elongation inhibitor cycloheximide (CHX)"
     . SPARSER::COLLECTION)
    ("BJ-hTERT, IR and H 2 O 2" . SPARSER::COLLECTION)
    ("carrying wild type p53 (HCT116, SH-SY5Y) and mutant p53 (T47D, Hela and Saos-2)"
     . SPARSER::COLLECTION)
    ("H 2 O 2 (800 μM) and IR (50 Gy)" . SPARSER::COLLECTION)
    ("BLM and re-accumulate" . SPARSER::COLLECTION)
    ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("a functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("whose encoded protein" . SPARSER::PROTEIN)
    ("ATM-Chk2-p53" . SPARSER::COLLECTION) ("pCDNA3" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("z-VAD-fmk" . SPARSER::DRUG)
    ("REGγ" . SPARSER::PROTEIN) ("VRX0466617" . SPARSER::DRUG)
    ("KU55933" . SPARSER::DRUG) ("p73/NF-Y" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("GOF" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("onco-miRs" . SPARSER::COLLECTION)
    ("Skp2, Pirh2, and PKC1" . SPARSER::COLLECTION)
    ("Skp2-Cks1" . SPARSER::COLLECTION)
    ("Skp2 and miR-17~92" . SPARSER::COLLECTION)
    ("only QKO (miR-17~92 KO and TKO) retina" . SPARSER::DRUG)
    ("normal retina" . SPARSER::DRUG)
    ("Myc ( xref ) and miR-17~92 ( xref , xref )" . SPARSER::COLLECTION)
    ("Pten and Bim" . SPARSER::COLLECTION) ("onco-miR" . SPARSER::COLLECTION)
    ("TKO" . SPARSER::PROTEIN) ("Rb1 and Skp2" . SPARSER::COLLECTION)
    ("mitotic cyclin/Cdk" . SPARSER::COLLECTION)
    ("Skp2 and p53" . SPARSER::COLLECTION)
    ("Pirh2 and PKC1" . SPARSER::COLLECTION)
    ("the essential amino acid lysine" . SPARSER::AMINO-ACID)
    ("the isogenic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutaminase" . SPARSER::PROTEIN) ("reductant" . SPARSER::MOLECULE)
    ("fructose" . SPARSER::PROTEIN) ("ATM or Chk2" . SPARSER::COLLECTION)
    ("hnRNPA0 and PARN" . SPARSER::COLLECTION) ("PARN" . SPARSER::PROTEIN)
    ("Chk2, Chk1, and MK2" . SPARSER::COLLECTION)
    ("p38-MK2" . SPARSER::COLLECTION) ("PIP" . SPARSER::PROTEIN)
    ("IGF2 and p53" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("Bromodomain" . SPARSER::PROTEIN) ("p53 or pRb" . SPARSER::COLLECTION)
    ("PB-Cre" . SPARSER::COLLECTION) ("PB" . SPARSER::PROTEIN)
    ("Pten and Skp2" . SPARSER::COLLECTION)
    ("Rb1 and p107 or Rb1 and p27" . SPARSER::COLLECTION)
    ("p107 or Rb1 and p27" . SPARSER::COLLECTION)
    ("Rb1 and p27" . SPARSER::COLLECTION) ("cyclin/Cdk" . SPARSER::COLLECTION)
    ("E2F1-cyclin" . SPARSER::COLLECTION) ("p27-cyclin" . SPARSER::COLLECTION)
    ("the entire IL" . SPARSER::PROTEIN) ("POMC-Cre" . SPARSER::COLLECTION)
    ("POMC" . SPARSER::PROTEIN) ("completely normal IL" . SPARSER::PROTEIN)
    ("proto-oncoprotein" . SPARSER::PROTEIN-PAIR) ("SYK" . SPARSER::PROTEIN)
    ("RB1 and MYCN" . SPARSER::COLLECTION)
    ("MDM2 and N-Myc" . SPARSER::COLLECTION)
    ("p53 and most certainly both pRb and p53" . SPARSER::COLLECTION)
    ("pRb, p53 and most certainly both pRb and p53" . SPARSER::COLLECTION)
    ("most certainly both pRb and p53" . SPARSER::COLLECTION)
    ("Cyclin D1 and MDM2" . SPARSER::COLLECTION)
    ("The nearby CDKN2B" . SPARSER::PROTEIN)
    ("p16 and Arf" . SPARSER::COLLECTION) ("Seq" . SPARSER::PROTEIN)
    ("sestrin and p53" . SPARSER::COLLECTION)
    ("sestrin or p53" . SPARSER::COLLECTION)
    ("sestrin" . SPARSER::PROTEIN-FAMILY)
    ("AMPK-sestrins-TSC2" . SPARSER::COLLECTION)
    ("sestrins" . SPARSER::PROTEIN-FAMILY)
    ("Pten, TSC2, and AMPKβ" . SPARSER::COLLECTION) ("lincRNA" . SPARSER::RNA)
    ("Snail ( xref ) and stem cell marker CD44 ( xref )" . SPARSER::COLLECTION)
    ("TIGAR and GLS2" . SPARSER::COLLECTION)
    ("p21, PUMA, and NOXA" . SPARSER::COLLECTION)
    ("p21, PUMA, or NOXA" . SPARSER::COLLECTION)
    ("p16-pRb" . SPARSER::COLLECTION) ("Arf-GFP" . SPARSER::COLLECTION)
    ("Arf-p53" . SPARSER::COLLECTION) ("E2F7" . SPARSER::PROTEIN)
    ("Bax, and BH3-only" . SPARSER::COLLECTION)
    ("PUMA and NOXA" . SPARSER::COLLECTION) ("kinase (PDK)" . SPARSER::KINASE)
    ("Pyruvate" . SPARSER::PROTEIN) ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("reductants" . SPARSER::MOLECULE)
    ("caspase-7 and p73" . SPARSER::COLLECTION)
    ("heterochromatic foci (SAHF)" . SPARSER::PROTEIN)
    ("local heterochromatic state" . SPARSER::BIO-STATE)
    ("deacetylases and methyltransferases" . SPARSER::COLLECTION)
    ("proteins, and DNA" . SPARSER::COLLECTION)
    ("p16-Luc" . SPARSER::COLLECTION) ("pRb, or Ets1" . SPARSER::COLLECTION)
    ("cyclin D1/Cdk4" . SPARSER::COLLECTION)
    ("the latter PI3K(Pten)-Akt" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("Pten" . SPARSER::PROTEIN)
    ("typical growth factors" . SPARSER::GROWTH-FACTOR)
    ("Ras-PI3K-Akt" . SPARSER::COLLECTION)
    ("Ras-Raf-Mek-Erk" . SPARSER::COLLECTION)
    ("p16-cyclin D1/Cdk4-pRb" . SPARSER::COLLECTION)
    ("pRb or p53" . SPARSER::COLLECTION) ("Rb1" . SPARSER::PROTEIN)
    ("genetically inactivated pRb and p53" . SPARSER::COLLECTION)
    ("RB1 and TP53" . SPARSER::COLLECTION)
    ("pRb and p53" . SPARSER::COLLECTION) ("b-1" . SPARSER::PROTEIN)
    ("Glut1" . SPARSER::PROTEIN) ("Cks1" . SPARSER::PROTEIN)
    ("Pirh2" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("PFK1" . SPARSER::PROTEIN) ("Gadd45a" . SPARSER::PROTEIN)
    ("hnRNPA0" . SPARSER::PROTEIN) ("PIP4K2C" . SPARSER::PROTEIN)
    ("PIP4K2A" . SPARSER::PROTEIN) ("PI-5" . SPARSER::PROTEIN)
    ("PI-4" . SPARSER::PROTEIN) ("PI5" . SPARSER::PROTEIN)
    ("PIP4K2B" . SPARSER::PROTEIN) ("OTX2" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("TRβ" . SPARSER::PROTEIN)
    ("sestrin 1" . SPARSER::PROTEIN) ("AMPKβ" . SPARSER::PROTEIN)
    ("miR-200c" . SPARSER::MOLECULE) ("GLS2" . SPARSER::PROTEIN)
    ("ASCT2" . SPARSER::PROTEIN) ("PDK4" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("Ets1" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("Pds1 and Ira1" . SPARSER::COLLECTION)
    ("Pds1 and Cdc20" . SPARSER::COLLECTION)
    ("the phosphorylation-defective Cdc20 S52AS88A mutant" . SPARSER::MUTANT)
    ("a phosphorylation-defective Cdc20 S52AS88A mutant" . SPARSER::MUTANT)
    ("Cdc20 and Pds1" . SPARSER::COLLECTION)
    ("Gpb1 and Gpb2" . SPARSER::COLLECTION)
    ("the triple Ira1, Ira2, and Mad2 knockout mutant" . SPARSER::MUTANT)
    ("Ira1, Ira2, and Mad2" . SPARSER::COLLECTION)
    ("Pds1 and Clb2" . SPARSER::COLLECTION)
    ("Pds1 and the mitotic cyclin Clb2" . SPARSER::COLLECTION)
    ("the mitotic cyclin Clb2" . SPARSER::PROTEIN)
    ("benomyl" . SPARSER::MOLECULE) ("a huge protein" . SPARSER::PROTEIN)
    ("Neurofibromin" . SPARSER::PROTEIN)
    ("Mad1, Mad2, Mad3, Bub1, Bub3 and Mps1" . SPARSER::COLLECTION)
    ("cysteine and serine-rich domain" . SPARSER::COLLECTION)
    ("cysteine and serine-rich domain/Ras-GTPase activating protein"
     . SPARSER::COLLECTION)
    ("neurofibromin, Ira1, and Ira2" . SPARSER::COLLECTION)
    ("mad2" . SPARSER::PROTEIN) ("mad" . SPARSER::PROTEIN)
    ("Ira1 and Ira2" . SPARSER::COLLECTION) ("ira2" . SPARSER::PROTEIN)
    ("Ira2" . SPARSER::PROTEIN)
    ("a cysteine and serine-rich domain/Ras-GTPase activating protein domain (CSRD/RasGAP) and a C-terminal domain (CTD)"
     . SPARSER::COLLECTION)
    ("CSRD/RasGAP" . SPARSER::COLLECTION)
    ("serine-rich domain/Ras-GTPase activating protein" . SPARSER::COLLECTION)
    ("RasGAP" . SPARSER::PROTEIN) ("neurofibromin" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("P-40" . SPARSER::PROTEIN)
    ("GAL1 -3" . SPARSER::PROTEIN) ("Gpb2" . SPARSER::PROTEIN)
    ("Gpb1" . SPARSER::PROTEIN) ("Clb2" . SPARSER::PROTEIN)
    ("GAL1" . SPARSER::PROTEIN) ("Mps1" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("Mad3" . SPARSER::PROTEIN)
    ("Ras-GDP" . SPARSER::PROTEIN) ("ira1" . SPARSER::PROTEIN)
    ("Pds1" . SPARSER::PROTEIN) ("Ira1" . SPARSER::PROTEIN)
    ("Ras-GTPase activating protein" . SPARSER::PROTEIN)
    ("serine-rich domain" . SPARSER::PROTEIN)
    ("Etoposide-treated RPE" . SPARSER::PROTEIN)
    ("U2OS cells continuously increase Cyclin B1-eYFP" . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::MOLECULE)
    ("KU60019 and UCN-01" . SPARSER::COLLECTION)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Importazole" . SPARSER::DRUG) ("LMB" . SPARSER::MOLECULE)
    ("p53-, p21-, and APC/C" . SPARSER::COLLECTION)
    ("Cdc20, NIPA, or β-TrCP" . SPARSER::COLLECTION)
    ("NIPA" . SPARSER::PROTEIN) ("p21-, p53- and APC/C" . SPARSER::COLLECTION)
    ("p21-" . SPARSER::PROTEIN) ("Etoposide or NCS" . SPARSER::COLLECTION)
    ("Etoposide and NCS" . SPARSER::COLLECTION) ("NCS" . SPARSER::PROTEIN)
    ("the topoisomerase II-inhibitor Etoposide" . SPARSER::PROTEIN)
    ("Cyclin A2, Cyclin B1, Plk1, Cdk1, and Cdk2" . SPARSER::COLLECTION)
    ("MK2, Chk1 and Chk2" . SPARSER::COLLECTION)
    ("ATM, ATR and DNA-PK" . SPARSER::COLLECTION)
    ("Neocarzinostatin" . SPARSER::PROTEIN)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("eYFP" . SPARSER::PROTEIN) ("Cyclin B1-eYFP" . SPARSER::COLLECTION)
    ("p21, p53, and APC/C" . SPARSER::COLLECTION)
    ("mitotic inducers" . SPARSER::MOLECULE) ("POH1" . SPARSER::PROTEIN)
    ("F-8" . SPARSER::PROTEIN) ("ZC3HC1" . SPARSER::PROTEIN)
    ("CDC20" . SPARSER::PROTEIN) ("KU60019" . SPARSER::DRUG)
    ("Exportin 1" . SPARSER::PROTEIN) ("Cdc25s" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("Leptomycin B" . SPARSER::MOLECULE)
    ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("Drosha" . SPARSER::PROTEIN) ("DDR-miRNAs" . SPARSER::COLLECTION)
    ("miR-34a and miR-215" . SPARSER::COLLECTION)
    ("hardly any miRNAs" . SPARSER::PROTEIN)
    ("CDK4, CDK6 and cyclin" . SPARSER::COLLECTION)
    ("an essential regulatory component" . SPARSER::COMPONENT)
    ("complex and strongly cell-type dependent patterns" . SPARSER::COLLECTION)
    ("NFkB or p53" . SPARSER::COLLECTION)
    ("previously unrecognized targets" . SPARSER::TARGET-PROTEIN)
    ("an isogenic derivative" . SPARSER::DERIVATIVE)
    ("3 well-ranked miRNAs" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("the 20 most highly-induced DDR miRNAs" . SPARSER::PROTEIN)
    ("the 20 most highly-induced DDR miRs" . SPARSER::PROTEIN)
    ("DDR or non-DDR" . SPARSER::COLLECTION) ("val" . SPARSER::AMINO-ACID)
    ("NAs" . SPARSER::PROTEIN) ("a new miRNA" . SPARSER::PROTEIN)
    ("p and −3" . SPARSER::COLLECTION) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("redundant miRNAs" . SPARSER::PROTEIN)
    ("the most robustly-induced miRNAs" . SPARSER::PROTEIN)
    ("a larger numberDof miRNAs" . SPARSER::PROTEIN)
    ("only 3 miRNAs" . SPARSER::PROTEIN) ("miRs" . SPARSER::PROTEIN)
    ("tRNAs (~0.42%) and small nucleolar (sno)RNAs (~0.34%)"
     . SPARSER::COLLECTION)
    ("small nucleolar (sno)RNAs" . SPARSER::RNA)
    ("miR-NAs" . SPARSER::COLLECTION) ("miR-16 and miR" . SPARSER::COLLECTION)
    ("c-5" . SPARSER::PROTEIN) ("small nucleolar RNA" . SPARSER::RNA)
    ("miR-92a" . SPARSER::MOLECULE) ("E-5" . SPARSER::PROTEIN)
    ("miR-365b-3p" . SPARSER::MOLECULE) ("b-5" . SPARSER::PROTEIN)
    ("miR-16" . SPARSER::PROTEIN) ("an unusual type" . TYPE)
    ("CEP55 and ESCRT" . SPARSER::COLLECTION) ("BCCIP" . SPARSER::PROTEIN)
    ("a cytokinetic regulator" . SPARSER::REGULATOR)
    ("the aa 173–264 fragment nor the point-mutant form" . SPARSER::COLLECTION)
    ("a cancer-associated mutation HMG20b mutant" . SPARSER::MUTANT)
    ("GST-BRCA2" . SPARSER::COLLECTION) ("BRCA2-HMG20b" . SPARSER::COLLECTION)
    ("FLAG-HMG20b" . SPARSER::COLLECTION)
    ("multi-nucleate" . SPARSER::PROTEIN-PAIR)
    ("the full-length protein and the N-terminal fragment"
     . SPARSER::COLLECTION)
    ("MKLP1 and Cep55" . SPARSER::COLLECTION)
    ("Cep55 and HMG20b" . SPARSER::COLLECTION)
    ("GFP-HMG20b" . SPARSER::COLLECTION)
    ("Alix, and Tsg101" . SPARSER::COLLECTION)
    ("CEP55-Alix" . SPARSER::COLLECTION) ("Tsg101" . SPARSER::PROTEIN)
    ("Tsg" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Alix" . SPARSER::PROTEIN)
    ("nickel" . SPARSER::MOLECULE) ("HMG20b and BRCA2" . SPARSER::COLLECTION)
    ("BRC" . SPARSER::PROTEIN)
    ("ovarian cancer suppressor protein" . SPARSER::PROTEIN)
    ("neuronal genes" . SPARSER::GENE)
    ("which forms part" . SPARSER::COMPONENT) ("Tetracycline" . SPARSER::DRUG)
    ("HMG20b-BRCA2" . SPARSER::COLLECTION) ("BRAF35" . SPARSER::PROTEIN)
    ("R-250" . SPARSER::PROTEIN) ("P-5" . SPARSER::PROTEIN)
    ("HMG20B" . SPARSER::PROTEIN) ("4-1" . SPARSER::PROTEIN)
    ("Cep55" . SPARSER::PROTEIN) ("MKLP1" . SPARSER::PROTEIN)
    ("CEP55" . SPARSER::PROTEIN) ("HMG2" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN) ("HMG20b" . SPARSER::PROTEIN)
    ("desialylated senile platelets and the AMR" . SPARSER::COLLECTION)
    ("desialylated senile platelets" . SPARSER::PROTEIN)
    ("JAK1/2" . SPARSER::PROTEIN)
    ("The clinically used JAK1/2 inhibitor AZD1480 and JAK2 inhibitors TG101348 and BMS911543 blocked STAT3 activation"
     . SPARSER::COLLECTION)
    ("AZD1480 and JAK2" . SPARSER::COLLECTION)
    ("JAK1/2-STAT3" . SPARSER::PROTEIN-PAIR)
    ("JAK2 and IL-6R" . SPARSER::COLLECTION)
    ("an endocytic receptor" . SPARSER::RECEPTOR)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("platelets and the AMR" . SPARSER::COLLECTION)
    ("the pro-apoptotic ABT-737" . SPARSER::DRUG)
    ("RAMPS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("platelets or inAsgr2" . SPARSER::COLLECTION)
    ("JAK2 and its downstream effector" . SPARSER::COLLECTION)
    ("neuraminidase" . SPARSER::PROTEIN)
    ("AZD1480 and TG101348" . SPARSER::COLLECTION)
    ("AZD1480 or the JAK2 inhibitor TG101348" . SPARSER::COLLECTION)
    ("STAT1, STAT5A, STAT5B and STAT6" . SPARSER::COLLECTION)
    ("possible JAK2 downstream effectors" . SPARSER::EFFECTOR)
    ("polypeptides" . SPARSER::PEPTIDE)
    ("TPO and its receptor" . SPARSER::COLLECTION) ("Mpl" . SPARSER::PROTEIN)
    ("St3gal4" . SPARSER::PROTEIN) ("/Asgr2" . SPARSER::COLLECTION)
    ("galactose" . SPARSER::MOLECULE)
    ("immature platelet fraction (IPF)" . SPARSER::COMPONENT)
    ("fraction (IPF)" . SPARSER::COMPONENT) ("Asgr2" . SPARSER::PROTEIN)
    ("gal" . SPARSER::PROTEIN) ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("HL-1" . SPARSER::PROTEIN) ("Hepatocytes" . SPARSER::PROTEIN)
    ("MKs" . SPARSER::PROTEIN) ("Thrombopoietin" . SPARSER::PROTEIN)
    ("Janus kinase 2 (JAK2) and the acute phase response signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("the acute phase response signal transducer and activator of transcription 3"
     . SPARSER::PROTEIN)
    ("TPO" . SPARSER::PROTEIN) ("thrombopoietin" . SPARSER::PROTEIN)
    ("AMR" . SPARSER::RECEPTOR) ("receptor (AMR)" . SPARSER::RECEPTOR)
    ("ABT-737" . SPARSER::DRUG) ("ASGR2" . SPARSER::PROTEIN)
    ("JAK2 inhibitor TG101348" . SPARSER::DRUG) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("TG101348" . SPARSER::DRUG)
    ("AZD1480" . SPARSER::DRUG) ("CLEC4H2" . SPARSER::PROTEIN)
    ("CLEC4H1" . SPARSER::PROTEIN) ("ST3" . SPARSER::PROTEIN)
    ("sialic acid" . SPARSER::MOLECULE) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("the food preservative tBHQ" . SPARSER::DRUG)
    ("IL-2 as well as other genes" . SPARSER::COLLECTION)
    ("NFAT, AP-1, and NF-κB" . SPARSER::COLLECTION) ("ADI" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA) set" . SPARSER::COLLECTION)
    ("IFNγ and IL-2" . SPARSER::COLLECTION)
    ("NFAT, AP-1, and NFκB" . SPARSER::COLLECTION)
    ("proteins, CD25 and CD69" . SPARSER::COLLECTION)
    ("HMOX-1, NQO1, and GCLC" . SPARSER::COLLECTION)
    ("NFAT, NFκB, and AP-1" . SPARSER::COLLECTION)
    ("IL-2 and IFNγ" . SPARSER::COLLECTION)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD25 and CD69" . SPARSER::COLLECTION)
    ("IL-2 and IFN-γ" . SPARSER::COLLECTION)
    ("anti-CD3/anti-CD28" . SPARSER::COLLECTION)
    ("HMOX-1, GCLC, and NQO1" . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("RPL13A" . SPARSER::PROTEIN) ("CD3ε" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("HMOX-1" . SPARSER::PROTEIN) ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("AKT-MTORC1-RPS6KB1" . SPARSER::PROTEIN)
    ("MTOR-RPS6KB1" . SPARSER::COLLECTION)
    ("a well-characterized stress-responsive transcription factor"
     . SPARSER::PROTEIN)
    ("ARG2 and RICTOR" . SPARSER::COLLECTION)
    ("AKT, MTORC1, and RPS6KB1" . SPARSER::COLLECTION)
    ("MTORC1-RPS6KB1" . SPARSER::COLLECTION) ("polyamine" . SPARSER::MOLECULE)
    ("SMC" . SPARSER::PROTEIN)
    ("the activated T172-PRKAA as well as total PRKAA ( xref )"
     . SPARSER::COLLECTION)
    ("TP53-S15" . SPARSER::COLLECTION)
    ("AKT and RPS6KB1" . SPARSER::COLLECTION)
    ("RICTOR and ARG2" . SPARSER::COLLECTION)
    ("MTORC2-AKT-MTORC1-RPS6KB1" . SPARSER::COLLECTION)
    ("cystine" . SPARSER::MOLECULE) ("ARG" . SPARSER::PROTEIN)
    ("ARG2 and RPS6KB1" . SPARSER::COLLECTION)
    ("LC3 , ULK1, or BECN1" . SPARSER::COLLECTION)
    ("TP53 and RPS6KB1" . SPARSER::COLLECTION)
    ("HA-PRKAA1" . SPARSER::COLLECTION)
    ("TP53 or RPS6KB1" . SPARSER::COLLECTION)
    ("TP53-S15:TP53" . SPARSER::BIO-COMPLEX)
    ("TP53, RPS6KB1 and PRKAA" . SPARSER::COLLECTION)
    ("TP53, RPS6KB1, and PRKAA" . SPARSER::COLLECTION)
    ("TP53-S15/TP53" . SPARSER::COLLECTION)
    ("TP53, and MTOR" . SPARSER::COLLECTION)
    ("ARG2 or the H160F mutant" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN)
    ("a vacuolar H + -ATPase inhibitor" . SPARSER::INHIBITOR)
    ("-ATPase" . SPARSER::COLLECTION) ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOS3/eNOS" . SPARSER::COLLECTION)
    ("RPTOR (regulatory associated protein of MTOR, complex 1) and RICTOR (RPTOR independent companion of MTOR, complex 2)"
     . SPARSER::COLLECTION)
    ("PRKAA and AKT" . SPARSER::COLLECTION) ("RPTOR" . SPARSER::PROTEIN)
    ("MTORC1 and MTORC2" . SPARSER::COLLECTION)
    ("TP53/p53" . SPARSER::COLLECTION) ("ATG12–ATG5" . SPARSER::COLLECTION)
    ("nonfunctional or dysfunctional substances" . SPARSER::SUBSTANCE)
    ("substances or organelles" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("arginase" . SPARSER::PROTEIN) ("PRKAA/AMPK" . SPARSER::COLLECTION)
    ("70kDa" . SPARSER::PROTEIN) ("PRKAA" . SPARSER::PROTEIN)
    ("RICTOR" . SPARSER::PROTEIN) ("arg" . SPARSER::AMINO-ACID)
    ("apoe" . SPARSER::PROTEIN) ("-MTOR" . SPARSER::COLLECTION)
    ("MTOR" . SPARSER::PROTEIN) ("PRKAA 1" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN)
    ("Bafilomycin A 1" . SPARSER::DRUG) ("Snf1" . SPARSER::PROTEIN-FAMILY)
    ("arginase activity" . SPARSER::PROTEIN) ("S-12" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("PtdIns3K" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN) ("bafilomycin A 1" . SPARSER::DRUG)
    ("L-ornithine" . SPARSER::DRUG) ("ATG13" . SPARSER::PROTEIN)
    ("unc-51 like autophagy activating kinase 1" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("MAP1LC3" . SPARSER::PROTEIN-FAMILY) ("L -arginine" . SPARSER::MOLECULE)
    ("RPS6KB1" . SPARSER::PROTEIN) ("MTORC1" . SPARSER::PROTEIN)
    ("MTORC2" . SPARSER::PROTEIN) ("Apolipoprotein E" . SPARSER::PROTEIN)
    ("arginase 2" . SPARSER::PROTEIN) ("ARG2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor and human epidermal growth factor receptor 2 and 3 proteins"
     . SPARSER::COLLECTION)
    ("ZSTK474 and OSI-906" . SPARSER::COLLECTION)
    ("everolimus and OSI-906" . SPARSER::COLLECTION)
    ("ganitumab" . SPARSER::DRUG) ("mTORC2 and PDK1" . SPARSER::COLLECTION)
    ("IGF1R, PI3K, and IRS1" . SPARSER::COLLECTION)
    ("Akt, mTOR, and S6K1" . SPARSER::COLLECTION)
    ("Akt and S6 protein" . SPARSER::COLLECTION) ("naïve" . SPARSER::PROTEIN)
    ("OSI-906 and ZSTK474" . SPARSER::COLLECTION)
    ("OSI-906 or NVP-AEW541" . SPARSER::COLLECTION)
    ("IGF1R-TKI" . SPARSER::COLLECTION) ("p-IRS1" . SPARSER::COLLECTION)
    ("Akt and ribosomal S6 protein" . SPARSER::COLLECTION)
    ("ribosomal S6 protein" . SPARSER::PROTEIN)
    ("ZSTK474 ( r  = 0.41, P  = 0.01, Fig. xref ) and NVP-BEZ235 ( r  = 0.45, P  = 0.004, data not shown)"
     . SPARSER::COLLECTION)
    ("PI3Ki-naïve" . SPARSER::COLLECTION) ("IGF1R-TKIs" . SPARSER::COLLECTION)
    ("ZSTK474, and IGF1R" . SPARSER::COLLECTION)
    ("IGF1R and the inefficacy" . SPARSER::COLLECTION)
    ("Insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("R-2" . SPARSER::PROTEIN) ("R-1" . SPARSER::PROTEIN)
    ("NVP-AEW541" . SPARSER::DRUG) ("NVP-BEZ235" . SPARSER::DRUG)
    ("PI3Ki" . SPARSER::PROTEIN) ("class 1A" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("OSI-906" . SPARSER::DRUG)
    ("ZSTK474" . SPARSER::DRUG)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("TGFβ and Smad" . SPARSER::COLLECTION)
    ("Smad 2 and Smad3" . SPARSER::COLLECTION)
    ("TGFβ-Smad" . SPARSER::COLLECTION) ("TAK1-" . SPARSER::PROTEIN)
    ("MDA-MB 468" . SPARSER::PROTEIN)
    ("Smad and non-Smad" . SPARSER::COLLECTION)
    ("p-p38, and p-c-JunSer63" . SPARSER::COLLECTION)
    ("p-Smad2" . SPARSER::COLLECTION) ("c-Jun or TRAF6" . SPARSER::COLLECTION)
    ("this pro-invasive transcription factor" . SPARSER::PROTEIN)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("c-Jun and Snail" . SPARSER::COLLECTION)
    ("the pro-invasive transcription factor Snail1" . SPARSER::PROTEIN)
    ("neither active p38 nor c-Jun" . SPARSER::COLLECTION)
    ("p-c-Jun" . SPARSER::COLLECTION) ("p38 and c-Jun" . SPARSER::COLLECTION)
    ("p38-c-Jun" . SPARSER::COLLECTION)
    ("p38α and c-Jun" . SPARSER::COLLECTION)
    ("PI3-kinase (LY294002) or JNK (SP600125)" . SPARSER::COLLECTION)
    ("Smad3 and Smad2" . SPARSER::COLLECTION)
    ("TGFβ-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a HA-tagged dominant-negative p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-JNK" . SPARSER::COLLECTION)
    ("control siRNA as well as TRAF6 UTR siRNA" . SPARSER::COLLECTION)
    ("siRNA, or TRAF6" . SPARSER::COLLECTION)
    ("Flag-TRAF6" . SPARSER::COLLECTION)
    ("p21 and c-Jun" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("siRNA, or non-targeting" . SPARSER::COLLECTION)
    ("c-Jun and p21" . SPARSER::COLLECTION)
    ("Smad4, Smad2 or Smad3" . SPARSER::COLLECTION)
    ("c-Jun and Snail1" . SPARSER::COLLECTION)
    ("the pro-invasive gene Snail1" . SPARSER::PROTEIN)
    ("c-Jun and Smad" . SPARSER::COLLECTION)
    ("the pro-invasive Snail1" . SPARSER::PROTEIN)
    ("Jun/Fos" . SPARSER::COLLECTION) ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("an important multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("Wnt and tyrosine kinase" . SPARSER::COLLECTION)
    ("TRAF's" . SPARSER::PROTEIN-FAMILY) ("TRAFs" . SPARSER::PROTEIN)
    ("form trimeric complexes" . SPARSER::BIO-COMPLEX)
    ("a ubiquitous cytokine" . SPARSER::PROTEIN)
    ("type I and type II" . SPARSER::COLLECTION)
    ("Smad7, p21 , and c-Jun" . SPARSER::COLLECTION)
    ("a multifunctional cytokine and crucial regulator" . SPARSER::COLLECTION)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("BD 1" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-FOS" . SPARSER::PROTEIN) ("SP 600125" . SPARSER::PROTEIN)
    ("p38 α" . SPARSER::PROTEIN) ("TGFβ2" . SPARSER::PROTEIN)
    ("PAI1" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-10" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("TRAF1" . SPARSER::PROTEIN) ("TRAF 1" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad 2" . SPARSER::PROTEIN) ("R-Smads" . SPARSER::PROTEIN)
    ("TβRII" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("TβRI" . SPARSER::PROTEIN) ("particular Poloxin" . SPARSER::DRUG)
    ("camptothecin" . SPARSER::DRUG) ("BI 2536 or BI" . SPARSER::COLLECTION)
    ("Erk2 or Akt/PKB" . SPARSER::COLLECTION)
    ("various caspases and apoptotic effectors [ xref ]" . SPARSER::COLLECTION)
    ("Plk1 and cyclin B1" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::MOLECULE)
    ("53BP1/γ-H2AX" . SPARSER::COLLECTION)
    ("DNA damage markers p53-binding protein 1 (53BP1) and γ-H2AX (Ser139)"
     . SPARSER::COLLECTION)
    ("PARP as well as caspase-3" . SPARSER::COLLECTION)
    ("further studies Poloxin" . SPARSER::DRUG)
    ("Poloxin and BI 2536" . SPARSER::COLLECTION)
    ("the centromere/kinetochore marker ACA (anti-centrosome antibody) and DNA"
     . SPARSER::COLLECTION)
    ("Poloxin and BI" . SPARSER::COLLECTION)
    ("25 nM BI 2536 or 25 nM BI 6727" . SPARSER::COLLECTION)
    ("BI 2536 and BI" . SPARSER::COLLECTION)
    ("Plk4 (SAK) and Plk5 [ xref ]" . SPARSER::COLLECTION)
    ("Plk1, Plk2 (SNK), Plk3 (FNK or PRK), Plk4 (SAK) and Plk5 [ xref ]"
     . SPARSER::COLLECTION)
    ("FNK or PRK" . SPARSER::COLLECTION) ("Plk4" . SPARSER::PROTEIN)
    ("PRK" . SPARSER::PROTEIN) ("SNK" . SPARSER::PROTEIN)
    ("Plk" . SPARSER::PROTEIN) ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional p21" . SPARSER::PROTEIN) ("Poloxin" . SPARSER::DRUG)
    ("p21 Cip1/CDKN1A" . SPARSER::COLLECTION)
    ("molecules and mechanisms" . SPARSER::COLLECTION)
    ("sip21" . SPARSER::PROTEIN) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Akt/PKB" . SPARSER::PROTEIN)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("Plk5" . SPARSER::PROTEIN)
    ("Plk3" . SPARSER::PROTEIN) ("Plk2" . SPARSER::PROTEIN)
    ("Rb-Bax" . SPARSER::COLLECTION)
    ("E2F and the c-abl tyrosine kinase" . SPARSER::COLLECTION)
    ("reliable specific antibodies" . SPARSER::ANTIBODY)
    ("cdki" . SPARSER::DRUG)
    ("WT Rb or the S807E mutant" . SPARSER::COLLECTION)
    ("PNUTS and Actin" . SPARSER::COLLECTION)
    ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("the mutated amino acid" . SPARSER::AMINO-ACID)
    ("alanine and glutamic acid" . SPARSER::COLLECTION)
    ("GST-Bax" . SPARSER::COLLECTION)
    ("Bax and not the related proteins Bad, Bcl2, and Bid ( xref )"
     . SPARSER::COLLECTION)
    ("Bad, Bcl2, and Bid" . SPARSER::COLLECTION)
    ("Actin antibodies (cytoplasmic) and AIF and Bak (mitochondria-localized proteins)"
     . SPARSER::COLLECTION)
    ("AIF and Bak" . SPARSER::COLLECTION) ("Mitochondria" . SPARSER::PROTEIN)
    ("specific amino acids of Rb that must be dephosphorylated"
     . SPARSER::PROTEIN)
    ("cdks" . SPARSER::PROTEIN) ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Finally using siRNA" . SPARSER::PROTEIN) ("PNUTS" . SPARSER::PROTEIN)
    ("Bax and Rb" . SPARSER::COLLECTION) ("Rb and Bax" . SPARSER::COLLECTION)
    ("β –Actin" . SPARSER::PROTEIN) ("c-abl" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID)
    ("Glutathione-S-Transferase" . SPARSER::PROTEIN)
    ("ANP32A" . SPARSER::PROTEIN) ("pp32" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("ATM and p53" . SPARSER::COLLECTION)
    ("DMSO or Nutlin-3" . SPARSER::COLLECTION) ("BI" . SPARSER::PROTEIN)
    ("mitochondria and ROS" . SPARSER::COLLECTION)
    ("Nutlin-3 and ATMi combination treatment" . SPARSER::COLLECTION)
    ("Sestrin" . SPARSER::PROTEIN-FAMILY)
    ("TP53INP1, SESN1, or SESN2" . SPARSER::COLLECTION)
    ("cellular ROS" . SPARSER::PROTEIN)
    ("C12ORF5, TP53I3 and TP53INP1" . SPARSER::COLLECTION)
    ("C12ORF5, SESN1, SESN2, and TP53INP1" . SPARSER::COLLECTION)
    ("PIG3 (TP53I3) and TIGAR (C12ORF5)" . SPARSER::COLLECTION)
    ("TIGAR" . SPARSER::PROTEIN)
    ("both mitochondria and mitochondrial ROS" . SPARSER::COLLECTION)
    ("mitochondrial ROS" . SPARSER::PROTEIN) ("MitoSox" . SPARSER::DRUG)
    ("Ataxia" . SPARSER::PROTEIN) ("RITA and Nutlin-3" . SPARSER::COLLECTION)
    ("mitochondrial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diacetate (DCFDA)" . SPARSER::MOLECULE) ("DCFDA" . SPARSER::DRUG)
    ("diacetate" . SPARSER::MOLECULE)
    ("BID and Caspase 8" . SPARSER::COLLECTION)
    ("a control shRNA or a NOXA-targeting shRNA" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins BAX and NOXA" . SPARSER::COLLECTION)
    ("BAX and NOXA" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("the p53 target gene BAX as well as Caspase 8" . SPARSER::COLLECTION)
    ("BAX and BID" . SPARSER::COLLECTION)
    ("genome-wide shRNA" . SPARSER::PROTEIN) ("CM-H" . SPARSER::MOLECULE)
    ("s 5a" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("COX IV" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("DRAM1" . SPARSER::PROTEIN) ("pro-oxidant" . SPARSER::MOLECULE)
    ("TP53INP1" . SPARSER::PROTEIN) ("SESN2" . SPARSER::PROTEIN)
    ("SESN1" . SPARSER::PROTEIN) ("C12ORF5" . SPARSER::PROTEIN)
    ("TP53I3" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("Caspases 3" . SPARSER::PROTEIN) ("KU-55933" . SPARSER::DRUG)
    ("Caspase 8" . SPARSER::PROTEIN)
    ("new mitotic cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("top2" . SPARSER::PROTEIN) ("dynein- and RZZ" . SPARSER::COLLECTION)
    ("dynein-" . SPARSER::PROTEIN) ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a phosphomimetic mutant" . SPARSER::MUTANT)
    ("BubR1 and undetectable Mad2" . SPARSER::COLLECTION)
    ("undetectable Mad2" . SPARSER::PROTEIN) ("EHNA" . SPARSER::NUCLEOBASE)
    ("adenine
(EHNA)"
     . SPARSER::MOLECULE)
    ("GFP-ZW10" . SPARSER::COLLECTION)
    ("Bub1 and
Zwint"
     . SPARSER::COLLECTION)
    ("Dynein" . SPARSER::PROTEIN) ("ZW10 and Zwilch" . SPARSER::COLLECTION)
    ("Zwint and Knl1" . SPARSER::COLLECTION) ("Knl1" . SPARSER::PROTEIN)
    ("Zwint" . SPARSER::PROTEIN) ("BubR1 and Bub1" . SPARSER::COLLECTION)
    ("intense Bub1 and BubR1" . SPARSER::COLLECTION)
    ("Bub1 and BubR1" . SPARSER::COLLECTION)
    ("the only penetrant trigger" . SPARSER::PROTEIN)
    ("either
PKCε siRNA or a
PKCε inhibitor"
     . SPARSER::COLLECTION)
    ("RPE-1-hTERT" . SPARSER::COLLECTION)
    ("nocodazole ( xref and xref ) or monastrol ( xref and xref )"
     . SPARSER::COLLECTION)
    ("Nocodazole" . SPARSER::DRUG)
    ("Ataxia telangiectasia mutated/ATM" . SPARSER::COLLECTION)
    ("RAD3-related" . SPARSER::PROTEIN)
    ("the most
efficient siRNA"
     . SPARSER::PROTEIN)
    ("mCherry-Histone2B" . SPARSER::COLLECTION)
    ("ATM-RAD3-related" . SPARSER::PROTEIN-PAIR)
    ("ICRF193 or bleomycin" . SPARSER::COLLECTION)
    ("RPE-hTERT" . SPARSER::COLLECTION) ("Sgo-1" . SPARSER::PROTEIN)
    ("Sgo" . SPARSER::PROTEIN) ("PICH-PS" . SPARSER::COLLECTION)
    ("light and electron" . SPARSER::COLLECTION)
    ("mCherry-H2B" . SPARSER::COLLECTION) ("topoII" . SPARSER::PROTEIN)
    ("dynein and CENP-E" . SPARSER::COLLECTION) ("Zwilch" . SPARSER::PROTEIN)
    ("Rod" . SPARSER::PROTEIN)
    ("Bub1, BubR1 and
Mad2"
     . SPARSER::COLLECTION)
    ("a diffusible inhibitor" . SPARSER::INHIBITOR)
    ("Various mitotic signalling
components"
     . SPARSER::COMPONENT)
    ("cyclinB1 and securin" . SPARSER::COLLECTION)
    ("securin" . SPARSER::PROTEIN) ("separase" . SPARSER::PROTEIN)
    ("PICH" . SPARSER::PROTEIN) ("catenanes" . SPARSER::DRUG)
    ("Mad2" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("Bis-TRIS" . SPARSER::MOLECULE) ("301A" . SPARSER::PROTEIN)
    ("SB1" . SPARSER::PROTEIN)
    ("Triton
X-100"
     . SPARSER::MOLECULE)
    ("cytoplasmic 2" . SPARSER::PROTEIN) ("T-Rex" . SPARSER::PROTEIN-FAMILY)
    ("class 2" . SPARSER::PROTEIN) ("CyclinB1" . SPARSER::PROTEIN)
    ("ATPase
activity"
     . SPARSER::PROTEIN)
    ("NaPP1" . SPARSER::PROTEIN) ("Plk-1" . SPARSER::PROTEIN)
    ("RPE-1" . SPARSER::PROTEIN) ("ICRF193" . SPARSER::DRUG)
    ("cdc20" . SPARSER::PROTEIN) ("ZW10" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("methylated lysines" . SPARSER::AMINO-ACID)
    ("methyltransferases and HATs" . SPARSER::COLLECTION)
    ("residual FOXA1" . SPARSER::PROTEIN) ("FOXA1-LSD1" . SPARSER::COLLECTION)
    ("LSD1 or CoREST" . SPARSER::COLLECTION)
    ("another protein or long noncoding RNA ( xref )" . SPARSER::COLLECTION)
    ("FLAG-LSD1" . SPARSER::COLLECTION)
    ("FOXA1 and the LSD1-CoREST complex ( xref )" . SPARSER::COLLECTION)
    ("/FOXA1" . SPARSER::COLLECTION) ("LSD1 and FOXA1" . SPARSER::COLLECTION)
    ("all underwent H3K4" . SPARSER::PROTEIN)
    ("PSA , NKX3.1 , PLZF , and SGK3" . SPARSER::COLLECTION)
    ("basal (prior to DHT stimulation) H3K4" . SPARSER::PROTEIN)
    ("LSD1 and H3T6ph" . SPARSER::COLLECTION)
    ("AR and LSD1" . SPARSER::COLLECTION) ("AR/LSD1" . SPARSER::COLLECTION)
    ("possibly reflecting subsequent chromatin" . SPARSER::PROTEIN)
    ("CoREST, HDAC1, and HDAC2" . SPARSER::COLLECTION)
    ("lower basal H3K4" . SPARSER::PROTEIN)
    ("higher basal H3K4" . SPARSER::PROTEIN)
    ("-ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("H3K4 and H3K9" . SPARSER::COLLECTION) ("CREG" . SPARSER::PROTEIN)
    ("AR-regulated transcriptional enhancers" . SPARSER::PROTEIN)
    ("DNase-seq" . SPARSER::PROTEIN-PAIR) ("DNase" . SPARSER::PROTEIN)
    ("pargyline and S2101" . SPARSER::COLLECTION) ("pargyline" . SPARSER::DRUG)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("REST or NF1" . SPARSER::COLLECTION) ("/LSD1" . SPARSER::COLLECTION)
    ("AR and gene" . SPARSER::COLLECTION) ("LSD1 and AR" . SPARSER::COLLECTION)
    ("histone or nonhistone" . SPARSER::COLLECTION)
    ("cryptic" . SPARSER::PROTEIN) ("LSD1, AR and FOXA1" . SPARSER::COLLECTION)
    ("LSD1-CoREST" . SPARSER::COLLECTION)
    ("enhancer-associated H3K4" . SPARSER::PROTEIN)
    ("abiraterone (CYP17A1 inhibitor that further suppresses androgen synthesis) and enzalutamide (AR antagonist)"
     . SPARSER::COLLECTION)
    ("residual androgens" . SPARSER::DRUG)
    ("metastatic PCa" . SPARSER::PROTEIN) ("CoREST" . SPARSER::PROTEIN)
    ("Demethylase" . SPARSER::PROTEIN) ("Lysine" . SPARSER::AMINO-ACID)
    ("NKX3.1" . SPARSER::PROTEIN) ("PKCβ" . SPARSER::PROTEIN)
    ("HHLA3" . SPARSER::PROTEIN) ("HMGB2" . SPARSER::PROTEIN)
    ("KIAA0040" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("(BETA" . SPARSER::PROTEIN) ("demethylase activity" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("H3T" . SPARSER::PROTEIN)
    ("E2 or RA" . SPARSER::COLLECTION) ("RA and BAY" . SPARSER::COLLECTION)
    ("the paradigmatic RA-responsive gene cyp26A" . SPARSER::PROTEIN)
    ("IKKα and Akt" . SPARSER::COLLECTION)
    ("LSD1 and JMJD2A" . SPARSER::COLLECTION) ("cyp" . SPARSER::PROTEIN)
    ("whose cognate receptors" . SPARSER::RECEPTOR) ("RAR" . SPARSER::PROTEIN)
    ("chromatin (DPC)" . SPARSER::BIO-COMPLEX) ("DPC" . SPARSER::MOLECULE)
    ("demethylases" . SPARSER::PROTEIN) ("ERα-" . SPARSER::PROTEIN)
    ("cysteine (NAC)" . SPARSER::MOLECULE) ("E2 and BAY" . SPARSER::COLLECTION)
    ("silent IKKα" . SPARSER::PROTEIN) ("BAY11-7082 (BAY)" . SPARSER::DRUG)
    ("the paradigmatic estrogen-responsive pS2 gene" . SPARSER::GENE)
    ("NFkB-inducer" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("E2 and RA" . SPARSER::COLLECTION) ("PCD" . SPARSER::PROTEIN)
    ("chromatin and DNA" . SPARSER::COLLECTION) ("E2-" . SPARSER::MOLECULE)
    ("RARs and RXRs" . SPARSER::COLLECTION) ("RXRs" . SPARSER::PROTEIN)
    ("RARs" . SPARSER::PROTEIN) ("ERα and ERβ" . SPARSER::COLLECTION)
    ("around octameric nucleosomes" . SPARSER::PROTEIN)
    ("Eukaryotic chromatin" . SPARSER::PROTEIN)
    ("phosphoryl" . SPARSER::MOLECULE)
    ("nucleosomal histone proteins" . SPARSER::PROTEIN)
    ("H3 histone" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("LY-294002" . SPARSER::PROTEIN) ("JMJD2A" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("PI-3Ks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LSD1" . SPARSER::PROTEIN)
    ("vestigial" . SPARSER::PROTEIN-FAMILY)
    ("RpL23a and RpL34" . SPARSER::COLLECTION)
    ("immuno-blot" . SPARSER::PROTEIN-PAIR) ("RpL34" . SPARSER::PROTEIN)
    ("RpL23a" . SPARSER::PROTEIN) ("the ribosomal genes" . SPARSER::GENE)
    ("grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("disc" . SPARSER::BIO-COMPLEX)
    ("c-Jun N-terminal kinase (JNK) and Brinker (brk, the upstream kinase and activator of JNK)"
     . SPARSER::COLLECTION)
    ("kinase and activator" . SPARSER::COLLECTION) ("dpp" . SPARSER::MOLECULE)
    ("larval wing discs" . SPARSER::BIO-COMPLEX) ("JNK-" . SPARSER::PROTEIN)
    ("at least 17 genes" . SPARSER::GENE)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("Mre11 and Rad50" . SPARSER::COLLECTION)
    ("treating larval imaginal eye and wing discs" . SPARSER::BIO-COMPLEX)
    ("discs" . SPARSER::BIO-COMPLEX) ("tifia" . SPARSER::PROTEIN)
    ("Fan" . SPARSER::PROTEIN) ("p21 and decapo" . SPARSER::COLLECTION)
    ("p21 or Drosophila" . SPARSER::COLLECTION)
    ("-promoter" . SPARSER::PROMOTER)
    ("three possible protein isoforms" . SPARSER::ISOFORM)
    ("MDM2 and Arf" . SPARSER::COLLECTION) ("MDM2-" . SPARSER::PROTEIN)
    ("triple knockout MEFs" . SPARSER::PROTEIN)
    ("Arf-MDM2-p53" . SPARSER::COLLECTION)
    ("neither MDM2 nor p53" . SPARSER::COLLECTION)
    ("a zinc-inducible metallothionin promoter" . SPARSER::PROMOTER)
    ("Ink4a-Arf" . SPARSER::COLLECTION)
    ("nucleophosmin (NPM1) as well as MDM2" . SPARSER::COLLECTION)
    ("RpL3" . SPARSER::PROTEIN) ("c-Myc and RpL11" . SPARSER::COLLECTION)
    ("RpL11 and c-Myc" . SPARSER::COLLECTION) ("SL1" . SPARSER::PROTEIN)
    ("Atg8a" . SPARSER::PROTEIN)
    ("40S subunits and 80S monosomes" . SPARSER::COLLECTION)
    ("an essential scaffold component" . SPARSER::COMPONENT)
    ("Pwp2h" . SPARSER::PROTEIN) ("titania" . SPARSER::PROTEIN)
    ("pwp2h" . SPARSER::PROTEIN) ("-uridine" . SPARSER::COLLECTION)
    ("uridine" . SPARSER::PROTEIN) ("pescadillo" . SPARSER::PROTEIN)
    ("the nucleolar complex" . SPARSER::BIO-COMPLEX)
    ("cisplatinum" . SPARSER::DRUG) ("TF-1" . SPARSER::PROTEIN)
    ("E2F-1 and Rb" . SPARSER::COLLECTION)
    ("RpL11 and POLR1A" . SPARSER::COLLECTION)
    ("RB1 and POLR1A" . SPARSER::COLLECTION)
    ("p53 and POLR1A" . SPARSER::COLLECTION) ("inp53" . SPARSER::PROTEIN)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("POLR1A and TP53" . SPARSER::COLLECTION)
    ("Metazoans" . SPARSER::PROTEIN-FAMILY)
    ("different ribosomal proteins" . SPARSER::PROTEIN)
    ("Dst1" . SPARSER::PROTEIN) ("dst1" . SPARSER::PROTEIN)
    ("the large ribosomal subunit" . SPARSER::FRAGMENT)
    ("the ribosomal proteins L11" . SPARSER::PROTEIN)
    ("inosine" . SPARSER::MOLECULE) ("Pwp2" . SPARSER::PROTEIN)
    ("MBF" . SPARSER::BIO-COMPLEX) ("the mature 5.8S rRNA" . SPARSER::PROTEIN)
    ("L18, L28, L35, L37 and L40" . SPARSER::COLLECTION)
    ("nine different large subunit ribosomal proteins" . SPARSER::PROTEIN)
    ("L32–L34" . SPARSER::COLLECTION) ("S13–S15" . SPARSER::COLLECTION)
    ("Gal" . SPARSER::PROTEIN) ("p53 or MDM2" . SPARSER::COLLECTION)
    ("625 nucleolar proteins" . SPARSER::PROTEIN)
    ("Comparative siRNA" . SPARSER::PROTEIN)
    ("an ancient form" . SPARSER::FORM) ("dao" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("elegans and Drosophila" . SPARSER::COLLECTION)
    ("receptor associated protein (TTRAP)" . SPARSER::PROTEIN)
    ("TTRAP" . SPARSER::PROTEIN) ("Nestin-Cre" . SPARSER::COLLECTION)
    ("Nestin" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("Utp" . SPARSER::PROTEIN) ("methylase" . SPARSER::PROTEIN)
    ("primarily one tissue type" . SPARSER::PROTEIN)
    ("NAIC" . SPARSER::PROTEIN) ("Cirhin" . SPARSER::PROTEIN)
    ("UTPs" . SPARSER::MOLECULE) ("snoRNA" . SPARSER::RNA)
    ("the small ribosomal subunit (SSU)" . SPARSER::FRAGMENT)
    ("SSU" . SPARSER::FRAGMENT) ("PLM" . SPARSER::PROTEIN)
    ("the few active rDNA genes" . SPARSER::GENE)
    ("RecQ" . SPARSER::PROTEIN-FAMILY) ("WRN" . SPARSER::PROTEIN)
    ("MRP" . SPARSER::PROTEIN) ("SBDS and nucleophosmin" . SPARSER::COLLECTION)
    ("SBDS and the bacterial ribosome" . SPARSER::COLLECTION)
    ("the bacterial ribosome" . SPARSER::BIO-COMPLEX)
    ("SBDS" . SPARSER::PROTEIN) ("fish, Narla and Ebert" . SPARSER::COLLECTION)
    ("RpL11 or RpS19" . SPARSER::COLLECTION)
    ("leucine or arginine" . SPARSER::COLLECTION)
    ("Diamond-Blackfan anemia (DBA)" . SPARSER::PROTEIN)
    ("60S subunit ribosomal proteins RPL5, RPL11, RPL26, or RPL35A"
     . SPARSER::COLLECTION)
    ("40S subunit ribosomal proteins RPS7, RPS10, RPS17, RPS19, RPS24, or RPS26"
     . SPARSER::COLLECTION)
    ("RPS7, RPS10, RPS17, RPS19, RPS24, or RPS26" . SPARSER::COLLECTION)
    ("RPL5, RPL11, RPL26, or RPL35A" . SPARSER::COLLECTION)
    ("exogenous TERT" . SPARSER::PROTEIN) ("pseudouridine" . SPARSER::MOLECULE)
    ("40S ribosomal subunits" . SPARSER::PROTEIN) ("Nhp2" . SPARSER::PROTEIN)
    ("Nop10" . SPARSER::PROTEIN) ("less severe forms" . SPARSER::FORM)
    ("TERC" . SPARSER::PROTEIN) ("snoRNP" . SPARSER::BIO-COMPLEX)
    ("POLR1D and POLR1C" . SPARSER::COLLECTION)
    ("UBF and Pol" . SPARSER::COLLECTION)
    ("the dense fibrillar component" . SPARSER::COMPONENT)
    ("Treacher" . SPARSER::PROTEIN)
    ("craniofacial malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("gene or H4" . SPARSER::COLLECTION)
    ("Rpd3-Sin3" . SPARSER::COLLECTION)
    ("TIF-1A, SL-1, and UBF" . SPARSER::COLLECTION)
    ("4E-BP and S6 kinase" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("Cajal" . SPARSER::PROTEIN) ("hypoxia, and UV" . SPARSER::COLLECTION)
    ("Camptothecin" . SPARSER::DRUG)
    ("cisplatin and oxaliplatin" . SPARSER::COLLECTION)
    ("a somewhat centralized GC" . SPARSER::PROTEIN)
    ("mitomycin C, mitoxantrone, and doxorubicin" . SPARSER::COLLECTION)
    ("which releases nucleolar and ribosomal proteins" . SPARSER::PROTEIN)
    ("a trimeric RNP complex" . SPARSER::BIO-COMPLEX)
    ("most ribosomal proteins" . SPARSER::PROTEIN)
    ("RpL5 and RpL11" . SPARSER::COLLECTION) ("RpL5" . SPARSER::PROTEIN)
    ("these ribosomal proteins" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("the granular component" . SPARSER::COMPONENT)
    ("ubiquitin and MDM2" . SPARSER::COLLECTION)
    ("normally lack Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mature 28S rRNA" . SPARSER::PROTEIN) ("Pes1" . SPARSER::PROTEIN)
    ("another nucleolar regulator" . SPARSER::REGULATOR)
    ("Nucleostemin" . SPARSER::PROTEIN) ("Arf and NPM1" . SPARSER::COLLECTION)
    ("a nucleolar endoribonuclease" . SPARSER::PROTEIN)
    ("an abundant nucleolar protein" . SPARSER::PROTEIN)
    ("nucleolar stress releases Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Subunit" . SPARSER::FRAGMENT)
    ("Immature 40S and 60S subunits" . SPARSER::FRAGMENT)
    ("RpS3, RpS7, RpL5, RpL11, RpL23, and RpL26" . SPARSER::COLLECTION)
    ("RpL" . SPARSER::PROTEIN) ("RpS" . SPARSER::PROTEIN)
    ("the large 60S ribosomal subunit" . SPARSER::FRAGMENT)
    ("Pol III-transcribed 5S rRNAs" . SPARSER::RNA)
    ("the small 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("nucleolar chromatin" . SPARSER::PROTEIN)
    ("CDK1/Cyclin" . SPARSER::COLLECTION) ("Arg-Gly-Gly" . SPARSER::COLLECTION)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("modulating p53’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("numatrin" . SPARSER::PROTEIN) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("fibrillarin and dyskerin" . SPARSER::COLLECTION)
    ("nucleophosmin and nucleolin" . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN) ("dyskerin" . SPARSER::PROTEIN)
    ("fibrillarin" . SPARSER::PROTEIN)
    ("these nucleolar proteins" . SPARSER::PROTEIN)
    ("Approximately 250 non-ribosomal nucleolar proteins" . SPARSER::PROTEIN)
    ("the nucleolar DFC" . SPARSER::DRUG) ("endo" . SPARSER::PROTEIN)
    ("snoRNPs" . SPARSER::BIO-COMPLEX) ("Pre-rRNA" . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG) ("IB and Pol" . SPARSER::COLLECTION)
    ("UBF" . SPARSER::PROTEIN)
    ("small and large ribosomal subunits" . SPARSER::PROTEIN)
    ("the ribosomal proteins" . SPARSER::PROTEIN)
    ("Nucleolar Stress Effectors" . SPARSER::EFFECTOR)
    ("Effectors" . SPARSER::EFFECTOR) ("FC and DFC" . SPARSER::COLLECTION)
    ("the peripheral granular component (GC)" . SPARSER::COMPONENT)
    ("the dense fibrillar component (DFC)" . SPARSER::COMPONENT)
    ("DFC" . SPARSER::DRUG)
    ("human cancers lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("snRNA" . SPARSER::RNA)
    ("lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which lacks p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metazoans" . SPARSER::PROTEIN-FAMILY) ("MEI-41" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN) ("Ku80" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("p68" . SPARSER::PROTEIN) ("DDX5" . SPARSER::PROTEIN)
    ("Ink4a" . SPARSER::PROTEIN) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspases-8" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WDR12" . SPARSER::PROTEIN) ("Bop1" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("POLR1A" . SPARSER::PROTEIN)
    ("F-1" . SPARSER::PROTEIN) ("Rrs1" . SPARSER::PROTEIN)
    ("rrs1" . SPARSER::PROTEIN)
    ("ribosome biogenesis factor" . SPARSER::PROTEIN)
    ("Cdc28" . SPARSER::PROTEIN) ("Yph1" . SPARSER::PROTEIN)
    ("Nop7" . SPARSER::PROTEIN) ("L40" . SPARSER::PROTEIN)
    ("L37" . SPARSER::PROTEIN) ("L35" . SPARSER::PROTEIN)
    ("L28" . SPARSER::PROTEIN) ("L18" . SPARSER::PROTEIN)
    ("L34" . SPARSER::PROTEIN) ("L32" . SPARSER::PROTEIN)
    ("L27" . SPARSER::PROTEIN) ("L13" . SPARSER::PROTEIN)
    ("L21" . SPARSER::PROTEIN) ("L19" . SPARSER::PROTEIN)
    ("S24" . SPARSER::PROTEIN) ("S23" . SPARSER::PROTEIN)
    ("S29" . SPARSER::PROTEIN) ("S26" . SPARSER::PROTEIN)
    ("Drosophila )" . SPARSER::PROTEIN) ("CAL1" . SPARSER::PROTEIN)
    ("SYM-1" . SPARSER::PROTEIN) ("CEP-1" . SPARSER::PROTEIN)
    ("receptor associated protein" . SPARSER::PROTEIN)
    ("DJ-1" . SPARSER::PROTEIN) ("PARK7" . SPARSER::PROTEIN)
    ("EMG1" . SPARSER::PROTEIN) ("NOL11" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("RPA194" . SPARSER::PROTEIN)
    ("mitochondrial RNA" . SPARSER::RNA) ("RPS14" . SPARSER::PROTEIN)
    ("RPL35A" . SPARSER::PROTEIN) ("RPL26" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("RPS26" . SPARSER::PROTEIN) ("RPS24" . SPARSER::PROTEIN)
    ("RPS19" . SPARSER::PROTEIN) ("RPS17" . SPARSER::PROTEIN)
    ("RPS10" . SPARSER::PROTEIN) ("RPS7" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia" . SPARSER::PROTEIN)
    ("X -linked" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA) ("DKC1" . SPARSER::PROTEIN)
    ("POLR1C" . SPARSER::PROTEIN) ("POLR1D" . SPARSER::PROTEIN)
    ("Nopp140" . SPARSER::PROTEIN) ("Tcof1" . SPARSER::PROTEIN)
    ("rpd3" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("elongation factor 2" . SPARSER::PROTEIN) ("TIF-1A" . SPARSER::PROTEIN)
    ("von Hippel-Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("thymidylate synthetase" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("rpL11" . SPARSER::PROTEIN)
    ("RpS6" . SPARSER::PROTEIN) ("GNL3L" . SPARSER::PROTEIN)
    ("NS1" . SPARSER::PROTEIN) ("GNL3" . SPARSER::PROTEIN)
    ("EBP2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DDX21" . SPARSER::PROTEIN)
    ("p14 Arf" . SPARSER::PROTEIN) ("p19 Arf" . SPARSER::PROTEIN)
    ("Upstream Binding Factor" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("NMD3" . SPARSER::PROTEIN) ("RpL11" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("NO38" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("Cbf5" . SPARSER::PROTEIN) ("methyl-transferase" . SPARSER::PROTEIN)
    ("PAF53" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("TIF-IA" . SPARSER::PROTEIN) ("SL-1" . SPARSER::PROTEIN)
    ("upstream binding factor" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("RNA polymerase I" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN)
    ("RFPL3 and RFP" . SPARSER::COLLECTION)
    ("the trimeric transcription factor NF-Y" . SPARSER::PROTEIN)
    ("carcinogenic genes COX-2 and hTERT" . SPARSER::COLLECTION)
    ("COX-2 and hTERT" . SPARSER::COLLECTION)
    ("carcinogenic genes promoter" . SPARSER::PROMOTER)
    ("carcinogenic genes" . SPARSER::GENE)
    ("protein and hTERT" . SPARSER::COLLECTION)
    ("RFPL3 and AP-2" . SPARSER::COLLECTION)
    ("-biotinylated 438-bp hTERT core promoter DNA" . SPARSER::DNA)
    ("Pulldown" . SPARSER::PROTEIN)
    ("carcinogenic genes COX-2" . SPARSER::PROTEIN)
    ("targetable driver oncogenes" . SPARSER::ONCOGENE)
    ("RFPL3 and hTERT" . SPARSER::COLLECTION)
    ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("Telomerase activity" . SPARSER::PROTEIN) ("3-2" . SPARSER::PROTEIN)
    ("Pax6" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("TBP-2" . SPARSER::PROTEIN) ("AP-2β" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN) ("streptavidin–agarose" . SPARSER::DRUG)
    ("RFPL1" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("RFPL3" . SPARSER::PROTEIN) ("RANTES and IP10" . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN) ("Biomarkers" . SPARSER::MOLECULE)
    ("PD-1/SHP-2" . SPARSER::COLLECTION)
    ("IL-4 and IL-5" . SPARSER::COLLECTION)
    ("IFN-γ, IL-2 and TNF-α" . SPARSER::COLLECTION)
    ("IFN-γ, IL-2, TNF-α, IL-6 and IL-17" . SPARSER::COLLECTION)
    ("IL-4, IL-10 and TGF-β" . SPARSER::COLLECTION) ("NKT" . SPARSER::PROTEIN)
    ("anti-PD-1/PD-L1" . SPARSER::COLLECTION)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("PD-1 and CTLA-4" . SPARSER::COLLECTION)
    ("TGF-β and IL-10" . SPARSER::COLLECTION)
    ("significantly more PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF-α (data not shown) and IL-2" . SPARSER::COLLECTION)
    ("p-STAT1/T-bet" . SPARSER::COLLECTION) ("fusaruside" . SPARSER::DRUG)
    ("PD-1 and IFN-γ" . SPARSER::COLLECTION)
    ("TNF-α (data not shown) and IL-2 (p=0.02, p=0.04)" . SPARSER::COLLECTION)
    ("the Th1 cytokines IFN-γ (p=0.008), TNF-α (data not shown) and IL-2 (p=0.02, p=0.04)"
     . SPARSER::COLLECTION)
    ("polyvalent PD-L1" . SPARSER::PROTEIN)
    ("highly expressed PD-1 showed lower p-STAT1" . SPARSER::COLLECTION)
    ("anti-CD3/-CD28/PD-L1" . SPARSER::COLLECTION)
    ("T-bet and p-S6" . SPARSER::COLLECTION) ("Foxp3-" . SPARSER::PROTEIN)
    ("slightly higher T-bet" . SPARSER::PROTEIN)
    ("perforin" . SPARSER::PROTEIN) ("p-STAT4" . SPARSER::COLLECTION)
    ("p-STAT1" . SPARSER::COLLECTION)
    ("the T cell receptor (TCR) and CD28" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR/p-S6" . SPARSER::COLLECTION)
    ("PD-1/SHP-2/p-STAT1/T-bet" . SPARSER::COLLECTION)
    ("PD-1 and type 1" . SPARSER::COLLECTION)
    ("PD-1/PD-L1" . SPARSER::COLLECTION)
    ("STAT1, T-bet and STAT4" . SPARSER::COLLECTION)
    ("IFN-γ and IL-12, STAT1 and STAT4" . SPARSER::COLLECTION)
    ("IL-12, STAT1 and STAT4" . SPARSER::COLLECTION)
    ("Tbx21" . SPARSER::PROTEIN) ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("CTLA-4 antagonistic mAb" . SPARSER::DRUG)
    ("CTLA-4, PD-1, BTLA and LAG-3" . SPARSER::COLLECTION)
    ("BTLA" . SPARSER::PROTEIN) ("PD-1 or SHP-2" . SPARSER::COLLECTION)
    ("PD-1/SHP-2/STAT1/T-bet" . SPARSER::COLLECTION)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("IP10" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("Foxp3" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("SH-PTP2" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("LAG-3" . SPARSER::PROTEIN) ("T-bet" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("PD-L1" . SPARSER::PROTEIN)
    ("Tc1" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TUSC4 or BRCA1" . SPARSER::COLLECTION)
    ("PDK1 and its co-activator Src ( xref )" . SPARSER::COLLECTION)
    ("BRCA1 and its identified E3 ligase Herc2" . SPARSER::COLLECTION)
    ("TUSC4 and BRCA1" . SPARSER::COLLECTION)
    ("that BRCA1's" . SPARSER::PROTEIN)
    ("Olaparib and Rucaparib" . SPARSER::COLLECTION)
    ("Rucaparib" . SPARSER::DRUG) ("Herc2 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 and Herc2" . SPARSER::COLLECTION)
    ("TUSC4, BRCA1, and Herc2" . SPARSER::COLLECTION)
    ("control IgG or an anti-BRCA1 antibody" . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("G2/M-" . SPARSER::PROTEIN) ("IR and UV" . SPARSER::COLLECTION)
    ("a bona fide tumor suppressor gene" . SPARSER::PROTEIN)
    ("BRCA1 and foci" . SPARSER::COLLECTION) ("permease" . SPARSER::PROTEIN)
    ("Herc2" . SPARSER::PROTEIN) ("Herc" . SPARSER::PROTEIN)
    ("TUSC4" . SPARSER::PROTEIN) ("E2F and c-Jun" . SPARSER::COLLECTION)
    ("c-Src and p85" . SPARSER::COLLECTION)
    ("poor prognostic biomarkers" . SPARSER::MOLECULE)
    ("volasertib or siRNA" . SPARSER::COLLECTION)
    ("PLK1 and PLK3" . SPARSER::COLLECTION)
    ("PLK2 (5 nM) and PLK3 (56 nM)" . SPARSER::COLLECTION)
    ("PLK1 (0.87 nM), PLK2 (5 nM) and PLK3 (56 nM)" . SPARSER::COLLECTION)
    ("PLK1, PLK2 and PLK3" . SPARSER::COLLECTION)
    ("tumor suppressive genes" . SPARSER::GENE) ("JUNB" . SPARSER::PROTEIN)
    ("anti-apoptotic genes (BCL-xL) and components of the AP-1 (JUNB) transcription complex ( xref )"
     . SPARSER::COLLECTION)
    ("AR and ERβ" . SPARSER::COLLECTION)
    ("androgen receptor (AR) and estrogen receptor beta (ERβ)"
     . SPARSER::COLLECTION)
    ("FOXM1 and PLK1" . SPARSER::COLLECTION)
    ("Ki67 and PLK1" . SPARSER::COLLECTION)
    ("FOXM1-EE" . SPARSER::PROTEIN-PAIR)
    ("PLK1 and FOXM1" . SPARSER::COLLECTION)
    ("ER, BCL-xL and JUNB" . SPARSER::COLLECTION)
    ("BCL-xL, and JUNB" . SPARSER::COLLECTION)
    ("84 ER-associated genes" . SPARSER::GENE)
    ("volasertib and PLK1" . SPARSER::COLLECTION)
    ("parental MCF7 and estrogen-independent MCF7/LTEDs" . SPARSER::COLLECTION)
    ("BCL-xL and JUNB" . SPARSER::COLLECTION)
    ("volasertib and fulvestrant" . SPARSER::COLLECTION)
    ("fulvestrant or volasertib" . SPARSER::COLLECTION)
    ("fulvestrant or the combination" . SPARSER::COLLECTION)
    ("fulvestrant and volasertib" . SPARSER::COLLECTION)
    ("PARP and phospho-Histone H2AX" . SPARSER::COLLECTION)
    ("MCF7 and MCF7/LTED" . SPARSER::COLLECTION)
    ("volasertib and the ER antagonist fulvestrant" . SPARSER::COLLECTION)
    ("BI2536 and volasertib" . SPARSER::COLLECTION)
    ("PLK1 and ER" . SPARSER::COLLECTION)
    ("SMAD, E-cadherin and ERBB3" . SPARSER::COLLECTION)
    ("Peak5-Luc" . SPARSER::COLLECTION)
    ("luciferase and renilla" . SPARSER::COLLECTION)
    ("Peak2 and Peak5" . SPARSER::COLLECTION)
    ("siRNA or fulvestrant" . SPARSER::COLLECTION)
    ("PR and TFF1" . SPARSER::COLLECTION)
    ("Trefoil factor 1 (TFF1) and growth regulation by estrogen in breast cancer 1 (GREB1; xref )"
     . SPARSER::COLLECTION)
    ("MERE-Luciferase" . SPARSER::COLLECTION) ("antiestrogen" . SPARSER::DRUG)
    ("HER2−" . SPARSER::PROTEIN) ("RPS6KA2 and GSG2" . SPARSER::COLLECTION)
    ("MERE-luc" . SPARSER::COLLECTION) ("MERE" . SPARSER::PROTEIN-FAMILY)
    ("renilla-luciferase" . SPARSER::COLLECTION)
    ("PLK2 and PLK3" . SPARSER::COLLECTION) ("PLKs" . SPARSER::PROTEIN)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("targetable molecules" . SPARSER::MOLECULE) ("AIs" . SPARSER::PROTEIN)
    ("inhibitors (AI)" . SPARSER::INHIBITOR)
    ("tamoxifen, fulvestrant and aromatase" . SPARSER::COLLECTION)
    ("anastrozole and letrozole" . SPARSER::COLLECTION)
    ("anastrozole" . SPARSER::DRUG) ("AI" . SPARSER::PROTEIN)
    ("Volasertib" . SPARSER::DRUG) ("volasertib" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("antiestrogens" . SPARSER::DRUG)
    ("phosphoinositide 3- kinase" . SPARSER::PROTEIN)
    ("Crk-associated substrate" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("AP-I" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("BCAR1" . SPARSER::PROTEIN) ("Histone H2AX" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("growth regulation by estrogen in breast cancer 1" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("Trefoil factor 1" . SPARSER::PROTEIN)
    ("Peak5" . SPARSER::PROTEIN) ("Peak2" . SPARSER::PROTEIN)
    ("RPS6KA2" . SPARSER::PROTEIN) ("GSG2" . SPARSER::PROTEIN)
    ("BCL-xL" . SPARSER::PROTEIN) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("prognostically relevant biomarkers" . SPARSER::MOLECULE)
    ("VEGF and endoglin" . SPARSER::COLLECTION) ("endoglin" . SPARSER::PROTEIN)
    ("other prognostic biomarkers" . SPARSER::MOLECULE)
    ("CD79b and CARD11" . SPARSER::COLLECTION)
    ("at least two tumor suppressor genes" . SPARSER::GENE)
    ("PRDM1 and TNFAIP3" . SPARSER::COLLECTION)
    ("a prognostic or theranostic biomarker" . SPARSER::MOLECULE)
    ("the International Extranodal Lymphoma Study Group" . SPARSER::MOLECULE)
    ("MYC-" . SPARSER::PROTEIN) ("MUM1/IRF4" . SPARSER::COLLECTION)
    ("informative FISH" . SPARSER::PROTEIN)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("successful FISH" . SPARSER::PROTEIN)
    ("MYC and BCL2" . SPARSER::COLLECTION) ("IRF4-" . SPARSER::PROTEIN)
    ("CD10-" . SPARSER::PROTEIN) ("rituximab" . SPARSER::DRUG)
    ("CSF" . SPARSER::PROTEIN)
    ("MYC and MYC-induced genes" . SPARSER::COLLECTION)
    ("oncogene, and deregulation" . SPARSER::COLLECTION)
    ("MYC/BCL2" . SPARSER::COLLECTION) ("CARD11" . SPARSER::PROTEIN)
    ("CD79b" . SPARSER::PROTEIN) ("TBL1XR1" . SPARSER::PROTEIN)
    ("MYD88" . SPARSER::PROTEIN) ("PRDM1" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN) ("MUM1" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("HER2 negative primary GC" . SPARSER::PROTEIN)
    ("neo" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("discordant and concordant GC" . SPARSER::PROTEIN)
    ("18 (17%) primary GC" . SPARSER::PROTEIN)
    ("N2 and N3" . SPARSER::COLLECTION) ("intestinal type" . TYPE)
    ("primary and metastatic GC" . SPARSER::PROTEIN)
    ("the primary GC" . SPARSER::PROTEIN) ("primary GC" . SPARSER::PROTEIN)
    ("primary GCs" . SPARSER::PROTEIN) ("pre-HCC" . SPARSER::COLLECTION)
    ("exogenous p53 or small peptides" . SPARSER::COLLECTION)
    ("exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ribosomal proteins" . SPARSER::PROTEIN)
    ("RP-MDM2-p53" . SPARSER::COLLECTION) ("HLI" . SPARSER::MOLECULE)
    ("antisense anti-MDM2 oligonucleotide and the in vivo antitumor activity"
     . SPARSER::COLLECTION)
    ("synthetic peptides or monoclonal antibodies" . SPARSER::COLLECTION)
    ("exogenous WT p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous therapeutic WT p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("high pathologic grade HCC" . SPARSER::PROTEIN)
    ("a low pathologic grade HCC" . SPARSER::PROTEIN)
    ("dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iron-responsive element-binding proteins" . SPARSER::PROTEIN)
    ("IRPs" . SPARSER::PROTEIN) ("SRF" . SPARSER::PROTEIN)
    ("HBx" . SPARSER::PROTEIN)
    ("several ribosomal proteins" . SPARSER::PROTEIN)
    ("RPs" . SPARSER::PROTEIN)
    ("the intronic p53-responsive promoter" . SPARSER::PROMOTER)
    ("polymorphism (SNP)" . SPARSER::PROTEIN) ("gankyrin" . SPARSER::PROTEIN)
    ("p53R172H" . SPARSER::PROTEIN) ("p53 R172H" . SPARSER::PROTEIN)
    ("the sequence-specific response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("target and negative regulator" . SPARSER::COLLECTION)
    ("L11" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("Sirt3" . SPARSER::PROTEIN) ("ING1" . SPARSER::PROTEIN)
    ("PRL-1" . SPARSER::PROTEIN) ("serum response factor" . SPARSER::PROTEIN)
    ("C2H2" . SPARSER::MOLECULE) ("KLF6" . SPARSER::PROTEIN)
    ("SNP 309" . SPARSER::PROTEIN) ("p19Arf" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN)
    ("IFN- γ and rapamycin" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("CCL2 and GBP1" . SPARSER::COLLECTION)
    ("TSC2/mTORC1" . SPARSER::COLLECTION)
    ("IRF7, β -tubulin and PARP" . SPARSER::COLLECTION)
    ("rapamycin and re-expression" . SPARSER::COLLECTION)
    ("TRIzol" . SPARSER::DRUG)
    ("FTS, rapamycin and TSC2" . SPARSER::COLLECTION)
    ("Rheb or pS6K" . SPARSER::COLLECTION)
    ("Rheb and pS6K" . SPARSER::COLLECTION)
    ("Rheb or Ras-GTP" . SPARSER::COLLECTION)
    ("active Ras-GTP and total Ras" . SPARSER::COLLECTION)
    ("Rheb and its downstream target S6K (p-T389)" . SPARSER::COLLECTION)
    ("Rheb and the downstream Rheb target pS6K" . SPARSER::COLLECTION)
    ("Ras, Rheb and the downstream Rheb target pS6K" . SPARSER::COLLECTION)
    ("75  μ M FTS or 10 nM rapamycin" . SPARSER::COLLECTION)
    ("75  μ M FTS and 5 nM rapamycin" . SPARSER::COLLECTION)
    ("FTS and rapamycin" . SPARSER::COLLECTION)
    ("Rheb/mTORC1" . SPARSER::COLLECTION) ("IRFs" . SPARSER::PROTEIN)
    ("Interferon" . SPARSER::PROTEIN) ("Sirolimus" . SPARSER::DRUG)
    ("COOH" . SPARSER::MOLECULE) ("FTS or rapamycin" . SPARSER::COLLECTION)
    ("Rheb/mTOR" . SPARSER::COLLECTION) ("salirasib" . SPARSER::DRUG)
    ("FTS" . SPARSER::PROTEIN) ("sirolimus" . SPARSER::DRUG)
    ("Rheb/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("HES6" . SPARSER::PROTEIN) ("IFITM1" . SPARSER::PROTEIN)
    ("IFIT2" . SPARSER::PROTEIN) ("GBP2" . SPARSER::PROTEIN)
    ("RSAD2" . SPARSER::PROTEIN) ("GENE1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFN- γ" . SPARSER::PROTEIN) ("IFN- β" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("β -Tubulin" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("IFN α" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("IRF9" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("IRF family" . SPARSER::PROTEIN)
    ("TNFR1, Fas, or DR5" . SPARSER::COLLECTION)
    ("TNFR1 and DR5" . SPARSER::COLLECTION)
    ("IRE1 and RIPK1" . SPARSER::COLLECTION)
    ("IRE1 and TNFR1" . SPARSER::COLLECTION)
    ("RIPK1 and IRE1" . SPARSER::COLLECTION)
    ("IRE1 or RIPK1" . SPARSER::COLLECTION)
    ("IRE1, RIPK1, and TNFR1" . SPARSER::COLLECTION)
    ("TNFR1 and RIPK1" . SPARSER::COLLECTION) ("Ire1" . SPARSER::PROTEIN)
    ("the classical death receptors TNFR1, FAS, and DR5" . SPARSER::COLLECTION)
    ("exogenous agonists" . SPARSER::AGONIST)
    ("caspase-8 or -3" . SPARSER::COLLECTION) ("Dr5" . SPARSER::PROTEIN)
    ("Tnfr" . SPARSER::PROTEIN) ("TNFR1, FAS, and DR5" . SPARSER::COLLECTION)
    ("their respective ligands" . SPARSER::LIGAND)
    ("caspase-8 and -3" . SPARSER::COLLECTION)
    ("TNF or TRAIL" . SPARSER::COLLECTION)
    ("RIPK1-caspase-8" . SPARSER::COLLECTION)
    ("caspase-8 and RIPK1" . SPARSER::COLLECTION)
    ("the primarily initiator caspase" . SPARSER::PROTEIN)
    ("RIPK1 and caspase-8" . SPARSER::COLLECTION)
    ("Ripk1 and caspase-8" . SPARSER::COLLECTION)
    ("tunicamycin-" . SPARSER::MOLECULE)
    ("caspase-9, -3 and PARP" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("Xbp-1" . SPARSER::PROTEIN)
    ("tunicamycin or thapsigargin" . SPARSER::COLLECTION)
    ("TNF or IL-1 β" . SPARSER::COLLECTION)
    ("RIPK1, and cIAP1/2" . SPARSER::COLLECTION) ("TNFRs" . SPARSER::PROTEIN)
    ("Nec1" . SPARSER::PROTEIN) ("Doxycycline" . SPARSER::DRUG)
    ("doxycyclin" . SPARSER::MOLECULE)
    ("inducers, thapsigargin and brefeldin A" . SPARSER::COLLECTION)
    ("caspase-9 and -3" . SPARSER::COLLECTION)
    ("TNFR and Toll-like" . SPARSER::COLLECTION)
    ("kinase and endoribonuclease" . SPARSER::COLLECTION)
    ("PERK and ATF6" . SPARSER::COLLECTION)
    ("Bcl-2, Bim, Puma, and Bax" . SPARSER::COLLECTION)
    ("JNK or CHOP" . SPARSER::COLLECTION) ("which aims" . SPARSER::PROTEIN)
    ("Z-VAD-fmk" . SPARSER::DRUG) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("Bap31" . SPARSER::PROTEIN) ("BAP31" . SPARSER::PROTEIN)
    ("death receptor 5" . SPARSER::PROTEIN)
    ("TNFR superfamily" . SPARSER::PROTEIN) ("IL-1 β" . SPARSER::PROTEIN)
    ("BV6" . SPARSER::MOLECULE)
    ("transforming growth factor-beta-activated kinase 1" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("NF- κ B" . SPARSER::PROTEIN)
    ("regulated kinase 1" . SPARSER::PROTEIN) ("caspase-2" . SPARSER::PROTEIN)
    ("C/EBP-homologous protein" . SPARSER::PROTEIN)
    ("inositol-requiring protein 1" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("Ripk1" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN)
    ("a potentially useful drug target and resistance biomarker"
     . SPARSER::COLLECTION)
    ("CK2—p-XRCC1—XRCC1" . SPARSER::COLLECTION)
    ("p-XRCC1" . SPARSER::COLLECTION)
    ("CK2 α and P-XRCC1" . SPARSER::COLLECTION)
    ("GFP-XRCC1" . SPARSER::COLLECTION) ("MEK-ERK1/2" . SPARSER::COLLECTION)
    ("PARP1 and γ H2AX" . SPARSER::COLLECTION)
    ("As 2 O 3 and VP16" . SPARSER::COLLECTION)
    ("flag-JWA" . SPARSER::COLLECTION) ("XRCC1 or JWA" . SPARSER::COLLECTION)
    ("CK2—p-XRCC1" . SPARSER::COLLECTION)
    ("JWA or XRCC1" . SPARSER::COLLECTION)
    ("JWA and XRCC1" . SPARSER::COLLECTION) ("CX" . SPARSER::PROTEIN-FAMILY)
    ("a widely used chemotherapeutic drug" . SPARSER::DRUG)
    ("gastric epithelial cells GES-1" . SPARSER::PROTEIN)
    ("DDP" . SPARSER::PROTEIN) ("JWA" . SPARSER::PROTEIN)
    ("ERk1/2" . SPARSER::PROTEIN) ("Ck2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK2 α" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("γ H2AX" . SPARSER::PROTEIN) ("ARL6ip5" . SPARSER::PROTEIN)
    ("EHT1864 or
Rac"
     . SPARSER::COLLECTION)
    ("Rac1 and DYRK
1B"
     . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION)
    ("effectors or scaffolds" . SPARSER::COLLECTION)
    ("Casodex" . SPARSER::DRUG) ("Src and Ras" . SPARSER::COLLECTION)
    ("Ras-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FlnA and integrin" . SPARSER::COLLECTION)
    ("DYRK 1B ( xref ) or Rac ( xref )" . SPARSER::COLLECTION)
    ("Rac/DYRK 1B" . SPARSER::COLLECTION)
    ("DYRK
1B and p27"
     . SPARSER::COLLECTION)
    ("DYRK" . SPARSER::PROTEIN) ("DYRKs" . SPARSER::PROTEIN)
    ("p27, wt or S10A" . SPARSER::COLLECTION) ("bright" . SPARSER::PROTEIN)
    ("the human wild-type p27 (wt p27) or a mutant" . SPARSER::COLLECTION)
    ("wt or S10A" . SPARSER::COLLECTION)
    ("neither estradiol nor the synthetic progestin R5020"
     . SPARSER::COLLECTION)
    ("estradiol or progesterone receptor" . SPARSER::COLLECTION)
    ("ER or
PgR"
     . SPARSER::COLLECTION)
    ("PgR" . SPARSER::PROTEIN) ("MEFs, MFs and HT1080" . SPARSER::COLLECTION)
    ("MFs" . SPARSER::PROTEIN) ("FlnA/Rac/DYRK 1B" . SPARSER::COLLECTION)
    ("AR/FlnA/Rac/DYRK 1B" . SPARSER::COLLECTION)
    ("Androgen/AR" . SPARSER::COLLECTION) ("AR/FlnA" . SPARSER::COLLECTION)
    ("a transcriptionally incompetent
AR"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and filamin" . SPARSER::COLLECTION) ("Androgens" . SPARSER::DRUG)
    ("AR/filamin" . SPARSER::COLLECTION)
    ("Rac and its downstream effector DYRK 1B" . SPARSER::COLLECTION)
    ("myelin
basic protein"
     . SPARSER::PROTEIN)
    ("P-Thr" . SPARSER::PROTEIN) ("c-22" . SPARSER::PROTEIN)
    ("CDK-4" . SPARSER::PROTEIN) ("tert-butyl" . SPARSER::MOLECULE)
    ("fluorescein
isothiocyanate"
     . SPARSER::MOLECULE)
    ("serum
albumin"
     . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("β 1" . SPARSER::PROTEIN)
    ("amino
acid"
     . SPARSER::AMINO-ACID)
    ("DYRK
1B"
     . SPARSER::PROTEIN)
    ("EHT1864" . SPARSER::DRUG) ("myelin basic protein" . SPARSER::PROTEIN)
    ("p27S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DYRK 1B" . SPARSER::PROTEIN)
    ("ubiquitin ligase and regulator" . SPARSER::COLLECTION)
    ("NCOA4 and ferritin" . SPARSER::COLLECTION)
    ("an autophagic cargo receptor" . SPARSER::RECEPTOR)
    ("ferritin–HERC2" . SPARSER::COLLECTION) ("Iron" . SPARSER::MOLECULE)
    ("HERC2 and E6AP" . SPARSER::COLLECTION)
    ("eIF4, prefoldin and mTORC1" . SPARSER::COLLECTION)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("actin and tubulin" . SPARSER::COLLECTION)
    ("eIF3
and prefoldin"
     . SPARSER::COLLECTION)
    ("prefoldins" . SPARSER::PROTEIN-FAMILY)
    ("Prefoldins" . SPARSER::PROTEIN-FAMILY)
    ("the eIF4 complex subunit G1" . SPARSER::PROTEIN)
    ("eIF4" . SPARSER::PROTEIN) ("prefoldin" . SPARSER::PROTEIN-FAMILY)
    ("HCIPs" . SPARSER::PROTEIN) ("HCIP" . SPARSER::PROTEIN)
    ("HERC2-HCIP" . SPARSER::PROTEIN-PAIR)
    ("the PhK catalytic subunit PHKG2
and the DNA repair endonuclease component MUS81"
     . SPARSER::COLLECTION)
    ("PHKB and EME1" . SPARSER::COLLECTION)
    ("FDFT1
and PHKB"
     . SPARSER::COLLECTION)
    ("relatively few proteins" . SPARSER::PROTEIN)
    ("lipid and glucose metabolism" . SPARSER::COLLECTION)
    ("AURKB
and PRKAR2B"
     . SPARSER::COLLECTION)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("structure-specific DNA" . SPARSER::DNA)
    ("a heterodimeric endonuclease complex" . SPARSER::BIO-COMPLEX)
    ("HERC2 and EIF3E" . SPARSER::COLLECTION)
    ("HERC2 and eIF3" . SPARSER::COLLECTION)
    ("PHKB and PHKG2" . SPARSER::COLLECTION) ("PhK" . SPARSER::PROTEIN)
    ("HERC2 and FTH1/FTL" . SPARSER::COLLECTION)
    ("FTH1/FTL" . SPARSER::COLLECTION) ("ferritin" . SPARSER::PROTEIN)
    ("HERC2 and BICD2, ZYFVE9 and KIF20A" . SPARSER::COLLECTION)
    ("BICD2, ZYFVE9 and KIF20A" . SPARSER::COLLECTION)
    ("paralogue" . SPARSER::PROTEIN)
    ("ZFYVE9 and KIF20A" . SPARSER::COLLECTION)
    ("BICD2 and ZFYVE9" . SPARSER::COLLECTION)
    ("The mitotic kinesin KIF20A" . SPARSER::PROTEIN)
    ("HERC2-ZFYVE9" . SPARSER::COLLECTION)
    ("the cellular transport
adaptor BICD2
and the endosomal protein ZFYVE9"
     . SPARSER::COLLECTION)
    ("HA-GFP" . SPARSER::COLLECTION)
    ("glycogen, and fatty
acid"
     . SPARSER::COLLECTION)
    ("the components of the glycogen
regulator phosphorylase kinase (PHKA1, PHKA2, PHKB, PHKG2) and the
establishment"
     . SPARSER::COLLECTION)
    ("FTH1 and FTL" . SPARSER::COLLECTION)
    ("PIK3R1 and
ENPP1"
     . SPARSER::COLLECTION)
    ("the previously unlinked
genes"
     . SPARSER::GENE)
    ("CALCA and FTH1" . SPARSER::COLLECTION) ("CALCA" . SPARSER::PROTEIN)
    ("vesicle-mediated transport-related GO BP" . SPARSER::PROTEIN)
    ("regulators and substrates" . SPARSER::COLLECTION)
    ("XPOT" . SPARSER::PROTEIN) ("RNGTT" . SPARSER::PROTEIN)
    ("ARAF" . SPARSER::PROTEIN) ("LRPPRC" . SPARSER::PROTEIN)
    ("TXLNG" . SPARSER::PROTEIN) ("FLII" . SPARSER::PROTEIN)
    ("the zinc finger and FYVE domain-containing
protein ZFYVE9 (also known as SARA)"
     . SPARSER::COLLECTION)
    ("BICD1 and BICD2" . SPARSER::COLLECTION) ("SARA" . SPARSER::PROTEIN)
    ("the centrosomal protein CEP170" . SPARSER::PROTEIN)
    ("metallochaperone" . SPARSER::PROTEIN)
    ("COPA, COPB1, COPB2, COPE, COPG1, COPG2, and COPZ1" . SPARSER::COLLECTION)
    ("COPA" . SPARSER::PROTEIN) ("pulldown and CompPASS" . SPARSER::COLLECTION)
    ("The mitochondrial antiviral signaling protein (MAVS)" . SPARSER::PROTEIN)
    ("protein (MAVS)" . SPARSER::PROTEIN)
    ("HLA-C
and HLA-E"
     . SPARSER::COLLECTION)
    ("MAVS" . SPARSER::PROTEIN) ("SPTLC2 and ASAH1" . SPARSER::COLLECTION)
    ("enzyme and cathepsin A" . SPARSER::COLLECTION)
    ("CTSA" . SPARSER::PROTEIN) ("sphingolipid" . SPARSER::MOLECULE)
    ("structure-specific
DNA"
     . SPARSER::DNA)
    ("EME1 and MUS81" . SPARSER::COLLECTION)
    ("endonuclease" . SPARSER::PROTEIN)
    ("RAB6A and RAB6B" . SPARSER::COLLECTION)
    ("approximately 1000 amino acids" . SPARSER::AMINO-ACID)
    ("ASW" . SPARSER::PROTEIN) ("HA-EIF3E" . SPARSER::COLLECTION)
    ("Secondary antibodies" . SPARSER::ANTIBODY)
    ("secondary antibody" . SPARSER::PROTEIN)
    ("HERC2 (BD Transduction
Laboratories, 1 μg/mL, mouse) and HA (Abcam, 2 μg/mL,
rabbit)"
     . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN)
    ("biological
knowledge-based HERC2"
     . SPARSER::PROTEIN)
    ("using Western Lightning chemiluminescent substrate" . SPARSER::SUBSTRATE)
    ("MR" . SPARSER::PROTEIN)
    ("HRP-conjugated
antimouse or antirabbit secondary antibodies"
     . SPARSER::ANTIBODY)
    ("HA-HRP" . SPARSER::COLLECTION) ("pulldowns" . SPARSER::PROTEIN)
    ("stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("human (UniProt release
2011_05) tryptic peptides"
     . SPARSER::PEPTIDE)
    ("LTQ" . SPARSER::MOLECULE) ("trypsinized" . SPARSER::PROTEIN)
    ("Blasticidin" . SPARSER::MOLECULE) ("PHKB" . SPARSER::PROTEIN)
    ("FTL" . SPARSER::PROTEIN) ("COPE" . SPARSER::PROTEIN)
    ("AURKB" . SPARSER::PROTEIN) ("HERC2-F3" . SPARSER::COLLECTION)
    ("a tetracycline
regulatable promoter"
     . SPARSER::PROMOTER)
    ("TOPO" . SPARSER::PROTEIN)
    ("-AGTGTCCTGTTAAATAATCTTG-3" . SPARSER::COLLECTION)
    ("-CAACCGCATCCAGGTCAAACG-3" . SPARSER::COLLECTION)
    ("-ACAGGGGCGTGAGTCCG-3" . SPARSER::COLLECTION)
    ("-CGTAGACCTGCTCAAGC-3" . SPARSER::COLLECTION)
    ("-ATGTGGCCACATCCTCCAACTCGG-3" . SPARSER::COLLECTION)
    ("-CGATGGATTGCATGATCTCAATGTGC-3" . SPARSER::COLLECTION)
    ("-AGGGTACCAACTCCATTTC-3" . SPARSER::COLLECTION)
    ("-CATTCCTGAGGGAATCG-3" . SPARSER::COLLECTION)
    ("-AGGCATCCATCAAAACATTTCG-3" . SPARSER::COLLECTION)
    ("-CGCAGCCATTACTGCAGAGATCC-3" . SPARSER::COLLECTION)
    ("-AAGACTCACAGATCCCCGTATTAATAAGG-3" . SPARSER::COLLECTION)
    ("-CATGCCCTCTGAATCTTTCTGTTTGG-3" . SPARSER::COLLECTION)
    ("-GGGGACAACTTTGTACAAGAAAGTTGGGTC-3" . SPARSER::COLLECTION)
    ("-GGGGACAACTTTGTACAAAAAAGTTGG-3" . SPARSER::COLLECTION)
    ("the amino
terminal hemagglutinin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HERC2–protein" . SPARSER::COLLECTION)
    ("the centrosomal
protein CP110"
     . SPARSER::PROTEIN)
    ("NEURL4 and HERC2" . SPARSER::COLLECTION)
    ("NEURL4 and E6AP" . SPARSER::COLLECTION) ("MDa" . SPARSER::DRUG)
    ("NEURL4 and UBE3A" . SPARSER::COLLECTION)
    ("HERC2 and proteins" . SPARSER::COLLECTION) ("XPA" . SPARSER::PROTEIN)
    ("at least one regulator of chromosome condensation
1"
     . SPARSER::PROTEIN)
    ("phosphorylase kinase,
beta-catenin, PI3 kinase, and proteins"
     . SPARSER::COLLECTION)
    ("coatomer" . SPARSER::BIO-COMPLEX)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mammalian
target of rapamycin"
     . SPARSER::PROTEIN)
    ("subunit G" . SPARSER::PROTEIN)
    ("fatty
acid"
     . SPARSER::MOLECULE)
    ("ATP6 V1A" . SPARSER::PROTEIN) ("NDUFA11" . SPARSER::PROTEIN)
    ("ATP5J" . SPARSER::PROTEIN) ("ENPP1" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("SLC27A4" . SPARSER::PROTEIN)
    ("SLC27A2" . SPARSER::PROTEIN) ("TOM22" . SPARSER::PROTEIN)
    ("SLC25A10" . SPARSER::PROTEIN) ("SLC25A4" . SPARSER::PROTEIN)
    ("RAB2A" . SPARSER::PROTEIN) ("ARCN1" . SPARSER::PROTEIN)
    ("GCN1L1" . SPARSER::PROTEIN) ("CBX2" . SPARSER::PROTEIN)
    ("RPS27L" . SPARSER::PROTEIN) ("PFDN6" . SPARSER::PROTEIN)
    ("PFDN5" . SPARSER::PROTEIN) ("PFDN4" . SPARSER::PROTEIN)
    ("VBP1" . SPARSER::PROTEIN) ("RER1" . SPARSER::PROTEIN)
    ("SNX6" . SPARSER::PROTEIN) ("TUBA1C" . SPARSER::PROTEIN)
    ("MYO9B" . SPARSER::PROTEIN) ("SPECC1L" . SPARSER::PROTEIN)
    ("LCP1" . SPARSER::PROTEIN)
    ("phosphorylase
kinase"
     . SPARSER::PROTEIN)
    ("PHKA2" . SPARSER::PROTEIN) ("PHKA1" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("syntaxin-3" . SPARSER::PROTEIN)
    ("Rab 5" . SPARSER::PROTEIN) ("ZFYVE9" . SPARSER::PROTEIN)
    ("BICD1" . SPARSER::PROTEIN) ("CEP170" . SPARSER::PROTEIN)
    ("SCO2" . SPARSER::PROTEIN) ("GLUD1" . SPARSER::PROTEIN)
    ("NCOA4" . SPARSER::PROTEIN)
    ("nuclear receptor coactivator 4" . SPARSER::PROTEIN)
    ("TMED10" . SPARSER::PROTEIN) ("COPG2" . SPARSER::PROTEIN)
    ("COPG1" . SPARSER::PROTEIN) ("COPB2" . SPARSER::PROTEIN)
    ("COPB1" . SPARSER::PROTEIN)
    ("coatomer
protein complex"
     . SPARSER::PROTEIN)
    ("HLA-E" . SPARSER::PROTEIN) ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("signal peptide" . SPARSER::PROTEIN) ("cathepsin A" . SPARSER::PROTEIN)
    ("ASAH1" . SPARSER::PROTEIN) ("SPTLC2" . SPARSER::PROTEIN)
    ("COMMD3" . SPARSER::PROTEIN) ("COMMD1" . SPARSER::PROTEIN)
    ("RAB6B" . SPARSER::PROTEIN) ("RAB6A" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("ARHGEF5" . SPARSER::PROTEIN)
    ("exchange
factor"
     . SPARSER::EXCHANGE-FACTOR)
    ("RCC1" . SPARSER::PROTEIN) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("WDR92" . SPARSER::PROTEIN) ("PRKAR2B" . SPARSER::PROTEIN)
    ("PHKG2" . SPARSER::PROTEIN) ("MUS81" . SPARSER::PROTEIN)
    ("KIF20A" . SPARSER::PROTEIN) ("HM13" . SPARSER::PROTEIN)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FTH1" . SPARSER::PROTEIN)
    ("FDFT1" . SPARSER::PROTEIN) ("EME1" . SPARSER::PROTEIN)
    ("EIF3M" . SPARSER::PROTEIN) ("EIF3H" . SPARSER::PROTEIN)
    ("EIF3E" . SPARSER::PROTEIN) ("CPT1A" . SPARSER::PROTEIN)
    ("COPZ1" . SPARSER::PROTEIN) ("BICD2" . SPARSER::PROTEIN)
    ("CP110" . SPARSER::PROTEIN) ("UBE3A" . SPARSER::PROTEIN)
    ("NEURL4" . SPARSER::PROTEIN) ("FBXL5" . SPARSER::PROTEIN)
    ("USP33" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("Angelman
Syndrome"
     . SPARSER::PROTEIN)
    ("E 6AP" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("regulator of chromosome condensation
1"
     . SPARSER::PROTEIN)
    ("phosphorylase kinase" . SPARSER::PROTEIN)
    ("eukaryotic
translation initiation factor 3 complex"
     . SPARSER::BIO-COMPLEX)
    ("Angelman Syndrome" . SPARSER::PROTEIN) ("HERC2" . SPARSER::PROTEIN)
    ("receptor and EZH2" . SPARSER::COLLECTION)
    ("PcG" . SPARSER::PROTEIN-FAMILY) ("PTPRD" . SPARSER::PROTEIN)
    ("P3 and PI" . SPARSER::COLLECTION) ("RTK/PI3K/AKT" . SPARSER::COLLECTION)
    ("STAT3 and these dimeric STAT3" . SPARSER::COLLECTION)
    ("these dimeric STAT3" . SPARSER::PROTEIN)
    ("INPP5F and STAT3" . SPARSER::COLLECTION)
    ("AKT and GSK3" . SPARSER::COLLECTION)
    ("INPP5F and adjacent genes" . SPARSER::COLLECTION)
    ("BAG3 (BCL2-associated athanogene 3) and MCMBP (Minichromosome Maintenance Complex Binding Protein)"
     . SPARSER::COLLECTION)
    ("MCMBP" . SPARSER::PROTEIN)
    ("cytokine- or growth factor-receptor" . SPARSER::COLLECTION)
    ("cytokine-" . SPARSER::PROTEIN) ("AKT-Gsk3β" . SPARSER::COLLECTION)
    ("Hdac2" . SPARSER::PROTEIN)
    ("the polyphosphoinositide phosphatases that regulate phosphatidylinositol 4, 5-bisphosphate (PtdIns [4, 5] P 2 [PIP2]) and phosphatidylinositol 3"
     . SPARSER::COLLECTION)
    ("the pivotal molecular mediators" . SPARSER::PROTEIN)
    ("polyphosphoinositide" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Receptor-type tyrosine-protein phosphatase delta" . SPARSER::PROTEIN)
    ("Minichromosome Maintenance Complex Binding Protein" . SPARSER::PROTEIN)
    ("Extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gsk3β" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4, 5-bisphosphate" . SPARSER::PIP2)
    ("INPP5F" . SPARSER::PROTEIN)
    ("Inositol Polyphosphate-5-Phosphatase F" . SPARSER::PROTEIN)
    ("TGFβ1-" . SPARSER::PROTEIN)
    ("Ca 2+ and K Ca 3.1 channel activity" . SPARSER::COLLECTION)
    ("differential Smad2" . SPARSER::PROTEIN)
    ("αSMA and actin" . SPARSER::COLLECTION)
    ("normal external Ca 2+" . SPARSER::CALCIUM-ION)
    ("αSMA and collagen" . SPARSER::COLLECTION)
    ("TATA box binding protein (TBP) and β-actin" . SPARSER::COLLECTION)
    ("the nuclear protein, TATA box binding protein (TBP) and β-actin"
     . SPARSER::COLLECTION)
    ("significantly higher constitutive αSMA" . SPARSER::PROTEIN)
    ("form hetero-oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("TGFβ1/Smad" . SPARSER::COLLECTION) ("Senicapoc" . SPARSER::DRUG)
    ("TRAM" . SPARSER::PROTEIN)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("TATA box binding protein" . SPARSER::PROTEIN) ("NCB1" . SPARSER::PROTEIN)
    ("IgG 2a" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("THY-1" . SPARSER::PROTEIN) ("surface protein" . SPARSER::PROTEIN)
    ("Ion channels" . SPARSER::PROTEIN-FAMILY) ("Smad 4" . SPARSER::PROTEIN)
    ("αSMA" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("the rare universal oncogenes" . SPARSER::ONCOGENE)
    ("whose components" . SPARSER::COMPONENT)
    ("Oct4/Sox2/Klf4" . SPARSER::COLLECTION)
    ("a universal regulator" . SPARSER::REGULATOR)
    ("pyrophosphate" . SPARSER::MOLECULE)
    ("proteins or RNAs" . SPARSER::COLLECTION) ("CLOCK" . SPARSER::PROTEIN)
    ("Max homodimers as well as heterodimers" . SPARSER::COLLECTION)
    ("Myc-Max" . SPARSER::COLLECTION) ("Mnt" . SPARSER::PROTEIN)
    ("Myc and other HLH-bZIP dimers" . SPARSER::COLLECTION)
    ("Huwe1" . SPARSER::PROTEIN)
    ("a highly sequence specific transcription factor" . SPARSER::PROTEIN)
    ("suprahysiological Myc" . SPARSER::PROTEIN)
    ("microRNAs and other non-coding RNAs" . SPARSER::COLLECTION)
    ("repressive mediators" . SPARSER::PROTEIN)
    ("Sin3b, Hbp1, Suv420h1, and Btg1" . SPARSER::COLLECTION)
    ("Btg1" . SPARSER::PROTEIN) ("Hbp1" . SPARSER::PROTEIN)
    ("Sin3b" . SPARSER::PROTEIN) ("widespread PRC2-" . SPARSER::PROTEIN)
    ("PRC2-" . SPARSER::PROTEIN) ("Ezh2" . SPARSER::PROTEIN)
    ("CDKN2B and CDKN1A" . SPARSER::COLLECTION) ("Myc-" . SPARSER::PROTEIN)
    ("all active promoters" . SPARSER::PROMOTER)
    ("target and non-target" . SPARSER::COLLECTION)
    ("enhancers and promoters" . SPARSER::COLLECTION)
    ("relevant enhancers" . SPARSER::PROTEIN)
    ("transcriptionally active genes" . SPARSER::GENE)
    ("nearly all promoters" . SPARSER::PROMOTER)
    ("the genome-wide map" . SPARSER::PROTEIN)
    ("euchromatic and hyperacetylated chromatin" . SPARSER::PROTEIN)
    ("TBP [ xref ], the chromatin regulators Tip60 [ xref ], and SWI/SNF [ xref ]"
     . SPARSER::COLLECTION)
    ("LID" . SPARSER::PROTEIN)
    ("the p300 histone acetylase and other histone-modifying enzymes"
     . SPARSER::COLLECTION)
    ("a repressive partner protein" . SPARSER::PROTEIN)
    ("all active genes" . SPARSER::GENE) ("even generic DNA" . SPARSER::DNA)
    ("prokaryotic repressors" . SPARSER::REPRESSOR)
    ("sequence-specific DNA binding proteins" . SPARSER::PROTEIN)
    ("dMyc and dMax" . SPARSER::COLLECTION)
    ("a helix-loop-helix basic leucine zipper protein" . SPARSER::PROTEIN)
    ("dMax" . SPARSER::PROTEIN) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("dMyc" . SPARSER::PROTEIN)
    ("c-Myc, N-Myc, or L-Myc" . SPARSER::COLLECTION)
    ("Klf4" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("PRPS2" . SPARSER::PROTEIN) ("Gcn5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("zinc finger protein" . SPARSER::PROTEIN)
    ("ribosomal protein L11" . SPARSER::PROTEIN)
    ("Myc protein" . SPARSER::PROTEIN) ("Suv420h1" . SPARSER::PROTEIN)
    ("Sin3" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("K4" . SPARSER::PROTEIN) ("serine 2" . SPARSER::PROTEIN)
    ("cyclin T1" . SPARSER::PROTEIN) ("Myc/Max" . SPARSER::PROTEIN)
    ("mTOR-p70S6K and AKT" . SPARSER::COLLECTION)
    ("mTOR-p70S6K" . SPARSER::PROTEIN) ("AMPK and mTOR" . SPARSER::COLLECTION)
    ("protein–" . SPARSER::PROTEIN) ("insulin-glucose" . SPARSER::PROTEIN)
    ("glucose and leucine" . SPARSER::COLLECTION)
    ("hyperinsulinemic-euglycemic clamp" . SPARSER::PROTEIN-FAMILY)
    ("mTOR-p70S6K-IRS" . SPARSER::PROTEIN-PAIR)
    ("p70S6K and IRS" . SPARSER::COLLECTION) ("GSKβ" . SPARSER::PROTEIN)
    ("p-GSKβ" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("mL −1 (quartiles 30.8, 61.8) and 51.9 µmol/µU min −1"
     . SPARSER::COLLECTION)
    ("mL −1 (43.3, 65.4) and 52.3 µmol/µU min −1" . SPARSER::COLLECTION)
    ("essential amino acid" . SPARSER::AMINO-ACID)
    ("Leucine" . SPARSER::AMINO-ACID)
    ("Basal arterial plasma glucose" . SPARSER::MOLECULE)
    ("Arterial Plasma Glucose" . SPARSER::MOLECULE)
    ("Glucose" . SPARSER::PROTEIN) ("-AMPK" . SPARSER::COLLECTION)
    ("insulin-stimulated glucose" . SPARSER::PROTEIN)
    ("leucine, isoleucine, and valine" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Skeletal muscle" . SPARSER::PROTEIN)
    ("protein and leucine" . SPARSER::COLLECTION)
    ("protein or leucine" . SPARSER::COLLECTION)
    ("whey protein (0.6 g/kg fat-free mass; n = 11) or leucine"
     . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION)
    ("insulin-mediated glucose" . SPARSER::PROTEIN)
    ("Amino Acid" . SPARSER::AMINO-ACID) ("anti–phospho" . SPARSER::PROTEIN)
    ("- 2" . SPARSER::PROTEIN) ("p-ACC" . SPARSER::PROTEIN)
    ("mL −1" . SPARSER::PROTEIN)
    ("systemic EBV + T cell LPD" . SPARSER::PROTEIN)
    ("cyclin E1 and Ki67" . SPARSER::COLLECTION)
    ("Ohshima A3 and B subtypes [ xref ]" . SPARSER::COLLECTION)
    ("ANKL" . SPARSER::PROTEIN)
    ("systemic EBV-positive T cell LPD" . SPARSER::PROTEIN)
    ("systemic EBV + T-cell LPD" . SPARSER::PROTEIN)
    ("systemic EBV-associated T/NK cell LPD" . SPARSER::PROTEIN)
    ("CCNE2/cyclin" . SPARSER::COLLECTION) ("methotrexate" . SPARSER::DRUG)
    ("TCRG" . SPARSER::PROTEIN) ("CD8-" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN) ("systemic form" . SPARSER::FORM)
    ("systemic and cutaneous forms" . SPARSER::FORM)
    ("EBV-associated T/NK LPD" . SPARSER::PROTEIN)
    ("systemic EBV-positive T-cell LPD" . SPARSER::PROTEIN)
    ("systemic LPDs" . SPARSER::PROTEIN) ("LPDs" . SPARSER::PROTEIN)
    ("the EBV-associated T/NK LPD" . SPARSER::PROTEIN)
    ("LPD" . SPARSER::PROTEIN) ("type (CAEBV)" . TYPE)
    ("E2 and Ki67" . SPARSER::COLLECTION)
    ("monomorphic lymphoid" . SPARSER::PROTEIN)
    ("The systemic form" . SPARSER::FORM) ("CCNE2" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("cyclinE2" . SPARSER::PROTEIN)
    ("ND 3" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral DNA and repair" . SPARSER::COLLECTION)
    ("DNA and repair" . SPARSER::COLLECTION)
    ("BLM and EXO1" . SPARSER::COLLECTION) ("damaged viral DNA" . SPARSER::DNA)
    ("exogenous DNA" . SPARSER::DNA)
    ("replicating viral chromatin" . SPARSER::PROTEIN)
    ("replicating SV40 DNA" . SPARSER::DNA)
    ("ATM, and ATR" . SPARSER::COLLECTION)
    ("viral and cellular DNA" . SPARSER::DNA)
    ("replisomes" . SPARSER::BIO-COMPLEX)
    ("CHK2 and CHK1" . SPARSER::COLLECTION)
    ("RPA and RAD51" . SPARSER::COLLECTION)
    ("RAD51, NBS1, and RPA" . SPARSER::COLLECTION)
    ("ATR or DNA-PK" . SPARSER::COLLECTION)
    ("ATRi or DMSO" . SPARSER::COLLECTION)
    ("cs and KU80" . SPARSER::COLLECTION) ("cs and KU" . SPARSER::COLLECTION)
    ("DMSO or ATRi" . SPARSER::COLLECTION)
    ("activated DNA-PK cs (marked by S2056 phosphorylation) and KU70"
     . SPARSER::COLLECTION)
    ("BLM and CtIP" . SPARSER::COLLECTION) ("DMSO-" . SPARSER::MOLECULE)
    ("NBS1, BLM, or CtIP" . SPARSER::COLLECTION)
    ("NBS1, CtIP, and BLM" . SPARSER::COLLECTION) ("ATR-" . SPARSER::PROTEIN)
    ("viral DNA replication foci" . SPARSER::PROTEIN)
    ("replicating single-stranded viral DNA" . SPARSER::DNA)
    ("RAD51 and RPA" . SPARSER::COLLECTION)
    ("replicating single-stranded DNA" . SPARSER::DNA)
    ("endonucleases" . SPARSER::PROTEIN)
    ("viral replication foci" . SPARSER::PROTEIN)
    ("RAD51 and EdU" . SPARSER::COLLECTION) ("ATRi-" . SPARSER::MOLECULE)
    ("ATR and DNA-PK" . SPARSER::COLLECTION)
    ("ATM and CDK" . SPARSER::COLLECTION)
    ("radiomimetic compound neocarzinostatin" . SPARSER::PROTEIN)
    ("CHK2 and NBS1" . SPARSER::COLLECTION)
    ("CHK1, CHK2, NBS1, and DNA-PK" . SPARSER::COLLECTION)
    ("CENPF" . SPARSER::PROTEIN)
    ("intense KU70/80 and DNA-PK cs foci" . SPARSER::PROTEIN)
    ("KU70, KU80, and DNA-PK" . SPARSER::COLLECTION)
    ("NBS1 pS343" . SPARSER::PROTEIN)
    ("cs , KU70, and KU80" . SPARSER::COLLECTION)
    ("BLM, RMI1/2, and Topoisomerase" . SPARSER::COLLECTION)
    ("Topoisomerase" . SPARSER::PROTEIN) ("BTR" . SPARSER::PROTEIN)
    ("formed intense foci" . SPARSER::PROTEIN) ("broken DNA" . SPARSER::DNA)
    ("ATR and/or ATM" . SPARSER::COLLECTION)
    ("concatemeric forms" . SPARSER::FORM) ("Dimer" . SPARSER::DIMER)
    ("ATR and ATM" . SPARSER::COLLECTION)
    ("virtually all viral DNA" . SPARSER::DNA)
    ("sigma" . SPARSER::PROTEIN-FAMILY) ("linear viral DNA" . SPARSER::DNA)
    ("arc" . SPARSER::PROTEIN) ("non-replicating viral DNAs" . SPARSER::DNA)
    ("the undigested viral DNA" . SPARSER::DNA)
    ("the viral DNA" . SPARSER::DNA) ("total viral DNA" . SPARSER::DNA)
    ("both ATRi and ATMi" . SPARSER::COLLECTION) ("ATRi" . SPARSER::MOLECULE)
    ("non-replicating linear viral DNA" . SPARSER::DNA)
    ("ATM or ATR" . SPARSER::COLLECTION)
    ("the viral origin recognition complex/replicative DNA helicase"
     . SPARSER::PROTEIN)
    ("viral chromatin" . SPARSER::PROTEIN)
    ("ATR or CtIP" . SPARSER::COLLECTION)
    ("the more processive nucleases EXO1" . SPARSER::PROTEIN)
    ("BLM/DNA2" . SPARSER::COLLECTION) ("ATM-" . SPARSER::PROTEIN)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("ATR/ATRIP" . SPARSER::COLLECTION)
    ("ATR and its related kinases" . SPARSER::COLLECTION)
    ("ataxia telangiectasia-mutated (ATM) and DNA-protein kinase catalytic subunit (DNA-PK cs )"
     . SPARSER::COLLECTION)
    ("PIKK" . SPARSER::KINASE)
    ("kinase, ataxia telangiectasia-mutated and rad3-related (ATR)"
     . SPARSER::COLLECTION)
    ("kinase, ataxia telangiectasia-mutated and rad3-related"
     . SPARSER::COLLECTION)
    ("broken viral DNA" . SPARSER::DNA)
    ("replicating viral DNA" . SPARSER::DNA) ("viral DNA" . SPARSER::DNA)
    ("cs and KU70/80" . SPARSER::COLLECTION)
    ("CtIP and BLM" . SPARSER::COLLECTION) ("cs" . SPARSER::PROTEIN)
    ("AZD2281" . SPARSER::DRUG) ("M-2" . SPARSER::PROTEIN)
    ("C–E" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("ICR1" . SPARSER::PROTEIN) ("RMI2" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("KU80" . SPARSER::PROTEIN)
    ("RMI1" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("Nu7026" . SPARSER::DRUG) ("Ku-55933" . SPARSER::DRUG)
    ("VE-821" . SPARSER::DRUG)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN) ("DNA2" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("KU70" . SPARSER::PROTEIN) ("CDK1 and CDC25C" . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("EPHB3 and PIP5K1A" . SPARSER::COLLECTION)
    ("receptors and ephrin" . SPARSER::COLLECTION)
    ("ephrin" . SPARSER::PROTEIN) ("Eph" . SPARSER::PROTEIN)
    ("a compensatory pro-survival and anti-apoptotic molecule"
     . SPARSER::MOLECULE)
    ("p21 and IKKε" . SPARSER::COLLECTION)
    ("IKKε and/or CHEK1" . SPARSER::COLLECTION)
    ("IKKε, CHEK1, and p53" . SPARSER::COLLECTION) ("FMS" . SPARSER::PROTEIN)
    ("CHEK1 and IKKε" . SPARSER::COLLECTION)
    ("IKKε or CHEK1" . SPARSER::COLLECTION)
    ("Either IKKε or control shRNA" . SPARSER::COLLECTION)
    ("either CHEK1 or control shRNA" . SPARSER::COLLECTION)
    ("two previously validated IKKε shRNAs" . SPARSER::RNA)
    ("CHEK1 , EPHB3 , and PIP5K1A" . SPARSER::COLLECTION)
    ("IKKε or control shRNA" . SPARSER::COLLECTION)
    ("ovarian cancer-specific IKKε signature genes" . SPARSER::GENE)
    ("several histological subtypes" . SPARSER::PROTEIN)
    ("IKKε, CHEK1 and p21" . SPARSER::COLLECTION)
    ("IKKε and CHEK1" . SPARSER::COLLECTION) ("OCs" . SPARSER::PROTEIN)
    ("cdc2" . SPARSER::PROTEIN) ("G-4" . SPARSER::PROTEIN)
    ("IKK ε" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("1-8" . SPARSER::PROTEIN) ("E 1" . SPARSER::MOLECULE)
    ("PIP 2" . SPARSER::PIP2) ("H2A" . SPARSER::PROTEIN)
    ("PF477736" . SPARSER::DRUG) ("MLK3" . SPARSER::PROTEIN)
    ("MLK2" . SPARSER::PROTEIN) ("MLK1" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN) ("MARK4" . SPARSER::PROTEIN)
    ("MARK2" . SPARSER::PROTEIN) ("MARK1" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("BX795" . SPARSER::DRUG)
    ("PIP5K1A" . SPARSER::PROTEIN) ("EPHB3" . SPARSER::PROTEIN)
    ("IKKε" . SPARSER::PROTEIN) ("the latter fraction" . SPARSER::COMPONENT)
    ("urinary DNA" . SPARSER::DNA) ("Urinary DNA" . SPARSER::DNA)
    ("UTs" . SPARSER::PROTEIN-FAMILY)
    ("a urinary biomarker" . SPARSER::MOLECULE)
    ("bulk urinary DNA" . SPARSER::DNA)
    ("highly malignant HCC" . SPARSER::PROTEIN)
    ("the exogenous CIK cell chemotaxis" . SPARSER::PROTEIN)
    ("oncolytic adenovirus AdSurp-Hsp70" . SPARSER::COLLECTION)
    ("immunomodulatory factor Hsp70" . SPARSER::PROTEIN)
    ("drugs and technologies" . SPARSER::COLLECTION)
    ("sera" . SPARSER::PROTEIN) ("Hexon and Hsp70" . SPARSER::COLLECTION)
    ("Hexon and the therapeutic gene Hsp70" . SPARSER::COLLECTION)
    ("Hexon" . SPARSER::PROTEIN)
    ("the CIK group or AdSurp-EGFP group" . SPARSER::COLLECTION)
    ("AdSurp-EGFP" . SPARSER::COLLECTION)
    ("AdSurp-Hsp70" . SPARSER::COLLECTION)
    ("an immunomodulatory gene" . SPARSER::GENE)
    ("adenoviral replication gene" . SPARSER::GENE)
    ("Hsp70 or P53" . SPARSER::COLLECTION)
    ("carcinoembryonic" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IK" . SPARSER::PROTEIN)
    ("DDR2 , KRAS , EGFR , BRAF , HRAS , NFE2L2 , CTNNB1 , MET , and STK11"
     . SPARSER::COLLECTION)
    ("FGFR1 and HER2 and gatekeeper" . SPARSER::COLLECTION)
    ("HER2 and gatekeeper" . SPARSER::COLLECTION)
    ("Caucasian NSCLC cohorts" . SPARSER::MOLECULE)
    ("smaller cohorts" . SPARSER::MOLECULE)
    ("erlotinib and bevacizumab" . SPARSER::COLLECTION)
    ("PIK3CA-" . SPARSER::PROTEIN)
    ("KRAS , HRAS and STK11" . SPARSER::COLLECTION)
    ("HER2 and FGFR1" . SPARSER::COLLECTION) ("x" . SPARSER::PROTEIN)
    ("other histological subtypes" . SPARSER::PROTEIN)
    ("further targetable oncogenes" . SPARSER::ONCOGENE)
    ("TTF1" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("P44" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("AD 2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMTV-Wnt1" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("TGF-β and GPCR" . SPARSER::COLLECTION)
    ("KRAS and YAP1" . SPARSER::COLLECTION)
    ("Vimentin and Slug" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("Snail and Vimentin" . SPARSER::COLLECTION)
    ("tumor-associated EMT" . SPARSER::PROTEIN)
    ("Snail1, ZEB1, and Twist" . SPARSER::COLLECTION)
    ("Vimentin, Fibronectin, and N-cadherin" . SPARSER::COLLECTION)
    ("FGF-1, FGF-2, FGF-3, FGF-7, FGF-9, FGF-10, FGF-18, FGF-19, FGF-20, FGF23 and FGFR1-4"
     . SPARSER::COLLECTION)
    ("a sensitive and specific diagnostic biomarker" . SPARSER::MOLECULE)
    ("Nuclear-YAP1 and FGF8" . SPARSER::COLLECTION)
    ("divergent expression proteins" . SPARSER::PROTEIN)
    ("further filtering candidate hub proteins" . SPARSER::PROTEIN)
    ("FGF8-YAP1" . SPARSER::COLLECTION)
    ("4,818 unique proteins" . SPARSER::PROTEIN) ("SSBP" . SPARSER::PROTEIN)
    ("DDI" . SPARSER::DRUG) ("bin" . SPARSER::PROTEIN)
    ("the STS and raw predicted dataset" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN) ("GSN" . SPARSER::PROTEIN)
    ("GSP" . SPARSER::PROTEIN)
    ("mesenchymal markers Vimentin and Snail" . SPARSER::COLLECTION)
    ("Vimentin and Snail" . SPARSER::COLLECTION)
    ("developmental and pathological EMT" . SPARSER::PROTEIN)
    ("strong FGF8" . SPARSER::PROTEIN)
    ("connective tissue growth factor (CTGF)" . SPARSER::PROTEIN)
    ("TEAD" . SPARSER::PROTEIN) ("an essential oncogene" . SPARSER::ONCOGENE)
    ("ErbB4, SMAD, RUNX, TBX5, p73 and TEAD1-4" . SPARSER::COLLECTION)
    ("FGF9, FGF10, FGF18, FGF-23 and FGFR2IIIc" . SPARSER::COLLECTION)
    ("FGF9 and FGFR2IIIc" . SPARSER::COLLECTION)
    ("FGF1, FGF7 and FGF10" . SPARSER::COLLECTION)
    ("FGF1, FGF2, FGF6, FGF9 and FGF17" . SPARSER::COLLECTION)
    ("morphogens, and inducers" . SPARSER::COLLECTION)
    ("morphogens" . SPARSER::PROTEIN) ("mitogens" . SPARSER::MITOGEN)
    ("CTGF and CYR61" . SPARSER::COLLECTION) ("Snail1" . SPARSER::PROTEIN)
    ("FGF23" . SPARSER::PROTEIN) ("FGF-20" . SPARSER::PROTEIN)
    ("FGF-19" . SPARSER::PROTEIN) ("FGF-18" . SPARSER::PROTEIN)
    ("FGF-10" . SPARSER::PROTEIN) ("FGF-9" . SPARSER::PROTEIN)
    ("FGF-7" . SPARSER::PROTEIN) ("FGF-3" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("FGF-1" . SPARSER::PROTEIN)
    ("TEAD4" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("MOB1" . SPARSER::PROTEIN) ("STE-20" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("androgen-induced growth factor" . SPARSER::PROTEIN)
    ("FGFR4" . SPARSER::PROTEIN) ("FGF-23" . SPARSER::PROTEIN)
    ("FGF18" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("FGF17" . SPARSER::PROTEIN) ("FGF6" . SPARSER::PROTEIN)
    ("FGF-8" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("IL-4 , IL-10 , MMP9 and collagen" . SPARSER::COLLECTION)
    ("integrins, proteins, and collagen" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN)
    ("a very complex chromatin" . SPARSER::BIO-COMPLEX)
    ("ac" . SPARSER::PROTEIN) ("the healthy state" . SPARSER::BIO-STATE)
    ("HDAC2 and acH4K16" . SPARSER::COLLECTION)
    ("HDAC2, p300, acH4K16 and acH3K9K14" . SPARSER::COLLECTION)
    ("acH" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("HLA-DRA and HLA-DPA1" . SPARSER::COLLECTION)
    ("the previously identified group" . SPARSER::MOLECULE)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("MS-275 or SAHA" . SPARSER::COLLECTION) ("scr" . SPARSER::PROTEIN)
    ("blot and semi-quantitative" . SPARSER::COLLECTION)
    ("SAHA and HDAC2" . SPARSER::COLLECTION)
    ("TNF-alpha and IL-6" . SPARSER::COLLECTION) ("CIITA" . SPARSER::PROTEIN)
    ("chromatin and trigger" . SPARSER::COLLECTION)
    ("entinostat" . SPARSER::DRUG)
    ("vorinostat (suberoylanilide hydroxamic acid or SAHA, Zolinza ® ) and romidepsin (FK228, depsipeptide, Istodax ® )"
     . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid or SAHA" . SPARSER::COLLECTION)
    ("Istodax" . SPARSER::DRUG) ("depsipeptide" . SPARSER::DRUG)
    ("romidepsin" . SPARSER::DRUG) ("Zolinza" . SPARSER::DRUG)
    ("HDACi" . SPARSER::MOLECULE)
    ("tumor protein 53-induced nuclear protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC2 and N-Myc" . SPARSER::COLLECTION)
    ("p21 and p57" . SPARSER::COLLECTION) ("dystrophic" . SPARSER::PROTEIN)
    ("homology, HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("Structural homology" . SPARSER::PROTEIN) ("IIb" . SPARSER::DRUG)
    ("HDAC3 and HDAC8" . SPARSER::COLLECTION)
    ("HATs and HDACs" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("vorinostat (SAHA)" . SPARSER::DRUG) ("vorinostat" . SPARSER::DRUG)
    ("De-" . SPARSER::MOLECULE) ("pcDNA 3" . SPARSER::PROTEIN)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("HLA-DOA" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("MHC class II transactivator" . SPARSER::PROTEIN)
    ("HLA complex" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("HLA-DPA1" . SPARSER::PROTEIN) ("HLA-DRA" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG) ("FK228" . SPARSER::DRUG)
    ("Hda1" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("Rpd3" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("Histone deacetylase 2" . SPARSER::PROTEIN)
    ("SLC45A3 (a prostate-specific androgen responsive gene) and exon"
     . SPARSER::COLLECTION)
    ("ESRP1 (an epithelial splicing regulatory protein) and exon"
     . SPARSER::COLLECTION)
    ("again fusions containing BRAF or RAF1" . SPARSER::COLLECTION)
    ("mitogen activated kinase-like protein (MAPK)" . SPARSER::PROTEIN)
    ("protein (MAPK)" . SPARSER::PROTEIN)
    ("BRAF and RAF1" . SPARSER::COLLECTION)
    ("only recently many aberrant forms" . SPARSER::FORM)
    ("a viral oncogene" . SPARSER::ONCOGENE)
    ("secondary mRNA" . SPARSER::PROTEIN)
    ("KRAS, BRAF or AKT" . SPARSER::COLLECTION)
    ("HGF-MET" . SPARSER::COLLECTION) ("RAFs and GFP" . SPARSER::COLLECTION)
    ("BRAF or RAF1" . SPARSER::COLLECTION)
    ("RAF1 or BRAF" . SPARSER::COLLECTION)
    ("available, and truncated forms" . SPARSER::FORM)
    ("Western Blot" . SPARSER::PROTEIN) ("Braf" . SPARSER::PROTEIN)
    ("shRNA-3" . SPARSER::COLLECTION)
    ("the library-derived Raf1" . SPARSER::PROTEIN)
    ("multiple possible truncated forms" . SPARSER::FORM)
    ("FLX" . SPARSER::PROTEIN) ("Raf1" . SPARSER::PROTEIN)
    ("HsK" . SPARSER::PROTEIN) ("HsS" . SPARSER::PROTEIN)
    ("PHA-665752 (PHA)" . SPARSER::DRUG)
    ("a different RTK or other cell signalling proteins [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("either small-molecule kinase inhibitors or monoclonal antibodies (mAbs)"
     . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("RAFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF1 and BRAF" . SPARSER::COLLECTION)
    ("valuable therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("delta-" . SPARSER::PROTEIN)
    ("epithelial splicing regulatory protein" . SPARSER::PROTEIN)
    ("ESRP1" . SPARSER::PROTEIN) ("SLC45A3" . SPARSER::PROTEIN)
    ("JNJ38877605" . SPARSER::DRUG)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("Salinomycin [ xref ] and inhibitors" . SPARSER::COLLECTION)
    ("Salinomycin" . SPARSER::DRUG) ("Myc and E2F" . SPARSER::COLLECTION)
    ("p14/Arf" . SPARSER::COLLECTION)
    ("N-cadherin and Bcl-xL" . SPARSER::COLLECTION)
    ("a strong N-Cadherin" . SPARSER::PROTEIN)
    ("at least three major components" . SPARSER::COMPONENT)
    ("Bcl-xL and Beclin1" . SPARSER::COLLECTION)
    ("microtubule-associated protein 1A/1B-light chain 3"
     . SPARSER::COLLECTION)
    ("BH3-mimetic drugs" . SPARSER::DRUG)
    ("their mesenchymal derivatives" . SPARSER::DERIVATIVE)
    ("MSP and MSP" . SPARSER::COLLECTION)
    ("EMT and Bcl-xL" . SPARSER::COLLECTION) ("wa" . SPARSER::MOLECULE)
    ("the pro-apoptotic Bcl-2 family members Bim and Puma"
     . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-2" . SPARSER::COLLECTION)
    ("only one protein" . SPARSER::PROTEIN)
    ("the radiomimetic neocarzinostatin" . SPARSER::PROTEIN)
    ("RAS and MSP" . SPARSER::COLLECTION)
    ("mesenchymal marker genes" . SPARSER::GENE)
    ("TNFalpha" . SPARSER::PROTEIN) ("neocarzinostatin" . SPARSER::PROTEIN)
    ("salinomycin [ xref ] and a number" . SPARSER::COLLECTION)
    ("Paclitaxel" . SPARSER::DRUG)
    ("Oxaliplatin, Taxol and Etoposide" . SPARSER::COLLECTION)
    ("CD24 or E-cadherin" . SPARSER::COLLECTION)
    ("CD44, Vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("Twist and Snail" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins Bim and Puma" . SPARSER::COLLECTION)
    ("Bim and Puma" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bim" . SPARSER::PROTEIN)
    ("LC3A" . SPARSER::PROTEIN) ("R-C" . SPARSER::PROTEIN)
    ("B-6" . SPARSER::PROTEIN) ("HSC70" . SPARSER::PROTEIN)
    ("H-5" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("LC3a" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("Abt-737" . SPARSER::DRUG) ("Bcl-xS" . SPARSER::PROTEIN)
    ("ha-RAS" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("Large T-antigen" . SPARSER::PROTEIN)
    ("BRCA2 or PALB2" . SPARSER::COLLECTION)
    ("BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("IR or MMC" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("FA-BRCA" . SPARSER::COLLECTION) ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("MMC" . SPARSER::PROTEIN) ("diepoxybutane" . SPARSER::MOLECULE)
    ("ER/PR" . SPARSER::COLLECTION) (":c" . SPARSER::BIO-COMPLEX)
    ("biallelic compound heterozygous variants" . SPARSER::VARIANT)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("biallelic BRCA1 mutations cause FA" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN)
    ("a hypomorphic BRCA1 BRCT (BRCA1 C-terminal) repeat missense allele"
     . SPARSER::ALLELE)
    ("BRCA1 and both the D2-I" . SPARSER::COLLECTION)
    ("BRCA2-PALB2" . SPARSER::COLLECTION)
    ("proteins and Rad51" . SPARSER::COLLECTION) ("ICLs" . SPARSER::PROTEIN)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("FANCS" . SPARSER::PROTEIN-FAMILY)
    ("a definitive FA susceptibility gene" . SPARSER::GENE)
    ("PALB2 (FANCN)" . SPARSER::PROTEIN) ("FANCN" . SPARSER::PROTEIN)
    ("ICL" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG) ("autosomal recessive" . SPARSER::PROTEIN)
    ("FA-S" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN)
    ("growth factors, cytokine and hormone" . SPARSER::COLLECTION)
    ("PAK1, FLNa, and SH2B1β" . SPARSER::COLLECTION)
    ("JAK2-PAK1-FLNa" . SPARSER::COLLECTION)
    ("PAK1/FLNa" . SPARSER::COLLECTION) ("ECM and MMP-3" . SPARSER::COLLECTION)
    ("Erk 1/2, p38 MAPK, and JNK 1/2" . SPARSER::COLLECTION)
    ("cytokines (PRL) and the ECM (collagen IV)" . SPARSER::COLLECTION)
    ("integrins and pTyr-PAK1" . SPARSER::COLLECTION)
    ("MMP-1 and -3" . SPARSER::COLLECTION) ("distinct MMPs" . SPARSER::PROTEIN)
    ("matrixes" . SPARSER::PROTEIN-FAMILY)
    ("integrins/DDRs" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-1, -2, and -3" . SPARSER::COLLECTION)
    ("PRL and PAK1" . SPARSER::COLLECTION)
    ("MMP-13 and MMP-14" . SPARSER::COLLECTION)
    ("PAK1 and JNK" . SPARSER::COLLECTION)
    ("dominant-negative PAK1 or knock-down PAK1" . SPARSER::COLLECTION)
    ("dominant-negative PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src/FAK" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("MAPK/AP-1" . SPARSER::COLLECTION)
    ("Rac1b and transcriptional factor Snail [ xref ]" . SPARSER::COLLECTION)
    ("considerable ECM" . SPARSER::PROTEIN)
    ("MMP-3, or stromelysin" . SPARSER::COLLECTION)
    ("laminins" . SPARSER::PROTEIN-FAMILY) ("stromelysin" . SPARSER::PROTEIN)
    ("aggrecan, entactin, tenascin, and perlican" . SPARSER::COLLECTION)
    ("tenascin" . SPARSER::PROTEIN) ("entactin" . SPARSER::PROTEIN)
    ("VII" . SPARSER::PROTEIN)
    ("a major proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPases, MAPKs, and PI3-kinases" . SPARSER::COLLECTION)
    ("integrins and discoidin" . SPARSER::COLLECTION)
    ("DDRs" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("matrix-receptors" . SPARSER::COLLECTION) ("acini" . SPARSER::PROTEIN)
    ("growth factors/cytokines" . SPARSER::COLLECTION)
    ("the focal complexes" . SPARSER::BIO-COMPLEX)
    ("the focal complex" . SPARSER::BIO-COMPLEX)
    ("the GIT1/βPIX/pTyr-PAK1 complex and subsequent formation of new paxillin-containing focal complexes"
     . SPARSER::COLLECTION)
    ("new paxillin-containing focal complexes" . SPARSER::BIO-COMPLEX)
    ("PRL/JAK2" . SPARSER::COLLECTION) ("PAK1/βPIX/GIT1" . SPARSER::COLLECTION)
    ("GIT1/βPIX/PAK1" . SPARSER::COLLECTION)
    ("this trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("GIT1 and GIT1" . SPARSER::COLLECTION) ("PAK1/βPIX" . SPARSER::COLLECTION)
    ("the βPIX protein as well as the GIT1 protein" . SPARSER::COLLECTION)
    ("Focal complexes" . SPARSER::BIO-COMPLEX)
    ("proteins, and regulators of GTPase activity" . SPARSER::REGULATOR)
    ("a focal complex" . SPARSER::BIO-COMPLEX)
    ("proteins, and regulators" . SPARSER::COLLECTION)
    ("larger focal complexes" . SPARSER::BIO-COMPLEX)
    ("FAK and paxillin" . SPARSER::COLLECTION) ("talin" . SPARSER::PROTEIN)
    ("JAK2/PAK1/FLNa-actin" . SPARSER::COLLECTION)
    ("JAK2/PAK1/FLNa" . SPARSER::COLLECTION)
    ("PRLR-JAK2" . SPARSER::COLLECTION)
    ("PAK1 or filamin" . SPARSER::COLLECTION)
    ("Filamins" . SPARSER::PROTEIN-FAMILY)
    ("filamins" . SPARSER::PROTEIN-FAMILY)
    ("Filamin" . SPARSER::PROTEIN-FAMILY) ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("threefold more GIT1" . SPARSER::PROTEIN)
    ("PAK1 and βPIX" . SPARSER::COLLECTION)
    ("this complex and formation of the four-molecule PAK1/βPIX/GIT1/paxillin signaling module transiently targets PAK1"
     . SPARSER::COLLECTION)
    ("the four-molecule PAK1/βPIX/GIT1/paxillin signaling module transiently targets PAK1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK1/βPIX/GIT1/paxillin" . SPARSER::COLLECTION)
    ("GIT-βPIX" . SPARSER::COLLECTION) ("GIT" . SPARSER::PROTEIN)
    ("βPIX and GIT1" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("βPIX/GIT1" . SPARSER::COLLECTION)
    ("Raf-1, MEK and Erk" . SPARSER::COLLECTION)
    ("further activating PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK1 and constitutively active JAK2 V617F" . SPARSER::COLLECTION)
    ("Akt [ xref ] and FLNa [ xref ]" . SPARSER::COLLECTION)
    ("FLNa" . SPARSER::PROTEIN) ("Y3F" . SPARSER::PROTEIN)
    ("JAK2-phosphorylation-deficient mutant PAK1 Y3F" . SPARSER::PROTEIN)
    ("PAK1 Y3F" . SPARSER::PROTEIN)
    ("HER3 (human epidermal growth factor receptor-3) and HER4 (human epidermal growth factor receptor-4)"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor-3" . SPARSER::COLLECTION)
    ("exogenous H4 histone" . SPARSER::PROTEIN)
    ("CtBP1 and Snail" . SPARSER::COLLECTION) ("PPARgamma" . SPARSER::PROTEIN)
    ("CtBP" . SPARSER::PROTEIN) ("Ajuba" . SPARSER::PROTEIN)
    ("Snail, SNAILP, and SLUG" . SPARSER::COLLECTION)
    ("pathogenic EMT" . SPARSER::PROTEIN)
    ("E-cadherin, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("myosin–actin" . SPARSER::COLLECTION)
    ("actin–myosin" . SPARSER::COLLECTION)
    ("myosins" . SPARSER::PROTEIN-FAMILY) ("cofilin" . SPARSER::PROTEIN)
    ("myosin light chain (MLC) and myosin light chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("p41-Arc" . SPARSER::COLLECTION) ("MLCK" . SPARSER::PROTEIN)
    ("Arc" . SPARSER::PROTEIN) ("FKHR" . SPARSER::PROTEIN)
    ("NIK" . SPARSER::PROTEIN) ("Ras, Raf-1, and Rac1" . SPARSER::COLLECTION)
    ("DLC1 and BimL" . SPARSER::COLLECTION) ("DLC1/BimL" . SPARSER::COLLECTION)
    ("BimL" . SPARSER::PROTEIN)
    ("the HIV viral Nef protein" . SPARSER::PROTEIN)
    ("the prosurvival proteins Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("PAK1/Nck" . SPARSER::COLLECTION) ("PIX/GIT1" . SPARSER::COLLECTION)
    ("several microtubule-associated proteins" . SPARSER::PROTEIN)
    ("Tubulin" . SPARSER::PROTEIN)
    ("centrosomes and aberrant mitoses [ xref ]" . SPARSER::COLLECTION)
    ("Etk/Bmx" . SPARSER::COLLECTION) ("Bmx" . SPARSER::PROTEIN)
    ("hyperactive PAK1 and its upstream regulator Rac3 [ xref ]"
     . SPARSER::COLLECTION)
    ("hyperactive PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both a kinase and a scaffolding protein" . SPARSER::COLLECTION)
    ("Nck-PAK1" . SPARSER::COLLECTION) ("PAK1-Nck" . SPARSER::COLLECTION)
    ("together both Akt and PDK1" . SPARSER::COLLECTION)
    ("Akt and PDK1" . SPARSER::COLLECTION)
    ("MEK and Raf-1" . SPARSER::COLLECTION)
    ("Raf-1, MEK, and ERK" . SPARSER::COLLECTION)
    ("Scaffold" . SPARSER::SCAFFOLD) ("POPX1 and POPX2" . SPARSER::COLLECTION)
    ("P35/Cdk5" . SPARSER::COLLECTION)
    ("first 70 amino acids of PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hPIP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRIPak" . SPARSER::PROTEIN)
    ("Cystein" . SPARSER::MOLECULE) ("Nischarin" . SPARSER::PROTEIN)
    ("Etk/BMX" . SPARSER::COLLECTION) ("BMX" . SPARSER::PROTEIN)
    ("Etk" . SPARSER::PROTEIN) ("Nck/Grb" . SPARSER::COLLECTION)
    ("Grb" . SPARSER::PROTEIN) ("FlnA" . SPARSER::PROTEIN)
    ("Rho-GTPase/PAK1" . SPARSER::COLLECTION)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("Cdc42 or Rac1" . SPARSER::COLLECTION) ("Inactive" . SPARSER::INACTIVE)
    ("GTPases, Cdc42, and Rac" . SPARSER::COLLECTION)
    ("PIX" . SPARSER::PROTEIN) ("Nck and Grb2" . SPARSER::COLLECTION)
    ("PAKs 1–3" . SPARSER::COLLECTION) ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("PRL-" . SPARSER::PROTEIN)
    ("a serine-threonine kinase p21-activated kinase 1 (PAK1) and its substrate"
     . SPARSER::COLLECTION)
    ("Nek3 and focal adhesion protein paxillin" . SPARSER::COLLECTION)
    ("Vav1/Vav2" . SPARSER::COLLECTION) ("NIMA" . SPARSER::PROTEIN-FAMILY)
    ("Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("cytokines, and growth factors" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("PRLRs" . SPARSER::PROTEIN)
    ("prolactin receptor (PRLR)" . SPARSER::PROTEIN)
    ("PRLR" . SPARSER::PROTEIN) ("PRL/PAK1" . SPARSER::COLLECTION)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("prolactin" . SPARSER::PROTEIN)
    ("JNK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk 1/2" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("MMP-14" . SPARSER::PROTEIN) ("pERK 1/2" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("Rac1b" . SPARSER::PROTEIN)
    ("PI3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neuronal migration" . SPARSER::PROTEIN)
    ("sphingosine kinase 1" . SPARSER::PROTEIN) ("SH2B1" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase" . SPARSER::PROTEIN)
    ("P 32" . SPARSER::PROTEIN) ("CtBP1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN) ("p41" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("dynein light chain 1" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN) ("Rac3" . SPARSER::PROTEIN)
    ("POPX2" . SPARSER::PROTEIN) ("POPX1" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("P35" . SPARSER::PROTEIN)
    ("PAKs 1" . SPARSER::PROTEIN) ("p21-Activated Kinase 1" . SPARSER::PROTEIN)
    ("SIRPα" . SPARSER::PROTEIN)
    ("signal regulatory protein" . SPARSER::PROTEIN)
    ("Nek3" . SPARSER::PROTEIN) ("prolactin receptor" . SPARSER::PROTEIN)
    ("βPIX" . SPARSER::PROTEIN) ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("calcium and F-actin" . SPARSER::COLLECTION)
    ("showed decreased intracellular calcium (Additional file xref : Figure S10) as well as numerous bacterial aggregates (Figure  xref )"
     . SPARSER::COLLECTION)
    ("EGFR or PDGFRβ" . SPARSER::COLLECTION)
    ("F-actin and calcium" . SPARSER::COLLECTION)
    ("PLCγ1 and calcium" . SPARSER::COLLECTION)
    ("regulators of calcium release and uptake (IP3R and SERCA2, respectively)"
     . SPARSER::COLLECTION)
    ("IP3R and SERCA2" . SPARSER::COLLECTION)
    ("EGFR and STAT5" . SPARSER::COLLECTION)
    ("Akt, STAT5 and PLCγ1" . SPARSER::COLLECTION)
    ("PDGFRβ and EGFR" . SPARSER::COLLECTION)
    ("EGFR and F-actin" . SPARSER::COLLECTION)
    ("EB, EGFR and F-actin" . SPARSER::COLLECTION)
    ("siRNA or IgG" . SPARSER::COLLECTION)
    ("Erlotinib, Cetuximab, and EGFR" . SPARSER::COLLECTION)
    ("PDGFR or FGFR" . SPARSER::COLLECTION) ("ionophore" . SPARSER::MOLECULE)
    ("Ionomycin" . SPARSER::DRUG) ("siRNA and PDGFRβ" . SPARSER::COLLECTION)
    ("siRNA or PDGFRβ" . SPARSER::COLLECTION)
    ("previously reported type" . TYPE)
    ("EGFR and PDGFRβ" . SPARSER::COLLECTION)
    ("drug-treated EBs" . SPARSER::PROTEIN)
    ("chlamydial Hsp60" . SPARSER::PROTEIN)
    ("Erlotinib and Cetuximab" . SPARSER::COLLECTION)
    ("the chlamydial Hsp60" . SPARSER::PROTEIN)
    ("Erlotinib or Cetuximab" . SPARSER::COLLECTION)
    ("Erlotinib, Cetuximab or EGFR" . SPARSER::COLLECTION)
    ("EGFR, PLCγ1, STAT5 and Akt" . SPARSER::COLLECTION)
    ("Cetuximab" . SPARSER::DRUG)
    ("PLCγ1, STAT5 and Akt" . SPARSER::COLLECTION)
    ("EGFR, Akt and PLCγ1" . SPARSER::COLLECTION)
    ("PLCγ1 (phospholipase Cγ1) and STAT proteins (signal transducers and activators of transcription)"
     . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("chlamydial FITC-conjugated anti-lipopolysaccharide (LPS) mAb"
     . SPARSER::DRUG)
    ("chlamydial EBs" . SPARSER::PROTEIN)
    ("PDGFRβ or FGFR" . SPARSER::COLLECTION)
    ("Erk1/2 and the downstream Bad protein" . SPARSER::COLLECTION)
    ("Bad" . SPARSER::PROTEIN) ("PI3K and Erk1/2" . SPARSER::COLLECTION)
    ("the EBs and the receptor" . SPARSER::COLLECTION)
    ("the chlamydial EBs" . SPARSER::PROTEIN)
    ("FGFR and PDGFRβ" . SPARSER::COLLECTION)
    ("infectious form" . SPARSER::FORM)
    ("EGFR and not PDGFRβ that affects the formation" . SPARSER::COLLECTION)
    ("EGFR and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("PLCγ1, Akt and STAT5" . SPARSER::COLLECTION) ("Fluo-4" . SPARSER::DRUG)
    ("anti -" . SPARSER::ANTIBODY) ("AG1478" . SPARSER::DRUG)
    ("SERCA2" . SPARSER::PROTEIN) ("IP3 receptor" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN) ("C-E" . SPARSER::PROTEIN)
    ("Pmp21" . SPARSER::PROTEIN) ("ER-, PR-, or HER2+" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("wine" . SPARSER::MOLECULE)
    ("ER and AR" . SPARSER::COLLECTION)
    ("This cross-sectional study aims" . SPARSER::PROTEIN)
    ("aims" . SPARSER::PROTEIN) ("dietary lignans" . SPARSER::MOLECULE)
    ("particular lignans" . SPARSER::MOLECULE)
    ("Dietary phytoestrogens" . SPARSER::MOLECULE)
    ("phytoestrogens" . SPARSER::MOLECULE)
    ("lignans and AR" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("Lignan" . SPARSER::MOLECULE) ("lignan" . SPARSER::MOLECULE)
    ("lignans" . SPARSER::MOLECULE) ("phytoestrogen" . SPARSER::MOLECULE)
    ("Lignans" . SPARSER::MOLECULE) ("HER 2" . SPARSER::PROTEIN)
    ("a new SNP" . SPARSER::PROTEIN)
    ("RHOB and FAM167A-BLK variants" . SPARSER::COLLECTION)
    ("Other genes such as STAT4 and loci" . SPARSER::COLLECTION)
    ("the two associated SNPs" . SPARSER::PROTEIN)
    ("FAM167A and BLK" . SPARSER::COLLECTION)
    ("AKT1/AKT" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("RHOB and SSc" . SPARSER::COLLECTION)
    ("allele and SSc" . SPARSER::COLLECTION) ("Genotypes" . SPARSER::PROTEIN)
    ("Alleles" . SPARSER::ALLELE) ("autoantibody" . SPARSER::PROTEIN)
    ("polymorphism" . SPARSER::PROTEIN) ("antibody (ACA)" . SPARSER::ANTIBODY)
    ("FAM167A (family with sequence similarity 167 member A) and BLK (B lymphoid tyrosine kinase) also known as C8orf13-BLK"
     . SPARSER::COLLECTION)
    ("only several tag-SNPs" . SPARSER::PROTEIN)
    ("the largest SSc patient group" . SPARSER::MOLECULE)
    ("RHOB and PSORS1C1" . SPARSER::COLLECTION)
    ("TNIP1, RHOB , and PSORS1C1" . SPARSER::COLLECTION)
    ("HLA-DQB1 and PSORS1C1" . SPARSER::COLLECTION) ("HLA" . SPARSER::PROTEIN)
    ("a French Caucasian SSc discovery cohort xref 17 single-nucleotide polymorphisms"
     . SPARSER::PROTEIN)
    ("RHOB and FAM167A-BLK polymorphisms" . SPARSER::COLLECTION)
    ("the RHOB and FAM167A-BLK genes" . SPARSER::COLLECTION)
    ("95% confidence interval (CI) = 1.05–2.50" . SPARSER::PROTEIN)
    ("RHOB and FAM167A-BLK gene polymorphisms" . SPARSER::COLLECTION)
    ("FAM167A-BLK" . SPARSER::COLLECTION) ("polymorphisms" . SPARSER::PROTEIN)
    ("BLK" . SPARSER::PROTEIN) ("RHOB" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("member A" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN)
    ("ras homolog gene family" . SPARSER::PROTEIN)
    ("PSORS1C1" . SPARSER::PROTEIN) ("HLA-DQB1" . SPARSER::PROTEIN)
    ("SNP" . SPARSER::PROTEIN) ("SNPs" . SPARSER::PROTEIN)
    ("p-SNPs" . SPARSER::PROTEIN-PAIR) ("p-SNP" . SPARSER::COLLECTION)
    ("their prospective cohort" . SPARSER::MOLECULE)
    ("foxo1, foxo3, and foxo4" . SPARSER::COLLECTION)
    ("foxo4" . SPARSER::PROTEIN)
    ("foxo3a or its homologues" . SPARSER::COLLECTION)
    ("foxo3a" . SPARSER::PROTEIN)
    ("FOXO1A , FOXO4, and FOXO6" . SPARSER::COLLECTION)
    ("gene ( APOE)" . SPARSER::GENE)
    ("longevity-associated gene" . SPARSER::GENE)
    ("foxo" . SPARSER::PROTEIN-FAMILY) ("foxo1" . SPARSER::PROTEIN)
    ("Foxo3" . SPARSER::PROTEIN) ("foxo3" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXO1A" . SPARSER::PROTEIN) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("forkhead box O3" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("the type and dose" . SPARSER::COLLECTION)
    ("SB203580, and HMGB1" . SPARSER::COLLECTION)
    ("HMGB1 (glycyrrhizic acid 10 mM/ml) and SB203580 (p38MAPK inhibitor)"
     . SPARSER::COLLECTION)
    ("LPS and HMGB1" . SPARSER::COLLECTION)
    ("TLR4-NF-κB" . SPARSER::COLLECTION)
    ("polysaccharide (PGPS)" . SPARSER::POLYSACCHARIDE)
    ("TLR2, TLR4 and RAGE" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("TLR2 (at higher doses of HMGB1) or TLR4 (at lower doses and may be with higher affinity)"
     . SPARSER::COLLECTION)
    ("Group (HMG)" . SPARSER::MOLECULE) ("ERK or JNK" . SPARSER::COLLECTION)
    ("pg" . SPARSER::MOLECULE)
    ("ERK, JNK, STAT1, c-JUN, p53, MEK-1, MSK-1, and ATF-2"
     . SPARSER::COLLECTION)
    ("TLR2 and TLR4" . SPARSER::COLLECTION)
    ("RAGE, TLR2, and TLR4" . SPARSER::COLLECTION)
    ("CSE and LPS" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("RAGE" . SPARSER::PROTEIN)
    ("a non-histone chromatin-associated nuclear protein" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY) ("TLR2" . SPARSER::PROTEIN)
    ("LPS and CSE" . SPARSER::COLLECTION) ("CSE" . SPARSER::PROTEIN)
    ("PTB and pPROM" . SPARSER::COLLECTION) ("tissue type" . SPARSER::PROTEIN)
    ("SB 203580" . SPARSER::DRUG) ("MSK-1" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("Pp38" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("IL1β" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HMGB1" . SPARSER::PROTEIN)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("viral receptors" . SPARSER::PROTEIN)
    ("CD4 and CCR5" . SPARSER::COLLECTION)
    ("macrophages and monocytes" . SPARSER::COLLECTION)
    ("YU2" . SPARSER::PROTEIN) ("CD4- and CCR5-gp120" . SPARSER::COLLECTION)
    ("CD4-" . SPARSER::PROTEIN) ("YU2-luc" . SPARSER::PROTEIN-PAIR)
    ("BaL-luc" . SPARSER::COLLECTION)
    ("HIV-1 BaL and HIV-1 YU2 ( xref A)" . SPARSER::COLLECTION)
    ("robust luciferase" . SPARSER::PROTEIN)
    ("both HIV-1 BaL and HIV-1 IIIB -infected MDMs" . SPARSER::COLLECTION)
    ("a stringent CD3 mask" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Luc" . SPARSER::PROTEIN) ("-eGFP-BaL" . SPARSER::COLLECTION)
    ("AZT" . SPARSER::DRUG) ("-receptor" . SPARSER::RECEPTOR)
    ("Jasplakinolide" . SPARSER::DRUG)
    ("jasplakinolide or amiloride" . SPARSER::COLLECTION)
    ("EIPA" . SPARSER::DRUG) ("amiloride" . SPARSER::DRUG)
    ("jasplakinolide" . SPARSER::DRUG)
    ("MDM-associated viral (v)DNA ( xref A) or luciferase content"
     . SPARSER::COLLECTION)
    ("the luciferase reporter HIV-1 infectious molecular clone (IMC) HIV-1 BaL-Luc"
     . SPARSER::PROTEIN-PAIR)
    ("MDM-associated viral (v)DNA" . SPARSER::DNA)
    ("BaL-Luc" . SPARSER::COLLECTION) ("/PS" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("MDMs " . SPARSER::PROTEIN)
    ("BaL" . SPARSER::PROTEIN)
    ("primary monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("MDMs" . SPARSER::PROTEIN) ("Macrophage" . SPARSER::PROTEIN)
    ("CCR5 and CXCR4" . SPARSER::COLLECTION)
    ("innate immune sentinels" . SPARSER::DRUG) ("sentinels" . SPARSER::DRUG)
    ("viral entry receptors" . SPARSER::RECEPTOR) ("CD14" . SPARSER::PROTEIN)
    ("p55" . SPARSER::PROTEIN) ("p17" . SPARSER::PROTEIN)
    ("sCD4" . SPARSER::PROTEIN) ("MDM 1" . SPARSER::PROTEIN)
    ("per 1 " . SPARSER::PROTEIN) ("T-Cell" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("A–S2" . SPARSER::PROTEIN)
    ("Caspase3" . SPARSER::PROTEIN) ("A–S1" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2 or NRF2" . SPARSER::COLLECTION)
    ("paraquat and doxorubicin" . SPARSER::COLLECTION)
    ("a chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("an oxidative stress-inducing agent paraquat" . SPARSER::MOLECULE)
    ("HER2-NRF2" . SPARSER::COLLECTION) ("HRG" . SPARSER::PROTEIN)
    ("HER2CA" . SPARSER::PROTEIN) ("GFP-NRF2" . SPARSER::COLLECTION)
    ("HER2CA-NRF2" . SPARSER::PROTEIN-PAIR)
    ("NRF2 or HER2CA" . SPARSER::COLLECTION)
    ("GSTP1 and CYP3A4" . SPARSER::COLLECTION)
    ("HO-1, MRP1, and MRP5" . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase catalytic subunit (GCLC) and MRP2"
     . SPARSER::COLLECTION)
    ("GSTA2, GSTP1, and CYP3A4" . SPARSER::COLLECTION)
    ("GCLC" . SPARSER::PROTEIN)
    ("antioxidant and detoxification genes" . SPARSER::COLLECTION)
    ("KEAP1-siRNA" . SPARSER::COLLECTION) ("quinone" . SPARSER::PROTEIN)
    ("tBHQ" . SPARSER::DRUG) ("HO-1 and MRP5" . SPARSER::COLLECTION)
    ("oxygenase" . SPARSER::PROTEIN)
    ("phospho-AKT (S473) and phospho-ERK1/2 (T202/Y204)" . SPARSER::COLLECTION)
    ("FLAG-NRF2" . SPARSER::COLLECTION)
    ("NRF2 and active" . SPARSER::COLLECTION)
    ("NRF2 and HER2" . SPARSER::COLLECTION) ("WTX" . SPARSER::PROTEIN)
    ("transducin" . SPARSER::PROTEIN)
    ("CNC homology-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("erythroid" . SPARSER::PROTEIN)
    ("member 1 (ABCB1) and ABCC3" . SPARSER::COLLECTION)
    ("survivin, p21, and p53" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("paraquat or doxorubicin" . SPARSER::COLLECTION)
    ("paraquat" . SPARSER::MOLECULE) ("NRF2 and HER2CA" . SPARSER::COLLECTION)
    ("GSTA2, GSTP1, CYP3A4, HO-1, MRP1, and MRP5" . SPARSER::COLLECTION)
    ("a constitutively active HER2 (HER2CA) and NRF2" . SPARSER::COLLECTION)
    ("proteins, HO-1 and MRP5" . SPARSER::COLLECTION)
    ("HER2 and NRF2" . SPARSER::COLLECTION) ("c-3" . SPARSER::PROTEIN)
    ("A–3" . SPARSER::PROTEIN) ("A –3" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("MRP4" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase catalytic subunit" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG)
    ("partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("CRIF1" . SPARSER::PROTEIN)
    ("CR6-interacting factor 1" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("ABCC3" . SPARSER::PROTEIN) ("family B" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("CYP3A4" . SPARSER::PROTEIN)
    ("GSTA2" . SPARSER::PROTEIN) ("MRP5" . SPARSER::PROTEIN)
    ("potentially receptor subunits" . SPARSER::FRAGMENT)
    ("Ras-ERK1/2" . SPARSER::COLLECTION) ("lovastatin" . SPARSER::DRUG)
    ("Alanine" . SPARSER::AMINO-ACID) ("neuronal mRNAs" . SPARSER::PROTEIN)
    ("4EBPs, S6Ks, and phospho-eIF4E" . SPARSER::COLLECTION)
    ("Mmp9 , Mmp2 , Mmp3 , Mmp7 , and Mmp24" . SPARSER::COLLECTION)
    ("Camk2a" . SPARSER::PROTEIN) ("Phopsho-eIF4E" . SPARSER::COLLECTION)
    ("protein and phospho-eIF4E" . SPARSER::COLLECTION)
    ("a cardinal effector" . SPARSER::EFFECTOR) ("DHPG" . SPARSER::DRUG)
    ("LTD and FXS-like" . SPARSER::COLLECTION)
    ("increased tonic-clonic seizures" . SPARSER::PROTEIN)
    ("significantly more active" . SPARSER::ACTIVE)
    ("seizures, and epilepsy" . SPARSER::COLLECTION)
    ("epilepsy" . SPARSER::PROTEIN) ("seizures" . SPARSER::PROTEIN)
    ("group 1-metabotropic glutamate receptors" . SPARSER::RECEPTOR)
    ("LTD" . SPARSER::PROTEIN)
    ("enhanced hippo-campal mGluR-LTD" . SPARSER::PROTEIN-PAIR)
    ("mGluR-LTD" . SPARSER::COLLECTION) ("/Eif4E" . SPARSER::COLLECTION)
    ("Eif4E" . SPARSER::PROTEIN)
    ("Mmp2 , Mmp3 , Mmp7 , and Mmp24" . SPARSER::COLLECTION)
    ("Mmp24" . SPARSER::PROTEIN) ("Mmp7" . SPARSER::PROTEIN)
    ("Polysomes" . SPARSER::BIO-COMPLEX) ("/Eif4e" . SPARSER::COLLECTION)
    ("Puromycin" . SPARSER::DRUG)
    ("significantly more puromycin" . SPARSER::DRUG)
    ("Eif4e" . SPARSER::PROTEIN) ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CA1" . SPARSER::PROTEIN) ("wire" . SPARSER::PROTEIN)
    ("p-eIF4E" . SPARSER::COLLECTION) ("eIF4E and MMP-9" . SPARSER::COLLECTION)
    ("antibiotic" . SPARSER::DRUG) ("minocycline" . SPARSER::DRUG)
    ("Minocycline" . SPARSER::DRUG)
    ("Metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NMDA" . SPARSER::MOLECULE) ("Mnk1 and Mnk2" . SPARSER::COLLECTION)
    ("CPEB" . SPARSER::PROTEIN)
    ("4E-BPs ( e ukaryotic I nitiation F actor 4E-B inding P roteins, which are inhibitors of eIF4E) and S6Ks (ribosomal protein S6 Kinases)"
     . SPARSER::COLLECTION)
    ("Kinases" . SPARSER::KINASE) ("BPs" . SPARSER::PROTEIN)
    ("PI3K/Akt/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("synaptic plasticity-related mRNAs" . SPARSER::PROTEIN)
    ("the metabotropic glutamate receptor" . SPARSER::PROTEIN)
    ("mGluR" . SPARSER::PROTEIN) ("ASD" . SPARSER::PROTEIN)
    ("FMRP" . SPARSER::PROTEIN) ("Mmp-9" . SPARSER::PROTEIN)
    ("Fmr1" . SPARSER::PROTEIN) ("pheno" . SPARSER::DRUG)
    ("4EBPs" . SPARSER::PROTEIN) ("K1" . SPARSER::PROTEIN)
    ("Map1B" . SPARSER::PROTEIN) ("Camk2" . SPARSER::PROTEIN)
    ("Shank3" . SPARSER::PROTEIN) ("Shank2" . SPARSER::PROTEIN)
    ("Shank1" . SPARSER::PROTEIN) ("Map1b" . SPARSER::PROTEIN)
    ("Dlg4" . SPARSER::PROTEIN) ("Mmp3" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN) ("Mnk2" . SPARSER::PROTEIN)
    ("Mnk1" . SPARSER::PROTEIN) ("element binding protein" . SPARSER::PROTEIN)
    ("4E-BP2" . SPARSER::PROTEIN) ("S6Ks" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN) ("glutamate receptor" . SPARSER::PROTEIN)
    ("FMR1" . SPARSER::PROTEIN)
    ("fragile X mental retardation 1" . SPARSER::PROTEIN)
    ("EGFR-RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("HMGA2 , LIN28 , SNAIL , HOXA7 or HOXA9" . SPARSER::COLLECTION)
    ("BRAF, ERK and let-7" . SPARSER::COLLECTION)
    ("The architectural transcription factor high mobility group AT-hook 2"
     . SPARSER::PROTEIN)
    ("Tet1 and Tet2" . SPARSER::COLLECTION) ("Dnmt" . SPARSER::PROTEIN)
    ("Fas and Sfrp1" . SPARSER::COLLECTION)
    ("KRAS and TET1" . SPARSER::COLLECTION)
    ("KRAS-ERK-TSG" . SPARSER::COLLECTION)
    ("Fas , Sfrp1 and Lox" . SPARSER::COLLECTION) ("Lox" . SPARSER::PROTEIN)
    ("Tet2 and Tet3" . SPARSER::COLLECTION) ("Tet3" . SPARSER::PROTEIN)
    ("TET1 and 5hmC" . SPARSER::COLLECTION)
    ("PD98059 or LY294002" . SPARSER::COLLECTION)
    ("2 μM PI3K inhibitor LY294002 ( xref ) or 30 μM MEK inhibitor PD98059 ( xref )"
     . SPARSER::COLLECTION)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("TET2 and TET3" . SPARSER::COLLECTION)
    ("methyltransferases, DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("DAPK , MGMT and DUOX1" . SPARSER::COLLECTION)
    ("Bisulfite" . SPARSER::MOLECULE)
    ("TIMP3 ( xref ) and GATA4 ( xref )" . SPARSER::COLLECTION)
    ("DAPK ( xref ), MGMT ( xref ), DUOX1 ( xref ), TIMP3 ( xref ) and GATA4 ( xref )"
     . SPARSER::COLLECTION)
    ("DAPK" . SPARSER::PROTEIN) ("hyperactive KRAS" . SPARSER::PROTEIN)
    ("myc-KRAS" . SPARSER::COLLECTION) ("RAS-ERK" . SPARSER::COLLECTION)
    ("proteins and 5hmC" . SPARSER::COLLECTION) ("fC" . SPARSER::PROTEIN)
    ("TET1, TET2 and TET3" . SPARSER::COLLECTION) ("iron" . SPARSER::MOLECULE)
    ("the principal mediators" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("Cytosine" . SPARSER::NUCLEOBASE)
    ("Hyperactive RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("KRAS, HRAS and NRAS" . SPARSER::COLLECTION)
    ("KRAS/TET1" . SPARSER::COLLECTION)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("NC1" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("HOXA7" . SPARSER::PROTEIN) ("LIN28" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA)
    ("high mobility group AT-hook 2" . SPARSER::PROTEIN)
    ("Sfrp1" . SPARSER::PROTEIN) ("Tet2" . SPARSER::PROTEIN)
    ("Tet1" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("DUOX1" . SPARSER::PROTEIN) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("TET3" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("Dnmt1" . SPARSER::PROTEIN) ("TET1" . SPARSER::PROTEIN)
    ("Rac1 and NF-κB" . SPARSER::COLLECTION)
    ("Sema3C or Rac1" . SPARSER::COLLECTION) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("Survivin and XIAP" . SPARSER::COLLECTION)
    ("PI3K–Akt and p38" . SPARSER::COLLECTION)
    ("aflibercept (VEGF-Trap) and bevacizumab (Avastin)" . SPARSER::COLLECTION)
    ("VEGF-Trap" . SPARSER::COLLECTION) ("Avastin" . SPARSER::DRUG)
    ("Trap" . SPARSER::PROTEIN) ("aflibercept" . SPARSER::DRUG)
    ("cultured NPCs and native NPCs" . SPARSER::COLLECTION)
    ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous Sema3C" . SPARSER::PROTEIN)
    ("Flag-Rac1Q61L" . SPARSER::COLLECTION)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("cyclinD1, XIAP and Survivin" . SPARSER::COLLECTION)
    ("p65/RelA" . SPARSER::COLLECTION) ("NSTCs and GSCs" . SPARSER::COLLECTION)
    ("the pharmacologic inhibitor NSC23766" . SPARSER::DRUG)
    ("MAPK, JNK, p53 or STAT" . SPARSER::COLLECTION)
    ("ERK or Akt" . SPARSER::COLLECTION)
    ("Ras, Akt and Rac" . SPARSER::COLLECTION) ("Plexins" . SPARSER::PROTEIN)
    ("Sema3C, PlexinA2/D1 and NRP1" . SPARSER::COLLECTION)
    ("Sema3C and its receptors PlexinA2/D1 and NRP1" . SPARSER::COLLECTION)
    ("NSTCs or NPCs" . SPARSER::COLLECTION)
    ("cleaved poly-ADP ribose polymerase (PARP) and the fraction"
     . SPARSER::COLLECTION)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("Sema3C or its receptors PlexinA2 or PlexinD1" . SPARSER::COLLECTION)
    ("Sema4A or Sema6A" . SPARSER::COLLECTION)
    ("NPCs, GSCs and NSTCs" . SPARSER::COLLECTION)
    ("Sema4A and Sema6A" . SPARSER::COLLECTION)
    ("PlexinD1 and PlexinA2" . SPARSER::COLLECTION)
    ("Additional exogenous Sema3C" . SPARSER::PROTEIN)
    ("NSTCs" . SPARSER::PROTEIN)
    ("PlexinA2, PlexinD1 or NRP1" . SPARSER::COLLECTION)
    ("exogenous recombinant human Sema3C" . SPARSER::PROTEIN)
    ("Sema3C, PlexinA2, PlexinD1 or NRP1" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN)
    ("Sema3C, PlexinA2 or PlexinD1" . SPARSER::COLLECTION)
    ("GFP-GSCs" . SPARSER::COLLECTION)
    ("GFP (GFP-GSC-shSema3C) or RFP (RFP-GSC)" . SPARSER::COLLECTION)
    ("healthy GSCs" . SPARSER::PROTEIN) ("GFP-NSTCs" . SPARSER::PROTEIN-PAIR)
    ("RFP-GSCs" . SPARSER::COLLECTION)
    ("Sema3C shRNA or NT shRNA" . SPARSER::COLLECTION)
    ("RFP or GFP" . SPARSER::COLLECTION)
    ("Sema3C or PlexinA2/D1" . SPARSER::COLLECTION)
    ("PlexinA2 or PlexinD1" . SPARSER::COLLECTION)
    ("Sox2 or Olig2" . SPARSER::COLLECTION)
    ("Sema3C and its receptors PlexinA2/D1" . SPARSER::COLLECTION)
    ("Sema3C and its receptors ( xref )" . SPARSER::COLLECTION)
    ("Sema3A and Sema3B" . SPARSER::COLLECTION) ("Sema3B" . SPARSER::PROTEIN)
    ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSCs and NSTCs" . SPARSER::COLLECTION)
    ("CD133, Olig2 and Sox2" . SPARSER::COLLECTION)
    ("PlexinA2 (p<0.0001) and PlexinD1 (p<0.0001)" . SPARSER::COLLECTION)
    ("Sema3C and PlexinA2/D1" . SPARSER::COLLECTION)
    ("PlexinA2 and PlexinD1" . SPARSER::COLLECTION)
    ("PlexinA2" . SPARSER::PROTEIN)
    ("Sema3C and Its Receptors PlexinA2/D1" . SPARSER::COLLECTION)
    ("plexin" . SPARSER::PROTEIN) ("semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("Neuropilins and plexins" . SPARSER::COLLECTION)
    ("plexins" . SPARSER::PROTEIN) ("Neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("Sema3C and its receptors" . SPARSER::COLLECTION)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("HGF/cMET" . SPARSER::COLLECTION) ("cMET" . SPARSER::PROTEIN)
    ("cell adhesion molecules and extracellular matrix components"
     . SPARSER::COLLECTION)
    ("NPCs" . SPARSER::MOLECULE) ("Rac1/NF-κB" . SPARSER::COLLECTION)
    ("GSCs" . SPARSER::PROTEIN) ("PI3K–Akt" . SPARSER::PROTEIN)
    ("LGR5" . SPARSER::PROTEIN) ("phospho-kinase" . SPARSER::PROTEIN)
    ("Sema6A" . SPARSER::PROTEIN) ("Sema4A" . SPARSER::PROTEIN)
    ("Sema3A" . SPARSER::PROTEIN) ("NRP2" . SPARSER::PROTEIN)
    ("NRP1" . SPARSER::PROTEIN) ("Neuropilin1" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("PlexinD1" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("Sema3C" . SPARSER::PROTEIN) ("prion" . SPARSER::PROTEIN-FAMILY)
    ("penetratin" . SPARSER::DRUG) ("CPP" . SPARSER::MOLECULE)
    ("CPPs" . SPARSER::MOLECULE) ("a fluorescent FAM" . SPARSER::PROTEIN)
    ("an essential
phenylalanine"
     . SPARSER::AMINO-ACID)
    ("dual p53-Mdm2 and p53-Mdm4 antagonists" . SPARSER::MOLECULE)
    ("McoTi-1-PMI" . SPARSER::COLLECTION) ("PMI" . SPARSER::PROTEIN)
    ("components or proteins" . SPARSER::COLLECTION)
    ("simply luciferase inhibitors" . SPARSER::INHIBITOR)
    ("Phe, Trp and Leu" . SPARSER::COLLECTION) ("Phe" . SPARSER::AMINO-ACID)
    ("pyrrolopyrimidine" . SPARSER::DRUG)
    ("all soluble cellular proteins" . SPARSER::PROTEIN)
    ("PLB" . SPARSER::PROTEIN) ("BRCA1-BARD1" . SPARSER::COLLECTION)
    ("Dual Mdm2 and Mdm4 antagonist SAH peptides" . SPARSER::PEPTIDE)
    ("these peptidic
drugs"
     . SPARSER::DRUG)
    ("Mdm2 and
Mdm4"
     . SPARSER::COLLECTION)
    ("Mdm2-Mdm4" . SPARSER::COLLECTION) ("RO" . SPARSER::PROTEIN)
    ("BiLC" . SPARSER::PROTEIN)
    ("a previously
reported small molecule p53-Mdm4 antagonist"
     . SPARSER::MOLECULE)
    ("p53- and Mdm2-BiLC" . SPARSER::COLLECTION)
    ("Mdm2-BiLC" . SPARSER::PROTEIN-PAIR)
    ("p53- and Mdm2-split" . SPARSER::COLLECTION)
    ("a small
molecule’s"
     . SPARSER::MOLECULE)
    ("peptide, and cyclotide" . SPARSER::COLLECTION)
    ("Several small molecule and peptide-based compounds"
     . SPARSER::COLLECTION)
    ("both ReBiL and
random integrated cells generated higher total BiLC"
     . SPARSER::COLLECTION)
    ("Ube2t and FANCL_C307A" . SPARSER::COLLECTION)
    ("ReBiL" . SPARSER::PROTEIN)
    ("Ube2t and FANCL or Ube2t" . SPARSER::COLLECTION)
    ("FANCL or Ube2t" . SPARSER::COLLECTION)
    ("mutant and wild type alleles" . SPARSER::COLLECTION)
    ("split fluorescent proteins" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN)
    ("molecule and peptide" . SPARSER::COLLECTION)
    ("stapled α-helical (SAH) peptides" . SPARSER::PEPTIDE)
    ("SAH" . SPARSER::MOLECULE) ("p53-Mdm4" . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION)
    ("an E3 ubiquitin ligase (Mdm2) and/or a transcriptional repressor (Mdm2 and Mdm4)"
     . SPARSER::COLLECTION)
    ("Mdm2 or Mdm4" . SPARSER::COLLECTION)
    ("Mdm2 and Mdm4" . SPARSER::COLLECTION)
    ("Ube2t-FANCL" . SPARSER::COLLECTION)
    ("Ube2t and FANCL" . SPARSER::COLLECTION)
    ("Ube2T and FANCL" . SPARSER::COLLECTION) ("Cre-" . SPARSER::PROTEIN)
    ("cell permeable PPI therapeutics and
elaboration"
     . SPARSER::COLLECTION)
    ("cell permeable PPI therapeutics" . SPARSER::THERAPEUTICS)
    ("some stapled α-helical
peptides"
     . SPARSER::PEPTIDE)
    ("an E3 ubiquitin ligase and an E2
ubiquitin-conjugating enzyme"
     . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("Trypsin inhibitor" . SPARSER::PROTEIN) ("Phenol-red" . SPARSER::DRUG)
    ("19A" . SPARSER::PROTEIN)
    ("cell
membrane"
     . SPARSER::PROTEIN)
    ("Ube2T" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("residual SIRT1" . SPARSER::PROTEIN)
    ("SCFAs or Sirtinol" . SPARSER::COLLECTION)
    ("PRC2 and the SIRT1-containing PRC4 complex" . SPARSER::COLLECTION)
    ("specific viral chromatins" . SPARSER::BIO-COMPLEX)
    ("chromatins" . SPARSER::BIO-COMPLEX) ("Ac" . SPARSER::PROTEIN)
    ("the viral LTR" . SPARSER::PROTEIN)
    ("the repressive histone" . SPARSER::PROTEIN)
    ("SIRT1, EZH2, and SUV39H1" . SPARSER::COLLECTION)
    ("SIRT1, EZH2 and SUV39H1" . SPARSER::COLLECTION)
    ("their cellular receptors GPR41 and/or GPR43" . SPARSER::COLLECTION)
    ("productive elongation" . SPARSER::PROTEIN) ("NELF" . SPARSER::PROTEIN)
    ("DSIF" . SPARSER::PROTEIN)
    ("the CDK9 serine/threonine kinase and a C-type regulatory cyclin"
     . SPARSER::COLLECTION)
    ("a C-type regulatory cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIV-1 viral RNA" . SPARSER::RNA)
    ("periodontitis and HIV-1 proviral DNA" . SPARSER::DNA)
    ("bacterial SCFAs" . SPARSER::MOLECULE)
    ("Sirtinol and SAHA" . SPARSER::COLLECTION)
    ("SAHA and Sirtinol" . SPARSER::COLLECTION) ("Sirtinol" . SPARSER::DRUG)
    ("RNAP" . SPARSER::PROTEIN) ("suppressive histone" . SPARSER::PROTEIN)
    ("H2B-Ac" . SPARSER::COLLECTION)
    ("both PRC2 (EZH2) and PRC4 (SIRT1)" . SPARSER::COLLECTION)
    ("a larger Polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("EZH2 and another subunit" . SPARSER::COLLECTION)
    ("a rabbit anti-EZH2 antibody or control IgG" . SPARSER::COLLECTION)
    ("EZH2 and SIRT1" . SPARSER::COLLECTION)
    ("repressive histone" . SPARSER::PROTEIN)
    ("EZH2 and histone" . SPARSER::COLLECTION)
    ("proteasome inhibitor MG-132 and proteasome inhibitor II (P-inh-II)"
     . SPARSER::COLLECTION)
    ("H3K27me3 and H3K9" . SPARSER::COLLECTION)
    ("EZH2 and SUV39H1" . SPARSER::COLLECTION)
    ("CDK9 and anti-pS529" . SPARSER::COLLECTION)
    ("CDK9 and CycT1" . SPARSER::COLLECTION)
    ("CycT1 (which leads to assembly of P-TEFb) and an AF750-conjugated antibody"
     . SPARSER::COLLECTION)
    ("an AF750-conjugated antibody" . SPARSER::PROTEIN)
    ("RNP" . SPARSER::PROTEIN) ("TRITC" . SPARSER::MOLECULE)
    ("T-cell receptor (TCR)" . SPARSER::PROTEIN)
    ("CD28 and CD3" . SPARSER::COLLECTION)
    ("an AF647-conjugated antibody" . SPARSER::PROTEIN)
    ("Ki67, CD25, CD69 and Cyclin D3" . SPARSER::COLLECTION)
    ("IL-2 and/or IL-23 (for Th17 cells)" . SPARSER::COLLECTION)
    ("env and nef genes" . SPARSER::COLLECTION)
    ("rev , env and nef genes" . SPARSER::COLLECTION)
    ("env" . SPARSER::PROTEIN) ("VSV" . SPARSER::PROTEIN)
    ("SCFA" . SPARSER::MOLECULE)
    ("at least five different SCFAs" . SPARSER::MOLECULE)
    ("the volatile SCFAs" . SPARSER::MOLECULE)
    ("Pg and Fn" . SPARSER::COLLECTION)
    ("the periodontal pathogens Pg" . SPARSER::MOLECULE)
    ("the proviral promoter" . SPARSER::PROMOTER)
    ("EZH2 (enhancer of Zeste homolog2) and SUV39H1 (suppressor of variegation 3–9 homolog1)"
     . SPARSER::COLLECTION)
    ("NF-κB and NFAT" . SPARSER::COLLECTION)
    ("an essential cofactor" . SPARSER::MOLECULE)
    ("a cellular elongation factor" . SPARSER::PROTEIN)
    ("Pg and Fusobacterium" . SPARSER::COLLECTION) ("Pg" . SPARSER::MOLECULE)
    ("the histone methyltransferases enhancer of Zeste homolog 2 (EZH2) and suppressor of variegation 3–9 homolog 1 (SUV39H1)"
     . SPARSER::COLLECTION)
    ("the proviral LTR" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("an essential cellular cofactor" . SPARSER::MOLECULE)
    ("both Jurkat and primary T-cell" . SPARSER::COLLECTION)
    ("primary T-cell" . SPARSER::PROTEIN) ("SCFAs" . SPARSER::MOLECULE)
    ("CyclinD3" . SPARSER::PROTEIN) ("GPR43" . SPARSER::PROTEIN)
    ("GPR41" . SPARSER::PROTEIN)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("SPT5" . SPARSER::PROTEIN) ("PRC-2" . SPARSER::PROTEIN)
    ("Gö6983" . SPARSER::DRUG) ("Cyclin T1" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("Cyclin D3" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("YM3" . SPARSER::DRUG) ("CyclinT1" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("Lys9" . SPARSER::PROTEIN)
    ("suppressor of variegation 3–9 homolog1" . SPARSER::PROTEIN)
    ("enhancer of Zeste homolog2" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("CycT1" . SPARSER::PROTEIN)
    ("Butyric acid" . SPARSER::MOLECULE) ("SUV39H1" . SPARSER::PROTEIN)
    ("suppressor of variegation 3–9 homolog 1" . SPARSER::PROTEIN)
    ("enhancer of Zeste homolog 2" . SPARSER::PROTEIN)
    ("sirtuin-1" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("short chain" . SPARSER::PROTEIN) ("wt and AR" . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("GR–HSP90" . SPARSER::COLLECTION)
    ("BCAS2 and HSP90" . SPARSER::COLLECTION)
    ("BCAS2–AR" . SPARSER::COLLECTION) ("DDB2-AR" . SPARSER::COLLECTION)
    ("CUL4A–DDB1" . SPARSER::COLLECTION)
    ("an environmental toxin" . SPARSER::MOLECULE)
    ("DDB1–CUL4B" . SPARSER::COLLECTION) ("dioxin" . SPARSER::MOLECULE)
    ("ARA55 and Stat5" . SPARSER::COLLECTION) ("Lv" . SPARSER::MOLECULE)
    ("p53 and RNA" . SPARSER::COLLECTION)
    ("17-AAG-disrupting AR protein" . SPARSER::PROTEIN)
    ("17-AAG-degradating AR protein" . SPARSER::PROTEIN)
    ("EtOH and DHT" . SPARSER::COLLECTION)
    ("DHT and EtOH" . SPARSER::COLLECTION)
    ("trimetric complex" . SPARSER::BIO-COMPLEX)
    ("BCAS2–AR–HSP90" . SPARSER::COLLECTION)
    ("Myc-HSP90" . SPARSER::COLLECTION) ("HA-AR" . SPARSER::COLLECTION)
    ("FLAG-BCAS2" . SPARSER::COLLECTION)
    ("a potential BCAS2-binding protein from proteomic assay ( xref ) and an essential molecular chaperone"
     . SPARSER::COLLECTION)
    ("an essential molecular chaperone" . SPARSER::PROTEIN)
    ("HSP90–AR" . SPARSER::COLLECTION) ("18 h and BCAS2" . SPARSER::COLLECTION)
    ("the heterologous SV40 promoter" . SPARSER::PROMOTER)
    ("p53 and BCAS2" . SPARSER::COLLECTION)
    ("AR and PSA" . SPARSER::COLLECTION) ("gene (PSA)" . SPARSER::GENE)
    ("AR and p53" . SPARSER::COLLECTION)
    ("BCAS2-decreasing p53 and in turn increasing AR" . SPARSER::COLLECTION)
    ("DHT and BCAS2" . SPARSER::COLLECTION) ("BACS" . SPARSER::PROTEIN)
    ("BCAS2 ( xref , lane 2) and ARA70 protein ( xref , lane 3)"
     . SPARSER::COLLECTION)
    ("GST-ARA70" . SPARSER::COLLECTION) ("GST-BCAS2" . SPARSER::COLLECTION)
    ("BCAS2, p53, and AR" . SPARSER::COLLECTION)
    ("a candidate AR-associated protein" . SPARSER::PROTEIN)
    ("AR-associated coregulatory proteins" . SPARSER::PROTEIN)
    ("metnase" . SPARSER::PROTEIN)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("receptor-" . SPARSER::RECEPTOR) ("BCAS2 and PCa" . SPARSER::COLLECTION)
    ("AR and HSP90" . SPARSER::COLLECTION)
    ("BCAS2 and AR" . SPARSER::COLLECTION)
    ("a potential AR-associated protein" . SPARSER::PROTEIN)
    ("CUL4B" . SPARSER::PROTEIN) ("ARA55" . SPARSER::PROTEIN)
    ("aa 1" . SPARSER::PROTEIN) ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α -tubulin" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("potassium hydroxide" . SPARSER::MOLECULE)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("ARA70" . SPARSER::PROTEIN) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("single-strand DNA-binding protein" . SPARSER::PROTEIN)
    ("PLRG1" . SPARSER::PROTEIN) ("CDC5L" . SPARSER::PROTEIN)
    ("spliceosomal complex" . SPARSER::BIO-COMPLEX)
    ("ER- α" . SPARSER::PROTEIN) ("BCAS2" . SPARSER::PROTEIN)
    ("mTOR-Chk1" . SPARSER::COLLECTION) ("hyperactive mTOR" . SPARSER::PROTEIN)
    ("ATM-Chk2" . SPARSER::COLLECTION)
    ("both siRNA and a specific inhibitor" . SPARSER::COLLECTION)
    ("PP242 and siRNA" . SPARSER::COLLECTION)
    ("mTORC1 and/or mTORC2" . SPARSER::COLLECTION)
    ("PP242 or siRNA" . SPARSER::COLLECTION) ("etoposide-" . SPARSER::PROTEIN)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("Chk1, and p53" . SPARSER::COLLECTION)
    ("Chk1, Chk2 and p53" . SPARSER::COLLECTION)
    ("an ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("mTOR and p53" . SPARSER::COLLECTION)
    ("mTOR and p70S6K" . SPARSER::COLLECTION)
    ("p70S6K and Akt" . SPARSER::COLLECTION)
    ("a topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("siRNA or an mTORC1/2 kinase inhibitor" . SPARSER::COLLECTION)
    ("DEPTOR, SIN1 and PRR5" . SPARSER::COLLECTION)
    ("PKC, Akt and SGK" . SPARSER::COLLECTION)
    ("PRAS40 and DEPTOR" . SPARSER::COLLECTION)
    ("S6 kinases, S6K1 and S6K2" . SPARSER::COLLECTION)
    ("LST8/GβL" . SPARSER::COLLECTION) ("DEPTOR" . SPARSER::PROTEIN)
    ("ATM, ATR and DNA-PKcs" . SPARSER::COLLECTION)
    ("mTORC2-Chk1" . SPARSER::COLLECTION) ("REDD1" . SPARSER::PROTEIN)
    ("MG-132" . SPARSER::DRUG) ("PRR5" . SPARSER::PROTEIN)
    ("SIN1" . SPARSER::PROTEIN) ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("GβL" . SPARSER::PROTEIN) ("LST8" . SPARSER::PROTEIN)
    ("unique txr genes" . SPARSER::GENE)
    ("Akt-FKBP-PHLPP" . SPARSER::COLLECTION) ("AK" . SPARSER::PROTEIN)
    ("FKBP5/AR/ABCB1" . SPARSER::COLLECTION)
    ("the mitotic inhibitor vincristine" . SPARSER::DRUG)
    ("The transcriptomic profiling performed here identified genes"
     . SPARSER::GENE)
    ("cisplatin or taxol" . SPARSER::COLLECTION)
    ("Highly-overexpressed genes" . SPARSER::GENE)
    ("AR and other protein components" . SPARSER::COLLECTION)
    ("the highly upregulated genes or potential txr genes"
     . SPARSER::COLLECTION)
    ("PR or GR" . SPARSER::COLLECTION) ("PR and GR" . SPARSER::COLLECTION)
    ("ABCB1, H1F0, BMP5, and FGFR" . SPARSER::COLLECTION)
    ("a powerful regulator or driver" . SPARSER::COLLECTION)
    ("c and c" . SPARSER::COLLECTION)
    ("FKBP5 or control shLuc" . SPARSER::COLLECTION)
    ("BMP5 and FGFR2" . SPARSER::COLLECTION)
    ("ABCB1 and H1F0" . SPARSER::COLLECTION)
    ("the canonical multidrug gene ABCB1 and a novel H1F0"
     . SPARSER::COLLECTION)
    ("these AR-regulated genes (which included two genes that were overexpressed less than 10 fold) and 13 genes"
     . SPARSER::COLLECTION)
    ("ABCB1, BMP5, FAT3, FGFR2, H1F0, SRCRB4D, STAG3, and TMPRSS15"
     . SPARSER::COLLECTION)
    ("AR and FKBP5" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("AR or FKBP5" . SPARSER::COLLECTION) ("pAkt and AR" . SPARSER::COLLECTION)
    ("Akt and FKBP5" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("FKBP5 and AR" . SPARSER::COLLECTION) ("flag-FKBP5" . SPARSER::COLLECTION)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("a scaffold protein and the AR" . SPARSER::COLLECTION)
    ("Reduced mitochondrial Bax" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("additional pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("caspase-3 and its substrate" . SPARSER::COLLECTION)
    ("poly-ADP" . SPARSER::PROTEIN)
    ("others chemotherapeutic drugs" . SPARSER::DRUG)
    ("genotoxins" . SPARSER::MOLECULE) ("AR, GR, and PR" . SPARSER::COLLECTION)
    ("taxanes, irinotecan, and etoposide" . SPARSER::COLLECTION)
    ("gemcitabine and cytosine arabinoside" . SPARSER::COLLECTION)
    ("cytidine" . SPARSER::MOLECULE) ("NF-κB or hormone" . SPARSER::COLLECTION)
    ("Akt-PHLPP" . SPARSER::COLLECTION)
    ("PHLPP, and chaperone" . SPARSER::COLLECTION)
    ("Akt and the progesterone receptor (PR)" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("FKBP" . SPARSER::PROTEIN) ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("PHLPP" . SPARSER::PROTEIN) ("Ras and receptor" . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("tau, stathmin, and MAP4" . SPARSER::COLLECTION)
    ("MDR-1/P-gp" . SPARSER::COLLECTION) ("MAPs" . SPARSER::PROTEIN)
    ("no valid biomarkers" . SPARSER::MOLECULE)
    ("at least 10 additional ABC proteins" . SPARSER::PROTEIN)
    ("nearly 20 different drugs" . SPARSER::DRUG)
    ("multidrug resistance protein 1, or MDR1" . SPARSER::COLLECTION)
    ("ATP-binding cassette (ABC)" . SPARSER::PROTEIN)
    ("The taxanes paclitaxel (taxol) and docetaxel" . SPARSER::COLLECTION)
    ("Akt/FKBP5/AR" . SPARSER::COLLECTION) ("FKBP5/AR" . SPARSER::COLLECTION)
    ("genotoxin" . SPARSER::MOLECULE) ("vincristine" . SPARSER::DRUG)
    ("Nar1" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("TMPRSS15" . SPARSER::PROTEIN) ("STAG3" . SPARSER::PROTEIN)
    ("SRCRB4D" . SPARSER::PROTEIN) ("H1F0" . SPARSER::PROTEIN)
    ("FAT3" . SPARSER::PROTEIN) ("BMP5" . SPARSER::PROTEIN)
    ("FKBP51" . SPARSER::PROTEIN) ("cytosine arabinoside" . SPARSER::DRUG)
    ("FK506" . SPARSER::DRUG) ("trans isomerase" . SPARSER::PROTEIN)
    ("FK506 binding protein 5" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("MAP4" . SPARSER::PROTEIN)
    ("abcb1" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("FK506-binding protein 5" . SPARSER::PROTEIN)
    ("VDR and histone H2B" . SPARSER::COLLECTION)
    ("VDR and HDAC3 and HDAC7" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC7" . SPARSER::COLLECTION)
    ("promoter and context" . SPARSER::COLLECTION)
    ("ER or PCNA" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("protein and histone" . SPARSER::COLLECTION)
    ("Pao" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRCA1-VDR" . SPARSER::COLLECTION)
    ("BRCA1 and vitamin D" . SPARSER::COLLECTION)
    ("growth inhibitory genes such as CDKNA1 and potential loss"
     . SPARSER::COLLECTION)
    ("at least one wild type allele" . SPARSER::ALLELE)
    ("our group and other groups examining" . SPARSER::COLLECTION)
    ("natural metabolites" . SPARSER::PROTEIN)
    ("vitamin D receptor (VDR) and its dimerization partner protein"
     . SPARSER::COLLECTION)
    ("Cyp24A1" . SPARSER::PROTEIN)
    ("BRCA1 and vitamin D 3" . SPARSER::COLLECTION)
    ("vitamin D 3 , VDR and BRCA1" . SPARSER::COLLECTION)
    ("c" . SPARSER::PROTEIN)
    ("BRCA1 and VDR spatially and temporally co-occupy vitamin D 3 response elements"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a complex and the presence of a ligand" . SPARSER::COLLECTION)
    ("BRCA1 and VDR" . SPARSER::COLLECTION)
    ("VDR or Brca1" . SPARSER::COLLECTION)
    ("vitamin D 3 and BRCA1" . SPARSER::COLLECTION)
    ("shBRCA1-#1-MCF7" . SPARSER::PROTEIN-PAIR)
    ("partially-silenced BRCA1-" . SPARSER::PROTEIN)
    ("propidium iodide staining and flow cytometry" . SPARSER::COLLECTION)
    ("non-targeting shRNAs (shBRCA1-#1, shBRCA1-#2, MCF7-SCR) and parental MCF7"
     . SPARSER::COLLECTION)
    ("parental MCF7" . SPARSER::PROTEIN) ("SCR" . SPARSER::PROTEIN)
    ("p21/waf" . SPARSER::COLLECTION) ("waf" . SPARSER::PROTEIN)
    ("EB1089 and no response" . SPARSER::COLLECTION)
    ("VDR and RXR" . SPARSER::COLLECTION)
    ("MCF7 and MDA-MB-231 mammospheres (Figure xref )" . SPARSER::COLLECTION)
    ("growth factors and EB1089" . SPARSER::COLLECTION)
    ("VDR or RXR" . SPARSER::COLLECTION) ("shBRCA1" . SPARSER::PROTEIN)
    ("MCF7-SCR" . SPARSER::COLLECTION) ("shBRCA1-MCF7" . SPARSER::PROTEIN-PAIR)
    ("EtOH" . SPARSER::MOLECULE) ("HDAC1/HDAC2" . SPARSER::COLLECTION)
    ("FANCJ" . SPARSER::PROTEIN) ("VDR-RXR" . SPARSER::COLLECTION)
    ("retinoid X receptor (RXR)" . SPARSER::PROTEIN) ("RXR" . SPARSER::PROTEIN)
    ("calcium and phosphate" . SPARSER::COLLECTION)
    ("a fat soluble hormone and a micronutrient" . SPARSER::COLLECTION)
    ("a fat soluble hormone" . SPARSER::MOLECULE)
    ("micronutrient" . SPARSER::MOLECULE)
    ("receptor (VDR)" . SPARSER::RECEPTOR)
    ("BRCA1 or p21waf1" . SPARSER::COLLECTION)
    ("seocalcitol (EB1089) and QW-1624F2-2" . SPARSER::COLLECTION)
    ("seocalcitol" . SPARSER::DRUG) ("a given genotype" . SPARSER::PROTEIN)
    ("micronutrients" . SPARSER::MOLECULE) ("Histone 4" . SPARSER::PROTEIN)
    ("Orc2" . SPARSER::PROTEIN) ("Hexadimethrine bromide" . SPARSER::MOLECULE)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC7" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("hnRNPA1" . SPARSER::PROTEIN) ("BXL0124" . SPARSER::DRUG)
    ("Vitamin D" . SPARSER::MOLECULE) ("keratin 18" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("CYP24" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("phenol-red" . SPARSER::DRUG) ("HDAC2" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN)
    ("Vitamin D 3" . SPARSER::MOLECULE) ("vitamin D 3" . SPARSER::MOLECULE)
    ("EB1089" . SPARSER::DRUG)
    ("helicases, BML and RECQL4" . SPARSER::COLLECTION)
    ("other mitotic genes" . SPARSER::GENE)
    ("Two mitotic genes" . SPARSER::GENE)
    ("BLM , PIF1 , and RECQL4" . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN) ("NEK1 and NEK9" . SPARSER::COLLECTION)
    ("CDCA" . SPARSER::MOLECULE) ("low-grade serous type" . TYPE)
    ("BRAF , CTNNB1 , KRAS , and PIK3CA" . SPARSER::COLLECTION)
    ("PID" . SPARSER::PROTEIN) ("intact TP53" . SPARSER::PROTEIN)
    ("BCLAF1 , CLCNKA , and MAGEC1" . SPARSER::COLLECTION)
    ("CLCNKA" . SPARSER::PROTEIN) ("FIS" . SPARSER::PROTEIN)
    ("PI3K/RAS" . SPARSER::COLLECTION)
    ("Type I and Type II" . SPARSER::COLLECTION)
    ("multiple histological types" . TYPE) ("ST2" . SPARSER::PROTEIN)
    ("the most aggressive histological type" . TYPE)
    ("RECQL4" . SPARSER::PROTEIN) ("PIF1" . SPARSER::PROTEIN)
    ("SKA3" . SPARSER::PROTEIN) ("NEK9" . SPARSER::PROTEIN)
    ("NEK1" . SPARSER::PROTEIN)
    ("Interferon Regulatory Factor 5" . SPARSER::PROTEIN)
    ("IRF5" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("p34" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("MAGEC1" . SPARSER::PROTEIN) ("BCLAF1" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN)
    ("a known metastasis suppressor and its expression" . SPARSER::COLLECTION)
    ("PI 3-K and INPP4B" . SPARSER::COLLECTION)
    ("both an oncogene and a tumor suppressor" . SPARSER::COLLECTION)
    ("PDK-1 and TORC2" . SPARSER::COLLECTION)
    ("p110α-specific inhibitors such as BYL-719 and A66" . SPARSER::COLLECTION)
    ("SGK3, GSK-3β, and Fbw7" . SPARSER::COLLECTION)
    ("Fbw7-GST" . SPARSER::COLLECTION)
    ("GSK650394, or GSK3" . SPARSER::COLLECTION)
    ("GSK650394 and SB415286" . SPARSER::COLLECTION)
    ("SGK3 and GSK-3β" . SPARSER::COLLECTION)
    ("SGK3, GSK-3β and Fbw7" . SPARSER::COLLECTION)
    ("two distinct shRNA" . SPARSER::PROTEIN)
    ("ubiquitin ligase and substrate" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("shRNA and INPP4B" . SPARSER::COLLECTION)
    ("MCF7 cells ( PIK3CA E545K, high SGK3, and high INPP4B, xref ) whereby SGK3 and INPP4B shRNA"
     . SPARSER::PROTEIN)
    ("respective catalytically-inactive mutants, and colonies"
     . SPARSER::COLLECTION)
    ("SGK3 or INPP4B" . SPARSER::COLLECTION)
    ("mutants, and colonies" . SPARSER::COLLECTION)
    ("SGK3 and INPP4B" . SPARSER::COLLECTION)
    ("SGK3 or pT320" . SPARSER::COLLECTION)
    ("myristoylated-Akt" . SPARSER::COLLECTION)
    ("charcoal-stripped media" . SPARSER::PROTEIN)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("SGK3 and NDRG1" . SPARSER::COLLECTION)
    ("the class III PI 3-K Vps34" . SPARSER::PROTEIN)
    ("Vps34" . SPARSER::PROTEIN) ("Vps" . SPARSER::PROTEIN)
    ("SGK3 and Akt" . SPARSER::COLLECTION)
    ("both BKM-120 and A66" . SPARSER::COLLECTION)
    ("a defined optimal Akt and SGK substrate" . SPARSER::SUBSTRATE)
    ("Akt and SGK" . SPARSER::COLLECTION)
    ("PIK3CA or PTEN" . SPARSER::COLLECTION)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION) ("lipids" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("HER2 and basal-like" . SPARSER::COLLECTION)
    ("Homology" . SPARSER::PROTEIN) ("Phox" . SPARSER::PROTEIN)
    ("SGK and Akt" . SPARSER::COLLECTION) ("SGK" . SPARSER::PROTEIN)
    ("SGK1 and SGK2" . SPARSER::COLLECTION)
    ("Glucocorticoid-regulated Kinase 3" . SPARSER::COLLECTION)
    ("Btk and Itk" . SPARSER::COLLECTION) ("Itk" . SPARSER::PROTEIN)
    ("INPP4A and INPP4B" . SPARSER::COLLECTION)
    ("polyphosphate" . SPARSER::MOLECULE) ("SHIP" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("PI 3-K and Akt" . SPARSER::COLLECTION)
    ("the phosphoinositide-dependent kinase-1 (PDK-1) and mammalian target of rapamycin complex"
     . SPARSER::COLLECTION)
    ("the catalytically competent conformation" . SPARSER::BIO-CONFORMATION)
    ("-P 3" . SPARSER::COLLECTION) ("PtdIns" . SPARSER::PROTEIN)
    ("INPP4B and SGK3" . SPARSER::COLLECTION) ("Fbw7" . SPARSER::PROTEIN)
    ("PIK3CA and INPP4B" . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase 3" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("SB415286" . SPARSER::DRUG)
    ("SKP1" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("GSK650394" . SPARSER::DRUG) ("IGF-1-" . SPARSER::PROTEIN)
    ("VPS34" . SPARSER::PROTEIN) ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("BKM-120" . SPARSER::DRUG)
    ("PI 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBW7" . SPARSER::PROTEIN) ("WD repeat domain" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("SGK2" . SPARSER::PROTEIN) ("SGK1" . SPARSER::PROTEIN)
    ("regulated Kinase 3" . SPARSER::PROTEIN) ("GRP1" . SPARSER::PROTEIN)
    ("PtdIns-3-P" . SPARSER::MOLECULE) ("INPP4A" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("PDK-1" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("Akt/ protein" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NDRG1" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("SGK3" . SPARSER::PROTEIN) ("regulated kinase 3" . SPARSER::PROTEIN)
    ("PI 3-K" . SPARSER::PROTEIN) ("Pak" . SPARSER::PROTEIN-FAMILY)
    ("Grb2/Gab2" . SPARSER::COLLECTION) ("FAK and Stat5" . SPARSER::COLLECTION)
    ("PRL" . SPARSER::PROTEIN) ("Prolactin" . SPARSER::PROTEIN)
    ("Stat5 and Gab2" . SPARSER::COLLECTION) ("PI3k/Akt" . SPARSER::COLLECTION)
    ("FAK/Tiam1/Rac1" . SPARSER::COLLECTION)
    ("colorectal cancer PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1/MgcRacGAP" . SPARSER::COLLECTION)
    ("BCL6 and Stat5" . SPARSER::COLLECTION)
    ("Stat5 and RacGTPases" . SPARSER::COLLECTION)
    ("FAK and Tiam1" . SPARSER::COLLECTION) ("COS" . SPARSER::MOLECULE)
    ("Vav1 and Vav2" . SPARSER::COLLECTION)
    ("Rac, Rho and Cdc42" . SPARSER::COLLECTION)
    ("FAK-Rac1-Tiam1" . SPARSER::COLLECTION)
    ("KIT and FLT3" . SPARSER::COLLECTION)
    ("kinases and Stats" . SPARSER::COLLECTION)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAK, Tiam1, and PAK1" . SPARSER::COLLECTION)
    ("FLT3 (FLT3ITD) and KIT (KITD816V)" . SPARSER::COLLECTION)
    ("FAK/Rac1-Tiam1/PAK1" . SPARSER::COLLECTION)
    ("Rac1GTPase/MgcRacGAP" . SPARSER::COLLECTION)
    ("MgcRacGAP" . SPARSER::PROTEIN) ("Bcl-xL and c-Myc" . SPARSER::COLLECTION)
    ("PAK1 and PAK2" . SPARSER::COLLECTION)
    ("PAK1, PAK2 and PAK3" . SPARSER::COLLECTION)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("FAK/Rac1" . SPARSER::COLLECTION)
    ("IPA-3 and PF-3758309" . SPARSER::COLLECTION)
    ("reduced tyrosine phosphorylated Stat5" . SPARSER::PROTEIN)
    ("PF-3758309 (PF)" . SPARSER::DRUG) ("kinase (PAK)" . SPARSER::KINASE)
    ("the primary cohorts" . SPARSER::MOLECULE)
    ("Rac1/Stat5" . SPARSER::COLLECTION)
    ("active Rac1 complex" . SPARSER::BIO-COMPLEX)
    ("Rac1 and Tiam1" . SPARSER::COLLECTION)
    ("an active Rac1-active Stat5 complex" . SPARSER::BIO-COMPLEX)
    ("Rac1-Stat5" . SPARSER::COLLECTION)
    ("Rac1 and active" . SPARSER::COLLECTION)
    ("Rac1 and Stat5" . SPARSER::COLLECTION)
    ("c-Myc and BclXL" . SPARSER::COLLECTION) ("BclXL" . SPARSER::PROTEIN)
    ("Raf and MEK" . SPARSER::COLLECTION)
    ("MEK (PD98059) or Raf (PLX4720) or Akt (124005) inhibitor"
     . SPARSER::COLLECTION)
    ("Raf (PLX4720) or Akt (124005) inhibitor" . SPARSER::COLLECTION)
    ("Rac1 or active" . SPARSER::COLLECTION)
    ("Stat5 and total Rac1" . SPARSER::COLLECTION)
    ("PI3Kinase/Akt" . SPARSER::COLLECTION)
    ("active Stat5 and total Rac1" . SPARSER::COLLECTION)
    ("Stat5-Rac1" . SPARSER::COLLECTION)
    ("Stat5 and Rac1" . SPARSER::COLLECTION)
    ("Rac1 and its upstream activator FAK" . SPARSER::COLLECTION)
    ("FAK and Rac1" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("hyperactive FAK" . SPARSER::PROTEIN) ("FRNK" . SPARSER::PROTEIN)
    ("ligand (FL)" . SPARSER::MOLECULE) ("FLT3 or KIT" . SPARSER::COLLECTION)
    ("FAK-" . SPARSER::PROTEIN) ("CBF" . SPARSER::PROTEIN)
    ("gleevec" . SPARSER::DRUG) ("FAK/Tiam1/Rac1/PAK1" . SPARSER::COLLECTION)
    ("RacGEF" . SPARSER::PROTEIN) ("precisely Stat5" . SPARSER::PROTEIN)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("currently available drugs" . SPARSER::DRUG)
    ("FLT3 and KIT" . SPARSER::COLLECTION) ("Flt3" . SPARSER::PROTEIN)
    ("Gab2" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("G-protein coupled" . SPARSER::PROTEIN) ("PAK3" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("PF-3758309" . SPARSER::DRUG) ("IPA-3" . SPARSER::MOLECULE)
    ("PLX4720" . SPARSER::DRUG) ("PI3Kinase" . SPARSER::PROTEIN)
    ("AC220" . SPARSER::DRUG) ("IL-3 receptor" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("RB-DNMT1" . SPARSER::COLLECTION)
    ("a relatively mitotic quiescent state" . SPARSER::BIO-STATE)
    ("E2F1, c-JUN, DNMT1, p21, and p16" . SPARSER::COLLECTION)
    ("MSCs or MSCs" . SPARSER::COLLECTION)
    ("E2F1 and stop" . SPARSER::COLLECTION)
    ("bone-marrow-derived MSCs" . SPARSER::PROTEIN)
    ("phospho-RB and DNMT1" . SPARSER::COLLECTION)
    ("p-MSCs" . SPARSER::COLLECTION)
    ("Bone-Marrow-Derived MSCs and MSCs" . SPARSER::COLLECTION)
    ("MSCs and MSCs" . SPARSER::COLLECTION)
    ("early-passage MSCs and late-passage MSCs" . SPARSER::COLLECTION)
    ("RB and c-JUN" . SPARSER::COLLECTION) ("exogenous RB" . SPARSER::PROTEIN)
    ("p16 and p21" . SPARSER::COLLECTION)
    ("DNMT1 and DNMT3b" . SPARSER::COLLECTION) ("DNMTs" . SPARSER::PROTEIN)
    ("showed RB’s" . SPARSER::PROTEIN)
    ("APO-1, p21, and p16" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("Alizarin" . SPARSER::DRUG) ("bromodeoxyuridine" . SPARSER::DRUG)
    ("RB2/p130" . SPARSER::COLLECTION)
    ("CDK2, cyclin D1, and E2F1" . SPARSER::COLLECTION)
    ("p21 and p16" . SPARSER::COLLECTION)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("RUNX2 and BSP" . SPARSER::COLLECTION) ("BSP" . SPARSER::PROTEIN)
    ("alizarin" . SPARSER::DRUG) ("ester (CFSE)" . SPARSER::MOLECULE)
    ("senescent MSCs" . SPARSER::PROTEIN) ("P21 and p16" . SPARSER::COLLECTION)
    ("mesodermal derivatives" . SPARSER::DERIVATIVE)
    ("DNMT3A or DNMT3B" . SPARSER::COLLECTION) ("MSCs" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("X-Gal" . SPARSER::MOLECULE)
    ("P23" . SPARSER::PROTEIN) ("DNMT3a" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("APO-1" . SPARSER::PROTEIN)
    ("RB2" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("Rad9-TopBP1" . SPARSER::COLLECTION)
    ("Treslin-TopBP1" . SPARSER::COLLECTION)
    ("TopBP1 and SIRT1 and" . SPARSER::COLLECTION)
    ("AMPK and SIRT1" . SPARSER::COLLECTION)
    ("PGC-1α, FOXOs, and p53" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("LKB1-AMPK-Raptor" . SPARSER::COLLECTION)
    ("an acetylation-mimetic mutant" . SPARSER::MUTANT)
    ("Rad9 or Treslin" . SPARSER::COLLECTION)
    ("complementary oligonucleotides" . SPARSER::MOLECULE)
    ("different species-specific secondary antibodies" . SPARSER::ANTIBODY)
    ("WT TopBP1 and its mutants" . SPARSER::COLLECTION)
    ("Duo" . SPARSER::PROTEIN) ("Treslin and Rad9" . SPARSER::COLLECTION)
    ("Rad9 and its subsequent chromatin" . SPARSER::COLLECTION)
    ("its subsequent chromatin" . SPARSER::PROTEIN)
    ("Flag-TopBP1" . SPARSER::COLLECTION)
    ("the acetylation-mimetic TopBP1" . SPARSER::PROTEIN)
    ("the acetylation-defective TopBP1 mutant" . SPARSER::MUTANT)
    ("TopBP1 and Rad9" . SPARSER::COLLECTION)
    ("Rad9 and TopBP1" . SPARSER::COLLECTION)
    ("TopBP1 chromatin loading and the ATR-Chk1 activation ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("HU or UV" . SPARSER::COLLECTION) ("Hydroxyurea" . SPARSER::DRUG)
    ("ATR and Chk1" . SPARSER::COLLECTION)
    ("extracellular glucose" . SPARSER::PROTEIN)
    ("TopBP1, 3KR, or 3KQ" . SPARSER::COLLECTION)
    ("the triple mutant" . SPARSER::MUTANT)
    ("K–R or K–Q" . SPARSER::COLLECTION) ("EDD" . SPARSER::PROTEIN)
    ("TopBP1 and Treslin" . SPARSER::COLLECTION)
    ("WT TopBP1 or the acetylation-mimetic 3KQ mutant" . SPARSER::COLLECTION)
    ("the acetylation-mimetic 3KQ mutant" . SPARSER::MUTANT)
    ("seven lysines of TopBP1" . SPARSER::PROTEIN)
    ("TopBP1 and p300" . SPARSER::COLLECTION)
    ("PCAF, Tip60, and hMOF" . SPARSER::COLLECTION) ("hMOF" . SPARSER::PROTEIN)
    ("deacetylases and acetyltransferases" . SPARSER::COLLECTION)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("TopBP1 and p53" . SPARSER::COLLECTION)
    ("FLAG-TopBP1" . SPARSER::COLLECTION) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("TopBP1 and SIRT1" . SPARSER::COLLECTION)
    ("a major SIRT1-associated protein" . SPARSER::PROTEIN)
    ("DBC1 and USP22" . SPARSER::COLLECTION)
    ("amino acid or serum" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("DBC1" . SPARSER::PROTEIN) ("kinase and Cdc25" . SPARSER::COLLECTION)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("TopBP1-Rad9" . SPARSER::COLLECTION)
    ("TopBP1-Treslin" . SPARSER::COLLECTION) ("Treslin" . SPARSER::PROTEIN)
    ("SIRT1-TopBP1" . SPARSER::COLLECTION) ("Nutrient" . SPARSER::MOLECULE)
    ("histone-H3" . SPARSER::PROTEIN) ("s21" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mcm10" . SPARSER::PROTEIN) ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("K–R" . SPARSER::PROTEIN) ("Cdc45" . SPARSER::PROTEIN)
    ("CDC45" . SPARSER::PROTEIN) ("USP22" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN) ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK3 and TSC2" . SPARSER::COLLECTION)
    ("STAT3/STAT5" . SPARSER::COLLECTION)
    ("STAT3 or STAT5" . SPARSER::COLLECTION)
    ("cytokines and leptin" . SPARSER::COLLECTION)
    ("PPARα and PPARδ" . SPARSER::COLLECTION)
    ("increased placental IL-1β" . SPARSER::PROTEIN)
    ("rpS6" . SPARSER::PROTEIN)
    ("mTOR (S2448) and 4EBP1 (at both T37/46 and T70)" . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION)
    ("ERK1/2, IκBα, JNK, and p38" . SPARSER::COLLECTION)
    ("MAPKs and NFκB" . SPARSER::COLLECTION)
    ("STAT, MAPKs, mTOR, and PPARγ" . SPARSER::COLLECTION)
    ("eukaryotic initiation factor 4E binding protein 1 (4EBP1) and ribosomal protein S6 (rpS6)"
     . SPARSER::COLLECTION)
    ("rpS" . SPARSER::PROTEIN)
    ("cytokines, hypoxia, and leptin" . SPARSER::COLLECTION)
    ("ERK, p38, and STAT" . SPARSER::COLLECTION)
    ("mitogen activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Activator" . SPARSER::ACTIVATOR)
    ("the peroxisome proliferator-activated receptor (PPAR)"
     . SPARSER::RECEPTOR)
    ("hypoxia and re-oxygenation" . SPARSER::COLLECTION)
    ("glucose and oxygen" . SPARSER::COLLECTION)
    ("NFκB and PPARγ" . SPARSER::COLLECTION)
    ("IRS1 or STAT" . SPARSER::COLLECTION)
    ("mTOR (S2448) and 4EBP1 (T37/46 and T70)" . SPARSER::COLLECTION)
    ("p65 and PPARγ" . SPARSER::COLLECTION) ("IRS1/Akt" . SPARSER::COLLECTION)
    ("oxygen and glucose" . SPARSER::COLLECTION) ("GSK3α" . SPARSER::PROTEIN)
    ("PPARδ" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("tuberous sclerosis 2" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("p20" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("PLK1 and/or BIRC5" . SPARSER::COLLECTION)
    ("BIRC5 and PLK1" . SPARSER::COLLECTION)
    ("DKK1 and SFRP1" . SPARSER::COLLECTION)
    ("protein and GSK3β" . SPARSER::COLLECTION)
    ("fibronectin receptor, and β1" . SPARSER::COLLECTION)
    ("cell surface-associated EGFR" . SPARSER::PROTEIN)
    ("consequent dysregulated PI3" . SPARSER::PROTEIN)
    ("classical dominant driving oncogenes" . SPARSER::ONCOGENE)
    ("driving oncogenes" . SPARSER::ONCOGENE)
    ("the estrogen receptor (ER) or HER-2 oncogene" . SPARSER::COLLECTION)
    ("BIRC5 and PLK-1" . SPARSER::COLLECTION)
    ("BIRC5 or PLK1" . SPARSER::COLLECTION)
    ("BIRC5 (survivin) and PLK1 (Polo-like kinase 1)" . SPARSER::COLLECTION)
    ("β1, and PIK3R2" . SPARSER::COLLECTION) ("ligand-" . SPARSER::LIGAND)
    ("the cell cycle-associated genes" . SPARSER::GENE)
    ("only 258 genes" . SPARSER::GENE) ("exogenous EGF" . SPARSER::PROTEIN)
    ("mTOR pS2448" . SPARSER::PROTEIN) ("MEK pS217" . SPARSER::PROTEIN)
    ("EGFR pY1068" . SPARSER::PROTEIN) ("c-Raf pS338" . SPARSER::PROTEIN)
    ("c-Met pY1235" . SPARSER::PROTEIN) ("P70s6K" . SPARSER::PROTEIN)
    ("aggressive types" . TYPE) ("claudin-7 and FoxM1" . SPARSER::COLLECTION)
    ("NF-κB-p65" . SPARSER::COLLECTION)
    ("p70S6K (SUM-149 only) and p70S6K pT389" . SPARSER::COLLECTION)
    ("mTOR pS2448, and PRAS40" . SPARSER::COLLECTION)
    ("p70S6K pT389" . SPARSER::PROTEIN)
    ("4EBP-1 and 4EBP-1" . SPARSER::COLLECTION)
    ("pS2448, and PRAS40" . SPARSER::COLLECTION)
    ("mTOR-associated proteins" . SPARSER::PROTEIN)
    ("proteins and phospho-proteins" . SPARSER::COLLECTION)
    ("src-pY527" . SPARSER::COLLECTION) ("EGFR-pY1068" . SPARSER::COLLECTION)
    ("Amphiregulin" . SPARSER::PROTEIN) ("EGF or AREG" . SPARSER::COLLECTION)
    ("a weak activator" . SPARSER::ACTIVATOR)
    ("MEK/MAPK" . SPARSER::COLLECTION) ("AREG and EGF" . SPARSER::COLLECTION)
    ("exogenous ligand" . SPARSER::LIGAND)
    ("AREG and EGFR" . SPARSER::COLLECTION)
    ("AREG- and EGF-stimulated MCF-10A" . SPARSER::COLLECTION)
    ("AREG-" . SPARSER::PROTEIN) ("pT" . SPARSER::PROTEIN)
    ("AREG/EGFR" . SPARSER::COLLECTION) ("IL1 and NF-κB" . SPARSER::COLLECTION)
    ("claudin" . SPARSER::PROTEIN) ("PLK1 and BIRC5" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION) ("PDK2" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("PLK-1" . SPARSER::PROTEIN) ("p85β" . SPARSER::PROTEIN)
    ("PIK3R2" . SPARSER::PROTEIN) ("ITGB1" . SPARSER::PROTEIN)
    ("s6K" . SPARSER::PROTEIN) ("P70" . SPARSER::PROTEIN)
    ("claudin-7" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("4EBP-1" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("BI 2536" . SPARSER::DRUG)
    ("YM155" . SPARSER::DRUG) ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-catenin" . SPARSER::PROTEIN)
    ("PLK1 and SCYL1 and TEX14" . SPARSER::COLLECTION)
    ("PLK1, SCYL1, and TEX14" . SPARSER::COLLECTION)
    ("several pharmacologic PLK1 inhibitors" . SPARSER::INHIBITOR)
    ("these neurotrophic receptors and ligands" . SPARSER::COLLECTION)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("neurotrophic receptors and their cognate ligands" . SPARSER::COLLECTION)
    ("neurotrophic receptors" . SPARSER::PROTEIN)
    ("SCYL1, TEX14, and PLK1" . SPARSER::COLLECTION)
    ("control-shRNA or combination-shTEX14+shSCYL1" . SPARSER::COLLECTION)
    ("shRNA or combination-shTEX14+shSCYL1" . SPARSER::COLLECTION)
    ("dox" . SPARSER::DRUG) ("dual shRNAs" . SPARSER::RNA)
    ("TEX14-" . SPARSER::PROTEIN) ("SCYL1 or TEX14" . SPARSER::COLLECTION)
    ("the transformed state" . SPARSER::BIO-STATE)
    ("smaller breast cancer cohorts" . SPARSER::MOLECULE)
    ("Oncogenes" . SPARSER::ONCOGENE)
    ("Both TEX14 (up to 35-fold) and PLK1 (up to 93-fold)"
     . SPARSER::COLLECTION)
    ("TEX14, SCYL1, or PLK1" . SPARSER::COLLECTION)
    ("TEX14, SCYL1, and PLK1" . SPARSER::COLLECTION)
    ("βTRCP and REST" . SPARSER::COLLECTION)
    ("TEX14-βTRCP" . SPARSER::COLLECTION)
    ("PLK1 or SCYL1" . SPARSER::COLLECTION)
    ("SCYL1 and PLK1" . SPARSER::COLLECTION)
    ("REST-βTRCP" . SPARSER::COLLECTION) ("βTRCP-REST" . SPARSER::COLLECTION)
    ("REST-PLK1" . SPARSER::COLLECTION) ("REST and PLK1" . SPARSER::COLLECTION)
    ("TEX14 and/or SCYL1" . SPARSER::COLLECTION)
    ("GST-fused" . SPARSER::COLLECTION)
    ("PLK1, SCYL1 and TEX14" . SPARSER::COLLECTION)
    ("SCYL1 and TEX14" . SPARSER::COLLECTION)
    ("TEX14 or SCYL1" . SPARSER::COLLECTION)
    ("TEX14 and SCYL1" . SPARSER::COLLECTION)
    ("PLK1 and REST" . SPARSER::COLLECTION)
    ("-substrates" . SPARSER::SUBSTRATE)
    ("PLK1, TEX14 and SCYL1" . SPARSER::COLLECTION)
    ("REST-ubiquitin ligase" . SPARSER::COLLECTION)
    ("kinase and kinase-like" . SPARSER::COLLECTION)
    ("mRFP" . SPARSER::PROTEIN) ("mRFP-REST" . SPARSER::COLLECTION)
    ("RDR" . SPARSER::PROTEIN) ("undetectable REST protein" . SPARSER::PROTEIN)
    ("βTRCP and proteasomal" . SPARSER::COLLECTION)
    ("neuronal gene" . SPARSER::GENE)
    ("neural and neuronal genes" . SPARSER::GENE)
    ("ER and HER2" . SPARSER::COLLECTION) ("STP-REST" . SPARSER::COLLECTION)
    ("REST" . SPARSER::PROTEIN) ("STP" . SPARSER::PROTEIN)
    ("CYL" . SPARSER::MOLECULE) ("FBXW11" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("SCYL1" . SPARSER::PROTEIN)
    ("TEX14" . SPARSER::PROTEIN) ("kinase-like" . SPARSER::PROTEIN-FAMILY)
    ("βTRCP" . SPARSER::PROTEIN) ("only EGFR homodimers" . SPARSER::HOMODIMER)
    ("the intact insulin receptor" . SPARSER::PROTEIN)
    ("nearly-intact receptor" . SPARSER::RECEPTOR)
    ("the intact receptor’s" . SPARSER::RECEPTOR)
    ("the crystallographic dimer" . SPARSER::DIMER)
    ("a well-defined domain II-mediated dimer" . SPARSER::DIMER)
    ("the monomeric receptor" . SPARSER::RECEPTOR)
    ("EGF or TGFα" . SPARSER::COLLECTION)
    ("each mutated sEGFR variant" . SPARSER::VARIANT)
    ("the precise conformation" . SPARSER::BIO-CONFORMATION)
    ("EGFR and sEGFR" . SPARSER::COLLECTION)
    ("any particular autoinhibitory dimeric conformation"
     . SPARSER::BIO-CONFORMATION)
    ("max" . SPARSER::PROTEIN) ("Solution" . SPARSER::MOLECULE)
    ("well-ordered domain II-mediated back-to-back dimers" . SPARSER::DIMER)
    ("the characteristic heart-shape dimer" . SPARSER::DIMER)
    ("dimer, and xref" . SPARSER::COLLECTION)
    ("loose domain II-mediated dimer" . SPARSER::DIMER)
    ("EM" . SPARSER::PROTEIN) ("EGF/sEGFR-Fc" . SPARSER::COLLECTION)
    ("pre-dimerized sEGFR" . SPARSER::PROTEIN)
    ("covalently-dimerized sEGFR-Fc" . SPARSER::COLLECTION)
    ("Fc-fused" . SPARSER::COLLECTION)
    ("the Y251A/R285S-mutated variant" . SPARSER::VARIANT)
    ("dimerization-defective sEGFR variants" . SPARSER::VARIANT)
    ("dimeric sEGFR" . SPARSER::PROTEIN)
    ("dimeric and monomeric sEGFR" . SPARSER::PROTEIN)
    ("just 60 nM EGF" . SPARSER::PROTEIN) ("EGF/sEGFR" . SPARSER::COLLECTION)
    ("monomeric sEGFR" . SPARSER::PROTEIN)
    ("the dimeric sEGFR-Fc or sEGFR-Zip proteins" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("Fc" . SPARSER::PROTEIN)
    ("sEGFR-Zip" . SPARSER::COLLECTION) ("sEGFR-Fc" . SPARSER::COLLECTION)
    ("sEGFR" . SPARSER::PROTEIN) ("EGFR/ErbB" . SPARSER::COLLECTION)
    ("intact hEGFR" . SPARSER::PROTEIN) ("hEGFR" . SPARSER::PROTEIN)
    ("intact EGFR" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("premenopausal estrogen" . SPARSER::MOLECULE) ("TERT" . SPARSER::PROTEIN)
    ("estrogen–hTERT" . SPARSER::PROTEIN) ("Cohort" . SPARSER::MOLECULE)
    ("genotype, or estrogen" . SPARSER::COLLECTION)
    ("KP and 78+" . SPARSER::COLLECTION)
    ("KP and SNAC-K" . SPARSER::COLLECTION)
    ("genotype or estrogen" . SPARSER::COLLECTION) ("KP" . SPARSER::PROTEIN)
    ("AUF1" . SPARSER::PROTEIN) ("OBFC1" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("HEDP" . SPARSER::DRUG) ("rhenium" . SPARSER::MOLECULE)
    ("samarium" . SPARSER::MOLECULE) ("strontium" . SPARSER::MOLECULE)
    ("radiopharmaceuticals" . SPARSER::DRUG) ("saracatinib" . SPARSER::DRUG)
    ("c-Src and AR" . SPARSER::COLLECTION)
    ("receptor and ligands" . SPARSER::COLLECTION)
    ("CK5, CK8 and KLK3" . SPARSER::COLLECTION) ("Maraviroc" . SPARSER::DRUG)
    ("CCL7 (5.2-fold) and CCL8 (8.6-fold)" . SPARSER::COLLECTION)
    ("CCR5 (11.3-fold), CCL7 (5.2-fold) and CCL8 (8.6-fold)"
     . SPARSER::COLLECTION)
    ("CCL5, CCL8 and CCL7" . SPARSER::COLLECTION)
    ("specific cytokine receptors and their ligands" . SPARSER::COLLECTION)
    ("CCR7, CCR5, CCRl, CCL8, CCL7, CCL2 and CCL1" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H & E)" . SPARSER::COLLECTION)
    ("CK8, and KLK3" . SPARSER::COLLECTION) ("Hematoxylin" . SPARSER::MOLECULE)
    ("phosphatase (TRAP)" . SPARSER::PHOSPHATASE) ("TRAP" . SPARSER::PROTEIN)
    ("a heterogeneous mixture" . SPARSER::MOLECULE)
    ("AR and CK8" . SPARSER::COLLECTION) ("vSrc" . SPARSER::PROTEIN)
    ("peptidase" . SPARSER::PROTEIN) ("kallikrein" . SPARSER::PROTEIN)
    ("CK5 and CK8" . SPARSER::COLLECTION) ("PEC" . SPARSER::PROTEIN)
    ("v-Src-PEC" . SPARSER::PROTEIN-PAIR)
    ("v-Src and Luc2-Tomato" . SPARSER::COLLECTION)
    ("Src and Lyn" . SPARSER::COLLECTION) ("CCL1" . SPARSER::PROTEIN)
    ("CCL7" . SPARSER::PROTEIN) ("CCL8" . SPARSER::PROTEIN)
    ("KLK3" . SPARSER::PROTEIN) ("V-Src" . SPARSER::PROTEIN)
    ("F-18" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK8" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("anti-phospho-p38 MAP kinase antibody (purchased from Cell Signaling Tech, USA, 1:1000) and β-actin (purchased from Sigma, USA, 1:5000)"
     . SPARSER::COLLECTION)
    ("peroxidase-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("Tech" . SPARSER::PROTEIN) ("anti-phospho" . SPARSER::PROTEIN)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("3% bovine serum albumin" . SPARSER::PROTEIN)
    ("SB431542 and SB203580" . SPARSER::COLLECTION)
    ("Sigma, and SB203580" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) or c-jun N-terminal kinase (JNK) ( xref )"
     . SPARSER::COLLECTION)
    ("only p38 MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cerebral endothelium-derived TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multipotent cytokine" . SPARSER::PROTEIN)
    ("anti-phospho-p38" . SPARSER::COLLECTION) ("β1" . SPARSER::PROTEIN)
    ("BBB" . SPARSER::PROTEIN)
    ("almost all extracellular matrix molecules" . SPARSER::MOLECULE)
    ("myelin" . SPARSER::PROTEIN)
    ("neurovascular mediators" . SPARSER::PROTEIN)
    ("TGF-β1 and MMP-9" . SPARSER::COLLECTION)
    ("transforming growth factor-β1" . SPARSER::PROTEIN-PAIR)
    ("derived growth factor-receptor" . SPARSER::PROTEIN)
    ("type 2 receptor" . SPARSER::PROTEIN) ("type1" . SPARSER::PROTEIN)
    ("PDGF-R" . SPARSER::PROTEIN)
    ("E7 and other proteins" . SPARSER::COLLECTION)
    ("which releases E2F" . SPARSER::PROTEIN-FAMILY)
    ("E7:pRb" . SPARSER::BIO-COMPLEX) ("pRb and MDM2" . SPARSER::COLLECTION)
    ("an E7:CBP/p300:pRb ternary complex" . SPARSER::BIO-COMPLEX)
    ("E7:CBP/p300:pRb" . SPARSER::BIO-COMPLEX)
    ("at least part" . SPARSER::COMPONENT)
    ("pRb and TAZ2" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("pRb and CBP/p300" . SPARSER::COLLECTION)
    ("E7, CBP and pRb" . SPARSER::COLLECTION)
    ("ternary complex" . SPARSER::BIO-COMPLEX)
    ("CR1-CR2" . SPARSER::COLLECTION)
    ("the binary TAZ2:ppE7" . SPARSER::BIO-COMPLEX)
    ("the monomeric ppE1A(1-51) peptide" . SPARSER::PEPTIDE)
    ("pRb and the retinoblastoma family members p107 and p130"
     . SPARSER::COLLECTION)
    ("E2F-responsive genes" . SPARSER::GENE)
    ("p107 and p130" . SPARSER::COLLECTION)
    ("E7, and protein" . SPARSER::COLLECTION)
    ("TAZ2 and the Retinoblastoma Protein" . SPARSER::COLLECTION)
    ("HPV6b" . SPARSER::PROTEIN) ("essential coactivators" . SPARSER::PROTEIN)
    ("p53, STAT1 and C/EBP" . SPARSER::COLLECTION)
    ("HPV6b-E7" . SPARSER::COLLECTION) ("TAZ1-E7" . SPARSER::COLLECTION)
    ("pulldown" . SPARSER::PROTEIN) ("Weaker" . SPARSER::PROTEIN)
    ("GST-pulldown" . SPARSER::PROTEIN-PAIR)
    ("simian virus 40 (SV40) large T antigen" . SPARSER::MOLECULE)
    ("monomeric mutants E7(1-51) or E7L67R" . SPARSER::COLLECTION)
    ("monomeric mutants E7" . SPARSER::PROTEIN-FAMILY)
    ("homozygous conditional (floxed) knockout alleles" . SPARSER::ALLELE)
    ("p300 and PCAF" . SPARSER::COLLECTION) ("E7 and E7" . SPARSER::COLLECTION)
    ("BP" . SPARSER::PROTEIN) ("IPs" . SPARSER::PROTEIN)
    ("the monomeric E7(1-51) peptide" . SPARSER::PEPTIDE)
    ("E7 and pRb" . SPARSER::COLLECTION)
    ("E7 and pRb-AB" . SPARSER::COLLECTION) ("TAZ2:E7" . SPARSER::BIO-COMPLEX)
    ("amylose" . SPARSER::MOLECULE)
    ("the two binary complexes" . SPARSER::BIO-COMPLEX)
    ("the binary TAZ2 and pRb-AB" . SPARSER::COLLECTION)
    ("the binary complexes" . SPARSER::BIO-COMPLEX)
    ("TAZ2:ppE7" . SPARSER::BIO-COMPLEX)
    ("TAZ2 and pRb-AB" . SPARSER::COLLECTION)
    ("binary complexes" . SPARSER::BIO-COMPLEX)
    ("TAZ2 and pRb" . SPARSER::COLLECTION)
    ("15 N-labeled ppE7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the smaller E7(1-51) peptide" . SPARSER::PEPTIDE)
    ("E7(1-98) and E7(1-51)" . SPARSER::COLLECTION)
    ("p53 and E7" . SPARSER::COLLECTION) ("Mapping" . SPARSER::PROTEIN)
    ("unlabeled ppE7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uniformly 15 N-labeled TAZ2 or TAZ1" . SPARSER::COLLECTION)
    ("TAZ2 or TAZ1" . SPARSER::COLLECTION)
    ("TAZ2 and TAZ1" . SPARSER::COLLECTION)
    ("designated ppE7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ppE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAZ1 and TAZ2" . SPARSER::COLLECTION) ("TAZ2" . SPARSER::PROTEIN)
    ("p53:TAZ2 and STAT1:TAZ2" . SPARSER::COLLECTION)
    ("STAT1:TAZ2" . SPARSER::PROTEIN-PAIR) ("p53:TAZ2" . SPARSER::PROTEIN-PAIR)
    ("Known TAZ domain binding partners STAT1 [ xref ] and p53 [ xref ]"
     . SPARSER::COLLECTION)
    ("CR1 and CR2" . SPARSER::COLLECTION)
    ("TAZ1 or TAZ2" . SPARSER::COLLECTION)
    ("Many oncogenic viral proteins" . SPARSER::PROTEIN)
    ("many viral proteins" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("the cyclic-AMP response element binding (CREB) binding protein (CBP) and its paralog p300"
     . SPARSER::COLLECTION)
    ("protein (CBP)" . SPARSER::PROTEIN)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("proteins, pRb, p107 and p130" . SPARSER::COLLECTION)
    ("simian virus 40 large T antigen" . SPARSER::MOLECULE)
    ("other oncogenic viral proteins" . SPARSER::PROTEIN)
    ("three conserved regions denoted CR1, CR2 and CR3" . SPARSER::COLLECTION)
    ("CR1, CR2 and CR3" . SPARSER::COLLECTION)
    ("the tumor suppressors p53 and the retinoblastoma protein pRb [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("a monomeric E7 polypeptide" . SPARSER::PROTEIN)
    ("HPV E7 and the tumor suppressor p53" . SPARSER::COLLECTION)
    ("the retinoblastoma protein (pRb) and the CREB-binding protein (CBP) and its paralog p300"
     . SPARSER::COLLECTION)
    ("the CREB-binding protein (CBP) and its paralog p300"
     . SPARSER::COLLECTION)
    ("HD2" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("ppE1" . SPARSER::PROTEIN) ("P/CAF" . SPARSER::PROTEIN)
    ("Retinoblastoma Protein" . SPARSER::PROTEIN) ("CH3" . SPARSER::MOLECULE)
    ("Ac-K" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("H- 15" . SPARSER::PROTEIN) ("GB1" . SPARSER::PROTEIN)
    ("TAZ1" . SPARSER::PROTEIN) ("cyclic-AMP" . SPARSER::MOLECULE)
    ("p130" . SPARSER::PROTEIN) ("CR3" . SPARSER::PROTEIN)
    ("CR2" . SPARSER::PROTEIN)
    ("a pharmaceutical inhibitor" . SPARSER::INHIBITOR)
    ("growth factor, cytokines and chemokines" . SPARSER::COLLECTION)
    ("a proliferation inducing ligand (APRIL)" . SPARSER::PROTEIN)
    ("family (BAFF)" . SPARSER::PROTEIN-FAMILY) ("APRIL" . SPARSER::PROTEIN)
    ("BAFF" . SPARSER::PROTEIN) ("-AKT" . SPARSER::COLLECTION)
    ("AKT and FAK" . SPARSER::COLLECTION)
    ("stiffness-associated proteins" . SPARSER::PROTEIN)
    ("AMD3100 or CXCR4" . SPARSER::COLLECTION)
    ("SDF1/CXCR4" . SPARSER::COLLECTION) ("SDF-1/CXCR-4" . SPARSER::COLLECTION)
    ("regulators of the interaction between MM cells and BMSCs [ xref ]"
     . SPARSER::COLLECTION)
    ("SDF-1 and its receptor" . SPARSER::COLLECTION)
    ("a spherical AFM" . SPARSER::PROTEIN) ("AFM" . SPARSER::PROTEIN)
    ("growth factors, cytokines and chemokines" . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG)
    ("fibronectin, collagen, laminin and osteopontin" . SPARSER::COLLECTION)
    ("cytokines, growth factors and chemokines" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("SDF-1/CXCR4/AKT" . SPARSER::COLLECTION)
    ("SDF-1 receptor" . SPARSER::PROTEIN)
    ("a proliferation inducing ligand" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("SDF1" . SPARSER::PROTEIN) ("CXCR-4" . SPARSER::PROTEIN)
    ("AMD 3100" . SPARSER::DRUG) ("Myosin light chain" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("AMD3100" . SPARSER::DRUG)
    ("CD138" . SPARSER::PROTEIN) ("KRAS, EGFR, and ALK" . SPARSER::COLLECTION)
    ("LKB1 and p53" . SPARSER::COLLECTION)
    ("TC and KRAS" . SPARSER::COLLECTION)
    ("TC and histology" . SPARSER::COLLECTION)
    ("TC and FFR" . SPARSER::COLLECTION) ("high primary TC" . SPARSER::PROTEIN)
    ("decreased primary TC" . SPARSER::PROTEIN)
    ("primary TC" . SPARSER::PROTEIN) ("KRAS-" . SPARSER::PROTEIN)
    ("FFR" . SPARSER::PROTEIN) ("Ethanol" . SPARSER::PROTEIN)
    ("SKRB-3" . SPARSER::COLLECTION) ("MAD" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("ER−" . SPARSER::PROTEIN)
    ("MCP-1 and CRR2" . SPARSER::COLLECTION) ("CRR" . SPARSER::PROTEIN)
    ("The mutational and truncated BRCA1" . SPARSER::PROTEIN)
    ("Pol III gene" . SPARSER::GENE) ("wt-BRCA1" . SPARSER::COLLECTION)
    ("pre-tRNA" . SPARSER::COLLECTION) ("leu" . SPARSER::AMINO-ACID)
    ("DNM" . SPARSER::PROTEIN) ("RPAs" . SPARSER::PROTEIN)
    ("pArg" . SPARSER::PROTEIN)
    ("oncoproteins, c-Jun, c-Fos and Myc" . SPARSER::COLLECTION)
    ("ethanol-induced tRNA Leu and 5S rRNA transcription in the cells"
     . SPARSER::COLLECTION)
    ("the Pol III gene" . SPARSER::GENE)
    ("RNA Pol I and III genes" . SPARSER::GENE)
    ("TFIIIC and RNA" . SPARSER::COLLECTION) ("TFIIIC" . SPARSER::PROTEIN)
    ("Brf1 and Bdp1" . SPARSER::COLLECTION) ("Bdp1" . SPARSER::PROTEIN)
    ("these oncogenic proteins and tumor suppressor" . SPARSER::COLLECTION)
    ("TFIIIB" . SPARSER::PROTEIN)
    ("Ras, c-Jun, and c-Myc" . SPARSER::COLLECTION)
    ("7SK RNA and U6 RNA ( xref ; xref ; xref )" . SPARSER::COLLECTION)
    ("tRNAs" . SPARSER::PROTEIN)
    ("tRNA Leu and 5S rRNA genes" . SPARSER::COLLECTION)
    ("a tumor suppressor and its mutation" . SPARSER::COLLECTION)
    ("Pol III genes" . SPARSER::GENE)
    ("pRb, p53, PTEN and Maf1" . SPARSER::COLLECTION)
    ("MCP-1" . SPARSER::PROTEIN)
    ("breast cancer type 1 susceptibility protein" . SPARSER::PROTEIN)
    ("Brf1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TATA box-binding protein" . SPARSER::PROTEIN) ("7SK" . SPARSER::RNA)
    ("heart-specific Rab1A transgenes" . SPARSER::PROTEIN)
    ("PI3K and PTEN" . SPARSER::COLLECTION)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("GTPase activating protein (GAP)" . SPARSER::PROTEIN)
    ("Rag A/RagB" . SPARSER::COLLECTION)
    ("Ras, Rho, Rac and Ral" . SPARSER::COLLECTION)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab1 and Rag" . SPARSER::COLLECTION)
    ("the hyper-active RagB GTP /RagC GDP complex" . SPARSER::BIO-COMPLEX)
    ("Rheb and Raptor" . SPARSER::COLLECTION)
    ("RagA and RagB" . SPARSER::COLLECTION)
    ("Rheb or RagA/RagB in RKO cells overexpressing GFP-Rab1A"
     . SPARSER::COLLECTION)
    ("GFP or GFP-Rab1A in NIH3T3 cells" . SPARSER::COLLECTION)
    ("GFP-Rab1A" . SPARSER::COLLECTION) ("Ras/MEK/ERK" . SPARSER::COLLECTION)
    ("Rab1A or PI3K" . SPARSER::COLLECTION) ("DLD" . SPARSER::PROTEIN)
    ("PI3K or MEK" . SPARSER::COLLECTION)
    ("Rab1B, Rheb, RagA, RagB, RagC and RagD" . SPARSER::COLLECTION)
    ("Rab1B" . SPARSER::PROTEIN) ("Rab1A and P-S6K1" . SPARSER::COLLECTION)
    ("Raptor-Rheb15" . SPARSER::PROTEIN-PAIR)
    ("Rheb and mTORC1" . SPARSER::COLLECTION)
    ("Rheb-Raptor" . SPARSER::COLLECTION)
    ("Rab1A and Raptor or mTOR" . SPARSER::COLLECTION)
    ("Raptor or mTOR" . SPARSER::COLLECTION)
    ("Rab1A and Rag" . SPARSER::COLLECTION) ("/RagC" . SPARSER::COLLECTION)
    ("Rab1A and two other major mTORC1 activators" . SPARSER::COLLECTION)
    ("Rheb and Rag" . SPARSER::COLLECTION)
    ("GDP and Rab1A" . SPARSER::COLLECTION)
    ("Rab1A-mTORC1" . SPARSER::COLLECTION)
    ("mTOR and Raptor" . SPARSER::COLLECTION)
    ("Myc-mTOR" . SPARSER::COLLECTION) ("Myc-Raptor" . SPARSER::COLLECTION)
    ("HA-Rab1A" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("GTP-" . SPARSER::NUCLEOTIDE) ("Ypt6 and Ypt7" . SPARSER::COLLECTION)
    ("Ypt1, Ypt6 and Ypt7" . SPARSER::COLLECTION)
    ("the two essential Rab genes" . SPARSER::GENE)
    ("Tet-YPT1" . SPARSER::COLLECTION) ("Tet" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTR and vacuole" . SPARSER::COLLECTION) ("GTR" . SPARSER::PROTEIN)
    ("vacuolar biogenesis mutant vps16" . SPARSER::PROTEIN)
    ("vps" . SPARSER::PROTEIN) ("Sch9 and Maf1" . SPARSER::COLLECTION)
    ("RagC/RagD" . SPARSER::COLLECTION) ("RagA/RagB" . SPARSER::COLLECTION)
    ("RagD" . SPARSER::PROTEIN) ("RagC" . SPARSER::PROTEIN)
    ("RagB" . SPARSER::PROTEIN) ("RagA" . SPARSER::PROTEIN)
    ("Gtr1 and Gtr2" . SPARSER::COLLECTION) ("Rags" . SPARSER::PROTEIN)
    ("an essential nutrient" . SPARSER::MOLECULE)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("everolimus" . SPARSER::DRUG)
    ("analogs" . SPARSER::ANALOG) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("a mTORC1 activator and an oncogene" . SPARSER::COLLECTION)
    ("AA-" . SPARSER::MOLECULE) ("Rheb-mTORC1" . SPARSER::COLLECTION)
    ("Lamp2" . SPARSER::PROTEIN) ("P-ERK" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("Rap2A" . SPARSER::PROTEIN)
    ("Rheb1" . SPARSER::PROTEIN) ("Rag A" . SPARSER::PROTEIN)
    ("Rab25" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("P-4" . SPARSER::PROTEIN) ("P-S6K" . SPARSER::PROTEIN)
    ("TX-100" . SPARSER::DRUG) ("S6K1" . SPARSER::PROTEIN)
    ("Tor1" . SPARSER::PROTEIN) ("Ypt7" . SPARSER::PROTEIN)
    ("Ypt6" . SPARSER::PROTEIN) ("ypt1" . SPARSER::PROTEIN)
    ("YPT1" . SPARSER::PROTEIN) ("Rho1" . SPARSER::PROTEIN)
    ("pep5" . SPARSER::PROTEIN) ("pep3" . SPARSER::PROTEIN)
    ("Maf1" . SPARSER::PROTEIN) ("Sch9" . SPARSER::PROTEIN)
    ("gtr2" . SPARSER::PROTEIN) ("gtr1" . SPARSER::PROTEIN)
    ("Ypt1" . SPARSER::PROTEIN) ("Gtr2" . SPARSER::PROTEIN)
    ("Gtr1" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("Rab1A" . SPARSER::PROTEIN) ("Rab1" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("Bax or Bak" . SPARSER::COLLECTION) ("Genotoxic drugs" . SPARSER::DRUG)
    ("proteins and DR5" . SPARSER::COLLECTION)
    ("cFLIP and anti-apoptotic" . SPARSER::COLLECTION)
    ("cFLIP" . SPARSER::PROTEIN)
    ("the conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("Drp1 and Bax/Bak" . SPARSER::COLLECTION)
    ("Fas ligand and mdivi-1" . SPARSER::COLLECTION)
    ("Drp1 or Bax/Bak" . SPARSER::COLLECTION)
    ("the Drp1 and Bax/Bak" . SPARSER::COLLECTION)
    ("Drp1, Bax and Bak" . SPARSER::COLLECTION)
    ("TNF superfamily ligands Fas ligand and TNF-α" . SPARSER::COLLECTION)
    ("Fas ligand and TNF-α" . SPARSER::COLLECTION)
    ("the essential component" . SPARSER::COMPONENT)
    ("DR4 and DcR1" . SPARSER::COLLECTION)
    ("DcR2 and DR5" . SPARSER::COLLECTION) ("DcR1" . SPARSER::PROTEIN)
    ("adriamycin and irradiation" . SPARSER::COLLECTION)
    ("adriamycin" . SPARSER::DRUG) ("melphalan" . SPARSER::DRUG)
    ("TRAIL or mdivi-1" . SPARSER::COLLECTION)
    ("caspase-9 and downstream caspases" . SPARSER::COLLECTION)
    ("tBid" . SPARSER::PROTEIN) ("Bid" . SPARSER::PROTEIN)
    ("FADD" . SPARSER::PROTEIN)
    ("the two important pro-apoptotic Bcl-2 family proteins Bax and Bak"
     . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("TRAIL and mdivi-1" . SPARSER::COLLECTION)
    ("mdivi-1" . SPARSER::COLLECTION) ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("TRAIL" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("Fas Ligand" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("death receptor 4" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("Drp1" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("Trichostatin" . SPARSER::MOLECULE) ("exogenous TLE1" . SPARSER::PROTEIN)
    ("the mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("TLE1-siRNA" . SPARSER::COLLECTION)
    ("the exogenous TLE1" . SPARSER::PROTEIN)
    ("GFP-TLE1" . SPARSER::COLLECTION)
    ("the GFP-tagged TLE1 or control GFP" . SPARSER::COLLECTION)
    ("the invasive suppressor E –cadherin gene" . SPARSER::GENE)
    ("ErbB1 and ErbB2" . SPARSER::COLLECTION) ("groucho" . SPARSER::PROTEIN)
    ("genes and the subsequent removal of acetyl" . SPARSER::COLLECTION)
    ("Gro" . SPARSER::PROTEIN) ("E-cadherin and EMT" . SPARSER::COLLECTION)
    ("Groucho" . SPARSER::PROTEIN) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("E –cadherin" . SPARSER::PROTEIN) ("Bit1" . SPARSER::PROTEIN)
    ("Histone Deacetylase" . SPARSER::PROTEIN) ("TLE1" . SPARSER::PROTEIN)
    ("a new novel centrosomal protein" . SPARSER::PROTEIN)
    ("centrosomal Chk1" . SPARSER::PROTEIN)
    ("centrosomal fractions" . SPARSER::COMPONENT)
    ("Hsp90 and pericentrin" . SPARSER::COLLECTION)
    ("ChK1 and γ-tubulin" . SPARSER::COLLECTION)
    ("the centrosomal fractions" . SPARSER::COMPONENT)
    ("centrosomal ChK1" . SPARSER::PROTEIN)
    ("pericentrin and γ-tubulin" . SPARSER::COLLECTION)
    ("pericentrin" . SPARSER::PROTEIN)
    ("UNC45A (DKAVEYGLIQPNQDGE)" . SPARSER::PROTEIN)
    ("the centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("UNC45A and γ-tubulin" . SPARSER::COLLECTION)
    ("a centrosomal protein" . SPARSER::PROTEIN)
    ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("homology, UNC45A and UNC45B" . SPARSER::COLLECTION)
    ("TPR" . SPARSER::PROTEIN) ("UNC45A and ChK1" . SPARSER::COLLECTION)
    ("a novel centrosomal protein" . SPARSER::PROTEIN)
    ("Myosin-9" . SPARSER::PROTEIN) ("MHC-A" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("ChK2" . SPARSER::PROTEIN)
    ("Hsp90β" . SPARSER::PROTEIN)
    ("centrosome-associated protein" . SPARSER::PROTEIN)
    ("cyclin-B" . SPARSER::PROTEIN-FAMILY)
    ("muscle specific" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ChK1" . SPARSER::PROTEIN)
    ("UNC45A" . SPARSER::PROTEIN)
    ("proteins, E-cadherin, vimentin, and CD44" . SPARSER::COLLECTION)
    ("CD44 and vimentin" . SPARSER::COLLECTION)
    ("vimentin, E-cadherin, and CD44" . SPARSER::COLLECTION)
    ("mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("the late recurrence group" . SPARSER::MOLECULE)
    ("CD44, CD54, and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("EMT and stem cell-like" . SPARSER::COLLECTION)
    ("vimentin and the known gastric cancer stem cell maker CD44"
     . SPARSER::COLLECTION)
    ("the known gastric cancer stem cell maker CD44" . SPARSER::PROTEIN)
    ("five EMT-related proteins (Snail-1, ZEB-1, E-cadherin, vimentin, and β-catenin) and the gastric cancer stem cell markers CD44 and CD54"
     . SPARSER::COLLECTION)
    ("the gastric cancer stem cell markers CD44 and CD54"
     . SPARSER::COLLECTION)
    ("ZEB-1, E-cadherin, vimentin, and β-catenin" . SPARSER::COLLECTION)
    ("CD44 and CD54" . SPARSER::COLLECTION) ("Snail-1" . SPARSER::COLLECTION)
    ("zinc finger E-box-binding homeobox 1" . SPARSER::PROTEIN)
    ("CD54" . SPARSER::PROTEIN) ("ZEB-1" . SPARSER::PROTEIN)
    ("An excellent example" . SPARSER::EXAMPLE)
    ("aberrant E2F1" . SPARSER::PROTEIN) ("CycA/cdk2" . SPARSER::COLLECTION)
    ("haploid" . SPARSER::PROTEIN) ("the infertile cohort" . SPARSER::MOLECULE)
    ("commonly occurring example" . SPARSER::EXAMPLE)
    ("a dosage-sensitive gene" . SPARSER::GENE)
    ("This duplicated region encompassed one gene" . SPARSER::GENE)
    ("E2F1-CycA/cdk2" . SPARSER::COLLECTION)
    ("strong brown DAB" . SPARSER::MOLECULE) ("DAB" . SPARSER::MOLECULE)
    ("Parental DNA" . SPARSER::DNA) ("CycA" . SPARSER::PROTEIN)
    ("a synonymous variant p" . SPARSER::PROTEIN)
    ("a nonsynonymous variant p" . SPARSER::PROTEIN)
    ("78 healthy fertile male" . SPARSER::MOLECULE)
    ("genes and areas" . SPARSER::COLLECTION) ("Male" . SPARSER::MOLECULE)
    ("Given E2F1’s" . SPARSER::PROTEIN) ("Given E2F1" . SPARSER::PROTEIN)
    ("E2f1" . SPARSER::PROTEIN)
    ("four distinct analytic components" . SPARSER::COMPONENT)
    ("MBD5" . SPARSER::PROTEIN) ("e-5" . SPARSER::PROTEIN)
    ("E–F" . SPARSER::PROTEIN) ("C–D" . SPARSER::PROTEIN)
    ("cdk2" . SPARSER::PROTEIN) ("beta-amyloid" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN) ("PXMP4" . SPARSER::PROTEIN)
    ("NECAB3" . SPARSER::PROTEIN) ("CBFA2" . SPARSER::PROTEIN)
    ("cytoskeletal actin" . SPARSER::PROTEIN)
    ("Cten and tensin 3" . SPARSER::COLLECTION)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("Cten-shRNA" . SPARSER::COLLECTION) ("Cten" . SPARSER::PROTEIN)
    ("tensin 3" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("S3i-201" . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("tensin-4" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("GPX1 , NFE2L2 , NOX3 , PON1 and GSTM2" . SPARSER::COLLECTION)
    ("variants and pathways" . SPARSER::COLLECTION)
    ("harmful hydrogen peroxide" . SPARSER::DRUG)
    ("the NOX3 intronic variants" . SPARSER::VARIANT)
    ("recipient NFE2L2 and donor NOX3" . SPARSER::COLLECTION)
    ("EL" . SPARSER::PROTEIN) ("NOX3 and NRF2" . SPARSER::COLLECTION)
    ("GPX1, NFE2L2, NOS3, GSTM2, NOX3, NOS1AP and PON1" . SPARSER::COLLECTION)
    ("the ancestral G allele" . SPARSER::ALLELE)
    ("nitric oxide synthase 1 adaptor protein ( NOS1AP, p=0.048) and paraoxonase-1 ( PON1 , p=0.03)"
     . SPARSER::COLLECTION)
    ("NOX3 (p=0.01), nitric oxide synthase 1 adaptor protein ( NOS1AP, p=0.048) and paraoxonase-1 ( PON1 , p=0.03)"
     . SPARSER::COLLECTION)
    ("paraoxonase" . SPARSER::PROTEIN)
    ("PGD and non PGD" . SPARSER::COLLECTION) ("ALI" . SPARSER::PROTEIN)
    ("GPX1 , NOX3 , and NFE2L2" . SPARSER::COLLECTION)
    ("NOX3 and NFE2L2" . SPARSER::COLLECTION)
    ("NOX3 and recipient NFE2L2 (p=0.026, p=0.017 and p=0.031)"
     . SPARSER::COLLECTION)
    ("glutathione peroxidase ( GPX1 ) and NRF-2 ( NFE2L2 )"
     . SPARSER::COLLECTION)
    ("developed grade 3 PGD" . SPARSER::PROTEIN)
    ("Group (LTOG)" . SPARSER::MOLECULE) ("PGD" . SPARSER::PROTEIN)
    ("Oxidant" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("PON1" . SPARSER::PROTEIN)
    ("NOS1AP" . SPARSER::PROTEIN)
    ("nitric oxide synthase 1 adaptor protein" . SPARSER::PROTEIN)
    ("GSTM2" . SPARSER::PROTEIN)
    ("glutathione S-transferase mu 2" . SPARSER::PROTEIN)
    ("NOS3" . SPARSER::PROTEIN) ("nitric oxide synthase 3" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("NRF-2" . SPARSER::PROTEIN)
    ("GPX1" . SPARSER::PROTEIN) ("NOX3" . SPARSER::PROTEIN)
    ("NADPH Oxidase 3" . SPARSER::PROTEIN)
    ("PP2A-C/B subunit" . SPARSER::COLLECTION)
    ("AMBRA1-PP2A" . SPARSER::COLLECTION)
    ("both PP2A and the phosphatase PP1" . SPARSER::COLLECTION)
    ("PP2A and cellular scaffolds" . SPARSER::COLLECTION)
    ("Ambra1 ( Ambra1  gt/gt ) or expressing AMBRA1" . SPARSER::COLLECTION)
    ("PXP" . SPARSER::PROTEIN)
    ("a constitutive active form of Ras (RasV12) and E1A"
     . SPARSER::COLLECTION)
    ("athymic mice primary MEFs" . SPARSER::PROTEIN)
    ("Given Ambra1’s" . SPARSER::PROTEIN) ("Given Ambra1" . SPARSER::PROTEIN)
    ("exogenous total C-MYC" . SPARSER::PROTEIN)
    ("AMBRA1 PXP" . SPARSER::PROTEIN)
    ("BECLIN 1 and ULK1" . SPARSER::COLLECTION)
    ("AMBRA1/PP2A/C-MYC" . SPARSER::COLLECTION)
    ("Rapamycin and Torin1" . SPARSER::COLLECTION)
    ("RAPTOR" . SPARSER::PROTEIN) ("Rapamycin" . SPARSER::DRUG)
    ("AMBRA1 and PP2A-C" . SPARSER::COLLECTION)
    ("C-MYC and PP2A-C" . SPARSER::COLLECTION) ("Pp2a-c" . SPARSER::PROTEIN)
    ("MEFs or AMBRA1" . SPARSER::COLLECTION)
    ("PP2A-C and PR65A" . SPARSER::COLLECTION)
    ("AMBRA1/PP2A-C" . SPARSER::COLLECTION)
    ("Ambra1 -defective MEFs" . SPARSER::PROTEIN)
    ("the Cyclin A and B mRNAs" . SPARSER::COLLECTION)
    ("transformed (by RasV12/E1A expression) Ambra1  gt/gt MEFs"
     . SPARSER::PROTEIN)
    ("gene-trap" . SPARSER::PROTEIN) ("BromodeoxyUridine" . SPARSER::DRUG)
    ("Ambra1" . SPARSER::PROTEIN)
    ("the pro-autophagic protein AMBRA1" . SPARSER::PROTEIN)
    ("this phosphatase’s" . SPARSER::PHOSPHATASE)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("ULK1 and AMBRA1" . SPARSER::COLLECTION)
    ("a haploinsufficient tumour suppressor gene" . SPARSER::GENE)
    ("C-MYC and its phosphatase PP2A" . SPARSER::COLLECTION)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN)
    ("G Protein" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("RPS6" . SPARSER::PROTEIN) ("P62" . SPARSER::PROTEIN)
    ("Beta Tubulin" . SPARSER::PROTEIN) ("ATG4C" . SPARSER::PROTEIN)
    ("ATG7" . SPARSER::PROTEIN) ("PR65" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("BECLIN 1" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("Pp2" . SPARSER::DRUG)
    ("PR65A" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PP2A-C" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("RasV12" . SPARSER::DRUG)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ULK1" . SPARSER::PROTEIN)
    ("mammalian target of Rapamycin" . SPARSER::PROTEIN)
    ("C-MYC" . SPARSER::PROTEIN) ("AMBRA1" . SPARSER::PROTEIN)
    ("this complex and E2F-associated transcriptional regulatory complexes"
     . SPARSER::COLLECTION)
    ("E2F-associated transcriptional regulatory complexes"
     . SPARSER::BIO-COMPLEX)
    ("a more broadly relevant THAP11/ZNF143/HCF-1 transcriptional regulatory complex"
     . SPARSER::BIO-COMPLEX)
    ("HCF-1- and ZNF143-" . SPARSER::COLLECTION) ("HCF-1-" . SPARSER::PROTEIN)
    ("THAP11 and chromatin-bound ZNF143" . SPARSER::COLLECTION)
    ("THAP11-HCF-1" . SPARSER::COLLECTION)
    ("HCF-1, or THAP11 and ZNF143" . SPARSER::COLLECTION)
    ("BUB1B , BOD1 , and RANGAP1" . SPARSER::COLLECTION)
    ("BUB1B and BUB3" . SPARSER::COLLECTION)
    ("KAT5/TIP60" . SPARSER::COLLECTION) ("KAT2B/PCAF" . SPARSER::COLLECTION)
    ("KAT2A/GCN5" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN) ("PCAF" . SPARSER::PROTEIN)
    ("E2F1, E2F4, or DP1" . SPARSER::COLLECTION)
    ("HCF-1 and zinc-finger transcription factors THAP11 and ZNF143"
     . SPARSER::COLLECTION)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("HCF-1 or THAP11" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("repressive RB1/E2F" . SPARSER::COLLECTION)
    ("RB1/E2F" . SPARSER::COLLECTION) ("BOD" . SPARSER::PROTEIN)
    ("ACLY" . SPARSER::PROTEIN)
    ("thymidine and nocodazole" . SPARSER::COLLECTION)
    ("HCF-1, THAP11, ZNF143, E2F1, and E2F4" . SPARSER::COLLECTION)
    ("E2F1-HCF-1" . SPARSER::COLLECTION)
    ("E2F1 and HCF-1" . SPARSER::COLLECTION)
    ("HCF-1 and THAP11" . SPARSER::COLLECTION)
    ("HCF-1 and the other proteins" . SPARSER::COLLECTION)
    ("either ZNF143 (1300) or THAP11 (471, xref )" . SPARSER::COLLECTION)
    ("ZNF143, THAP11, and E2F1" . SPARSER::COLLECTION)
    ("HOMER" . SPARSER::PROTEIN-FAMILY)
    ("HCF-1 and E2F1" . SPARSER::COLLECTION)
    ("THAP11, ZNF143, and E2F" . SPARSER::COLLECTION)
    ("E2F1 , CCNA2 , CCNE1 , and CDK1" . SPARSER::COLLECTION)
    ("MCM4 and PCNA" . SPARSER::COLLECTION)
    ("E2F/THAP11/ZNF143" . SPARSER::COLLECTION) ("Rbl1" . SPARSER::PROTEIN)
    ("E2F1 and E2F3" . SPARSER::COLLECTION)
    ("heterodimeric partner DP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RBL1 , CDC25A , CDC6 , and MCM3" . SPARSER::COLLECTION)
    ("protein and chromatin" . SPARSER::COLLECTION)
    ("E2F1, E2F3a, and E2F4" . SPARSER::COLLECTION)
    ("soluble THAP11" . SPARSER::PROTEIN)
    ("protein/HCF-1" . SPARSER::COLLECTION)
    ("anti-THAP11 or anti-ZNF143" . SPARSER::COLLECTION)
    ("THAP11, HCF-1 and ZNF143" . SPARSER::COLLECTION)
    ("occupancy at most promoters" . SPARSER::PROMOTER)
    ("ZNF143, THAP11, and HCF-1" . SPARSER::COLLECTION)
    ("THAP11 and HCF-1" . SPARSER::COLLECTION)
    ("HCF-1 or ZNF143" . SPARSER::COLLECTION)
    ("HCF-1 and ZNF143" . SPARSER::COLLECTION)
    ("THAP11, ZNF143, or HCF-1" . SPARSER::COLLECTION)
    ("THAP11 and/or ZNF143" . SPARSER::COLLECTION)
    ("CDC25A , CDC6 , and MCM3" . SPARSER::COLLECTION)
    ("THAP11, HCF-1, and ZNF143" . SPARSER::COLLECTION)
    ("HCF-1, THAP11, and ZNF143" . SPARSER::COLLECTION)
    ("THAP11 or ZNF143" . SPARSER::COLLECTION)
    ("HBB and CHRM1" . SPARSER::COLLECTION)
    ("THAP11/ZNF143" . SPARSER::COLLECTION) ("HBB" . SPARSER::PROTEIN)
    ("E2F-" . SPARSER::PROTEIN-FAMILY) ("Promoters" . SPARSER::PROMOTER)
    ("RBL1 and CDC25A" . SPARSER::COLLECTION)
    ("THAP1 and HCF-1" . SPARSER::COLLECTION)
    ("putative HCF-1-associated transcriptional regulators"
     . SPARSER::PROTEIN-FAMILY)
    ("HCF-1, and deubiquitinase" . SPARSER::COLLECTION)
    ("Yin" . SPARSER::PROTEIN) ("E2F1 and E2F4" . SPARSER::COLLECTION)
    ("E2F1, E2F4, and E2F3a" . SPARSER::COLLECTION) ("HBM" . SPARSER::PROTEIN)
    ("tetrapeptide" . SPARSER::MOLECULE)
    ("histones and other chromatin" . SPARSER::COLLECTION)
    ("THAP11/ZNF143/HCF-1" . SPARSER::COLLECTION)
    ("THAP11, ZNF143, and HCF-1" . SPARSER::COLLECTION)
    ("THAP11 and ZNF143" . SPARSER::COLLECTION) ("pGL4" . SPARSER::PROTEIN)
    ("ESCO2" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("BUB3" . SPARSER::PROTEIN) ("PR-Set7" . SPARSER::PROTEIN)
    ("KMT5A" . SPARSER::PROTEIN) ("SETD8" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("KAT5" . SPARSER::PROTEIN)
    ("KAT2B" . SPARSER::PROTEIN) ("KAT2A" . SPARSER::PROTEIN)
    ("RANGAP1" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("MAP3K10" . SPARSER::PROTEIN) ("MCM4" . SPARSER::PROTEIN)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("protein-G" . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("CHRM1" . SPARSER::PROTEIN)
    ("RBL1" . SPARSER::PROTEIN) ("THAP1" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN) ("BRCA1 associated protein" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("VP16" . SPARSER::DRUG)
    ("ZNF143" . SPARSER::PROTEIN) ("THAP11" . SPARSER::PROTEIN)
    ("HCF-1" . SPARSER::PROTEIN) ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("key adipogenic genes" . SPARSER::GENE)
    ("PPARG , CEBPA , ADIPOQ , LPL , LEP , PLIN1 , and FABP4"
     . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("a natural enhancer" . SPARSER::PROTEIN)
    ("an early global regulator" . SPARSER::REGULATOR)
    ("ITGA1 , ITGA4 , ITGA5 , ITGA6 , ITGA9 , ITGA11 , ITGB5 , and ITGBL1"
     . SPARSER::COLLECTION)
    ("highly significant and contained classic genes" . SPARSER::GENE)
    ("PPARG , CEBPA , LPL , ADIPOQ , LEP , and FABP4" . SPARSER::COLLECTION)
    ("LEP" . SPARSER::PROTEIN) ("ADIPOQ" . SPARSER::PROTEIN)
    ("LPL" . SPARSER::PROTEIN) ("Maps" . SPARSER::PROTEIN)
    ("rosiglitazone, and IBMX" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("phenotypic markers FABP4 and PLIN1" . SPARSER::COLLECTION)
    ("MYC , CEBPB , and CEBPD" . SPARSER::COLLECTION)
    ("FABP4 and PLIN1" . SPARSER::COLLECTION)
    ("MYC, CEBPB , and CEBPD" . SPARSER::COLLECTION)
    ("WNT2 and TGFB1" . SPARSER::COLLECTION)
    ("PLIN1 and fatty acid binding protein" . SPARSER::COLLECTION)
    ("CEBPA , PPARG , FABP4 , and PLIN1" . SPARSER::COLLECTION)
    ("WNT and TGF-β" . SPARSER::COLLECTION)
    ("PPARG and FABP4" . SPARSER::COLLECTION)
    ("MYC, PPARG and FABP4" . SPARSER::COLLECTION)
    ("a lipid droplet protein expressed in mature adipocytes"
     . SPARSER::PROTEIN)
    ("PPARG and PLIN1" . SPARSER::COLLECTION)
    ("the neutral lipid" . SPARSER::LIPID)
    ("PPARG and non-targeting" . SPARSER::COLLECTION)
    ("confluent ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neutral lipid" . SPARSER::LIPID) ("rosiglitazone" . SPARSER::DRUG)
    ("IBMX" . SPARSER::MOLECULE) ("CD105 and CD44" . SPARSER::COLLECTION)
    ("CD31 and CD45" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("human subcutaneous ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CEBPB and CEBPD" . SPARSER::COLLECTION)
    ("CEBPA and PPARG" . SPARSER::COLLECTION) ("PPARG" . SPARSER::PROTEIN)
    ("CEBPA" . SPARSER::PROTEIN) ("CEBPD" . SPARSER::PROTEIN)
    ("CEBPB" . SPARSER::PROTEIN) ("preadipocytes" . SPARSER::PROTEIN)
    ("the stromal vascular fraction" . SPARSER::COMPONENT)
    ("multipotent ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glucocorticoid" . SPARSER::PROTEIN)
    ("multipotent ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibronectin receptor" . SPARSER::PROTEIN) ("ITGBL1" . SPARSER::PROTEIN)
    ("ITGB5" . SPARSER::PROTEIN) ("ITGA11" . SPARSER::PROTEIN)
    ("ITGA9" . SPARSER::PROTEIN) ("ITGA6" . SPARSER::PROTEIN)
    ("ITGA5" . SPARSER::PROTEIN) ("ITGA4" . SPARSER::PROTEIN)
    ("ITGA1" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("fatty acid binding protein" . SPARSER::PROTEIN)
    ("Lipid droplet" . SPARSER::PROTEIN) ("WNT2" . SPARSER::PROTEIN)
    ("Wnt10b" . SPARSER::PROTEIN) ("D35" . SPARSER::PROTEIN)
    ("FABP4" . SPARSER::PROTEIN) ("protein expressed in" . SPARSER::PROTEIN)
    ("PLIN1" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("C-15" . SPARSER::PROTEIN) ("A-FABP" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN)
    ("These latter molecules" . SPARSER::MOLECULE)
    ("protein, RBM10 and TOX3" . SPARSER::COLLECTION)
    ("SGTA, CNOT3 and ASPH" . SPARSER::COLLECTION) ("SGTA" . SPARSER::PROTEIN)
    ("proteins, ABBC2 and GLIS 2" . SPARSER::COLLECTION)
    ("No previously defined melanoma biomarkers" . SPARSER::MOLECULE)
    ("relevant biomarkers" . SPARSER::MOLECULE)
    ("Melanoma Inhibitory Activity (MIA)" . SPARSER::PROTEIN)
    ("MIA" . SPARSER::PROTEIN) ("dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("no minimally invasive pharmacodynamic biomarkers" . SPARSER::MOLECULE)
    ("receive Vemurafenib" . SPARSER::DRUG) ("PXK" . SPARSER::PROTEIN)
    ("transmembrane transporter" . SPARSER::PROTEIN) ("CRX" . SPARSER::PROTEIN)
    ("KLF17 and TOX3" . SPARSER::COLLECTION)
    ("ZC3H6 and CNOT3" . SPARSER::COLLECTION)
    ("possible associated biomarkers" . SPARSER::MOLECULE)
    ("TRA" . SPARSER::PROTEIN) ("TMZ and FM" . SPARSER::COLLECTION)
    ("4 CR and 12 PR" . SPARSER::COLLECTION) ("Vemurafenib" . SPARSER::DRUG)
    ("SELDI" . SPARSER::PROTEIN)
    ("differentially expressed peptides" . SPARSER::PEPTIDE)
    ("Fotemustine (FM)" . SPARSER::DRUG)
    ("sequential non-therapeutic low dose TMZ" . SPARSER::DRUG)
    ("FM" . SPARSER::PROTEIN) ("Fotemustine" . SPARSER::DRUG)
    ("procarbazine, dacarbazine and temozolomide" . SPARSER::COLLECTION)
    ("TMZ" . SPARSER::DRUG) ("temozolomide" . SPARSER::DRUG)
    ("dacarbazine" . SPARSER::DRUG) ("procarbazine" . SPARSER::DRUG)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("drugs, and ipilimumab" . SPARSER::COLLECTION)
    ("ipilimumab" . SPARSER::DRUG)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("ABCC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SELDI-TOF" . SPARSER::COLLECTION)
    ("BRAF, vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("SPATA8" . SPARSER::PROTEIN)
    ("PAIP2B" . SPARSER::PROTEIN) ("SMURF2" . SPARSER::PROTEIN)
    ("IL7RA" . SPARSER::PROTEIN) ("GLIS 2" . SPARSER::PROTEIN)
    ("SLAIN 1" . SPARSER::PROTEIN) ("Apolipoprotein-A1" . SPARSER::PROTEIN)
    ("Apolipoprotein-E" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Melanoma Inhibitory Activity" . SPARSER::PROTEIN)
    ("C-Reactive Protein" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("TBC1D23" . SPARSER::PROTEIN) ("GGT7" . SPARSER::PROTEIN)
    ("hydrolase activity" . SPARSER::PROTEIN) ("IL7" . SPARSER::PROTEIN)
    ("AQP11" . SPARSER::PROTEIN) ("MTERFD1" . SPARSER::PROTEIN)
    ("CNOT3" . SPARSER::PROTEIN) ("ZC3H6" . SPARSER::PROTEIN)
    ("CA4" . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("CTLA-4" . SPARSER::PROTEIN) ("ZBTB44" . SPARSER::PROTEIN)
    ("KLF17" . SPARSER::PROTEIN) ("RIN1" . SPARSER::PROTEIN)
    ("TSPO2" . SPARSER::PROTEIN) ("TOX3" . SPARSER::PROTEIN)
    ("RBM10" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("SLAIN1" . SPARSER::PROTEIN)
    ("the TCGA ovarian cancer cohort" . SPARSER::MOLECULE)
    ("topotecan" . SPARSER::DRUG) ("HR  " . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN)
    ("TCGA ovarian cancer cohort" . SPARSER::MOLECULE)
    ("CR and platinum" . SPARSER::COLLECTION)
    ("RAD genes and DNA repair genes" . SPARSER::COLLECTION)
    ("ATM , ATR and CHEK1/2" . SPARSER::COLLECTION)
    ("chemicals" . SPARSER::MOLECULE) ("CNC" . SPARSER::PROTEIN)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("CHEK1" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN)
    ("molecules or antibodies" . SPARSER::COLLECTION)
    ("chloroquine and brefeldin A" . SPARSER::COLLECTION)
    ("chlorpromazine, nystatin or methyl-β-cyclodextrin" . SPARSER::COLLECTION)
    ("clathrin-" . SPARSER::PROTEIN) ("nystatin" . SPARSER::DRUG)
    ("chlorpromazine" . SPARSER::DRUG)
    ("which targets human Bcl-2 mRNA" . SPARSER::PROTEIN)
    ("mh1" . SPARSER::PROTEIN) ("mh" . SPARSER::MOLECULE)
    ("oligonucleotides or siRNA" . SPARSER::COLLECTION)
    ("Jak–Stat" . SPARSER::COLLECTION) ("Stat" . SPARSER::PROTEIN)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1, sgHT2 and sgHT5" . SPARSER::COLLECTION)
    ("DNA-synthesis" . SPARSER::DNA) ("Cisplatin" . SPARSER::DRUG)
    ("cyclin D1 and cisplatin" . SPARSER::COLLECTION) ("Mito" . SPARSER::DRUG)
    ("sgL" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D1 and control sgRNA (sgLucHep3)" . SPARSER::COLLECTION)
    ("acceptor and T" . SPARSER::COLLECTION)
    ("14-nt linear RNA (L) type and heptamer RNA (H) type" . TYPE)
    ("type and heptamer" . SPARSER::COLLECTION) ("longer RNAs" . SPARSER::RNA)
    ("Bcl2 or WT1" . SPARSER::COLLECTION)
    ("RNA, and 14-nt" . SPARSER::COLLECTION)
    ("the associated kinase" . SPARSER::KINASE)
    ("Ras-MEK-ERK" . SPARSER::COLLECTION)
    ("active complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSC-2 and HSC-3" . SPARSER::COLLECTION) ("HSC-3" . SPARSER::PROTEIN)
    ("HSC-2" . SPARSER::PROTEIN)
    ("the target RNA and an artificial small guide RNA (sgRNA)"
     . SPARSER::COLLECTION)
    ("an artificial small guide RNA" . SPARSER::RNA)
    ("tRNase ZL-utilizing efficacious gene" . SPARSER::GENE)
    ("brefeldin A" . SPARSER::MOLECULE) ("RB protein" . SPARSER::PROTEIN)
    ("L type" . SPARSER::PROTEIN) ("A 20 µ" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("green fluorescent" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("types and ethnicities" . SPARSER::COLLECTION)
    ("mutated Pro72 allele" . SPARSER::ALLELE)
    ("food and environment xref" . SPARSER::COLLECTION)
    ("cytosine" . SPARSER::NUCLEOBASE) ("delG" . SPARSER::PROTEIN)
    ("Arg/Arg" . SPARSER::COLLECTION) ("Pro/Pro" . SPARSER::COLLECTION)
    ("proline (Pro72) or arginine (Arg72)" . SPARSER::COLLECTION)
    ("polyproline" . SPARSER::PROTEIN) ("Pro/Arg" . SPARSER::COLLECTION)
    ("alcohol and tobacco" . SPARSER::COLLECTION)
    ("the healthy control group" . SPARSER::MOLECULE)
    ("P190" . SPARSER::PROTEIN) ("open angle" . SPARSER::PROTEIN)
    ("tagged-Ub or substrates" . SPARSER::COLLECTION)
    ("Gly-Gly-Met" . SPARSER::COLLECTION) ("poses" . SPARSER::PROTEIN)
    ("stalled ribosomes" . SPARSER::BIO-COMPLEX)
    ("latent membrane protein 1, and inhibitor of differentiation 2"
     . SPARSER::COLLECTION)
    ("SUMO or Nedd8" . SPARSER::COLLECTION) ("SUMO" . SPARSER::PROTEIN)
    ("lysine-reactive E2s" . SPARSER::MOLECULE)
    ("the minimal peptide substrate" . SPARSER::SUBSTRATE)
    ("RBP" . SPARSER::PROTEIN) ("RPB8 nor Ub" . SPARSER::COLLECTION)
    ("RPB8 and tau" . SPARSER::COLLECTION) ("robust Ub" . SPARSER::PROTEIN)
    ("fungi" . SPARSER::PROTEIN) ("dimeric Ube2w" . SPARSER::PROTEIN)
    ("canonical UBC" . SPARSER::PROTEIN) ("CSP" . SPARSER::PROTEIN)
    ("CS-Rosetta" . SPARSER::PROTEIN-PAIR)
    ("canonical E2s" . SPARSER::MOLECULE) ("spin" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE) ("RDC" . SPARSER::DRUG)
    ("canonical E2" . SPARSER::MOLECULE) ("CSPs" . SPARSER::PROTEIN)
    ("a monomeric Ube2w mutant" . SPARSER::MUTANT)
    ("unique Ub" . SPARSER::PROTEIN)
    ("N-terminally tagged Ub" . SPARSER::PROTEIN)
    ("prolines" . SPARSER::AMINO-ACID) ("‘substrate’" . SPARSER::SUBSTRATE)
    ("glycines" . SPARSER::AMINO-ACID) ("methionine" . SPARSER::AMINO-ACID)
    ("-Ub" . SPARSER::COLLECTION) ("an anti-Ub" . SPARSER::ANTIBODY)
    ("HA-Ub" . SPARSER::COLLECTION)
    ("a robust Ube2w substrate" . SPARSER::SUBSTRATE)
    ("tau, ataxin-3, FANCL, FANCD2, and Ube2w" . SPARSER::COLLECTION)
    ("FANCL" . SPARSER::PROTEIN) ("Carboxy" . SPARSER::MOLECULE)
    ("Ubc13/MMS2" . SPARSER::COLLECTION)
    ("the minimal RING heterodimer" . SPARSER::HETERODIMER)
    ("Ube2w, UbcH5c, UbcH7, and Ube2e1" . SPARSER::COLLECTION)
    ("BRCA1/BARD1" . SPARSER::COLLECTION) ("Polymerase" . SPARSER::PROTEIN)
    ("subsequent Ub" . SPARSER::PROTEIN) ("UBC" . SPARSER::PROTEIN)
    ("serine, threonine, and cysteine" . SPARSER::COLLECTION)
    ("Ube2e1 and Ube2t" . SPARSER::COLLECTION) ("Ube2t" . SPARSER::PROTEIN)
    ("Ube2e1" . SPARSER::PROTEIN) ("Ube2k" . SPARSER::PROTEIN)
    ("Ubc13/Mms2" . SPARSER::COLLECTION) ("RBR" . SPARSER::PROTEIN-FAMILY)
    ("HECT" . SPARSER::PROTEIN) ("thioester" . SPARSER::MOLECULE)
    ("Ube2w" . SPARSER::PROTEIN) ("a  2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pf1" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("A-A-G" . SPARSER::PROTEIN) ("Ube1" . SPARSER::PROTEIN)
    ("Ataxin-3" . SPARSER::PROTEIN) ("ERK3" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 3" . SPARSER::PROTEIN)
    ("inhibitor of differentiation 2" . SPARSER::PROTEIN)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("C91" . SPARSER::PROTEIN) ("V30" . SPARSER::PROTEIN)
    ("pK a" . SPARSER::PROTEIN) ("Met-Gly" . SPARSER::MOLECULE)
    ("H – 15" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("ataxin-3" . SPARSER::PROTEIN) ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("small ubiquitin-like modifier 2" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("Gly-Ser" . SPARSER::MOLECULE)
    ("MMS2" . SPARSER::PROTEIN) ("UbcH7" . SPARSER::PROTEIN)
    ("RPB8" . SPARSER::PROTEIN) ("Subunit 8" . SPARSER::PROTEIN)
    ("e1" . SPARSER::MOLECULE) ("UbcH5c" . SPARSER::PROTEIN)
    ("Mms2" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("E2s" . SPARSER::MOLECULE) ("poly-ubiquitin" . SPARSER::PROTEIN)
    ("p53 and its downstream targets" . SPARSER::COLLECTION)
    ("BAX and PMAIP1" . SPARSER::COLLECTION) ("TSG" . SPARSER::PROTEIN)
    ("p53 and its targets" . SPARSER::COLLECTION) ("Sox30" . SPARSER::PROTEIN)
    ("a putative epigenetic biomarker" . SPARSER::MOLECULE)
    ("MSP and BGS" . SPARSER::COLLECTION)
    ("PMAIP1 , p21 and BAX" . SPARSER::COLLECTION)
    ("the highly possible target gene" . SPARSER::GENE)
    ("SOX30-" . SPARSER::PROTEIN) ("the possible target gene" . SPARSER::GENE)
    ("SOX30 and p53" . SPARSER::COLLECTION)
    ("p53 and its downstream target genes" . SPARSER::COLLECTION)
    ("BAX, PMAIP1 and p21" . SPARSER::COLLECTION) ("micro RNA" . SPARSER::RNA)
    ("EdU" . SPARSER::DRUG) ("exogenous SOX30" . SPARSER::PROTEIN)
    ("WB" . SPARSER::PROTEIN)
    ("western blot (WB) and immunohistochemistry" . SPARSER::COLLECTION)
    ("western blot (WB)" . SPARSER::PROTEIN) ("Nile" . SPARSER::PROTEIN)
    ("group (HMG)" . SPARSER::MOLECULE) ("TSGs" . SPARSER::PROTEIN)
    ("a novel transcriptional activating factor" . SPARSER::PROTEIN)
    ("SRY" . SPARSER::PROTEIN) ("HMG-box" . SPARSER::PROTEIN)
    ("PMAIP1" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("SOX30" . SPARSER::PROTEIN)
    ("several NER and DNA damage response (DDR) protein" . SPARSER::COLLECTION)
    ("GGR" . SPARSER::PROTEIN)
    ("Polη ( xref ) as well as its known transcription activator p53"
     . SPARSER::COLLECTION)
    ("Polη and Mdm2" . SPARSER::COLLECTION)
    ("increased cellular Polη" . SPARSER::PROTEIN)
    ("USP7 and Polη" . SPARSER::COLLECTION)
    ("the anti-GFP" . SPARSER::ANTIBODY) ("FLAG-USP7" . SPARSER::COLLECTION)
    ("EGFP-Polη" . SPARSER::COLLECTION)
    ("anti-Polη and anti-USP7" . SPARSER::COLLECTION)
    ("Polη and USP7" . SPARSER::COLLECTION)
    ("FLAG-tagged wild-type USP7 or catalytically inactive USP7 (USP7-CS)"
     . SPARSER::COLLECTION)
    ("USP7-CS" . SPARSER::COLLECTION)
    ("Polη as well as p53" . SPARSER::COLLECTION)
    ("Polη and p53" . SPARSER::COLLECTION)
    ("HBX 41108 (3 μM) only partially reduced Mdm2" . SPARSER::PROTEIN)
    ("Polη" . SPARSER::PROTEIN) ("GFP-Polη" . SPARSER::COLLECTION)
    ("Mdm2 and subsequently stabilizing p53" . SPARSER::COLLECTION)
    ("p53 and Polη" . SPARSER::COLLECTION) ("cellular USP7" . SPARSER::PROTEIN)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("CPD" . SPARSER::PROTEIN)
    ("XPV" . SPARSER::PROTEIN)
    ("its catalytically-defective mutants" . SPARSER::MUTANT)
    ("HBX 41108" . SPARSER::DRUG) ("USP28" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN) ("Rad30" . SPARSER::PROTEIN)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("DNA polymerase eta" . SPARSER::PROTEIN)
    ("TSC/mTOR" . SPARSER::COLLECTION)
    ("the SMA promoter-driven Cre" . SPARSER::PROTEIN)
    ("a Tamoxifen-inducible SMA-driven cre recombinase" . SPARSER::PROTEIN)
    ("vascular Tsc1 and littermate" . SPARSER::COLLECTION)
    ("Tsc1 and littermate" . SPARSER::COLLECTION)
    ("phenylephrine" . SPARSER::DRUG)
    ("their conditional alleles" . SPARSER::ALLELE)
    ("wSMAcre-ER" . SPARSER::PROTEIN-PAIR)
    ("the conditional allele" . SPARSER::ALLELE)
    ("aortic smooth muscle" . SPARSER::PROTEIN) ("cSMAcre" . SPARSER::PROTEIN)
    ("cSMAcre-ER" . SPARSER::PROTEIN-PAIR)
    ("allele and a SMA allele" . SPARSER::COLLECTION)
    ("the vascular smooth muscle" . SPARSER::PROTEIN)
    ("glycogen and collagen" . SPARSER::COLLECTION)
    ("Glycogen and collagen" . SPARSER::COLLECTION)
    ("Glycogen" . SPARSER::PROTEIN) ("drosophila" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN) ("Hydralazine" . SPARSER::DRUG)
    ("SMAcre-ER" . SPARSER::COLLECTION)
    ("a pure vasodilator" . SPARSER::PROTEIN)
    ("vasodilator" . SPARSER::PROTEIN) ("Tsc1/Tsc2" . SPARSER::COLLECTION)
    ("growth factors, AKT, and AMP-activated" . SPARSER::COLLECTION)
    ("functional hamartin or tuberin" . SPARSER::COLLECTION)
    ("hamartin or tuberin" . SPARSER::COLLECTION)
    ("hamartin-tuberin" . SPARSER::COLLECTION)
    ("p70 S6 kinase (S6K) and eukaryotic translation-initiation factor 4E-binding protein"
     . SPARSER::COLLECTION)
    ("eukaryotic translation-initiation factor 4E-binding protein"
     . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hamartin and tuberin" . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("rain" . SPARSER::PROTEIN)
    ("rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tuberin" . SPARSER::PROTEIN)
    ("hamartin" . SPARSER::PROTEIN)
    ("Peripheral vascular smooth muscle" . SPARSER::PROTEIN)
    ("Tsc1 and Tsc2" . SPARSER::COLLECTION) ("Tsc2" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN) ("Tsc1c/cSMAcre-ER" . SPARSER::COLLECTION)
    ("peripheral vascular smooth muscle" . SPARSER::PROTEIN)
    ("antihypertensive" . SPARSER::DRUG)
    ("phospho-histone 3 and PCNA" . SPARSER::COLLECTION)
    ("vascular smooth muscle" . SPARSER::PROTEIN) ("cSM" . SPARSER::PROTEIN)
    ("Tsc1" . SPARSER::PROTEIN) ("MYH7" . SPARSER::PROTEIN)
    ("PH3" . SPARSER::MOLECULE) ("pS6" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("SM22" . SPARSER::PROTEIN)
    ("initiation factor 4E-binding protein" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("two currently druggable targets" . SPARSER::TARGET-PROTEIN)
    ("different pathological types" . TYPE)
    ("ROS1 and RET" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("a prospective EGFR" . SPARSER::PROTEIN)
    ("a prospective ALK" . SPARSER::PROTEIN) ("cigarettes" . SPARSER::DRUG)
    ("pathological types" . TYPE) ("IIIB" . SPARSER::DRUG)
    ("Han" . SPARSER::PROTEIN)
    ("Food and Drug Administration and the European Medicines Agency xref  xref  xref"
     . SPARSER::COLLECTION)
    ("Medicines" . SPARSER::DRUG)
    ("the Echinoderm microtubule-associated protein like-4 ( EML4 ) and anaplastic lymphoma kinase ( ALK )"
     . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("TKIs" . SPARSER::PROTEIN)
    ("EML4-ALK" . SPARSER::COLLECTION) ("ROS1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("Echinoderm microtubule-associated protein like-4" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("GCs" . SPARSER::PROTEIN)
    ("the secondary messengers inositol 1,4,5-trisphosphate and diacylglycerol (DAG)"
     . SPARSER::COLLECTION)
    ("inositol 1,4,5-trisphosphate and diacylglycerol (DAG)"
     . SPARSER::MOLECULE)
    ("inositol 1,4,5-trisphosphate and diacylglycerol" . SPARSER::COLLECTION)
    ("DAG" . SPARSER::DAG) ("phospholipase" . SPARSER::PROTEIN)
    ("GCA" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("phospholipase C epsilon 1" . SPARSER::PROTEIN)
    ("PLCE1" . SPARSER::PROTEIN)
    ("Phospholipase C epsilon 1" . SPARSER::PROTEIN)
    ("FASN/HER2" . SPARSER::COLLECTION) ("PI3k-Akt" . SPARSER::COLLECTION)
    ("ErbB/FASN" . SPARSER::COLLECTION) ("ErbB and FASN" . SPARSER::COLLECTION)
    ("HER2–PI3K/Akt–FASN" . SPARSER::COLLECTION)
    ("the most important biosynthetic enzymes" . SPARSER::ENZYME)
    ("FASN and HER2" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("HER2 and FASN" . SPARSER::COLLECTION)
    ("fatty acid synthase (FASN) and HER2 (ErbB2)" . SPARSER::COLLECTION)
    ("FASN" . SPARSER::PROTEIN) ("H–E" . SPARSER::PROTEIN)
    ("Fatty acid synthase" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("TGF-β1–mediated tubular EMT" . SPARSER::PROTEIN)
    ("Brachyury, Slug and Snail" . SPARSER::COLLECTION)
    ("Slug or Snail" . SPARSER::COLLECTION)
    ("Snail or Slug" . SPARSER::COLLECTION)
    ("Snail, Slug and Brachyury" . SPARSER::COLLECTION)
    ("ZEB" . SPARSER::PROTEIN) ("repressors" . SPARSER::REPRESSOR)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("mediating tubular EMT" . SPARSER::PROTEIN) ("Xbra" . SPARSER::PROTEIN)
    ("Snail/Slug" . SPARSER::COLLECTION)
    ("Brachyury/Snail/Slug" . SPARSER::COLLECTION)
    ("Brachyury and TGF-β1" . SPARSER::COLLECTION)
    ("siRNA-Slug" . SPARSER::COLLECTION) ("siRNA-Snail" . SPARSER::COLLECTION)
    ("Brachyury-Snail/Slug" . SPARSER::COLLECTION)
    ("HK-2-Brachyury" . SPARSER::COLLECTION)
    ("RI and his colleagues" . SPARSER::COLLECTION)
    ("fibronectin, α-SMA and vimentin" . SPARSER::COLLECTION)
    ("Brachyury" . SPARSER::PROTEIN)
    ("siRNA-Brachyury" . SPARSER::PROTEIN-PAIR)
    ("α-smooth-muscle actin (α-SMA) and vimentin" . SPARSER::COLLECTION)
    ("fibronectin, α-smooth-muscle actin (α-SMA) and vimentin"
     . SPARSER::COLLECTION)
    ("E-cadherin and plakoglobin" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("TGF-β1-induced tubular EMT" . SPARSER::PROTEIN)
    ("TGF-β1-induced renal tubular EMT" . SPARSER::PROTEIN)
    ("tubular EMT" . SPARSER::PROTEIN)
    ("promoting tubular EMT" . SPARSER::PROTEIN)
    ("type II and type I" . SPARSER::COLLECTION)
    ("Tubular EMT" . SPARSER::PROTEIN) ("Slug and Snail" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("renal tubular EMT" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate" . SPARSER::MOLECULE)
    ("AG -3" . SPARSER::PROTEIN) ("SIS3" . SPARSER::MOLECULE)
    ("smad3" . SPARSER::PROTEIN) ("Brachyury protein" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN) ("E–cadherin" . SPARSER::PROTEIN)
    ("TLR4 and α4β1" . SPARSER::COLLECTION) ("TLR4-EDA" . SPARSER::COLLECTION)
    ("IL-8 and TNFα" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Receptors (TLR)" . SPARSER::RECEPTOR)
    ("fibronectin and the α4β1 integrin" . SPARSER::COLLECTION)
    ("smooth muscle actin ( xref ) and vimentin ( xref )"
     . SPARSER::COLLECTION)
    ("collagen and smooth muscle" . SPARSER::COLLECTION)
    ("α4β1, α4β7 and α9β1" . SPARSER::COLLECTION)
    ("α4β1 and the EDA isoform" . SPARSER::COLLECTION)
    ("peptide or a scrambled version" . SPARSER::COLLECTION)
    ("α4β7 (FIB504) or TLR4" . SPARSER::COLLECTION) ("FIB" . SPARSER::PROTEIN)
    ("integrin and Toll-Like" . SPARSER::COLLECTION)
    ("α4β7, TLR4 and α4β1" . SPARSER::COLLECTION)
    ("α4β7 or TLR4" . SPARSER::COLLECTION)
    ("actin and pMLC" . SPARSER::COLLECTION)
    ("full-length recombinant cellular FN" . SPARSER::PROTEIN)
    ("rec" . SPARSER::PROTEIN) ("FN" . SPARSER::PROTEIN)
    ("actin and p-MLC" . SPARSER::COLLECTION)
    ("either actin (compare panels a and d) or p-MLC (compare panels f and i)"
     . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND) ("α4β1" . SPARSER::PROTEIN)
    ("plasma fibronectin (pFN) or co-coated" . SPARSER::COLLECTION)
    ("α4β1-EDA" . SPARSER::PROTEIN-PAIR)
    ("transmembrane dimeric receptors" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN) ("-fibronectin" . SPARSER::COLLECTION)
    ("critical biochemical and mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("an insoluble polymerized form" . SPARSER::FORM)
    ("both a soluble form" . SPARSER::FORM)
    ("multifunctional glycoprotein" . SPARSER::PROTEIN)
    ("either siRNA or blocking antibody" . SPARSER::COLLECTION)
    ("fibronectin or EDA-derived peptides" . SPARSER::COLLECTION)
    ("myosin-light chain" . SPARSER::COLLECTION)
    ("EDA and EDB" . SPARSER::COLLECTION) ("EDB" . SPARSER::PROTEIN)
    ("EDA" . SPARSER::PROTEIN) ("Fibronectin" . SPARSER::PROTEIN)
    ("oligo-nucleotides" . SPARSER::MOLECULE) ("p160ROCK" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("syndecan-4" . SPARSER::PROTEIN) ("α4β7" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("two NC derivatives, the DRG and the SG" . SPARSER::COLLECTION)
    ("Axin2-rtTA DRG (reduction of TrkC + neurons only) and Nf2 cKO DRG (reductions of both TrkB + and TrkC + neurons)"
     . SPARSER::COLLECTION)
    ("NeuroD or Isl1/2" . SPARSER::COLLECTION) ("NeuroD" . SPARSER::PROTEIN)
    ("Ngn2 and Ngn1" . SPARSER::COLLECTION)
    ("Wnt1-Creembryos" . SPARSER::PROTEIN-PAIR)
    ("Sox10-Cre" . SPARSER::COLLECTION) ("Yap/Taz" . SPARSER::PROTEIN)
    ("the multipotent state" . SPARSER::BIO-STATE)
    ("Nf2-Yap/Taz" . SPARSER::PROTEIN-PAIR)
    ("Yap cKO (Yap Flox/Flox ;Wnt1-Cre) and Nf2" . SPARSER::COLLECTION)
    ("/Sox10" . SPARSER::COLLECTION) ("Flox" . SPARSER::PROTEIN)
    ("Wnt1-Cre" . SPARSER::COLLECTION) ("Sox10-rtTA" . SPARSER::COLLECTION)
    ("rtTA" . SPARSER::PROTEIN) ("Axin2-rtTA" . SPARSER::COLLECTION)
    ("dams" . SPARSER::PROTEIN) ("TetO-YAP1" . SPARSER::COLLECTION)
    ("TetO" . SPARSER::PROTEIN) ("cKO" . SPARSER::PROTEIN)
    ("optic lobe" . SPARSER::PROTEIN) ("Yki" . SPARSER::PROTEIN)
    ("Ezrin/Radixin/Moesin" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("Moesin" . SPARSER::PROTEIN) ("Radixin" . SPARSER::PROTEIN)
    ("Ezrin" . SPARSER::PROTEIN) ("Nf2/Merlin" . SPARSER::COLLECTION)
    ("Merlin" . SPARSER::PROTEIN) ("TrkA" . SPARSER::PROTEIN)
    ("TrkC" . SPARSER::PROTEIN) ("TrkB" . SPARSER::PROTEIN)
    ("Trk" . SPARSER::PROTEIN) ("DRG" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("TrkC tyrosine kinase" . SPARSER::PROTEIN)
    ("S100β" . SPARSER::PROTEIN) ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sox10" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("brain lipid binding protein" . SPARSER::PROTEIN)
    ("Isl1" . SPARSER::PROTEIN) ("Ngn2" . SPARSER::PROTEIN)
    ("Ngn1" . SPARSER::PROTEIN) ("Nf2" . SPARSER::PROTEIN)
    ("Activin and Nodal" . SPARSER::COLLECTION)
    ("SB431542 and gemcitibine" . SPARSER::COLLECTION)
    ("both SB431542 and gemcitibine effectively reduced tumor growth in pancreatic carcinoma ( xref )"
     . SPARSER::COLLECTION)
    ("TGFβ and Activin" . SPARSER::COLLECTION)
    ("either growth factors (bFGF and EGF) or cytokines (TNF and TGFβ)"
     . SPARSER::COLLECTION)
    ("bFGF and EGF" . SPARSER::COLLECTION)
    ("Nodal or Activin" . SPARSER::COLLECTION)
    ("basic fibroblast growth factor (bFGF) and epithelial growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("growth factor (EGF)" . SPARSER::GROWTH-FACTOR)
    ("Nodal and Activin" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("Nodal/Activin" . SPARSER::COLLECTION)
    ("regulators and self-renewing factors required for CIC phenotypes"
     . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("an important extracellular cytokine" . SPARSER::PROTEIN)
    ("TMAs" . SPARSER::MOLECULE) ("ADC and 18/23" . SPARSER::COLLECTION)
    ("the largest cohort" . SPARSER::MOLECULE)
    ("MMP2 and MMP9 , and lysyl oxidase ( LOX)" . SPARSER::COLLECTION)
    ("MMP2 and MMP9 , and lysyl oxidase" . SPARSER::COLLECTION)
    ("MMP9 , and lysyl oxidase" . SPARSER::COLLECTION)
    ("MYCN, SOX2, KLF4 , and HMGA2" . SPARSER::COLLECTION)
    ("SNAI1 , SNAI2 , and ZEB2" . SPARSER::COLLECTION)
    ("Activin, Nodal and TGFβ" . SPARSER::COLLECTION)
    ("mesenchymal markers CDH2" . SPARSER::PROTEIN)
    ("N-cadherin and VIM" . SPARSER::COLLECTION)
    ("TWIST1/Twist" . SPARSER::COLLECTION)
    ("RelA and SMAD2" . SPARSER::COLLECTION)
    ("SB431542 or ALK5i" . SPARSER::COLLECTION)
    ("Activin type I receptor (ALK4), TGFβ type I receptor (ALK5), and Nodal type I receptor (ALK7)"
     . SPARSER::COLLECTION)
    ("TGFβ/Activin/Nodal" . SPARSER::COLLECTION)
    ("bone morphogenic protein" . SPARSER::PROTEIN)
    ("TGFβ, and Activin" . SPARSER::COLLECTION)
    ("TNF, TGFβ, and Activin" . SPARSER::COLLECTION)
    ("NF-κB and SMAD" . SPARSER::COLLECTION)
    ("Activin and TNF" . SPARSER::COLLECTION)
    ("TGFβ and TNF" . SPARSER::COLLECTION)
    ("Inhibin or other Activins" . SPARSER::COLLECTION)
    ("NODAL" . SPARSER::PROTEIN) ("inhibin" . SPARSER::PROTEIN)
    ("Inhibins" . SPARSER::PROTEIN) ("Inhibin" . SPARSER::PROTEIN)
    ("TNF and TGFβ" . SPARSER::COLLECTION)
    ("residual TNF or TGFβ" . SPARSER::COLLECTION)
    ("TNF or TGFβ" . SPARSER::COLLECTION)
    ("cytokine-treated 3D" . SPARSER::PROTEIN-FAMILY)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("media (CM)" . SPARSER::PROTEIN)
    ("the mesenchymal state" . SPARSER::BIO-STATE)
    ("EMT and CIC" . SPARSER::COLLECTION) ("SNAI2/Slug" . SPARSER::COLLECTION)
    ("Twist1/Twist" . SPARSER::COLLECTION)
    ("Sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and IKK" . SPARSER::COLLECTION)
    ("transcriptionally competent NF-κB" . SPARSER::PROTEIN)
    ("p50 and RelA" . SPARSER::COLLECTION)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("Tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("TGFβ, Nodal, and Activins" . SPARSER::COLLECTION)
    ("Activins" . SPARSER::PROTEIN) ("Nodal" . SPARSER::PROTEIN)
    ("Cytokines and growth factors" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN)
    ("regulators and self-renewal factors that sustain" . SPARSER::COLLECTION)
    ("INHBA/Activin" . SPARSER::COLLECTION) ("morphogen" . SPARSER::PROTEIN)
    ("Activin" . SPARSER::PROTEIN) ("INHBA" . SPARSER::PROTEIN)
    ("Soluble growth factors and cytokines" . SPARSER::COLLECTION)
    ("lysyl oxidase" . SPARSER::PROTEIN) ("COL22A1" . SPARSER::PROTEIN)
    ("type XXII" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("ALK7" . SPARSER::PROTEIN)
    ("Activin A" . SPARSER::MOLECULE) ("type V" . SPARSER::PROTEIN)
    ("ALK5" . SPARSER::PROTEIN) ("SB431542" . SPARSER::DRUG)
    ("ALK4" . SPARSER::PROTEIN) ("Twist1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("receptors and EphA4" . SPARSER::COLLECTION) ("EphA4" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("MET, ERBB2, and IGF-1R" . SPARSER::COLLECTION)
    ("imatinib-" . SPARSER::DRUG) ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("sunitinib" . SPARSER::DRUG)
    ("FGFRs and their ligands" . SPARSER::COLLECTION)
    ("FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("even larger cohorts" . SPARSER::MOLECULE)
    ("KIT and FGFR" . SPARSER::COLLECTION)
    ("the dual inhibitor CHIR-258" . SPARSER::DRUG)
    ("KIT and FGFRs" . SPARSER::COLLECTION) ("dovitinib" . SPARSER::DRUG)
    ("MEK, or ERK" . SPARSER::COLLECTION)
    ("MEK, and ERK" . SPARSER::COLLECTION)
    ("imatinib and AZD-6244" . SPARSER::COLLECTION)
    ("RAF/MAPK" . SPARSER::COLLECTION)
    ("imatinib and PLX-4720" . SPARSER::COLLECTION)
    ("imatinib and PD173074" . SPARSER::COLLECTION)
    ("imatinib and the selective FGFR inhibitor PD173074"
     . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("FGFR1 or FGFR2" . SPARSER::COLLECTION)
    ("FGFR1, FGFR2, and FGFR3" . SPARSER::COLLECTION)
    ("imatinib and FGF2" . SPARSER::COLLECTION)
    ("SCF or FGF2" . SPARSER::COLLECTION)
    ("FGF2 and SCF" . SPARSER::COLLECTION)
    ("particular FGF2" . SPARSER::PROTEIN)
    ("the prototypic ligand" . SPARSER::LIGAND)
    ("SCF and FGF2" . SPARSER::COLLECTION)
    ("phospho-KIT and phospho-FGFR3" . SPARSER::COLLECTION)
    ("FGFR3 and KIT" . SPARSER::COLLECTION)
    ("KIT, FGFR3, or TYK2" . SPARSER::COLLECTION)
    ("KIT, FGFR3, and TYK2" . SPARSER::COLLECTION)
    ("TYK2 and FGFR3" . SPARSER::COLLECTION)
    ("possible alternative therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("NRAS and KRAS" . SPARSER::COLLECTION) ("comparative RNA" . SPARSER::RNA)
    ("KIT and its downstream signaling molecules" . SPARSER::COLLECTION)
    ("FGF8, FGF9, and FGF10" . SPARSER::COLLECTION)
    ("FGF3, FGF8, and FGF10" . SPARSER::COLLECTION) ("FGFs" . SPARSER::PROTEIN)
    ("KIT and PDGFRA" . SPARSER::COLLECTION)
    ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("KIT/PDGFRA" . SPARSER::COLLECTION)
    ("platelet-derived growth factor receptor alpha (PDGFRA)"
     . SPARSER::PROTEIN)
    ("existing FGFR inhibitors and multi-kinase inhibitors"
     . SPARSER::COLLECTION)
    ("KIT and FGFR3" . SPARSER::COLLECTION) ("IGF-1R" . SPARSER::PROTEIN)
    ("S6K2" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("PI103" . SPARSER::DRUG) ("B-Raf" . SPARSER::PROTEIN)
    ("PLX-4720" . SPARSER::DRUG)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("CHIR-258" . SPARSER::DRUG)
    ("PI-103" . SPARSER::DRUG) ("AZD-6244" . SPARSER::DRUG)
    ("PD173074" . SPARSER::DRUG) ("FGF9" . SPARSER::PROTEIN)
    ("FGF10" . SPARSER::PROTEIN) ("FGF3" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETV1" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol-3-kinase" . SPARSER::PROTEIN-FAMILY)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN) ("Notch3 and miR-221" . SPARSER::COLLECTION)
    ("MDM2 and miR-221" . SPARSER::COLLECTION)
    ("Notch3-MDM2" . SPARSER::COLLECTION)
    ("the contrary Notch3" . SPARSER::PROTEIN) ("p-MDM2" . SPARSER::COLLECTION)
    ("pMDM" . SPARSER::DRUG) ("MDM2 and Cyclin G1" . SPARSER::COLLECTION)
    ("p53(Ser-20) and p53(Ser-15)" . SPARSER::COLLECTION)
    ("GSIs" . SPARSER::PROTEIN) ("supports western blot" . SPARSER::PROTEIN)
    ("Notch3, Cyclin G1 and PCNA" . SPARSER::COLLECTION)
    ("Cyclin G1 and PCNA" . SPARSER::COLLECTION)
    ("Notch3 and PCNA" . SPARSER::COLLECTION)
    ("Cyclin G1 and Notch3" . SPARSER::COLLECTION) ("DENA" . SPARSER::PROTEIN)
    ("miR-221 and Hes1" . SPARSER::COLLECTION)
    ("Hes1 and p53" . SPARSER::COLLECTION)
    ("Hes1 and miR-221" . SPARSER::COLLECTION)
    ("Notch3 and Hes1" . SPARSER::COLLECTION)
    ("Notch3 and MDM2" . SPARSER::COLLECTION)
    ("Notch3, Hes1, Cyclin G1 and MDM2" . SPARSER::COLLECTION)
    ("proteins and miR-221" . SPARSER::COLLECTION)
    ("CyclinG1, MDM2 and p53" . SPARSER::COLLECTION)
    ("Notch3 and p53" . SPARSER::COLLECTION)
    ("NC and Notch3" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("Notch3 and Cyclin G1" . SPARSER::COLLECTION) ("SMP" . SPARSER::PROTEIN)
    ("bHLH" . SPARSER::PROTEIN) ("p53/miR-221" . SPARSER::COLLECTION)
    ("normal chondrocytes" . SPARSER::PROTEIN)
    ("Cyclin G1 and MDM2" . SPARSER::COLLECTION)
    ("a homologous protein" . SPARSER::PROTEIN) ("c-src" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN) ("p53 and MDM2" . SPARSER::COLLECTION)
    ("p53 and the protein" . SPARSER::COLLECTION)
    ("this evolutionary conserved family" . SPARSER::PROTEIN-FAMILY)
    ("Nutilin-3" . SPARSER::COLLECTION)
    ("p53, miR-221 and MDM2" . SPARSER::COLLECTION)
    ("successfully target Notch receptors" . SPARSER::RECEPTOR)
    ("MiR-221" . SPARSER::PROTEIN) ("Notch-3" . SPARSER::PROTEIN)
    ("GL2" . SPARSER::DRUG) ("gamma-secretase" . SPARSER::PROTEIN)
    ("CyclinG1" . SPARSER::PROTEIN) ("siN3" . SPARSER::PROTEIN)
    ("cyclin G1" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("Cyclin G1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("suboptimal EGFR" . SPARSER::PROTEIN)
    ("exogenous DNA target" . SPARSER::TARGET-PROTEIN)
    ("EZ" . SPARSER::PROTEIN-FAMILY) ("adequate DNA" . SPARSER::DNA)
    ("EGFR or BRAF" . SPARSER::COLLECTION)
    ("potato-specific DNA" . SPARSER::DNA) ("Sah" . SPARSER::MOLECULE)
    ("amplifiable DNA" . SPARSER::DNA) ("PLZF" . SPARSER::PROTEIN)
    ("Formalin" . SPARSER::MOLECULE)
    ("vemurafenib and BRAF" . SPARSER::COLLECTION)
    ("vemurafenib" . SPARSER::DRUG) ("EGFR/BRAF" . SPARSER::COLLECTION)
    ("1 µL" . SPARSER::PROTEIN) ("TBXAS1" . SPARSER::PROTEIN)
    ("RAG1" . SPARSER::PROTEIN) ("A–M" . SPARSER::PROTEIN)
    ("1–8" . SPARSER::PROTEIN) ("the defective ADAM10" . SPARSER::PROTEIN)
    ("the cell-permeable Pro peptide" . SPARSER::PEPTIDE)
    ("NMDARs" . SPARSER::PROTEIN) ("AMPA" . SPARSER::MOLECULE)
    ("local ADAM10" . SPARSER::PROTEIN)
    ("dendritic ADAM10 and PSD-95 puncta" . SPARSER::PROTEIN)
    ("ADAM10 and PSD-95" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("peptide or Ala" . SPARSER::COLLECTION)
    ("the previously characterized cell-penetrating Pro peptide"
     . SPARSER::PEPTIDE)
    ("ADAM10/PSD-95" . SPARSER::COLLECTION)
    ("ADAM10/dsRed-ER" . SPARSER::COLLECTION) ("soma" . SPARSER::DRUG)
    ("ER and ER" . SPARSER::COLLECTION) ("dsRed-ER" . SPARSER::COLLECTION)
    ("PSD" . SPARSER::PROTEIN) ("dsRed" . SPARSER::PROTEIN)
    ("brefeldin" . SPARSER::PROTEIN)
    ("the synaptic membrane fraction" . SPARSER::COMPONENT)
    ("homogenate (HOMO)" . SPARSER::PROTEIN) ("homogenate" . SPARSER::PROTEIN)
    ("TIF and microsomal fraction (P3)" . SPARSER::COLLECTION)
    ("microsomal fraction" . SPARSER::COMPONENT)
    ("ADAM10 and SAP97" . SPARSER::COLLECTION)
    ("the phosphomimetic mutants" . SPARSER::MUTANT)
    ("YFP-SAP97wt" . SPARSER::COLLECTION) ("sAPP" . SPARSER::PROTEIN)
    ("a more rigid conformation" . SPARSER::BIO-CONFORMATION)
    ("x-ray" . SPARSER::PROTEIN-PAIR)
    ("GluA1 and GluN2A" . SPARSER::COLLECTION) ("SAP97wt" . SPARSER::PROTEIN)
    ("GST-SAP97wt or S/T" . SPARSER::COLLECTION)
    ("HOOK-GK" . SPARSER::COLLECTION) ("GST-SAP97-GK" . SPARSER::COLLECTION)
    ("HOOK" . SPARSER::PROTEIN-FAMILY) ("GK" . SPARSER::PROTEIN)
    ("GST-SAP97wt" . SPARSER::COLLECTION) ("YFP-SAP97" . SPARSER::COLLECTION)
    ("PDBu" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("Both the sequential deletion mutants" . SPARSER::MUTANT)
    ("ADAM10 or SAP97" . SPARSER::COLLECTION)
    ("the Triton-insoluble fraction (TIF)" . SPARSER::COMPONENT)
    ("TIF" . SPARSER::PROTEIN) ("Triton" . SPARSER::MOLECULE)
    ("BRET" . SPARSER::PROTEIN) ("ADAM10/SAP97" . SPARSER::COLLECTION)
    ("the membrane-associated guanylate kinase family"
     . SPARSER::PROTEIN-FAMILY)
    ("scaffolds" . SPARSER::SCAFFOLD) ("finely tune ADAM10" . SPARSER::PROTEIN)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("amyloid" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("disintegrin" . SPARSER::PROTEIN) ("ATP 2 " . SPARSER::PROTEIN)
    ("TBS 1" . SPARSER::PROTEIN) ("SDS 1" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GluN2A" . SPARSER::PROTEIN)
    ("GluA1" . SPARSER::PROTEIN) ("AKAP150" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("MMPs and VEGF" . SPARSER::COLLECTION)
    ("protease-inducer" . SPARSER::COLLECTION)
    ("FAK-paxillin" . SPARSER::COLLECTION)
    ("Rac1 and Src" . SPARSER::COLLECTION)
    ("the CRK-associated Rac GEF DOCK8" . SPARSER::PROTEIN)
    ("CD147-integrin" . SPARSER::COLLECTION)
    ("p130Cas-CRK" . SPARSER::COLLECTION)
    ("an FAK-associated adaptor protein" . SPARSER::PROTEIN)
    ("CRK" . SPARSER::PROTEIN) ("CD147-FAK" . SPARSER::COLLECTION)
    ("at least 11 genes" . SPARSER::GENE) ("Rho/ROCK" . SPARSER::COLLECTION)
    ("integrin-associated FAK and Src" . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION)
    ("ECM-integrin" . SPARSER::COLLECTION)
    ("actin as well as numerous actin-interacting proteins and a wide variety"
     . SPARSER::COLLECTION)
    ("numerous actin-interacting proteins and a wide variety"
     . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::PROTEIN)
    ("an aggressive solitary HCC" . SPARSER::PROTEIN)
    ("Src dominant-positive mutant" . SPARSER::MUTANT)
    ("I-1 or CD147" . SPARSER::COLLECTION)
    ("STAT3 and Rac1 activity" . SPARSER::COLLECTION)
    ("Rho-ROCK" . SPARSER::COLLECTION) ("DOCK8 or Rac1" . SPARSER::COLLECTION)
    ("Rac1 and DOCK8" . SPARSER::COLLECTION)
    ("neither CD147 nor Src" . SPARSER::COLLECTION)
    ("GEF or GAP" . SPARSER::COLLECTION) ("CD147 or Src" . SPARSER::COLLECTION)
    ("integrin/FAK" . SPARSER::COLLECTION) ("si-FAK" . SPARSER::PROTEIN-PAIR)
    ("Rac/WAVE" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("CD147 and Src" . SPARSER::COLLECTION)
    ("CD147-pcDNA3.1" . SPARSER::COLLECTION)
    ("p-MLC2/MLC2" . SPARSER::COLLECTION)
    ("prominent cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("nuclease (ZFN)" . SPARSER::PROTEIN)
    ("extracellular proteases" . SPARSER::PROTEIN)
    ("CD147 and Annexin" . SPARSER::COLLECTION) ("Annexin" . SPARSER::PROTEIN)
    ("DOCK11" . SPARSER::PROTEIN) ("DOCK1" . SPARSER::PROTEIN)
    ("pp60c-Src" . SPARSER::PROTEIN)
    ("myosin light chain 2" . SPARSER::PROTEIN) ("p130Cas" . SPARSER::PROTEIN)
    ("DOCK180" . SPARSER::PROTEIN) ("Robo1" . SPARSER::PROTEIN)
    ("WP1066" . SPARSER::DRUG) ("PF573,228" . SPARSER::DRUG)
    ("I-1" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("WAVE2" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("DOCK8" . SPARSER::PROTEIN) ("CD147" . SPARSER::PROTEIN)
    ("associated genes" . SPARSER::GENE)
    ("NANOG, OCT43/4 and SOX2" . SPARSER::COLLECTION)
    ("SOX10, and POU2F1" . SPARSER::COLLECTION)
    ("POU6F1 and MEIS1" . SPARSER::COLLECTION)
    ("NANOG and OCT3/4 and SOX2" . SPARSER::COLLECTION)
    ("Interleukins" . SPARSER::PROTEIN)
    ("113 POL II bound genes" . SPARSER::GENE)
    ("kinase/Erk" . SPARSER::COLLECTION) ("Ras/Raf/Map" . SPARSER::COLLECTION)
    ("the nodal genes and their network members" . SPARSER::COLLECTION)
    ("HOX" . SPARSER::PROTEIN)
    ("POU2F1 (OCT1) and POU6F1 (POU domain, Class 6, Transcriptional factor 1)"
     . SPARSER::COLLECTION)
    ("SOX10, POU2F1 (OCT1) and POU6F1 (POU domain, Class 6, Transcriptional factor 1)"
     . SPARSER::COLLECTION)
    ("PREB-1" . SPARSER::COLLECTION) ("PREB" . SPARSER::PROTEIN)
    ("NANOG, SOX2, OCT3/4, and CREB1" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("HSPB2 [ xref ] and RAP1A [ xref ]" . SPARSER::COLLECTION)
    ("RHEB" . SPARSER::PROTEIN) ("VASP" . SPARSER::PROTEIN)
    ("the 3350 significantly HER2 dependent differentially" . SPARSER::PROTEIN)
    ("686 POL II bound genes" . SPARSER::GENE)
    ("POL II bound genes" . SPARSER::GENE) ("TFIID" . SPARSER::PROTEIN)
    ("SEMA3F, BLVRB, PTPRF, MARCKS, and CQQ6" . SPARSER::COLLECTION)
    ("PTPRF" . SPARSER::PROTEIN) ("SEMA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRAS" . SPARSER::PROTEIN) ("this latter class" . CLASS)
    ("HER2-dependent POL II binding genes" . SPARSER::GENE)
    ("proteins, phosphoproteins, and voltage gated" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("the 678 unique genes" . SPARSER::GENE)
    ("NANOG/AKT" . SPARSER::COLLECTION)
    ("their associated genes" . SPARSER::GENE)
    ("the identified POL II bound homeobox genes" . SPARSER::GENE)
    ("NANOG, OCT3/4 and SOX2" . SPARSER::COLLECTION)
    ("HOXC6 and HOXC8" . SPARSER::COLLECTION)
    ("POL II bound homeobox genes" . SPARSER::GENE)
    ("POLII" . SPARSER::PROTEIN) ("the 12 POL II subunits" . SPARSER::PROTEIN)
    ("complex (PIC)" . SPARSER::BIO-COMPLEX) ("PIC" . SPARSER::BIO-COMPLEX)
    ("Promoter" . SPARSER::PROMOTER)
    ("the three well-recognized RNA polymerases" . SPARSER::PROTEIN)
    ("randomly selected genes and kappa values" . SPARSER::COLLECTION)
    ("Kappa" . SPARSER::PROTEIN-FAMILY) ("BCa" . SPARSER::PROTEIN)
    ("CD24−" . SPARSER::PROTEIN) ("ALDH" . SPARSER::PROTEIN)
    ("microenvironment-dependent genes" . SPARSER::GENE)
    ("Lapatinib and combination therapies" . SPARSER::COLLECTION)
    ("Pertuzumab" . SPARSER::DRUG) ("synergizes" . SPARSER::PROTEIN)
    ("Trastuzumab" . SPARSER::DRUG) ("Herceptin" . SPARSER::DRUG)
    ("Phospholipase C, and STAT" . SPARSER::COLLECTION)
    ("HER2/HER3" . SPARSER::COLLECTION)
    ("EGFR, HER3 and HER4" . SPARSER::COLLECTION)
    ("Heterodimer" . SPARSER::HETERODIMER)
    ("these HER2-dependent POL II binding genes" . SPARSER::GENE)
    ("POL" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("HOXA10" . SPARSER::PROTEIN)
    ("OCT43" . SPARSER::DRUG) ("MEIS1" . SPARSER::PROTEIN)
    ("p95" . SPARSER::PROTEIN) ("P13" . SPARSER::PROTEIN)
    ("POU domain" . SPARSER::PROTEIN) ("POU6F1" . SPARSER::PROTEIN)
    ("OCT1" . SPARSER::PROTEIN) ("POU2F1" . SPARSER::PROTEIN)
    ("SOX10" . SPARSER::PROTEIN) ("TRANScription FACtor" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("WHSC1" . SPARSER::PROTEIN) ("RbAp46" . SPARSER::PROTEIN)
    ("RBBP7" . SPARSER::PROTEIN) ("PGAP1" . SPARSER::PROTEIN)
    ("NUMA1" . SPARSER::PROTEIN) ("CtBP2" . SPARSER::PROTEIN)
    ("ATP5G1" . SPARSER::PROTEIN) ("Sequestosome 1" . SPARSER::PROTEIN)
    ("RAP-1A" . SPARSER::PROTEIN) ("Presenilin 2" . SPARSER::PROTEIN)
    ("BRD2" . SPARSER::PROTEIN) ("VRK2" . SPARSER::PROTEIN)
    ("RIF1" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("CLIC4" . SPARSER::PROTEIN) ("FBXO2" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("interleukin 5" . SPARSER::PROTEIN)
    ("RAP1A" . SPARSER::PROTEIN) ("HSPB2" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("GPC1" . SPARSER::PROTEIN) ("DDR1" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("SDC1" . SPARSER::PROTEIN) ("Fibronectin1" . SPARSER::PROTEIN)
    ("CCR4 associated factor 2" . SPARSER::PROTEIN)
    ("PAPSS2" . SPARSER::PROTEIN) ("CNOT2" . SPARSER::PROTEIN)
    ("inhibits CDK4)" . SPARSER::PROTEIN) ("PPP3CC" . SPARSER::PROTEIN)
    ("STMN3" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN) ("voltage gated" . SPARSER::PROTEIN)
    ("HOXC8" . SPARSER::PROTEIN) ("HOXC6" . SPARSER::PROTEIN)
    ("HOXB7" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("Phospholipase C" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("anti apoptotic transcription factor" . SPARSER::PROTEIN)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("NFKBIA and TNFAIP3" . SPARSER::COLLECTION)
    ("MK-1775 and the Chk1 inhibitor MK-8776" . SPARSER::COLLECTION)
    ("p16INK4" . SPARSER::PROTEIN) ("CDK4-cyclin D1" . SPARSER::COLLECTION)
    ("CDK2-cyclin" . SPARSER::COLLECTION) ("p53 and ATM" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("antimetabolites" . SPARSER::DRUG)
    ("SRC" . SPARSER::PROTEIN)
    ("c-JUN, GADD45B, TNFAIP3 and NFKBI" . SPARSER::COLLECTION)
    ("NFKBI" . SPARSER::PROTEIN) ("MK" . SPARSER::PROTEIN)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("PF-00477736 and PD-0332991" . SPARSER::COLLECTION)
    ("CDK4/6-cyclin D1" . SPARSER::COLLECTION) ("RPMI8226" . SPARSER::PROTEIN)
    ("CDK/cyclins" . SPARSER::COLLECTION)
    ("PF-00477736 and MK-1775" . SPARSER::COLLECTION)
    ("CDKN2A, CDK4, TP53 and ATM" . SPARSER::COLLECTION)
    ("CDK2 and CDK1" . SPARSER::COLLECTION)
    ("PF-00477736 and Wee1" . SPARSER::COLLECTION)
    ("a Chk1 inhibitor (PF-00477736) and a Wee1 inhibitor (MK-1775)"
     . SPARSER::COLLECTION)
    ("Chk1 and Wee1" . SPARSER::COLLECTION) ("S-G2" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("γH2AX" . SPARSER::PROTEIN)
    ("HBL-1" . SPARSER::PROTEIN) ("C-JUN" . SPARSER::PROTEIN)
    ("MK-8776" . SPARSER::DRUG) ("REC-1" . SPARSER::PROTEIN)
    ("GADD45B" . SPARSER::PROTEIN) ("c-JUN" . SPARSER::PROTEIN)
    ("PD-0332991" . SPARSER::DRUG) ("MK-1775" . SPARSER::DRUG)
    ("PF-00477736" . SPARSER::DRUG) ("multiple relevant genes" . SPARSER::GENE)
    ("BRCA1,  BRCA2 , and PALB2" . SPARSER::COLLECTION)
    ("PALB2, CHEK2 , BARD1 , ATM , PTEN , and TP53" . SPARSER::COLLECTION)
    ("gene " . SPARSER::GENE) ("BRCA 1 and BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , TP53 , PTEN , STK11 , and CDH1" . SPARSER::COLLECTION)
    ("cohort, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 , CHEK2 , and TP53" . SPARSER::COLLECTION)
    ("BRCA2 , CHEK2 and TP53" . SPARSER::COLLECTION)
    ("at least one gene" . SPARSER::GENE) ("the last exon" . SPARSER::PROTEIN)
    ("RAD51C or RAD51D" . SPARSER::COLLECTION)
    ("BRCA1 (29) and BRCA2 (23)" . SPARSER::COLLECTION)
    ("BRCA1 (MIM 113705) and BRCA2 (MIM 600185)" . SPARSER::COLLECTION)
    ("estrogen, progesterone, and HER2" . SPARSER::COLLECTION)
    ("PALB2, CHEK2, BARD1, ATM, PTEN , or TP53" . SPARSER::COLLECTION)
    ("RAD51C" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("Mdmx-p53" . SPARSER::COLLECTION)
    ("p53-Mdmx" . SPARSER::COLLECTION)
    ("GC and this subtype" . SPARSER::COLLECTION) ("MDM" . SPARSER::PROTEIN)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("associated GC" . SPARSER::PROTEIN)
    ("elevated Mdmx and/or Mdm2 proteins" . SPARSER::COLLECTION)
    ("Mdm2 and Mdmx" . SPARSER::COLLECTION)
    ("Mdm2 and/or MdmX proteins" . SPARSER::COLLECTION)
    ("Mdm2 or Mdmx" . SPARSER::COLLECTION) ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("IGC and DGC" . SPARSER::COLLECTION) ("IGC" . SPARSER::PROTEIN)
    ("intestinal and diffuse subtypes" . SPARSER::PROTEIN)
    ("the two histological subtypes" . SPARSER::PROTEIN)
    ("their respective subtypes" . SPARSER::PROTEIN)
    ("neutral and acid mucins" . SPARSER::PROTEIN)
    ("mucins" . SPARSER::PROTEIN)
    ("harboured concurrent GC" . SPARSER::PROTEIN)
    ("Mdmx (also known as Mdm4) and Mdm2 (known collectively as Mdm proteins)"
     . SPARSER::COLLECTION)
    ("Mdm" . SPARSER::PROTEIN) ("GC (DGC)" . SPARSER::PROTEIN)
    ("DGC" . SPARSER::PROTEIN) ("mucin" . SPARSER::PROTEIN) ("Types" . TYPE)
    ("intestinal type GC (IGC)" . SPARSER::PROTEIN)
    ("GC (IGC)" . SPARSER::PROTEIN) ("Mdmx" . SPARSER::PROTEIN)
    ("concurrent GC (IM+GC) and GC" . SPARSER::COLLECTION)
    ("concurrent GC" . SPARSER::PROTEIN) ("melting" . SPARSER::DRUG)
    ("mdm2" . SPARSER::PROTEIN) ("p53 regulator" . SPARSER::PROTEIN)
    ("Mdm4" . SPARSER::PROTEIN) ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the combinatory treatment group" . SPARSER::MOLECULE)
    ("a crucial trigger" . SPARSER::PROTEIN)
    ("5-FU and SU11274" . SPARSER::COLLECTION)
    ("cisplatin, irinotecan and sorafenib" . SPARSER::COLLECTION)
    ("HGF/c-Met" . SPARSER::COLLECTION) ("5-FU or Taxol" . SPARSER::COLLECTION)
    ("5-FU or PHA-665752" . SPARSER::COLLECTION)
    ("5-FU, PHA-665752 or 5-FU" . SPARSER::COLLECTION)
    ("5-FU and PHA-665752" . SPARSER::COLLECTION)
    ("5-FU or PHA" . SPARSER::COLLECTION) ("PHA" . SPARSER::DRUG)
    ("5-FU and c-Met" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("Taxol and DOX" . SPARSER::COLLECTION)
    ("5-FU, cisplatin, Taxol, and irinotecan" . SPARSER::COLLECTION)
    ("DOX, and DOX" . SPARSER::COLLECTION) ("DOX" . SPARSER::DRUG)
    ("c-Met-shRNA3" . SPARSER::PROTEIN-PAIR)
    ("c-Met-shRNA" . SPARSER::COLLECTION)
    ("siRNAs, and siRNA3" . SPARSER::COLLECTION)
    ("both an essential gene" . SPARSER::GENE)
    ("whose only known natural ligand" . SPARSER::LIGAND)
    ("the crucial biomarker" . SPARSER::MOLECULE)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("5-FU and Taxol" . SPARSER::COLLECTION)
    ("cisplatin, irinotecan or sorafenib" . SPARSER::COLLECTION)
    ("an essential gene" . SPARSER::GENE) ("SP5" . SPARSER::PROTEIN)
    ("PHA-665752" . SPARSER::DRUG) ("cortical actin" . SPARSER::PROTEIN)
    ("Prdx6" . SPARSER::PROTEIN) ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("membranous Prdx1" . SPARSER::PROTEIN)
    ("phosphatase 1, and MAPK" . SPARSER::COLLECTION)
    ("Prdx1 and phopho-p38 MAPK" . SPARSER::COLLECTION)
    ("phopho-p38" . SPARSER::COLLECTION)
    ("Prdx1 and phospho-p38" . SPARSER::COLLECTION)
    ("the peripheral actin" . SPARSER::PROTEIN)
    ("MAPK and phospho-MAPKAP2" . SPARSER::COLLECTION)
    ("Prdx1 and the active form" . SPARSER::COLLECTION)
    ("wild-type Prdx1 (Prdx1 WT ) and a mutant form (Prdx1 C52A/C173A )"
     . SPARSER::COLLECTION)
    ("ASK1 and phospho-JNK" . SPARSER::COLLECTION)
    ("phospho-ASK1 and phospho-JNK" . SPARSER::COLLECTION)
    ("phospho-ASK1 or phospho-JNK" . SPARSER::COLLECTION)
    ("MAPK, or JNK" . SPARSER::COLLECTION) ("Form" . SPARSER::FORM)
    ("-RNA" . SPARSER::RNA) ("-siRNA" . SPARSER::COLLECTION)
    ("peripheral actin" . SPARSER::PROTEIN)
    ("a therapeutic target and/or a target" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("kinase, and PTEN" . SPARSER::COLLECTION)
    ("JNK and MKK3" . SPARSER::COLLECTION) ("thioredoxin" . SPARSER::PROTEIN)
    ("MAPKKK" . SPARSER::PROTEIN) ("Prdx" . SPARSER::PROTEIN-FAMILY)
    ("peroxiredoxins" . SPARSER::PROTEIN)
    ("MAPK, and complexes" . SPARSER::COLLECTION)
    ("Prdx1 and p38" . SPARSER::COLLECTION) ("PDAC" . SPARSER::MOLECULE)
    ("Peroxiredoxin 6" . SPARSER::PROTEIN)
    ("phospholipase A 2" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN) ("c-JNK" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("MAPKAPK2" . SPARSER::PROTEIN) ("Anti–" . SPARSER::ANTIBODY)
    ("MAPK-activated protein kinase 2" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("MKK6" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN) ("MKK4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("Peroxiredoxin 1" . SPARSER::PROTEIN)
    ("Prdx1" . SPARSER::PROTEIN) ("peroxiredoxin 1" . SPARSER::PROTEIN)
    ("AP1 and β-catenin" . SPARSER::COLLECTION)
    ("Vav1-JNK" . SPARSER::COLLECTION)
    ("an increased perinuclear β-catenin" . SPARSER::PROTEIN)
    ("E-cadherin-Wnt receptor" . SPARSER::COLLECTION)
    ("Vav1 and its oncogenic forms" . SPARSER::COLLECTION)
    ("β-catenin and its phosphorylated forms" . SPARSER::COLLECTION)
    ("Axin and APC" . SPARSER::COLLECTION) ("Rac/JNK" . SPARSER::COLLECTION)
    ("Ser/Thr" . SPARSER::COLLECTION) ("Src and Abl" . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX) ("pS675-" . SPARSER::PROTEIN)
    ("pS675" . SPARSER::PROTEIN)
    ("α-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("pS675-β-catenin" . SPARSER::PROTEIN-PAIR)
    ("β-catenin-TCF/LEF" . SPARSER::COLLECTION)
    ("GST-SH" . SPARSER::COLLECTION)
    ("Vav1 and β-catenin" . SPARSER::COLLECTION)
    ("either β-catenin or its triple phosphorylated form (Ser33/37/Thr41)"
     . SPARSER::COLLECTION)
    ("its triple phosphorylated form" . SPARSER::FORM)
    ("Rac1 and JNK2" . SPARSER::COLLECTION) ("Vav1/JNK" . SPARSER::COLLECTION)
    ("Vav and Rac/Rho GTPases [ xref ]" . SPARSER::COLLECTION)
    ("stress-activated protein p38 (SAPK) kinases" . SPARSER::PROTEIN)
    ("Rac/Rho" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the dominant-negative form" . SPARSER::FORM)
    ("p21protein-activated protein kinase" . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("oncoproteins" . SPARSER::PROTEIN)
    ("Rac1 and RhoA" . SPARSER::COLLECTION) ("onco-Vav1" . SPARSER::COLLECTION)
    ("transformed foci" . SPARSER::PROTEIN) ("wt" . SPARSER::PROTEIN)
    ("Src, Grb2 or Abl" . SPARSER::COLLECTION)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("tyrosines" . SPARSER::AMINO-ACID) ("wt-Vav1" . SPARSER::COLLECTION)
    ("Calponin (CH)" . SPARSER::PROTEIN) ("DH" . SPARSER::PROTEIN)
    ("Dbl" . SPARSER::PROTEIN) ("Calponin" . SPARSER::PROTEIN)
    ("Vav1, Vav2 and Vav3" . SPARSER::COLLECTION)
    ("Vav2 and Vav3" . SPARSER::COLLECTION) ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("GEF" . SPARSER::GEF) ("a new Vav1" . SPARSER::PROTEIN)
    ("onco-Vav" . SPARSER::COLLECTION) ("Rho/Rac" . SPARSER::COLLECTION)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR) ("Vav" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("T-1" . SPARSER::PROTEIN)
    ("pRK5" . SPARSER::PROTEIN) ("vav1" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("pS33" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("p38 SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NH2" . SPARSER::MOLECULE)
    ("c-jun" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("p21protein" . SPARSER::PROTEIN) ("C-SH3" . SPARSER::PROTEIN)
    ("CSH3" . SPARSER::PROTEIN) ("β catenin" . SPARSER::PROTEIN)
    ("dynamin 2" . SPARSER::PROTEIN)
    ("transforming protein" . SPARSER::PROTEIN) ("Vav3" . SPARSER::PROTEIN)
    ("proto-oncogene Vav" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("Src-homology" . SPARSER::PROTEIN)
    ("relevant proteins" . SPARSER::PROTEIN)
    ("chromatin, and estrogen" . SPARSER::COLLECTION)
    ("DLC1-ER" . SPARSER::COLLECTION)
    ("DLC1 and cell-cycle genes" . SPARSER::COLLECTION)
    ("AP1 ( xref ; xref ; xref ) and CREB ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("GATA1, GATA2, and GATA3" . SPARSER::COLLECTION)
    ("AP1 and CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tensin" . SPARSER::PROTEIN)
    ("RhoGAP" . SPARSER::PROTEIN)
    ("the exonic splicing enhancer" . SPARSER::PROTEIN)
    ("dominant-negative mutant" . SPARSER::MUTANT)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("genes and diseases" . SPARSER::COLLECTION)
    ("DLC1:CDK6" . SPARSER::BIO-COMPLEX)
    ("DLC1, and DLC1" . SPARSER::COLLECTION) ("BB" . SPARSER::MOLECULE)
    ("bB" . SPARSER::MOLECULE)
    ("CDKN1B, PECAM1, p53, Claudin7, CHK1, Transglutaminase 2, ACC, PRDX1, GSK3, and PKCα"
     . SPARSER::COLLECTION)
    ("ACC" . SPARSER::PROTEIN)
    ("low cyclin D1 and high caveolin 1 (, C and D)" . SPARSER::COLLECTION)
    ("caveolin 1 and CDKN1B" . SPARSER::COLLECTION)
    ("caveolin 1 and cyclin D1" . SPARSER::COLLECTION)
    ("DLC1, and cyclin D1 and CDKN1B" . SPARSER::COLLECTION)
    ("cyclin D1 and CDKN1B" . SPARSER::COLLECTION)
    ("DLC1 or CDK6" . SPARSER::COLLECTION)
    ("the relevant genes" . SPARSER::GENE)
    ("AG (aA) and AA (bb)" . SPARSER::COLLECTION) ("bb" . SPARSER::MOLECULE)
    ("aA" . SPARSER::MOLECULE) ("the common and rare allele" . SPARSER::ALLELE)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("PEX" . SPARSER::PROTEIN)
    ("the common and rare alleles" . SPARSER::ALLELE)
    ("POSH" . SPARSER::PROTEIN) ("their relevant proteins" . SPARSER::PROTEIN)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("cyclinD1/CDK4/6" . SPARSER::COLLECTION)
    ("Ink4 and p21" . SPARSER::COLLECTION)
    ("the heterodimeric transcription factor complex" . SPARSER::BIO-COMPLEX)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("E2F/DP" . SPARSER::COLLECTION)
    ("DP" . SPARSER::PROTEIN) ("holoenzyme" . SPARSER::PROTEIN)
    ("CDK6, CDK4, CDKN2A, and CDKN2B" . SPARSER::COLLECTION)
    ("functional DLC1" . SPARSER::PROTEIN)
    ("DLC1 and CDK6" . SPARSER::COLLECTION) ("GATA2" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("TNFRSF13B" . SPARSER::PROTEIN)
    ("caveolin1" . SPARSER::PROTEIN) ("PRDX1" . SPARSER::PROTEIN)
    ("Transglutaminase 2" . SPARSER::PROTEIN) ("Claudin7" . SPARSER::PROTEIN)
    ("PECAM1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("E−9" . SPARSER::PROTEIN) ("E−5" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("Caveolin 1" . SPARSER::PROTEIN)
    ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("Ink4" . SPARSER::PROTEIN) ("Cancer-1" . SPARSER::PROTEIN)
    ("CDKN2B" . SPARSER::PROTEIN) ("target and effector" . SPARSER::COLLECTION)
    ("a probable transcriptional target" . SPARSER::TARGET-PROTEIN)
    ("E2F1 and MYBL2" . SPARSER::COLLECTION) ("GSK3-" . SPARSER::PROTEIN)
    ("certain tumor suppressive genes" . SPARSER::GENE)
    ("Ke" . SPARSER::MOLECULE) ("MTIs" . SPARSER::PROTEIN)
    ("mTOR and mTOR" . SPARSER::COLLECTION) ("p-AKT1" . SPARSER::COLLECTION)
    ("AKT1 and mTOR" . SPARSER::COLLECTION)
    ("AKT1, pAKT1, mTOR and pmTOR" . SPARSER::COLLECTION)
    ("MiR" . SPARSER::PROTEIN)
    ("MiRNA-149 directly targets AKT1" . SPARSER::PROTEIN)
    ("MiRNA" . SPARSER::PROTEIN) ("AKT1-mTOR" . SPARSER::COLLECTION)
    ("AKT1, AKT2, AKT3, AR, CDK2, CDK4, CDK6, E2F1, IGF1R, MYBL2, NR3C1, PTPN1, RAC1, RELA, RHOA and SOCS1"
     . SPARSER::COLLECTION)
    ("essential genes" . SPARSER::GENE)
    ("gene and protein" . SPARSER::COLLECTION)
    ("genes or gene" . SPARSER::COLLECTION)
    ("respectively target AKT1, AKT2 and AKT3" . SPARSER::COLLECTION)
    ("hsa" . SPARSER::PROTEIN)
    ("1881 (2588) precursor (mature) miRNAs" . SPARSER::PROTEIN)
    ("a tumor suppressive miRNA" . SPARSER::PROTEIN)
    ("AKT1/mTOR" . SPARSER::COLLECTION)
    ("the duplex miRNA:mRNA" . SPARSER::BIO-COMPLEX)
    ("miRNA-AKT" . SPARSER::COLLECTION) ("miRNA:mRNA" . SPARSER::BIO-COMPLEX)
    ("AKTs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT1, AKT2 and AKT3" . SPARSER::COLLECTION)
    ("3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("GIT1" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("PTPN1" . SPARSER::PROTEIN) ("NR3C1" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN) ("AKT1 " . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("AKT2" . SPARSER::PROTEIN)
    ("IL-1 beta, Cox2 and iNos" . SPARSER::COLLECTION)
    ("MMP1, MMP3, and MMP-13" . SPARSER::COLLECTION)
    ("MMP-13, Ihh and ADAMTS-5" . SPARSER::COLLECTION)
    ("collagen, and MMP-13" . SPARSER::COLLECTION)
    ("Runx2 and HDAC4" . SPARSER::COLLECTION)
    ("Runx2, Ihh and MMP-13" . SPARSER::COLLECTION)
    ("collagen and MMP-13" . SPARSER::COLLECTION)
    ("Runx2, Ihh, MMP-13 and type X" . SPARSER::COLLECTION)
    ("aggrecan, and type II" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC4" . SPARSER::COLLECTION)
    ("collagen and aggrecan" . SPARSER::COLLECTION)
    ("TSA (10 ng/ml or 100 ng/ml) or HDAC4 (0.1 μg, 0.2 μg or 0.4 μg)"
     . SPARSER::COLLECTION)
    ("Runx2 or MMP-13" . SPARSER::COLLECTION)
    ("GFP-HDAC4" . SPARSER::COLLECTION) ("HDAC4-GFP" . SPARSER::COLLECTION)
    ("HDAC4 and Runx2" . SPARSER::COLLECTION)
    ("β-actin and Coomassie" . SPARSER::COLLECTION)
    ("MMP-13 and type X" . SPARSER::COLLECTION)
    ("collagen, Ihh, and MMP-13" . SPARSER::COLLECTION)
    ("the hypertrophic state" . SPARSER::BIO-STATE)
    ("Chondrocytes" . SPARSER::PROTEIN)
    ("matrix metalloproteases (MMPs) and type X collagen"
     . SPARSER::COLLECTION)
    ("Hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN) ("aggrecan" . SPARSER::PROTEIN)
    ("iNos" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("Exogenous HDAC4" . SPARSER::PROTEIN)
    ("increased Runx2 and other OA-related genes" . SPARSER::COLLECTION)
    ("MMP-13, Ihh and type X" . SPARSER::COLLECTION)
    ("Runx2 and MMP-13" . SPARSER::COLLECTION)
    ("Runx2 and OA-related genes" . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("Ihh" . SPARSER::PROTEIN) ("C-b" . SPARSER::PROTEIN)
    ("Safranin O" . SPARSER::DRUG) ("TG -3" . SPARSER::PROTEIN)
    ("ADAMTS-5" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("Type X" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("C -3" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE) ("IL-1 beta" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("Histone deacetylase 4" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("Cox2" . SPARSER::PROTEIN)
    ("ADAMTS-4" . SPARSER::PROTEIN) ("type X" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("the stabilized XRCC1/pHSP90 complex and XRCC1" . SPARSER::COLLECTION)
    ("the stabilized XRCC1/(p) HSP90 complex and XRCC1" . SPARSER::COLLECTION)
    ("NER" . SPARSER::PROTEIN)
    ("IR, H 2 O 2 or cisplatin" . SPARSER::COLLECTION)
    ("Polβ or HSP90" . SPARSER::COLLECTION)
    ("a static heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("essential BER proteins" . SPARSER::PROTEIN)
    ("HSP90/XRCC1" . SPARSER::COLLECTION) ("Cis-pt" . SPARSER::COLLECTION)
    ("pt" . SPARSER::PROTEIN) ("XRCC1/Polβ" . SPARSER::COLLECTION)
    ("an alternate (active) repair complex" . SPARSER::BIO-COMPLEX)
    ("Pt" . SPARSER::PROTEIN)
    ("Polβ nor HSP90 (denoted as XRCC1*, see xref )" . SPARSER::COLLECTION)
    ("Cis-Pt" . SPARSER::COLLECTION) ("Cis" . SPARSER::PROTEIN)
    ("HSP90 or Polβ" . SPARSER::COLLECTION)
    ("a strong heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("free XRCC1 (not bound to Polβ) and HSP90 form" . SPARSER::COLLECTION)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("the Polβ-proficient isogenic WT MEFs" . SPARSER::PROTEIN)
    ("XRCC1 and HSP90" . SPARSER::COLLECTION)
    ("APE1 nor PCNA" . SPARSER::COLLECTION)
    ("HSP90 and XRCC1" . SPARSER::COLLECTION) ("Polβ(WT)" . SPARSER::PROTEIN)
    ("EGFP or Polβ(TM)" . SPARSER::COLLECTION)
    ("EGFP or Polβ" . SPARSER::COLLECTION)
    ("XRCC1 and other BER related proteins" . SPARSER::COLLECTION)
    ("HA-HSP90" . SPARSER::COLLECTION) ("XRCC1-KD" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("copGFP-Polβ (TM)" . SPARSER::COLLECTION)
    ("copGFP-Polβ(TM)" . SPARSER::COLLECTION)
    ("copGFP-Polβ(WT)" . SPARSER::COLLECTION) ("copGFP" . SPARSER::PROTEIN)
    ("CopGFP-Polβ" . SPARSER::PROTEIN-PAIR) ("Light" . SPARSER::PROTEIN)
    ("Polβ(TM) in U2OS cells" . SPARSER::PROTEIN)
    ("copGFP-Polβ" . SPARSER::COLLECTION) ("TRE" . SPARSER::PROTEIN)
    ("tetR" . SPARSER::PROTEIN-FAMILY) ("TREs" . SPARSER::PROTEIN)
    ("Polβ(WT) or Polβ(TM)" . SPARSER::COLLECTION)
    ("polymers" . SPARSER::MOLECULE) ("Polβ-KD" . SPARSER::PROTEIN-PAIR)
    ("MPG, Polβ and XRCC1" . SPARSER::COLLECTION) ("lyase" . SPARSER::PROTEIN)
    ("Flag-Polβ(WT)" . SPARSER::COLLECTION)
    ("XRCC1 or Polβ" . SPARSER::COLLECTION)
    ("Flag-Polβ(TM)" . SPARSER::COLLECTION)
    ("Polβ and XRCC1" . SPARSER::COLLECTION)
    ("Polβ or XRCC1" . SPARSER::COLLECTION)
    ("the lentiviral-expressed Flag-Polβ transgene" . SPARSER::PROTEIN)
    ("Polβ and the V303 loop mutants" . SPARSER::COLLECTION)
    ("Polβ" . SPARSER::PROTEIN)
    ("the Polβ/XRCC1 heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("Flag-Polβ" . SPARSER::COLLECTION) ("XRCC1/HSP90" . SPARSER::COLLECTION)
    ("MULE" . SPARSER::PROTEIN) ("XRCC1 and Polβ" . SPARSER::COLLECTION)
    ("secondary BER protein" . SPARSER::PROTEIN)
    ("aprataxin and Poly(ADP-ribose) polymerase" . SPARSER::COLLECTION)
    ("aprataxin" . SPARSER::PROTEIN)
    ("An essential component" . SPARSER::COMPONENT)
    ("a tight heterodimer complex" . SPARSER::BIO-COMPLEX)
    ("ABT888" . SPARSER::DRUG) ("18h" . SPARSER::PROTEIN)
    ("OGG1" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("p14ARF" . SPARSER::PROTEIN) ("R-R" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("Phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("N-Ethylmaleimide" . SPARSER::MOLECULE) ("ddH2" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("ABT-888" . SPARSER::DRUG)
    ("APE1" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("lyase activity" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN)
    ("the conformationally flexible K107–E128 peptide" . SPARSER::PEPTIDE)
    ("RNA-interaction" . SPARSER::RNA)
    ("the unliganded protein and the cross-linked complex (Supplementary Table S4)"
     . SPARSER::COLLECTION)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("the available TS protein" . SPARSER::PROTEIN)
    ("the Pneumocystis carinii TS and the human TS mutant R163K [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the smaller RNA" . SPARSER::RNA)
    ("a shorter TS1–14 oligonucleotide" . SPARSER::MOLECULE)
    ("a smaller energy barrier" . SPARSER::PROTEIN)
    ("the shortest variant" . SPARSER::VARIANT)
    ("an internal ribosome entry site-driven Renilla luciferase"
     . SPARSER::PROTEIN)
    ("liganded" . SPARSER::MOLECULE)
    ("a nucleic acid-binding protein" . SPARSER::PROTEIN)
    ("PDPA" . SPARSER::MOLECULE)
    ("the previously observed active and inactive conformations"
     . SPARSER::BIO-CONFORMATION)
    ("sulphate" . SPARSER::MOLECULE)
    ("active and inactive" . SPARSER::COLLECTION) ("TOF" . SPARSER::PROTEIN)
    ("IDA" . SPARSER::PROTEIN) ("Da" . SPARSER::MOLECULE)
    ("TFA" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("Tempo" . SPARSER::DRUG) ("RP" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE) ("ice-cold trypsin" . SPARSER::PROTEIN)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2 mM DTT and 10% (v/v) glycerol" . SPARSER::COLLECTION)
    ("the protein and the RNA" . SPARSER::COLLECTION)
    ("RCSB" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("20 mM 2-mercaptoethanol (‘high salt’) or 30% PEG [poly(ethylene glycol)]"
     . SPARSER::COLLECTION)
    ("protein and TS1-33" . SPARSER::COLLECTION) ("PEG" . SPARSER::PROTEIN)
    ("sulfate" . SPARSER::MOLECULE) ("Gold" . SPARSER::MOLECULE)
    ("4 mM DTT and 4 mM MgCl 2" . SPARSER::COLLECTION)
    ("Mops" . SPARSER::MOLECULE) ("Fractions" . SPARSER::COMPONENT)
    ("Bacterial TS" . SPARSER::PROTEIN) ("thiouridine" . SPARSER::MOLECULE)
    ("Nucleic acids and hTS (human thymidylate synthase) protein"
     . SPARSER::PROTEIN)
    ("ultra-pure RNase-free water" . SPARSER::MOLECULE)
    ("ampicillin" . SPARSER::DRUG) ("IPTG" . SPARSER::MOLECULE)
    ("DTT, THF, Tris and acetonitrile" . SPARSER::COLLECTION)
    ("acetonitrile" . SPARSER::MOLECULE)
    ("mercaptoethanol" . SPARSER::MOLECULE) ("Salts" . SPARSER::DRUG)
    ("Sepharose" . SPARSER::MOLECULE) ("Reagents" . SPARSER::MOLECULE)
    ("raltitrexed" . SPARSER::DRUG) ("whose subunits" . SPARSER::PROTEIN)
    ("deoxythymidine" . SPARSER::MOLECULE) ("dTTP" . SPARSER::MOLECULE)
    ("the human thymidylate synthase and its cognate mRNA"
     . SPARSER::COLLECTION)
    ("tetrahydrofolate" . SPARSER::MOLECULE) ("THF" . SPARSER::MOLECULE)
    ("dUMP" . SPARSER::DUMP) ("its own mRNA" . SPARSER::PROTEIN)
    ("MS2" . SPARSER::PROTEIN) ("2–4 " . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("p53 or p53" . SPARSER::COLLECTION) ("RLIM" . SPARSER::PROTEIN)
    ("BEC" . SPARSER::MOLECULE)
    ("stathmin (Op18) or Lasp1 ( xref ; xref )" . SPARSER::COLLECTION)
    ("Lasp1" . SPARSER::PROTEIN) ("Lasp" . SPARSER::DRUG)
    ("stathmin" . SPARSER::PROTEIN)
    ("p21, p53R2, and GADD45" . SPARSER::COLLECTION)
    ("p53R2" . SPARSER::PROTEIN) ("proteins and miRNAs" . SPARSER::COLLECTION)
    ("pcDNA3" . SPARSER::PROTEIN) ("pcDNA3-p53" . SPARSER::COLLECTION)
    ("primary HCCs" . SPARSER::PROTEIN) ("shR-p53" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE)
    ("miR-125b and miR-22" . SPARSER::COLLECTION)
    ("directly target p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, and p53" . SPARSER::COLLECTION)
    ("miRNAs and p53" . SPARSER::COLLECTION) ("MOAP1" . SPARSER::PROTEIN)
    ("Op18" . SPARSER::PROTEIN)
    ("Enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("LRP1" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("miR-125b" . SPARSER::MOLECULE) ("CCL22" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("miR-133a" . SPARSER::PROTEIN)
    ("FZD7" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("severe PVR" . SPARSER::PROTEIN) ("p21 and PVR" . SPARSER::COLLECTION)
    ("SMCs" . SPARSER::PROTEIN)
    ("interferon-β and tumor necrosis factor-α" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION) ("ophthalmic" . SPARSER::DRUG)
    ("CDK 2 and cyclins" . SPARSER::COLLECTION) ("CDKI" . SPARSER::DRUG)
    ("PRP" . SPARSER::PROTEIN) ("very poor inducers" . SPARSER::MOLECULE)
    ("periostin and fibroblast-like" . SPARSER::COLLECTION)
    ("periostin" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("the peripheral retina" . SPARSER::DRUG)
    ("CDK 2 and cyclin" . SPARSER::COLLECTION)
    ("CDK2 and CyclinE" . SPARSER::COLLECTION)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY)
    ("PBS, rAd-NC and rAd-p21" . SPARSER::COLLECTION)
    ("PBS and rAd-NC" . SPARSER::COLLECTION)
    ("experimental PVR" . SPARSER::PROTEIN)
    ("CDKs and cyclinE" . SPARSER::COLLECTION)
    ("quaternary complexes" . SPARSER::BIO-COMPLEX) ("CDKIs" . SPARSER::DRUG)
    ("CDK 2 and cyclinE" . SPARSER::COLLECTION) ("retinas" . SPARSER::DRUG)
    ("p21, CDK 2 and cyclinE" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY) ("RPE" . SPARSER::PROTEIN)
    ("PVR" . SPARSER::PROTEIN) ("interferon-β" . SPARSER::DRUG)
    ("T-3" . SPARSER::PROTEIN) ("G-3" . SPARSER::PROTEIN)
    ("GAG-3" . SPARSER::PROTEIN) ("CDK 2" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN)
    ("gambogic acid-loaded magnetic Fe 3 O 4 nanoparticles"
     . SPARSER::MOLECULE)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("N-cadherin, E-cadherin and VEGF" . SPARSER::COLLECTION)
    ("ETS-1 and EMT-related molecules N-cadherin and E-cadherin"
     . SPARSER::COLLECTION)
    ("N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("c-ets-1" . SPARSER::COLLECTION)
    ("integrins ( xref , xref ) and cadherins ( xref , xref )"
     . SPARSER::COLLECTION)
    ("N-cadherin, vimentin and fibronectin" . SPARSER::COLLECTION)
    ("ETS-1-shRNA" . SPARSER::COLLECTION)
    ("ETS-1 and EMT-related molecules" . SPARSER::COLLECTION)
    ("ETS-1 , N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("ETS-1, N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin and VEGF" . SPARSER::COLLECTION)
    ("ETS-1 , E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("ETS-1 and VEGF" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN)
    ("N-cadherin and vascular endothelial" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("v-ets" . SPARSER::COLLECTION) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ets-1" . SPARSER::PROTEIN) ("ETS-1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN)
    ("the respective protein" . SPARSER::PROTEIN) ("Neu" . SPARSER::PROTEIN)
    ("mouse monoclonal anti-EGFR antibody (Santa Cruz) and anti-mouse Alexa Fluor 488-conjugated antibodies (Invitrogen, Life Technologies)"
     . SPARSER::COLLECTION)
    ("anti-mouse Alexa Fluor 488-conjugated antibodies" . SPARSER::ANTIBODY)
    ("mouse monoclonal anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("ice-cold methanol" . SPARSER::MOLECULE)
    ("Rpl13a and GAPDH" . SPARSER::COLLECTION)
    ("Rpl13a, HPRT and Ywhaz" . SPARSER::COLLECTION)
    ("Rpl13a" . SPARSER::PROTEIN) ("mixtures" . SPARSER::MOLECULE)
    ("reverse transcriptase (for mAChRs) or M-MuLV reverse transcriptase (for other experiments; both from NEB, Frankfurt, Germany)"
     . SPARSER::COLLECTION)
    ("NEB" . SPARSER::PROTEIN) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNAse" . SPARSER::PROTEIN)
    ("a mouse monoclonal anti-myc antibody" . SPARSER::ANTIBODY)
    ("Mouse monoclonal anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("0.5% Triton X-100 and 60 mM" . SPARSER::COLLECTION)
    ("1 mM sodium orthovanadate and 1 mM sodium fluoride"
     . SPARSER::COLLECTION)
    ("pERK and ubiquitin" . SPARSER::COLLECTION)
    ("ERK and phosphotyrosine" . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN)
    ("pAkt (Ser473) and pEGFR (Tyr1068)" . SPARSER::COLLECTION)
    ("monoclonal rabbit antibodies" . SPARSER::ANTIBODY)
    ("Monoclonal mouse antibodies" . SPARSER::ANTIBODY)
    ("Akt and pEGFR" . SPARSER::COLLECTION)
    ("PP2 and PP3" . SPARSER::COLLECTION)
    ("PD 153035 and AG9" . SPARSER::COLLECTION) ("stimulant" . SPARSER::DRUG)
    ("1% sodium pyruvate and 1% non-essential amino acids (all from Life Technologies)"
     . SPARSER::COLLECTION)
    ("pyruvate" . SPARSER::PROTEIN)
    ("Human TGF-alpha and human HB-EGF" . SPARSER::COLLECTION)
    ("PD 153035, AG9, batimastat, PP3 and Bisindolylmaleimide I"
     . SPARSER::COLLECTION)
    ("batimastat" . SPARSER::DRUG)
    ("tropicamide, PP2 and Ly 294002" . SPARSER::COLLECTION)
    ("Sigma-Aldrich" . SPARSER::COLLECTION) ("telenzepine" . SPARSER::DRUG)
    ("EGFR/MAP kinase" . SPARSER::COLLECTION)
    ("kinases and PKC" . SPARSER::COLLECTION)
    ("most efficient inducers" . SPARSER::MOLECULE)
    ("HB-EGF and betacellulin" . SPARSER::COLLECTION)
    ("EGF, HB-EGF, TGF-α, AREG, EREG and betacellulin" . SPARSER::COLLECTION)
    ("betacellulin" . SPARSER::PROTEIN)
    ("AREG and epiregulin (EREG)" . SPARSER::COLLECTION)
    ("AREG and epiregulin" . SPARSER::COLLECTION) ("EREG" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN)
    ("HB-EGF and TGF-α" . SPARSER::COLLECTION) ("AREG" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN) ("EGF and TGF-α" . SPARSER::COLLECTION)
    ("EGFR or other proteins" . SPARSER::COLLECTION)
    ("Src and PI3K" . SPARSER::COLLECTION)
    ("EGFR and MAP kinase" . SPARSER::COLLECTION)
    ("MAP kinase and Akt" . SPARSER::COLLECTION)
    ("TGF-α and HB-EGF" . SPARSER::COLLECTION) ("Heparin" . SPARSER::PROTEIN)
    ("EGF and CCh" . SPARSER::COLLECTION) ("Batimastat" . SPARSER::DRUG)
    ("kinases and PI3K" . SPARSER::COLLECTION)
    ("PP2 and Ly 294002" . SPARSER::COLLECTION) ("BIM" . SPARSER::PROTEIN)
    ("the inhibitors resulted in significant inhibition of Akt activity"
     . SPARSER::INHIBITOR)
    ("at least ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tropicamide" . SPARSER::DRUG) ("Telenzepine" . SPARSER::DRUG)
    ("atropine" . SPARSER::DRUG)
    ("cFos ( xref G) and Dusp1 ( xref H)" . SPARSER::COLLECTION)
    ("Dusp1" . SPARSER::PROTEIN)
    ("cFos and the dual specificity phosphatase Dusp1" . SPARSER::COLLECTION)
    ("the dual specificity phosphatase Dusp1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Egr1" . SPARSER::PROTEIN) ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cFos" . SPARSER::PROTEIN)
    ("EGF (16 nM) or nicotine (100 µM)" . SPARSER::COLLECTION)
    ("EGF, TGF-α or HB-EGF" . SPARSER::COLLECTION)
    ("EGFR, Erb-B2 and Erb-B3" . SPARSER::COLLECTION)
    ("Many GPCRs and other receptors" . SPARSER::COLLECTION)
    ("ERB" . SPARSER::PROTEIN) ("TMP" . SPARSER::TMP)
    ("extracellular signal regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ach" . SPARSER::PROTEIN) ("subunits and mAChR" . SPARSER::COLLECTION)
    ("M 2 and M 4" . SPARSER::COLLECTION)
    ("receptors (GPCR)" . SPARSER::RECEPTOR)
    ("heterotrimeric guanine nucleotide binding proteins" . SPARSER::PROTEIN)
    ("The nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("ACh and its receptors" . SPARSER::COLLECTION) ("ACh" . SPARSER::PROTEIN)
    ("kinases or protein" . SPARSER::COLLECTION)
    ("the cholinergic agonist carbachol" . SPARSER::DRUG)
    ("carbachol" . SPARSER::DRUG) ("muscarinic" . SPARSER::PROTEIN)
    ("Mitogen" . SPARSER::MITOGEN) ("etc ." . SPARSER::PROTEIN)
    ("–3 µ" . SPARSER::PROTEIN) ("TGF-alpha" . SPARSER::PROTEIN)
    ("Bisindolylmaleimide I" . SPARSER::DRUG) ("PP3" . SPARSER::PROTEIN)
    ("AG9" . SPARSER::PROTEIN)
    ("Growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("G–I" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("Ly 294002" . SPARSER::MOLECULE) ("B–D" . SPARSER::PROTEIN)
    ("CHRM3" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN)
    ("PD 153035" . SPARSER::DRUG) ("HB-EGF" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erb-B" . SPARSER::PROTEIN) ("Erb-B2" . SPARSER::PROTEIN)
    ("M 2" . SPARSER::MOLECULE)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("M 1" . SPARSER::MOLECULE)
    ("protein and transcription factor" . SPARSER::COLLECTION)
    ("epigenetic PHD3" . SPARSER::PROTEIN)
    ("a methylated PHD3 promoter" . SPARSER::PROMOTER)
    ("cofactors (Fe 2+ , ascorbate) and co-substrates (O 2 , 2-oxoglurate)"
     . SPARSER::COLLECTION)
    ("hypoxia and nutrient" . SPARSER::COLLECTION)
    ("PHD3 and EGFR" . SPARSER::COLLECTION)
    ("Grb2 and Shc" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("Axl" . SPARSER::PROTEIN)
    ("PDGFRα, VEGFR1 and EphB2" . SPARSER::COLLECTION)
    ("the hydroxylase-deficient PHD3 mutant" . SPARSER::MUTANT)
    ("PHD3 and PHD3" . SPARSER::COLLECTION)
    ("HIF1α and/or HIF2α" . SPARSER::COLLECTION)
    ("HIF or NF-κB" . SPARSER::COLLECTION)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("TdT" . SPARSER::PROTEIN) ("PHD/HIF" . SPARSER::COLLECTION)
    ("genetically inactivated PHD3" . SPARSER::PROTEIN)
    ("chronic hypoxia" . SPARSER::PROTEIN) ("acute hypoxia" . SPARSER::PROTEIN)
    ("Lentiviral PHD3" . SPARSER::PROTEIN)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION)
    ("a methylated promoter" . SPARSER::PROMOTER)
    ("Azacytidine" . SPARSER::DRUG) ("CAIX" . SPARSER::PROTEIN)
    ("PHD1 (refs xref , xref ) and PHD2 (refs xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("HIF, and PHD" . SPARSER::COLLECTION) ("PHDs" . SPARSER::PROTEIN)
    ("HIFs" . SPARSER::PROTEIN) ("Hypoxia" . SPARSER::PROTEIN)
    ("HIF and NF-κB" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("DNA Polymerase" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("EGLN3" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("Not1" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("KIF1B" . SPARSER::PROTEIN)
    ("EphB2" . SPARSER::PROTEIN) ("HIF2α" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN) ("PHD3" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("a more important prognostic biomarker" . SPARSER::MOLECULE)
    ("SIRT1-Notch1" . SPARSER::COLLECTION) ("lysines" . SPARSER::AMINO-ACID)
    ("NICD" . SPARSER::PROTEIN) ("protein and Notch1" . SPARSER::COLLECTION)
    ("Notch1 or N1IC" . SPARSER::COLLECTION)
    ("possible target genes" . SPARSER::GENE) ("RANKL" . SPARSER::PROTEIN)
    ("p53 [ xref ] and c-Myc [ xref ]" . SPARSER::COLLECTION)
    ("SIRT1and N1IC" . SPARSER::COLLECTION) ("ER and PR" . SPARSER::COLLECTION)
    ("SIRT1 and Snail" . SPARSER::COLLECTION)
    ("SIRT1, N1IC and Snail" . SPARSER::COLLECTION)
    ("SIRT1, N1IC, and snail" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("SIRT1 and components" . SPARSER::COLLECTION)
    ("SIRT1 and Notch1" . SPARSER::COLLECTION)
    ("Notch1 and N1IC" . SPARSER::COLLECTION) ("varieties" . SPARSER::VARIETY)
    ("the Notch1 receptor and the ligand" . SPARSER::COLLECTION)
    ("DLL1-3" . SPARSER::COLLECTION) ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("novel molecular prognostic biomarkers" . SPARSER::MOLECULE)
    ("SIRT1 and N1IC" . SPARSER::COLLECTION)
    ("SIRT1, N1IC, and Snail" . SPARSER::COLLECTION) ("CD8" . SPARSER::PROTEIN)
    ("notch1" . SPARSER::PROTEIN)
    ("Notch1 intracellular domain" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("DLL1" . SPARSER::PROTEIN)
    ("Jagged2" . SPARSER::PROTEIN) ("Jagged1" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN)
    ("topical small molecule" . SPARSER::MOLECULE)
    ("cytosolic STAT3 and mitochondrial proteins" . SPARSER::COLLECTION)
    ("Grim19" . SPARSER::PROTEIN) ("TAK1:RIP1K" . SPARSER::PROTEIN-PAIR)
    ("monomers and dimers" . SPARSER::COLLECTION)
    ("transcriptionally active STAT3 dimers" . SPARSER::DIMER)
    ("RIPK" . SPARSER::PROTEIN) ("DAI" . SPARSER::PROTEIN)
    ("NFκB and type I" . SPARSER::COLLECTION)
    ("both caspase-1 (pyroptosis) and RIP1K (necroptosis)"
     . SPARSER::COLLECTION)
    ("VACV-WR" . SPARSER::COLLECTION) ("WR" . SPARSER::PROTEIN)
    ("Cho" . SPARSER::PROTEIN) ("NFκB, TNF-α, and IFN-β" . SPARSER::COLLECTION)
    ("STAT3 and TAK1" . SPARSER::COLLECTION)
    ("both STAT3 and the innate signaling kinase TAK1" . SPARSER::COLLECTION)
    ("the major cytokine" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION) ("flagellin" . SPARSER::PROTEIN)
    ("NF-κB, IFN-β and ISRE" . SPARSER::COLLECTION)
    ("NFκB, IFN-β and ISRE" . SPARSER::COLLECTION)
    ("NF-κB, IFN-β, or ISRE" . SPARSER::COLLECTION)
    ("Keratinocytes" . SPARSER::PROTEIN)
    ("NF-κB and type I" . SPARSER::COLLECTION)
    ("Stattic and Nec-1" . SPARSER::COLLECTION) ("Stattic-" . SPARSER::DRUG)
    ("caspase-1, RIP1K or STAT3" . SPARSER::COLLECTION)
    ("ACAM" . SPARSER::PROTEIN)
    ("an early-late viral promoter" . SPARSER::PROMOTER)
    ("ACAM-luc" . SPARSER::COLLECTION)
    ("siRNA or Stattic" . SPARSER::COLLECTION) ("hyper" . SPARSER::PROTEIN)
    ("hyper-IgE" . SPARSER::COLLECTION)
    ("an effective antiviral barrier" . SPARSER::PROTEIN)
    ("kinase and STAT3" . SPARSER::COLLECTION)
    ("kinase or caspase-1" . SPARSER::COLLECTION)
    ("Complex I" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("NALP1" . SPARSER::PROTEIN) ("RIP3" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("Ac-DEVD-CHO" . SPARSER::DRUG) ("Caspase-1" . SPARSER::PROTEIN)
    ("Nec-1" . SPARSER::PROTEIN) ("necrostatin-1" . SPARSER::MOLECULE)
    ("caspase-1" . SPARSER::PROTEIN)
    ("STATIP1 , STAT3 , and ABCB1" . SPARSER::COLLECTION)
    ("BCR-ABL and STAT3" . SPARSER::COLLECTION)
    ("STAT3 , CCND1 and BCL - XL" . SPARSER::COLLECTION)
    ("CCND1 and BCL - XL" . SPARSER::COLLECTION)
    ("the viral Src oncoprotein" . SPARSER::PROTEIN)
    ("STAT3 , STATIP1 and ABCB1" . SPARSER::COLLECTION)
    ("imatinib" . SPARSER::DRUG) ("LLL" . SPARSER::MOLECULE)
    ("CCND1 , BCL - XL and STAT3" . SPARSER::COLLECTION)
    ("cellular growth promoters and inhibitors of apoptosis [ xref ]"
     . SPARSER::COLLECTION)
    ("STAT3 and STATIP1" . SPARSER::COLLECTION)
    ("Imatinib (IM)" . SPARSER::DRUG)
    ("STATIP1 and STAT3" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY)
    ("PI3K/PTEN/Akt/mTOR" . SPARSER::COLLECTION)
    ("VEGF and TWIST1" . SPARSER::COLLECTION)
    ("BCL - XL and CCND1" . SPARSER::COLLECTION)
    ("PIM1 and c-Myc" . SPARSER::COLLECTION)
    ("kinases (TK)" . SPARSER::PROTEIN)
    ("receptor and non-receptor" . SPARSER::COLLECTION)
    ("EGFR, gp130, Ras, Src and Abl" . SPARSER::COLLECTION)
    ("Abl" . SPARSER::PROTEIN)
    ("growth factors and oncogenic proteins [ xref ]" . SPARSER::COLLECTION)
    ("BCR-ABL or STAT3" . SPARSER::COLLECTION)
    ("CCND1 and BCL-XL" . SPARSER::COLLECTION) ("E-F" . SPARSER::PROTEIN)
    ("C-D" . SPARSER::PROTEIN) ("STATIP 1" . SPARSER::PROTEIN)
    ("STAT3-interacting protein 1" . SPARSER::PROTEIN)
    ("PIM1" . SPARSER::PROTEIN) ("BCL - XL" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("STATIP1" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("luminal and basal cells" . SPARSER::COLLECTION)
    ("BRCA1, miR-146a and EGFR" . SPARSER::COLLECTION)
    ("EGFR-RAS-MEK" . SPARSER::COLLECTION) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("RAS/MAP kinase" . SPARSER::COLLECTION)
    ("Phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Raf-1 and Ras" . SPARSER::COLLECTION)
    ("TRAF6 and IRAK 1" . SPARSER::COLLECTION) ("mature forms" . SPARSER::FORM)
    ("DROSHA" . SPARSER::PROTEIN) ("Tanic" . SPARSER::DRUG)
    ("EGFR or basal cytokeratins ( xref , xref )" . SPARSER::COLLECTION)
    ("functional BRCA1" . SPARSER::PROTEIN)
    ("EGFR, Raf-1 and Ras" . SPARSER::COLLECTION)
    ("-complemented" . SPARSER::COLLECTION) ("LNA" . SPARSER::PROTEIN)
    ("protein/protein" . SPARSER::COLLECTION)
    ("siRNA or siRNA" . SPARSER::COLLECTION) ("luc" . SPARSER::PROTEIN)
    ("an important prognostic biomarker" . SPARSER::MOLECULE)
    ("distinct miRNAs" . SPARSER::PROTEIN) ("insC" . SPARSER::PROTEIN)
    ("BRCA1 and EGFR" . SPARSER::COLLECTION) ("/HER2" . SPARSER::COLLECTION)
    ("/PR" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("evolutionarily conserved small noncoding RNAs approximately 21 nucleotides"
     . SPARSER::NUCLEOTIDE)
    ("MicroRNAs" . SPARSER::RNA)
    ("a 1,863-amino-acid nuclear phosphoprotein" . SPARSER::PROTEIN)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR/ErbB1/HER1) and basal cytokeratins (CK5, CK6, CK14 and CK17)"
     . SPARSER::COLLECTION)
    ("CK5, CK6, CK14 and CK17" . SPARSER::COLLECTION)
    ("EGFR/ErbB1/HER1" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("progesterone receptor (PR) and the human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("TN" . SPARSER::PROTEIN) ("BRCA1 and miR-146a" . SPARSER::COLLECTION)
    ("IRAK 1" . SPARSER::PROTEIN) ("CK17" . SPARSER::PROTEIN)
    ("CK14" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP70 and MDM2" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("chaperonin" . SPARSER::PROTEIN)
    ("strongly binding mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDM2 and TAp63α" . SPARSER::COLLECTION)
    ("p53—MDM2" . SPARSER::COLLECTION) ("p53 or TAp73" . SPARSER::COLLECTION)
    ("TAp63 or TAp73" . SPARSER::COLLECTION) ("p53R175H" . SPARSER::PROTEIN)
    ("TAp63 and TAp73" . SPARSER::COLLECTION)
    ("p53 and TA/ΔNp73α" . SPARSER::COLLECTION)
    ("p53 and TAp73α" . SPARSER::COLLECTION)
    ("MDM2 instead of p53" . SPARSER::COLLECTION)
    ("MDM2 and TAp73α" . SPARSER::COLLECTION)
    ("p53 and TAp73α or ΔNp73α" . SPARSER::COLLECTION)
    ("p53/p63" . SPARSER::COLLECTION) ("p73 and p53" . SPARSER::COLLECTION)
    ("even wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tetramers" . SPARSER::TETRAMER)
    ("77 additional unique amino acids" . SPARSER::AMINO-ACID)
    ("an inactive compact dimer" . SPARSER::DIMER)
    ("further TAp63α mutants" . SPARSER::MUTANT)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the principal ubiquitin ligases" . SPARSER::LIGASE)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION) ("TA" . SPARSER::PROTEIN)
    ("p73 and p53R273H" . SPARSER::COLLECTION)
    ("p53/p63/p73" . SPARSER::COLLECTION) ("p63 or p73" . SPARSER::COLLECTION)
    ("p63/p73" . SPARSER::COLLECTION) ("p63 and p73" . SPARSER::COLLECTION)
    ("5–2 " . SPARSER::PROTEIN)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN)
    ("herpesvirus-associated ubiquitin-specific protease" . SPARSER::PROTEIN)
    ("polypeptide 1" . SPARSER::PROTEIN)
    ("heat-shock protein 70" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("ΔNp63α" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("ANKRD11" . SPARSER::PROTEIN)
    ("TOPBP1" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("facultative heterochromatin" . SPARSER::PROTEIN)
    ("DAXX" . SPARSER::PROTEIN)
    ("pericentric heterochromatin" . SPARSER::PROTEIN)
    ("Onecut1 and KIhI31" . SPARSER::COLLECTION) ("Onecut1" . SPARSER::PROTEIN)
    ("RNA or DNA" . SPARSER::COLLECTION) ("roX" . SPARSER::PROTEIN)
    ("MLE" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("Parp12, Rnf19b , and Spock2" . SPARSER::COLLECTION)
    ("Rnf19b" . SPARSER::PROTEIN) ("Parp" . SPARSER::PROTEIN)
    ("ATRX function causes improper PRC2" . SPARSER::PROTEIN)
    ("autosomal genes" . SPARSER::GENE)
    ("all autosomal PRC2 target genes" . SPARSER::GENE)
    ("21,677 annotated unique RefSeq genes" . SPARSER::GENE)
    ("the ATRX-RNA-PRC2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("ATRX-" . SPARSER::PROTEIN) ("lox" . SPARSER::PROTEIN)
    ("LOX" . SPARSER::PROTEIN) ("Jarid1c" . SPARSER::PROTEIN)
    ("ATRX, EZH2, and H3K27me3" . SPARSER::COLLECTION)
    ("ATRX, PRC2, and Xist" . SPARSER::COLLECTION) ("Allele" . SPARSER::ALLELE)
    ("cas" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mus" . SPARSER::PROTEIN)
    ("Mus" . SPARSER::PROTEIN) ("Hot" . SPARSER::PROTEIN)
    ("The ATRX:RNA:PRC2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("PRC2-ATRX" . SPARSER::COLLECTION) ("ATRX:RNA:PRC2" . SPARSER::COLLECTION)
    ("a dsDNA-ATRX-RNA ternary complex" . SPARSER::BIO-COMPLEX)
    ("EZH2/SUZ12" . SPARSER::COLLECTION) ("RNases" . SPARSER::PROTEIN)
    ("the nonhydrolysable analog" . SPARSER::ANALOG)
    ("ATRX and ATP" . SPARSER::COLLECTION)
    ("ATRX and/or ATP" . SPARSER::COLLECTION)
    ("PRC2-RNA binding" . SPARSER::COLLECTION)
    ("a stable ternary complex" . SPARSER::BIO-COMPLEX)
    ("dsDNA" . SPARSER::PROTEIN)
    ("an RNA:ATRX:dsDNA ternary complex" . SPARSER::BIO-COMPLEX)
    ("RNA:ATRX:dsDNA" . SPARSER::COLLECTION)
    ("an ATRX-RNA-DNA ternary complex" . SPARSER::BIO-COMPLEX)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("ATRX-PRC2" . SPARSER::COLLECTION)
    ("an ATRX-RNA-PRC2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("ATRX and PRC2" . SPARSER::COLLECTION) ("subfragments" . SPARSER::PROTEIN)
    ("RNA and dsDNA" . SPARSER::COLLECTION)
    ("RNA and DNA" . SPARSER::COLLECTION) ("CTCF" . SPARSER::PROTEIN)
    ("MBP and mouse Hotair dsDNAs ( xref ; K d ≫200 nM)" . SPARSER::COLLECTION)
    ("ribozyme" . SPARSER::RNA) ("Maltose" . SPARSER::MOLECULE)
    ("Subfragments" . SPARSER::PROTEIN)
    ("excellent fit" . SPARSER::PROTEIN-FAMILY)
    ("ATRX-Xist" . SPARSER::COLLECTION) ("EZH2-Xist" . SPARSER::COLLECTION)
    ("Neither EZH2 nor ATRX" . SPARSER::COLLECTION)
    ("EZH2 and Xist" . SPARSER::COLLECTION) ("UV" . SPARSER::PROTEIN)
    ("Xist and ATRX" . SPARSER::COLLECTION) ("UV-RIP" . SPARSER::PROTEIN-PAIR)
    ("RIP" . SPARSER::PROTEIN) ("KD, EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("an autosomal transgene" . SPARSER::PROTEIN) ("NANOG" . SPARSER::PROTEIN)
    ("Xist, EZH2, or H3K27me3" . SPARSER::COLLECTION)
    ("shATRX-1" . SPARSER::COLLECTION)
    ("mental retardation and alpha-thalassemia" . SPARSER::COLLECTION)
    ("tri" . SPARSER::PROTEIN) ("TRX" . SPARSER::PROTEIN)
    ("PHD" . SPARSER::PROTEIN)
    ("DNA and mononucleosomes" . SPARSER::COLLECTION)
    ("ATPase and helicase" . SPARSER::COLLECTION)
    ("FLAG-mH2A" . SPARSER::COLLECTION)
    ("PARP1 and linker" . SPARSER::COLLECTION)
    ("MECP2 and HP1" . SPARSER::COLLECTION) ("macroH2A" . SPARSER::PROTEIN)
    ("Regulator" . SPARSER::REGULATOR)
    ("JARID2 and AEPB2" . SPARSER::COLLECTION) ("Jumonji" . SPARSER::PROTEIN)
    ("sequence-specific DNA-binding proteins" . SPARSER::PROTEIN)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("Xist and Tsix" . SPARSER::COLLECTION) ("Xic" . SPARSER::PROTEIN)
    ("RepA/Xist" . SPARSER::COLLECTION) ("RepA" . SPARSER::PROTEIN)
    ("Xist and PRC2" . SPARSER::COLLECTION) ("ATRX" . SPARSER::PROTEIN)
    ("Xist" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("a 20 µ" . SPARSER::PROTEIN) ("ATR-X" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("h11" . SPARSER::PROTEIN)
    ("Spock2" . SPARSER::PROTEIN) ("Tmem200a" . SPARSER::PROTEIN)
    ("Gpr26" . SPARSER::PROTEIN) ("Chr13" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("AMP-PNP" . SPARSER::MOLECULE)
    ("RNA binding" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA-Binding Protein" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("MECP2" . SPARSER::PROTEIN) ("mH2A" . SPARSER::PROTEIN)
    ("Zinc-finger protein" . SPARSER::PROTEIN) ("JARID2" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("Dasatinib and Bosutinib" . SPARSER::COLLECTION)
    ("Bosutinib" . SPARSER::DRUG) ("pErk" . SPARSER::PROTEIN)
    ("pSrc" . SPARSER::PROTEIN) ("Fyn-Stat3" . SPARSER::COLLECTION)
    ("Fyn (or other Src family kinases) and Stat3" . SPARSER::COLLECTION)
    ("EGFR and MET" . SPARSER::COLLECTION)
    ("the dominant RTK" . SPARSER::PROTEIN)
    ("GPCRs and Src" . SPARSER::COLLECTION)
    ("Tgfb2 and Bmp2" . SPARSER::COLLECTION) ("Tgfb2" . SPARSER::PROTEIN)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("the tyrosine kinase Fyn and the transcription factor Stat3"
     . SPARSER::COLLECTION)
    ("Fzd2 and its cognate ligands Wnt5a and Wnt5b" . SPARSER::COLLECTION)
    ("Fzd2, CDH1, and MMP9" . SPARSER::COLLECTION)
    ("Fzd2–Fyn–Stat3" . SPARSER::COLLECTION)
    ("Fzd2 and/or Wnt5a/b" . SPARSER::COLLECTION)
    ("late stage HCC" . SPARSER::PROTEIN)
    ("monoclonal anti-Fzd2 antibodies" . SPARSER::ANTIBODY)
    ("a potential anti-Fzd2" . SPARSER::ANTIBODY)
    ("the latter received transfection reagent" . SPARSER::MOLECULE)
    ("Fzd2-siRNA" . SPARSER::COLLECTION) ("multi" . SPARSER::PROTEIN)
    ("Staurosporine" . SPARSER::MOLECULE)
    ("possibly other proteins" . SPARSER::PROTEIN)
    ("multi-protein" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("mer" . SPARSER::PROTEIN)
    ("PERP" . SPARSER::PROTEIN)
    ("a pan-specific anti-phosphotyrosine antibody" . SPARSER::ANTIBODY)
    ("Bmp2, Cdh1 and Krt19" . SPARSER::COLLECTION) ("Tgfb1" . SPARSER::PROTEIN)
    ("the mesenchymal markers Mmp2, Snai2 and Mmp9" . SPARSER::COLLECTION)
    ("Mmp2, Snai2 and Mmp9" . SPARSER::COLLECTION)
    ("Cdh1, Bmp2 and Tspan13" . SPARSER::COLLECTION)
    ("Tspan13" . SPARSER::PROTEIN) ("Bmp2" . SPARSER::PROTEIN)
    ("Bmp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fzd2 or Fyn" . SPARSER::COLLECTION)
    ("The pan-specific Src family kinase (SFK) inhibitor Dasatinib"
     . SPARSER::DRUG)
    ("LASSO" . SPARSER::DRUG) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("EGFR family kinase inhibitors (Lapatinib, Erlotinib, Gefitinib) or c-Met kinase inhibitors (SU11274 and Crizotinib)"
     . SPARSER::COLLECTION)
    ("EGF or HGF" . SPARSER::COLLECTION)
    ("SU11274 and Crizotinib" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("Lapatinib" . SPARSER::DRUG)
    ("ROR1, ROR2, and RYK" . SPARSER::COLLECTION)
    ("Fzd2 and Wnt5a" . SPARSER::COLLECTION) ("RYK" . SPARSER::PROTEIN)
    ("Stat3 and Akt" . SPARSER::COLLECTION)
    ("40 RTKs and 12 downstream signaling kinases" . SPARSER::COLLECTION)
    ("tofacitinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("JAKs" . SPARSER::PROTEIN)
    ("a heterotrimeric G-protein" . SPARSER::PROTEIN)
    ("αβγ-trimeric G proteins" . SPARSER::PROTEIN)
    ("toxin, Gallein, and Suramin" . SPARSER::COLLECTION)
    ("Suramin" . SPARSER::DRUG) ("Gallein" . SPARSER::MOLECULE)
    ("toxin" . SPARSER::MOLECULE)
    ("Snai2 (Slug) and Mmp9" . SPARSER::COLLECTION)
    ("Cdh1, and Ocln" . SPARSER::COLLECTION)
    ("Cdh1, Krt19 and Ocln" . SPARSER::COLLECTION)
    ("GST-Stat3" . SPARSER::COLLECTION)
    ("Fzd2 and Stat3" . SPARSER::COLLECTION)
    ("MAPK/Elk-1" . SPARSER::COLLECTION) ("Ras-ERK" . SPARSER::COLLECTION)
    ("exogenous Wnt5a" . SPARSER::PROTEIN)
    ("Stat3, Mek1/2, and Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases (JAK)" . SPARSER::PROTEIN) ("-Janus" . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("IL2RG, STAM, PLAU, SerpinE1 and MMP3" . SPARSER::COLLECTION)
    ("STAM" . SPARSER::PROTEIN) ("Elk-1 and Sp1" . SPARSER::COLLECTION)
    ("either Fzd2-specific shRNA (FOCUS-shFzd2) or control-shRNAs (FOCUS-shCtl)"
     . SPARSER::COLLECTION)
    ("Wnt5–Fzd2-mediated EMT" . SPARSER::PROTEIN)
    ("β-catenin-TCF" . SPARSER::COLLECTION)
    ("PI3K, CK1, PKA, PKC, JNK, mTOR, and Dvl" . SPARSER::COLLECTION)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("well-differentiated HCC" . SPARSER::PROTEIN)
    ("Wnt5/Fzd2" . SPARSER::COLLECTION)
    ("E-cadherin, Occludin, MMP9, and Slug" . SPARSER::COLLECTION)
    ("Occludin" . SPARSER::PROTEIN) ("Mmp9" . SPARSER::PROTEIN)
    ("Cdh1" . SPARSER::PROTEIN) ("Ocln" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("75 EMT-associated genes" . SPARSER::GENE)
    ("Wnt5 and Fzd2" . SPARSER::COLLECTION)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("Wnt5–Fzd2" . SPARSER::COLLECTION)
    ("Wnt5a , Wnt5b , and Fzd2" . SPARSER::COLLECTION)
    ("Fzd2 and Wnt5a/Wnt5b" . SPARSER::COLLECTION)
    ("Fzd2 and its cognate ligands ( Wnt5a and Wnt5b )" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("Fyn tyrosine kinase and the Stat3 transcriptional regulator"
     . SPARSER::COLLECTION)
    ("several previously unrecognized molecules" . SPARSER::MOLECULE)
    ("kinase, and Stat3" . SPARSER::COLLECTION)
    ("Wnt5a and Wnt5b" . SPARSER::COLLECTION)
    ("Wnt and Fzd" . SPARSER::COLLECTION)
    ("nonconconical Wnt components" . SPARSER::COMPONENT)
    ("PKC and JNK" . SPARSER::COLLECTION)
    ("Wnt/βcatenin" . SPARSER::COLLECTION) ("Fzd" . SPARSER::PROTEIN-FAMILY)
    ("Snail and Twist" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION) ("Twist" . SPARSER::PROTEIN)
    ("Snail" . SPARSER::PROTEIN) ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Fyn and Stat3" . SPARSER::COLLECTION)
    ("the Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b"
     . SPARSER::COLLECTION)
    ("Oncostatin M" . SPARSER::PROTEIN) ("3d" . SPARSER::PROTEIN-FAMILY)
    ("Glutathione- S -transferase" . SPARSER::PROTEIN)
    ("SU11274" . SPARSER::DRUG) ("ROR1" . SPARSER::PROTEIN)
    ("Erk1" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SerpinE1" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("XAV939" . SPARSER::DRUG)
    ("TDZD-8" . SPARSER::DRUG) ("Snai2" . SPARSER::PROTEIN)
    ("Spp1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mmp2" . SPARSER::PROTEIN)
    ("Krt19" . SPARSER::PROTEIN) ("KRT18" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN)
    ("seven-transmembrane" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Stat3" . SPARSER::PROTEIN)
    ("Fzd2" . SPARSER::PROTEIN) ("Frizzled2" . SPARSER::PROTEIN)
    ("detailed maps" . SPARSER::PROTEIN) ("macromolecules" . SPARSER::MOLECULE)
    ("Reference binary interactome maps" . SPARSER::PROTEIN)
    ("systematic binary maps" . SPARSER::PROTEIN)
    ("Systematic binary mapping" . SPARSER::PROTEIN)
    ("our systematic binary map" . SPARSER::PROTEIN)
    ("TCF12 and TCF3" . SPARSER::COLLECTION) ("ranked genes" . SPARSER::GENE)
    ("CTBP2 or IKZF1" . SPARSER::COLLECTION)
    ("CTBP2 and IKZF1" . SPARSER::COLLECTION)
    ("IKZF1 and FLI1" . SPARSER::COLLECTION)
    ("cancer-associated proteins" . SPARSER::PROTEIN)
    ("the systematic map" . SPARSER::PROTEIN)
    ("protein or gene" . SPARSER::COLLECTION)
    ("well-studied proteins" . SPARSER::PROTEIN) ("NB" . SPARSER::PROTEIN)
    ("PrePPI-HC" . SPARSER::COLLECTION) ("HC" . SPARSER::PROTEIN)
    ("igh" . SPARSER::PROTEIN) ("systematic maps" . SPARSER::PROTEIN)
    ("AANAT and BHLHE40" . SPARSER::COLLECTION)
    ("RAD51D-IKZF1" . SPARSER::COLLECTION)
    ("AANAT-BHLHE40" . SPARSER::COLLECTION) ("AANAT" . SPARSER::PROTEIN)
    ("at least one disease-associated variant" . SPARSER::VARIANT)
    ("binary interactors" . SPARSER::PROTEIN)
    ("CDKN2C and CDKN2D" . SPARSER::COLLECTION)
    ("CCND1 and CCND3" . SPARSER::COLLECTION)
    ("the literature-based interaction map" . SPARSER::PROTEIN)
    ("Slim" . SPARSER::PROTEIN) ("Map" . SPARSER::PROTEIN)
    ("larger protein" . SPARSER::PROTEIN)
    ("the largest experimentally-determined binary interaction map"
     . SPARSER::PROTEIN)
    ("MAPPIT" . SPARSER::PROTEIN)
    ("a new proteome-scale binary interaction map" . SPARSER::PROTEIN)
    ("A proteome-wide binary interactome map" . SPARSER::PROTEIN)
    ("orf" . SPARSER::PROTEIN) ("trap (MAPPIT)" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("Lit-BS" . SPARSER::COLLECTION)
    ("BS" . SPARSER::PROTEIN) ("Lit" . SPARSER::PROTEIN)
    ("lit" . SPARSER::PROTEIN)
    ("a comprehensive binary reference PPI map" . SPARSER::PROTEIN)
    ("approximately 20,000 protein-coding genes" . SPARSER::GENE)
    ("Even considering only one splice variant" . SPARSER::VARIANT)
    ("empirically-controlled ( xref ) high-quality proteome-scale interactome reference maps"
     . SPARSER::PROTEIN)
    ("First-generation binary PPI interactome maps" . SPARSER::PROTEIN)
    ("post-translational modifiers and their targets" . SPARSER::COLLECTION)
    ("post-translational modifiers" . SPARSER::MOLECULE)
    ("modifiers" . SPARSER::MOLECULE) ("genes and gene" . SPARSER::COLLECTION)
    ("gene or gene" . SPARSER::COLLECTION)
    ("our systematic map" . SPARSER::PROTEIN)
    ("a systematic map" . SPARSER::PROTEIN) ("NEDD8" . SPARSER::PROTEIN)
    ("SUMO4" . SPARSER::PROTEIN) ("SUMO3" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("TCF12" . SPARSER::PROTEIN)
    ("ID3" . SPARSER::PROTEIN) ("FLI1" . SPARSER::PROTEIN)
    ("CTBP2" . SPARSER::PROTEIN)
    ("C-terminal Binding Protein" . SPARSER::PROTEIN)
    ("IKZF1" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("BHLHE40" . SPARSER::PROTEIN) ("HOOK1" . SPARSER::PROTEIN)
    ("CCND3" . SPARSER::PROTEIN) ("CDKN2D" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("in Chinese hamster" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("this new taxane" . SPARSER::DRUG)
    ("cabazitaxel and the first generation taxanes, paclitaxel and docetaxel"
     . SPARSER::COLLECTION)
    ("siRNAs or antisense" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG)
    ("docetaxel or paclitaxel" . SPARSER::COLLECTION)
    ("the co-selected ABCB1 -negative MCF-7/CTAX-P variant" . SPARSER::VARIANT)
    ("ABCC2 , ABCC10 , or ABCG2" . SPARSER::COLLECTION)
    ("/P-gp" . SPARSER::COLLECTION)
    ("ERCC1 and Fanconi anemia" . SPARSER::COLLECTION)
    ("FANCF" . SPARSER::PROTEIN) ("BAX and BAD" . SPARSER::COLLECTION)
    ("BIRC5 , and Livin/" . SPARSER::COLLECTION) ("Livin" . SPARSER::PROTEIN)
    ("Survivin" . SPARSER::PROTEIN) ("BAD" . SPARSER::PROTEIN)
    ("paclitaxel or docetaxel" . SPARSER::COLLECTION)
    ("polymerized tubulin" . SPARSER::PROTEIN)
    ("soluble tubulin" . SPARSER::PROTEIN) ("polymer" . SPARSER::MOLECULE)
    ("the soluble form" . SPARSER::FORM)
    ("residual bound BODIPY-paclitaxel" . SPARSER::DRUG)
    ("bound BODIPY-paclitaxel" . SPARSER::DRUG)
    ("bound fluorescent-labeled paclitaxel" . SPARSER::DRUG)
    ("anthracyclines or platinum" . SPARSER::COLLECTION)
    ("Taxane" . SPARSER::DRUG)
    ("anthracyclines, doxorubicin and daunorubicin" . SPARSER::COLLECTION)
    ("BODIPY-paclitaxel" . SPARSER::DRUG) ("daunorubicin" . SPARSER::DRUG)
    ("anthracyclines" . SPARSER::MOLECULE) ("Rhodamine" . SPARSER::PROTEIN)
    ("cabazitaxel and docetaxel" . SPARSER::COLLECTION)
    ("MXR" . SPARSER::PROTEIN) ("/BCRP" . SPARSER::COLLECTION)
    ("/MRP7" . SPARSER::COLLECTION) ("/MRP2" . SPARSER::COLLECTION)
    ("BCRP" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("beta-1 tubulin (Class I, M40) and alpha-tubulin (K-α1)"
     . SPARSER::COLLECTION)
    ("taxanes, paclitaxel and docetaxel" . SPARSER::COLLECTION)
    ("OV" . SPARSER::MOLECULE) ("MES" . SPARSER::MOLECULE)
    ("SRB" . SPARSER::PROTEIN-FAMILY) ("Cabazitaxel" . SPARSER::DRUG)
    ("prednisolone" . SPARSER::DRUG) ("prednisone" . SPARSER::DRUG)
    ("multiple paclitaxel- and docetaxel-selected variants in human breast"
     . SPARSER::COLLECTION)
    ("paclitaxel-" . SPARSER::DRUG)
    ("The taxanes paclitaxel (Taxol) and docetaxel (Taxotere)"
     . SPARSER::COLLECTION)
    ("Taxotere" . SPARSER::DRUG) ("Taxol" . SPARSER::DRUG)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("alkaloids and colchicine" . SPARSER::COLLECTION)
    ("cabazitaxel or docetaxel" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG) ("colchicine" . SPARSER::DRUG)
    ("alkaloids" . SPARSER::MOLECULE) ("-docetaxel" . SPARSER::DRUG)
    ("BODIPY" . SPARSER::DRUG)
    ("paclitaxel and docetaxel" . SPARSER::COLLECTION)
    ("cabazitaxel" . SPARSER::DRUG) ("TUBB4" . SPARSER::PROTEIN)
    ("GPX3" . SPARSER::PROTEIN) ("glutathione peroxidase 3" . SPARSER::PROTEIN)
    ("group F" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("BIRC7" . SPARSER::PROTEIN) ("BIRC4" . SPARSER::PROTEIN)
    ("BIRC3" . SPARSER::PROTEIN) ("cIAP-2" . SPARSER::PROTEIN)
    ("BIRC2" . SPARSER::PROTEIN) ("cIAP-1" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("ABCC10" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("alpha-tubulin" . SPARSER::PROTEIN)
    ("beta-1" . SPARSER::PROTEIN) ("Texas-Red" . SPARSER::DRUG)
    ("MRP7" . SPARSER::PROTEIN) ("MRP2" . SPARSER::PROTEIN)
    ("sulforhodamine B" . SPARSER::MOLECULE)
    ("transporter activity" . SPARSER::PROTEIN) ("XRP6258" . SPARSER::DRUG)
    ("TUBB3" . SPARSER::PROTEIN)
    ("a biologically relevant SZ candidate gene" . SPARSER::GENE)
    ("perinatal" . SPARSER::PROTEIN) ("mTOR-P70S6K" . SPARSER::COLLECTION)
    ("70-kDa ribosomal S6 protein kinase" . SPARSER::KINASE)
    ("p70S6K" . SPARSER::PROTEIN) ("Dpysl2" . SPARSER::PROTEIN)
    ("the SZ-associated risk allele" . SPARSER::ALLELE)
    ("these SZ-associated variants" . SPARSER::VARIANT)
    ("the superior temporal lobe" . SPARSER::PROTEIN)
    ("genotype and DPYSL2" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("actin or luciferase" . SPARSER::COLLECTION)
    ("polyribosome" . SPARSER::BIO-COMPLEX)
    ("the temporal lobe" . SPARSER::PROTEIN)
    ("the orthologous ZF genes" . SPARSER::GENE) ("hpf" . SPARSER::PROTEIN)
    ("orthologs" . SPARSER::PROTEIN) ("ZF" . SPARSER::PROTEIN)
    ("chimeric mRNA" . SPARSER::PROTEIN) ("Pr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Disease-associated variants" . SPARSER::VARIANT)
    ("a heterozygous allele" . SPARSER::ALLELE)
    ("multiple neuronal enhancers" . SPARSER::PROTEIN)
    ("amino acids (AA)" . SPARSER::AMINO-ACID)
    ("around DPYSL2" . SPARSER::PROTEIN) ("DAOA" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("SSL" . SPARSER::PROTEIN)
    ("dpysl2" . SPARSER::PROTEIN) ("paralogs" . SPARSER::PROTEIN)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN) ("M−R" . SPARSER::PROTEIN)
    ("ADRA1A" . SPARSER::PROTEIN) ("β- actin" . SPARSER::PROTEIN)
    ("B-F" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("G−L" . SPARSER::PROTEIN) ("G−R" . SPARSER::PROTEIN)
    ("I−P" . SPARSER::PROTEIN) ("E−H" . SPARSER::PROTEIN)
    ("B−F" . SPARSER::PROTEIN) ("A−C" . SPARSER::PROTEIN)
    ("A−F" . SPARSER::PROTEIN) ("B-A" . SPARSER::PROTEIN)
    ("PCR2" . SPARSER::PROTEIN) ("MAP2" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("CRMP2" . SPARSER::PROTEIN)
    ("response mediator protein" . SPARSER::PROTEIN)
    ("chr8" . SPARSER::PROTEIN) ("NRG3" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("DISC1" . SPARSER::PROTEIN)
    ("DTNBP1" . SPARSER::PROTEIN) ("DPYSL2" . SPARSER::PROTEIN)
    ("ErbB4 and their relevant growth factor heregulin" . SPARSER::COLLECTION)
    ("Phosphorylated EGFR, ErbB2, ErbB3, ErbB4 and their relevant growth factor heregulin"
     . SPARSER::COLLECTION)
    ("their relevant growth factor heregulin" . SPARSER::PROTEIN)
    ("ErbB2 or ErbB4" . SPARSER::COLLECTION)
    ("EGFR, ErbB2 or ErbB3" . SPARSER::COLLECTION)
    ("EGFR, ErbB2, and ErbB3" . SPARSER::COLLECTION)
    ("the full-length ErbB2 (185 kD) and ErbB3 (180 kD)" . SPARSER::COLLECTION)
    ("ErbB3 or pErbB3" . SPARSER::COLLECTION)
    ("heterogeneous ErbB2" . SPARSER::PROTEIN)
    ("heregulin/ErbB" . SPARSER::COLLECTION)
    ("heregulin and vascular endothelial" . SPARSER::COLLECTION)
    ("interleukin-1, prostaglandin E 2 , hepatocyte growth factor and keratinocyte growth factor"
     . SPARSER::COLLECTION)
    ("heregulin, EGFR, pEGFR, ErbB2, pErbB2, ErbB3, pErbB3, ErbB4 and pErbB4"
     . SPARSER::COLLECTION)
    ("lV" . SPARSER::MOLECULE)
    ("heregulin, pEGFR, pErbB2, ErbB3, pErbB3, ErbB4 and pErbB4"
     . SPARSER::COLLECTION)
    ("ErbB3 or ErbB4" . SPARSER::COLLECTION)
    ("EGFR, pEGFR, ErbB2 and pErbB3" . SPARSER::COLLECTION)
    ("heregulin, pEGFR, ErbB2, pErbB2, and ErbB3" . SPARSER::COLLECTION)
    ("receptors and heregulin" . SPARSER::COLLECTION)
    ("ErbB4 and pErbB4" . SPARSER::COLLECTION)
    ("ErbB3 and pErbB3" . SPARSER::COLLECTION)
    ("ErbB2 and pErbB2" . SPARSER::COLLECTION)
    ("EGFR and pEGFR" . SPARSER::COLLECTION)
    ("heregulin, EGFR, ErbB2, ErbB3, ErbB4, pEGFR, pErbB2, pErbB3 and pErbB4"
     . SPARSER::COLLECTION)
    ("Heregulin, ErbB1-4, and pErbB1-4" . SPARSER::COLLECTION)
    ("the ErbB2 (C-18) and ErbB3 (C-17) proteins (Figure  xref A)"
     . SPARSER::COLLECTION)
    ("approximately 180 kD" . SPARSER::PROTEIN) ("PY" . SPARSER::MOLECULE)
    ("EGFR, ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("family and heregulin" . SPARSER::COLLECTION)
    ("both an ErbB3 and an ErbB4 ligand [ xref ]" . SPARSER::COLLECTION)
    ("ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("The low molecular weight tyrosine kinase inhibitors and the monoclonal antibodies"
     . SPARSER::COLLECTION)
    ("the monoclonal antibodies" . SPARSER::ANTIBODY)
    ("ErbB3/HER3" . SPARSER::COLLECTION)
    ("ErbB1/HER1/EGFR" . SPARSER::COLLECTION) ("ErbB" . SPARSER::PROTEIN)
    ("heregulin-ErbB" . SPARSER::COLLECTION)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("exogenous heregulin" . SPARSER::PROTEIN)
    ("ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN)
    ("both an ErbB3 and an ErbB4 ligand" . SPARSER::COLLECTION)
    ("Heregulin" . SPARSER::PROTEIN)
    ("ErbB2, ErbB3, and ErbB4" . SPARSER::COLLECTION)
    ("ErbB4" . SPARSER::PROTEIN) ("ErbB2" . SPARSER::PROTEIN)
    ("/ErbB1" . SPARSER::COLLECTION)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("prostaglandin E 2" . SPARSER::MOLECULE) ("180 kD" . SPARSER::PROTEIN)
    ("ErbB3 " . SPARSER::PROTEIN) ("anti-ErbB2" . SPARSER::DRUG)
    ("Anti-ErbB2" . SPARSER::DRUG) ("HER4" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("Isoform" . SPARSER::ISOFORM) ("Akt1, Akt2 or Akt3" . SPARSER::COLLECTION)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("hepatocytes and MEFs" . SPARSER::COLLECTION) ("MCD" . SPARSER::PROTEIN)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("experiments further supports mTORC1" . SPARSER::PROTEIN)
    ("rapamycin and Torin-1" . SPARSER::COLLECTION)
    ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("both LY294002 and DEBC" . SPARSER::COLLECTION)
    ("fully functional ABCA1" . SPARSER::PROTEIN)
    ("extracellular acceptors" . SPARSER::MOLECULE)
    ("acceptors" . SPARSER::MOLECULE) ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("CE" . SPARSER::MOLECULE) ("ester (CE)" . SPARSER::MOLECULE)
    ("PKA, PKC, Cdc42, CK2 and JAK2" . SPARSER::COLLECTION)
    ("a major barrier" . SPARSER::PROTEIN)
    ("lipid poor pre-β HDL or its major protein apoA-I" . SPARSER::COLLECTION)
    ("namely lipid poor pre-β HDL" . SPARSER::PROTEIN)
    ("CHD" . SPARSER::PROTEIN) ("HDL" . SPARSER::PROTEIN)
    ("rapamycin or Torin-1" . SPARSER::COLLECTION)
    ("SREBP-2" . SPARSER::PROTEIN) ("SREBP-1c" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("casein kinase 2" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("Flotillin-2" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("Torin 1" . SPARSER::DRUG) ("HSP-70" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN) ("flotillin-2" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("Torin-1" . SPARSER::DRUG) ("mTORC1" . SPARSER::PROTEIN)
    ("apoA-I" . SPARSER::PROTEIN) ("apolipoprotein A-I" . SPARSER::PROTEIN)
    ("ABCA1" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("mTOR and MEK" . SPARSER::COLLECTION) ("yrs" . SPARSER::PROTEIN)
    ("pemetrexed and/or bevacizumab" . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("erlotinib, vandetanib, bexarotene and sorafenib" . SPARSER::COLLECTION)
    ("bexarotene" . SPARSER::DRUG) ("vandetanib" . SPARSER::DRUG)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG)
    ("purine or pyrimidine" . SPARSER::COLLECTION)
    ("pyrimidine" . SPARSER::DRUG) ("purine" . SPARSER::DRUG)
    ("EGFR and ALK" . SPARSER::COLLECTION) ("STK11" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("cyclin B1 and phospho-H3" . SPARSER::COLLECTION)
    ("most commonly studied using microtubule inhibitors or other anti-mitotic agents"
     . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("cyclin B1 and P-H3" . SPARSER::COLLECTION)
    ("exogenous cyclin B1-GFP" . SPARSER::COLLECTION)
    ("cyclin B1 and phospho-histone 3" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("cyclin B1-GFP" . SPARSER::COLLECTION)
    ("GFP- or cyclin B1-R42A-GFP-tranfected" . SPARSER::COLLECTION)
    ("GFP-" . SPARSER::PROTEIN) ("GFP and cyclin B1" . SPARSER::COLLECTION)
    ("tubulin" . SPARSER::PROTEIN) ("vinblastine" . SPARSER::DRUG)
    ("lamins and linker" . SPARSER::COLLECTION) ("lamins" . SPARSER::PROTEIN)
    ("Cdk1/cyclin B1" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdc20" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("P81" . SPARSER::PROTEIN)
    ("g protein" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("P-H3" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("anti-mitotic" . SPARSER::MOLECULE)
    ("Rac1, PLCγ2, NOX1 and integrin" . SPARSER::COLLECTION)
    ("Lyn, Syk, and PI3K" . SPARSER::COLLECTION)
    ("Lyn and PI3K" . SPARSER::COLLECTION)
    ("the redox-and GPVI-associated signaling molecule" . SPARSER::MOLECULE)
    ("the generic PLC inhibitor" . SPARSER::INHIBITOR)
    ("PI3-K, Btk, Rac1 and PLCγ2" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("VWF" . SPARSER::PROTEIN)
    ("the crucial PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases, Pyk2 and FAK" . SPARSER::COLLECTION)
    ("an active NOX complex" . SPARSER::BIO-COMPLEX)
    ("Rac1 and Hic-5" . SPARSER::COLLECTION)
    ("the generic inhibitor" . SPARSER::INHIBITOR)
    ("BAPTA" . SPARSER::MOLECULE) ("Wortmannin" . SPARSER::PROTEIN)
    ("LAT" . SPARSER::PROTEIN) ("ROS and FAK" . SPARSER::COLLECTION)
    ("arginine-glycine-aspartic acid" . SPARSER::COLLECTION)
    ("surface PS (Annexin V binding) and P-selectin (CD62P)"
     . SPARSER::COLLECTION)
    ("Fibrinogen" . SPARSER::PROTEIN) ("Slack" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("fibrinogen" . SPARSER::PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("PF-228, and Pyk2" . SPARSER::COLLECTION)
    ("a proximal signaling molecule" . SPARSER::MOLECULE)
    ("PS" . SPARSER::PROTEIN)
    ("other important downstream signaling molecules such as phosphoinositide 3-kinase (PI3-K) and phospholipase C (PLC)-γ isoforms xref"
     . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("Rac and Rho" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target (FAT)" . SPARSER::TARGET-PROTEIN)
    ("proteins, Paxillin, and Hic-5" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN)
    ("FAK (125 kDa) and Pyk2 (110 kDa)" . SPARSER::COLLECTION)
    ("the FAK family, FAK (125 kDa) and Pyk2 (110 kDa)" . SPARSER::COLLECTION)
    ("FAK and Pyk2" . SPARSER::COLLECTION) ("kinase (FAK)" . SPARSER::KINASE)
    ("tyrosine kinase (PTK)" . SPARSER::PROTEIN)
    ("a GPVI-associated complex" . SPARSER::BIO-COMPLEX)
    ("subunit, p47 phox , Hic5, and proline" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("Glycoprotein" . SPARSER::PROTEIN)
    ("PI3-K and Bruton" . SPARSER::COLLECTION)
    ("PKC, Hic-5, NOX1 and α IIb β 3" . SPARSER::COLLECTION)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("FAK or Pyk2" . SPARSER::COLLECTION)
    ("PF-228 and Tyrphostin" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pyk2 and FAK" . SPARSER::COLLECTION) ("Aims" . SPARSER::PROTEIN)
    ("NOX" . SPARSER::PROTEIN) ("TRAF4/p47 phox" . SPARSER::COLLECTION)
    ("GPVI" . SPARSER::PROTEIN) ("Hic" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thromboxane A2" . SPARSER::MOLECULE) ("αIIbβ3" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3,4,5-triphosphate" . SPARSER::PIP3)
    ("SLP-76" . SPARSER::PROTEIN)
    ("Linker for Activation of T-cells" . SPARSER::PROTEIN)
    ("FcRγ" . SPARSER::PROTEIN) ("NOX2" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("H 2 DCFDA" . SPARSER::DRUG)
    ("p-selectin" . SPARSER::PROTEIN) ("PGE 1" . SPARSER::DRUG)
    ("PF-573228" . SPARSER::DRUG) ("light chain" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("p130cas" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("NOX1" . SPARSER::PROTEIN)
    ("Hic-5" . SPARSER::PROTEIN) ("PLCγ2" . SPARSER::PROTEIN)
    ("α IIb β 3" . SPARSER::PROTEIN) ("CD62P" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("PF-228" . SPARSER::DRUG)
    ("collagen receptor" . SPARSER::PROTEIN) ("p47 phox" . SPARSER::PROTEIN)
    ("TRAF4" . SPARSER::PROTEIN)
    ("de novo high-resolution p53 genome-wide binding maps" . SPARSER::PROTEIN)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("transformed state" . SPARSER::BIO-STATE) ("mismatch" . SPARSER::PROTEIN)
    ("bad" . SPARSER::PROTEIN) ("LTRs" . SPARSER::PROTEIN)
    ("Significantly higher fraction" . SPARSER::COMPONENT)
    ("ALU" . SPARSER::PROTEIN) ("TES" . SPARSER::PROTEIN)
    ("PDGFC and PLK2" . SPARSER::COLLECTION)
    ("BBC3/PUMA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("PDGFC" . SPARSER::PROTEIN) ("hg" . SPARSER::MOLECULE)
    ("CDKN1A and MDM2" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERV1" . SPARSER::PROTEIN)
    ("PET1" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("PLK2" . SPARSER::PROTEIN) ("GA 2" . SPARSER::PROTEIN)
    ("5 FU" . SPARSER::DRUG) ("NEAT1 and AR" . SPARSER::COLLECTION)
    ("the inter-chromosomal space ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cues and ligand" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("AR inhibitors and the lack of AR or ERβ" . SPARSER::COLLECTION)
    ("AR or ERβ" . SPARSER::COLLECTION)
    ("a favourable GS" . SPARSER::PROTEIN-FAMILY)
    ("MET and GS" . SPARSER::COLLECTION) ("BCR and MET" . SPARSER::COLLECTION)
    ("RNA-fluorescent" . SPARSER::RNA)
    ("enzalutamide and bicalutamide" . SPARSER::COLLECTION)
    ("ICI and 4OHT" . SPARSER::COLLECTION) ("ICI" . SPARSER::DRUG)
    ("the ERα antagonists ICI 182,780 (ICI) and 4-hydroxy tamoxifen (4OHT)"
     . SPARSER::COLLECTION)
    ("ICI 182,780 (ICI)" . SPARSER::DRUG)
    ("anti-oestrogens and anti-androgens" . SPARSER::COLLECTION)
    ("NEAT1 and ERα" . SPARSER::COLLECTION)
    ("NEAT1 and non-targeting" . SPARSER::COLLECTION)
    ("streptavidin–biotin" . SPARSER::PROTEIN-PAIR) ("anti" . SPARSER::PROTEIN)
    ("antisense-NEAT1" . SPARSER::COLLECTION)
    ("Streptavidin" . SPARSER::PROTEIN)
    ("NEAT1, or antisense" . SPARSER::COLLECTION) ("NR" . SPARSER::PROTEIN)
    ("nucleosomal histones" . SPARSER::PROTEIN)
    ("H3K4Me3 and H3AcK9" . SPARSER::COLLECTION)
    ("PSMA-luc" . SPARSER::PROTEIN-PAIR)
    ("NEAT1 and chromatin" . SPARSER::COLLECTION)
    ("prostate-specific membrane antigen ( PSMA ) and alpha-methylacyl-CoA racemase ( AMACR)"
     . SPARSER::COLLECTION)
    ("AMACR" . SPARSER::PROTEIN) ("PSMA" . SPARSER::PROTEIN)
    ("NEAT1 and the associated genes" . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE)
    ("NEAT1-ERα" . SPARSER::COLLECTION) ("NEAT1" . SPARSER::PROTEIN)
    ("ERα-NEAT1" . SPARSER::COLLECTION) ("ERα and NEAT1" . SPARSER::COLLECTION)
    ("ERα and AR" . SPARSER::COLLECTION) ("E2 or R1881" . SPARSER::COLLECTION)
    ("bivalent H3K4Me3" . SPARSER::PROTEIN) ("Acetyl" . SPARSER::MOLECULE)
    ("radical" . SPARSER::MOLECULE) ("The shorter isoform" . SPARSER::ISOFORM)
    ("the putatively ERα-regulated intergenic lncRNAs" . SPARSER::RNA)
    ("140 intergenic lncRNAs" . SPARSER::RNA)
    ("1,314 and 1,399 intergenic lncRNAs" . SPARSER::RNA)
    ("PCa and NEPC" . SPARSER::COLLECTION)
    ("6,850 intergenic lncRNAs" . SPARSER::RNA)
    ("ERα and NCI-H660" . SPARSER::COLLECTION) ("LnCaP" . SPARSER::PROTEIN)
    ("GS" . SPARSER::PROTEIN-FAMILY) ("PCa" . SPARSER::PROTEIN)
    ("androgen/AR" . SPARSER::COLLECTION) ("TMPRSS2-ERG" . SPARSER::COLLECTION)
    ("ERG" . SPARSER::PROTEIN)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("abiraterone" . SPARSER::DRUG) ("Androgen" . SPARSER::PROTEIN)
    ("transducers" . SPARSER::PROTEIN) ("androgen or AR" . SPARSER::COLLECTION)
    ("putatively ERα-regulated intergenic long non-coding RNAs" . SPARSER::RNA)
    ("lncRNA" . SPARSER::RNA) ("lncRNAs" . SPARSER::RNA)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("a 15 " . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("EBAG9" . SPARSER::PROTEIN) ("4OHT" . SPARSER::DRUG)
    ("ICI 182,780" . SPARSER::DRUG) ("anti-oestrogens" . SPARSER::DRUG)
    ("small nuclear RNA" . SPARSER::RNA) ("SNRNP70" . SPARSER::PROTEIN)
    ("GJB1" . SPARSER::PROTEIN)
    ("alpha-methylacyl-CoA racemase" . SPARSER::PROTEIN)
    ("prostate-specific membrane antigen" . SPARSER::PROTEIN)
    ("top 1" . SPARSER::PROTEIN) ("H3K4Me3" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("arsenate" . SPARSER::MOLECULE) ("CD95/Fas" . SPARSER::COLLECTION)
    ("primary MDS" . SPARSER::PROTEIN)
    ("Bcl-XL, Bcl-2, XIAP, and FLIP" . SPARSER::COLLECTION)
    ("RA/RARS" . SPARSER::COLLECTION) ("RARS" . SPARSER::PROTEIN)
    ("NF-κB dependent apoptotic cytokines" . SPARSER::PROTEIN)
    ("TNFα and FasL" . SPARSER::COLLECTION)
    ("NF-κB, and hTERT" . SPARSER::COLLECTION)
    ("Sp-1 and Myc" . SPARSER::COLLECTION)
    ("NF-κB, SP-1, and AP-1" . SPARSER::COLLECTION)
    ("proteins, FLIP, BCL2 and BCL-XL" . SPARSER::COLLECTION)
    ("PI and annexin V" . SPARSER::COLLECTION)
    ("caspase-3, caspase-8, and PARP" . SPARSER::COLLECTION)
    ("an effective therapeutic reagent" . SPARSER::MOLECULE)
    ("caspase-8, NF-κB and hTERT" . SPARSER::COLLECTION)
    ("SP-1 and AP-1" . SPARSER::COLLECTION)
    ("an antioxidant and an inhibitor of NF-κB" . SPARSER::COLLECTION)
    ("mRNA and Protein" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL, XIAP, and FLIP" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL, FLIP and XIAP" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL and FLIP" . SPARSER::COLLECTION)
    ("FLIP" . SPARSER::PROTEIN)
    ("PARP (116 kDa) and the cleavage fragment" . SPARSER::COLLECTION)
    ("the 20 kDa and 42 kDa active forms" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-8" . SPARSER::COLLECTION)
    ("Caspases" . SPARSER::PROTEIN)
    ("Caspase-3 and Caspase-8" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE) ("Sp1, and estrogen" . SPARSER::COLLECTION)
    ("Myc/Mad" . SPARSER::COLLECTION) ("Mad" . SPARSER::PROTEIN)
    ("a therapeutic reagent" . SPARSER::MOLECULE)
    ("traditional Chinese medicine" . SPARSER::DRUG) ("APL" . SPARSER::PROTEIN)
    ("PDTC" . SPARSER::DRUG) ("pyrrolidine" . SPARSER::DRUG)
    ("MDS" . SPARSER::PROTEIN) ("ML1" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("Sp-1" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("SP-1" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN) ("NB4" . SPARSER::PROTEIN)
    ("Arsenic trioxide" . SPARSER::MOLECULE)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("As 2 O 3" . SPARSER::DRUG)
    ("arsenic trioxide" . SPARSER::MOLECULE) ("SKM-1" . SPARSER::PROTEIN)
    ("a novel prognostic and therapeutic biomarker" . SPARSER::MOLECULE)
    ("a therapeutic biomarker" . SPARSER::MOLECULE)
    ("doxorubicin or docetaxel" . SPARSER::COLLECTION)
    ("p21, p27, DDB2 and p53" . SPARSER::COLLECTION)
    ("CUL4A and EGFR" . SPARSER::COLLECTION) ("EGFR-AKT" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("EGFR and CUL4A" . SPARSER::COLLECTION)
    ("Western blot and IF" . SPARSER::COLLECTION)
    ("blot and IF" . SPARSER::COLLECTION)
    ("docetaxel and doxorubicin" . SPARSER::COLLECTION)
    ("H1299-CUL4A and H1650-CUL4A" . SPARSER::COLLECTION)
    ("undetectable or low CUL4A" . SPARSER::PROTEIN)
    ("DDB1 and the FBXW5 substrate receptor" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("the multifunctional ubiquitin ligase E3 complex" . SPARSER::BIO-COMPLEX)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("a promising therapy target and a potential biomarker"
     . SPARSER::COLLECTION)
    ("SOX4" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("DDB2" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("FBXW5" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("DLC1" . SPARSER::PROTEIN) ("Cul4A" . SPARSER::PROTEIN)
    ("cullin family" . SPARSER::PROTEIN-FAMILY) ("CUL4A" . SPARSER::PROTEIN)
    ("RHO and ROCK" . SPARSER::COLLECTION)
    ("APC or CTNNB1" . SPARSER::COLLECTION)
    ("c-MYC and Cyclin D1" . SPARSER::COLLECTION)
    ("SW480/ADH" . SPARSER::COLLECTION) ("ADH" . SPARSER::PROTEIN)
    ("E-cadherin or TCF4" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION)
    ("APC or other genes" . SPARSER::COLLECTION) ("NOD" . SPARSER::PROTEIN)
    ("Wnt5a" . SPARSER::PROTEIN) ("Wnt/PCP" . SPARSER::COLLECTION)
    ("lysozyme" . SPARSER::PROTEIN) ("SOX2 and IL6" . SPARSER::COLLECTION)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("c-MYC as well as other Wnt target genes" . SPARSER::COLLECTION)
    ("cyclin D1, Claudin 1 and LEF1" . SPARSER::COLLECTION)
    ("the enterocytic differentiation markers sucrose-isomaltase (SI,) alkaline phosphatase (AP) and dipeptidyl peptidase 4 (DPP4; xref )"
     . SPARSER::COLLECTION)
    ("the enterocytic differentiation markers sucrose-isomaltase (SI,) alkaline phosphatase (AP)"
     . SPARSER::PROTEIN-FAMILY)
    ("alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("isomaltase" . SPARSER::PROTEIN) ("ROCK and DIAPH1" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("RHOA (T19N) or RHOA-specific shRNAs ( xref )" . SPARSER::COLLECTION)
    ("RHOA and growth/differentiation" . SPARSER::COLLECTION)
    ("controlVil-Cre" . SPARSER::COLLECTION)
    ("theVil-Cre" . SPARSER::COLLECTION) ("AOM" . SPARSER::PROTEIN)
    ("the intestine-specific Villin 1 promoter" . SPARSER::PROMOTER)
    ("Vil-Cre" . SPARSER::COLLECTION)
    ("Lysophosphatidic acid (LPA)" . SPARSER::LPA) ("LPA" . SPARSER::LPA)
    ("Apc" . SPARSER::PROTEIN) ("c-MYC or Cyclin D1" . SPARSER::COLLECTION)
    ("RHOA, RAC1 and CDC42" . SPARSER::COLLECTION) ("GDIs" . SPARSER::PROTEIN)
    ("GEFs" . SPARSER::PROTEIN)
    ("effector or target molecules" . SPARSER::COLLECTION)
    ("a GTP-bound active form and an inactive GDP-bound form"
     . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RHOA" . SPARSER::PROTEIN)
    ("claudin1" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("p-Nitrophenyl" . SPARSER::MOLECULE)
    ("dipeptidyl-peptidase" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("LEF-1" . SPARSER::PROTEIN)
    ("wnt5a" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("IWR-1" . SPARSER::PROTEIN)
    ("G-protein coupled receptor activity" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("Claudin 1" . SPARSER::PROTEIN)
    ("DPP4" . SPARSER::PROTEIN) ("dipeptidyl peptidase 4" . SPARSER::PROTEIN)
    ("PKN1" . SPARSER::PROTEIN) ("DIAPH1" . SPARSER::PROTEIN)
    ("RHO family" . SPARSER::PROTEIN) ("Villin 1" . SPARSER::PROTEIN)
    ("Lysophosphatidic acid" . SPARSER::LPA) ("RAC1" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("IgG, IgE or IgY" . SPARSER::COLLECTION)
    ("Dok-3 and CD22" . SPARSER::COLLECTION)
    ("functional Btk" . SPARSER::PROTEIN) ("Tec" . SPARSER::PROTEIN)
    ("ITTs" . SPARSER::MOLECULE) ("DAP10 and CD28" . SPARSER::COLLECTION)
    ("Dlg-1" . SPARSER::PROTEIN) ("Dlg" . SPARSER::PROTEIN)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ITT-less" . SPARSER::MOLECULE)
    ("the intact ITT" . SPARSER::MOLECULE) ("Grb2/GRAP" . SPARSER::COLLECTION)
    ("Grb2 and Btk" . SPARSER::COLLECTION) ("Cit-neg" . SPARSER::PROTEIN-PAIR)
    ("Cit-pos" . SPARSER::PROTEIN-PAIR) ("Cit" . SPARSER::PROTEIN)
    ("mIgG2a" . SPARSER::PROTEIN) ("Src- or Syk-family" . SPARSER::COLLECTION)
    ("Src-" . SPARSER::PROTEIN)
    ("the c-Cbl (2nd panel from the top) and Cbl-b (not shown) ubiquitin ligases"
     . SPARSER::COLLECTION)
    ("Grb2 and GRAP" . SPARSER::COLLECTION)
    ("mIgG2a-BCRs" . SPARSER::PROTEIN-PAIR)
    ("adaptor protein (GRAP)" . SPARSER::PROTEIN) ("GRAP" . SPARSER::PROTEIN)
    ("mIgM" . SPARSER::PROTEIN) ("such chimeric BCRs" . SPARSER::PROTEIN)
    ("-cre" . SPARSER::COLLECTION) ("Rag1" . SPARSER::PROTEIN)
    ("VLPs" . SPARSER::PROTEIN) ("Rag" . SPARSER::PROTEIN)
    ("cre" . SPARSER::PROTEIN)
    ("memory-type BCRs and the adaptor protein Grb2" . SPARSER::COLLECTION)
    ("a functional duo" . SPARSER::PROTEIN) ("duo" . SPARSER::PROTEIN)
    ("essential component" . SPARSER::COMPONENT)
    ("the universal adaptor protein Grb2" . SPARSER::PROTEIN)
    ("mIgM-BCRs" . SPARSER::COLLECTION) ("BCRs" . SPARSER::PROTEIN)
    ("a functional ITT" . SPARSER::MOLECULE)
    ("mIgG-BCRs" . SPARSER::COLLECTION)
    ("EGFP and/or RFP ( xref )" . SPARSER::COLLECTION)
    ("a red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("γ2am" . SPARSER::PROTEIN) ("RFP" . SPARSER::PROTEIN)
    ("YF" . SPARSER::MOLECULE)
    ("the ubiquitous adaptor protein Grb2" . SPARSER::PROTEIN)
    ("an essential ITT effector" . SPARSER::EFFECTOR)
    ("BCR and Syk" . SPARSER::COLLECTION)
    ("Syk ( xref upper panel, lanes 3 and 4) and SLP65 ( xref )"
     . SPARSER::COLLECTION)
    ("Src-family kinases (SFKs) or Syk" . SPARSER::COLLECTION)
    ("PP1 or PP2" . SPARSER::COLLECTION) ("Citrine" . SPARSER::PROTEIN)
    ("a fluorescent protein" . SPARSER::PROTEIN) ("YA" . SPARSER::MOLECULE)
    ("primordial mIgY molecules" . SPARSER::MOLECULE)
    ("coreceptor" . SPARSER::PROTEIN)
    ("The ubiquitous adaptor protein Grb2" . SPARSER::PROTEIN)
    ("mIgG and mIgE" . SPARSER::COLLECTION)
    ("the 10 membrane-proximal amino acids of mammalian mIgG"
     . SPARSER::PROTEIN)
    ("the 10 membrane-proximal amino acids" . SPARSER::AMINO-ACID)
    ("letter" . SPARSER::MOLECULE)
    ("diacylglycerol and inositol-1,4" . SPARSER::COLLECTION)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("tyrosine kinase (Btk) and phospholipase C-γ2 (PLC-γ2)"
     . SPARSER::COLLECTION)
    ("a multimolecular protein complex" . SPARSER::BIO-COMPLEX)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLP65 (BLNK)" . SPARSER::PROTEIN)
    ("BLNK" . SPARSER::PROTEIN) ("Igα and Igβ" . SPARSER::COLLECTION)
    ("Syk/ZAP70" . SPARSER::COLLECTION)
    ("either membrane-bound IgM (mIgM) or class-switched mIg isotypes"
     . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("IgM" . SPARSER::PROTEIN)
    ("distinct kinases and adaptor proteins" . SPARSER::COLLECTION)
    ("Btk" . SPARSER::PROTEIN) ("mIgG-BCR" . SPARSER::COLLECTION)
    ("signalosome" . SPARSER::PROTEIN) ("BCR" . SPARSER::PROTEIN)
    ("mIgG" . SPARSER::PROTEIN) ("Syk" . SPARSER::PROTEIN)
    ("mIgGs" . SPARSER::PROTEIN) ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ITT" . SPARSER::MOLECULE) ("CO 3" . SPARSER::PROTEIN)
    ("wt/wt" . SPARSER::PROTEIN) ("NK1.1" . SPARSER::PROTEIN)
    ("6B" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("grb2" . SPARSER::PROTEIN)
    ("Tyrosine kinase" . SPARSER::PROTEIN) ("Indo-1" . SPARSER::MOLECULE)
    ("Bach2" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("DAP10" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cbl-b" . SPARSER::PROTEIN) ("C γ 1" . SPARSER::PROTEIN)
    ("Cγ1" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("BAY61-3606" . SPARSER::DRUG) ("PLC-γ" . SPARSER::PROTEIN-FAMILY)
    ("CD22" . SPARSER::PROTEIN) ("Dok-3" . SPARSER::PROTEIN)
    ("SAP97" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("IP3" . SPARSER::IP3) ("PLC-γ2" . SPARSER::PROTEIN)
    ("SLP65" . SPARSER::PROTEIN) ("ZAP70" . SPARSER::PROTEIN)
    ("Igβ" . SPARSER::PROTEIN) ("CD79a" . SPARSER::PROTEIN)
    ("Igα" . SPARSER::PROTEIN) ("Spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("AMPK and αC-helix" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("four interconnected moveable parts" . SPARSER::COMPONENT)
    ("lobes" . SPARSER::PROTEIN)
    ("cellular cofactor(s) or other (e.g., β1-subunit containing) AMPK isoforms"
     . SPARSER::COLLECTION)
    ("cellular cofactor" . SPARSER::MOLECULE) ("the larger ATP" . SPARSER::ATP)
    ("αRIM-2/CBS-3" . SPARSER::COLLECTION) ("CBS-3" . SPARSER::PROTEIN)
    ("αRIM-CBS-3" . SPARSER::PROTEIN-PAIR)
    ("CBS-1 and CBS-3" . SPARSER::COLLECTION)
    ("CBS-2/αRIM-1" . SPARSER::COLLECTION) ("αRIM-1" . SPARSER::COLLECTION)
    ("-β2" . SPARSER::COLLECTION) ("AID and KD" . SPARSER::COLLECTION)
    ("the KD and the AID" . SPARSER::COLLECTION)
    ("AID-KD" . SPARSER::COLLECTION) ("lobe" . SPARSER::PROTEIN)
    ("KD and AID" . SPARSER::COLLECTION) ("-ATP" . SPARSER::ATP)
    ("glycogen and CD" . SPARSER::COLLECTION) ("CBD" . SPARSER::DRUG)
    ("glycogen and cyclodextrin" . SPARSER::COLLECTION)
    ("prep" . SPARSER::PROTEIN) ("Carbohydrate" . SPARSER::MOLECULE)
    ("ATP-competitive" . SPARSER::ATP)
    ("whose phosphate group" . SPARSER::MOLECULE)
    ("stabilizers" . SPARSER::MOLECULE)
    ("AMP or glycogen" . SPARSER::COLLECTION)
    ("active AMP- and cyclodextrin-bound AMPK" . SPARSER::COLLECTION)
    ("AMP-" . SPARSER::AMP) ("CBS1 and CBS3" . SPARSER::COLLECTION)
    ("acceptor" . SPARSER::MOLECULE)
    ("nucleotides and carbohydrates" . SPARSER::COLLECTION)
    ("AMP and ATP" . SPARSER::COLLECTION) ("αRIM" . SPARSER::PROTEIN)
    ("the inactive human AMPK KD-AID complex" . SPARSER::BIO-COMPLEX)
    ("CBM" . SPARSER::PROTEIN) ("CBM-KD" . SPARSER::PROTEIN-PAIR)
    ("glycogen and the glycogen-mimic cyclodextrin" . SPARSER::COLLECTION)
    ("glycogen and the non-physiological glycogen-mimic cyclodextrin"
     . SPARSER::COLLECTION)
    ("AID-αRIM" . SPARSER::COLLECTION) ("KD-AID" . SPARSER::COLLECTION)
    ("hook" . SPARSER::PROTEIN-FAMILY)
    ("an almost full length mammalian AMPK complex" . SPARSER::BIO-COMPLEX)
    ("CBS-1, CBS-3, and CBS-4" . SPARSER::COLLECTION)
    ("AMP, ADP, or ATP" . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN) ("cystathionine" . SPARSER::MOLECULE)
    ("axin" . SPARSER::PROTEIN) ("CaMKK" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("RIM" . SPARSER::PROTEIN)
    ("heterotrimeric serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("alternate AID (AMP)" . SPARSER::PROTEIN)
    ("AMP and glycogen" . SPARSER::COLLECTION) ("AID" . SPARSER::PROTEIN)
    ("holo-AMPK" . SPARSER::COLLECTION) ("AMPK-α1" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("PP2Cα" . SPARSER::PROTEIN)
    ("HK 2" . SPARSER::PROTEIN) ("β- mercaptoethanol" . SPARSER::MOLECULE)
    ("iminodiacetic acid" . SPARSER::MOLECULE)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("2-4" . SPARSER::PROTEIN)
    ("α1β1" . SPARSER::PROTEIN) ("RIM1" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("AMPK α1" . SPARSER::PROTEIN)
    ("Alpha-" . SPARSER::PROTEIN) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("32P" . SPARSER::|32P|) ("K33" . SPARSER::PROTEIN)
    ("B-factor" . SPARSER::PROTEIN) ("CBS1" . SPARSER::PROTEIN)
    ("A769662" . SPARSER::DRUG) ("CBS-2" . SPARSER::PROTEIN)
    ("CBS-1" . SPARSER::PROTEIN) ("p53 or p16" . SPARSER::COLLECTION)
    ("monomeric and dimeric forms" . SPARSER::FORM)
    ("IKK γ or MCL-1" . SPARSER::COLLECTION)
    ("HSP70, HSPB8, p62 or 14-3-3" . SPARSER::COLLECTION)
    ("Huntingtin" . SPARSER::PROTEIN) ("crystallin" . SPARSER::PROTEIN)
    ("toxic protein" . SPARSER::PROTEIN)
    ("IGFBP5 or SOC3" . SPARSER::COLLECTION) ("IL-6-" . SPARSER::PROTEIN)
    ("SKP2/p27" . SPARSER::COLLECTION) ("STAT3–SKP2–p27" . SPARSER::COLLECTION)
    ("Myc-14-3-3" . SPARSER::COLLECTION)
    ("insoluble fraction" . SPARSER::COMPONENT)
    ("soluble fraction" . SPARSER::COMPONENT)
    ("soluble and insoluble parts" . SPARSER::COMPONENT)
    ("BIS and 14-3-3" . SPARSER::COLLECTION)
    ("STAT3, SKP2 and p27" . SPARSER::COLLECTION)
    ("BIS and STAT3" . SPARSER::COLLECTION)
    ("JAK or mTOR" . SPARSER::COLLECTION)
    ("STAT3, JAK2 and mTOR" . SPARSER::COLLECTION)
    ("JAK and mTOR" . SPARSER::COLLECTION)
    ("two dominant-negative mutants" . SPARSER::MUTANT)
    ("Y705F-STAT3 and S727A-STAT3" . SPARSER::COLLECTION)
    ("dominant-negative STAT3" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("BIS and p27" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("STAT3 and SKP2" . SPARSER::COLLECTION)
    ("p27 or p53" . SPARSER::COLLECTION) ("p53 and p21" . SPARSER::COLLECTION)
    ("p-pRB" . SPARSER::COLLECTION)
    ("p53, p21, p27 and pRB" . SPARSER::COLLECTION)
    ("gradually increased senescence-associated β -galactosidase"
     . SPARSER::PROTEIN)
    ("intact p27" . SPARSER::PROTEIN) ("p53–p21" . SPARSER::COLLECTION)
    ("/STAT3/SKP2" . SPARSER::COLLECTION) ("MCL" . SPARSER::PROTEIN)
    ("IL-6 or JAK2" . SPARSER::COLLECTION) ("salinomycin" . SPARSER::DRUG)
    ("SKP2–p27" . SPARSER::COLLECTION) ("p53 and p16" . SPARSER::COLLECTION)
    ("SKP2 and p27" . SPARSER::COLLECTION) ("Clu" . SPARSER::PROTEIN)
    ("p21 or pRB" . SPARSER::COLLECTION)
    ("STAT3/SKP2/p27" . SPARSER::COLLECTION)
    ("STAT3 and p27" . SPARSER::COLLECTION) ("Bis" . SPARSER::PROTEIN)
    ("insoluble STAT3" . SPARSER::PROTEIN)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("S-phase kinase-associated protein" . SPARSER::PROTEIN)
    ("p53, p21 or p16" . SPARSER::COLLECTION)
    ("suppressor (BIS)" . SPARSER::SUPPRESSOR) ("BIS" . SPARSER::PROTEIN)
    ("IKK γ" . SPARSER::PROTEIN) ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("HspB8" . SPARSER::PROTEIN) ("p62" . SPARSER::PROTEIN)
    ("HSPB8" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("IGFBP5" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("PPA2" . SPARSER::PROTEIN) ("β -Gal" . SPARSER::PROTEIN)
    ("BAG3" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("AP-1 or C/EBP" . SPARSER::COLLECTION)
    ("NF κ B and AP-1" . SPARSER::COLLECTION)
    ("NF κ B, AP-1 and C/EBP" . SPARSER::COLLECTION)
    ("IL-6 and IL-6R" . SPARSER::COLLECTION)
    ("TNF α , IGFBP-7 and VEGF" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("a complex mixture of extracellular proteins and soluble factors"
     . SPARSER::COLLECTION)
    ("kinases (JNK)" . SPARSER::PROTEIN)
    ("p53 and p27 Kip1" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN) ("PTEN/p27KIP1" . SPARSER::COLLECTION)
    ("p19ARF/p53/p21CIP1/WAF1" . SPARSER::COLLECTION)
    ("p16INK4a/pRB" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("This polymorphic variant" . SPARSER::VARIANT)
    ("its 374I polymorphic variant" . SPARSER::VARIANT)
    ("INK4a/ARF" . SPARSER::COLLECTION)
    ("myelin-basic protein (MBP) or myristoylated alanine-rich C-kinase substrate (MARCKS)"
     . SPARSER::COLLECTION)
    ("exogenous substrates" . SPARSER::SUBSTRATE)
    ("substrate (MARCKS)" . SPARSER::SUBSTRATE)
    ("this polymorphic variant" . SPARSER::VARIANT)
    ("MARCKS" . SPARSER::PROTEIN) ("myristoylated" . SPARSER::PROTEIN)
    ("The PKC η polymorphic variant" . SPARSER::VARIANT)
    ("IL-6 and its receptor" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) and insulin-like growth factor-binding protein (IGFBP-7)"
     . SPARSER::COLLECTION)
    ("cytokines, growth factors and proteases-collectively"
     . SPARSER::COLLECTION)
    ("etoposide ( xref ) or H 2 O 2 ( xref )" . SPARSER::COLLECTION)
    ("-H2A histone family" . SPARSER::COLLECTION) ("Etoposide" . SPARSER::DRUG)
    ("senescence-associated β -galactosidase" . SPARSER::PROTEIN)
    ("H 2 O 2 or etoposide" . SPARSER::COLLECTION)
    ("both interleukin-6 (IL-6) and its receptor" . SPARSER::COLLECTION)
    ("gene ( PRKCH )" . SPARSER::GENE) ("valine" . SPARSER::AMINO-ACID)
    ("PRKCH" . SPARSER::PROTEIN) ("p16 INK4a or p53" . SPARSER::COLLECTION)
    ("p53, p16 INK4a or ARF" . SPARSER::COLLECTION)
    ("the human polymorphic variant" . SPARSER::VARIANT)
    ("IL-6 and IL-6 receptor" . SPARSER::COLLECTION)
    ("p21 Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-tumorigenic mediators" . SPARSER::PROTEIN)
    ("β -Actin" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("K 3" . SPARSER::PROTEIN) ("Kinase activity" . SPARSER::PROTEIN)
    ("ATP 4" . SPARSER::PROTEIN) ("PS 25 " . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE) ("HA 5" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("CXCR1" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("p27KIP1" . SPARSER::PROTEIN) ("p21CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p19ARF" . SPARSER::PROTEIN) ("p16INK4a" . SPARSER::PROTEIN)
    ("INK4a" . SPARSER::PROTEIN) ("sh-RNA" . SPARSER::RNA)
    ("C-kinase" . SPARSER::PROTEIN) ("myelin-basic protein" . SPARSER::PROTEIN)
    ("Cos-7" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("IGFBP-7" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("γ -H2AX" . SPARSER::PROTEIN)
    ("member X" . SPARSER::PROTEIN) ("H2A histone family" . SPARSER::PROTEIN)
    ("DcR2" . SPARSER::PROTEIN) ("PKC ι" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("PKC α" . SPARSER::PROTEIN)
    ("PKC δ" . SPARSER::PROTEIN) ("β -gal" . SPARSER::PROTEIN)
    ("β -galactosidase" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("this more easily targetable protein" . SPARSER::PROTEIN)
    ("fluoropyrimidine" . SPARSER::DRUG) ("Shmt1" . SPARSER::PROTEIN)
    ("the nonessential amino acids serine and glycine" . SPARSER::COLLECTION)
    ("serine and glycine" . SPARSER::COLLECTION)
    ("thymidylate" . SPARSER::MOLECULE) ("SAM" . SPARSER::MOLECULE)
    ("purines" . SPARSER::DRUG) ("TS" . SPARSER::PROTEIN)
    ("glycine or serine" . SPARSER::COLLECTION)
    ("both PI (after 72 h) and AnnexinV (after 48 h)" . SPARSER::COLLECTION)
    ("pifithrin-" . SPARSER::DRUG) ("pifithrin" . SPARSER::DRUG)
    ("p53 and scr" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("AAD" . SPARSER::MOLECULE) ("SHMT2 and SHMT2 α" . SPARSER::COLLECTION)
    ("mitochondrial SHMT2" . SPARSER::PROTEIN)
    ("the iSHMT2 completely knockdowns both isoforms" . SPARSER::ISOFORM)
    ("SHMT1 and SHMT2" . SPARSER::COLLECTION)
    ("serine/glycine" . SPARSER::COLLECTION) ("SHMTs" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("formate" . SPARSER::MOLECULE)
    ("dTMP" . SPARSER::MOLECULE) ("folate" . SPARSER::MOLECULE)
    ("folates" . SPARSER::MOLECULE) ("serine or glycine" . SPARSER::COLLECTION)
    ("serine hydroxymethyltransferase (SHMT)" . SPARSER::PROTEIN)
    ("SHMT" . SPARSER::PROTEIN)
    ("amino acids and nucleotides" . SPARSER::COLLECTION)
    ("Serum Albumin" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("Annexin-V" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("β-ACTIN" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("S-Adenosylmethionine" . SPARSER::DRUG)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("thymidine monophosphate" . SPARSER::THYMIDINE-MONOPHOSPHATE)
    ("Serine hydroxymethyltransferase" . SPARSER::PROTEIN)
    ("SHMT1" . SPARSER::PROTEIN) ("SHMT2" . SPARSER::PROTEIN)
    ("serine hydroxymethyltransferase" . SPARSER::PROTEIN)
    ("further more advanced KRAS" . SPARSER::PROTEIN)
    ("Raf and PI3K" . SPARSER::COLLECTION) ("HRas" . SPARSER::PROTEIN)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("anti-EGFR and anti-HER2" . SPARSER::COLLECTION)
    ("BRAF and p53" . SPARSER::COLLECTION)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Gln" . SPARSER::AMINO-ACID)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SAK" . SPARSER::PROTEIN)
    ("the similarly charged Lys" . SPARSER::AMINO-ACID)
    ("EGFR or HER2" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least three distinct RAS proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("a monomeric membrane-localized G protein" . SPARSER::PROTEIN)
    ("receptor and non-receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("viral transforming genes" . SPARSER::GENE) ("MSH6" . SPARSER::PROTEIN)
    ("FAM175A" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("K-ras" . SPARSER::PROTEIN) ("sporadic forms" . SPARSER::FORM)
    ("hPer2–hp53" . SPARSER::COLLECTION)
    ("unconventional drug" . SPARSER::DRUG) ("tetramer" . SPARSER::TETRAMER)
    ("Mdm2 and MdmX" . SPARSER::COLLECTION) ("MdmX" . SPARSER::PROTEIN)
    ("its tetrameric form" . SPARSER::FORM)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("rhythmic hPer2" . SPARSER::PROTEIN)
    ("hPer2, hCry1, and hp53 or a fraction of these molecules"
     . SPARSER::COMPONENT)
    ("hPer2, hCry1, and hp53" . SPARSER::COLLECTION)
    ("their respective complexes" . SPARSER::BIO-COMPLEX)
    ("hp53, hPer2, and Mdm2" . SPARSER::COLLECTION)
    ("a global interactome map" . SPARSER::PROTEIN)
    ("circadian-regulated cell cycle genes" . SPARSER::GENE)
    ("CCND1 , WEE1 , MYC , GADD45α , and CDKN1a" . SPARSER::COLLECTION)
    ("Per2 and Bmal1" . SPARSER::COLLECTION)
    ("WEE1 , MYC , and CDKN1a" . SPARSER::COLLECTION)
    ("circadian components" . SPARSER::COMPONENT)
    ("neither FLAG-hp53(ch)hPer2 nor FLAG-hp53(ch)hPer2(356-574/683-872)"
     . SPARSER::COLLECTION)
    ("WAF/CIP1" . SPARSER::COLLECTION) ("WAF" . SPARSER::PROTEIN)
    ("ATM/ATR" . SPARSER::COLLECTION) ("BAX and GADD45α" . SPARSER::COLLECTION)
    ("SFN and CDKN1a" . SPARSER::COLLECTION)
    ("a dominant-negative complex" . SPARSER::BIO-COMPLEX)
    ("SFN" . SPARSER::PROTEIN) ("hp53 and hPer2" . SPARSER::COLLECTION)
    ("FLAG-hp53(ch)GST, and FLAG-NLS-hp53(ch)GST" . SPARSER::PROTEIN)
    ("GST, and FLAG-NLS-hp53" . SPARSER::COLLECTION)
    ("flexible linkers" . SPARSER::LINKER) ("linkers" . SPARSER::LINKER)
    ("bipartite" . SPARSER::PROTEIN) ("-hp53" . SPARSER::COLLECTION)
    ("myc -tagged hp53 and its chimera form" . SPARSER::COLLECTION)
    ("FLAG-hp53(ch)hPer2(356-574/683-872) and FLAG-hp53(ch)hPer2"
     . SPARSER::COLLECTION)
    ("an nondissociable hp53/hPer2 complex" . SPARSER::BIO-COMPLEX)
    ("just hp53" . SPARSER::PROTEIN)
    ("hp53 and its chimera proteins" . SPARSER::COLLECTION)
    ("hp53" . SPARSER::PROTEIN) ("-Mdm2" . SPARSER::COLLECTION)
    ("FLAG-hp53" . SPARSER::COLLECTION)
    ("a nondissociable hp53/hPer2 complex" . SPARSER::BIO-COMPLEX)
    ("covalently bound complex" . SPARSER::BIO-COMPLEX)
    ("full-length or glutathione S -transferase" . SPARSER::COLLECTION)
    ("hPer2 and hp53" . SPARSER::COLLECTION) ("Mdm2/hp53" . SPARSER::PROTEIN)
    ("FLAG-Mdm2/hp53" . SPARSER::COLLECTION) ("-hPer2" . SPARSER::COLLECTION)
    ("FLAG-Mdm2" . SPARSER::COLLECTION) ("–MG132" . SPARSER::COLLECTION)
    ("FLAG-hPer2" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("the complex's" . SPARSER::BIO-COMPLEX)
    ("the circadian factor hPer2" . SPARSER::PROTEIN)
    ("suppressor and checkpoint" . SPARSER::COLLECTION)
    ("circadian molecules" . SPARSER::MOLECULE)
    ("hPer2, hp53, and Mdm2" . SPARSER::COLLECTION)
    ("p21 CIP1/WAF1" . SPARSER::COLLECTION) ("CDKN1a" . SPARSER::PROTEIN)
    ("TP53 and BAX" . SPARSER::COLLECTION)
    ("MYC , BCL2L1 , and BCL2" . SPARSER::COLLECTION)
    ("CCNB1 and MYC" . SPARSER::COLLECTION)
    ("The transcription factor and checkpoint-component p53 (human p53 transcription factor [hp53])"
     . SPARSER::COLLECTION)
    ("a multilevel cellular clock" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein (ATR)" . SPARSER::PROTEIN)
    ("ATM and Chk2" . SPARSER::COLLECTION) ("hTim" . SPARSER::PROTEIN)
    ("Timeless" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Per3-" . SPARSER::PROTEIN)
    ("Per1-" . SPARSER::PROTEIN) ("Per1 and Per2" . SPARSER::COLLECTION)
    ("Vipr2" . SPARSER::PROTEIN) ("Nocturnin" . SPARSER::PROTEIN)
    ("Opn" . SPARSER::PROTEIN) ("Csnk1d" . SPARSER::PROTEIN)
    ("Csnk1e" . SPARSER::PROTEIN) ("timeless" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tau" . SPARSER::PROTEIN) ("Cry1 and Cry2" . SPARSER::COLLECTION)
    ("Cry2" . SPARSER::PROTEIN) ("Cry1" . SPARSER::PROTEIN)
    ("Bmal1/Mop3" . SPARSER::COLLECTION) ("Bmal1" . SPARSER::PROTEIN)
    ("Clock" . SPARSER::PROTEIN) ("period 1–3" . SPARSER::COLLECTION)
    ("a functional clock" . SPARSER::PROTEIN)
    ("the circadian tumor suppressor hPer2" . SPARSER::PROTEIN)
    ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("the trimeric complex" . SPARSER::BIO-COMPLEX)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("Circadian period proteins" . SPARSER::PROTEIN)
    ("The trimeric complex" . SPARSER::BIO-COMPLEX)
    ("β-gal" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GADD45" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("NLS1" . SPARSER::PROTEIN) ("myc -tagged" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("Period 2" . SPARSER::PROTEIN)
    ("per3" . SPARSER::PROTEIN) ("per1" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN) ("Per3" . SPARSER::PROTEIN)
    ("Per1" . SPARSER::PROTEIN) ("Dec 1" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("Arnt1" . SPARSER::PROTEIN)
    ("Mop3" . SPARSER::PROTEIN) ("CKIε" . SPARSER::PROTEIN)
    ("period 1" . SPARSER::PROTEIN) ("hPer2" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("Per2" . SPARSER::PROTEIN)
    ("an uncommon variant" . SPARSER::VARIANT)
    ("VEGF/VEGFR2" . SPARSER::COLLECTION)
    ("β1 integrin and the integrin receptor-like protein TEM8"
     . SPARSER::COLLECTION)
    ("a novel cancer pharmacogenetic biomarker" . SPARSER::MOLECULE)
    ("were run" . SPARSER::PROTEIN-FAMILY)
    ("a nonsynonymous variant" . SPARSER::VARIANT)
    ("the causative variants" . SPARSER::VARIANT)
    ("FIP1L1 , PDGFRA , KIT , and KDR" . SPARSER::COLLECTION)
    ("KIT" . SPARSER::PROTEIN) ("PDGFRA" . SPARSER::PROTEIN)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular VEGF" . SPARSER::PROTEIN)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vascular endothelial growth factor receptor 2 (VEGFR2) and other kinases"
     . SPARSER::COLLECTION)
    ("Pazopanib" . SPARSER::DRUG) ("targets and classes" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("pazopanib" . SPARSER::DRUG)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("VEGFR" . SPARSER::PROTEIN) ("TEM8" . SPARSER::PROTEIN)
    ("VEGF-C" . SPARSER::PROTEIN) ("FIP1" . SPARSER::PROTEIN)
    ("FIP1L1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("angiogenesis inhibitor" . SPARSER::DRUG)
    ("vascular endothelial growth factor receptor-2" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("DACH1 and/or THSD4" . SPARSER::COLLECTION)
    ("BCL2 , DACH1 and THSD4" . SPARSER::COLLECTION)
    ("BCL2 and DACH1" . SPARSER::COLLECTION) ("BEGAIN" . SPARSER::PROTEIN)
    ("IL5/GFP" . SPARSER::COLLECTION) ("A-B" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN)
    ("BMP2, ERBB4 and KIF16B" . SPARSER::COLLECTION)
    ("suppressor and tumor" . SPARSER::COLLECTION)
    ("BCL2, THSD4 and DACH1" . SPARSER::COLLECTION)
    ("the telomerase catalytic subunit hTert, SV40 large-T antigen (LT) and the oncoprotein H-Ras [ xref ]"
     . SPARSER::COLLECTION)
    ("LT" . SPARSER::PROTEIN) ("hTert" . SPARSER::PROTEIN)
    ("BCL2, DACH1 and THSD4" . SPARSER::COLLECTION)
    ("both tumor promoter [ xref ] and tumor suppressor [ xref ]"
     . SPARSER::COLLECTION)
    ("GATA3 regulated genes" . SPARSER::GENE)
    ("four publicly available cohorts" . SPARSER::MOLECULE)
    ("ER (ERα) and co-regulates" . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN)
    ("tumorigenesis-associated genes" . SPARSER::GENE)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN) ("CEP70" . SPARSER::PROTEIN)
    ("VTCN1" . SPARSER::PROTEIN) ("KRT23" . SPARSER::PROTEIN)
    ("CHI3" . SPARSER::PROTEIN) ("KIF16B" . SPARSER::PROTEIN)
    ("ERBB4" . SPARSER::PROTEIN) ("HFM1" . SPARSER::PROTEIN)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("IL5" . SPARSER::PROTEIN) ("per 1" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("alpha subunit" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("THSD4" . SPARSER::PROTEIN)
    ("DACH1" . SPARSER::PROTEIN) ("GATA binding protein 3" . SPARSER::PROTEIN)
    ("polyglutamine" . SPARSER::MOLECULE)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("BCL2, RELA, FAS, EEF1A2 and NR4A2" . SPARSER::COLLECTION)
    ("KDM1A, KDM4C, SIRT1, CTBP1, NR2C1 and SMARCD3" . SPARSER::COLLECTION)
    ("ERCC2 and ERCC3" . SPARSER::COLLECTION)
    ("ERCC1, ERCC2, ERCC3, ERCC5 and FEN1" . SPARSER::COLLECTION)
    ("The classical AR complex" . SPARSER::BIO-COMPLEX)
    ("other adrenal androgens" . SPARSER::DRUG)
    ("DHEA or androstenedione" . SPARSER::COLLECTION)
    ("androstenedione" . SPARSER::PROTEIN) ("DHEA" . SPARSER::DRUG)
    ("antagonists and LHRH" . SPARSER::COLLECTION) ("LHRH" . SPARSER::PROTEIN)
    ("–independent/castrate resistant prostate cancer (AIPC/CRPC) state and support"
     . SPARSER::COLLECTION)
    ("estradiol, dexamethasone and progesterone" . SPARSER::COLLECTION)
    ("HSP70, HSP90, p300 and components" . SPARSER::COLLECTION)
    ("CGH" . SPARSER::PROTEIN) ("subsequent GSEA" . SPARSER::PROTEIN)
    ("cortisol" . SPARSER::DRUG)
    ("the N-terminal FXXLF motif peptide or the TIF2 coactivator peptide"
     . SPARSER::COLLECTION)
    ("Testosterone" . SPARSER::MOLECULE) ("LBD" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("AR-LBD" . SPARSER::PROTEIN-PAIR)
    ("testosterone-" . SPARSER::MOLECULE)
    ("globular protein conformations" . SPARSER::BIO-CONFORMATION)
    ("runs" . SPARSER::PROTEIN-FAMILY)
    ("the ligand-dependent gene expression pattern ontological classes"
     . CLASS)
    ("sterol" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("testosterone and DHT" . SPARSER::COLLECTION)
    ("AR-estradiol-stimulated complexes" . SPARSER::BIO-COMPLEX)
    ("AR-DHT" . SPARSER::COLLECTION)
    ("progesterone and dexamethasone" . SPARSER::COLLECTION)
    ("Hierarchical clustering heat-maps" . SPARSER::PROTEIN)
    ("heat-maps" . SPARSER::PROTEIN) ("Hormone" . SPARSER::MOLECULE)
    ("finasteride" . SPARSER::DRUG) ("DHT" . SPARSER::PROTEIN)
    ("androgens" . SPARSER::DRUG)
    ("the possible distinct complexes" . SPARSER::BIO-COMPLEX)
    ("ligand and co-factor" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("polyribosomes" . SPARSER::BIO-COMPLEX) ("androgen" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN) ("enzalutamide" . SPARSER::DRUG)
    ("subversive ARs" . SPARSER::PROTEIN)
    ("ARs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bicalutamide" . SPARSER::DRUG)
    ("flutamide" . SPARSER::DRUG) ("the protein’s" . SPARSER::PROTEIN)
    ("AR-protein" . SPARSER::COLLECTION) ("prostatic" . SPARSER::PROTEIN)
    ("testosterone, estradiol, progesterone, dexamethasone, and cyproterone"
     . SPARSER::COLLECTION)
    ("cyproterone" . SPARSER::DRUG) ("progesterone" . SPARSER::PROTEIN)
    ("estradiol" . SPARSER::PROTEIN) ("testosterone" . SPARSER::MOLECULE)
    ("mibolerone" . SPARSER::DRUG) ("dihydrotestosterone" . SPARSER::DRUG)
    ("progestins" . SPARSER::DRUG) ("estrogens" . SPARSER::MOLECULE)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("NR4A2" . SPARSER::PROTEIN)
    ("EEF1A2" . SPARSER::PROTEIN) ("SMARCD3" . SPARSER::PROTEIN)
    ("NR2C1" . SPARSER::PROTEIN) ("CTBP1" . SPARSER::PROTEIN)
    ("KDM4C" . SPARSER::PROTEIN) ("KDM1A" . SPARSER::PROTEIN)
    ("FEN1" . SPARSER::PROTEIN) ("ERCC5" . SPARSER::PROTEIN)
    ("ERCC3" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("TIF2" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("17β-Estradiol" . SPARSER::PROTEIN) ("TIP3" . SPARSER::PROTEIN)
    ("anti-androgen" . SPARSER::DRUG) ("anti-androgens" . SPARSER::DRUG)
    ("histological types" . TYPE) ("The histological types" . TYPE)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("genotypes" . SPARSER::PROTEIN)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("Genotype" . SPARSER::PROTEIN) ("AG" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("cyclin D1a" . SPARSER::PROTEIN)
    ("BYL719 and the PI3K p110β inhibitor AZD6482" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN)
    ("phospho-AKT and phospho-S6" . SPARSER::COLLECTION)
    ("AKT and the downstream effectors PRAS40" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::MOLECULE)
    ("allele and protein" . SPARSER::COLLECTION)
    ("FGFR1 and EI4EBP1" . SPARSER::COLLECTION)
    ("PIK3CA , ESR1 , and BRCA2" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("aromatase" . SPARSER::PROTEIN)
    ("receptor (ER)" . SPARSER::RECEPTOR) ("IA" . SPARSER::MOLECULE)
    ("Class" . CLASS) ("PTEN-" . SPARSER::PROTEIN)
    ("new light" . SPARSER::PROTEIN) ("PI3Kβ" . SPARSER::PROTEIN)
    ("AZD6482" . SPARSER::DRUG) ("BKM120" . SPARSER::DRUG)
    ("p110" . SPARSER::PROTEIN) ("PI3K inhibitor BKM120" . SPARSER::DRUG)
    ("PRAS40" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("MAP3K1" . SPARSER::PROTEIN)
    ("anti-oestrogen" . SPARSER::DRUG) ("p11" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("BYL719" . SPARSER::DRUG)
    ("PI3Kα" . SPARSER::PROTEIN)
    ("nonspecific
DNA"
     . SPARSER::DNA)
    ("UNG" . SPARSER::PROTEIN)
    ("abasic product
DNA"
     . SPARSER::DNA)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("the large nonelectrostatic component" . SPARSER::COMPONENT)
    ("the nonspecific and specific complexes" . SPARSER::BIO-COMPLEX)
    ("a large nonelectrostatic component" . SPARSER::COMPONENT)
    ("Repressor" . SPARSER::REPRESSOR)
    ("a loosely associated state" . SPARSER::BIO-STATE)
    ("the nonspecific DNA complex" . SPARSER::BIO-COMPLEX)
    ("AP" . SPARSER::PROTEIN) ("duplex DNA" . SPARSER::DNA)
    ("substrate and product" . SPARSER::COLLECTION)
    ("a 2-AP" . SPARSER::PROTEIN-PAIR) ("PUA" . SPARSER::PROTEIN-FAMILY)
    ("Uracil" . SPARSER::DRUG) ("DNA and enzyme" . SPARSER::COLLECTION)
    ("enzyme and DNA" . SPARSER::COLLECTION)
    ("the nonspecific
complex"
     . SPARSER::BIO-COMPLEX)
    ("Leu" . SPARSER::AMINO-ACID)
    ("simple polyelectrolyte" . SPARSER::MOLECULE)
    ("the nonelectrostatic
binding component"
     . SPARSER::COMPONENT)
    ("the large weakly hydrated chloride anion" . SPARSER::MOLECULE)
    ("hydrated" . SPARSER::MOLECULE) ("monovalent salts" . SPARSER::DRUG)
    ("salts" . SPARSER::DRUG) ("KCl" . SPARSER::MOLECULE)
    ("the nonspecific complex" . SPARSER::BIO-COMPLEX)
    ("both
nonspecific and specific DNA"
     . SPARSER::DNA)
    ("protein and DNA" . SPARSER::COLLECTION) ("CC" . SPARSER::PROTEIN-FAMILY)
    ("polyelectrolyte" . SPARSER::MOLECULE) ("cation" . SPARSER::MOLECULE)
    ("the electrostatic component" . SPARSER::COMPONENT)
    ("cations" . SPARSER::MOLECULE)
    ("the electrostatic
component"
     . SPARSER::COMPONENT)
    ("condensation (CC)" . SPARSER::PROTEIN-FAMILY)
    ("a loosely associated enzyme state" . SPARSER::BIO-STATE)
    ("nonspecific DNA" . SPARSER::DNA) ("rare uracil" . SPARSER::DRUG)
    ("uracil" . SPARSER::DRUG) ("hOGG1" . SPARSER::PROTEIN)
    ("N 1" . SPARSER::PROTEIN) ("potassium fluoride" . SPARSER::MOLECULE)
    ("terminal transferase" . SPARSER::PROTEIN) ("cm –1" . SPARSER::PROTEIN)
    ("mM –1" . SPARSER::PROTEIN) ("Mono-S" . SPARSER::DRUG)
    ("DNA
glycosylase"
     . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN)
    ("other antiviral innate immune molecules Cav-1" . SPARSER::PROTEIN)
    ("innate antiviral factors Cav-1" . SPARSER::PROTEIN)
    ("APOBEC3G, TRIMa and tetherin" . SPARSER::COLLECTION)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antisense" . SPARSER::PROTEIN) ("ribozymes" . SPARSER::RNA)
    ("the antiviral genes" . SPARSER::GENE) ("HLR" . SPARSER::PROTEIN)
    ("U87-CD4-CXCR4" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN) ("IRES" . SPARSER::PROTEIN)
    ("RRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (RRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("IRES-GFP" . SPARSER::PROTEIN-PAIR) ("FACs" . SPARSER::PROTEIN)
    ("rev" . SPARSER::PROTEIN-FAMILY) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("still some Cav-1" . SPARSER::PROTEIN)
    ("LTR-IR-GFP-IR-Cav-1" . SPARSER::COLLECTION)
    ("GFP and Cav-1" . SPARSER::COLLECTION)
    ("LTR-GFP-IR-Cav-1" . SPARSER::COLLECTION) ("LTR-IR" . SPARSER::COLLECTION)
    ("pNL" . SPARSER::PROTEIN) ("LTR" . SPARSER::PROTEIN)
    ("LTR-Cav-1" . SPARSER::COLLECTION)
    ("Cav-1 and HIV Env" . SPARSER::COLLECTION) ("Env" . SPARSER::PROTEIN)
    ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("phospholipids and sphingolipids [ xref - xref ]" . SPARSER::COLLECTION)
    ("sphingolipids" . SPARSER::MOLECULE) ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("Cav-1 and GFP" . SPARSER::COLLECTION) ("APOBEC3G" . SPARSER::PROTEIN)
    ("U3" . SPARSER::PROTEIN) ("cav-1" . SPARSER::PROTEIN)
    ("NL4" . SPARSER::PROTEIN) ("NL 4" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cav-1" . SPARSER::PROTEIN) ("selumetinib" . SPARSER::DRUG)
    ("the histological and molecular subtypes" . SPARSER::PROTEIN)
    ("BRAF, KRAS, NRAS and ERBB2" . SPARSER::COLLECTION)
    ("ERCC1, AKT and EMT" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("MEK and platinum" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("MEK1 and ERCC1" . SPARSER::COLLECTION)
    ("AKT and EMT" . SPARSER::COLLECTION)
    ("PD0325901 and carboplatin" . SPARSER::COLLECTION)
    ("RTF1, CSDE1, CNOT8 and MEK1" . SPARSER::COLLECTION)
    ("gene silencing and carboplatin treatment" . SPARSER::COLLECTION)
    ("JRK (p = 3.2E-05), CNOT8 (p = 2.2E-04), FUBP1 (p = 0.014) and MEK1 (p = 0.0078)"
     . SPARSER::COLLECTION)
    ("taxol and platinum" . SPARSER::COLLECTION)
    ("no approved predictive biomarker" . SPARSER::MOLECULE)
    ("CTR" . SPARSER::PROTEIN) ("carboplatin" . SPARSER::DRUG)
    ("gold" . SPARSER::MOLECULE) ("HR " . SPARSER::PROTEIN)
    ("JRK (p = 3.2E-05), MEK1 (p = 0.0078), FUBP1 (p = 0.014) and CNOT8 (p = 0.00022)"
     . SPARSER::COLLECTION)
    ("MEK1, CSDE1, CNOT8 and RTF1" . SPARSER::COLLECTION)
    ("JRK, CNOT8, RTF1, CCT3, NFAT2CIP, MEK1, FUBP1 and CSDE1"
     . SPARSER::COLLECTION)
    ("JRK" . SPARSER::PROTEIN) ("ES-2" . SPARSER::PROTEIN)
    ("Platinum" . SPARSER::MOLECULE) ("DNA-PK" . SPARSER::PROTEIN)
    ("PD-0325901" . SPARSER::DRUG)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP2K1" . SPARSER::PROTEIN) ("E-12" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("FOXC2" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("KLF8" . SPARSER::PROTEIN)
    ("ZEB2" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("ATP7B" . SPARSER::PROTEIN) ("CTR1" . SPARSER::PROTEIN)
    ("NFAT2" . SPARSER::PROTEIN) ("CCT3" . SPARSER::PROTEIN)
    ("RTF1" . SPARSER::PROTEIN) ("CNOT8" . SPARSER::PROTEIN)
    ("ALDH2 , CCNE1 and SMAD3" . SPARSER::COLLECTION)
    ("p21/p27" . SPARSER::COLLECTION)
    ("p53, SKP2 and CKS1" . SPARSER::COLLECTION)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("VHL, MET and TSC1/2" . SPARSER::COLLECTION)
    ("only some selected genes" . SPARSER::GENE)
    ("CCNE1 , SMAD3 and ALDH2" . SPARSER::COLLECTION)
    ("SMAD3 and CCNE1" . SPARSER::COLLECTION)
    ("CDC25A , CDK2 and CDKN1C" . SPARSER::COLLECTION)
    ("SMAD4 , SKI and CDKN1C" . SPARSER::COLLECTION)
    ("included well-recognized tumor suppressors and oncogenes"
     . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("TP53 , HRAS , PIK3CA and CCND1" . SPARSER::COLLECTION)
    ("the potential cancer-relevant genes" . SPARSER::GENE)
    ("GSEA" . SPARSER::PROTEIN)
    ("glycine, serine and threonine" . SPARSER::COLLECTION)
    ("MAPK and PI3K-Akt" . SPARSER::COLLECTION)
    ("differentially expressed genes" . SPARSER::GENE)
    ("Glycine" . SPARSER::AMINO-ACID) ("PPAR" . SPARSER::PROTEIN)
    ("gene " . SPARSER::GENE)
    ("nearly all the transcribed genes" . SPARSER::GENE)
    ("analgesics" . SPARSER::DRUG) ("aggressive type" . TYPE)
    ("ALDH2, CCNE1 and SMAD3" . SPARSER::COLLECTION)
    ("CCNE1 and SMAD3" . SPARSER::COLLECTION) ("CKS1" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("IGFBP-5" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("CDKN1C" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("ALDH2" . SPARSER::PROTEIN)
    ("BAL" . SPARSER::PROTEIN) ("calpeptin" . SPARSER::MOLECULE)
    ("ethanol" . SPARSER::MOLECULE) ("CAPN8 and CAPN9" . SPARSER::COLLECTION)
    ("calpains" . SPARSER::PROTEIN) ("LGMD2A" . SPARSER::PROTEIN)
    ("Calpains" . SPARSER::PROTEIN) ("SNARE" . SPARSER::PROTEIN)
    ("which spans three genes" . SPARSER::GENE) ("IgE" . SPARSER::PROTEIN)
    ("the Th2 master regulatory transcription factor" . SPARSER::PROTEIN)
    ("Il4" . SPARSER::PROTEIN) ("interferon" . SPARSER::PROTEIN)
    ("IFN" . SPARSER::DRUG) ("a BRCA-2-associated protein" . SPARSER::PROTEIN)
    ("EMSY" . SPARSER::PROTEIN) ("WDR36 and GALNT14" . SPARSER::COLLECTION)
    ("TSLP, c11orf30, CAPN14, STAT6, ANKRD27 and NOVA1" . SPARSER::COLLECTION)
    ("the associated variants" . SPARSER::VARIANT)
    ("The genome-wide significant variants" . SPARSER::VARIANT)
    ("TSLP, c110rf30 and CAPN14" . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("IL-5 and IL-13" . SPARSER::COLLECTION) ("allergens" . SPARSER::MOLECULE)
    ("allergen" . SPARSER::MOLECULE) ("melanogenic enzymes" . SPARSER::ENZYME)
    ("c11orf30 and STAT6" . SPARSER::COLLECTION)
    ("TSLP/WDR36" . SPARSER::COLLECTION) ("TSLP" . SPARSER::PROTEIN)
    ("proton pump" . SPARSER::PROTEIN) ("CAPN9" . SPARSER::PROTEIN)
    ("CAPN8" . SPARSER::PROTEIN) ("CAPN3" . SPARSER::PROTEIN)
    ("calpain 13" . SPARSER::PROTEIN) ("VAMP7" . SPARSER::PROTEIN)
    ("XKR6" . SPARSER::PROTEIN) ("RGS9BP" . SPARSER::PROTEIN)
    ("PDCD5" . SPARSER::PROTEIN) ("IL-4R" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("BRCA-2" . SPARSER::PROTEIN) ("LRRC32" . SPARSER::PROTEIN)
    ("GALNT14" . SPARSER::PROTEIN) ("P 5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOVA1" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("OR 2" . SPARSER::MOLECULE)
    ("−3" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("CAPN14" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("c11orf30" . SPARSER::PROTEIN) ("WDR36" . SPARSER::PROTEIN)
    ("any chemotherapeutic drug" . SPARSER::DRUG)
    ("substitution-inert ligands" . SPARSER::LIGAND)
    ("amine" . SPARSER::MOLECULE)
    ("The substitution-inert polynuclear platinum" . SPARSER::MOLECULE)
    ("GDI" . SPARSER::PROTEIN) ("RI" . SPARSER::MOLECULE)
    ("OHP" . SPARSER::PROTEIN) ("caspase-8 and PARP-1" . SPARSER::COLLECTION)
    ("tBID" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("20 μM cisplatin or TriplatinNC" . SPARSER::COLLECTION)
    ("cisplatin or TriplatinNC" . SPARSER::COLLECTION)
    ("-S-G 2" . SPARSER::COLLECTION)
    ("condensation and DNA" . SPARSER::COLLECTION)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("β-tubulin and nucleophosmin" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN) ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("p53 or p21" . SPARSER::COLLECTION)
    ("p53
and p21"
     . SPARSER::COLLECTION)
    ("naturally occurring
spermine"
     . SPARSER::PROTEIN)
    ("spermine" . SPARSER::PROTEIN)
    ("protein
(TBP)"
     . SPARSER::PROTEIN)
    ("mature 28S and 18S rRNA" . SPARSER::PROTEIN)
    ("the mature 28S, 18S, and 5.8S rRNA" . SPARSER::PROTEIN)
    ("mature
rRNAs"
     . SPARSER::RNA)
    ("snoRNAs" . SPARSER::RNA) ("rRNAs" . SPARSER::RNA)
    ("pre-rRNA" . SPARSER::COLLECTION) ("rDNA" . SPARSER::PROTEIN)
    ("any
soluble molecule"
     . SPARSER::MOLECULE)
    ("Tamra" . SPARSER::MOLECULE) ("polyarginines" . SPARSER::MOLECULE)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("polyarginine" . SPARSER::MOLECULE)
    ("guanidino" . SPARSER::MOLECULE) ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("PDB" . SPARSER::MOLECULE) ("oligosaccharide" . SPARSER::MOLECULE)
    ("oligosaccharides" . SPARSER::MOLECULE)
    ("cisplatin or oxaliplatin" . SPARSER::COLLECTION)
    ("labile" . SPARSER::PROTEIN)
    ("Oxaliplatin, cisplatin, and 5-FU" . SPARSER::COLLECTION)
    ("Oxaliplatin" . SPARSER::DRUG)
    ("drugs, oxaliplatin and cisplatin" . SPARSER::COLLECTION)
    ("antimetabolite" . SPARSER::DRUG) ("ARF" . SPARSER::PROTEIN)
    ("nucleophiles" . SPARSER::MOLECULE)
    ("p53 mutant or null
cell lines"
     . SPARSER::COLLECTION)
    ("tRNA and DNA" . SPARSER::COLLECTION) ("tRNA" . SPARSER::PROTEIN)
    ("-3 and PARP-1" . SPARSER::COLLECTION) ("rRNA" . SPARSER::PROTEIN)
    ("polynuclear
platinum"
     . SPARSER::MOLECULE)
    ("Such
substitution-inert complexes form"
     . SPARSER::FORM)
    ("PPCs" . SPARSER::PROTEIN)
    ("substitution-inert
derivative"
     . SPARSER::DERIVATIVE)
    ("BBR" . SPARSER::PROTEIN) ("derivative" . SPARSER::DERIVATIVE)
    ("A-T" . SPARSER::PROTEIN) ("CH 2" . SPARSER::PROTEIN)
    ("NH 3" . SPARSER::MOLECULE) ("Caspase-8" . SPARSER::PROTEIN)
    ("procaspase-9" . SPARSER::PROTEIN) ("S-G 2" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("β-tubulin" . SPARSER::PROTEIN)
    ("cyclin-dependent
kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("small nucleolar RNAs" . SPARSER::RNA) ("β-Gal" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("alpha-Tubulin" . SPARSER::PROTEIN)
    ("beta-Actin" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("s
5A"
     . SPARSER::PROTEIN)
    ("PARP-1" . SPARSER::PROTEIN) ("streptavidin" . SPARSER::PROTEIN)
    ("the
enzyme’s"
     . SPARSER::ENZYME)
    ("the anionic form" . SPARSER::FORM) ("pyrene" . SPARSER::PROTEIN)
    ("SAHA
and TSA"
     . SPARSER::COLLECTION)
    ("a strong nucleophile" . SPARSER::MOLECULE)
    ("The catalytic divalent metal ions" . SPARSER::MOLECULE)
    ("nucleophile" . SPARSER::MOLECULE)
    ("at least three inhibitors" . SPARSER::INHIBITOR)
    ("an aromatic amino acid" . SPARSER::AMINO-ACID)
    ("an artificial peptide" . SPARSER::PEPTIDE)
    ("the enzyme and
the ligands"
     . SPARSER::COLLECTION)
    ("S19–S21" . SPARSER::COLLECTION) ("S13–S18" . SPARSER::COLLECTION)
    ("SAHA and C6-" . SPARSER::COLLECTION)
    ("the latter ligands" . SPARSER::LIGAND)
    ("the active
site resident Zn 2+ ion"
     . SPARSER::MOLECULE)
    ("the active site resident Zn 2+ ion" . SPARSER::MOLECULE)
    ("aqueous solution" . SPARSER::MOLECULE)
    ("hydroxamate and thiol" . SPARSER::COLLECTION)
    ("TSA and SAHA" . SPARSER::COLLECTION)
    ("the active site resident
Zn 2+ ion"
     . SPARSER::MOLECULE)
    ("SAHA,
t-SAHA, TSA, and C7-"
     . SPARSER::COLLECTION)
    ("the active site
resident Zn 2+ ion"
     . SPARSER::MOLECULE)
    ("ins" . SPARSER::PROTEIN) ("Hepes" . SPARSER::MOLECULE)
    ("hydroxamate or thiol" . SPARSER::COLLECTION)
    ("only one methylene group" . SPARSER::MOLECULE)
    ("the former ligand" . SPARSER::LIGAND)
    ("the latter ligand" . SPARSER::LIGAND) ("the enzyme’s" . SPARSER::ENZYME)
    ("hydroxamate- and thiol-SAHA" . SPARSER::COLLECTION)
    ("hydroxamate-" . SPARSER::MOLECULE) ("SAHA and TSA" . SPARSER::COLLECTION)
    ("obs" . SPARSER::PROTEIN)
    ("100 mM NaCl
and 1 mM TCEP"
     . SPARSER::COLLECTION)
    ("TCEP" . SPARSER::MOLECULE) ("MH" . SPARSER::MOLECULE)
    ("thiol" . SPARSER::MOLECULE) ("coumarin" . SPARSER::DRUG)
    ("hydroxamate" . SPARSER::MOLECULE)
    ("their plausible complexes" . SPARSER::BIO-COMPLEX)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("SAHA and Romidepsin" . SPARSER::COLLECTION)
    ("Romidepsin" . SPARSER::DRUG)
    ("histones as well
as non-histone proteins"
     . SPARSER::COLLECTION)
    ("malleable enzyme" . SPARSER::ENZYME)
    ("enzymes and proteins" . SPARSER::COLLECTION)
    ("moderately tight-binding HDAC8
inhibitors"
     . SPARSER::INHIBITOR)
    ("the active site resident water molecules" . SPARSER::MOLECULE)
    ("metalloenzymes" . SPARSER::PROTEIN-FAMILY)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("the most highly malleable enzyme" . SPARSER::ENZYME)
    ("M –1" . SPARSER::PROTEIN) ("OBP3" . SPARSER::PROTEIN)
    ("OH –" . SPARSER::MOLECULE) ("S21" . SPARSER::PROTEIN)
    ("K –1" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("butyric acid" . SPARSER::MOLECULE) ("N 2" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic
acid"
     . SPARSER::MOLECULE)
    ("HMG–CoA" . SPARSER::DRUG) ("gp120" . SPARSER::DRUG)
    ("CD4" . SPARSER::PROTEIN) ("HDAC11" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("HDAC8" . SPARSER::PROTEIN)
    ("dual tyrosine kinase inhibitors" . SPARSER::INHIBITOR)
    ("RAS, PI3K-Akt, STAT and β-catenin" . SPARSER::COLLECTION)
    ("MAPK, Akt and JNK" . SPARSER::COLLECTION)
    ("cytokine-cytokine" . SPARSER::COLLECTION)
    ("tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("mock or miR-control transfectants" . SPARSER::PROTEIN)
    ("EGFR, RET and c-Met" . SPARSER::COLLECTION)
    ("EGFR , RET and c-Met" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("transfectants" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR ) and hepatocyte growth factor receptor ( c-Met )"
     . SPARSER::COLLECTION)
    ("miR-27b mature miRNAs" . SPARSER::PROTEIN) ("27b" . SPARSER::PROTEIN)
    ("several tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("ncRNA" . SPARSER::RNA) ("ncRNAs" . SPARSER::RNA)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("the epidermal growth factor receptor ( EGFR ) and hepatocyte growth factor receptor ( c-Met )"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mature miR-23b or miR-27b miRNAs" . SPARSER::PROTEIN)
    ("miR-27b" . SPARSER::COLLECTION)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("miR-7" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("Stattic" . SPARSER::DRUG) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("two epithelial mesenchymal transition- (EMT-) related molecules"
     . SPARSER::MOLECULE)
    ("EMT-" . SPARSER::PROTEIN) ("CCR7/JAK2/STAT3" . SPARSER::COLLECTION)
    ("Src and Pyk2" . SPARSER::COLLECTION)
    ("JAK1, JAK2, and c-Src" . SPARSER::COLLECTION)
    ("PI3K, Src, pyk2, and STAT3" . SPARSER::COLLECTION)
    ("CCL2/CCR2-STAT3" . SPARSER::COLLECTION)
    ("CCL2 and CCR2" . SPARSER::COLLECTION)
    ("effectors, JAK2 and STAT3" . SPARSER::COLLECTION)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("that PP2 and A9" . SPARSER::COLLECTION)
    ("PI3K, Src, and pyk2" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("CCR7, and AG490" . SPARSER::COLLECTION)
    ("mAb" . SPARSER::DRUG) ("PCI" . SPARSER::PROTEIN)
    ("CCL19 and its receptor" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN) ("CCR7 and STAT3" . SPARSER::COLLECTION)
    ("JAk2/STAT3" . SPARSER::COLLECTION) ("Src and pyk2" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("pyk2, and Src" . SPARSER::COLLECTION)
    ("PI3K/cdc42" . SPARSER::COLLECTION) ("Pyk2" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("CXCR7" . SPARSER::PROTEIN)
    ("JAk2" . SPARSER::PROTEIN) ("CCL19" . SPARSER::PROTEIN)
    ("pyk2" . SPARSER::PROTEIN) ("cdc42" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN) ("excellular matrix" . SPARSER::PROTEIN-FAMILY)
    ("the unique types" . TYPE) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("key proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adipocytokine" . SPARSER::PROTEIN-FAMILY)
    ("resistin, MMP-2, and miR-519d" . SPARSER::COLLECTION)
    ("resistin and miR-519d, MMP-2 and miR-519d" . SPARSER::COLLECTION)
    ("resistin and MMP-2" . SPARSER::COLLECTION)
    ("MMP-2 and resistin" . SPARSER::COLLECTION)
    ("Resistin-shRNA" . SPARSER::PROTEIN-PAIR)
    ("MMP-2, and miR-519d" . SPARSER::COLLECTION)
    ("MMP-2-3" . SPARSER::COLLECTION) ("AMPK and p38" . SPARSER::COLLECTION)
    ("the MMP-2 mRNA (WT-MMP-2-3′ UTR) and mismatches" . SPARSER::COLLECTION)
    ("possible miRNAs" . SPARSER::PROTEIN)
    ("p38 and AMPK" . SPARSER::COLLECTION)
    ("p53 and DNA" . SPARSER::COLLECTION)
    ("PTEN, AKT3 and TIMP2" . SPARSER::COLLECTION)
    ("CDKN1A/p21" . SPARSER::COLLECTION) ("onco-miRNA" . SPARSER::COLLECTION)
    ("MiRNAs" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("MMP-1, MMP-2, MMP-3, MMP-9, and MMP-13" . SPARSER::COLLECTION)
    ("endopeptidases" . SPARSER::PROTEIN)
    ("proteins, growth factors, and cytokines" . SPARSER::COLLECTION)
    ("AMPK/p38" . SPARSER::COLLECTION)
    ("AMP-activated protein kinase (AMPK) and p38 inhibitors"
     . SPARSER::COLLECTION)
    ("resistin" . SPARSER::PROTEIN) ("adipokine" . SPARSER::PROTEIN-FAMILY)
    ("Resistin" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN)
    ("serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("Compound C" . SPARSER::MOLECULE) ("TIMP2" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-3" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("type and extent" . SPARSER::COLLECTION)
    ("consecutive guanines" . SPARSER::NUCLEOBASE)
    ("guanines" . SPARSER::NUCLEOBASE) ("CHK1/CHK2" . SPARSER::COLLECTION)
    ("CHK2 or CHK2" . SPARSER::COLLECTION) ("delC" . SPARSER::PROTEIN)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("circadian clock proteins" . SPARSER::PROTEIN)
    ("the human circadian clock" . SPARSER::PROTEIN)
    ("period circadian protein 3" . SPARSER::PROTEIN)
    ("period circadian protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMELESS" . SPARSER::PROTEIN)
    ("the DDR and the circadian clock ( xref )" . SPARSER::COLLECTION)
    ("The circadian clock" . SPARSER::PROTEIN)
    ("CHK2 and the circadian clock" . SPARSER::COLLECTION)
    ("demethylase" . SPARSER::PROTEIN) ("Tel1 and Rad53" . SPARSER::COLLECTION)
    ("protective histones" . SPARSER::PROTEIN)
    ("a small (16500 bp) heteroplasmic DNA" . SPARSER::DNA)
    ("the normal DDR" . SPARSER::PROTEIN)
    ("DNA damage-independent nuclear foci" . SPARSER::PROTEIN)
    ("The viral Tax protein" . SPARSER::PROTEIN)
    ("DNA-PKcs, Ku70, MDC1, BRCA1, and CHK2" . SPARSER::COLLECTION)
    ("episomal DNA" . SPARSER::DNA)
    ("p53, BLM, and Mre11" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("CHK2 and other DDR proteins" . SPARSER::COLLECTION)
    ("iPS" . SPARSER::PROTEIN) ("p53 and p63" . SPARSER::COLLECTION)
    ("meiotic" . SPARSER::DRUG) ("elegans" . SPARSER::PROTEIN)
    ("CHK2 and BRCA1" . SPARSER::COLLECTION)
    ("even more complex" . SPARSER::BIO-COMPLEX)
    ("radiomimetic drugs" . SPARSER::DRUG) ("ATM-CHK2" . SPARSER::COLLECTION)
    ("an inactive dominant-negative CHK2 mutant" . SPARSER::MUTANT)
    ("CHK2, PML, and p53" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION) ("SASP" . SPARSER::PROTEIN)
    ("TRF1, TRF2, TPP1, POT1, TIN2, and RAP1" . SPARSER::COLLECTION)
    ("exonucleases" . SPARSER::PROTEIN) ("Shelterin" . SPARSER::PROTEIN)
    ("shelterin" . SPARSER::PROTEIN)
    ("an acetylase (either p300 or Tip60) and the complex"
     . SPARSER::COLLECTION)
    ("p300 or Tip60" . SPARSER::COLLECTION) ("VHL" . SPARSER::PROTEIN)
    ("CHK2 and p53" . SPARSER::COLLECTION) ("CHK2–p53" . SPARSER::COLLECTION)
    ("anoikis" . SPARSER::PROTEIN)
    ("those encoding apoptotic and mitogenic proteins" . SPARSER::PROTEIN)
    ("virtually all HuR-mRNA" . SPARSER::COLLECTION)
    ("HuR-mRNA" . SPARSER::COLLECTION)
    ("IR, p53 and histone" . SPARSER::COLLECTION)
    ("the E3 ubiquitin protein ligase (MDM2) and the Mdm2-like p53-binding protein (HDMX)"
     . SPARSER::COLLECTION)
    ("Mdm2-like p53-binding protein (HDMX)" . SPARSER::PROTEIN)
    ("HDMX" . SPARSER::PROTEIN)
    ("transcription factor and tumor suppressor protein" . SPARSER::COLLECTION)
    ("ATR-CHK1" . SPARSER::COLLECTION)
    ("the dual specificity protein kinase TTK/hMps1" . SPARSER::COLLECTION)
    ("TTK/hMps1" . SPARSER::COLLECTION) ("TTK" . SPARSER::PROTEIN)
    ("STRAP" . SPARSER::PROTEIN) ("CHK2 and ATM" . SPARSER::COLLECTION)
    ("p21 and p53" . SPARSER::COLLECTION) ("Che-1" . SPARSER::COLLECTION)
    ("the transcriptionally inactive pRb/E2F-1 complex" . SPARSER::BIO-COMPLEX)
    ("pRb/E2F-1" . SPARSER::COLLECTION) ("cyclinB1/Cdk1" . SPARSER::COLLECTION)
    ("ATM and CHK2" . SPARSER::COLLECTION)
    ("KAP-1 and the nucleosome remodeler protein (CHD3)" . SPARSER::COLLECTION)
    ("nucleosome" . SPARSER::BIO-COMPLEX) ("histones" . SPARSER::PROTEIN)
    ("PARP1, ATM, ATR, p53, BLM, and BRCA2" . SPARSER::COLLECTION)
    ("BLM" . SPARSER::PROTEIN) ("nucleobases" . SPARSER::NUCLEOBASE)
    ("Rad51-BRCA2" . SPARSER::COLLECTION) ("exonuclease" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN)
    ("BRCA1 ( xref ) and BRCA2 ( xref )" . SPARSER::COLLECTION)
    ("the two breast cancer susceptibility proteins, BRCA1 ( xref ) and BRCA2 ( xref )"
     . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, KAP-1, and p53" . SPARSER::COLLECTION)
    ("PP2A ( xref ) and WIP1 ( xref ; xref )" . SPARSER::COLLECTION)
    ("proteasomes" . SPARSER::PROTEIN)
    ("After the DDR has run" . SPARSER::PROTEIN-FAMILY)
    ("has run" . SPARSER::PROTEIN-FAMILY)
    ("serine/threonine protein phosphatase 2A (PP2A; xref ) protein phosphatase 1D (WIP1; xref ) and serine/threonine protein phosphatase 1 (PP1; xref )"
     . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia and a main component" . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN)
    ("chromatin or centrosomes" . SPARSER::COLLECTION)
    ("exogenous CHK2" . SPARSER::PROTEIN) ("BJ-hTERT" . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("broken chromatin" . SPARSER::PROTEIN)
    ("fully active monomers" . SPARSER::MONOMER)
    ("monomers" . SPARSER::MONOMER)
    ("an inactive monomeric form" . SPARSER::FORM)
    ("SCD and FHA" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("forkhead" . SPARSER::PROTEIN)
    ("threonine-glutamine" . SPARSER::COLLECTION)
    ("serine-glutamine" . SPARSER::COLLECTION) ("SCD" . SPARSER::PROTEIN)
    ("TQ" . SPARSER::DRUG) ("polypeptide" . SPARSER::PROTEIN)
    ("Rad53 and Schizosaccharomyces" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN) ("viral proteins" . SPARSER::PROTEIN)
    ("ATM-ATR" . SPARSER::COLLECTION)
    ("ATM ( xref ) and CHK1" . SPARSER::COLLECTION)
    ("MDC1, 53BP1, and BRCA1" . SPARSER::COLLECTION)
    ("TopBP1 and claspin" . SPARSER::COLLECTION) ("claspin" . SPARSER::PROTEIN)
    ("ATM and ATR" . SPARSER::COLLECTION)
    ("namely serine/threonine protein kinase ATM (also called ataxia telangiectasia mutated) and serine/threonine protein kinase ATR (also called ataxia telangiectasia and Rad3-related protein)"
     . SPARSER::COLLECTION)
    ("the apical (initiating) kinases" . SPARSER::KINASE)
    ("namely serine/threonine protein kinase ATM" . SPARSER::PROTEIN)
    ("circadian proteins" . SPARSER::PROTEIN)
    ("the circadian clock" . SPARSER::PROTEIN) ("clock" . SPARSER::PROTEIN)
    ("DDR" . SPARSER::PROTEIN) ("toxins" . SPARSER::MOLECULE)
    ("PRD4" . SPARSER::PROTEIN) ("PER3" . SPARSER::PROTEIN)
    ("PER1" . SPARSER::PROTEIN) ("Rph1" . SPARSER::PROTEIN)
    ("Tel1" . SPARSER::PROTEIN) ("Tax protein" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("EBNA3C" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NBS1" . SPARSER::PROTEIN)
    ("RAP1" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("POT1" . SPARSER::PROTEIN) ("TPP1" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN)
    ("von Hippel–Lindau disease" . SPARSER::PROTEIN)
    ("von Hippel–Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("CABIN1" . SPARSER::PROTEIN)
    ("calcineurin binding protein 1" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("Hu-antigen R" . SPARSER::PROTEIN)
    ("H1.2" . SPARSER::PROTEIN)
    ("Mdm2-like p53-binding protein" . SPARSER::PROTEIN)
    ("hMps1" . SPARSER::PROTEIN) ("p53 cofactor" . SPARSER::PROTEIN)
    ("receptor-associated protein" . SPARSER::PROTEIN)
    ("apoptosis antagonizing transcription factor" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdk1" . SPARSER::PROTEIN)
    ("cyclinB1" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("CHD3" . SPARSER::PROTEIN)
    ("KRAB-associated protein 1" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("FoxM1" . SPARSER::PROTEIN)
    ("forkhead box protein M1" . SPARSER::PROTEIN) ("KAP-1" . SPARSER::PROTEIN)
    ("PIRH2" . SPARSER::PROTEIN)
    ("p53-induced RING-H2 protein" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("WIP1" . SPARSER::PROTEIN)
    ("protein phosphatase 1D" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("Cullin 1" . SPARSER::PROTEIN) ("a polypeptide" . SPARSER::PROTEIN)
    ("Cds1" . SPARSER::PROTEIN) ("Rad53" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("TopBP1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN)
    ("DUBs and other enzymes" . SPARSER::COLLECTION)
    ("anchors" . SPARSER::ANCHOR) ("USP4 and USP15" . SPARSER::COLLECTION)
    ("a flexible linker" . SPARSER::LINKER)
    ("possible regulators" . SPARSER::REGULATOR) ("Enzyme" . SPARSER::ENZYME)
    ("USP7 and Ubp8" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("AV" . SPARSER::MOLECULE) ("DUSP and Ubl" . SPARSER::COLLECTION)
    ("protein, and USP15" . SPARSER::COLLECTION)
    ("USP11 and USP15" . SPARSER::COLLECTION)
    ("nonspecific off-rate components" . SPARSER::COMPONENT)
    ("SPR" . SPARSER::PROTEIN) ("a shorter linker" . SPARSER::LINKER)
    ("the flexible linker" . SPARSER::LINKER)
    ("USP4–ubiquitin" . SPARSER::COLLECTION)
    ("minimal substrates" . SPARSER::SUBSTRATE) ("TAMRA" . SPARSER::MOLECULE)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("the minimal substrate" . SPARSER::SUBSTRATE)
    ("the minimal substrate Ub–Rhod" . SPARSER::COLLECTION)
    ("Ub-Prg" . SPARSER::COLLECTION) ("Prg" . SPARSER::PROTEIN)
    ("the six non-crystallographic symmetry-related molecules"
     . SPARSER::MOLECULE)
    ("USP2, USP8 and USP21" . SPARSER::COLLECTION) ("apo" . SPARSER::PROTEIN)
    ("palm" . SPARSER::PROTEIN) ("GFO" . SPARSER::PROTEIN)
    ("Ub–Rhod" . SPARSER::COLLECTION)
    ("ubiquitin–rhodamine" . SPARSER::COLLECTION) ("Rhod" . SPARSER::PROTEIN)
    ("Ub" . SPARSER::PROTEIN) ("rhodamine" . SPARSER::PROTEIN)
    ("fragments—domain 1" . SPARSER::COLLECTION)
    ("thermolysin" . SPARSER::PROTEIN)
    ("USP15 (57% identity) and USP11 (46% identity)" . SPARSER::COLLECTION)
    ("linker" . SPARSER::LINKER) ("TRAF2 and TRAF6" . SPARSER::COLLECTION)
    ("TGF" . SPARSER::DRUG) ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("GMP" . SPARSER::GMP) ("SL" . SPARSER::PROTEIN)
    ("SAGA" . SPARSER::PROTEIN) ("grasp" . SPARSER::PROTEIN)
    ("diglycine" . SPARSER::MOLECULE) ("USP" . SPARSER::PROTEIN)
    ("papain" . SPARSER::PROTEIN) ("DUBs" . SPARSER::PROTEIN)
    ("USPs" . SPARSER::PROTEIN) ("Ubl" . SPARSER::PROTEIN)
    ("DUSP–Ubl" . SPARSER::COLLECTION) ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a productive conformation" . SPARSER::BIO-CONFORMATION)
    ("Ubiquitin" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("Sulfo-NHS" . SPARSER::DRUG) ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("two domains" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("Isoform 2" . SPARSER::PROTEIN) ("UbcH5C" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("CD–" . SPARSER::PROTEIN) ("USP14" . SPARSER::PROTEIN)
    ("BL2" . SPARSER::PROTEIN) ("USP21" . SPARSER::PROTEIN)
    ("USP2" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("USP8" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("USP11" . SPARSER::PROTEIN) ("USP15" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("SART3" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("Sgf11" . SPARSER::PROTEIN-FAMILY)
    ("USP4" . SPARSER::PROTEIN) ("chaperones" . SPARSER::PROTEIN)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("GRP78 and leptin" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("Further studies using siRNA or STAT3 inhibitors" . SPARSER::INHIBITOR)
    ("siRNA or STAT3" . SPARSER::COLLECTION)
    ("LY294002 and rapamycin" . SPARSER::COLLECTION)
    ("LY294002 and mTOR" . SPARSER::COLLECTION)
    ("LY294002 and PD98059" . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("Raf/MEK1/ERK" . SPARSER::COLLECTION)
    ("Akt and ERK1/2" . SPARSER::COLLECTION)
    ("LY294002 (5 μM) and PD98059 (10 μM)" . SPARSER::COLLECTION)
    ("PI3K and MEK, LY294002 and PD98059" . SPARSER::COLLECTION)
    ("MEK, LY294002 and PD98059" . SPARSER::COLLECTION)
    ("GRP78 and eIF2α" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("C/EBP homologous protein (CHOP)" . SPARSER::PROTEIN)
    ("the ER stress-related apoptotic transcription factor" . SPARSER::PROTEIN)
    ("ATF6 and eukaryotic initiation factor 2α (eIF2α)" . SPARSER::COLLECTION)
    ("eIF2α" . SPARSER::PROTEIN) ("tunicamycin" . SPARSER::MOLECULE)
    ("ObRb" . SPARSER::PROTEIN) ("Akt and ERK" . SPARSER::COLLECTION)
    ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("STAT3, Akt, and ERK" . SPARSER::COLLECTION)
    ("SH-SY5Y-ObRb" . SPARSER::COLLECTION)
    ("PKR-like endoplasmic reticulum-resident kinase (PERK)" . SPARSER::KINASE)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("LY294002, and mTOR" . SPARSER::COLLECTION) ("rapamycin" . SPARSER::DRUG)
    ("IRE1-XBP1" . SPARSER::COLLECTION) ("Ob-Rb" . SPARSER::COLLECTION)
    ("Leptin" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("anti-ERK" . SPARSER::PROTEIN) ("CA-3" . SPARSER::PROTEIN)
    ("XBP-1" . SPARSER::PROTEIN) ("long form" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("X-box-binding protein 1" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("Ob-R" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::PROTEIN) ("XBP1" . SPARSER::PROTEIN)
    ("IRE1" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("a powerful biomarker" . SPARSER::MOLECULE)
    ("CIII" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Apolipoprotein" . SPARSER::MOLECULE)
    ("only one allele" . SPARSER::ALLELE)
    ("Approximately 400–450 proteins" . SPARSER::PROTEIN)
    ("run" . SPARSER::PROTEIN-FAMILY)
    ("ATM (p = 0.012) and IGF1R (p = 0.025)" . SPARSER::COLLECTION)
    ("BRCA1 (p = 0.03), BIRC5 (p = 0.035), CCND2 (p0.034), ATM (p = 0.012) and IGF1R (p = 0.025)"
     . SPARSER::COLLECTION)
    ("TGFB1 (p = 0.084) and TP53 (p = 0.334)" . SPARSER::COLLECTION)
    ("CTSD" . SPARSER::PROTEIN)
    ("CR10, CR11, CR18 and CR25" . SPARSER::COLLECTION)
    ("TNFRSF10C (p = 0.005) and PYCARD (p = 0.02)" . SPARSER::COLLECTION)
    ("HIC1 (p = 0.02), CDH13 (p = 0.01), CDH1 (p = 0.025), CDKNA2 (p = 0.002), MGMT (p = 0.002), CCNA1 (p = 0.037), TNFRSF10C (p = 0.005) and PYCARD (p = 0.02)"
     . SPARSER::COLLECTION)
    ("TNFRSF10C (p = 0.029) and PYCARD (p = 0.269)" . SPARSER::COLLECTION)
    ("HIC1 (p = 0.093), CDH13 (p = 0.014), CDH1 (p = 0.011), CDKN2A (p = 0.167), MGMT (p = 0.067), SLIT2 (p = 0.013), CCNA1 (p = 0.075), TNFRSF10C (p = 0.029) and PYCARD (p = 0.269)"
     . SPARSER::COLLECTION)
    ("PYCARD" . SPARSER::PROTEIN) ("the triple negative type" . TYPE)
    ("methylated BRCA1 promoter in WBC and early onset" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("MSP" . SPARSER::PROTEIN)
    ("methylated BRCA1 promoter in WBC and the risk" . SPARSER::COLLECTION)
    ("breast-ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("the hereditary type" . TYPE) ("a normally active gene" . SPARSER::GENE)
    ("BRCA1 and 15 other important cancer –related genes"
     . SPARSER::COLLECTION)
    ("methylated BRCA1 promoter" . SPARSER::PROMOTER)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("CDKN2" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN) ("MAPK3" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN) ("TNFRSF10C" . SPARSER::PROTEIN)
    ("CCNA1" . SPARSER::PROTEIN) ("SLIT2" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("CDH13" . SPARSER::PROTEIN)
    ("HIC1" . SPARSER::PROTEIN) ("BRCA 1" . SPARSER::PROTEIN)
    ("Breast Cancer Associated gene1" . SPARSER::PROTEIN)
    ("E1 and eIF" . SPARSER::COLLECTION) ("reagents" . SPARSER::MOLECULE)
    ("NF-κB-driven eIF4E1" . SPARSER::PROTEIN) ("almost all types" . TYPE)
    ("eIF4E1 and eIF4E3-driven" . SPARSER::COLLECTION)
    ("excessive eIF4E1" . SPARSER::PROTEIN)
    ("the monosomal and early polysomal fractions" . SPARSER::COMPONENT)
    ("DTD" . SPARSER::PROTEIN) ("POLA2 and DDX49" . SPARSER::COLLECTION)
    ("SUDHL-2" . SPARSER::COLLECTION)
    ("BTK, YY1 and CDK6" . SPARSER::COLLECTION) ("BTK" . SPARSER::PROTEIN)
    ("n-Myc , HMGA1 , CDX2 and TWIST1" . SPARSER::COLLECTION)
    ("ADAR" . SPARSER::PROTEIN) ("dicer" . SPARSER::PROTEIN)
    ("PCNA and CDK2" . SPARSER::COLLECTION) ("PCNA" . SPARSER::PROTEIN)
    ("eIF4E1 or eIF4E3" . SPARSER::COLLECTION)
    ("eIF4A and eIF4G" . SPARSER::COLLECTION)
    ("eIF4E3 and eIF4G" . SPARSER::COLLECTION) ("delta" . SPARSER::PROTEIN)
    ("cyclin D1 and VEGF" . SPARSER::COLLECTION)
    ("MNK2 and MNK1-TD mutant (a constitutively activated MNK1 mutant)"
     . SPARSER::COLLECTION)
    ("the commercial phospho-specific antibody" . SPARSER::ANTIBODY)
    ("constitutively phosphorylated eIF4E1 and phosphorylation-deficient eIF4E1 proteins"
     . SPARSER::COLLECTION)
    ("phosphonull" . SPARSER::PROTEIN) ("its physical form" . SPARSER::FORM)
    ("Cercosporamide" . SPARSER::DRUG)
    ("cercosporamide and CGP57380" . SPARSER::COLLECTION)
    ("cercosporamide" . SPARSER::DRUG)
    ("the polysomal fraction" . SPARSER::COMPONENT)
    ("the heavy polysomal fraction" . SPARSER::COMPONENT)
    ("polysome" . SPARSER::BIO-COMPLEX) ("sucrose" . SPARSER::MOLECULE)
    ("shRNA or non-target" . SPARSER::COLLECTION) ("shRNAs" . SPARSER::RNA)
    ("eIF4E1 and mRNA" . SPARSER::COLLECTION)
    ("MNK-TD and MNK-AA" . SPARSER::COLLECTION) ("TD" . SPARSER::PROTEIN)
    ("MNK1-TD and MNK1-AA" . SPARSER::COLLECTION)
    ("MNK1-TD" . SPARSER::COLLECTION)
    ("MNK1-phosphonull" . SPARSER::PROTEIN-PAIR) ("CFSE" . SPARSER::DRUG)
    ("p38-MAPK" . SPARSER::COLLECTION)
    ("the longer isoforms" . SPARSER::ISOFORM) ("MNK2a" . SPARSER::PROTEIN)
    ("p38 and not ERK in DLBCL" . SPARSER::COLLECTION)
    ("MNK1-" . SPARSER::PROTEIN) ("HLY" . SPARSER::PROTEIN)
    ("eIF4E1 and eIF4E2" . SPARSER::COLLECTION) ("eIF4E2" . SPARSER::PROTEIN)
    ("ERK or p38 MAPKs" . SPARSER::COLLECTION) ("gemcitabine" . SPARSER::DRUG)
    ("MNK2a-p38 MAPKs" . SPARSER::PROTEIN-PAIR)
    ("the longer isoform" . SPARSER::ISOFORM)
    ("the longer alternate splice form" . SPARSER::FORM)
    ("ERK and p38 MAPKs" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ribavirin" . SPARSER::DRUG) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("eIF4E1 and eIF4E3" . SPARSER::COLLECTION)
    ("a highly aggressive and heterogeneous type" . TYPE)
    ("eIF4E3" . SPARSER::PROTEIN) ("MNK1 and MNK2" . SPARSER::COLLECTION)
    ("MNK1 or MNK2" . SPARSER::COLLECTION) ("eIF4E1" . SPARSER::PROTEIN)
    ("eIF" . SPARSER::PROTEIN) ("K-N" . SPARSER::PROTEIN)
    ("DDX49" . SPARSER::PROTEIN) ("POLA2" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("DICER1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("CDX2" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("n-Myc" . SPARSER::PROTEIN)
    ("RNA-specific" . SPARSER::PROTEIN)
    ("adenosine deaminase" . SPARSER::PROTEIN) ("MKNK2" . SPARSER::PROTEIN)
    ("CGP57380" . SPARSER::DRUG) ("actinomycin-D" . SPARSER::MOLECULE)
    ("S1b" . SPARSER::PROTEIN) ("MCL-1" . SPARSER::PROTEIN)
    ("VX702" . SPARSER::DRUG) ("FTY720" . SPARSER::DRUG)
    ("protein phosphatase 2" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("AZD6244" . SPARSER::DRUG) ("m 7 G" . SPARSER::MOLECULE)
    ("p38 MAPKs" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("MNK2" . SPARSER::PROTEIN) ("MNK1" . SPARSER::PROTEIN)
    ("Van" . SPARSER::PROTEIN) ("type and latency" . SPARSER::COLLECTION)
    ("the last group" . SPARSER::MOLECULE)
    ("TWIST, YB-1 and HER2" . SPARSER::COLLECTION)
    ("TWIST and YB-1" . SPARSER::COLLECTION) ("TWIST" . SPARSER::PROTEIN)
    ("TWIST-YB-1" . SPARSER::COLLECTION)
    ("a larger EBVaGC cohort" . SPARSER::MOLECULE)
    ("LMP2A and HER2" . SPARSER::COLLECTION)
    ("LMP2A− (n=39) and LMP2A+ (n=24)" . SPARSER::COLLECTION)
    ("LMP2A−" . SPARSER::PROTEIN)
    ("SGC7901-LMP2A and SGC7901-pBabe" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN) ("group and HER2" . SPARSER::COLLECTION)
    ("EBER" . SPARSER::RNA) ("HER2, and trastuzumab" . SPARSER::COLLECTION)
    ("arm" . SPARSER::PROTEIN) ("EBNA1, EBERs and BARTs" . SPARSER::COLLECTION)
    ("LMP1 and LMP2" . SPARSER::COLLECTION)
    ("two EBV-encoded small non-coding RNAs (EBERs 1 and 2) and the BamHI"
     . SPARSER::COLLECTION)
    ("LMPs" . SPARSER::PROTEIN) ("NPC" . SPARSER::MOLECULE)
    ("lymphoid" . SPARSER::PROTEIN) ("LMP2A−/HER2" . SPARSER::COLLECTION)
    ("HER2, TWIST and YB-1" . SPARSER::COLLECTION)
    ("HER2 and LMP2A" . SPARSER::COLLECTION) ("Lamin B1" . SPARSER::PROTEIN)
    ("LMP2B" . SPARSER::PROTEIN) ("3A3" . SPARSER::PROTEIN)
    ("A11" . SPARSER::PROTEIN) ("RNA-1" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lamin B1" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("LMP2" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN) ("EBNA1" . SPARSER::PROTEIN)
    ("EBNA-LP" . SPARSER::PROTEIN) ("LMP2A" . SPARSER::PROTEIN)
    ("/cyclin" . SPARSER::COLLECTION) ("TSC2 and TSC1" . SPARSER::COLLECTION)
    ("TSC" . SPARSER::PROTEIN) ("MYCN" . SPARSER::PROTEIN)
    ("MYC" . SPARSER::PROTEIN) ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("PCTK1 and c-Myc" . SPARSER::COLLECTION)
    ("cyclin Y (CCNY)" . SPARSER::PROTEIN) ("CCNY" . SPARSER::PROTEIN)
    ("MBP" . SPARSER::PROTEIN) ("SNX27, MAGI3 and PTPN3" . SPARSER::COLLECTION)
    ("Zonula" . SPARSER::PROTEIN) ("Discs" . SPARSER::BIO-COMPLEX)
    ("carboxy" . SPARSER::MOLECULE) ("c-Myc and protein" . SPARSER::COLLECTION)
    ("SHH" . SPARSER::PROTEIN)
    ("so far few validated molecular targets" . SPARSER::TARGET-PROTEIN)
    ("trypan" . SPARSER::DRUG) ("Trypan" . SPARSER::DRUG)
    ("4E-BP and S6 protein" . SPARSER::COLLECTION)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("p-4E-BP" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("Indirubin" . SPARSER::DRUG)
    ("nad" . SPARSER::MOLECULE) ("DFG" . SPARSER::PROTEIN)
    ("the inhibitor and the side" . SPARSER::COLLECTION)
    ("amide" . SPARSER::MOLECULE) ("indole" . SPARSER::DRUG)
    ("indirubin" . SPARSER::DRUG) ("CB" . SPARSER::PROTEIN)
    ("c-Myc-ER" . SPARSER::COLLECTION)
    ("a monomeric serine-threonine protein kinase" . SPARSER::KINASE)
    ("at least 2 different siRNAs" . SPARSER::PROTEIN)
    ("3 distinct siRNAs" . SPARSER::PROTEIN)
    ("protein and lipid" . SPARSER::COLLECTION) ("HTS" . SPARSER::PROTEIN)
    ("genes and pathways" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("LCA" . SPARSER::PROTEIN) ("Group" . SPARSER::MOLECULE)
    ("Shh" . SPARSER::PROTEIN)
    ("EPHA7 (EPH receptor A7) and PCTK1 (PCTAIRE protein kinase 1)"
     . SPARSER::COLLECTION)
    ("AKAP12 ( A-kinase anchor protein), CSNK1α1 (casein kinase 1, alpha 1), EPHA7 (EPH receptor A7) and PCTK1 (PCTAIRE protein kinase 1)"
     . SPARSER::COLLECTION)
    ("PCTAIRE" . SPARSER::PROTEIN) ("cMYC" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("RNase A" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("Ephrin receptor" . SPARSER::PROTEIN)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("TSC1" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("cyclin Y" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN) ("PCTAIRE-1" . SPARSER::PROTEIN)
    ("Myelin Basic Protein" . SPARSER::PROTEIN) ("PTPN3" . SPARSER::PROTEIN)
    ("MAGI3" . SPARSER::PROTEIN) ("SNX27" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("p-S6" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("PCTAIRE1" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("ephrin receptor" . SPARSER::PROTEIN)
    ("Casein kinase 1" . SPARSER::PROTEIN) ("PCTK1" . SPARSER::PROTEIN)
    ("EPH receptor A7" . SPARSER::PROTEIN) ("EPHA7" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("A-kinase anchor protein" . SPARSER::PROTEIN)
    ("AKAP12" . SPARSER::PROTEIN) ("VEGF-A and VEGF-B" . SPARSER::COLLECTION)
    ("ABCG2 and ABCB1" . SPARSER::COLLECTION)
    ("Wnt5A, β-catenin and VEGF-A" . SPARSER::COLLECTION)
    ("VEGF, Wnt5A and ABCB1" . SPARSER::COLLECTION)
    ("a more extensive cohort" . SPARSER::MOLECULE)
    ("mitoxantrone" . SPARSER::DRUG)
    ("ABCB1, GSTpi, MGMT, Upa and TGM2" . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN) ("GSTpi" . SPARSER::PROTEIN)
    ("hydralazine and magnesium valproate" . SPARSER::COLLECTION)
    ("doxorubicin and cyclophosphamide" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG) ("valproate" . SPARSER::DRUG)
    ("hydralazine" . SPARSER::DRUG) ("PKA- and NF-kappa" . SPARSER::COLLECTION)
    ("PKA and NF-kappa" . SPARSER::COLLECTION) ("PKA-" . SPARSER::PROTEIN)
    ("docetaxel" . SPARSER::DRUG) ("PKA and ER" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE)
    ("Wnt5A and NFATc2" . SPARSER::COLLECTION)
    ("Wnt5A and its receptor" . SPARSER::COLLECTION)
    ("paclitaxel, oxaliplatin, 5-fluorouracil, epirubicin and etoposide"
     . SPARSER::COLLECTION)
    ("epirubicin" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("β-catenin and Wnt1" . SPARSER::COLLECTION)
    ("paclitaxel and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("paclitaxel" . SPARSER::DRUG)
    ("TCF4/β-catenin" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("Wnt5A or ABCB1" . SPARSER::COLLECTION)
    ("VEGF and Wnt5A" . SPARSER::COLLECTION)
    ("VEGF and ABCB1" . SPARSER::COLLECTION)
    ("Wnt5A and ABCB1" . SPARSER::COLLECTION)
    ("Wnt5A, ABCB1 and VEGF" . SPARSER::COLLECTION)
    ("89.5% and 85.4% in 1 μg control antibody and 0.85 μM doxorubicin co-treated MCF7/ADR2"
     . SPARSER::COLLECTION)
    ("β-catenin, c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("Wnt5A/PKA/β-catenin" . SPARSER::COLLECTION)
    ("Antibody" . SPARSER::PROTEIN) ("Calcein" . SPARSER::MOLECULE)
    ("ABCB1-luciferase" . SPARSER::COLLECTION)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("phosphorylated GSK3β (Ser 9) and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin, ABCB1, c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("PKA and β-catenin" . SPARSER::COLLECTION)
    ("phosphorylated β-catenin (Thr41/Ser45) and GSK3β" . SPARSER::COLLECTION)
    ("cyclic AMP response element (CRE)-binding proteins and subsequent CRE activation"
     . SPARSER::COLLECTION)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cAMP/PKA" . SPARSER::COLLECTION)
    ("PRKACA, PRKACB and PRKACG" . SPARSER::COLLECTION)
    ("PRKACG" . SPARSER::PROTEIN) ("PRKACB" . SPARSER::PROTEIN)
    ("PRKACA" . SPARSER::PROTEIN)
    ("Wnt5A-activated Protein Kinase" . SPARSER::COLLECTION)
    ("Wnt5A and β-catenin" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("cellular Wnt5A" . SPARSER::PROTEIN) ("western blot" . SPARSER::PROTEIN)
    ("Wnt2, Wnt5A and Wnt7A" . SPARSER::COLLECTION)
    ("Wnt7A" . SPARSER::PROTEIN)
    ("ABCB1, β-catenin, c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("ABCB1, cyclin D1, c-Myc and VEGF" . SPARSER::COLLECTION)
    ("PKA/β-catenin" . SPARSER::COLLECTION)
    ("ABCB1 and VEGF" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("multidrug" . SPARSER::PROTEIN)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("a well-discussed non-canonical Wnt protein" . SPARSER::PROTEIN)
    ("PCP" . SPARSER::PROTEIN)
    ("also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1)"
     . SPARSER::COLLECTION)
    ("P-gp or Pgp" . SPARSER::COLLECTION) ("Pgp" . SPARSER::PROTEIN)
    ("the drug's" . SPARSER::DRUG)
    ("the drug-resistance protein ABCB1 and β-catenin-related genes"
     . SPARSER::COLLECTION)
    ("VEGF and/or ABCB1" . SPARSER::COLLECTION)
    ("Wnt5A, VEGF and/or ABCB1" . SPARSER::COLLECTION)
    ("CRE" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("Wnt5A" . SPARSER::PROTEIN) ("ADR" . SPARSER::PROTEIN)
    ("Multidrug" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("green-fluorescent protein" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("COBRA 1" . SPARSER::PROTEIN) ("Wnt 5" . SPARSER::PROTEIN)
    ("MDR-1" . SPARSER::PROTEIN) ("C-K" . SPARSER::PROTEIN)
    ("VEGF-B" . SPARSER::PROTEIN) ("FZD1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("TGM2" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN) ("NFATc2" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("ROR2" . SPARSER::PROTEIN)
    ("retinoic acid receptor gamma" . SPARSER::PROTEIN)
    ("PITX2" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("Fzd1" . SPARSER::PROTEIN) ("Wnt receptor" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN)
    ("activated Protein Kinase" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("Wnt7" . SPARSER::PROTEIN)
    ("Wnt2" . SPARSER::PROTEIN) ("Wnt-5" . SPARSER::PROTEIN)
    ("Wnt3A" . SPARSER::PROTEIN)
    ("ATP-binding cassette sub-family B member 1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Wnt5" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("anti-viral and infection responses" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION)
    ("a pleiotropic inflammatory cytokine" . SPARSER::PROTEIN)
    ("NFκB as well as p53" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("p53 or p65" . SPARSER::COLLECTION)
    ("the most synergistic genes" . SPARSER::GENE)
    ("AP-1 [ xref – xref ] or ER [ xref ]" . SPARSER::COLLECTION)
    ("NFkB" . SPARSER::PROTEIN) ("p53- or NFκB-" . SPARSER::COLLECTION)
    ("NFκB-" . SPARSER::PROTEIN) ("p65 or p53" . SPARSER::COLLECTION)
    ("MDA and MCF7" . SPARSER::COLLECTION)
    ("S100A8, S100A9 and CXCL12" . SPARSER::COLLECTION)
    ("CXCL12 and several Serpins" . SPARSER::COLLECTION)
    ("IL6, IL17, IL15 and its receptor, S100A8 and S100A9"
     . SPARSER::COLLECTION)
    ("its receptor, S100A8 and S100A9" . SPARSER::COLLECTION)
    ("a first line chemotherapeutic drug" . SPARSER::DRUG)
    ("cytokine and NFκB" . SPARSER::COLLECTION) ("traits" . SPARSER::PROTEIN)
    ("NTN1 and ETV7" . SPARSER::COLLECTION)
    ("NTN1, ETV7 and LAMP3" . SPARSER::COLLECTION)
    ("PLK3 and UNC5B" . SPARSER::COLLECTION)
    ("p53 and p21 protein" . SPARSER::COLLECTION) ("DT" . SPARSER::PROTEIN)
    ("/CD24" . SPARSER::COLLECTION)
    ("SOX9 [ xref ] and GBX2 [ xref ]" . SPARSER::COLLECTION)
    ("EMT" . SPARSER::PROTEIN)
    ("PLK3, NTN1, ETV7, UNC5B and LAMP3" . SPARSER::COLLECTION)
    ("LAMP3 and ETV7" . SPARSER::COLLECTION)
    ("DCC1 and UNC5B" . SPARSER::COLLECTION)
    ("PLK3, NTN1 and UNC5B" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG) ("BAY" . SPARSER::DRUG)
    ("BAY 11–7082 (BAY)" . SPARSER::DRUG) ("NPPC" . SPARSER::PROTEIN)
    ("PLAU" . SPARSER::PROTEIN) ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFKBIA, IRF7 and STAT1" . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("GO" . SPARSER::PROTEIN) ("pfp" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN)
    ("doxorubicin and TNF" . SPARSER::COLLECTION)
    ("the p53 and p65/RELA proteins" . SPARSER::COLLECTION)
    ("p65/RELA" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("P21 and MDM2" . SPARSER::COLLECTION)
    ("Doxorubicin (Doxo) and TNF" . SPARSER::COLLECTION)
    ("Doxorubicin and TNF" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("p50/RELA" . SPARSER::COLLECTION)
    ("essential regulators" . SPARSER::REGULATOR)
    ("NFκB and p53" . SPARSER::COLLECTION)
    ("highly synergistic genes" . SPARSER::GENE)
    ("p53 or NFκB" . SPARSER::COLLECTION)
    ("doxorubicin (Doxo, 1.5μM) and the NFκB inducer TNF-alpha (TNF⍺, 5ng/ml)"
     . SPARSER::COLLECTION)
    ("p53 and NFκB" . SPARSER::COLLECTION)
    ("chemo-attractant" . SPARSER::PROTEIN) ("anti-Histone" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("BAY11-7082" . SPARSER::DRUG) ("Phenol Red" . SPARSER::DRUG)
    ("L-Glutamine" . SPARSER::MOLECULE) ("p73" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("17β-estradiol" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("S100A9" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("IL15" . SPARSER::PROTEIN)
    ("IL17" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("DCC1" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("BAY 11–7082" . SPARSER::DRUG)
    ("FOXC1" . SPARSER::PROTEIN) ("EGR2" . SPARSER::PROTEIN)
    ("TNFRSF10B" . SPARSER::PROTEIN) ("EDN2" . SPARSER::PROTEIN)
    ("GBX2" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("DUSP5" . SPARSER::PROTEIN) ("NTN1" . SPARSER::PROTEIN)
    ("UNC5B" . SPARSER::PROTEIN) ("LAMP3" . SPARSER::PROTEIN)
    ("PLK3" . SPARSER::PROTEIN) ("Nutlin-3a" . SPARSER::DRUG)
    ("NFκB" . SPARSER::PROTEIN) ("apt" . SPARSER::PROTEIN)
    ("palliative HCCs or HCC" . SPARSER::COLLECTION)
    ("HCCs or HCC" . SPARSER::COLLECTION) ("TCF and LEF" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("c- myc or cyclin D1" . SPARSER::COLLECTION)
    ("a key downstream effector and a crucial signaling molecule"
     . SPARSER::COLLECTION)
    ("a double-functional molecule" . SPARSER::MOLECULE)
    ("–1" . SPARSER::PROTEIN)
    ("tumor encapsulation and alpha fetal protein (AFP)" . SPARSER::PROTEIN)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("met" . SPARSER::AMINO-ACID)
    ("c-myc , cyclin-D1 , and survivin" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("cadherin–catenin" . SPARSER::COLLECTION)
    ("Kinase" . SPARSER::KINASE) ("Casein" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("E-cadherin–catenin" . SPARSER::COLLECTION)
    ("CSF1R, CTNNB1, KRAS, BRAF, NRAS, ERBB2, MET, PIK3CA, JAK1 , and SMO"
     . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN) ("MET" . SPARSER::PROTEIN)
    ("genes and signaling pathways" . SPARSER::COLLECTION)
    ("AFP" . SPARSER::PROTEIN) ("RFS" . SPARSER::PROTEIN)
    ("WNT/β-catenin" . SPARSER::COLLECTION) ("c- myc" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("S19" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("S16" . SPARSER::PROTEIN) ("S15" . SPARSER::PROTEIN)
    ("Beta-catenin" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("CKIα" . SPARSER::PROTEIN) ("Axin1" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN) ("derivatives" . SPARSER::DERIVATIVE)
    ("SSX1/SSX2" . SPARSER::COLLECTION)
    ("CTA family synovial sarcoma X chromosome breakpoint (SSX) proteins"
     . SPARSER::PROTEIN)
    ("SSX" . SPARSER::PROTEIN) ("CTA" . SPARSER::PROTEIN)
    ("tumor-associated proteins" . SPARSER::PROTEIN) ("ZIP" . SPARSER::PROTEIN)
    ("Rb and E2F1" . SPARSER::COLLECTION) ("–c-kit" . SPARSER::COLLECTION)
    ("SCF–c-kit" . SPARSER::COLLECTION) ("SCF–CD117" . SPARSER::COLLECTION)
    ("c-Kit-SCF" . SPARSER::COLLECTION)
    ("β-arrestin-1 and Src" . SPARSER::COLLECTION)
    ("vital genes" . SPARSER::GENE) ("K-Ras and p53" . SPARSER::COLLECTION)
    ("nitrosamines" . SPARSER::MOLECULE)
    ("control siRNA or ARRB1/β-arrestin-1 siRNA" . SPARSER::COLLECTION)
    ("NSCL" . SPARSER::PROTEIN) ("JAK/STAT" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN) ("Src as well as EGFR" . SPARSER::COLLECTION)
    ("Src and EGFR" . SPARSER::COLLECTION) ("Gefitinib" . SPARSER::DRUG)
    ("Src, PI3K, MEK and EGFR" . SPARSER::COLLECTION)
    ("the shortest SCF promoter fragment" . SPARSER::FRAGMENT)
    ("shorter promoter" . SPARSER::PROMOTER)
    ("Rb or the full-length Rb" . SPARSER::COLLECTION)
    ("pGL3-SCF" . SPARSER::COLLECTION)
    ("ARRB1/-arrestin-1" . SPARSER::COLLECTION)
    ("E2Fs and Rb" . SPARSER::COLLECTION)
    ("an irrelevant antibody" . SPARSER::PROTEIN)
    ("Rb or E2F1" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("DHFR" . SPARSER::PROTEIN)
    ("transcription factor and nicotine" . SPARSER::COLLECTION)
    ("siRNA or siRNAs" . SPARSER::COLLECTION)
    ("Nicotine and EGF" . SPARSER::COLLECTION)
    ("PBS or nicotine" . SPARSER::COLLECTION)
    ("COL4A4 , NFASC and ZNF137" . SPARSER::COLLECTION)
    ("COL4A4 , NFASC , SCF and ZNF137" . SPARSER::COLLECTION)
    ("NFASC" . SPARSER::PROTEIN)
    ("296 genes that were upregulated and 208" . SPARSER::COLLECTION)
    ("a control non-targeting siRNA or a siRNA" . SPARSER::COLLECTION)
    ("β-arrestin-1 or E2F1" . SPARSER::COLLECTION)
    ("nicotine and EGF" . SPARSER::COLLECTION)
    ("Stem cell factor/c-Kit ligand" . SPARSER::COLLECTION)
    ("β2AR-β-arrestin-1" . SPARSER::COLLECTION)
    ("Rb-E2F" . SPARSER::PROTEIN-PAIR)
    ("a multifunctional scaffolding protein" . SPARSER::PROTEIN)
    ("an oligomeric complex" . SPARSER::BIO-COMPLEX)
    ("ERK, EGFR, Src and AKT" . SPARSER::COLLECTION)
    ("adrenergic" . SPARSER::PROTEIN)
    ("norepinephrine and epinephrine" . SPARSER::COLLECTION)
    ("epinephrine" . SPARSER::DRUG) ("norepinephrine" . SPARSER::DRUG)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("the major addictive component" . SPARSER::COMPONENT)
    ("Nicotine" . SPARSER::DRUG) ("a major cytokine" . SPARSER::PROTEIN)
    ("ARRB1/β-arrestin-1" . SPARSER::COLLECTION) ("nicotine" . SPARSER::DRUG)
    ("N2" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("SSX2" . SPARSER::PROTEIN)
    ("SSX1" . SPARSER::PROTEIN) ("Y chromosome" . SPARSER::PROTEIN)
    ("PCDH11Y" . SPARSER::PROTEIN) ("PI3K–AKT–mTOR" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("PP2" . SPARSER::DRUG)
    ("arrestin-1" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("c-Fos" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("β-Arrestin-1" . SPARSER::PROTEIN)
    ("ZNF137" . SPARSER::PROTEIN) ("COL4A4" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("c-Kit ligand" . SPARSER::PROTEIN)
    ("β2AR" . SPARSER::PROTEIN) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F1" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("Stem cell factor" . SPARSER::PROTEIN) ("G-protein" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("ARRB1" . SPARSER::PROTEIN)
    ("β-arrestin-1" . SPARSER::PROTEIN) ("MEC" . SPARSER::PROTEIN)
    ("genotype" . SPARSER::PROTEIN) ("BRCA1- and BRCA2-" . SPARSER::COLLECTION)
    ("BRCA2-" . SPARSER::PROTEIN) ("BRCA1-" . SPARSER::PROTEIN)
    ("metabolite" . SPARSER::MOLECULE) ("-mutant" . SPARSER::MUTANT)
    ("even less BRCA1" . SPARSER::PROTEIN)
    ("the available BRCA1" . SPARSER::PROTEIN)
    ("intact BRCA1" . SPARSER::PROTEIN)
    ("the UV pre-treated heterozygotes" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("heterozygotes" . SPARSER::PROTEIN)
    ("a BRCA1-associated nuclease" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("CtIP" . SPARSER::PROTEIN)
    ("IdU" . SPARSER::DRUG) ("53BP1 and γ-H2AX" . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN) ("53BP1 and/or γ- H2AX" . SPARSER::COLLECTION)
    ("one mutated allele" . SPARSER::ALLELE) ("MECs" . SPARSER::PROTEIN)
    ("a lentiviral BRCA1" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("pRPA" . SPARSER::PROTEIN) ("HU" . SPARSER::DRUG)
    ("phospho-RPA32-coated single-stranded DNA" . SPARSER::DNA)
    ("ATRIP/ATR" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("ATRIP" . SPARSER::PROTEIN) ("olaparib" . SPARSER::DRUG)
    ("inhibitors (PI)" . SPARSER::INHIBITOR) ("DSBR" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("the latter BRCA1" . SPARSER::PROTEIN) ("BUdR" . SPARSER::PROTEIN)
    ("CD44, CD49f, CD24 and EpCAM" . SPARSER::COLLECTION)
    ("EpCAM" . SPARSER::PROTEIN) ("FACS" . SPARSER::PROTEIN)
    ("hME" . SPARSER::PROTEIN) ("an essential component" . SPARSER::COMPONENT)
    ("an E3 ubiquitin ligase and a multi-functional scaffold"
     . SPARSER::COLLECTION)
    ("a multi-functional scaffold" . SPARSER::SCAFFOLD)
    ("ovarian cancer susceptibility gene" . SPARSER::GENE)
    ("ovarian cancer suppressor" . SPARSER::SUPPRESSOR)
    ("HR-DSBR" . SPARSER::COLLECTION) ("homologous recombination- type" . TYPE)
    ("multiple normal BRCA1" . SPARSER::PROTEIN) ("Slug" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE) ("S25" . SPARSER::PROTEIN)
    ("Cre1" . SPARSER::PROTEIN) ("1-B" . SPARSER::PROTEIN)
    ("brca1" . SPARSER::PROTEIN) ("Meox2" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("CYP1A" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("p-S" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("γ- H2AX" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("TPX2" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("drugs or drug" . SPARSER::COLLECTION)
    ("unstable mRNA" . SPARSER::PROTEIN) ("acute phase genes" . SPARSER::GENE)
    ("IL-2 or VEGF" . SPARSER::COLLECTION)
    ("p21 and CDC2" . SPARSER::COLLECTION)
    ("either NF90 or its binding partner NF45" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION) ("sorafenib" . SPARSER::DRUG)
    ("B/ CDK1 and cyclin" . SPARSER::COLLECTION)
    ("Roscovitine" . SPARSER::DRUG)
    ("eight commonly used antineoplastic drugs as well as the CDKs inhibitor roscovitine (Selleck, Houston, TX, USA)"
     . SPARSER::COLLECTION)
    ("eight commonly used antineoplastic drugs" . SPARSER::DRUG)
    ("various chemotherapeutic drugs" . SPARSER::DRUG)
    ("exogenous Myc-tagged NF90 (terminal) protein" . SPARSER::PROTEIN)
    ("Commercial antibodies" . SPARSER::ANTIBODY)
    ("GST-NF90" . SPARSER::COLLECTION)
    ("NF90 and the cyclin E1" . SPARSER::COLLECTION)
    ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("cyclin D1, cyclin E1 and MAPK6" . SPARSER::COLLECTION)
    ("-2-" . SPARSER::PROTEIN) ("NF90 or NF110" . SPARSER::COLLECTION)
    ("NF90 and the larger alternative splice variant NF110"
     . SPARSER::COLLECTION)
    ("the larger alternative splice variant NF110" . SPARSER::DRUG)
    ("HuR" . SPARSER::PROTEIN)
    ("the pathogenic genes and molecular mechanisms of HCC formation"
     . SPARSER::COLLECTION)
    ("the pathogenic genes" . SPARSER::GENE)
    ("-1, MyoD, p21 and CDC2" . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN) ("Tau" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("roscovitine" . SPARSER::DRUG)
    ("NF90 and cyclin E1" . SPARSER::COLLECTION) ("dsRNA" . SPARSER::RNA)
    ("β2-microglobulin" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("RPLP0" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–2 µ" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("B/ CDK1" . SPARSER::PROTEIN) ("MAPK6" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("NF45" . SPARSER::PROTEIN)
    ("NF110" . SPARSER::DRUG) ("bcl-2" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN)
    ("interleukin enhancer binding factor 3" . SPARSER::PROTEIN)
    ("NFAR1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("NF90" . SPARSER::PROTEIN) ("cyclin E1" . SPARSER::PROTEIN)
    ("WANG" . SPARSER::PROTEIN) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("AICAR and probucol" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("Cip" . SPARSER::PROTEIN)
    ("probucol and AMPK" . SPARSER::COLLECTION)
    ("ROS-LKB1" . SPARSER::COLLECTION) ("oxidants" . SPARSER::MOLECULE)
    ("LKB1-AMPK/p27 Kip1" . SPARSER::COLLECTION)
    ("LKB1 and AMPK" . SPARSER::COLLECTION) ("AICAR-" . SPARSER::PROTEIN)
    ("AICAR" . SPARSER::PROTEIN) ("probucol or AMPK" . SPARSER::COLLECTION)
    ("LKB1 siRNA ( xref ) and AMPKα siRNA ( xref )" . SPARSER::COLLECTION)
    ("ROS-LKB1-AMPK" . SPARSER::COLLECTION) ("thymidine" . SPARSER::PROTEIN)
    ("Tempol" . SPARSER::DRUG) ("DHE" . SPARSER::DRUG)
    ("reactive oxygen" . SPARSER::MOLECULE) ("SAMS" . SPARSER::PROTEIN)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("at least 13 downstream kinases" . SPARSER::PROTEIN)
    ("genesis" . SPARSER::PROTEIN)
    ("MG132 (proteasome inhibitor) or compound C (AMPK inhibitor)"
     . SPARSER::COLLECTION)
    ("LKB1, AMPK or p27 Kip1" . SPARSER::COLLECTION) ("tempol" . SPARSER::DRUG)
    ("probucol" . SPARSER::DRUG)
    ("the relevant signaling proteins" . SPARSER::PROTEIN)
    ("an in situ fluorescent substrate" . SPARSER::SUBSTRATE)
    ("Western blot" . SPARSER::PROTEIN) ("Probucol" . SPARSER::DRUG)
    ("Cdk2" . SPARSER::PROTEIN) ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chymotrypsin-like" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("AMPKα1" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("fatty acid" . SPARSER::MOLECULE) ("AMP-activated" . SPARSER::PROTEIN)
    ("Liver kinase B1" . SPARSER::PROTEIN) ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("compound C" . SPARSER::MOLECULE) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U87" . SPARSER::PROTEIN) ("proteins and p53" . SPARSER::COLLECTION)
    ("mitotic centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN)
    ("Fn1, NuMA, EWSR1 and RBMX" . SPARSER::COLLECTION)
    ("Pin1 and CDK1" . SPARSER::COLLECTION)
    ("JNK1 and CDK1" . SPARSER::COLLECTION)
    ("kinase and phosphatase" . SPARSER::COLLECTION)
    ("CKII" . SPARSER::PROTEIN) ("CDK1 and PP2A" . SPARSER::COLLECTION)
    ("a mitotic substrate" . SPARSER::SUBSTRATE)
    ("CDK1/cyclin B1" . SPARSER::COLLECTION)
    ("the 785 amino acids of Sp1" . SPARSER::PROTEIN)
    ("in turn causes Sp1" . SPARSER::PROTEIN) ("TM" . SPARSER::PROTEIN)
    ("nuclear mitotic apparatus protein" . SPARSER::PROTEIN)
    ("Fn1" . SPARSER::PROTEIN) ("RBMX" . SPARSER::PROTEIN)
    ("NuMA" . SPARSER::PROTEIN) ("Sp1 and its mutants" . SPARSER::COLLECTION)
    ("MEF and MEF" . SPARSER::COLLECTION) ("CIP/WAP" . SPARSER::COLLECTION)
    ("WAP" . SPARSER::PROTEIN) ("RNF4 and full-length" . SPARSER::COLLECTION)
    ("GFP-Sp1" . SPARSER::COLLECTION) ("CIP" . SPARSER::PROTEIN)
    ("peptides and phospho-peptides" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("PPIase" . SPARSER::PROTEIN) ("oligopeptides" . SPARSER::MOLECULE)
    ("Wild-type Pin1 and its mutants" . SPARSER::COLLECTION)
    ("GST-Sp1" . SPARSER::COLLECTION) ("Sp1 and CDK1" . SPARSER::COLLECTION)
    ("cyclin B1 and H3S10" . SPARSER::COLLECTION)
    ("Sp1 and Pin1" . SPARSER::COLLECTION) ("GST-Pin1" . SPARSER::COLLECTION)
    ("recombinant wild-type Pin1 and a Pin1" . SPARSER::COLLECTION)
    ("mitotic Sp1" . SPARSER::PROTEIN) ("cyclin B1/CDK1" . SPARSER::COLLECTION)
    ("BNIP-H/Caytaxin" . SPARSER::COLLECTION) ("Caytaxin" . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN) ("pSer" . SPARSER::PROTEIN)
    ("cis-trans" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("casein" . SPARSER::PROTEIN) ("serine or threonine" . SPARSER::COLLECTION)
    ("-type" . TYPE) ("glutamine" . SPARSER::AMINO-ACID)
    ("GC" . SPARSER::PROTEIN) ("-Sp1" . SPARSER::COLLECTION)
    ("phospho-Sp1 and CDK1" . SPARSER::COLLECTION)
    ("-Pro" . SPARSER::COLLECTION)
    ("Cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("derived growth factor-D" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("fibronectin 1" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("hnRNP-G" . SPARSER::PROTEIN)
    ("15A1" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("SO 4" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("pGL2" . SPARSER::PROTEIN) ("penicillin G" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("SEPT9" . SPARSER::PROTEIN) ("BNIP-H" . SPARSER::PROTEIN)
    ("BPGAP1" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("JNK1" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("c-Jun" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("C 2 H 2" . SPARSER::MOLECULE) ("RNF4" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("cycD1–CDK4" . SPARSER::COLLECTION)
    ("c-Myc and Ras" . SPARSER::COLLECTION)
    ("STK33 and Ras" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("KRAS, HRAS or NRAS" . SPARSER::COLLECTION) ("hot" . SPARSER::PROTEIN)
    ("NRAS" . SPARSER::PROTEIN) ("HRAS" . SPARSER::PROTEIN)
    ("H-Ras, N-Ras and K-Ras" . SPARSER::COLLECTION)
    ("proteins, H-Ras, N-Ras, K-Ras4A and K-Ras4B" . SPARSER::COLLECTION)
    ("HCC therapeutic medicine" . SPARSER::DRUG) ("medicine" . SPARSER::DRUG)
    ("Myc" . SPARSER::PROTEIN) ("Max and bends DNA" . SPARSER::COLLECTION)
    ("-CACGTG-3" . SPARSER::COLLECTION) ("Max" . SPARSER::PROTEIN)
    ("TRRAP, GCN5 and TBP" . SPARSER::COLLECTION) ("TBP" . SPARSER::PROTEIN)
    ("TRRAP" . SPARSER::PROTEIN) ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("albumin" . SPARSER::PROTEIN) ("protein or mRNA" . SPARSER::COLLECTION)
    ("GST-STK33" . SPARSER::COLLECTION)
    ("glutathione S-transferase (GST)" . SPARSER::PROTEIN)
    ("aa" . SPARSER::MOLECULE) ("STK33 and c-Myc" . SPARSER::COLLECTION)
    ("both preneoplastic foci" . SPARSER::PROTEIN)
    ("preneoplastic foci" . SPARSER::PROTEIN)
    ("TAM-treated STK33KO flox/flox" . SPARSER::COLLECTION)
    ("BrdU and Ki67" . SPARSER::COLLECTION)
    ("shRNA and SMMC7721/STK33" . SPARSER::COLLECTION)
    ("shRNA and SMMC7721/Ctrl" . SPARSER::COLLECTION)
    ("Ctrl" . SPARSER::PROTEIN) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("retina" . SPARSER::DRUG) ("STK33/c-Myc" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("Cre" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("TAM" . SPARSER::PROTEIN)
    ("Tamoxifen" . SPARSER::MOLECULE) ("HCC" . SPARSER::PROTEIN)
    ("cycD1" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("HR 2" . SPARSER::PROTEIN) ("N-Ras" . SPARSER::PROTEIN)
    ("aa1" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("ERT2" . SPARSER::PROTEIN) ("STK33" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG) ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("– 1" . SPARSER::PROTEIN) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("CCNE1" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("IRE1α/JNK" . SPARSER::COLLECTION) ("endoribonuclease" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("mRNAs" . SPARSER::PROTEIN) ("a 42 kDa soluble form" . SPARSER::FORM)
    ("calpain" . SPARSER::PROTEIN)
    ("the proteasome inhibitor MG132 or lysosome inhibitor chloroquine"
     . SPARSER::COLLECTION)
    ("NCD or HFD" . SPARSER::COLLECTION)
    ("protein kinase R-like ER kinase (PERK) and activating transcription factor 6 (ATF6)"
     . SPARSER::COLLECTION)
    ("kinase (PERK)" . SPARSER::KINASE) ("PERK" . SPARSER::PROTEIN)
    ("inositol" . SPARSER::PROTEIN)
    ("IR, IRS, EGFR and PDGFR" . SPARSER::COLLECTION)
    ("tyrosine-phosphorylated EGFR [ xref ] and PDGFR [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("IR and IRS" . SPARSER::COLLECTION)
    ("IRS" . SPARSER::PROTEIN) ("chloroquine" . SPARSER::PROTEIN)
    ("elongation" . SPARSER::PROTEIN) ("PI3K or Akt" . SPARSER::COLLECTION)
    ("Akti" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("bacterial recombinant GST fusion proteins" . SPARSER::PROTEIN)
    ("Nck and PTP1B" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("HA-Nck1 and FLAG-PTP1B" . SPARSER::COLLECTION)
    ("FLAG-PTP1B" . SPARSER::COLLECTION) ("HA-Nck1" . SPARSER::PROTEIN-PAIR)
    ("Nck1/PTP1B" . SPARSER::COLLECTION)
    ("PTP1B and Nck" . SPARSER::COLLECTION)
    ("proteins and pY" . SPARSER::COLLECTION)
    ("RTKs and RTK" . SPARSER::COLLECTION) ("Nck2" . SPARSER::PROTEIN)
    ("Nck1-2" . SPARSER::COLLECTION) ("Nck1-1" . SPARSER::COLLECTION)
    ("/β-Actin" . SPARSER::COLLECTION) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("NCD" . SPARSER::PROTEIN-FAMILY) ("glycogen" . SPARSER::PROTEIN)
    ("the eukaryotic initiation factor 2" . SPARSER::PROTEIN)
    ("RTKs or RTK" . SPARSER::COLLECTION) ("RTK" . SPARSER::PROTEIN)
    ("Nck1 and Nck2" . SPARSER::COLLECTION) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("IR and IRS-1" . SPARSER::COLLECTION) ("IRSs" . SPARSER::PROTEIN)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs) or tyrosine-phosphorylated (pY) substrates"
     . SPARSER::COLLECTION)
    ("pY" . SPARSER::PROTEIN) ("RTKs" . SPARSER::PROTEIN)
    ("Nck1 and PTP1B" . SPARSER::COLLECTION)
    ("primary hepatocytes" . SPARSER::PROTEIN) ("Nck1" . SPARSER::PROTEIN)
    ("Nck" . SPARSER::PROTEIN) ("glucose oxidase" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("PDGF-BB" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("protein kinase R" . SPARSER::PROTEIN) ("IRE1α" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("forkhead box O1" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("IRS-1" . SPARSER::PROTEIN) ("insulin receptor" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Aldrich" . SPARSER::PROTEIN) ("appropriate media" . SPARSER::PROTEIN)
    ("the confluent monolayers" . SPARSER::PROTEIN) ("tip" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("Salt" . SPARSER::MOLECULE)
    ("ILK dominant-negative mutant" . SPARSER::MUTANT)
    ("EGFR dominant-negative mutant (EGFRVIII) (Plasmid 11015) and their control vector pBABE-puro (Plasmid 1764)"
     . SPARSER::COLLECTION)
    ("EGFR dominant-negative mutant (EGFRVIII)" . SPARSER::MUTANT)
    ("EGFP-PTEN" . SPARSER::COLLECTION) ("EGFRVIII" . SPARSER::PROTEIN)
    ("Myr" . SPARSER::MOLECULE) ("Neo" . SPARSER::PROTEIN)
    ("MP" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("Glo" . SPARSER::PROTEIN) ("pRL-TK" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN) ("pRL" . SPARSER::PROTEIN)
    ("borate" . SPARSER::MOLECULE) ("acrylamide" . SPARSER::MOLECULE)
    ("polyacrylamide" . SPARSER::DRUG) ("cpm" . SPARSER::PROTEIN)
    ("Sephadex" . SPARSER::DRUG) ("dCTP" . SPARSER::MOLECULE)
    ("ACA" . SPARSER::PROTEIN) ("AAT" . SPARSER::PROTEIN)
    ("GAA" . SPARSER::PROTEIN) ("AGT" . SPARSER::PROTEIN)
    ("GAT" . SPARSER::PROTEIN) ("ATG" . SPARSER::DRUG)
    ("IL" . SPARSER::PROTEIN) ("Reagent" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN) ("orthovanadate" . SPARSER::MOLECULE)
    ("aprotinin" . SPARSER::DRUG) ("leupeptin" . SPARSER::DRUG)
    ("A nonspecific scrambled siRNA" . SPARSER::PROTEIN)
    ("the commercial siRNA IQGAP1-HSS113014" . SPARSER::COLLECTION)
    ("-GGCCCUACAGAUUCCUGCAGCUAAA-3" . SPARSER::COLLECTION)
    ("-UUUAGCUGCAGGAAUCUGUAGGGCC-3" . SPARSER::COLLECTION)
    ("IQGAP1-HSS113014" . SPARSER::COLLECTION) ("HSS" . SPARSER::PROTEIN)
    ("puromycin" . SPARSER::DRUG) ("Sigma–Aldrich" . SPARSER::COLLECTION)
    ("polybrene" . SPARSER::MOLECULE) ("Luciferase" . SPARSER::PROTEIN)
    ("protein/β-actin" . SPARSER::COLLECTION)
    ("HRP-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("PVDF" . SPARSER::DRUG) ("Proteins" . SPARSER::PROTEIN)
    ("NaN" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("UK" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("Pro" . SPARSER::AMINO-ACID) ("PC" . SPARSER::PROTEIN)
    ("ILK, pNF-κB, or Ki-67" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("ILK, Ki-67, pNF-κB, NF-κB, and pERK1/2" . SPARSER::COLLECTION)
    ("HRP- or fluorescence-labeled secondary antibodies" . SPARSER::COLLECTION)
    ("fluorescence-labeled secondary antibodies" . SPARSER::ANTIBODY)
    ("HRP-" . SPARSER::PROTEIN) ("PBS" . SPARSER::PROTEIN)
    ("formaldehyde" . SPARSER::MOLECULE) ("methanol" . SPARSER::MOLECULE)
    ("wax" . SPARSER::MOLECULE) ("paraformaldehyde" . SPARSER::DRUG)
    ("l -glutamine and 15 mM HEPES" . SPARSER::COLLECTION)
    ("streptomycin" . SPARSER::DRUG) ("FBS" . SPARSER::PROTEIN)
    ("HEPES" . SPARSER::MOLECULE) ("RPMI" . SPARSER::PROTEIN)
    ("nutrient" . SPARSER::MOLECULE) ("Pei" . SPARSER::MOLECULE)
    ("KRAS , PIK3CA , CDH1 , and CTNNB1" . SPARSER::COLLECTION)
    ("KRAS and MLH1" . SPARSER::COLLECTION) ("Bank" . SPARSER::PROTEIN)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MLH1" . SPARSER::PROTEIN)
    ("food" . SPARSER::MOLECULE) ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("goat" . SPARSER::PROTEIN) ("Fluor" . SPARSER::MOLECULE)
    ("Mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("β-actin and FLAG" . SPARSER::COLLECTION)
    ("anti-Ras, and anti-IQGAP1, anti-IQGAP2, and anti-IQGAP3"
     . SPARSER::COLLECTION)
    ("anti-IQGAP1, anti-IQGAP2, and anti-IQGAP3" . SPARSER::COLLECTION)
    ("pc-Raf" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("pRSK" . SPARSER::PROTEIN) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("iodide (PI)" . SPARSER::PROTEIN)
    ("The NF-κB inhibitor caffeic acid phenethyl ester (CAPE)"
     . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE)
    ("U0126 and PD98059" . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("phenylindole" . SPARSER::MOLECULE)
    ("FTI" . SPARSER::DRUG) ("hydrochloride" . SPARSER::MOLECULE)
    ("State" . SPARSER::BIO-STATE) ("Chen" . SPARSER::PROTEIN)
    ("Chemicals and antibodies" . SPARSER::COLLECTION)
    ("Chemicals" . SPARSER::MOLECULE) ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("EGFR and integrins" . SPARSER::COLLECTION)
    ("hydrogen peroxide and H. pylori" . SPARSER::COLLECTION)
    ("ILK/ERK/AKT" . SPARSER::COLLECTION)
    ("ILK, ERK, and AKT" . SPARSER::COLLECTION)
    ("client proteins" . SPARSER::PROTEIN)
    ("c-Raf/ERK1/2" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("cell growth-associated IL-6" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("GTPases, kinases, and receptors" . SPARSER::COLLECTION)
    ("ILK/IQGAP1/Ras" . SPARSER::COLLECTION)
    ("ILK–IQGAP1" . SPARSER::COLLECTION)
    ("Rho–GTP-binding protein" . SPARSER::COLLECTION)
    ("Raf/MAPK" . SPARSER::COLLECTION) ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTP" . SPARSER::NUCLEOTIDE) ("Ras/ERK1/2" . SPARSER::COLLECTION)
    ("PI3K and Ras" . SPARSER::COLLECTION)
    ("AKT and MAPKs" . SPARSER::COLLECTION) ("Aberrant ILK" . SPARSER::PROTEIN)
    ("IQGAP/Ras/c-Raf/MEK1/2/ERK1/2/RSK/NF-κB" . SPARSER::COLLECTION)
    ("ILK/NF-κB" . SPARSER::COLLECTION)
    ("ILK [ xref ] and NF-κB [ xref ]" . SPARSER::COLLECTION)
    ("EGF/EGFR/PI3K/HSP90" . SPARSER::COLLECTION) ("VIII" . SPARSER::PROTEIN)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("ERK1/2 and NF-κB" . SPARSER::COLLECTION)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("ILK/IQGAP1" . SPARSER::COLLECTION)
    ("ILK and IQGAP1" . SPARSER::COLLECTION)
    ("LY294002 and 17-AAG" . SPARSER::COLLECTION)
    ("5-FU or cisplatin" . SPARSER::COLLECTION)
    ("PI3K/HSP90/ILK/MEK1/2/NF-κB" . SPARSER::COLLECTION)
    ("ILK or IQGAP1" . SPARSER::COLLECTION)
    ("5-FU and cisplatin" . SPARSER::COLLECTION)
    ("PI3K and HSP90" . SPARSER::COLLECTION)
    ("HSP90-associated E3 ligases" . SPARSER::LIGASE)
    ("cullin 4A, and cullin 4B" . SPARSER::COLLECTION)
    ("HSP90–ILK" . SPARSER::COLLECTION) ("SAHA" . SPARSER::DRUG)
    ("AAG" . SPARSER::PROTEIN) ("c-Raf/MEK1/2/ERK1/2" . SPARSER::COLLECTION)
    ("PDK1/AKT" . SPARSER::COLLECTION)
    ("PDK1, AKT, and PAK1" . SPARSER::COLLECTION)
    ("PI3K/PDK1/AKT" . SPARSER::COLLECTION)
    ("AKT or ILK" . SPARSER::COLLECTION)
    ("MEK1/2/ERK1/2" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("PI3K, ILK, and Ras" . SPARSER::COLLECTION)
    ("MEK1/2, PI3K, ILK, or Ras" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("ERK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("A262V" . SPARSER::PROTEIN)
    ("only kinase domain-containing ILK" . SPARSER::PROTEIN)
    ("ILK A262V" . SPARSER::PROTEIN)
    ("Further inhibiting ILK" . SPARSER::PROTEIN)
    ("the IQGAP1–Ras complex and ERK1/2-mediated cell growth"
     . SPARSER::COLLECTION)
    ("IQGAP1 and Ras" . SPARSER::COLLECTION)
    ("a potential complex" . SPARSER::BIO-COMPLEX)
    ("ILK, IQGAP1, and Ras" . SPARSER::COLLECTION)
    ("c-Raf/MEK1/2/ERK1/2/RSK" . SPARSER::COLLECTION)
    ("IQGAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("AKT and GSK-3β" . SPARSER::COLLECTION)
    ("NF-κB-associated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2, and PI3K" . SPARSER::COLLECTION)
    ("c-Raf" . SPARSER::PROTEIN-PAIR)
    ("AKT, ERK1/2, and IκBα" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("IQGAP1–Ras" . SPARSER::COLLECTION) ("CAPE" . SPARSER::PROTEIN)
    ("THP-1" . SPARSER::PROTEIN) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("shock protein (HSP) 90 client protein" . SPARSER::PROTEIN)
    ("protein (HSP)" . SPARSER::PROTEIN) ("PI3K/PTEN" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("microRNA" . SPARSER::RNA)
    ("myogenic" . SPARSER::PROTEIN) ("RAC and CDC42" . SPARSER::COLLECTION)
    ("RAC" . SPARSER::PROTEIN) ("IKKα and IKKß" . SPARSER::COLLECTION)
    ("ILK/AKT" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("PINCH" . SPARSER::PROTEIN) ("ILKAP" . SPARSER::PROTEIN)
    ("the 20-kDa regulatory light" . SPARSER::PROTEIN)
    ("PHI-1, KEPI, and CPI-17" . SPARSER::COLLECTION)
    ("paxillin" . SPARSER::PROTEIN) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("light" . SPARSER::PROTEIN) ("calponin" . SPARSER::PROTEIN)
    ("affixin" . SPARSER::PROTEIN) ("ankyrin (ANK)" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN) ("ANK" . SPARSER::PROTEIN)
    ("ankyrin" . SPARSER::PROTEIN) ("serine/threonine" . SPARSER::COLLECTION)
    ("Integrin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ILK-" . SPARSER::PROTEIN)
    ("an HSP90-associated E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2/NF-κB" . SPARSER::COLLECTION) ("–Ras" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE) ("ILK" . SPARSER::PROTEIN)
    ("integrin" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG)
    ("potassium chloride" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("S14" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("IQGAP2" . SPARSER::PROTEIN) ("cullin-4" . SPARSER::PROTEIN)
    ("α at" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("pMEK1" . SPARSER::PROTEIN) ("pPDK1" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("H-1" . SPARSER::PROTEIN)
    ("GW5074" . SPARSER::DRUG) ("S13" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("Ras GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTP-binding protein" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("S12" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("cullin 4B" . SPARSER::PROTEIN) ("cullin 4A" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("S9B" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PDK1" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("ILK 1" . SPARSER::PROTEIN)
    ("IQGAP3" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("protein phosphatase 2C" . SPARSER::PROTEIN) ("CPI-17" . SPARSER::PROTEIN)
    ("PHI-1" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("myosin light chain" . SPARSER::PROTEIN)
    ("LC20" . SPARSER::PROTEIN) ("β-parvin" . SPARSER::PROTEIN)
    ("PIP3" . SPARSER::PIP3) ("PI 3" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("PI 4" . SPARSER::PROTEIN)
    ("pleckstrin homology" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IQGAP1" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("GES-1" . SPARSER::PROTEIN)
    ("secretory miRNAs" . SPARSER::PROTEIN) ("miRNAs" . SPARSER::PROTEIN)
    ("microRNAs" . SPARSER::RNA) ("approximately 37 kDa" . SPARSER::PROTEIN)
    ("intracellular and extracellular YB-1" . SPARSER::PROTEIN)
    ("the inflammatory infiltrating macrophages and tissue-resident macrophages"
     . SPARSER::COLLECTION)
    ("tissue-resident macrophages" . SPARSER::PROTEIN)
    ("acetyl" . SPARSER::MOLECULE) ("exporting IL-6 mRNA" . SPARSER::PROTEIN)
    ("secretory YB-1" . SPARSER::PROTEIN)
    ("mRNA or TNF-α" . SPARSER::COLLECTION) ("ActD" . SPARSER::MOLECULE)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("extracellular YB-1" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN) ("LPS or CpG-DNA" . SPARSER::COLLECTION)
    ("LPS- or CpG-DNA-stimulated" . SPARSER::COLLECTION)
    ("LPS-" . SPARSER::PROTEIN)
    ("CpG-DNA-stimulated macrophages" . SPARSER::PROTEIN)
    ("agonist" . SPARSER::AGONIST) ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("LPS-treated macrophages" . SPARSER::PROTEIN)
    ("a pleiotropic protein" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION) ("CSD" . SPARSER::PROTEIN)
    ("proline" . SPARSER::AMINO-ACID) ("soluble mediators" . SPARSER::PROTEIN)
    ("macrophages actively secret YB-1" . SPARSER::PROTEIN)
    ("Cytokine" . SPARSER::PROTEIN)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("Exoribonuclease activity" . SPARSER::PROTEIN)
    ("Gag-Pol" . SPARSER::PROTEIN) ("Actinomycin D" . SPARSER::MOLECULE)
    ("CXCL1" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("exoribonuclease activity" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("GM-CSF" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("HDAC6" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("YB-1" . SPARSER::PROTEIN)
    ("Y-box-binding protein 1" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("ion" . SPARSER::MOLECULE)
    ("TLR10 and NFKB1" . SPARSER::COLLECTION)
    ("IRAK1-IRAK4-TRAF6" . SPARSER::COLLECTION) ("QC" . SPARSER::PROTEIN)
    ("MHC" . SPARSER::PROTEIN) ("HNS" . SPARSER::MOLECULE)
    ("AAO" . SPARSER::PROTEIN) ("Foxc1" . SPARSER::PROTEIN)
    ("LUN-1" . SPARSER::COLLECTION) ("Zfx" . SPARSER::PROTEIN)
    ("LUN" . SPARSER::PROTEIN)
    ("functional allelic variants" . SPARSER::VARIANT)
    ("REL, TNFAIP3, REL and TNIP1" . SPARSER::COLLECTION)
    ("all the functional allelic variants" . SPARSER::VARIANT)
    ("the allelic variants" . SPARSER::VARIANT)
    ("NFKB1, REL, UBE2L3, TNFAIP3 and TNIP1" . SPARSER::COLLECTION)
    ("migraine" . SPARSER::PROTEIN)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN)
    ("REL , TNFAIP3 and NFKB1" . SPARSER::COLLECTION)
    ("REL and TNFAIP3" . SPARSER::COLLECTION)
    ("TNFAIP3 and TNIP1" . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor (TNFR) and antigen receptors"
     . SPARSER::COLLECTION)
    ("Toll-like receptors (TLRs), Interleukin-1 receptor (IL-1R), tumor necrosis factor receptor (TNFR) and antigen receptors"
     . SPARSER::COLLECTION)
    ("receptor (TNFR)" . SPARSER::RECEPTOR) ("p65–p50" . SPARSER::COLLECTION)
    ("IkB" . SPARSER::PROTEIN) ("RHD" . SPARSER::PROTEIN)
    ("p105 and p100" . SPARSER::COLLECTION)
    ("p50 and p52" . SPARSER::COLLECTION)
    ("RELA (p65), RELB, REL (c-Rel), NF-κB1 (p105) and NF-κB2 (p100)"
     . SPARSER::COLLECTION)
    ("RELB" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("a crucial pleiotropic transcription factor (TF)" . SPARSER::PROTEIN)
    ("RA" . SPARSER::PROTEIN)
    ("autoantibodies or circulating immune complexes (CIC)"
     . SPARSER::COLLECTION)
    ("MHC class I polypeptide-related sequence A (MICA) and Toll-like receptor 10 ( TLR10 , rs11096955) gene"
     . SPARSER::COLLECTION)
    ("complexes (CIC)" . SPARSER::BIO-COMPLEX) ("MICA" . SPARSER::PROTEIN)
    ("CIC" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("harmless unrecognized substances" . SPARSER::SUBSTANCE)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("substances" . SPARSER::SUBSTANCE) ("p " . SPARSER::PROTEIN)
    ("two potential regulatory variants" . SPARSER::VARIANT)
    ("allelic variants" . SPARSER::VARIANT)
    ("REL , TNFAIP3 , NFKB1 and TNIP1" . SPARSER::COLLECTION)
    ("REL" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("UBC13" . SPARSER::PROTEIN) ("IRAK4" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("DMRT1" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("S2" . SPARSER::MOLECULE) ("A20" . SPARSER::PROTEIN)
    ("tumor necrosis factor alpha-induced protein 3" . SPARSER::PROTEIN)
    ("UBE2L3" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("Interleukin-1" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("Toll-like receptor 10" . SPARSER::PROTEIN)
    ("MHC class I polypeptide-related sequence A" . SPARSER::PROTEIN)
    ("IL-1B" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("TLR10" . SPARSER::PROTEIN) ("TNIP1" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("TNFAIP3" . SPARSER::PROTEIN)
    ("IFN-alpha2 and JAK2-inhibitors" . SPARSER::COLLECTION)
    ("IFN-alpha2 and JAK2-inhibitor" . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("oxidative stress/antioxidative defence genes" . SPARSER::GENE)
    ("antioxidative defence genes" . SPARSER::GENE)
    ("Nrf2, TP53 and ATM" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG)
    ("all three MPNs and several GPx" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("SirT3 and SirT7" . SPARSER::COLLECTION)
    ("SirT2 and SirT6" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("UCP2 and SIRT2" . SPARSER::COLLECTION) ("DNA-stability" . SPARSER::DNA)
    ("p53 and FoxO3" . SPARSER::COLLECTION) ("statins" . SPARSER::DRUG)
    ("NF-E2 and Nrf2" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("several proinflammatory cytokines" . SPARSER::PROTEIN)
    ("SDF-1/CXCR4" . SPARSER::COLLECTION) ("myeloid" . SPARSER::PROTEIN)
    ("ARE-transcriptional" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("important antioxidative defence genes" . SPARSER::GENE)
    ("several oxidative stress genes" . SPARSER::GENE)
    ("FC " . SPARSER::PROTEIN) ("−1.5 and −1.5" . SPARSER::PROTEIN)
    ("FC −1.5" . SPARSER::PROTEIN) ("FC  " . SPARSER::PROTEIN)
    ("FC" . SPARSER::PROTEIN) ("FoxO3, TP53 and ATM" . SPARSER::COLLECTION)
    ("ATM" . SPARSER::PROTEIN)
    ("35, 40, and 46 oxidative stress genes" . SPARSER::GENE)
    ("oxidative stress genes" . SPARSER::GENE)
    ("PV, and PMF" . SPARSER::COLLECTION) ("HSPC" . SPARSER::PROTEIN)
    ("leukocytes and platelets" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("Nrf2 and CXCR4" . SPARSER::COLLECTION)
    ("HSCs" . SPARSER::PROTEIN) ("NFE2L2 or Nrf2" . SPARSER::COLLECTION)
    ("ATOX1, DEFB122, GPX8, PRDX2, PRDX6, PTGS1, and SEPP1"
     . SPARSER::COLLECTION)
    ("AKR1B1, CYBA, SIRT2, TTN, and UCP2" . SPARSER::COLLECTION)
    ("PV and PMF" . SPARSER::COLLECTION) ("TTN" . SPARSER::PROTEIN)
    ("CYBA" . SPARSER::PROTEIN) ("PMF" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("SirT7" . SPARSER::PROTEIN) ("SirT3" . SPARSER::PROTEIN)
    ("SirT6" . SPARSER::PROTEIN) ("SirT2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("IFN-alpha" . SPARSER::PROTEIN) ("IFN-alpha2" . SPARSER::PROTEIN)
    ("interferon-alpha" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("IL-1beta" . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("−2" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("FoxO3" . SPARSER::PROTEIN)
    ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("set 1" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("UCP2" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("AKR1B1" . SPARSER::PROTEIN) ("SEPP1" . SPARSER::PROTEIN)
    ("PTGS1" . SPARSER::PROTEIN) ("PRDX6" . SPARSER::PROTEIN)
    ("PRDX2" . SPARSER::PROTEIN) ("GPX8" . SPARSER::PROTEIN)
    ("ATOX1" . SPARSER::PROTEIN)
    ("these potential molecules" . SPARSER::MOLECULE)
    ("BKCa/caveolin-1" . SPARSER::COLLECTION)
    ("ion channels and other catalytically active molecules"
     . SPARSER::COLLECTION)
    ("macromolecular signaling complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin-D1 and cyclin-dependent kinase 4" . SPARSER::COLLECTION)
    ("the essential constituent protein" . SPARSER::PROTEIN)
    ("phosphatases and endothelial nitric oxide synthase (eNOS)"
     . SPARSER::COLLECTION)
    ("tyrosine kinase receptors, phosphatases and endothelial nitric oxide synthase (eNOS)"
     . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("caveolin-1 (pCav-1) or BKCa (pBKCa)" . SPARSER::COLLECTION)
    ("pCav-1" . SPARSER::COLLECTION) ("siCav-1" . SPARSER::COLLECTION)
    ("BKCa or caveolin-1" . SPARSER::COLLECTION)
    ("BKCa and caveolin-1" . SPARSER::COLLECTION)
    ("anti-BKCa and anti-caveolin-1" . SPARSER::COLLECTION)
    ("This macromolecular signaling complex" . SPARSER::BIO-COMPLEX)
    ("Slo" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("MaxiK" . SPARSER::PROTEIN) ("BK" . SPARSER::PROTEIN)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("caveolin" . SPARSER::PROTEIN)
    ("a multifunctional scaffold protein" . SPARSER::PROTEIN)
    ("suppressor and promoter" . SPARSER::COLLECTION)
    ("the principal structural component" . SPARSER::COMPONENT)
    ("clathrin" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("BKCa" . SPARSER::PROTEIN) ("BKCa-siRNA" . SPARSER::PROTEIN-PAIR)
    ("caveolin-1 and BKCa" . SPARSER::COLLECTION)
    ("Bis-Tris" . SPARSER::MOLECULE) ("Membrane Protein" . SPARSER::PROTEIN)
    ("Membrane protein" . SPARSER::PROTEIN) ("protein- G" . SPARSER::PROTEIN)
    ("IP3R" . SPARSER::PROTEIN) ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("cyclin-D1" . SPARSER::PROTEIN) ("I–V" . SPARSER::PROTEIN)
    ("IP 3 R3" . SPARSER::PROTEIN) ("IP 3 receptor" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("KCNMA1" . SPARSER::PROTEIN)
    ("v-myc avian myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("DNAs" . SPARSER::DNA) ("cadherins and form" . SPARSER::COLLECTION)
    ("promoter and restoration" . SPARSER::COLLECTION)
    ("siRNA or β-catenin" . SPARSER::COLLECTION)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("the membranous β-catenin" . SPARSER::PROTEIN)
    ("β-catenin or E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin-siRNA" . SPARSER::COLLECTION)
    ("β-catenin-siRNA" . SPARSER::COLLECTION)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("CpG" . SPARSER::PROTEIN) ("−1" . SPARSER::PROTEIN)
    ("HBE" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("bisulfite" . SPARSER::MOLECULE) ("SPC" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("aza" . SPARSER::DRUG) ("deoxycytidine" . SPARSER::PROTEIN)
    ("Aza" . SPARSER::DRUG) ("P-cadherin" . SPARSER::PROTEIN)
    ("dual-luciferase" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("A-2" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN)
    ("CALM3 and other target genes" . SPARSER::COLLECTION)
    ("SES" . SPARSER::PROTEIN) ("SMARCD1/EGFR" . SPARSER::COLLECTION)
    ("SMARCD1 and EGFR" . SPARSER::COLLECTION)
    ("CALM3 and rs12461917" . SPARSER::COLLECTION)
    ("CALM1 , CALM2 and CALM3" . SPARSER::COLLECTION)
    ("CALM" . SPARSER::PROTEIN) ("a vital regulator" . SPARSER::REGULATOR)
    ("the three genotypic variants" . SPARSER::VARIANT)
    ("TC" . SPARSER::PROTEIN) ("p12" . SPARSER::PROTEIN)
    ("Cyp1" . SPARSER::PROTEIN) ("Cyp" . SPARSER::PROTEIN)
    ("smoke" . SPARSER::MOLECULE) ("SD" . SPARSER::PROTEIN)
    ("Tobacco" . SPARSER::DRUG) ("VDR" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE)
    ("SWItch/Sucrose NonFermentable (SWI/SNF) chromatin-remodeling complexes"
     . SPARSER::BIO-COMPLEX)
    ("SWI/SNF" . SPARSER::COLLECTION) ("Sucrose" . SPARSER::MOLECULE)
    ("leptin" . SPARSER::PROTEIN) ("estrone" . SPARSER::DRUG)
    ("Fat" . SPARSER::PROTEIN) ("MSC" . SPARSER::PROTEIN)
    ("EGFR or its other effectors" . SPARSER::COLLECTION)
    ("CALM3 and the related gene EGFR" . SPARSER::COLLECTION)
    ("CaM and its downstream effectors" . SPARSER::COLLECTION)
    ("calcineurin and CaM kinase" . SPARSER::COLLECTION)
    ("calcineurin" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("CaM" . SPARSER::PROTEIN) ("Wa" . SPARSER::MOLECULE)
    ("these genes and body composition levels" . SPARSER::COLLECTION)
    ("fat (PTF)" . SPARSER::PROTEIN) ("fat (PTBF)" . SPARSER::PROTEIN)
    ("fat (TF)" . SPARSER::PROTEIN) ("fat (TBF)" . SPARSER::PROTEIN)
    ("receptors and osteoprotegerin" . SPARSER::COLLECTION)
    ("osteoprotegerin" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("Estrogen" . SPARSER::MOLECULE) ("osteoclasts" . SPARSER::PROTEIN)
    ("EGFR , CALM3 and SMARCD1" . SPARSER::COLLECTION)
    ("FNK" . SPARSER::PROTEIN)
    ("CALM3 (calmodulin 3, calcium-modulated protein 3) and SMARCD1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily d member 1)"
     . SPARSER::COLLECTION)
    ("fat" . SPARSER::PROTEIN) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("calmodulin" . SPARSER::PROTEIN)
    ("CALM2" . SPARSER::PROTEIN) ("CALM1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("subfamily D" . SPARSER::PROTEIN) ("BAF60a" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("CaM kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("early growth response 2" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("lipoprotein receptor" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("member 1" . SPARSER::PROTEIN)
    ("subfamily d" . SPARSER::PROTEIN) ("SMARCD1" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("CALM3" . SPARSER::PROTEIN)
    ("nocodazole" . SPARSER::DRUG) ("astral-microtubules" . SPARSER::PROTEIN)
    ("Plk1 and the CENP-O complex" . SPARSER::COLLECTION)
    ("transgenes" . SPARSER::PROTEIN) ("CENP-Q transgenes" . SPARSER::PROTEIN)
    ("the phospho-mimetic CENP-Q S50D –eGFP transgene" . SPARSER::PROTEIN)
    ("Plk1 and CENP-Q" . SPARSER::COLLECTION) ("–eGFP" . SPARSER::COLLECTION)
    ("Plk1 and CENP-O" . SPARSER::COLLECTION)
    ("CENP-A (kinetochore marker) and γ-tubulin (spindle pole marker)"
     . SPARSER::COLLECTION)
    ("Eg5" . SPARSER::PROTEIN) ("monastrol" . SPARSER::DRUG)
    ("CENP-E or CENP-Q" . SPARSER::COLLECTION)
    ("astral microtubules" . SPARSER::PROTEIN)
    ("300 nM GSK925293" . SPARSER::PROTEIN) ("GSK" . SPARSER::PROTEIN)
    ("eGFP–centrin1" . SPARSER::COLLECTION)
    ("eGFP–CENP-A" . SPARSER::COLLECTION)
    ("CENP-Q and CENP-E" . SPARSER::COLLECTION) ("Histone" . SPARSER::PROTEIN)
    ("CENP-A (to mark kinetochores) and DAPI (to mark the chromosome position)"
     . SPARSER::COLLECTION)
    ("CENP-Q–eGFP" . SPARSER::COLLECTION)
    ("monomer red fluorescent protein (mRFP)-tagged α-tubulin"
     . SPARSER::PROTEIN)
    ("mRFP–α-tubulin" . SPARSER::COLLECTION)
    ("Histone2B–eGFP" . SPARSER::COLLECTION)
    ("Ndc80, Kif18A, Ska3 or MCAK" . SPARSER::COLLECTION)
    ("Kif18A" . SPARSER::PROTEIN) ("MCAK" . SPARSER::PROTEIN)
    ("CENP-Q-eGFP" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("CENP-Q and CENP-U" . SPARSER::COLLECTION)
    ("CENP-H, CENP-I, CENP-K and CENP-M" . SPARSER::COLLECTION)
    ("CENP-C and CENP-N" . SPARSER::COLLECTION)
    ("CENP-T, CENP-W, CENP-S and CENP-X" . SPARSER::COLLECTION)
    ("nucleosomes" . SPARSER::BIO-COMPLEX)
    ("Ndc80 and Ska" . SPARSER::COLLECTION) ("Ska" . SPARSER::PROTEIN)
    ("the minus-end-directed motor dynein ( xref ) or the plus-end-directed kinesin CENP-E ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("the plus-end-directed kinesin CENP-E" . SPARSER::PROTEIN)
    ("the minus-end-directed motor dynein" . SPARSER::PROTEIN)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dynein" . SPARSER::PROTEIN)
    ("microtubules" . SPARSER::PROTEIN)
    ("CENP-O, CENP-P, CENP-Q and CENP-U" . SPARSER::COLLECTION)
    ("H2B" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("Hec1" . SPARSER::PROTEIN) ("GSK923295" . SPARSER::DRUG)
    ("non-selective" . SPARSER::PROTEIN) ("CENP-L" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("γ-tubulin" . SPARSER::PROTEIN) ("KIF11" . SPARSER::PROTEIN)
    ("centrin1" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("Histone2B" . SPARSER::PROTEIN) ("Ska3" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("CENP-M" . SPARSER::PROTEIN) ("CENP-K" . SPARSER::PROTEIN)
    ("CENP-I" . SPARSER::PROTEIN) ("CENP-H" . SPARSER::PROTEIN)
    ("CENP-X" . SPARSER::PROTEIN) ("CENP-S" . SPARSER::PROTEIN)
    ("CENP-W" . SPARSER::PROTEIN) ("CENP-T" . SPARSER::PROTEIN)
    ("Histone 3" . SPARSER::PROTEIN) ("CENP-N" . SPARSER::PROTEIN)
    ("CENP-C" . SPARSER::PROTEIN) ("Ndc80" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("polo-like kinase" . SPARSER::PROTEIN)
    ("CENP-U" . SPARSER::PROTEIN) ("CENP-P" . SPARSER::PROTEIN)
    ("CENP-O" . SPARSER::PROTEIN) ("CENP-Q" . SPARSER::PROTEIN)
    ("CENP-E" . SPARSER::PROTEIN)
    ("preferentially target tumor-specific super-enhancers" . SPARSER::PROTEIN)
    ("BRD4 and CDK7" . SPARSER::COLLECTION) ("Drugs" . SPARSER::DRUG)
    ("MYB-CBP" . SPARSER::COLLECTION)
    ("allele or mutant" . SPARSER::COLLECTION)
    ("CBP-MYB" . SPARSER::COLLECTION)
    ("their respective enhancers" . SPARSER::PROTEIN)
    ("their own enhancers" . SPARSER::PROTEIN)
    ("TAL1, GATA3, and RUNX1" . SPARSER::COLLECTION)
    ("TAL1 and MYB" . SPARSER::COLLECTION)
    ("the leukemic cell state" . SPARSER::BIO-STATE)
    ("Polycomb" . SPARSER::PROTEIN)
    ("MYB and its potent transcriptional coactivator" . SPARSER::COLLECTION)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("RUNX1, GATA3, and ETS1" . SPARSER::COLLECTION)
    ("TAL1/E-protein" . SPARSER::COLLECTION)
    ("MYB and TAL1" . SPARSER::COLLECTION) ("Pol" . SPARSER::PROTEIN)
    ("newly available MYB-specific antibodies" . SPARSER::ANTIBODY)
    ("TAL1, GATA3, RUNX1, E2A and HEB" . SPARSER::COLLECTION)
    ("enhancer" . SPARSER::PROTEIN)
    ("either the wild-type allele or each of the TAL1 -enhancer mutation alleles upstream of luciferase"
     . SPARSER::COLLECTION)
    ("each case only one allele" . SPARSER::ALLELE)
    ("MuTE-positive Jurkat" . SPARSER::PROTEIN) ("GT" . SPARSER::PROTEIN)
    ("TAL1, GATA3, RUNX1, and HEB" . SPARSER::COLLECTION)
    ("HEB" . SPARSER::PROTEIN) ("HSPCs" . SPARSER::PROTEIN)
    ("Jurkat" . SPARSER::PROTEIN) ("SCL-" . SPARSER::PROTEIN)
    ("SCL" . SPARSER::PROTEIN) ("A quintessential example" . SPARSER::EXAMPLE)
    ("MYB and CBP" . SPARSER::COLLECTION)
    ("a major leukemogenic transcriptional complex" . SPARSER::BIO-COMPLEX)
    ("RUNX1, GATA-3, and TAL1" . SPARSER::COLLECTION)
    ("CBP" . SPARSER::PROTEIN) ("MYB" . SPARSER::PROTEIN)
    ("super-enhancers" . SPARSER::PROTEIN) ("enhancers" . SPARSER::PROTEIN)
    ("CDK7" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("guide RNA" . SPARSER::RNA) ("guide RNAs" . SPARSER::RNA)
    ("CREB-binding protein" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("E-protein" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("MED1" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("CD34" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN) ("p33" . SPARSER::PROTEIN)
    ("GATA-3" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("TAL1" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("XIAP and Smac/DIABLO" . SPARSER::COLLECTION)
    ("mitochondrial Smac/DIABLO" . SPARSER::PROTEIN)
    ("cytochrome c and AIF" . SPARSER::COLLECTION)
    ("HSP72 and XIAP" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX) ("creatinine" . SPARSER::PROTEIN)
    ("sham" . SPARSER::DRUG)
    ("cytochrome c and apoptosis-inducing" . SPARSER::COLLECTION)
    ("AIF" . SPARSER::PROTEIN) ("Medicine" . SPARSER::DRUG)
    ("chaperone" . SPARSER::PROTEIN) ("renal I/R" . SPARSER::PROTEIN)
    ("proteins (IAP)" . SPARSER::PROTEIN)
    ("pro and anti-apoptotic" . SPARSER::COLLECTION)
    ("multiple toxic proteins" . SPARSER::PROTEIN)
    ("XIAP and pro-caspase 3" . SPARSER::COLLECTION)
    ("Smac/DIABLO and XIAP" . SPARSER::COLLECTION)
    ("PI (DIABLO)" . SPARSER::PROTEIN) ("DIABLO" . SPARSER::PROTEIN)
    ("PI" . SPARSER::PROTEIN) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smac" . SPARSER::PROTEIN) ("caspases" . SPARSER::PROTEIN)
    ("XIAP" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("Smac/DIABLO" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("gonadotropins/GnRH" . SPARSER::COLLECTION) ("MRI" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("gonadotropins" . SPARSER::PROTEIN)
    ("MAPK and PI3-K" . SPARSER::COLLECTION)
    ("Fgf8 and Fgf4" . SPARSER::COLLECTION)
    ("FGF8 and FGFR1" . SPARSER::COLLECTION) ("Fgf4" . SPARSER::PROTEIN)
    ("Fgf8" . SPARSER::PROTEIN) ("Fgfr1" . SPARSER::PROTEIN)
    ("the central ray" . SPARSER::PROTEIN)
    ("the consanguineous family 1" . SPARSER::PROTEIN)
    ("a pleiotropic gene" . SPARSER::GENE)
    ("KS and SHFM" . SPARSER::COLLECTION)
    ("KS and cleft lip" . SPARSER::COLLECTION) ("his" . SPARSER::AMINO-ACID)
    ("the mature form" . SPARSER::FORM)
    ("the partially processed immature receptor" . SPARSER::RECEPTOR)
    ("sugars" . SPARSER::MOLECULE) ("mannose" . SPARSER::MOLECULE)
    ("Endo" . SPARSER::PROTEIN) ("ß-actin" . SPARSER::COLLECTION)
    ("PNGase" . SPARSER::PROTEIN) ("Peptide" . SPARSER::PEPTIDE)
    ("140 kDa and 120 kDa ( xref )" . SPARSER::COLLECTION)
    ("kinase and FRS2α" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("Val-Thr" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("Val" . SPARSER::AMINO-ACID) ("FGFRs" . SPARSER::PROTEIN)
    ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("FGF1, and FRS2α" . SPARSER::COLLECTION)
    ("the homozygous missense mutation p" . SPARSER::PROTEIN)
    ("male" . SPARSER::MOLECULE) ("rays" . SPARSER::PROTEIN)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FGFR" . SPARSER::PROTEIN)
    ("both KS and normosmic CHH" . SPARSER::COLLECTION)
    ("KS" . SPARSER::PROTEIN) ("hormone" . SPARSER::MOLECULE)
    ("gonadotropin" . SPARSER::PROTEIN) ("MIM" . SPARSER::PROTEIN)
    ("FR" . SPARSER::PROTEIN) ("the homozygous p" . SPARSER::PROTEIN)
    ("GnRH" . SPARSER::PROTEIN) ("non-syndromic" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("family 7" . SPARSER::PROTEIN)
    ("family 4" . SPARSER::PROTEIN) ("family 3" . SPARSER::PROTEIN)
    ("family 2" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN) ("1-4" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3) ("Mg 2+" . SPARSER::MOLECULE)
    ("MgCl2" . SPARSER::MOLECULE) ("FGFR2" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN) ("FRS2" . SPARSER::PROTEIN)
    ("ID 3" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("HS6ST1" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("KISS1" . SPARSER::PROTEIN) ("KISS1R" . SPARSER::PROTEIN)
    ("GNRH1" . SPARSER::PROTEIN) ("TAC3" . SPARSER::PROTEIN)
    ("TACR3" . SPARSER::PROTEIN) ("PROK2" . SPARSER::PROTEIN)
    ("PROKR2" . SPARSER::PROTEIN) ("KAL1" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("phospholipase C gamma" . SPARSER::PROTEIN-FAMILY)
    ("heparan sulfate" . SPARSER::MOLECULE)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("FRS2α" . SPARSER::PROTEIN)
    ("typical Bcl-2 inhibitor and Gal-3 inhibitor" . SPARSER::COLLECTION)
    ("typical Bcl-2 inhibitor" . SPARSER::INHIBITOR)
    ("a triple complex" . SPARSER::BIO-COMPLEX)
    ("Gal-3, Bax and Bcl-2" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax/Bak" . SPARSER::COLLECTION)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 and Bcl-2" . SPARSER::COLLECTION)
    ("BRAF and RAS" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VC" . SPARSER::MOLECULE)
    ("asparagine" . SPARSER::AMINO-ACID)
    ("Bax and Gal-3" . SPARSER::COLLECTION)
    ("Gal-3, and Gal-3" . SPARSER::COLLECTION) ("oligomers" . SPARSER::PROTEIN)
    ("MCP" . SPARSER::PROTEIN)
    ("caspase-8, p-ERK and p-Akt" . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION) ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("caspase" . SPARSER::PROTEIN) ("DISC" . SPARSER::BIO-COMPLEX)
    ("Ligands" . SPARSER::LIGAND)
    ("tumor necrosis factor receptor 1 (TNFR1) and Fas/CD95"
     . SPARSER::COLLECTION)
    ("Fas/CD95" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("Gal-3 and anti-apoptotic" . SPARSER::COLLECTION)
    ("Gal-3 and Bax" . SPARSER::COLLECTION) ("Bcl-xl" . SPARSER::PROTEIN)
    ("Gal-3 protein as well as the pro-apoptotic protein Bax"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("CDDP or DXR" . SPARSER::COLLECTION) ("doxorubicin" . SPARSER::PROTEIN)
    ("DXR" . SPARSER::PROTEIN) ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("Bcl-2/Bax" . SPARSER::COLLECTION) ("glycine" . SPARSER::AMINO-ACID)
    ("tryptophan" . SPARSER::AMINO-ACID) ("aspartate" . SPARSER::PROTEIN)
    ("protein and serine" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("small N-terminal part and collagen-like sequence" . SPARSER::COLLECTION)
    ("galactoside" . SPARSER::MOLECULE) ("galectins" . SPARSER::PROTEIN)
    ("MOMP" . SPARSER::PROTEIN) ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("homology" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("iodine" . SPARSER::MOLECULE)
    ("PTC" . SPARSER::PROTEIN) ("endocrine" . SPARSER::PROTEIN)
    ("Thyroid" . SPARSER::PROTEIN) ("Gal-3/Bax" . SPARSER::COLLECTION)
    ("carbohydrate" . SPARSER::MOLECULE) ("Bax" . SPARSER::PROTEIN)
    ("thyroid" . SPARSER::PROTEIN) ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1A" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("Tween20" . SPARSER::MOLECULE)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Sh-RNA" . SPARSER::RNA) ("G418" . SPARSER::MOLECULE)
    ("Bcl2" . SPARSER::PROTEIN) ("doxorubicin hydrochloride" . SPARSER::DRUG)
    ("BH1" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("PI3K-Akt" . SPARSER::PROTEIN)
    ("3-1" . SPARSER::PROTEIN) ("TPC1" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytochrome c" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("Gal-3" . SPARSER::PROTEIN)
    ("Galectin-3" . SPARSER::PROTEIN)
    ("FNA-HER2 positive metastatic ALNs" . SPARSER::MOLECULE)
    ("our discordant cases underwent NAC" . SPARSER::PROTEIN)
    ("pre-" . SPARSER::PROTEIN)
    ("FNA-HER2 positive metastatic ALN" . SPARSER::MOLECULE)
    ("discordant HER2 genes" . SPARSER::GENE)
    ("metastatic ALN" . SPARSER::MOLECULE)
    ("all 13 metastatic ALNs" . SPARSER::MOLECULE)
    ("our metastatic ALNs" . SPARSER::MOLECULE)
    ("preoperative ALN" . SPARSER::MOLECULE)
    ("CEA, CA15-3, and CYFRA 21-1" . SPARSER::COLLECTION)
    ("metastatic ALNs and primary cancers" . SPARSER::COLLECTION)
    ("their metastatic ALNs" . SPARSER::MOLECULE) ("ER-" . SPARSER::PROTEIN)
    ("14 other metastatic ALNs" . SPARSER::MOLECULE)
    ("whose corresponding metastatic ALNs" . SPARSER::MOLECULE)
    ("two metastatic ALNs" . SPARSER::MOLECULE)
    ("14 metastatic ALNs" . SPARSER::MOLECULE)
    ("28 metastatic ALNs" . SPARSER::MOLECULE)
    ("the concordant metastatic ALNs" . SPARSER::MOLECULE)
    ("Two metastatic ALNs" . SPARSER::MOLECULE)
    ("136 metastatic ALNs" . SPARSER::MOLECULE)
    ("ALNs and HER2" . SPARSER::COLLECTION)
    ("the benign ALNs" . SPARSER::MOLECULE)
    ("the 138 metastatic ALNs" . SPARSER::MOLECULE)
    ("The 29 benign ALNs" . SPARSER::MOLECULE)
    ("the metastatic ALNs" . SPARSER::MOLECULE)
    ("HER2, ER, PR, AR, and Ki-67" . SPARSER::COLLECTION)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most common histologic type" . TYPE) ("ECD" . SPARSER::PROTEIN)
    ("trastuzumab" . SPARSER::DRUG)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("CEA" . SPARSER::PROTEIN)
    ("Carcinoembryonic" . SPARSER::PROTEIN)
    ("preoperative US-FNA" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("ultrasonographically suspicious ALNs" . SPARSER::MOLECULE)
    ("FNA-HER2-positive metastatic ALNs" . SPARSER::MOLECULE)
    ("108 metastatic ALNs" . SPARSER::MOLECULE) ("ALN" . SPARSER::MOLECULE)
    ("All 29 benign ALNs" . SPARSER::MOLECULE) ("FNA" . SPARSER::PROTEIN)
    ("benign ALNs" . SPARSER::MOLECULE) ("FNA-HER2" . SPARSER::COLLECTION)
    ("benign and metastatic ALNs" . SPARSER::MOLECULE)
    ("metastatic ALNs" . SPARSER::MOLECULE) ("ALNs" . SPARSER::MOLECULE)
    ("CA15-3" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("CA 15-3" . SPARSER::PROTEIN)
    ("cancer antigen 15-3" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN)
    ("LIMK, Cofilin or angiomotin" . SPARSER::COLLECTION)
    ("kinase and actin" . SPARSER::COLLECTION) ("Cofilin" . SPARSER::PROTEIN)
    ("angiomotin" . SPARSER::PROTEIN) ("LIMK" . SPARSER::PROTEIN)
    ("permanent active LATS kinase mutant" . SPARSER::MUTANT)
    ("substance" . SPARSER::SUBSTANCE) ("Podocin" . SPARSER::PROTEIN)
    ("doxycycline" . SPARSER::DRUG) ("KIBRA/WWC1" . SPARSER::COLLECTION)
    ("KIBRA" . SPARSER::PROTEIN) ("LATS1 and LATS2" . SPARSER::COLLECTION)
    ("pre" . SPARSER::PROTEIN) ("Losartan" . SPARSER::PROTEIN)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("the most pharmacologically relevant GPCRs"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("renin–angiotensin–aldosterone" . SPARSER::COLLECTION)
    ("aldosterone" . SPARSER::PROTEIN) ("angiotensin" . SPARSER::PROTEIN)
    ("renin" . SPARSER::PROTEIN) ("Serine" . SPARSER::AMINO-ACID)
    ("Drosophila" . SPARSER::PROTEIN)
    ("the glomerular filtration barrier" . SPARSER::PROTEIN)
    ("water" . SPARSER::MOLECULE) ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the large tumor suppressor kinase (LATS) and its substrate"
     . SPARSER::COLLECTION)
    ("the co-transcription factor Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("kinase (LATS)" . SPARSER::KINASE) ("LATS" . SPARSER::PROTEIN)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPHS2" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("1–1 " . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("β -tubulin" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("pMD2" . SPARSER::MOLECULE) ("CO2" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("G protein" . SPARSER::PROTEIN)
    ("Caspase 7" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN)
    ("transcriptional coactivator with PDZ-binding motif" . SPARSER::PROTEIN)
    ("WWC1" . SPARSER::PROTEIN) ("LATS2" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("Latrunculin B" . SPARSER::DRUG)
    ("Angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("G α  q" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("AT1" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN)
    ("large tumor suppressor" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transforming Growth Factor-" . SPARSER::PROTEIN)
    ("ligands and inhibitors" . SPARSER::COLLECTION)
    ("SMAD4, p53 and Wnt" . SPARSER::COLLECTION)
    ("SMAD4 or p53" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("SMAD4 and WT p53" . SPARSER::COLLECTION) ("fluorouracil" . SPARSER::DRUG)
    ("/APC/Axin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("TCF" . SPARSER::PROTEIN) ("Wnt pathway-associated genes" . SPARSER::GENE)
    ("AXIN2 and c-MYC" . SPARSER::COLLECTION)
    ("membranous β -catenin" . SPARSER::PROTEIN) ("noggin" . SPARSER::PROTEIN)
    ("BMP–Wnt" . SPARSER::COLLECTION) ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRE" . SPARSER::PROTEIN) ("WRE/MRE-luciferase" . SPARSER::COLLECTION)
    ("versa" . SPARSER::PROTEIN)
    ("nuclear SMAD4 and nuclear β -catenin" . SPARSER::COLLECTION)
    ("β -catenin, SMAD4 and p53" . SPARSER::COLLECTION)
    ("BMP2, BMP4, BMP 6 and BMP9" . SPARSER::COLLECTION)
    ("BMP2, BMP4, BMP6 and BMP9" . SPARSER::COLLECTION)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP and Wnt" . SPARSER::COLLECTION)
    ("aberrant p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HGF" . SPARSER::PROTEIN)
    ("Forkhead" . SPARSER::PROTEIN) ("APC/CTNNB1" . SPARSER::COLLECTION)
    ("BMPs" . SPARSER::PROTEIN) ("p53 and SMAD4" . SPARSER::COLLECTION)
    ("MTT" . SPARSER::MOLECULE) ("BMP/Wnt" . SPARSER::COLLECTION)
    ("SMAD4, p53 and β -catenin" . SPARSER::COLLECTION)
    ("CRCs" . SPARSER::PROTEIN) ("SMAD4 and p53" . SPARSER::COLLECTION)
    ("BMP" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("ALK3" . SPARSER::PROTEIN) ("BMPR1A" . SPARSER::PROTEIN)
    ("GSK3 β" . SPARSER::PROTEIN) ("protein dishevelled" . SPARSER::PROTEIN)
    ("DVL1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTNNBIP1" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN) ("BMP 6" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BMPR2" . SPARSER::PROTEIN)
    ("LDN-193189" . SPARSER::DRUG) ("L -glutamine" . SPARSER::MOLECULE)
    ("SW480" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("D-6" . SPARSER::PROTEIN) ("l −1" . SPARSER::PROTEIN)
    ("BMP9" . SPARSER::PROTEIN) ("BMP6" . SPARSER::PROTEIN)
    ("BMP4" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COX2" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("p53 and Chk1" . SPARSER::COLLECTION)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("UL21a-RXL" . SPARSER::COLLECTION)
    ("trans" . SPARSER::PROTEIN-FAMILY)
    ("the MCM-directed viral inhibitors" . SPARSER::INHIBITOR)
    ("MCM" . SPARSER::PROTEIN) ("Cyclin A2-MCM7" . SPARSER::COLLECTION)
    ("MCM3AP and HCMV-IE2" . SPARSER::COLLECTION)
    ("acetylase" . SPARSER::PROTEIN) ("Geminin" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("hpi" . SPARSER::PROTEIN)
    ("RXL" . SPARSER::PROTEIN) ("pUL21a-RXL" . SPARSER::COLLECTION)
    ("Cyclin A2 and Cyclin B1" . SPARSER::COLLECTION)
    ("interactors" . SPARSER::PROTEIN)
    ("this essential viral transcription factor" . SPARSER::PROTEIN)
    ("IE1 and IE2" . SPARSER::COLLECTION)
    ("these cells premature condensation" . SPARSER::PROTEIN-FAMILY)
    ("their extended conformation or beads-on-a-string appearance"
     . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CENP-A and DAPI" . SPARSER::COLLECTION)
    ("pUL21a-RXL2mut" . SPARSER::COLLECTION) ("centromeres" . SPARSER::PROTEIN)
    ("Cyclin A2, Cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("Cyclin A2 and pUL21a" . SPARSER::COLLECTION)
    ("this essential mitotic kinase" . SPARSER::KINASE)
    ("UL21a-RXL2mut" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("herpesviral DNA polymerases" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN) ("PFA" . SPARSER::MOLECULE)
    ("the viral DNA polymerase" . SPARSER::PROTEIN)
    ("UL21a-RXL2" . SPARSER::COLLECTION)
    ("Cyclin A2 and B1-directed" . SPARSER::COLLECTION)
    ("masks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mut" . SPARSER::PROTEIN)
    ("UL21a" . SPARSER::PROTEIN)
    ("Cyclin A2, Cyclin B1 and APC5" . SPARSER::COLLECTION)
    ("Cyclin E1" . SPARSER::PROTEIN) ("UL21a-PR" . SPARSER::PROTEIN-PAIR)
    ("APCmut" . SPARSER::PROTEIN) ("Cyclin A2 and APC5" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pUL21a-APCmut" . SPARSER::PROTEIN-PAIR)
    ("a previously described pUL21a-PR AA mutant" . SPARSER::MUTANT)
    ("pUL21a-PR" . SPARSER::COLLECTION) ("RXL2" . SPARSER::PROTEIN)
    ("a strong competitive inhibitor" . SPARSER::INHIBITOR)
    ("pUL21a-RXL2" . SPARSER::COLLECTION)
    ("substrate or inhibitor" . SPARSER::COLLECTION)
    ("Cyclin-CDK" . SPARSER::COLLECTION)
    ("CDK and mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("PUL21a" . SPARSER::PROTEIN) ("AXA" . SPARSER::MOLECULE)
    ("the viral Cyclin A2 substrate pp150" . SPARSER::PROTEIN)
    ("the small HCMV early-late protein pUL21a" . SPARSER::PROTEIN)
    ("pUL21a" . SPARSER::PROTEIN) ("cellular Cyclin A2" . SPARSER::PROTEIN)
    ("substrates and inhibitors" . SPARSER::COLLECTION)
    ("Cyclin A2-CDK2" . SPARSER::COLLECTION)
    ("pre-immediate early" . SPARSER::PROTEIN-PAIR)
    ("a unique cell cycle state" . SPARSER::BIO-STATE)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin E1-CDK2" . SPARSER::PROTEIN-PAIR)
    ("Cyclin A2 and CDK2" . SPARSER::COLLECTION)
    ("Cyclin B1–CDK1" . SPARSER::COLLECTION)
    ("Cyclin A2–CDK1" . SPARSER::PROTEIN-PAIR)
    ("Cyclin A2 and B1 proteins" . SPARSER::COLLECTION)
    ("pRb–E2F-controlled genes" . SPARSER::GENE)
    ("Cyclin D1–CDK4/6" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("mitogen" . SPARSER::MITOGEN) ("pUL21a-Cyclin A2" . SPARSER::COLLECTION)
    ("the essential viral IE2 protein" . SPARSER::PROTEIN)
    ("Cyclin A2, and ii" . SPARSER::COLLECTION)
    ("Cyclin A2-CDK" . SPARSER::COLLECTION) ("Interactors" . SPARSER::PROTEIN)
    ("the related chromosome-associated IE1 protein" . SPARSER::PROTEIN)
    ("the essential viral IE2" . SPARSER::PROTEIN) ("APC" . SPARSER::PROTEIN)
    ("cyclosome" . SPARSER::PROTEIN)
    ("premature chromatin condensation" . SPARSER::PROTEIN-FAMILY)
    ("Cyclin B1-CDK1" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("chromatin" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("YL1" . SPARSER::PROTEIN)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("cyclin A2" . SPARSER::PROTEIN)
    ("cyclinA2" . SPARSER::PROTEIN) ("pp65" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("H-12" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("E2" . SPARSER::MOLECULE)
    ("SP2" . SPARSER::PROTEIN) ("D-1" . SPARSER::PROTEIN)
    ("pp71" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("IE3" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("MCM3AP" . SPARSER::PROTEIN) ("MCM3" . SPARSER::PROTEIN)
    ("pUL117" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("APC4" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("pH3" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN) ("APC5" . SPARSER::PROTEIN)
    ("E1" . SPARSER::MOLECULE) ("p57" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T-P" . SPARSER::PROTEIN) ("pp150" . SPARSER::PROTEIN)
    ("immediate early" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("de-" . SPARSER::MOLECULE)
    ("CDK4/6" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IE1" . SPARSER::PROTEIN) ("IE2" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("TP53 or TP53" . SPARSER::COLLECTION)
    ("T antigen or SV40" . SPARSER::COLLECTION)
    ("CDKN1A, WAF1 or CIP1" . SPARSER::COLLECTION)
    ("a shorter FUS-DDIT3 fusion protein" . SPARSER::PROTEIN)
    ("DNA-damage" . SPARSER::DNA) ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Antibodies" . SPARSER::ANTIBODY) ("trypsin" . SPARSER::PROTEIN)
    ("fragments" . SPARSER::FRAGMENT) ("the normal FUS" . SPARSER::PROTEIN)
    ("the larger 56 kD protein" . SPARSER::PROTEIN)
    ("our western blot" . SPARSER::PROTEIN)
    ("only sporadic TP53" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("DL" . SPARSER::MOLECULE)
    ("the characteristic fusion oncogene FUS-DDIT3" . SPARSER::COLLECTION)
    ("the characteristic fusion gene" . SPARSER::GENE)
    ("downstream western blot" . SPARSER::PROTEIN)
    ("transgene" . SPARSER::PROTEIN) ("PTEN" . SPARSER::PROTEIN)
    ("Trabectedin" . SPARSER::DRUG) ("CHOP or GADD153" . SPARSER::COLLECTION)
    ("CHOP" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("complex and heterogeneous chromosome aberrations" . SPARSER::COLLECTION)
    ("functional TP53 genes and this" . SPARSER::COLLECTION)
    ("Ion" . SPARSER::MOLECULE)
    ("cell lines expressed normal TP53 proteins" . SPARSER::PROTEIN)
    ("EWSR1-DDIT3" . SPARSER::COLLECTION) ("FUS-DDIT3" . SPARSER::COLLECTION)
    ("FUS" . SPARSER::PROTEIN) ("T antigens" . SPARSER::MOLECULE)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1A" . SPARSER::PROTEIN)
    ("53 kD" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("Protein-A" . SPARSER::PROTEIN) ("GADD153" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("EWSR1" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("CAS" . SPARSER::PROTEIN)
    ("FAK" . SPARSER::PROTEIN) ("effectors" . SPARSER::EFFECTOR)
    ("STAT and NF-κB" . SPARSER::COLLECTION)
    ("multiple substrates ( xref , xref , xref – xref ) and many of these play key roles in intracellular signaling pathways that influence transcription factor activity ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("ligand (EGF)" . SPARSER::MOLECULE) ("p-Src or Src" . SPARSER::COLLECTION)
    ("Luc siRNA or two different Fn14 siRNAs" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN)
    ("Fn14 and ribosomal protein L13a" . SPARSER::COLLECTION)
    ("a proteolytically-cleaved isoform" . SPARSER::ISOFORM)
    ("significantly more Fn14 protein" . SPARSER::PROTEIN)
    ("p100/p52" . SPARSER::COLLECTION)
    ("ERK, JNK, Akt, and STAT3" . SPARSER::COLLECTION)
    ("Lyn or Lck" . SPARSER::COLLECTION)
    ("luciferase (Luc) siRNA or two different Src siRNAs"
     . SPARSER::COLLECTION)
    ("Fgr, Fyn, nor Hck ( xref )" . SPARSER::COLLECTION)
    ("tyrosine phosphorylated Src, Lyn and Lck" . SPARSER::COLLECTION)
    ("Src, Lyn and Lck" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("Fgr" . SPARSER::PROTEIN) ("Blk" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN) ("Lyn" . SPARSER::PROTEIN)
    ("EGF:EGFR" . SPARSER::BIO-COMPLEX) ("DMSO" . SPARSER::MOLECULE)
    ("constitutively active EGFR ( xref ) and Src ( xref , xref )"
     . SPARSER::COLLECTION)
    ("H1975" . SPARSER::PROTEIN) ("Fn14 and GAPDH" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN) ("p" . SPARSER::PROTEIN)
    ("EGFR and Src" . SPARSER::COLLECTION)
    ("erlotinib or dasatinib" . SPARSER::COLLECTION)
    ("blot" . SPARSER::PROTEIN) ("DPP" . SPARSER::MOLECULE)
    ("STAT" . SPARSER::PROTEIN) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Dasatinib" . SPARSER::DRUG)
    ("exhibited strong p-EGFR (Y-1068) antibody" . SPARSER::ANTIBODY)
    ("p-EGFR" . SPARSER::COLLECTION) ("TWEAK-" . SPARSER::PROTEIN)
    ("TWEAK and Fn14" . SPARSER::COLLECTION) ("biologics" . SPARSER::DRUG)
    ("Tumor necrosis factor (TNF)-like weak inducer" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN) ("TKI" . SPARSER::PROTEIN)
    ("ACs" . SPARSER::PROTEIN) ("oncoprotein" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG) ("TWEAK/Fn14" . SPARSER::COLLECTION)
    ("TWEAK:Fn14" . SPARSER::BIO-COMPLEX)
    ("the pro-inflammatory cytokine TWEAK" . SPARSER::PROTEIN)
    ("The TNF receptor superfamily member Fn14" . SPARSER::PROTEIN)
    ("TWEAK" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB2" . SPARSER::PROTEIN) ("PTK6" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("c-Src" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein L13a" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("BAY 11-7082" . SPARSER::DRUG)
    ("U0126" . SPARSER::DRUG) ("MK-2206" . SPARSER::MOLECULE)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("TNFSF12" . SPARSER::PROTEIN)
    ("TNFRSF12A" . SPARSER::PROTEIN) ("Fn14" . SPARSER::PROTEIN)
    ("Pemetrexed" . SPARSER::DRUG) ("pathologic subtypes" . SPARSER::PROTEIN)
    ("VEGF and the SUV" . SPARSER::COLLECTION) ("SUV" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("celecoxib" . SPARSER::DRUG) ("ADC and SQC" . SPARSER::COLLECTION)
    ("invasive ADC" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("the most famous biomarker" . SPARSER::MOLECULE)
    ("transporter" . SPARSER::PROTEIN) ("histological type" . TYPE)
    ("nodal" . SPARSER::PROTEIN) ("SQC" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("tumor angiogenic biomarkers" . SPARSER::MOLECULE)
    ("the histological subtypes" . SPARSER::PROTEIN) ("FDG" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MIB-1" . SPARSER::PROTEIN) ("vascular endothelial" . SPARSER::PROTEIN)
    ("Cox-2" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Nat" . SPARSER::PROTEIN) ("E6 and E7" . SPARSER::COLLECTION)
    ("p53 and E6AP" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("Given p53’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Given p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metabolites" . SPARSER::MOLECULE)
    ("lipooligosaccharide" . SPARSER::MOLECULE)
    ("Nutlin3a and RITA" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("AKT/PKB" . SPARSER::COLLECTION) ("threonine" . SPARSER::AMINO-ACID)
    ("PKB" . SPARSER::PROTEIN)
    ("the bacterial
protein synthesis inhibitor CAM"
     . SPARSER::PROTEIN)
    ("p53-MDM2" . SPARSER::COLLECTION) ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("p53 and CTL2" . SPARSER::COLLECTION)
    ("Nutlin3a or CAM" . SPARSER::COLLECTION)
    ("MDM2–p53" . SPARSER::COLLECTION) ("IBs" . SPARSER::DRUG)
    ("infectious EBs" . SPARSER::PROTEIN) ("EBs" . SPARSER::PROTEIN)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("electron" . SPARSER::MOLECULE)
    ("infectious CTL2" . SPARSER::PROTEIN)
    ("secreted
bacterial effector molecules"
     . SPARSER::MOLECULE)
    ("secreted
bacterial proteases"
     . SPARSER::PROTEIN)
    ("the bacterial protein
synthesis inhibitor chloramphenicol"
     . SPARSER::DRUG)
    ("CAM" . SPARSER::PROTEIN) ("chloramphenicol" . SPARSER::DRUG)
    ("total
MDM2 and bacterial
Hsp60 protein"
     . SPARSER::COLLECTION)
    ("phosphorylated MDM2, total
MDM2 and bacterial
Hsp60 protein"
     . SPARSER::COLLECTION)
    ("bacterial
Hsp60 protein"
     . SPARSER::PROTEIN)
    ("Nutlin3a or RITA" . SPARSER::COLLECTION) ("RITA" . SPARSER::PROTEIN)
    ("phospho-MDM2 and p53" . SPARSER::COLLECTION) ("cis-" . SPARSER::PROTEIN)
    ("imidazoline" . SPARSER::MOLECULE) ("cis" . SPARSER::PROTEIN)
    ("Nutlins" . SPARSER::DRUG) ("keratin-8 or vimentin" . SPARSER::COLLECTION)
    ("keratin-8 and vimentin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN)
    ("MG132 and lactacystin" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("metallothionein" . SPARSER::PROTEIN) ("Venus" . SPARSER::PROTEIN)
    ("p53-Venus" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("pMT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MCF7" . SPARSER::PROTEIN)
    ("chlamydial proteases" . SPARSER::PROTEIN) ("mask" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribonucleotide" . SPARSER::MOLECULE) ("MDM2-p53" . SPARSER::COLLECTION)
    ("p53–MDM2" . SPARSER::COLLECTION) ("NP40" . SPARSER::MOLECULE)
    ("P40" . SPARSER::PROTEIN) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nonidet P-40" . SPARSER::DRUG) ("CCL-2" . SPARSER::PROTEIN)
    ("cytokeratin-8" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("E6AP" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine residue" . SPARSER::MOLECULE)
    ("ataxia
telangiectasia mutated"
     . SPARSER::PROTEIN)
    ("tumour necrosis
factor"
     . SPARSER::PROTEIN)
    ("ml −1" . SPARSER::PROTEIN) ("Hsp60" . SPARSER::PROTEIN)
    ("Nutlin3a" . SPARSER::DRUG) ("keratin-8" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("Double Minute
2"
     . SPARSER::PROTEIN)
    ("53BP1" . SPARSER::PROTEIN) ("pEF1" . SPARSER::PROTEIN)
    ("CTL2" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("Double Minute 2" . SPARSER::PROTEIN) ("alcohol" . SPARSER::DRUG)
    ("cigarette" . SPARSER::DRUG)
    ("The MMP1 (human collagenase-1) and MMP3 (human stromelysin-1) genes"
     . SPARSER::COLLECTION)
    ("collagenase-1" . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GGA" . SPARSER::MOLECULE)
    ("repressor" . SPARSER::REPRESSOR) ("elastin" . SPARSER::PROTEIN)
    ("collagenase" . SPARSER::PROTEIN)
    ("zinc-dependent enzymes" . SPARSER::ENZYME)
    ("MMP1 , MMP3 , and MMP9" . SPARSER::COLLECTION)
    ("MMP1 , MMP3 , or MMP9" . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least 20 proteolytic enzymes" . SPARSER::ENZYME)
    ("tobacco" . SPARSER::DRUG) ("Alcohol" . SPARSER::DRUG)
    ("The 2 major pathological types" . TYPE) ("EAC" . SPARSER::PROTEIN)
    ("MMP1 and MMP9" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("MMP1 and MMP3" . SPARSER::COLLECTION)
    ("zinc-dependent proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("OR 1" . SPARSER::PROTEIN)
    ("stromelysin-1" . SPARSER::PROTEIN) ("DDH 2" . SPARSER::PROTEIN)
    ("G-6A" . SPARSER::PROTEIN) ("G-5" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("PDGFD/PDGFRβ" . SPARSER::COLLECTION)
    ("GFP" . SPARSER::PROTEIN) ("TEL-PDGFRβ" . SPARSER::COLLECTION)
    ("TEL" . SPARSER::PROTEIN) ("DAPI" . SPARSER::DRUG)
    ("BrdU" . SPARSER::DRUG) ("Imatinib" . SPARSER::DRUG)
    ("Tivozanib" . SPARSER::DRUG) ("PDGFD and PDGFRß" . SPARSER::COLLECTION)
    ("GW14.5" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("GW14.5-GW18.2" . SPARSER::PROTEIN-PAIR)
    ("C8orf4 , FAM107A , FOXN4 , ITGA2 , LRIG3 , LRRC17 , PAM , PDGFD , PDLIM3 , RFTN2 , SLC2A10 , SP110 , STOX1 , and ZC3HAV1"
     . SPARSER::COLLECTION)
    ("PAM" . SPARSER::PROTEIN) ("FAM" . SPARSER::PROTEIN)
    ("ON" . SPARSER::PROTEIN) ("DS" . SPARSER::PROTEIN)
    ("homologous genes" . SPARSER::GENE)
    ("PSAT1 , DDAH1 , AIF1L , PSRC1 , and ACSS1" . SPARSER::COLLECTION)
    ("CKS2 , RACGAP1 , MELK , CCNB1 , CCNA2 , ASPM , and MKI67"
     . SPARSER::COLLECTION)
    ("MELK" . SPARSER::PROTEIN) ("NOTCH2 and HES1" . SPARSER::COLLECTION)
    ("SFRP1 , FZD8 , and LRP4" . SPARSER::COLLECTION)
    ("Wnt-βcatenin" . SPARSER::COLLECTION)
    ("VIM and PAX6 , and SOX" . SPARSER::COLLECTION)
    ("PAX6 , and SOX" . SPARSER::COLLECTION)
    ("Sox2 , SOX3 , SOX9 , and SOX21" . SPARSER::COLLECTION)
    ("hRG and mRG" . SPARSER::COLLECTION) ("ID" . SPARSER::PROTEIN)
    ("FACS-mRG" . SPARSER::PROTEIN-PAIR)
    ("TBR1 , FEZF2 , RELN , and SATB2" . SPARSER::COLLECTION)
    ("RELN" . SPARSER::PROTEIN)
    ("VIM , SOX2 , NOTCH1 , and PAX6" . SPARSER::COLLECTION)
    ("VIM" . SPARSER::PROTEIN) ("Genes" . SPARSER::GENE)
    ("ME" . SPARSER::PROTEIN)
    ("outer subventricular (oRG) subtypes" . SPARSER::PROTEIN)
    ("mRG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GW" . SPARSER::PROTEIN)
    ("hRG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PDGFD" . SPARSER::PROTEIN)
    ("secreted growth factor" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("Pdgfrβ" . SPARSER::PROTEIN) ("ZC3HAV1" . SPARSER::PROTEIN)
    ("STOX1" . SPARSER::PROTEIN) ("SP110" . SPARSER::PROTEIN)
    ("SLC2A10" . SPARSER::PROTEIN) ("RFTN2" . SPARSER::PROTEIN)
    ("PDLIM3" . SPARSER::PROTEIN) ("LRRC17" . SPARSER::PROTEIN)
    ("LRIG3" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("C8orf4" . SPARSER::PROTEIN) ("BMP7" . SPARSER::PROTEIN)
    ("ABHD3" . SPARSER::PROTEIN) ("ACSS1" . SPARSER::PROTEIN)
    ("PSRC1" . SPARSER::PROTEIN) ("AIF1" . SPARSER::PROTEIN)
    ("DDAH1" . SPARSER::PROTEIN) ("PSAT1" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("RACGAP1" . SPARSER::PROTEIN)
    ("CKS2" . SPARSER::PROTEIN) ("LRP4" . SPARSER::PROTEIN)
    ("FZD8" . SPARSER::PROTEIN) ("SFRP1" . SPARSER::PROTEIN)
    ("βcatenin" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN) ("SOX21" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("SOX3" . SPARSER::PROTEIN)
    ("Sox2" . SPARSER::PROTEIN) ("SATB2" . SPARSER::PROTEIN)
    ("TBR1" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("GLAST1" . SPARSER::PROTEIN)
    ("SLC1A3" . SPARSER::PROTEIN) ("maternal allele" . SPARSER::ALLELE)
    ("RNase" . SPARSER::PROTEIN)
    ("membrane-associated guanylate kinases" . SPARSER::PROTEIN)
    ("WT1 , ZC3H12C, DLGAP2 , and GPR1" . SPARSER::COLLECTION)
    ("ZC3H12C, DLGAP2 , and GPR1" . SPARSER::COLLECTION)
    ("WT1, ZC3H12C, DLGAP2 , and GPR1" . SPARSER::COLLECTION)
    ("ATP10A and rs6992443" . SPARSER::COLLECTION)
    ("approximately 150 imprinted genes" . SPARSER::GENE)
    ("FER-" . SPARSER::PROTEIN) ("SLC24A4/RIN3" . SPARSER::COLLECTION)
    ("MS4A4/MS4A6E" . SPARSER::COLLECTION)
    ("HLA-DRB1/HLA- DRB5" . SPARSER::COLLECTION) ("FER" . SPARSER::PROTEIN)
    ("PICALM" . SPARSER::PROTEIN) ("CLU" . SPARSER::PROTEIN)
    ("APOE" . SPARSER::PROTEIN)
    ("ZC3H12C, DLGAP2 and GPR1" . SPARSER::COLLECTION)
    ("WT1, ZC3H12C, DLGAP2 and GPR1" . SPARSER::COLLECTION)
    ("Gene" . SPARSER::GENE)
    ("Zinc Finger CCCH-Type containing 12C" . SPARSER::PROTEIN)
    ("Wilms tumor 1" . SPARSER::PROTEIN) ("Wilms Tumor 1" . SPARSER::PROTEIN)
    ("G Protein-Coupled Receptor 1" . SPARSER::PROTEIN)
    ("disks large-associated protein 2" . SPARSER::PROTEIN)
    ("ATP10A" . SPARSER::PROTEIN) ("CASS4" . SPARSER::PROTEIN)
    ("ABCA7" . SPARSER::PROTEIN) ("CD33" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("RIN3" . SPARSER::PROTEIN)
    ("SLC24A4" . SPARSER::PROTEIN) ("MS4A6E" . SPARSER::PROTEIN)
    ("MS4A4" . SPARSER::PROTEIN) ("SORL1" . SPARSER::PROTEIN)
    ("PTK2B" . SPARSER::PROTEIN) ("ZCWPW1" . SPARSER::PROTEIN)
    ("NME8" . SPARSER::PROTEIN) ("EPHA1" . SPARSER::PROTEIN)
    ("HLA- DRB5" . SPARSER::PROTEIN) ("HLA-DRB1" . SPARSER::PROTEIN)
    ("TREM2" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("INPP5D" . SPARSER::PROTEIN) ("BIN1" . SPARSER::PROTEIN)
    ("CR1" . SPARSER::PROTEIN) ("GPR1" . SPARSER::PROTEIN)
    ("DLGAP2" . SPARSER::PROTEIN) ("ZC3H12C" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("GRB10" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN)
    ("complex, and Rieske" . SPARSER::COLLECTION)
    ("cytochrome" . SPARSER::PROTEIN)
    ("mitochondrial GSK-3β and molecules" . SPARSER::COLLECTION)
    ("GSK-3β and molecules" . SPARSER::COLLECTION)
    ("Nicorandil" . SPARSER::DRUG) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("respiratory chain complexes" . SPARSER::BIO-COMPLEX)
    ("the calcein-loadable mitochondria" . SPARSER::PROTEIN)
    ("exogenous hydrogen peroxide" . SPARSER::DRUG)
    ("GSK-3β and ROS" . SPARSER::COLLECTION)
    ("LiCl or nicorandil" . SPARSER::COLLECTION)
    ("ROS, and GSK-3β" . SPARSER::COLLECTION)
    ("nicorandil, diazoxide and LiCl" . SPARSER::COLLECTION)
    ("continual mPTP" . SPARSER::PROTEIN) ("MPG or NAC" . SPARSER::COLLECTION)
    ("NAC" . SPARSER::PROTEIN) ("residual ROS" . SPARSER::PROTEIN)
    ("nicorandil or AA" . SPARSER::COLLECTION)
    ("dehydrogenase" . SPARSER::PROTEIN)
    ("nicorandil or LiCl" . SPARSER::COLLECTION) ("DCF" . SPARSER::PROTEIN)
    ("glycogen synthase (GS)" . SPARSER::PROTEIN-FAMILY)
    ("LiCl" . SPARSER::DRUG) ("MPG" . SPARSER::PROTEIN)
    ("nitrate" . SPARSER::MOLECULE) ("HD" . SPARSER::PROTEIN)
    ("nicorandil or diazoxide" . SPARSER::COLLECTION)
    ("diazoxide" . SPARSER::DRUG) ("nicorandil" . SPARSER::DRUG)
    ("cyclophilin" . SPARSER::PROTEIN) ("cyclosporine" . SPARSER::DRUG)
    ("clearly discrete mitochondrial calcein" . SPARSER::MOLECULE)
    ("IAA almost completely depleted ATP" . SPARSER::ATP)
    ("rod" . SPARSER::PROTEIN) ("tracer" . SPARSER::MOLECULE)
    ("deoxyglucose" . SPARSER::MOLECULE) ("mPTPs" . SPARSER::PROTEIN)
    ("mitochondrial ATPase" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("oxidant" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("mitochondrial calcein" . SPARSER::MOLECULE)
    ("mitochondria" . SPARSER::PROTEIN) ("calcein" . SPARSER::MOLECULE)
    ("mPTP" . SPARSER::PROTEIN) ("antimycin" . SPARSER::DRUG)
    ("TMRE" . SPARSER::MOLECULE) ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("ATP" . SPARSER::ATP) ("hydrogen peroxide" . SPARSER::DRUG)
    ("1–1" . SPARSER::PROTEIN) ("voltage-dependent" . SPARSER::PROTEIN)
    ("VDAC1" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("CoCl 2" . SPARSER::MOLECULE) ("N-acetyl-cysteine" . SPARSER::DRUG)
    ("H-2" . SPARSER::PROTEIN) ("D- 3" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("GSK-3β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("TRAF2, TRAF6, NEMO, Akt, JNK, Smad7, TAK1, Bcl3 and RIP1"
     . SPARSER::COLLECTION)
    ("shMKP-1" . SPARSER::COLLECTION) ("MKP-1 and IL-8" . SPARSER::COLLECTION)
    ("ERK and MEK" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN) ("siRNA-CYLD" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("TRAF6 and Akt" . SPARSER::COLLECTION)
    ("deubiquitinase (DUB)" . SPARSER::DEUBIQUITINASE)
    ("DUB" . SPARSER::PROTEIN) ("MEK/ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chemokine" . SPARSER::PROTEIN)
    ("numerous proinflammatory chemokines" . SPARSER::PROTEIN)
    ("OM and COPD" . SPARSER::COLLECTION) ("COPD" . SPARSER::PROTEIN)
    ("media (OM)" . SPARSER::PROTEIN) ("OM" . SPARSER::PROTEIN)
    ("Cyld" . SPARSER::PROTEIN) ("CYLD" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("chemokines" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("MKP1" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-ERK" . SPARSER::PROTEIN) ("Bcl3" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("Smad7" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("MIP-2" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("Phosphatase-1" . SPARSER::PROTEIN)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("interleukin-8" . SPARSER::PROTEIN) ("DAMPs" . SPARSER::DAMP)
    ("iNOS or nNOS, p53, or NF-κB" . SPARSER::COLLECTION)
    ("nNOS, p53, or NF-κB" . SPARSER::COLLECTION)
    ("iNOS, p53, or NF-κB" . SPARSER::COLLECTION)
    ("p53, NF-κB, and iNOS or nNOS" . SPARSER::COLLECTION)
    ("NF-κB, iNOS, SIRT1, and p65" . SPARSER::COLLECTION)
    ("p65, p50, or IKK" . SPARSER::COLLECTION)
    ("promoters" . SPARSER::PROMOTER) ("macrophage" . SPARSER::PROTEIN)
    ("MDM2 and HDM2" . SPARSER::COLLECTION)
    ("hepatocytes and skeletal muscle" . SPARSER::COLLECTION)
    ("p65 (NF-κB) and p53" . SPARSER::COLLECTION)
    ("iNOS or nNOS" . SPARSER::COLLECTION)
    ("SIRT1, p53, and NF-κB" . SPARSER::COLLECTION)
    ("muscle-specific ubiquitin ligases" . SPARSER::LIGASE)
    ("Fas and FasL" . SPARSER::COLLECTION)
    ("Atrogin-1 and Murf1" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("Fas" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("the striatum or the substantia nigra pars reticulata"
     . SPARSER::COLLECTION)
    ("both an intracellular signaling molecule and an intercellular messenger ( xref , xref )"
     . SPARSER::COLLECTION)
    ("dopamine" . SPARSER::PROTEIN) ("striatum" . SPARSER::PROTEIN)
    ("MPTP and 7-NI" . SPARSER::COLLECTION)
    ("nNOS, p53, or p65" . SPARSER::COLLECTION)
    ("astrocytes" . SPARSER::PROTEIN) ("microglia" . SPARSER::PROTEIN)
    ("nNOS or iNOS" . SPARSER::COLLECTION) ("MPTP" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("endotoxins" . SPARSER::MOLECULE) ("nitrite" . SPARSER::MOLECULE)
    ("siRNAs" . SPARSER::PROTEIN) ("LPS and cytokines" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN)
    ("both SIRT1 and other HDACs" . SPARSER::COLLECTION)
    ("GSNO and TSA" . SPARSER::COLLECTION)
    ("GSNO or TSA" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE) ("HDAC" . SPARSER::PROTEIN)
    ("expressed exogenous wild-type SIRT1" . SPARSER::PROTEIN)
    ("SIRT1 or SIRT1" . SPARSER::COLLECTION)
    ("1 H -[1,2,4]oxadiazolo[4,3- a ]quinoxalin-1-one (ODQ)"
     . SPARSER::MOLECULE)
    ("ODQ" . SPARSER::MOLECULE)
    ("a cell-permeable cGMP analog" . SPARSER::ANALOG)
    ("bromo" . SPARSER::MOLECULE) ("analog" . SPARSER::ANALOG)
    ("cGMP" . SPARSER::PROTEIN) ("GSNO or SNAP" . SPARSER::COLLECTION)
    ("wild-type p53 or K382A p53 ( xref )" . SPARSER::COLLECTION)
    ("exogenous wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymerase" . SPARSER::PROTEIN)
    ("etoposide ( xref ) or bleomycin ( xref )" . SPARSER::COLLECTION)
    ("SNAP ( xref and xref ) or GNSO ( xref )" . SPARSER::COLLECTION)
    ("ethylenediamine (TPEN)" . SPARSER::DRUG) ("EGTA" . SPARSER::MOLECULE)
    ("TPEN" . SPARSER::DRUG) ("ethylenediamine" . SPARSER::DRUG)
    ("chelator" . SPARSER::MOLECULE) ("SNAP and GSNO" . SPARSER::COLLECTION)
    ("GSNO" . SPARSER::MOLECULE) ("Ascorbate" . SPARSER::MOLECULE)
    ("SOX" . SPARSER::MOLECULE) ("thiols (SOX)" . SPARSER::MOLECULE)
    ("DTT" . SPARSER::MOLECULE) ("dithiothreitol" . SPARSER::PROTEIN)
    ("SNAP and carmustine" . SPARSER::COLLECTION)
    ("ascorbate" . SPARSER::MOLECULE) ("Carmustine" . SPARSER::DRUG)
    ("S -nitroso- N -acetylpenicillamine (SNAP)" . SPARSER::MOLECULE)
    ("BCNU" . SPARSER::DRUG) ("carmustine" . SPARSER::DRUG)
    ("SNAP" . SPARSER::PROTEIN) ("ribosylase" . SPARSER::PROTEIN)
    ("FLAG-SIRT1" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("cysteines" . SPARSER::AMINO-ACID) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("peptides" . SPARSER::PEPTIDE) ("p53, and NF-κB" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN)
    ("p65 and upstream signaling molecules" . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE) ("Cys" . SPARSER::AMINO-ACID)
    ("The prototypic form" . SPARSER::FORM)
    ("p65 and p50 or p52" . SPARSER::COLLECTION)
    ("p50 or p52" . SPARSER::COLLECTION) ("peroxisome" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("adenosine" . SPARSER::PROTEIN)
    ("lysine" . SPARSER::AMINO-ACID) ("HDACs" . SPARSER::PROTEIN)
    ("deacetylases" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE) ("nicotinamide" . SPARSER::PROTEIN)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("NF-κB– and p53-related proteins ( xref – xref )" . SPARSER::COLLECTION)
    ("NF-κB–" . SPARSER::PROTEIN) ("thiols" . SPARSER::MOLECULE)
    ("iNOS-" . SPARSER::PROTEIN) ("endothelial NOS" . SPARSER::PROTEIN)
    ("neuronal NOS" . SPARSER::PROTEIN) ("synthase (NOS)" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("nNOS" . SPARSER::PROTEIN)
    ("NOS" . SPARSER::PROTEIN) ("synthase" . SPARSER::PROTEIN)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("p53 and p65" . SPARSER::COLLECTION) ("subunit" . SPARSER::FRAGMENT)
    ("RelA" . SPARSER::PROTEIN)
    ("the transcription factors p53 and nuclear factor κB (NF-κB)"
     . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("Akt1" . SPARSER::PROTEIN)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("muscle-specific RING finger protein" . SPARSER::PROTEIN)
    ("toll-like receptor 4" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN)
    ("superfamily member 6" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("BCL2" . SPARSER::PROTEIN) ("PJ34" . SPARSER::DRUG)
    ("32 P" . SPARSER::|32P|) ("Protein A" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("streptavidin-agarose" . SPARSER::DRUG)
    ("pH 3" . SPARSER::MOLECULE) ("Lys 9" . SPARSER::PROTEIN)
    ("PEG 2" . SPARSER::PROTEIN) ("N -ethylmaleimide" . SPARSER::MOLECULE)
    ("N3" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("Murf1" . SPARSER::PROTEIN)
    ("Atrogin-1" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::MOLECULE)
    ("1 H -[1,2,4]oxadiazolo[4,3- a ]quinoxalin-1-one" . SPARSER::MOLECULE)
    ("guanosine monophosphate" . SPARSER::MOLECULE)
    ("caspase-3" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("S -nitrosothiols" . SPARSER::MOLECULE)
    ("S -nitroso- N -acetylpenicillamine" . SPARSER::MOLECULE)
    ("M1" . SPARSER::MOLECULE) ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("homolog of" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inducible NOS" . SPARSER::PROTEIN) ("Nitric oxide" . SPARSER::MOLECULE)
    ("SIRT1" . SPARSER::PROTEIN) ("nitric oxide" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Skp1, Cul1 or Rbx1/Roc1" . SPARSER::COLLECTION)
    ("RNF121 and β-TrCP" . SPARSER::COLLECTION) ("Nedd8" . SPARSER::PROTEIN)
    ("RNF121 and IκBα" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("both IKK and its target IκBα" . SPARSER::COLLECTION)
    ("IRAK1 or RIP2" . SPARSER::COLLECTION)
    ("TNFR, TLR4 or NOD1" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and NOD2"
     . SPARSER::COLLECTION)
    ("dipeptide (MDP)" . SPARSER::MOLECULE) ("viral RNAs" . SPARSER::RNA)
    ("IE-DAP" . SPARSER::COLLECTION) ("dipeptide" . SPARSER::MOLECULE)
    ("muramyl" . SPARSER::MOLECULE) ("DAP" . SPARSER::PROTEIN)
    ("RNAs" . SPARSER::RNA)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAPKs" . SPARSER::PROTEIN)
    ("p65/p50" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("RNF121 and RNF175" . SPARSER::COLLECTION)
    ("Myc-tagged or endogenous RNF121" . SPARSER::COLLECTION)
    ("ER" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("alanine" . SPARSER::AMINO-ACID) ("cys" . SPARSER::AMINO-ACID)
    ("NFAT-" . SPARSER::PROTEIN) ("IFNβ-" . SPARSER::PROTEIN)
    ("NFAT" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("NF-κB and NF-κB" . SPARSER::COLLECTION) ("c-IAPs" . SPARSER::COLLECTION)
    ("IAPs" . SPARSER::PROTEIN) ("TRADD" . SPARSER::PROTEIN)
    ("oligoribonucleotides" . SPARSER::MOLECULE)
    ("pro-inflammatory cytokines or anti-apoptotic proteins"
     . SPARSER::PROTEIN)
    ("cytokines or anti-apoptotic" . SPARSER::COLLECTION)
    ("kinases, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("NEMO" . SPARSER::PROTEIN) ("polyubiquitin" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::MOLECULE) ("inducers" . SPARSER::MOLECULE)
    ("the Rel family and the NF-κB dimers" . SPARSER::COLLECTION)
    ("Inhibitor" . SPARSER::INHIBITOR) ("dimers" . SPARSER::DIMER)
    ("Rel" . SPARSER::PROTEIN) ("subunits" . SPARSER::FRAGMENT)
    ("RLRs" . SPARSER::PROTEIN) ("NLRs" . SPARSER::PROTEIN)
    ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("Receptors" . SPARSER::PROTEIN) ("IKK" . SPARSER::PROTEIN)
    ("a new Golgi Apparatus-resident protein" . SPARSER::PROTEIN)
    ("new modulators" . SPARSER::PROTEIN) ("TNFR" . SPARSER::PROTEIN)
    ("siRNA" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("RIP2" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("NOD2" . SPARSER::PROTEIN)
    ("NOD1" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain-containing protein 1"
     . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("retinoic acid" . SPARSER::MOLECULE) ("TLR4" . SPARSER::PROTEIN)
    ("Toll-Like-Receptor 4" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p50" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("RNF175" . SPARSER::PROTEIN) ("Brefeldin A" . SPARSER::MOLECULE)
    ("Myc-tagged" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("RING finger protein" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("RNF121" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("CRC and use simpler" . SPARSER::COLLECTION)
    ("formalin" . SPARSER::MOLECULE)
    ("retrospective patient cohorts" . SPARSER::MOLECULE)
    ("a potential biomarker" . SPARSER::MOLECULE) ("classes" . CLASS)
    ("mRNA or immunohistochemistry" . SPARSER::COLLECTION)
    ("Wang" . SPARSER::PROTEIN) ("YAP1 or TAZ" . SPARSER::COLLECTION)
    ("potential predictive biomarker" . SPARSER::MOLECULE)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("locoregional CRC" . SPARSER::PROTEIN) ("BRAF" . SPARSER::PROTEIN)
    ("activin" . SPARSER::PROTEIN)
    ("WNT, mitogen-activated protein kinase, phosphoinositide 3-kinase, transforming growth factor-, and p53"
     . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("partial" . SPARSER::PROTEIN)
    ("CR" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("199 unique genes" . SPARSER::GENE) ("YAP1 and TAZ" . SPARSER::COLLECTION)
    ("its downstream oncogene YAP1 and the related TAZ" . SPARSER::COLLECTION)
    ("TAZ" . SPARSER::PROTEIN) ("metastatic CRC" . SPARSER::PROTEIN)
    ("stage IV CRC and wild-type KRAS" . SPARSER::COLLECTION)
    ("IYCC and AYCC" . SPARSER::COLLECTION) ("IYCC" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("cetuximab" . SPARSER::DRUG)
    ("activated YAP1 CRC (AYCC) or inactivated YAP1 CRC (IYCC)"
     . SPARSER::COLLECTION)
    ("CRC (IYCC)" . SPARSER::PROTEIN) ("CRC (AYCC)" . SPARSER::PROTEIN)
    ("CRC" . SPARSER::PROTEIN) ("receptor type" . SPARSER::PROTEIN)
    ("ACVR2A" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN) ("1–4" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("functionally relevant missense variants" . SPARSER::VARIANT)
    ("CDH1 pathogenic variants" . SPARSER::VARIANT)
    ("β -catenin and PIPKI γ" . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT)
    ("E-cadherin pathogenic variants" . SPARSER::VARIANT)
    ("those expressing pathogenic variants" . SPARSER::VARIANT)
    ("class" . CLASS) ("complement" . SPARSER::PROTEIN)
    ("pathogenic variant" . SPARSER::VARIANT)
    ("The neutral variant" . SPARSER::VARIANT) ("Ser" . SPARSER::AMINO-ACID)
    ("Gly" . SPARSER::AMINO-ACID) ("Asp" . SPARSER::AMINO-ACID)
    ("EC" . SPARSER::PROTEIN) ("Ala" . SPARSER::AMINO-ACID)
    ("weaker" . SPARSER::PROTEIN) ("Lys" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("MMR" . SPARSER::PROTEIN) ("protein (WT)" . SPARSER::PROTEIN)
    ("sharp" . SPARSER::PROTEIN) ("a compensated map" . SPARSER::PROTEIN)
    ("aberrant foci" . SPARSER::PROTEIN) ("foci" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("pathogenic variants" . SPARSER::VARIANT)
    ("Original IF" . SPARSER::PROTEIN) ("maps" . SPARSER::PROTEIN)
    ("relevant germline E-cadherin missense variants" . SPARSER::VARIANT)
    ("map" . SPARSER::PROTEIN) ("IF" . SPARSER::PROTEIN)
    ("Functional E-cadherin" . SPARSER::PROTEIN)
    ("families" . SPARSER::PROTEIN-FAMILY) ("HDGC" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE) ("p120-catenin" . SPARSER::PROTEIN)
    ("PIPKI γ" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell membrane" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("local VEGF" . SPARSER::PROTEIN) ("its homomeric form" . SPARSER::FORM)
    ("a homodimer or a heterodimer" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("ligases" . SPARSER::LIGASE)
    ("eukaryotic proteins" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("soluble ADAM17" . SPARSER::PROTEIN)
    ("EGF" . SPARSER::PROTEIN) ("TNF" . SPARSER::PROTEIN)
    ("LPS" . SPARSER::PROTEIN) ("PlGF and PMA" . SPARSER::COLLECTION)
    ("GM6001 and TAPI-1" . SPARSER::COLLECTION)
    ("severe proteinuria" . SPARSER::PROTEIN)
    ("proteinuria" . SPARSER::PROTEIN)
    ("VEGFR2 or the Flt1-VEGFR2 heterodimer" . SPARSER::COLLECTION)
    ("monomer" . SPARSER::MONOMER) ("heparin" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("Flt1 and VEGFR2" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER) ("homodimers" . SPARSER::HOMODIMER)
    ("Flt1 and c-CBL" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("CD2AP and VEGF-activated Flt1" . SPARSER::COLLECTION)
    ("CHO" . SPARSER::PROTEIN) ("polyubiquitination" . SPARSER::PROTEIN)
    ("AA" . SPARSER::MOLECULE) ("Ligand" . SPARSER::LIGAND)
    ("a cell-permeable PKC inhibitor" . SPARSER::INHIBITOR)
    ("isoform" . SPARSER::ISOFORM) ("ADAMs" . SPARSER::PROTEIN)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("ADAM10 and ADAM 17" . SPARSER::COLLECTION)
    ("ADAM 10 and ADAM 17" . SPARSER::COLLECTION)
    ("ADAM 10 and/or ADAM 17" . SPARSER::COLLECTION)
    ("examples" . SPARSER::EXAMPLE)
    ("Both GM6001 and TAPI-1" . SPARSER::COLLECTION)
    ("TAPI-1" . SPARSER::COLLECTION) ("metalloproteinase" . SPARSER::PROTEIN)
    ("AF" . SPARSER::PROTEIN) ("HEK" . SPARSER::PROTEIN)
    ("mRNA and protein" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("ADAM" . SPARSER::PROTEIN) ("VEGF and PlGF" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM) ("substrates" . SPARSER::SUBSTRATE)
    ("soluble receptor ligands" . SPARSER::LIGAND)
    ("antagonists" . SPARSER::MOLECULE) ("VEGFR2/FLK1" . SPARSER::COLLECTION)
    ("disorganized embryonic vasculature" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN)
    ("the homomeric Flt1 receptor" . SPARSER::RECEPTOR)
    ("phosphatidylinositol 3-kinase (PI3-Kinase) and MAP kinases"
     . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("PlGF and VEGF-A" . SPARSER::COLLECTION)
    ("Flt1-VEGFR2" . SPARSER::COLLECTION) ("dimer" . SPARSER::DIMER)
    ("PlGF" . SPARSER::PROTEIN)
    ("The transmembrane protein Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) or FLT1 (fms-like tyrosine kinase-1)"
     . SPARSER::COLLECTION)
    ("tyrosine kinase-1" . SPARSER::COLLECTION) ("Ig" . SPARSER::MOLECULE)
    ("antagonist" . SPARSER::MOLECULE) ("heterodimer" . SPARSER::HETERODIMER)
    ("Flt1 and Flt1" . SPARSER::COLLECTION) ("proteasomal" . SPARSER::PROTEIN)
    ("PKC" . SPARSER::PROTEIN) ("ADAM10 and ADAM17" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("alternately transcribed soluble Flt1" . SPARSER::PROTEIN)
    ("VEGF" . SPARSER::PROTEIN) ("kinase activity" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN) ("GF109203X" . SPARSER::DRUG)
    ("5–2" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("CD2AP" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("N-term" . SPARSER::PROTEIN) ("phospholipase C" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("AC-3" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("ANTI-" . SPARSER::ANTIBODY)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("c-Cbl" . SPARSER::PROTEIN)
    ("C-Cbl" . SPARSER::PROTEIN) ("HSP 90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Flk-1" . SPARSER::PROTEIN) ("α Tubulin" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("ADAM 17" . SPARSER::PROTEIN) ("ADAM 10" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("N1" . SPARSER::PROTEIN)
    ("FLK1" . SPARSER::PROTEIN) ("FLT-1" . SPARSER::PROTEIN)
    ("Flt 1" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF-A" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLT1" . SPARSER::PROTEIN) ("VEGFR1" . SPARSER::PROTEIN)
    ("Vascular Endothelial Growth Factor Receptor 1" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("c-CBL" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN) ("ADAM10" . SPARSER::PROTEIN)
    ("Flt1" . SPARSER::PROTEIN) ("cadherin or α catenin" . SPARSER::COLLECTION)
    ("p120 and RhoA-GDP" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("Fyn" . SPARSER::PROTEIN) ("GDP" . SPARSER::NUCLEOTIDE)
    ("Src-Vav2" . SPARSER::COLLECTION) ("guanine" . SPARSER::PROTEIN)
    ("CD148-E-cadherin" . SPARSER::COLLECTION)
    ("CS or control GST" . SPARSER::COLLECTION)
    ("p120, β-catenin, and E-cadherin" . SPARSER::COLLECTION)
    ("vanadate" . SPARSER::MOLECULE)
    ("the wild-type CD148 (GST-CD148 WT) or control GST" . SPARSER::COLLECTION)
    ("p120 and β- catenin" . SPARSER::COLLECTION)
    ("GST-CD148" . SPARSER::COLLECTION) ("pervanadate" . SPARSER::PROTEIN)
    ("DA" . SPARSER::MOLECULE) ("E-cadherin and CD148" . SPARSER::COLLECTION)
    ("Rac1, RhoA, and Cdc42" . SPARSER::COLLECTION)
    ("PBD-GST or RBD-GST" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("E-cadherin and p120 or β-catenin" . SPARSER::COLLECTION)
    ("p120 or β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin and catenins" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD148 and E-cadherin" . SPARSER::COLLECTION)
    ("physically and functionally links cadherin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rho-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPases" . SPARSER::GTPASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classical cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins, p120 and β-catenin" . SPARSER::COLLECTION)
    ("calcium" . SPARSER::CALCIUM) ("component" . SPARSER::COMPONENT)
    ("growth factor receptors and their signaling proteins"
     . SPARSER::COLLECTION)
    ("HGFR" . SPARSER::PROTEIN) ("receptors" . SPARSER::RECEPTOR)
    ("a transmembrane PTP" . SPARSER::PROTEIN) ("PTPRJ" . SPARSER::PROTEIN)
    ("PTP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein tyrosine kinases (PTKs) and phosphatases (PTPs)"
     . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("E-cadherin and p120" . SPARSER::COLLECTION)
    ("p120, β-catenin, and Src" . SPARSER::COLLECTION)
    ("shRNA" . SPARSER::PROTEIN) ("p120 and β-catenin" . SPARSER::COLLECTION)
    ("Src" . SPARSER::PROTEIN)
    ("E-cadherin, p120, and β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin/catenin" . SPARSER::COLLECTION) ("GTPase" . SPARSER::GTPASE)
    ("inactive (CS)" . SPARSER::INACTIVE)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CS" . SPARSER::PROTEIN)
    ("cadherin/catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("tyrosine" . SPARSER::AMINO-ACID)
    ("Shp2" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("β- catenin" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("NSC23766" . SPARSER::DRUG) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("Protein-G" . SPARSER::PROTEIN) ("Na 3 Vo 4" . SPARSER::MOLECULE)
    ("NP-40" . SPARSER::DRUG) ("MgCl 2" . SPARSER::MOLECULE)
    ("NSC 23766" . SPARSER::DRUG) ("Rac 1" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("IgG2a" . SPARSER::PROTEIN) ("C-2" . SPARSER::PROTEIN)
    ("pp120" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("VE-cadherin" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("p85" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DEP-1" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("Rac1" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("E-cadherin" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("CD148" . SPARSER::PROTEIN) ("cytokines" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("zfPAI-1" . SPARSER::COLLECTION) ("bony fish" . SPARSER::PROTEIN)
    ("fish" . SPARSER::PROTEIN) ("van" . SPARSER::PROTEIN)
    ("a nonionic detergent" . SPARSER::MOLECULE)
    ("detergent" . SPARSER::MOLECULE) ("asparagines" . SPARSER::AMINO-ACID)
    ("Asn" . SPARSER::AMINO-ACID) ("variants" . SPARSER::VARIANT)
    ("variant" . SPARSER::VARIANT) ("isoleucine" . SPARSER::AMINO-ACID)
    ("parts" . SPARSER::COMPONENT) ("α 1-acid glycoprotein" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND)
    ("PAI-1 and vitronectin" . SPARSER::COLLECTION)
    ("vitronectin" . SPARSER::PROTEIN)
    ("a multifunctional glycoprotein" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("Vitronectin" . SPARSER::PROTEIN)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("guanidinium" . SPARSER::MOLECULE) ("arginine" . SPARSER::AMINO-ACID)
    ("electronegative ions" . SPARSER::MOLECULE) ("barrier" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("nitrogen" . SPARSER::MOLECULE)
    ("ions" . SPARSER::MOLECULE) ("His" . SPARSER::AMINO-ACID)
    ("histidine" . SPARSER::AMINO-ACID) ("NaCl" . SPARSER::PROTEIN)
    ("salt" . SPARSER::MOLECULE) ("variety" . SPARSER::VARIETY)
    ("an energetically more favorable inactive latent state"
     . SPARSER::BIO-STATE)
    ("latent PAI-1" . SPARSER::PROTEIN) ("Partial" . SPARSER::PROTEIN)
    ("the nonreactive latent form" . SPARSER::FORM)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intima-media" . SPARSER::PROTEIN-PAIR) ("media" . SPARSER::PROTEIN)
    ("a substrate of the protease and not" . SPARSER::COLLECTION)
    ("SDS" . SPARSER::PROTEIN) ("the amino terminal part" . SPARSER::COMPONENT)
    ("Met" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("solvent" . SPARSER::MOLECULE) ("ester" . SPARSER::MOLECULE)
    ("serpin and protease" . SPARSER::COLLECTION)
    ("three interconvertible conformations" . SPARSER::BIO-CONFORMATION)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("cofactor" . SPARSER::MOLECULE)
    ("principal inhibitor" . SPARSER::INHIBITOR)
    ("laminin, type IV collagen, and fibronectin" . SPARSER::COLLECTION)
    ("fibronectin" . SPARSER::PROTEIN) ("laminin" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN) ("Plasmin" . SPARSER::PROTEIN)
    ("inhibitors (PAI)" . SPARSER::INHIBITOR)
    ("activators (PA)" . SPARSER::ACTIVATOR) ("PAI" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("Plasminogen" . SPARSER::PROTEIN)
    ("t" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("LRP or tPA" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("both tissue-type and urokinase-type plasminogen activators"
     . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("tPA" . SPARSER::PROTEIN)
    ("Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1)"
     . SPARSER::COLLECTION)
    ("inactive" . SPARSER::INACTIVE) ("platelets" . SPARSER::PROTEIN)
    ("hepatocytes" . SPARSER::PROTEIN)
    ("dinucleotide (CA)" . SPARSER::MOLECULE)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("fragment" . SPARSER::FRAGMENT)
    ("dinucleotide" . SPARSER::MOLECULE) ("lipoprotein" . SPARSER::PROTEIN)
    ("LDL" . SPARSER::PROTEIN) ("endotoxin" . SPARSER::MOLECULE)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("antibodies" . SPARSER::ANTIBODY) ("RCL" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE) ("a globular protein" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("potential molecular target" . SPARSER::TARGET-PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("biomarker" . SPARSER::MOLECULE)
    ("α 2-antiplasmin or thrombin activatable fibrinolysis inhibitor (TAFI) or plasminogen activator inhibitors"
     . SPARSER::COLLECTION)
    ("α 2-antiplasmin or thrombin activatable fibrinolysis inhibitor (TAFI)"
     . SPARSER::INHIBITOR)
    ("inhibitor (TAFI)" . SPARSER::INHIBITOR) ("thrombin" . SPARSER::PROTEIN)
    ("t-PA and u-PA" . SPARSER::COLLECTION) ("fibrin" . SPARSER::MOLECULE)
    ("plasmin" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("forms" . SPARSER::FORM) ("proteases" . SPARSER::PROTEIN)
    ("serine" . SPARSER::AMINO-ACID)
    ("PAI-1, tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA)"
     . SPARSER::COLLECTION)
    ("the inhibitory serpins and the noninhibitory serpins [ xref ]"
     . SPARSER::COLLECTION)
    ("the noninhibitory serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Serpins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kDa" . SPARSER::PROTEIN)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA)"
     . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("plasminogen" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("1-2 " . SPARSER::PROTEIN)
    ("P10" . SPARSER::PROTEIN) ("P80" . SPARSER::PROTEIN)
    ("P16" . SPARSER::PROTEIN) ("serpin family" . SPARSER::PROTEIN)
    ("α 1-antitrypsin" . SPARSER::PROTEIN) ("L-NAME" . SPARSER::MOLECULE)
    ("type IV collagen" . SPARSER::PROTEIN) ("TGF-b1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("interleukin-1" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR) ("alpha-" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID)
    ("plasminogen activator" . SPARSER::PROTEIN)
    ("serine proteinase" . SPARSER::PROTEIN) ("u-PA" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("disease-associated genes" . SPARSER::GENE)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("the mouse dermal over-expressed genes" . SPARSER::GENE)
    ("Chromatin" . SPARSER::PROTEIN)
    ("pro-fibrotic β-catenin" . SPARSER::PROTEIN)
    ("proteoglycans, glycoproteins, and matrix" . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad2 and Smad3" . SPARSER::COLLECTION) ("bleomycin" . SPARSER::DRUG)
    ("the fibrotic ECM" . SPARSER::PROTEIN) ("molecule" . SPARSER::MOLECULE)
    ("dermal fibroblast nuclear β-catenin" . SPARSER::PROTEIN)
    ("fibrotic ECM" . SPARSER::PROTEIN) ("antiserum" . SPARSER::PROTEIN)
    ("Biglycan" . SPARSER::PROTEIN) ("proteoglycan" . SPARSER::PROTEIN)
    ("leucine" . SPARSER::AMINO-ACID) ("biglycan" . SPARSER::PROTEIN)
    ("proteoglycans" . SPARSER::PROTEIN) ("Sp5 and Osr2" . SPARSER::COLLECTION)
    ("Sp5" . SPARSER::PROTEIN)
    ("These disease-associated genes" . SPARSER::GENE)
    ("at least one type" . TYPE) ("human homologous gene" . SPARSER::GENE)
    ("Sox8, Jundm2, and Irf4" . SPARSER::COLLECTION)
    ("Irf4" . SPARSER::PROTEIN) ("Tcf1" . SPARSER::PROTEIN)
    ("Tcf7l2" . SPARSER::PROTEIN) ("Irf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Thbs4 , Ccn3/Nov, and Fbln1" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("Thbs4, Ccn3/Nov , and Fbln1" . SPARSER::COLLECTION)
    ("CCN3/NOV" . SPARSER::COLLECTION) ("Fbln1" . SPARSER::PROTEIN)
    ("Thbs4" . SPARSER::PROTEIN) ("NOV" . SPARSER::PROTEIN)
    ("Ccn" . SPARSER::PROTEIN-FAMILY) ("RNA" . SPARSER::RNA)
    ("Fbn1" . SPARSER::PROTEIN) ("Fbn" . SPARSER::PROTEIN)
    ("the predominant type" . TYPE) ("hypodermis" . SPARSER::PROTEIN)
    ("abnormal ECM" . SPARSER::PROTEIN)
    ("phosphorylated (active) Smad2 (pSmad2) and Smad3 (pSmad3)"
     . SPARSER::COLLECTION)
    ("mediators" . SPARSER::PROTEIN) ("cytometry" . SPARSER::PROTEIN)
    ("actin" . SPARSER::PROTEIN) ("smooth muscle" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("monocytes" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("YFP" . SPARSER::PROTEIN)
    ("Tcf/Lef family transcriptional cofactors" . SPARSER::PROTEIN)
    ("cofactors" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("novel pro-fibrotic molecules" . SPARSER::MOLECULE)
    ("molecules" . SPARSER::MOLECULE) ("effector" . SPARSER::EFFECTOR)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("collagen" . SPARSER::PROTEIN)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECM" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-16" . SPARSER::PROTEIN)
    ("Osr2" . SPARSER::PROTEIN) ("Jundm2" . SPARSER::PROTEIN)
    ("Sox8" . SPARSER::PROTEIN) ("HNF1" . SPARSER::PROTEIN)
    ("fibulin-1" . SPARSER::PROTEIN) ("thrombospondin-4" . SPARSER::PROTEIN)
    ("CCN3" . SPARSER::PROTEIN) ("fibrillin-1" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Smad3" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PDGFRβ" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("Serpine1" . SPARSER::PROTEIN) ("Col1a1" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alleles" . SPARSER::ALLELE) ("Mutant" . SPARSER::MUTANT)
    ("allele" . SPARSER::ALLELE)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR and β-catenin" . SPARSER::COLLECTION)
    ("Grb2 and Ras" . SPARSER::COLLECTION)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pro" . SPARSER::AMINO-ACID)
    ("residual WT p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oncomorphic p53 proteins" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein BAK and the cell cycle regulator p21 (CIP1/WAF1)"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BAK" . SPARSER::PROTEIN)
    ("CIP1/WAF1" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("part" . SPARSER::COMPONENT) ("taxol" . SPARSER::DRUG)
    ("R175H, R248Q, and Y220C oncomorphic p53 mutant proteins"
     . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT) ("oncomorphic TP53" . SPARSER::PROTEIN)
    ("mutants" . SPARSER::MUTANT) ("log-rank" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN)
    ("oncomorphic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPPA" . SPARSER::PROTEIN) ("intron-exon" . SPARSER::COLLECTION)
    ("exon" . SPARSER::PROTEIN) ("Exon" . SPARSER::PROTEIN)
    ("platinum and taxane" . SPARSER::COLLECTION) ("IV" . SPARSER::PROTEIN)
    ("platinum-" . SPARSER::MOLECULE) ("taxane" . SPARSER::DRUG)
    ("platinum" . SPARSER::MOLECULE) ("suppressor" . SPARSER::SUPPRESSOR)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WAF1" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("β-actin" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("P72" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TP53" . SPARSER::PROTEIN)
    ("AC" . SPARSER::PROTEIN) ("oncogene" . SPARSER::ONCOGENE)
    ("subtypes" . SPARSER::PROTEIN) ("SOX2 and TP63" . SPARSER::COLLECTION)
    ("FISH" . SPARSER::PROTEIN) ("/Akt" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA/SOX2" . SPARSER::COLLECTION) ("HR" . SPARSER::PROTEIN)
    ("seven" . SPARSER::PROTEIN) ("TMA" . SPARSER::MOLECULE)
    ("proteins, FGFR1, PIK3CA and SOX2" . SPARSER::COLLECTION)
    ("cohorts" . SPARSER::MOLECULE) ("SOX2 and PIK3CA" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE) ("MAP" . SPARSER::PROTEIN)
    ("SQ" . SPARSER::MOLECULE)
    ("prognostic or predictive biomarkers" . SPARSER::MOLECULE)
    ("ERCC1 and RRM1" . SPARSER::COLLECTION)
    ("cisplatin (CDDP)" . SPARSER::MOLECULE) ("CDDP" . SPARSER::DRUG)
    ("cisplatin" . SPARSER::DRUG) ("adjuvant" . SPARSER::DRUG)
    ("IB" . SPARSER::DRUG) ("Adjuvant" . SPARSER::DRUG)
    ("pemetrexed and bevacizumab" . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG) ("pemetrexed" . SPARSER::DRUG)
    ("gefitinib, erlotinib and crizotinib" . SPARSER::COLLECTION)
    ("crizotinib" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("gefitinib" . SPARSER::DRUG) ("ALK" . SPARSER::PROTEIN)
    ("EGFR" . SPARSER::PROTEIN) ("ADC" . SPARSER::PROTEIN)
    ("PIK3CA and SOX2" . SPARSER::COLLECTION) ("/SOX2" . SPARSER::COLLECTION)
    ("cohort" . SPARSER::MOLECULE) ("States" . SPARSER::BIO-STATE)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE)
    ("FGFR1, PIK3CA and SOX2" . SPARSER::COLLECTION) ("p63" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–3" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RRM1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("flavopiridol" . SPARSER::DRUG) ("leukemia" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("staurosporine" . SPARSER::MOLECULE)
    ("modulators" . SPARSER::PROTEIN)
    ("ink4c , and p19 ink4d" . SPARSER::COLLECTION)
    ("waf1 , p27 Kip1 , and p57 Kip2" . SPARSER::COLLECTION)
    ("family" . SPARSER::PROTEIN-FAMILY)
    ("the previously described CDC25 inhibitors" . SPARSER::INHIBITOR)
    ("PC-3" . SPARSER::PROTEIN) ("LNCaP" . SPARSER::PROTEIN)
    ("EK" . SPARSER::PROTEIN) ("cytotoxic" . SPARSER::PROTEIN)
    ("the CDC2-cyclin B heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("CDC2-cyclin" . SPARSER::COLLECTION)
    ("MAPK-CDC25B-CDC2-cyclin" . SPARSER::COLLECTION)
    ("MAPK-CDC25B" . SPARSER::COLLECTION)
    ("SB 239063 and FK-3000" . SPARSER::COLLECTION)
    ("MAPK and phospho-CDC25B" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RB" . SPARSER::PROTEIN)
    ("FK-3000 and 120-min" . SPARSER::COLLECTION)
    ("chemical" . SPARSER::MOLECULE)
    ("neither CDC25A nor CDC25C" . SPARSER::COLLECTION)
    ("CDC2/cyclin" . SPARSER::COLLECTION)
    ("silymarin and silibinin" . SPARSER::COLLECTION)
    ("furan" . SPARSER::MOLECULE) ("benzoyl" . SPARSER::MOLECULE)
    ("silibinin" . SPARSER::DRUG) ("silymarin" . SPARSER::DRUG)
    ("Examples" . SPARSER::EXAMPLE) ("Thr" . SPARSER::AMINO-ACID)
    ("Tyr" . SPARSER::AMINO-ACID) ("CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("CDC25A, CDC25B, and CDC265C" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN)
    ("CDKs or cell cycle protein kinases" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN) ("drugs" . SPARSER::DRUG)
    ("kinases" . SPARSER::KINASE) ("phosphatases" . SPARSER::PHOSPHATASE)
    ("inhibitors" . SPARSER::INHIBITOR) ("proteins" . SPARSER::PROTEIN)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("regulators" . SPARSER::REGULATOR)
    ("form various cyclin-CDK heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION) ("kinase" . SPARSER::KINASE)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKs" . SPARSER::PROTEIN)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type" . TYPE)
    ("drug" . SPARSER::DRUG) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK" . SPARSER::PROTEIN) ("UCN-01" . SPARSER::DRUG)
    ("7-hydroxystaurosporine" . SPARSER::DRUG) ("p57 Kip2" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("waf1" . SPARSER::PROTEIN)
    ("p19 ink4d" . SPARSER::PROTEIN) ("ink4c" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("p15 ink4b" . SPARSER::PROTEIN)
    ("p16 ink4a" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Annexin V" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("anti-β" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG) ("anti-" . SPARSER::ANTIBODY)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("sodium bicarbonate" . SPARSER::DRUG)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDC2" . SPARSER::PROTEIN) ("SB 239063" . SPARSER::MOLECULE)
    ("G 2 /M" . SPARSER::PROTEIN) ("CDC-2" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDC25B" . SPARSER::PROTEIN)
    ("FK-3000" . SPARSER::DRUG)
    ("prediabetic and diabetic states" . SPARSER::BIO-STATE)
    ("San" . SPARSER::PROTEIN) ("Prism" . SPARSER::PROTEIN)
    ("TX" . SPARSER::PROTEIN)
    ("A horseradish peroxidase (HRP)-conjugated secondary antibody"
     . SPARSER::PROTEIN)
    ("peroxidase (HRP)" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("active" . SPARSER::ACTIVE)
    ("-GTCACAGTGACTCAGCAGAATCTG-3" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("Protein" . SPARSER::PROTEIN)
    ("naphthalene" . SPARSER::MOLECULE) ("mixture" . SPARSER::MOLECULE)
    ("reagent" . SPARSER::MOLECULE) ("oxidase" . SPARSER::PROTEIN)
    ("xanthine" . SPARSER::MOLECULE) ("GPx or GR" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("substrate" . SPARSER::SUBSTRATE)
    ("DTNB" . SPARSER::PROTEIN) ("bis" . SPARSER::PROTEIN)
    ("dithio" . SPARSER::MOLECULE) ("hydrazine" . SPARSER::DRUG)
    ("VA" . SPARSER::MOLECULE)
    ("MDA, GSH, GPx, GR and SOD-1" . SPARSER::COLLECTION)
    ("Active" . SPARSER::ACTIVE) ("fraction" . SPARSER::COMPONENT)
    ("solution" . SPARSER::MOLECULE)
    ("GSH and activity of GPx and GR" . SPARSER::COLLECTION)
    ("MDA and GSH" . SPARSER::COLLECTION) ("EDTA-blood" . SPARSER::MOLECULE)
    ("EDTA" . SPARSER::MOLECULE) ("types" . TYPE)
    ("FPG and HbA1c" . SPARSER::COLLECTION) ("los" . SPARSER::MOLECULE)
    ("state" . SPARSER::BIO-STATE) ("target" . SPARSER::TARGET-PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("most severe hyperglycemic states" . SPARSER::BIO-STATE)
    ("receive either curcumin" . SPARSER::DRUG)
    ("activator" . SPARSER::ACTIVATOR) ("curcumin" . SPARSER::DRUG)
    ("agonists" . SPARSER::AGONIST) ("catalase and GPx" . SPARSER::COLLECTION)
    ("catalase" . SPARSER::PROTEIN)
    ("the major antioxidant" . SPARSER::PROTEIN)
    ("both exogenous and endogenous antioxidants" . SPARSER::DRUG)
    ("antioxidants" . SPARSER::DRUG)
    ("sulfonylureas and biguanides" . SPARSER::COLLECTION)
    ("biguanides" . SPARSER::MOLECULE) ("sulfonylureas" . SPARSER::MOLECULE)
    ("ADA" . SPARSER::PROTEIN) ("enzyme" . SPARSER::ENZYME)
    ("GSH and GSH" . SPARSER::COLLECTION)
    ("GSH and lipid peroxidation" . SPARSER::COLLECTION) ("DNA" . SPARSER::DNA)
    ("guanosine" . SPARSER::MOLECULE) ("ABTS" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("glucose and HbA1c" . SPARSER::COLLECTION)
    ("DM2-NC and DM2-C" . SPARSER::COLLECTION)
    ("CTRL and PRE" . SPARSER::COLLECTION) ("GPx and GR" . SPARSER::COLLECTION)
    ("GSSG" . SPARSER::DRUG) ("disulfide" . SPARSER::MOLECULE)
    ("CTRL and DM2-C" . SPARSER::COLLECTION) ("form" . SPARSER::FORM)
    ("diphenyl" . SPARSER::DRUG) ("-1" . SPARSER::PROTEIN)
    ("NC" . SPARSER::PROTEIN)
    ("triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C)"
     . SPARSER::COLLECTION)
    ("TG" . SPARSER::PROTEIN) ("triglycerides" . SPARSER::MOLECULE)
    ("DBP" . SPARSER::PROTEIN) ("SBP" . SPARSER::PROTEIN)
    ("group" . SPARSER::MOLECULE) ("HOMA-IR" . SPARSER::COLLECTION)
    ("IR" . SPARSER::PROTEIN) ("lipid" . SPARSER::LIPID)
    ("CTRL" . SPARSER::PROTEIN) ("ligase (GCL)" . SPARSER::LIGASE)
    ("superoxide" . SPARSER::MOLECULE) ("GR" . SPARSER::PROTEIN)
    ("GPx" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("promoter" . SPARSER::PROMOTER) ("complex" . SPARSER::BIO-COMPLEX)
    ("Kelch-like ECH-associated inhibitor 1" . SPARSER::PROTEIN)
    ("inhibitor" . SPARSER::INHIBITOR) ("protein" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("regulator" . SPARSER::REGULATOR)
    ("gene" . SPARSER::GENE) ("hyperglycemia" . SPARSER::PROTEIN)
    ("ROS" . SPARSER::PROTEIN) ("oxygen" . SPARSER::MOLECULE)
    ("prediabetic states" . SPARSER::BIO-STATE) ("states" . SPARSER::BIO-STATE)
    ("hemoglobin" . SPARSER::MOLECULE) ("dL" . SPARSER::MOLECULE)
    ("FPG" . SPARSER::PROTEIN-FAMILY) ("glucose" . SPARSER::PROTEIN)
    ("MDA and superoxide dismutase activity" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("cysteine" . SPARSER::AMINO-ACID)
    ("fractions" . SPARSER::COMPONENT)
    ("glutathione (GSH) and malondialdehyde (MDA) content"
     . SPARSER::COLLECTION)
    ("186 diabetic type 2" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("MDA" . SPARSER::DRUG) ("malondialdehyde" . SPARSER::MOLECULE)
    ("GSH" . SPARSER::DRUG) ("glutathione" . SPARSER::DRUG)
    ("antioxidant" . SPARSER::PROTEIN) ("redox" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE) ("H 2 O 2" . SPARSER::DRUG)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("glutathione S -transferase A1" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("HDL-C" . SPARSER::PROTEIN)
    ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("SOD-1" . SPARSER::PROTEIN) ("glutathione reductase" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Keap1" . SPARSER::PROTEIN) ("inhibitor 1" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("superoxide anions" . SPARSER::MOLECULE) ("HbA1" . SPARSER::PROTEIN)
    ("superoxide dismutase activity" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor-2" . SPARSER::PROTEIN)))